<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7767343</article-id><article-id pub-id-type="doi">10.3390/md18120657</article-id><article-id pub-id-type="publisher-id">marinedrugs-18-00657</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Bioactive Compounds from Marine Heterobranchs</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5489-8376</contrib-id><name><surname>Avila</surname><given-names>Conxita</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-18-00657">1</xref><xref rid="c1-marinedrugs-18-00657" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9028-274X</contrib-id><name><surname>Angulo-Preckler</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-18-00657">1</xref><xref ref-type="aff" rid="af2-marinedrugs-18-00657">2</xref></contrib></contrib-group><aff id="af1-marinedrugs-18-00657"><label>1</label>Department of Evolutionary Biology, Ecology, and Environmental Sciences, Biodiversity Research Institute (IrBIO), Faculty of Biology, University of Barcelona, Av. Diagonal 643, 08028 Barcelona, Catalonia, Spain; <email>carlos.a.preckler@uit.no</email></aff><aff id="af2-marinedrugs-18-00657"><label>2</label>Norwegian College of Fishery Science, UiT The Arctic University of Norway, Hansine Hansens veg 18, 9019 Troms&#x000f8;, Norway</aff><author-notes><corresp id="c1-marinedrugs-18-00657"><label>*</label>Correspondence: <email>conxita.avila@ub.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>18</volume><issue>12</issue><elocation-id>657</elocation-id><history><date date-type="received"><day>21</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>07</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The natural products of heterobranch molluscs display a huge variability both in structure and in their bioactivity. Despite the considerable lack of information, it can be observed from the recent literature that this group of animals possesses an astonishing arsenal of molecules from different origins that provide the molluscs with potent chemicals that are ecologically and pharmacologically relevant. In this review, we analyze the bioactivity of more than 450 compounds from ca. 400 species of heterobranch molluscs that are useful for the snails to protect themselves in different ways and/or that may be useful to us because of their pharmacological activities. Their ecological activities include predator avoidance, toxicity, antimicrobials, antifouling, trail-following and alarm pheromones, sunscreens and UV protection, tissue regeneration, and others. The most studied ecological activity is predation avoidance, followed by toxicity. Their pharmacological activities consist of cytotoxicity and antitumoral activity; antibiotic, antiparasitic, antiviral, and anti-inflammatory activity; and activity against neurodegenerative diseases and others. The most studied pharmacological activities are cytotoxicity and anticancer activities, followed by antibiotic activity. Overall, it can be observed that heterobranch molluscs are extremely interesting in regard to the study of marine natural products in terms of both chemical ecology and biotechnology studies, providing many leads for further detailed research in these fields in the near future.</p></abstract><kwd-group><kwd>marine natural products</kwd><kwd>Mollusca</kwd><kwd>Gastropoda</kwd><kwd>chemical ecology</kwd></kwd-group></article-meta></front><body><sec id="sec1-marinedrugs-18-00657"><title>1. Background</title><p>Marine heterobranch molluscs are a well-known source of marine natural products (MNPs) that have been studied in depth over the years [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B3-marinedrugs-18-00657" ref-type="bibr">3</xref>]. MNPs from heterobranchs show an amazing structural diversity and display a wide variety of biological activities, as reported in previous reviews [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B3-marinedrugs-18-00657" ref-type="bibr">3</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>]. In general, MNPs have been demonstrated to be crucial in many ecological interactions among marine organisms, regulating several aspects of reproduction, development, settlement, growth, defense, and others [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B5-marinedrugs-18-00657" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>,<xref rid="B7-marinedrugs-18-00657" ref-type="bibr">7</xref>]. Some general reviews have reported a significant amount of detailed information on the structure of MNPs, marine chemical ecology, and marine chemistry, or have analyzed some particular mollusc compounds [<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>,<xref rid="B8-marinedrugs-18-00657" ref-type="bibr">8</xref>,<xref rid="B9-marinedrugs-18-00657" ref-type="bibr">9</xref>,<xref rid="B10-marinedrugs-18-00657" ref-type="bibr">10</xref>,<xref rid="B11-marinedrugs-18-00657" ref-type="bibr">11</xref>,<xref rid="B12-marinedrugs-18-00657" ref-type="bibr">12</xref>,<xref rid="B13-marinedrugs-18-00657" ref-type="bibr">13</xref>,<xref rid="B14-marinedrugs-18-00657" ref-type="bibr">14</xref>,<xref rid="B15-marinedrugs-18-00657" ref-type="bibr">15</xref>,<xref rid="B16-marinedrugs-18-00657" ref-type="bibr">16</xref>,<xref rid="B17-marinedrugs-18-00657" ref-type="bibr">17</xref>,<xref rid="B18-marinedrugs-18-00657" ref-type="bibr">18</xref>]. The yearly reports by Blunt and collaborators [<xref rid="B5-marinedrugs-18-00657" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>] have provided very accurate information on new marine natural products. Previous reviews have also dealt with the different chemical structures found in heterobranchs, the origin and anatomical allocation of their compounds, their biosynthesis, biogeography, and their evolutionary patterns [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B19-marinedrugs-18-00657" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-18-00657" ref-type="bibr">20</xref>,<xref rid="B21-marinedrugs-18-00657" ref-type="bibr">21</xref>,<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B23-marinedrugs-18-00657" ref-type="bibr">23</xref>,<xref rid="B24-marinedrugs-18-00657" ref-type="bibr">24</xref>,<xref rid="B25-marinedrugs-18-00657" ref-type="bibr">25</xref>,<xref rid="B26-marinedrugs-18-00657" ref-type="bibr">26</xref>,<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-18-00657" ref-type="bibr">28</xref>,<xref rid="B29-marinedrugs-18-00657" ref-type="bibr">29</xref>]. Therefore, all of these topics will not be considered again here.</p><p>Furthermore, MNPs have been described to be potentially useful as drugs, and some of them are already available on the market [<xref rid="B7-marinedrugs-18-00657" ref-type="bibr">7</xref>,<xref rid="B8-marinedrugs-18-00657" ref-type="bibr">8</xref>,<xref rid="B10-marinedrugs-18-00657" ref-type="bibr">10</xref>,<xref rid="B12-marinedrugs-18-00657" ref-type="bibr">12</xref>,<xref rid="B30-marinedrugs-18-00657" ref-type="bibr">30</xref>,<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B32-marinedrugs-18-00657" ref-type="bibr">32</xref>,<xref rid="B33-marinedrugs-18-00657" ref-type="bibr">33</xref>]. Remarkably, many MNPs possess unique chemical structures that are totally absent in terrestrial or freshwater environments [<xref rid="B32-marinedrugs-18-00657" ref-type="bibr">32</xref>,<xref rid="B34-marinedrugs-18-00657" ref-type="bibr">34</xref>,<xref rid="B35-marinedrugs-18-00657" ref-type="bibr">35</xref>,<xref rid="B36-marinedrugs-18-00657" ref-type="bibr">36</xref>,<xref rid="B37-marinedrugs-18-00657" ref-type="bibr">37</xref>]. Five drugs, at least, have been isolated from marine invertebrates and are approved for different (mostly anticancer) purposes, including cytarabine (Ara-C), eribulin mesylate, ziconotide, brentuximab vedotin, and trabectedin, obtained from two sponges, two molluscs, and a tunicate, respectively [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B33-marinedrugs-18-00657" ref-type="bibr">33</xref>,<xref rid="B38-marinedrugs-18-00657" ref-type="bibr">38</xref>]. These molecules include very different chemical structures, from nucleosides to peptides, alkaloids, macrolides, and antibody&#x02013;drug conjugates (ADCs). Many other compounds are currently in phase III, phase II, and phase I clinical trials, including several heterobranch compounds, and could soon be on the market [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>]. Moreover, many studies deal with MNPs bioactivity, mechanisms of action, virtual screening, synthesis, derivatives, ADMET (absorption, distribution, metabolism, excretion, and toxicity), and others in an attempt to increase the chances of finding new useful drugs [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B32-marinedrugs-18-00657" ref-type="bibr">32</xref>,<xref rid="B33-marinedrugs-18-00657" ref-type="bibr">33</xref>,<xref rid="B34-marinedrugs-18-00657" ref-type="bibr">34</xref>,<xref rid="B35-marinedrugs-18-00657" ref-type="bibr">35</xref>,<xref rid="B36-marinedrugs-18-00657" ref-type="bibr">36</xref>,<xref rid="B37-marinedrugs-18-00657" ref-type="bibr">37</xref>,<xref rid="B38-marinedrugs-18-00657" ref-type="bibr">38</xref>,<xref rid="B39-marinedrugs-18-00657" ref-type="bibr">39</xref>,<xref rid="B40-marinedrugs-18-00657" ref-type="bibr">40</xref>,<xref rid="B41-marinedrugs-18-00657" ref-type="bibr">41</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>]. Some databases are also very good tools to search the details of MNPs described to date, such as MarinLit (<uri xlink:href="http://pubs.rsc.org/marinlit/">http://pubs.rsc.org/marinlit/</uri>). In cancer research, for example, NPs are considered very relevant as potential drug leads, and approximately 80% of the approved chemotherapeutic drugs and more than 50% of all drugs are based on bioactive natural products, while almost 90% of human diseases are treated with natural products or their derivatives [<xref rid="B39-marinedrugs-18-00657" ref-type="bibr">39</xref>,<xref rid="B40-marinedrugs-18-00657" ref-type="bibr">40</xref>,<xref rid="B41-marinedrugs-18-00657" ref-type="bibr">41</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>]. Thus, many MNPs are being tested as antitumor agents because of their potent growth inhibition against human tumor cells, both in vitro and in vivo in murine models (and others), as well as in cancer clinical trials [<xref rid="B39-marinedrugs-18-00657" ref-type="bibr">39</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>].</p><p>In fact, marine organisms are still considered an underexplored source of NPs, displaying specific biological activities, with biomedically interesting applications to be potentially used as drugs [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B5-marinedrugs-18-00657" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>,<xref rid="B8-marinedrugs-18-00657" ref-type="bibr">8</xref>,<xref rid="B10-marinedrugs-18-00657" ref-type="bibr">10</xref>,<xref rid="B29-marinedrugs-18-00657" ref-type="bibr">29</xref>,<xref rid="B30-marinedrugs-18-00657" ref-type="bibr">30</xref>,<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B44-marinedrugs-18-00657" ref-type="bibr">44</xref>]. Many compounds found in heterobranchs are also promising drugs and are being tested under clinical trials [<xref rid="B36-marinedrugs-18-00657" ref-type="bibr">36</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>,<xref rid="B45-marinedrugs-18-00657" ref-type="bibr">45</xref>,<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>]. However, as far as we know, there has not yet been a comprehensive published review on the bioactivity of MNPs from heterobranch molluscs, despite the fact that this is one of the most chemodiverse invertebrate groups [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>]. For this reason, we summarize here all the ecological and pharmacological activities reported in heterobranch molluscs, trying to emphasize in the assays carried out, whether they are or not ecologically and biomedically significant, and their potential interest, since it seemed timely and necessary now. As previously mentioned, this review does not cover other ecological or evolutionary aspects that are already covered in previous reviews [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>], nor the chemical synthesis of the MNPs. The aim of this review is, therefore, to showcase the main ecological and pharmacological bioactivities of the chemical compounds found in heterobranch molluscs, describing in which groups they are found and their particular bioactivities with all of the information we have been able to compile up to June 2020. </p><p>Heterobranch molluscs are soft-bodied and mostly shell-less animals that live all around the planet at all latitudes and depths [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. These animals are often protected by chemical strategies, although they may also present behavioral and/or morphological strategies to combine them with [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>]. As a result of the most recent evolutionary, phylogenetic, and taxonomical studies on the group, heterobranch gastropods now comprise the classical &#x0201c;Opisthobranchia&#x0201d; and the marine &#x0201c;Pulmonata&#x0201d; together with several other groups, reaching a total of more than 33,000 species, although the most well-known groups account for only ca. 9000 species [<xref rid="B47-marinedrugs-18-00657" ref-type="bibr">47</xref>,<xref rid="B48-marinedrugs-18-00657" ref-type="bibr">48</xref>,<xref rid="B49-marinedrugs-18-00657" ref-type="bibr">49</xref>,<xref rid="B50-marinedrugs-18-00657" ref-type="bibr">50</xref>,<xref rid="B51-marinedrugs-18-00657" ref-type="bibr">51</xref>]. Among these, only about 400 species have been chemically analyzed, and, therefore, a lot of compounds remain to be potentially discovered [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B5-marinedrugs-18-00657" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>,<xref rid="B52-marinedrugs-18-00657" ref-type="bibr">52</xref>]. Among the chemically studied heterobranch species, a wide variety of compounds has been described, many of them being bioactive at the ecological and/or pharmacological level [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B8-marinedrugs-18-00657" ref-type="bibr">8</xref>]. At the ecological level, some NPs are used for protection against potential predators and competitors, enhancing their ecological performance, while others may have a role in their reproduction, development, growth, and feeding behavior [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B8-marinedrugs-18-00657" ref-type="bibr">8</xref>]. In heterobranch molluscs, NPs may be de novo biosynthesized by the animals, obtained from their diet (biotransformed or not), or perhaps even produced by symbionts [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. In any case, all of them are considered in this review because they are found in and used by the molluscs.</p><p>This review analyzes the bioactive compounds by activity (ecological and pharmacological, and different subtopics within them) and by taxonomical groups. Heterobranchs classically include eight major taxa: Nudibranchia, Pleurobranchoidea (or Pleurobranchida), Tylodinoidea (or Umbraculida), Cephalaspidea, Anaspidea (or Aplysiida), Pteropoda, Sacoglossa, and Pulmonata (<xref rid="marinedrugs-18-00657-t001" ref-type="table">Table 1</xref>) [<xref rid="B47-marinedrugs-18-00657" ref-type="bibr">47</xref>,<xref rid="B48-marinedrugs-18-00657" ref-type="bibr">48</xref>,<xref rid="B49-marinedrugs-18-00657" ref-type="bibr">49</xref>,<xref rid="B50-marinedrugs-18-00657" ref-type="bibr">50</xref>]. All of these taxa have different morphological and anatomical characteristics; different diet, behavioral, and ecological traits; and different chemical strategies [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Nudibranchs (sea slugs) are carnivorous and comprise Doridacea, Dendronotida, Euarminida, and Aeolidida, and are considered the most diverse group, with Doridacea feeding on porifera (sponges), bryozoans, tunicates, or other &#x0201c;opisthobranchs&#x0201d;, Dendronotids prey on cnidarians (usually octocorals or hydrozoans) or some small animals (crustaceans or turbellarians), Euarminida feed on octocoral cnidarians or bryozoans, and Aeolidida are mainly cnidarian feeders [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>]. All of them lack a shell in adult stage, and they possess interesting chemistry that may be de novo biosynthesized or obtained from their diet of the above-mentioned prey [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Pleurobranchoidea (side-gill slugs) are usually ascidian feeders or generalist scavengers, while Tylodinoidea (false limpets) feed on sponges, and Cephalaspidea (head-shielded slugs and snails) may be algal feeders or voracious predators of other animals (other &#x0201c;opisthobranchs&#x0201d;, including other cephalaspideans), sponges, annelids, and others [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>]. Anaspideans (sea hares) are herbivorous, feeding on different kinds of algae, but also on sea grasses, or even cyanobacteria. On the other hand, pelagic Pteropods (sea angels) are planktonic and feed on phytoplankton or other pteropods, while Sacoglossans and Pulmonates are herbivorous that feed on different types of algae [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>].</p></sec><sec id="sec2-marinedrugs-18-00657"><title>2. Ecological Activity</title><sec id="sec2dot1-marinedrugs-18-00657"><title>2.1. Predation</title><p>Heterobranch mollusc are protected against predation by a vast array of defensive strategies, many of which are combined with or include the use of natural products (<xref ref-type="fig" rid="marinedrugs-18-00657-f001">Figure 1</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f002">Figure 2</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f003">Figure 3</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f004">Figure 4</xref> and <xref ref-type="fig" rid="marinedrugs-18-00657-f005">Figure 5</xref>) [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. These chemical strategies may, in fact, be useful against many different kinds of predators, which can usually be grouped into three main types: fish, crabs, and sea stars, although other potential predators, such as anemones, sea spiders, etc., have also been reported (<xref rid="marinedrugs-18-00657-t002" ref-type="table">Table 2</xref>) [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Whether defensive strategies used against one predator are also effective against another potential predator is seldom reported in the literature. Furthermore, when laboratory assays are carried out using non-sympatric potential predators, the presumed ecological roles become highly speculative, because laboratory results cannot and should not be directly extrapolated to the field. The possibility that chemical compounds are used in the field against a wider range of predators than those usually tested in the laboratory remains to be proven in most cases [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. In general, as reported below, very few studies have been conducted in the field against sympatric predators, and, thus, the ecological role of NPs in the field should be carefully considered.</p><sec id="sec2dot1dot1-marinedrugs-18-00657"><title>2.1.1. Nudibranchia</title><sec><title>Doridacea</title><p>This is the most studied group of heterobranchs regarding compounds against predation (<xref ref-type="fig" rid="marinedrugs-18-00657-f001">Figure 1</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f002">Figure 2</xref> and <xref ref-type="fig" rid="marinedrugs-18-00657-f003">Figure 3</xref>). Even the most basal species are protected against potential predators, such as the Antarctic <italic>Bathydoris hodgsoni</italic> [<xref rid="B53-marinedrugs-18-00657" ref-type="bibr">53</xref>,<xref rid="B54-marinedrugs-18-00657" ref-type="bibr">54</xref>]. This large slug presents the drimane sesquiterpene hodgsonal (<bold>1</bold>), which is located in its mantle and dorsal papillae, and which is suggested to be de novo biosynthesized. Hodgsonal (<bold>1</bold>) was the first described 2-substituted drimane sesquiterpene from a marine organism [<xref rid="B55-marinedrugs-18-00657" ref-type="bibr">55</xref>,<xref rid="B56-marinedrugs-18-00657" ref-type="bibr">56</xref>]. While <italic>B. hodgsoni</italic> is chemically protected against sympatric predators, such as the sea star <italic>Odontaster validus</italic> and the anemone <italic>Epiactis</italic> sp., its egg masses seem to rely only on physical defenses [<xref rid="B54-marinedrugs-18-00657" ref-type="bibr">54</xref>,<xref rid="B57-marinedrugs-18-00657" ref-type="bibr">57</xref>]. The related Antarctic species, <italic>Prodoris (Bathydoris) clavigera</italic> also possesses chemical defenses against <italic>O. validus</italic>, but the compounds behind this activity have not been yet described (C Avila and K Iken, unpublished results; [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]).</p><p>The most studied group within Doridacea are the Doridoidei, comprising the well-known dorids, phyllids, and chromodorids, among others. The Antarctic <italic>Doris (Austrodoris) kerguelenensis</italic> possesses a series of diterpene diacylglycerides (<bold>2</bold>) along with monoacylglycerides, and monoacylglycerides of regular fatty acids, which are located in the mantle and deter sympatric predators, such as sea stars (<italic>O. validus</italic>) and anemones (<italic>Epiactis</italic> sp.) [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B58-marinedrugs-18-00657" ref-type="bibr">58</xref>,<xref rid="B59-marinedrugs-18-00657" ref-type="bibr">59</xref>,<xref rid="B60-marinedrugs-18-00657" ref-type="bibr">60</xref>,<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>]. This slug possesses many other molecules that may not be involved in defense against predators, including additional diterpene glycerides with different skeletons, such as <italic>ent</italic>-labdane, labdane, halimane, clerodane, and isocopalane diterpenes, as well as norsesquiterpenes [<xref rid="B18-marinedrugs-18-00657" ref-type="bibr">18</xref>,<xref rid="B58-marinedrugs-18-00657" ref-type="bibr">58</xref>,<xref rid="B59-marinedrugs-18-00657" ref-type="bibr">59</xref>,<xref rid="B62-marinedrugs-18-00657" ref-type="bibr">62</xref>,<xref rid="B63-marinedrugs-18-00657" ref-type="bibr">63</xref>,<xref rid="B64-marinedrugs-18-00657" ref-type="bibr">64</xref>,<xref rid="B65-marinedrugs-18-00657" ref-type="bibr">65</xref>,<xref rid="B66-marinedrugs-18-00657" ref-type="bibr">66</xref>,<xref rid="B67-marinedrugs-18-00657" ref-type="bibr">67</xref>]. Cryptic speciation has been reported in <italic>D. kerguelenensis,</italic> and this could be behind their chemical variability, even at the intrapopulation level, as well as perhaps the presence of different terpene synthase variants involved in their de novo biosynthesis [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B67-marinedrugs-18-00657" ref-type="bibr">67</xref>,<xref rid="B68-marinedrugs-18-00657" ref-type="bibr">68</xref>,<xref rid="B69-marinedrugs-18-00657" ref-type="bibr">69</xref>,<xref rid="B70-marinedrugs-18-00657" ref-type="bibr">70</xref>]. Since these compounds occur in complex mixtures in the slug, it seems difficult to trace the bioactivity to the individual compounds. <italic>Doris</italic> (<italic>Archidoris)</italic> species also present similar glycerid compounds [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B71-marinedrugs-18-00657" ref-type="bibr">71</xref>].</p><p>Several species have been reported to use steroids against potential predators. This is the case of <italic>Aldisa sanguinea</italic>, and perhaps also the Brazilian <italic>Doris</italic> aff. <italic>verrucosa</italic> [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B72-marinedrugs-18-00657" ref-type="bibr">72</xref>]. The steroidal acids, 3-oxo-chol-4-ene-24-oic acid (<bold>3</bold>) and its unsaturated analogue (<bold>4</bold>) were reported from <italic>Aldisa sanguinea</italic> (<italic>A. cooperi</italic>), probably originated from some related inactive compounds from its diet of the sponge <italic>Anthoarcuata graceae</italic> [<xref rid="B73-marinedrugs-18-00657" ref-type="bibr">73</xref>]. The 3-oxo-chol-4-ene-24-oic acid (<bold>3</bold>) deterred feeding in the common freshwater goldfish (<italic>Carassius auratus</italic>) in laboratory assays [<xref rid="B73-marinedrugs-18-00657" ref-type="bibr">73</xref>]. Similarly, a progesterone homologue was found in the mantle of <italic>Aldisa smaragdina</italic> from Spain [<xref rid="B74-marinedrugs-18-00657" ref-type="bibr">74</xref>]. Another species<italic>, A. andersoni</italic> from India, is protected against predators by two phorboxazoles, 9-chloro-phorbazole D (<bold>5</bold>) and <italic>N</italic>1-methyl-phorbazole A (<bold>6</bold>), and the phorbazoles A (<bold>7</bold>), B (<bold>8</bold>), and D (<bold>9</bold>) located in their mantle and viscera [<xref rid="B55-marinedrugs-18-00657" ref-type="bibr">55</xref>,<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-18-00657" ref-type="bibr">76</xref>]. The phorbazoles are chlorinated phenyl-pyrrolyloxazoles that were previously found in the sponge <italic>Phorbas</italic> aff. <italic>clathrata</italic>, and, therefore, a dietary origin from a sponge has been suggested [<xref rid="B55-marinedrugs-18-00657" ref-type="bibr">55</xref>,<xref rid="B56-marinedrugs-18-00657" ref-type="bibr">56</xref>,<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-18-00657" ref-type="bibr">76</xref>]. The two phorboxazoles (<bold>5,6</bold>) and phorbazole A (<bold>7</bold>) were tested in the laboratory at 1 mg/mL against the shrimp <italic>Palaemon elegans</italic> and showed to be deterrent, although they were not in their natural concentration [<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>,<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>].</p><p>The Pacific slug <italic>Sclerodoris tanya</italic> presents the sesquiterpene glyceride esters tanyolides A (<bold>10</bold>) and B (<bold>11</bold>) in its mantle, reported to be effective deterrents against sympatric fish predators, such as <italic>Gibbonsia elegans</italic> and <italic>Paraclinus integrippinis</italic> at 1 mg/pellet [<xref rid="B78-marinedrugs-18-00657" ref-type="bibr">78</xref>]. The Mediterranean <italic>Paradoris (Discodoris) indecora</italic> incorporates furanosesterterpenes, including variabilin (<bold>12</bold>), from its sponge preys <italic>Ircinia variabilis</italic> and <italic>I. fasciculata</italic> [<xref rid="B79-marinedrugs-18-00657" ref-type="bibr">79</xref>] as deterrents against fish predation [<xref rid="B79-marinedrugs-18-00657" ref-type="bibr">79</xref>]. Variabilin (<bold>12</bold>) was tested in the laboratory at 300 &#x003bc;g/cm<sup>2</sup> against freshwater and marine fishes [<xref rid="B79-marinedrugs-18-00657" ref-type="bibr">79</xref>].</p><p><italic>Dendrodoris</italic> species are well studied, with polygodial (<bold>13</bold>) from <italic>D. limbata</italic> being the first example of de novo biosynthesis in nudibranchs [<xref rid="B80-marinedrugs-18-00657" ref-type="bibr">80</xref>,<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>]. Polygodial (<bold>13</bold>), a drimane sesquiterpene, was first described in plants, where it is a deterrent against herbivores [<xref rid="B82-marinedrugs-18-00657" ref-type="bibr">82</xref>], and it is a deterrent in the slug against predation by marine and freshwater fish [<xref rid="B80-marinedrugs-18-00657" ref-type="bibr">80</xref>]. Polygodial (<bold>13</bold>) was found to be transformed from olepupuane (<bold>14</bold>) once secreted from the mantle cells, since it is not present in vivo in the slug tissues [<xref rid="B80-marinedrugs-18-00657" ref-type="bibr">80</xref>,<xref rid="B83-marinedrugs-18-00657" ref-type="bibr">83</xref>,<xref rid="B84-marinedrugs-18-00657" ref-type="bibr">84</xref>]. Furthermore, some fatty acid-esterified sesquiterpenoids were also found in <italic>D. limbata</italic>, and later in other species, generally found in the reproductive organs and egg masses and possibly with other functions, or perhaps just being stored as putative precursors of polygodial (<bold>13</bold>) [<xref rid="B85-marinedrugs-18-00657" ref-type="bibr">85</xref>]. Further studies with many other <italic>Dendrodoris</italic> species around the planet have yielded similar drimane sesquiterpenes located in the mantle, such as in <italic>D. arborescens</italic>, <italic>D. carbunculosa</italic>, <italic>D. denisoni, D. grandiflora</italic>, <italic>D. carbunculosa</italic>, <italic>D. krebsii, D. nigra</italic>, and <italic>D. tuberculosa</italic>, which are suggested to be used as feeding deterrents against predators [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B86-marinedrugs-18-00657" ref-type="bibr">86</xref>,<xref rid="B87-marinedrugs-18-00657" ref-type="bibr">87</xref>,<xref rid="B88-marinedrugs-18-00657" ref-type="bibr">88</xref>,<xref rid="B89-marinedrugs-18-00657" ref-type="bibr">89</xref>,<xref rid="B90-marinedrugs-18-00657" ref-type="bibr">90</xref>,<xref rid="B91-marinedrugs-18-00657" ref-type="bibr">91</xref>,<xref rid="B92-marinedrugs-18-00657" ref-type="bibr">92</xref>,<xref rid="B93-marinedrugs-18-00657" ref-type="bibr">93</xref>,<xref rid="B94-marinedrugs-18-00657" ref-type="bibr">94</xref>]. In particular, <italic>D. arborescens</italic> presents 7-deacetoxyolepupuane (<bold>15</bold>) [<xref rid="B87-marinedrugs-18-00657" ref-type="bibr">87</xref>], <italic>D. carbunculosa</italic> possesses dendrocarbins A&#x02013;N (<bold>16</bold>) [<xref rid="B86-marinedrugs-18-00657" ref-type="bibr">86</xref>], <italic>D. krebsi</italic> also has drimane sesquiterpenes and esters [<xref rid="B89-marinedrugs-18-00657" ref-type="bibr">89</xref>,<xref rid="B90-marinedrugs-18-00657" ref-type="bibr">90</xref>], and <italic>D. denisoni</italic> has cinnamolide (<bold>17</bold>), olepupuane (<bold>14</bold>), and polygodial (<bold>13</bold>) in its mantle [<xref rid="B88-marinedrugs-18-00657" ref-type="bibr">88</xref>].</p><p><italic>Doriopsilla</italic> species also present similar metabolites to the related genus <italic>Dendrodoris</italic>. The Atlantic <italic>Doriopsilla pelseneeri</italic> presents the furanosesquiterpene alcohols pelseneeriols-1 and -2 (<bold>18</bold>) in the mantle [<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B85-marinedrugs-18-00657" ref-type="bibr">85</xref>,<xref rid="B95-marinedrugs-18-00657" ref-type="bibr">95</xref>,<xref rid="B96-marinedrugs-18-00657" ref-type="bibr">96</xref>,<xref rid="B97-marinedrugs-18-00657" ref-type="bibr">97</xref>]. <italic>D. albopunctata</italic> and <italic>D. areolata</italic> also have drimane sesquiterpenes and <italic>ent</italic>-pallescensin A (<bold>19</bold>) [<xref rid="B89-marinedrugs-18-00657" ref-type="bibr">89</xref>]. Other <italic>Doriopsilla</italic> species studied possess also drimane sesquiterpenoids and sesquiterpenoids with the <italic>ent</italic>-pallescensin A (<bold>19</bold>) skeleton in the mantle, including <italic>D. janaina</italic> and <italic>D. pharpa</italic> [<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B89-marinedrugs-18-00657" ref-type="bibr">89</xref>,<xref rid="B95-marinedrugs-18-00657" ref-type="bibr">95</xref>,<xref rid="B96-marinedrugs-18-00657" ref-type="bibr">96</xref>,<xref rid="B97-marinedrugs-18-00657" ref-type="bibr">97</xref>,<xref rid="B98-marinedrugs-18-00657" ref-type="bibr">98</xref>]. These natural products are de novo biosynthesized by the slugs, such as 15-acetoxy-<italic>ent</italic>-pallescensin (<bold>20</bold>) via the mevalonic pathway in <italic>D. areolata</italic> and <italic>Doriopsilla</italic> sp. [<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B96-marinedrugs-18-00657" ref-type="bibr">96</xref>,<xref rid="B97-marinedrugs-18-00657" ref-type="bibr">97</xref>,<xref rid="B99-marinedrugs-18-00657" ref-type="bibr">99</xref>]. It has been suggested that these compounds are used for defense against predators, but very few assays have been reported [<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B96-marinedrugs-18-00657" ref-type="bibr">96</xref>]. These include only the extracts of <italic>D. pharpa</italic> presenting polygodial (<bold>13</bold>), which deter feeding of the blenny fish <italic>Chasmodes bosquianus</italic> and the mummichog fish <italic>Fundulus heteroclitus</italic>, which even learned to avoid food items with extracts of slugs, and also deter the crabs <italic>Callinectes similus</italic> and <italic>Panopeus herbstii</italic> in the field [<xref rid="B98-marinedrugs-18-00657" ref-type="bibr">98</xref>].</p><p>The group of phyllidids has also been well studied over the last years [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>]. These are usually brightly colored tropical animals, very specious, and quite similar in their external morphology, which has often resulted in some misidentifications [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>,<xref rid="B100-marinedrugs-18-00657" ref-type="bibr">100</xref>]. These slugs are characterized by presenting isocyanate compounds that display a wide array of activities, apart from avoiding predation (see below) [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B104-marinedrugs-18-00657" ref-type="bibr">104</xref>,<xref rid="B105-marinedrugs-18-00657" ref-type="bibr">105</xref>]. The first species studied was <italic>Phyllidia varicosa</italic> from Hawai&#x02019;i, where a toxic compound, 9-<italic>iso</italic>cyanopupukeanane (<bold>21</bold>), and a tricyclic sesquiterpene isocyanide were described almost 50 years ago [<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>]. The compound was also found in its prey, the sponge <italic>Ciocalypta (Hymeniacidon)</italic> sp. [<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>], and a related compound was subsequently reported in the slug, 2-<italic>iso</italic>cyanopupukeanane (<bold>22</bold>) [<xref rid="B107-marinedrugs-18-00657" ref-type="bibr">107</xref>]. The extracts of Palauan <italic>P. varicosa</italic> deterred feeding by sympatric reef fish at natural concentration [<xref rid="B108-marinedrugs-18-00657" ref-type="bibr">108</xref>]. Similarly, the extracts from other species from Guam of the related genus <italic>Phyllidia</italic>, <italic>Phyllidiella</italic>, <italic>Phyllidiopsis</italic>, and <italic>Fryeria</italic> are deterrent to the sympatric crabs <italic>Leptodius</italic> sp., the mantle extracts being more deterrent than the viscera extracts [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. A fast transformation of the secreted compounds was reported and was related to the loss of the deterrent activity [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. The analysis of the sesquiterpene isocyanides that these slugs present suggests a broad diet of different demosponges, indicating a wide feeding variability [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>]. Some experiments with agar-based food combined with different color patterns were also conducted, and the results showed that phyllidiids were defended against fish predators [<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. <italic>P. varicosa</italic> also possesses two 9-thiocyanatopupukeanane sesquiterpenes found in epimeric mixture; these were traced to its prey, the demosponge <italic>Axinyssa aculeata</italic> [<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>]. One of them is located in the mantle and is probably related to defense, but both compounds are found in the viscera, indicating their dietary origin. <italic>Phyllidia coelestis</italic> from Thailand also contains two pupukeanane sesquiterpenoids suggested to be used as for defense against predators [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>,<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>]. <italic>Phyllidia elegans</italic> from Guam was a deterrent against reef fish, although the natural products have not been yet identified [<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. Other <italic>Phyllidia</italic> species contain related compounds, such as <italic>Phyllidia picta</italic> from Bali yielding two axane sesquiterpenoids, pictaisonitrile-1 (<bold>23</bold>) and pictaisonitrile-2, and <italic>Phyllidia</italic> sp. From Sri Lanka presenting the sponge-related 3-<italic>iso</italic>cyano-theonellin (similar to a cyanide from <italic>Axinyssa</italic>), together with some nitrogenous bisabolene sesquiterpenes [<xref rid="B112-marinedrugs-18-00657" ref-type="bibr">112</xref>,<xref rid="B113-marinedrugs-18-00657" ref-type="bibr">113</xref>,<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B115-marinedrugs-18-00657" ref-type="bibr">115</xref>].</p><p><italic>Phyllidia varicosa</italic>, <italic>P. ocellata</italic>, <italic>Phyllidiella pustulosa,</italic> and <italic>Phillidiopsis krempfi</italic> from Australia also present three more sesquiterpene isonitriles, 10-<italic>epi</italic>-axisonitrile-3, 10-<italic>iso</italic>cyano-4-cadinene, and 2-<italic>iso</italic>cyanotrachyopsane, and the peroxide 1,7-<italic>epi</italic>dioxy-5-cadinene, together with some more sesquiterpene isonitriles [<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B116-marinedrugs-18-00657" ref-type="bibr">116</xref>]. Moreover, <italic>Phyllidia ocellata</italic> and <italic>Phyllidiella pustulosa</italic> contain stereoisomers of 10-<italic>iso</italic>cyano-4-amorphene and of 4-<italic>iso</italic>cyano-9-amorphene, respectively [<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B116-marinedrugs-18-00657" ref-type="bibr">116</xref>]. <italic>Phyllidia coelestis</italic> and <italic>Phyllidiella pustulosa</italic> from South China and their potential prey <italic>Acanthella cavernosa</italic> contain a nitrogenous cadinane-type sesquiterpenoid, xidaoisocyanate A (<bold>24</bold>), together with other sesquiterpenoids and diterpenoids [<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. <italic>P. pustulosa</italic> from Fiji possesses axisonitrile-3 (<bold>25</bold>), an isothiocyanate, and some minor related sesquiterpenes [<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>]. In China and Vietnam, <italic>P. pustulosa</italic> also presents sesquiterpene isocyanides, isothiocyanate, as well as some sterols, some of them also reported in <italic>Acanthella</italic> sponges, while in Japan, a sesquiterpene isonitrile is reported [<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B121-marinedrugs-18-00657" ref-type="bibr">121</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>]. Samples from Hainan island present diterpenes together with sesquiterpenes, with the diterpenes amphilectene (<bold>26</bold>), kalihinol-A (<bold>27</bold>), and kalihinol-E (<bold>28</bold>) being previously found in sponges, and the sesquiterpene <italic>ent</italic>-stylotelline (<bold>29</bold>) being the enantiomer of the sponge compound stylotellin [<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>]. Amphilectene (<bold>26</bold>), kalihinol-A (<bold>27</bold>), and kalihinol-E (<bold>28</bold>) display deterrence in the laboratory against the allopatric goldfish <italic>C. auratus</italic> at 50 &#x003bc;g/cm<sup>2</sup> [<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>]. <italic>P. pustulosa</italic> is therefore a chemically rich species, containing a wide variety of compounds, perhaps related to its unrestricted sponge diet, or to the presence of unknown cryptic species, but only a few of their metabolites have been tested against predation. Moreover, in field experiments, living <italic>Phyllidiella granulatus</italic> were offered to fish but were never consumed, while crude lipophilic extracts of three species of phyllidiids were shown to be effective against fish predation [<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. These were <italic>Phyllidia varicosa</italic> from Palau, <italic>P. elegans</italic> from Guam, and <italic>Phyllidiella pustulosa</italic> from Palau, where crude extracts at natural concentrations deterred feeding by sympatric reef fish, such as <italic>Abudefduf sexfasciatus</italic>, <italic>A. vaigiensis</italic>, <italic>Cheilinus fasciatus</italic>, <italic>Thalassoma lutescens</italic>, <italic>T. hardwickii</italic>, <italic>Naso vlamingii</italic>, and <italic>Bodianus axillaris</italic>, although <italic>P. pustulosa</italic> extracts from Guam did not [<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. In this study, the authors reported that visual and chemical cues are more effective against fish when used together than either of them alone [<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. </p><p>Another exhaustively studied group is that of &#x0201c;chromodoridids&#x0201d;, which possess a huge diversity of compounds from their diet of demosponges, often accumulating them in mantle dermal formations (MDFs) [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>,<xref rid="B124-marinedrugs-18-00657" ref-type="bibr">124</xref>]. This group was recently the subject of important taxonomical revisions that resulted in changes in several genus names [<xref rid="B125-marinedrugs-18-00657" ref-type="bibr">125</xref>]. One of the first species studied was <italic>Cadlina luteomarginata</italic>, where natural mixtures of three isocyanides and three isothiocyanates from its sponge prey were found, with the isocyanides (<bold>30</bold>) being deterrent in laboratory assays against goldfish at 10 &#x003bc;g/mL and both mixtures being deterrent against the woolly sculpin <italic>Clinocottus analis</italic> [<xref rid="B126-marinedrugs-18-00657" ref-type="bibr">126</xref>,<xref rid="B127-marinedrugs-18-00657" ref-type="bibr">127</xref>]. Some terpenoids from <italic>C. luteomarginata</italic> are de novo biosynthesized, while others are obtained from its sponge diet [<xref rid="B128-marinedrugs-18-00657" ref-type="bibr">128</xref>]. Specimens from British Columbia present de novo produced albicanyl acetate (<bold>31</bold>), cadlinaldehyde (<bold>32</bold>) and luteone (<bold>33</bold>) [<xref rid="B128-marinedrugs-18-00657" ref-type="bibr">128</xref>]. Albicanyl acetate (<bold>31</bold>), which is concentrated in mantle and mucus, was shown to be deterrent [<xref rid="B129-marinedrugs-18-00657" ref-type="bibr">129</xref>]. The related 1a,2a-diacetoxyalbicanyl acetate (<bold>34</bold>) was found in their egg masses and was suggested to be involved in defense against predators based on structural similarity [<xref rid="B128-marinedrugs-18-00657" ref-type="bibr">128</xref>,<xref rid="B130-marinedrugs-18-00657" ref-type="bibr">130</xref>]. </p><p><italic>Chromodoris</italic> is among the most studied heterobranch genus, although many studies were published using different names [<xref rid="B76-marinedrugs-18-00657" ref-type="bibr">76</xref>,<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B132-marinedrugs-18-00657" ref-type="bibr">132</xref>,<xref rid="B133-marinedrugs-18-00657" ref-type="bibr">133</xref>,<xref rid="B134-marinedrugs-18-00657" ref-type="bibr">134</xref>,<xref rid="B135-marinedrugs-18-00657" ref-type="bibr">135</xref>,<xref rid="B136-marinedrugs-18-00657" ref-type="bibr">136</xref>,<xref rid="B137-marinedrugs-18-00657" ref-type="bibr">137</xref>,<xref rid="B138-marinedrugs-18-00657" ref-type="bibr">138</xref>,<xref rid="B139-marinedrugs-18-00657" ref-type="bibr">139</xref>,<xref rid="B140-marinedrugs-18-00657" ref-type="bibr">140</xref>,<xref rid="B141-marinedrugs-18-00657" ref-type="bibr">141</xref>,<xref rid="B142-marinedrugs-18-00657" ref-type="bibr">142</xref>,<xref rid="B143-marinedrugs-18-00657" ref-type="bibr">143</xref>,<xref rid="B144-marinedrugs-18-00657" ref-type="bibr">144</xref>,<xref rid="B145-marinedrugs-18-00657" ref-type="bibr">145</xref>,<xref rid="B146-marinedrugs-18-00657" ref-type="bibr">146</xref>,<xref rid="B147-marinedrugs-18-00657" ref-type="bibr">147</xref>,<xref rid="B148-marinedrugs-18-00657" ref-type="bibr">148</xref>,<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>,<xref rid="B150-marinedrugs-18-00657" ref-type="bibr">150</xref>,<xref rid="B151-marinedrugs-18-00657" ref-type="bibr">151</xref>,<xref rid="B152-marinedrugs-18-00657" ref-type="bibr">152</xref>,<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>,<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>,<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B158-marinedrugs-18-00657" ref-type="bibr">158</xref>,<xref rid="B159-marinedrugs-18-00657" ref-type="bibr">159</xref>,<xref rid="B160-marinedrugs-18-00657" ref-type="bibr">160</xref>,<xref rid="B161-marinedrugs-18-00657" ref-type="bibr">161</xref>,<xref rid="B162-marinedrugs-18-00657" ref-type="bibr">162</xref>,<xref rid="B163-marinedrugs-18-00657" ref-type="bibr">163</xref>,<xref rid="B164-marinedrugs-18-00657" ref-type="bibr">164</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>]. These slugs accumulate mostly terpenoids from their diet sponges, and many different structures have been reported, including sesquiterpenes, diterpenes and nor-diterpenes, sesterterpenes, macrolides, and bromophenols [<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B132-marinedrugs-18-00657" ref-type="bibr">132</xref>,<xref rid="B133-marinedrugs-18-00657" ref-type="bibr">133</xref>,<xref rid="B135-marinedrugs-18-00657" ref-type="bibr">135</xref>,<xref rid="B136-marinedrugs-18-00657" ref-type="bibr">136</xref>,<xref rid="B137-marinedrugs-18-00657" ref-type="bibr">137</xref>,<xref rid="B138-marinedrugs-18-00657" ref-type="bibr">138</xref>,<xref rid="B139-marinedrugs-18-00657" ref-type="bibr">139</xref>,<xref rid="B140-marinedrugs-18-00657" ref-type="bibr">140</xref>,<xref rid="B141-marinedrugs-18-00657" ref-type="bibr">141</xref>,<xref rid="B142-marinedrugs-18-00657" ref-type="bibr">142</xref>,<xref rid="B143-marinedrugs-18-00657" ref-type="bibr">143</xref>,<xref rid="B144-marinedrugs-18-00657" ref-type="bibr">144</xref>,<xref rid="B145-marinedrugs-18-00657" ref-type="bibr">145</xref>,<xref rid="B146-marinedrugs-18-00657" ref-type="bibr">146</xref>,<xref rid="B147-marinedrugs-18-00657" ref-type="bibr">147</xref>,<xref rid="B148-marinedrugs-18-00657" ref-type="bibr">148</xref>,<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>,<xref rid="B150-marinedrugs-18-00657" ref-type="bibr">150</xref>,<xref rid="B151-marinedrugs-18-00657" ref-type="bibr">151</xref>,<xref rid="B152-marinedrugs-18-00657" ref-type="bibr">152</xref>,<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>,<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>,<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B158-marinedrugs-18-00657" ref-type="bibr">158</xref>,<xref rid="B159-marinedrugs-18-00657" ref-type="bibr">159</xref>,<xref rid="B160-marinedrugs-18-00657" ref-type="bibr">160</xref>,<xref rid="B161-marinedrugs-18-00657" ref-type="bibr">161</xref>,<xref rid="B162-marinedrugs-18-00657" ref-type="bibr">162</xref>,<xref rid="B163-marinedrugs-18-00657" ref-type="bibr">163</xref>,<xref rid="B164-marinedrugs-18-00657" ref-type="bibr">164</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>]. Previous studies analyzed the chemistry in the Mediterranean species <italic>C. luterorosea</italic>, <italic>C. purpurea</italic>, <italic>C. krohni</italic>, and <italic>C. britoi</italic> [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>], containing diterpenoids from <italic>Spongilla</italic> sponges, while tropical species such as <italic>C. mandapamensis</italic> from India contain spongiadiol (<bold>35</bold>), previously found in sponges from Australia, within a mixture of related spongiane compounds [<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>]. In the Red Sea, <italic>C. africana</italic> presents the furanoterpene kurospongin (<bold>36</bold>), as well as a 14-membered macrolide with an attached 2-thiazolidinone unit, latrunculin B (<bold>37</bold>) [<xref rid="B167-marinedrugs-18-00657" ref-type="bibr">167</xref>,<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>]. Kurospongin (<bold>36</bold>) was obtained also from a <italic>Spongia</italic> sp. in Okinawa and reported to be deterrent [<xref rid="B167-marinedrugs-18-00657" ref-type="bibr">167</xref>,<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>]. Latrunculin B (<bold>37</bold>) was also found in <italic>C. (Glossodoris) quadricolor</italic> [<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>] and in the sponge <italic>Latrunculia magnifica</italic> [<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>]. In fact, also latrunculin A (<bold>38</bold>) is a sponge compound initially found in <italic>L. magnifica</italic> and reported in the MDFs of several <italic>Chromodoris</italic> species [<xref rid="B136-marinedrugs-18-00657" ref-type="bibr">136</xref>,<xref rid="B141-marinedrugs-18-00657" ref-type="bibr">141</xref>,<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B164-marinedrugs-18-00657" ref-type="bibr">164</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>]. Other macrolides, such as laulimalide (<bold>39</bold>) and <italic>iso</italic>laulimalide (<bold>40</bold>), were reported in <italic>C. lochi</italic> and its sponge prey, <italic>Hyattella</italic> sp. [<xref rid="B142-marinedrugs-18-00657" ref-type="bibr">142</xref>,<xref rid="B172-marinedrugs-18-00657" ref-type="bibr">172</xref>,<xref rid="B173-marinedrugs-18-00657" ref-type="bibr">173</xref>,<xref rid="B174-marinedrugs-18-00657" ref-type="bibr">174</xref>]. <italic>C. hamiltoni</italic> from South Africa presents hamiltonins A&#x02013;D (<bold>41,42</bold>), atypical chlorinated homoditerpenes, as well as the sesterterpene hamiltonin E (<bold>42</bold>) and latrunculins A and B (<bold>37,38</bold>), while specimens from Mozambique possess two spongian diterpene lactones in addition to latrunculin B (<bold>37</bold>) [<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>]. Many other compounds have been described in this genus, often located in the MDFs and suggesting a defensive role, but unfortunately very few tests for deterrence have been carried out [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>].</p><p>In the genus <italic>Glossodoris</italic>, <italic>G. vespa</italic> and <italic>G. averni</italic> from Australia, as well as <italic>G. pallida</italic> from China, contain 12-deacetoxy-12-oxoscalaradial (<bold>43</bold>), while <italic>G. pallida</italic> from Guam contains some sesquiterpenes, such as scalaradial (<bold>44</bold>), deacetylscalaradial (<bold>45</bold>), and deoxoscalarin (<bold>46</bold>) [<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B177-marinedrugs-18-00657" ref-type="bibr">177</xref>]. The sesquiterpenes from <italic>G. pallida</italic> from Guam, located in their MDFs, have been proven to act as deterrents against sympatric reef fish (<italic>Abudefduf sexfasciatus</italic>, among others) and crabs (<italic>Leptodius</italic> sp.) at natural concentrations [<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B177-marinedrugs-18-00657" ref-type="bibr">177</xref>]. Further studies with <italic>G. vespa</italic> showed high concentrations of sesquiterpenes in mantle rim tissues that were more unpalatable to the allopatric palaemonid shrimp <italic>Palaemon serenus</italic> than metabolites from the viscera, suggesting selective accumulation of dietary compounds or perhaps even biotransformation to more potent defenses [<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]. </p><p>As taxonomical studies progress, many <italic>Chromodoris</italic> and <italic>Glossodoris</italic> species have been renamed, such as <italic>Goniobranchus</italic>, <italic>Ardeadoris</italic>, <italic>Doriprismatica</italic>, <italic>Felimare,</italic> and <italic>Felimida</italic>, respectively [<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>,<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B179-marinedrugs-18-00657" ref-type="bibr">179</xref>,<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B181-marinedrugs-18-00657" ref-type="bibr">181</xref>,<xref rid="B182-marinedrugs-18-00657" ref-type="bibr">182</xref>,<xref rid="B183-marinedrugs-18-00657" ref-type="bibr">183</xref>,<xref rid="B184-marinedrugs-18-00657" ref-type="bibr">184</xref>,<xref rid="B185-marinedrugs-18-00657" ref-type="bibr">185</xref>]. <italic>Goniobranchus collingwoodi</italic> presents six spongian-16-one diterpenes in the mantle, and the extract of the whole body displayed deterrence against the allopatric palaemonid shrimp <italic>P. serenus</italic> [<xref rid="B185-marinedrugs-18-00657" ref-type="bibr">185</xref>]. <italic>G. reticulatus</italic> from Australia contains a dialdehyde sesquiterpene and its ring-closed acetal, also reported in <italic>G. sinensis</italic> from China, where they are described to be deterrents against <italic>Palaemon elegans</italic> [<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]. Specimens of <italic>G. splendidus</italic> from different localities in east Australia were described to present different abundances, types, and richness of natural products in addition to high individual variation between specimens from the same population [<xref rid="B187-marinedrugs-18-00657" ref-type="bibr">187</xref>]. These variations resulted in different potencies when deterring feeding in the allopatric, generalist rock-pool shrimp <italic>P. serenus</italic>, but in all cases, the specimens showed deterrent activity [<xref rid="B187-marinedrugs-18-00657" ref-type="bibr">187</xref>,<xref rid="B188-marinedrugs-18-00657" ref-type="bibr">188</xref>]. Other <italic>Goniobranchus</italic> species, such as <italic>G. albonarus</italic>, present diterpenes and nor-diterpenes obtained from their sponge prey, but they have not been tested for feeding deterrence [<xref rid="B189-marinedrugs-18-00657" ref-type="bibr">189</xref>,<xref rid="B190-marinedrugs-18-00657" ref-type="bibr">190</xref>,<xref rid="B191-marinedrugs-18-00657" ref-type="bibr">191</xref>,<xref rid="B192-marinedrugs-18-00657" ref-type="bibr">192</xref>].</p><p>Another interesting genus within this chromodorid group is <italic>Ceratosoma</italic>, because these species present a dorsal protuberance containing MDFs loaded with furanosesquiterpenoids. Although a defensive role has been suggested and it seems highly probable, it still remains to be demonstrated using sympatric predators [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B193-marinedrugs-18-00657" ref-type="bibr">193</xref>]. These species include <italic>C. trilobatum</italic> and <italic>C. gracillimum</italic> from China, which possess pallescensin-B (<bold>47</bold>), (&#x02013;)-furodysinin (<bold>48</bold>), (&#x02013;)-dehydroherbadysidolide (<bold>49</bold>), and (&#x02013;)-herbadysidolide (<bold>50</bold>) previously reported for <italic>Dysidea</italic> sponges [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B193-marinedrugs-18-00657" ref-type="bibr">193</xref>,<xref rid="B194-marinedrugs-18-00657" ref-type="bibr">194</xref>,<xref rid="B195-marinedrugs-18-00657" ref-type="bibr">195</xref>,<xref rid="B196-marinedrugs-18-00657" ref-type="bibr">196</xref>,<xref rid="B197-marinedrugs-18-00657" ref-type="bibr">197</xref>]. From them, (&#x02013;)-furodysinin (<bold>48</bold>) shows deterrent activity against the goldfish <italic>Carassius auratus</italic> in the laboratory [<xref rid="B194-marinedrugs-18-00657" ref-type="bibr">194</xref>]. Another compound, nakafuran-9 (<bold>51</bold>), present in <italic>C. gracillimum</italic> specimens from Hainan, was also reported as a deterrent [<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>]. In Australia, <italic>C. trilobatum</italic> possesses furodysinin (<bold>48</bold>), furodysin (<bold>58</bold>), and dendrolasin (<bold>55</bold>) in the viscera and, additionally, agassizin (<bold>59</bold>) and dehydroherbadysidolide (<bold>49</bold>) in the mantle, while <italic>C. brevicaudatum</italic> presents mixtures of the same compounds along with some unidentified metabolites [<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>].</p><p><italic>Hypselodoris</italic> is another well-studied genus, although some species are now named <italic>Felimare</italic> or even <italic>Risbecia</italic> [<xref rid="B125-marinedrugs-18-00657" ref-type="bibr">125</xref>,<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>,<xref rid="B198-marinedrugs-18-00657" ref-type="bibr">198</xref>,<xref rid="B199-marinedrugs-18-00657" ref-type="bibr">199</xref>,<xref rid="B200-marinedrugs-18-00657" ref-type="bibr">200</xref>,<xref rid="B201-marinedrugs-18-00657" ref-type="bibr">201</xref>,<xref rid="B202-marinedrugs-18-00657" ref-type="bibr">202</xref>,<xref rid="B203-marinedrugs-18-00657" ref-type="bibr">203</xref>,<xref rid="B204-marinedrugs-18-00657" ref-type="bibr">204</xref>,<xref rid="B205-marinedrugs-18-00657" ref-type="bibr">205</xref>,<xref rid="B206-marinedrugs-18-00657" ref-type="bibr">206</xref>,<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>,<xref rid="B208-marinedrugs-18-00657" ref-type="bibr">208</xref>]. All of these species possess diet-derived furanosesquiterpenes, among other terpenoids, located in their MDFs [<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>,<xref rid="B198-marinedrugs-18-00657" ref-type="bibr">198</xref>,<xref rid="B199-marinedrugs-18-00657" ref-type="bibr">199</xref>,<xref rid="B200-marinedrugs-18-00657" ref-type="bibr">200</xref>,<xref rid="B201-marinedrugs-18-00657" ref-type="bibr">201</xref>,<xref rid="B202-marinedrugs-18-00657" ref-type="bibr">202</xref>,<xref rid="B203-marinedrugs-18-00657" ref-type="bibr">203</xref>,<xref rid="B204-marinedrugs-18-00657" ref-type="bibr">204</xref>,<xref rid="B205-marinedrugs-18-00657" ref-type="bibr">205</xref>,<xref rid="B206-marinedrugs-18-00657" ref-type="bibr">206</xref>,<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>,<xref rid="B208-marinedrugs-18-00657" ref-type="bibr">208</xref>,<xref rid="B209-marinedrugs-18-00657" ref-type="bibr">209</xref>]. Longifolin (<bold>52</bold>) is one of the main furanosesquiterpenes found in these groups, is located in MDFs, and is a deterrent in the lab against the goldfish <italic>Carassius auratus</italic>, like several other compounds of theirs [<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B198-marinedrugs-18-00657" ref-type="bibr">198</xref>,<xref rid="B201-marinedrugs-18-00657" ref-type="bibr">201</xref>,<xref rid="B208-marinedrugs-18-00657" ref-type="bibr">208</xref>]. Many of these molecules are obtained from <italic>Dysidea</italic> sponge species [<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>,<xref rid="B200-marinedrugs-18-00657" ref-type="bibr">200</xref>,<xref rid="B206-marinedrugs-18-00657" ref-type="bibr">206</xref>,<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>]. Some of the studied species include the Mediterranean <italic>F. picta webbi</italic>, <italic>F. villafranca</italic>, <italic>F. cantabrica</italic>, <italic>F. tricolor</italic>, <italic>F. fontandraui</italic>, and others, presenting longifolin (<bold>52</bold>) and some related compounds [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B124-marinedrugs-18-00657" ref-type="bibr">124</xref>]. In the laboratory, the crude extracts of <italic>F. cantabrica</italic> displayed stronger deterrence against the allopatric shrimp <italic>Palaemon elegans</italic> than extracts from their prey sponge, <italic>Dysidea fragilis</italic>, suggesting a selective accumulation of compounds [<xref rid="B206-marinedrugs-18-00657" ref-type="bibr">206</xref>]. The main chemical behind the deterrence was nakafuran-9 (<bold>51</bold>). The Mediterranean and North Atlantic species mentioned above have aposematic colorations and conform M&#x000fc;llerian mimicry groups [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B210-marinedrugs-18-00657" ref-type="bibr">210</xref>]. <italic>F. fontandraui</italic>, however, does not present MDFs and presents tavacpallescensin (<bold>53</bold>) in its mantle rim [<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>,<xref rid="B205-marinedrugs-18-00657" ref-type="bibr">205</xref>,<xref rid="B210-marinedrugs-18-00657" ref-type="bibr">210</xref>,<xref rid="B211-marinedrugs-18-00657" ref-type="bibr">211</xref>]. Tavacpallescensin (<bold>53</bold>) is a deterrent against the allopatric shrimp <italic>Palaemon elegans</italic> at 1 mg/mL in the laboratory, a very low concentration compared to that reported in its mantle (25.98 &#x000b1; 1.41 mg/mL) [<xref rid="B205-marinedrugs-18-00657" ref-type="bibr">205</xref>]. In the Atlantic, <italic>F. picta webbi</italic> presents longifolin (<bold>52</bold>) and tavacfuran, while <italic>F. picta azorica</italic> also presents microcionin-1 [<xref rid="B212-marinedrugs-18-00657" ref-type="bibr">212</xref>]. <italic>Hypselodoris capensis</italic> presents the feeding deterrents nakafuran-8 (<bold>54</bold>) and -9 (<bold>51</bold>), which are active against the reef fishes <italic>Chaetodon</italic> spp., together with the sesterterpene 22-deoxy-23-hydroxymethyl-variabilin and other sesquiterpenes and sesterterpenes from its presumed prey, the sponges <italic>Fasciospongia</italic> sp. and <italic>Dysidea</italic> sp. [<xref rid="B213-marinedrugs-18-00657" ref-type="bibr">213</xref>]. The Australian <italic>H. obscura</italic> contains dendrolasin (<bold>55</bold>), (&#x02013;)-euryfuran (<bold>56</bold>), and (+)-pallescensin A (<bold>57</bold>), while <italic>H. whitei</italic> presents (&#x02013;)-euryfuran (<bold>56</bold>), (&#x02013;)-furodysin (<bold>58</bold>), (&#x02013;)-furosydinin (<bold>48</bold>), and dendrolasin (<bold>55</bold>), some of which are deterrents against the shrimp <italic>P. elegans</italic>, as previously mentioned [<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]. <italic>H. infucata</italic> from Hawai&#x02019;i also possesses nakafuran-8 (<bold>54</bold>) and -9 (<bold>51</bold>), probably obtained from <italic>Dysidea fragilis</italic> [<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>]. In Bali, <italic>H. infucata</italic> presents (&#x02013;)-furodysinin (<bold>48</bold>), and its crude extract is repellent against the sympatric shrimp <italic>Penaeus vannamei</italic> at natural concentration [<xref rid="B214-marinedrugs-18-00657" ref-type="bibr">214</xref>]. In Hawai&#x02019;i, <italic>H. infucata</italic> (<italic>Chromodoris maridadilus</italic>) contains a 3:1 mixture of nakafuran-8 (<bold>54</bold>) and nakafuran-9 (<bold>51</bold>), like its sponge prey <italic>Dysidea fragilis</italic>, both reported to be deterrent [<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>]<italic>. H. bennetti</italic> and <italic>H. obscura</italic> from Australia contain euryfuran (<bold>56</bold>), but <italic>H. obscura</italic> also has furodysinin (<bold>48</bold>), furodysin (<bold>58</bold>), and dendrolasin (<bold>55</bold>), while <italic>H. bennetti</italic> presents agassizin (<bold>59</bold>), dehydroherbadysidolide (<bold>49</bold>), and pallescensone (<bold>60</bold>) [<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]. In addition, in Australia, <italic>H. tryoni</italic> presents dehydroherbadysidolide (<bold>49</bold>), furodysinin (<bold>48</bold>), nakafuran-9 (<bold>51</bold>), and dendrolasin (<bold>55</bold>) [<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]. In India, <italic>H. kanga</italic> and its prey sponge <italic>Dysidea</italic> sp. also present furodysinin (<bold>48</bold>) [<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>]. In Brazil, <italic>H. lajensis</italic> presents furodysinin lactone (<bold>61</bold>), also originated from <italic>Dysidea</italic> species [<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>]. Other <italic>Hypselodoris</italic> species such as <italic>H. jacksoni</italic> contain similar or related compounds, but no activity against potential predators has been shown [<xref rid="B209-marinedrugs-18-00657" ref-type="bibr">209</xref>]. Similarly, the related <italic>Mexichromis festiva</italic> has euryfuran (<bold>56</bold>) and dendrolasin (<bold>55</bold>), while <italic>M. mariei</italic> presents only euryfuran (<bold>56</bold>) [<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]. Other chromodoridid genera like <italic>Tyrinna</italic> contain interesting compounds, but none of them have been demonstrated to be used against predation to date [<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B179-marinedrugs-18-00657" ref-type="bibr">179</xref>,<xref rid="B215-marinedrugs-18-00657" ref-type="bibr">215</xref>,<xref rid="B216-marinedrugs-18-00657" ref-type="bibr">216</xref>]. </p><p>The genus <italic>Hexabranchus</italic> mainly contains macrolides. In several locations around the Pacific and the Indo-Pacific, <italic>H. sanguineus</italic> presents several macrocyclic lactones, but only kabiramides and halichondramide derivatives have been proved to be deterrents against the sympatric fish <italic>Thalassoma lunare</italic> and the crab <italic>Dardanus megistos</italic> [<xref rid="B217-marinedrugs-18-00657" ref-type="bibr">217</xref>,<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>,<xref rid="B220-marinedrugs-18-00657" ref-type="bibr">220</xref>]. Active compounds consist mainly of kabiramide C (<bold>62</bold>) and halichondramide derivatives, such as dihydrohalichondramide (<bold>63</bold>) [<xref rid="B217-marinedrugs-18-00657" ref-type="bibr">217</xref>,<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B220-marinedrugs-18-00657" ref-type="bibr">220</xref>,<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>]. These macrolides are found in the slugs and even at higher concentrations in their spawn, suggesting a defensive role [<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>]. Since these compounds are found in mantle and viscera, they are suggested to be obtained and biotransformed from their diet of <italic>Halichondria</italic> sponges [<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>]. <italic>H. sanguineus</italic> from Fiji contains also macrolides along with two thiazole cyclic peptides, sanguinamides A (<bold>64</bold>) and B [<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>]. </p><p>Finally, within the group of nembrothids, the tambjamines (<bold>65&#x02013;71</bold>) are alkaloids obtained from their diet of several species [<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]. <italic>Tambja abdere</italic> and <italic>T. eliora</italic> in the east Pacific accumulate tambjamines (<bold>65&#x02013;71</bold>) from the bryozoan <italic>Sessibugula translucens,</italic> and they are in turn preyed on by another nembrothid slug, <italic>Roboastra tigris</italic> [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B224-marinedrugs-18-00657" ref-type="bibr">224</xref>,<xref rid="B225-marinedrugs-18-00657" ref-type="bibr">225</xref>]. In Micronesia, <italic>Nembrotha</italic> species present tambjamines (<bold>65&#x02013;71</bold>) from their ascidian prey, <italic>Atapozoa</italic> sp. [<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>,<xref rid="B227-marinedrugs-18-00657" ref-type="bibr">227</xref>]. These compounds include mixtures of tambjamine A (<bold>65</bold>), B (<bold>66</bold>), C (<bold>67</bold>), D (<bold>68</bold>), E (<bold>69</bold>), and F (<bold>70</bold>); a tambjamine aldehyde (<bold>71</bold>); and a blue tetrapyrrol (<bold>72</bold>) [<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>]. Crude extracts and mixtures containing tambjamine C (<bold>67</bold>) and F (<bold>70</bold>) and the tetrapyrrol (<bold>72</bold>) are reported to be deterrents against fish at (or below) natural concentrations, while tambjamines A (<bold>65</bold>) and E (<bold>69</bold>) are not deterrents [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>]. <italic>R. tigris</italic> feeds on <italic>T. abdere</italic> and <italic>T. eliora,</italic> accumulating tambjamines A&#x02013;D (<bold>65&#x02013;68</bold>) [<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]. Both <italic>Tambja</italic> species and <italic>R. tigris</italic> are able to detect the tambjamines released into the mucus by chemoreception and thus chemically locate their prey [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]. When the concentration of tambjamines is very high, <italic>R. tigris</italic> may reject its prey [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]. Similarly, tambjamines have also been reported in <italic>T. ceutae</italic> and <italic>T. stegosauriformis</italic> and their bryozoan prey, <italic>Bugula dentata</italic> [<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>,<xref rid="B228-marinedrugs-18-00657" ref-type="bibr">228</xref>].</p></sec><sec><title>Dendronotida</title><p>In Florida, <italic>Tritonia hamnerorum</italic> presents julieannafuran (<bold>73</bold>), a furano-germacrene obtained from its diet, the sea fan <italic>Gorgonia ventalina</italic> [<xref rid="B229-marinedrugs-18-00657" ref-type="bibr">229</xref>]. Julieannafuran (<bold>73</bold>) has been shown in reliable field assays to be a deterrent at natural concentrations against sympatric reef fish, such as <italic>Thalassoma bifasciatum</italic>, as well as in the laboratory [<xref rid="B229-marinedrugs-18-00657" ref-type="bibr">229</xref>]. The Antarctic <italic>Tritonia challengeriana,</italic> instead, has been proved to be chemically protected against feeding by the sympatric sea stars <italic>Odontaster validus</italic>, but no compounds have been identified from it to date ([<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>], Avila and K Iken, unpublished results). Furthermore, in Antarctica, <italic>Tritoniella belli</italic> sequesters 1-O-hexadecyl glycerol (chimyl alcohol) (<bold>74</bold>) from its diet, the stoloniferan coral <italic>Clavularia frankliniana</italic> [<xref rid="B230-marinedrugs-18-00657" ref-type="bibr">230</xref>,<xref rid="B231-marinedrugs-18-00657" ref-type="bibr">231</xref>,<xref rid="B232-marinedrugs-18-00657" ref-type="bibr">232</xref>]. This compound provides protection against the potential sympatric predator, the sea star <italic>O. validus</italic>, which is also deterred by the mantle tissue of the slug ([<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B230-marinedrugs-18-00657" ref-type="bibr">230</xref>,<xref rid="B231-marinedrugs-18-00657" ref-type="bibr">231</xref>,<xref rid="B232-marinedrugs-18-00657" ref-type="bibr">232</xref>], Avila and Iken, unpublished results). The spawn of <italic>T. belli</italic> is also chemically defended against predators [<xref rid="B232-marinedrugs-18-00657" ref-type="bibr">232</xref>,<xref rid="B233-marinedrugs-18-00657" ref-type="bibr">233</xref>]. </p><p><italic>Tritoniopsis elegans</italic> presents the sesquiterpenes tritoniopsins A&#x02013;D (<bold>75&#x02013;78</bold>) in the mantle, which are obtained from its diet of the soft coral <italic>Cladiella krempfi</italic> [<xref rid="B234-marinedrugs-18-00657" ref-type="bibr">234</xref>]. Tritoniopsins A (<bold>75</bold>) and B (<bold>76</bold>) are the major compounds, with tritoniopsin A (<bold>75</bold>) more abundant in the slug and tritoniopsin B (<bold>76</bold>) in the soft coral, thus suggesting a selective accumulation by the slug, which incorporates it in its mantle possibly for protection against potential predators [<xref rid="B234-marinedrugs-18-00657" ref-type="bibr">234</xref>]. </p><p>The Mediterranean <italic>Marionia blainvillea</italic> presents homarine (<bold>79</bold>), a widespread zwitterionic natural product described to be a feeding deterrent, but it has not been tested against sympatric predators of the slug [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]. Homarine (<bold>79</bold>) has been suggested to derive from its cnidarian diet and could be the only defense of this slug that has no nematocysts [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]. Furthermore, homarine (<bold>79</bold>) has been found in other molluscs, for example, in Antarctica (<italic>Marseniopsis mollis</italic>), where it was described to deter feeding in the seastar <italic>Odontaster validus</italic> [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B236-marinedrugs-18-00657" ref-type="bibr">236</xref>].</p><p>The colorful <italic>Tethys fimbria</italic> was described to de novo biosynthesize a series of prostaglandins (PG) and PG&#x02013;lactones [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>,<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>,<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>]. These compounds are well known in many organisms as promotors of hormonal responses [<xref rid="B28-marinedrugs-18-00657" ref-type="bibr">28</xref>]. Different PGEs, such as PGE<sub>2</sub>-1,15-lactone (<bold>80</bold>) and PGE<sub>3</sub>-1,15-lactone (<bold>81</bold>) are found in <italic>T. fimbria</italic> cerata [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>], while PGFs are present in the reproductive system of the slugs [<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>]. Since cerata are detached when the animal is disturbed, together with a copious amount of mucus and a strong antero-posterior waving movement, PGEs are suggested to be involved somehow in defense, autotomy, and/or tissue protection, as well as further regeneration of cerata, while PGE&#x02013;lactones (<bold>80,81</bold>) are converted to the free acid forms PGE<sub>2</sub> and PGE<sub>3</sub>, respectively [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>]. Similarly, <italic>Melibe viridis</italic> contains one of these prostaglandin lactones (<bold>80</bold>) in its mucus and cerata, suggested to be used for defense against predators [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>].</p></sec><sec><title>Euarminida</title><p>Only one species has been suggested to use defensive compounds in this group [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>], the Antarctic <italic>Charcotia granulosa</italic> [<xref rid="B241-marinedrugs-18-00657" ref-type="bibr">241</xref>,<xref rid="B242-marinedrugs-18-00657" ref-type="bibr">242</xref>], although no experiments have proved this yet. This species possesses a unique linear homosesterterpene lactone, granuloside (<bold>82</bold>), probably stored in its MDF-like structures [<xref rid="B242-marinedrugs-18-00657" ref-type="bibr">242</xref>]. Granuloside (<bold>82</bold>) was isolated from the lipophilic extract of the mantle of the slug, while it was absent in the gut and digestive gland as well as in the prey of the nudibranch, the bryozoan <italic>Beania erecta</italic>, strongly supporting its de novo biosynthetic origin. Sesterterpenes are known in nudibranchs [<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>], but, to date, granuloside (<bold>82</bold>) is the only known linear homosesterterpene in nature. </p></sec><sec><title>Aeolidida</title><p>Homarine (<bold>79</bold>), previously mentioned above, has been also found in the Atlantic aeolidids <italic>Cratena pilata</italic> and <italic>Cuthona gymnota,</italic> the Pacific <italic>Hermissenda crassicornis</italic>, the Australian <italic>Phestilla lugubris,</italic> and the Mediterranean <italic>Cuthona coerulea</italic> [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B92-marinedrugs-18-00657" ref-type="bibr">92</xref>,<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]. It has been suggested that the slugs obtain homarine (<bold>79</bold>) from their diet of hydrozoans or other cnidarians [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]. <italic>Flabellina exoptata</italic>, <italic>F. ischitana</italic>, <italic>F. pedate,</italic> and <italic>F. affinis</italic> also contain homarine (<bold>79</bold>) [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B243-marinedrugs-18-00657" ref-type="bibr">243</xref>]. Despite the fact that homarine (<bold>79</bold>) has not been tested specifically for these species, its potential deterrent role cannot be overruled (see above) and may complement their cnidocyst defenses. </p><p><italic>Phyllodesmium</italic> species do not to present functional cnidocysts, and, thus, their chemical defenses become their only protective shield, together with their cryptic behavior [<xref rid="B244-marinedrugs-18-00657" ref-type="bibr">244</xref>,<xref rid="B245-marinedrugs-18-00657" ref-type="bibr">245</xref>,<xref rid="B246-marinedrugs-18-00657" ref-type="bibr">246</xref>,<xref rid="B247-marinedrugs-18-00657" ref-type="bibr">247</xref>,<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]. <italic>P. magnum</italic> from China presents an uncommon asteriscane sesquiterpene related to 11&#x003b2;-acetoxypukalide (<bold>83</bold>), as well as some other sesquiterpenes [<xref rid="B249-marinedrugs-18-00657" ref-type="bibr">249</xref>]. 11&#x003b2;-acetoxypukalide (<bold>83</bold>) was previously reported to be the chemical defense of <italic>P. guamensis</italic> from Guam, which accumulate it in their cerata, and it was suggested to be obtained from feeding on <italic>Sinularia</italic> soft corals [<xref rid="B246-marinedrugs-18-00657" ref-type="bibr">246</xref>]. 11&#x003b2;-Acetoxypukalide (<bold>83</bold>) was shown to deter feeding by the sympatric omnivorous pufferfish <italic>Canthigaster solandri</italic> at concentrations at least an order of magnitude lower than those found in their cerata (0.5% of dry mass in artificial food) [<xref rid="B246-marinedrugs-18-00657" ref-type="bibr">246</xref>]. Previously, trocheliophorol (<bold>84</bold>) was also found to be accumulated in the cerata of the Australian <italic>P. longicirrum</italic> and in its prey, the soft coral <italic>Sarcophyton trocheliophorum</italic> [<xref rid="B245-marinedrugs-18-00657" ref-type="bibr">245</xref>]. Four more polycyclic diterpenes and other compounds were described from <italic>P. longicirrum</italic>, some of them (for example, 4-oxochatancin (<bold>85</bold>), (2S)-<italic>iso</italic>sarcophytoxide (<bold>86</bold>), and cembranoid bisepoxide 12) being deterrent also to the pufferfish <italic>C. solandri</italic> [<xref rid="B250-marinedrugs-18-00657" ref-type="bibr">250</xref>,<xref rid="B251-marinedrugs-18-00657" ref-type="bibr">251</xref>]. The 4-oxochatancin (<bold>85</bold>) is probably obtained from a diet of <italic>Sarcophyton</italic> corals [<xref rid="B28-marinedrugs-18-00657" ref-type="bibr">28</xref>,<xref rid="B250-marinedrugs-18-00657" ref-type="bibr">250</xref>,<xref rid="B251-marinedrugs-18-00657" ref-type="bibr">251</xref>]. <italic>P. longicirrum</italic> also possesses many other compounds, including steroids, cembranoid diterpenes, biscembranoids, and the above-mentioned chatancin diterpenes [<xref rid="B251-marinedrugs-18-00657" ref-type="bibr">251</xref>]. Other <italic>Phyllodesmium</italic> species have been reported to contain other interesting natural products, but its role in deterring potential predators has not been proved to date [<xref rid="B244-marinedrugs-18-00657" ref-type="bibr">244</xref>,<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]. </p></sec></sec><sec id="sec2dot1dot2-marinedrugs-18-00657"><title>2.1.2. Pleurobranchoidea </title><p>This group is well known for presenting acidic secretions that may deter putative predators [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Examples, with pHs as low as 1&#x02013;2 include <italic>Pleurobranchaea californica, Berthellina citrina</italic>, and <italic>Pleurobranchus strongi</italic> from the Pacific, as well as <italic>Berthella plumula</italic> and <italic>Pleurobranchus membranaceus</italic> from the North Atlantic. In addition, <italic>Berthella</italic> sp. 1 from the Mediterranean and <italic>Berthella</italic> sp. 2 from Antarctica display pH ~1 [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. <italic>P. californica</italic> and <italic>P. membranaceus</italic> have also been described to possess buccal acid glands [<xref rid="B124-marinedrugs-18-00657" ref-type="bibr">124</xref>,<xref rid="B252-marinedrugs-18-00657" ref-type="bibr">252</xref>]. Both <italic>Berthella</italic> and <italic>Berthellina</italic> are usually consumers of demosponges and occasionally of calcareous sponges and corals [<xref rid="B253-marinedrugs-18-00657" ref-type="bibr">253</xref>], and no chemical defenses have been described for them besides the acid secretions mentioned above. Similarly, the Antarctic <italic>Bathyberthella antarctica</italic> presents defensive acid secretions in its mantle [<xref rid="B254-marinedrugs-18-00657" ref-type="bibr">254</xref>,<xref rid="B255-marinedrugs-18-00657" ref-type="bibr">255</xref>].</p></sec><sec id="sec2dot1dot3-marinedrugs-18-00657"><title>2.1.3. Tylodinoidea</title><p><italic>Tylodina</italic> species seem to be protected from predation by using sponge compounds and crypsis. <italic>Tylodina fungina</italic> from the Pacific contains an ester derivative of the brominated isoxazoline alkaloid 3,5-dibromotyrosine (<bold>87</bold>), which is a known feeding deterrent in sponges of the genus <italic>Aplysina</italic> [<xref rid="B256-marinedrugs-18-00657" ref-type="bibr">256</xref>]. <italic>T. perversa</italic> from the Mediterranean possesses similar metabolites from the sponge <italic>Aplysina aerophoba</italic> [<xref rid="B257-marinedrugs-18-00657" ref-type="bibr">257</xref>]. Finally, <italic>T. corticalis</italic> from Australia selectively accumulates several bromotyrosine-derived alkaloids from its sponge diet, <italic>Pseudoceratina purpurea</italic>, which contains a larger variety of these compounds [<xref rid="B258-marinedrugs-18-00657" ref-type="bibr">258</xref>]. In all cases, the natural products are sequestered by the molluscs and can then be found in the mantle, mucus, reproductive organs, and egg masses [<xref rid="B259-marinedrugs-18-00657" ref-type="bibr">259</xref>,<xref rid="B260-marinedrugs-18-00657" ref-type="bibr">260</xref>]. In the case of <italic>T. perversa,</italic> they feed preferentially on the symbiotic tissues of sponge prey loaded with cyanobacteria [<xref rid="B261-marinedrugs-18-00657" ref-type="bibr">261</xref>]. Furthermore, the slugs combine chemical defense with crypsis, while their mimetic yellow color (as well as that of their egg masses) on <italic>Aplysina</italic> species is due to uranidine, a phenolic pigment that becomes dark by oxidation when exposed to air, and it is also derived from the sponge [<xref rid="B262-marinedrugs-18-00657" ref-type="bibr">262</xref>,<xref rid="B263-marinedrugs-18-00657" ref-type="bibr">263</xref>].</p></sec><sec id="sec2dot1dot4-marinedrugs-18-00657"><title>2.1.4. Cephalaspidea</title><p>Species of the genus <italic>Philine</italic> often secrete sulfuric acid from subepithelial notal glands, and this is supposed to be a defense against predators, similarly to acid-secreting nudibranchs and pleurobranchoids [<xref rid="B124-marinedrugs-18-00657" ref-type="bibr">124</xref>,<xref rid="B264-marinedrugs-18-00657" ref-type="bibr">264</xref>]. <italic>P. quadripartita</italic> from the Mediterranean, Atlantic, South Africa, and Indo-Pacific is an example, possessing sulfuric and hydrochloric acid in acidic glands [<xref rid="B265-marinedrugs-18-00657" ref-type="bibr">265</xref>,<xref rid="B266-marinedrugs-18-00657" ref-type="bibr">266</xref>]. Some other cephalaspideans are able to de novo biosynthesize their own chemical defenses, such as <italic>Bulla striata,</italic> a generalist algal feeder found in the Atlantic and the Mediterranean [<xref rid="B267-marinedrugs-18-00657" ref-type="bibr">267</xref>,<xref rid="B268-marinedrugs-18-00657" ref-type="bibr">268</xref>]. Remarkably, cephalaspideans, such as the voracious predator <italic>Philinopsis depicta</italic>, are able to prey on <italic>B. striata</italic>, thus obtaining chemical defenses from them&#x02014;in this case, the polypropionates aglajnes 1&#x02013;3 (<bold>88</bold>), using them for their own defense, with aglajne-1 being the most deterrent [<xref rid="B269-marinedrugs-18-00657" ref-type="bibr">269</xref>,<xref rid="B270-marinedrugs-18-00657" ref-type="bibr">270</xref>,<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>]. Similarly, the Pacific species <italic>P. speciosa</italic> contains the polypropionates niuhinones A and B (<bold>89</bold>), as well as a pyridine derivate pulo&#x02019;upone (<bold>90</bold>) reported to be deterrent, and although their origin is not yet known, <italic>P. speciosa</italic> probably also relies on other cephalaspideans [<xref rid="B272-marinedrugs-18-00657" ref-type="bibr">272</xref>,<xref rid="B273-marinedrugs-18-00657" ref-type="bibr">273</xref>]. In fact, niuhinones A and B (<bold>89</bold>) have also been found in the Atlantic species <italic>B. occidentalis</italic>, along with the acyclic polypropionate, niuhinone C (<bold>89</bold>) [<xref rid="B274-marinedrugs-18-00657" ref-type="bibr">274</xref>]. <italic>P. speciosa</italic> also presents other compounds, such as the depsipeptide kulolide-1, a linear tetrapeptide (see below), pupukeamide, additional peptides, and the macrolide tolytoxin-23-acetate [<xref rid="B275-marinedrugs-18-00657" ref-type="bibr">275</xref>,<xref rid="B276-marinedrugs-18-00657" ref-type="bibr">276</xref>,<xref rid="B277-marinedrugs-18-00657" ref-type="bibr">277</xref>]. Similarly, <italic>Bulla gouldiana</italic> possesses an isomer of pulo&#x02019;upone (<bold>90</bold>) which is further found in its cephalaspidean predator, <italic>Navanax inermis,</italic> and suggested to be used for its own protection [<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]. Moreover, <italic>Nakamigawaia spiralis</italic> from Guam has been reported to chemically deter sympatric reef fish, but the active compounds have not been identified to date [<xref rid="B279-marinedrugs-18-00657" ref-type="bibr">279</xref>].</p><p>Homarine (<bold>79</bold>), again, could be used against predators in this group of heterobranchs, since it has been found in the Mediterranean <italic>Aglaja tricolorata</italic>, probably from its diet of sea slugs, such as dendronotaceans and/or aeolidids [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>].</p><p>Another interesting group is that of <italic>Haminoea</italic> species. In Guam, <italic>H. cymbalum</italic> uses a halogenated polyacetate, kumepaloxane (<bold>91</bold>), which it secretes when it is disturbed and which deters porcupine fish [<xref rid="B280-marinedrugs-18-00657" ref-type="bibr">280</xref>]. Similarly, a chemically related brominated tetrahydropyran has been found in the same species from India, as well as in <italic>H. cyanomarginata</italic> from the Mediterranean, strongly deterring predation by the generalist crustacean <italic>Palaemon elegans</italic> [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>]. Moreover, the spawn of <italic>H. virescens</italic> from the Pacific has been shown to deter feeding in decapod crustaceans, although the compound(s) has not yet been identified [<xref rid="B281-marinedrugs-18-00657" ref-type="bibr">281</xref>].</p><p>In Guam, <italic>Sagaminopteron</italic> species concentrate polybrominated diphenyl ethers, probably for defense against potential predators, although this has not yet been demonstrated. <italic>S. nigropunctatum</italic> and <italic>S. psychedelicum</italic> both feed on the sponge <italic>Dysidea granulosa</italic> and sequester the sponge-polybrominated diphenyl ethers, concentrating them in their mantle and parapodia [<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>]. One of the compounds, 3,5 dibromo-2-(2&#x02032;,4&#x02032;-dibromo-phenoxy)phenol (<bold>92</bold>), is found at higher concentrations in the slug&#x02019;s parapodia (8&#x02013;10%) than in the sponge or the rest of tissues of the slug (2&#x02013;4%), thus supporting a potential defensive role [<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>].</p></sec><sec id="sec2dot1dot5-marinedrugs-18-00657"><title>2.1.5. Anaspidea</title><p>Although sea hares are among the most studied heterobranch groups and many compounds have been described, not so many studies have focused on metabolites used to avoid predation [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>,<xref rid="B283-marinedrugs-18-00657" ref-type="bibr">283</xref>]. Usually, sea hares obtain natural products from their red algal food and are often able to biotransform them [<xref rid="B284-marinedrugs-18-00657" ref-type="bibr">284</xref>,<xref rid="B285-marinedrugs-18-00657" ref-type="bibr">285</xref>,<xref rid="B286-marinedrugs-18-00657" ref-type="bibr">286</xref>]. Surprising reports on sea hares include specimens of <italic>Aplysia fasciata</italic> (<italic>A. brasiliana</italic>) being rejected by sharks, even when hidden in fish fillets [<xref rid="B287-marinedrugs-18-00657" ref-type="bibr">287</xref>]. The sharks avoided all of the pieces, except for the buccal mass, presumably containing no defensive metabolites [<xref rid="B287-marinedrugs-18-00657" ref-type="bibr">287</xref>]. In fact, it is well known that sea hares present glandular structures containing deterring compounds, which may be secreted or stored in their external tissues. <italic>A. juliana</italic> is known to use opaline and ink secretions to deter crabs, while <italic>A. californica, A. dactylomela</italic>, and <italic>A. parvula</italic> present aplysioviolin (<bold>93</bold>) and phycoerythrobilin, biotransformed from their algal food in the ink gland and used to avoid blue crabs&#x02019; predation [<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>,<xref rid="B289-marinedrugs-18-00657" ref-type="bibr">289</xref>,<xref rid="B290-marinedrugs-18-00657" ref-type="bibr">290</xref>]. Enzymatic interactions between opaline and ink secretions in <italic>A. californica</italic> involving escapin result in hydrogen peroxide production, and this induces deterrence against crabs, spiny lobsters, fishes, and anemones, as widely described in the literature [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B291-marinedrugs-18-00657" ref-type="bibr">291</xref>,<xref rid="B292-marinedrugs-18-00657" ref-type="bibr">292</xref>,<xref rid="B293-marinedrugs-18-00657" ref-type="bibr">293</xref>,<xref rid="B294-marinedrugs-18-00657" ref-type="bibr">294</xref>,<xref rid="B295-marinedrugs-18-00657" ref-type="bibr">295</xref>,<xref rid="B296-marinedrugs-18-00657" ref-type="bibr">296</xref>,<xref rid="B297-marinedrugs-18-00657" ref-type="bibr">297</xref>]. Significant deterrence was also described when <italic>A. californica</italic> was fed on <italic>Ulva</italic> (green algae) and on <italic>Plocamium</italic> (red algae) and given to kelp bass (<italic>Paralabrax clathratus</italic>), and the effect proved to be stronger when the sea hare had fed on <italic>Plocamium</italic> (richer in natural products) [<xref rid="B298-marinedrugs-18-00657" ref-type="bibr">298</xref>]. <italic>A. parvula</italic> from Guam accumulates apakaochtodenes A (<bold>94</bold>) and B, two halogenated monoterpenes, from their red algal food <italic>Portieria hornemanii</italic>, using them as repellents against potential sympatric reef fish predators at natural concentrations [<xref rid="B299-marinedrugs-18-00657" ref-type="bibr">299</xref>]. In New Zealand, the same species contains several brominated and chlorinated terpenoids from the red algae <italic>Plocamium costatum</italic>, among which costatone (<bold>95</bold>) is found 14 times more concentrated in the slug than in the algae, supporting a potential defensive role [<xref rid="B88-marinedrugs-18-00657" ref-type="bibr">88</xref>,<xref rid="B300-marinedrugs-18-00657" ref-type="bibr">300</xref>].</p><p><italic>Stylocheilus</italic> feeds on cyanobacteria using compounds from their diet to deter predators [<xref rid="B301-marinedrugs-18-00657" ref-type="bibr">301</xref>]. In Hawai&#x02019;i, <italic>S. longicauda</italic> presents aplysiatoxin (<bold>96</bold>), debromoaplysiatoxin (<bold>97</bold>), stylocheilamide (<bold>98</bold>) and some complex proline esters (makalika ester (<bold>99</bold>) and makalikone ester (<bold>100</bold>)) together with lyngbyatoxin A acetate (<bold>101</bold>) [<xref rid="B302-marinedrugs-18-00657" ref-type="bibr">302</xref>,<xref rid="B303-marinedrugs-18-00657" ref-type="bibr">303</xref>,<xref rid="B304-marinedrugs-18-00657" ref-type="bibr">304</xref>,<xref rid="B305-marinedrugs-18-00657" ref-type="bibr">305</xref>]. Stylocheilamide (<bold>98</bold>) was later considered to be identical to acetyl malyngamide I, previously described from the Hawaiian cyanobacteria <italic>Lyngbya majuscula</italic> [<xref rid="B306-marinedrugs-18-00657" ref-type="bibr">306</xref>]. Moreover, the alkaloids malyngamides O (<bold>102</bold>) and P (<bold>103</bold>) were also found in the sea hare, being also structurally related to <italic>L. majuscula</italic> compounds [<xref rid="B307-marinedrugs-18-00657" ref-type="bibr">307</xref>]. Malyngamides A (<bold>104</bold>) and B were first found in <italic>Microcoleus lyngbyaceus</italic> (probably <italic>L. majuscula</italic>) [<xref rid="B308-marinedrugs-18-00657" ref-type="bibr">308</xref>]. In Guam, <italic>S. longicauda</italic> contains malyngamydes from the cyanobacteria and biotransforms malyngamyde B into an acetate. It has been proved that <italic>S. longicauda</italic> compounds are deterrents against sympatric fish (such as the pufferfish <italic>Canthigaster solandri</italic>), amphipods, crabs (<italic>Leptodius</italic> spp.), and even the herbivorous cephalaspidean <italic>Diniatys dentifer</italic> [<xref rid="B309-marinedrugs-18-00657" ref-type="bibr">309</xref>,<xref rid="B310-marinedrugs-18-00657" ref-type="bibr">310</xref>].</p><p><italic>Bursatella leachii plei</italic> from Puerto Rico presents bursatellin (<bold>105</bold>), a diol nitrile alkaloid, structurally related to chloramphenicol, while <italic>B. leachii</italic> from the Mediterranean possesses the (+) and (&#x02013;) isomers of bursatellin (<bold>105</bold>), in their external extracts, but no deterrent activity has been reported to date [<xref rid="B311-marinedrugs-18-00657" ref-type="bibr">311</xref>,<xref rid="B312-marinedrugs-18-00657" ref-type="bibr">312</xref>].</p></sec><sec id="sec2dot1dot6-marinedrugs-18-00657"><title>2.1.6. Pteropoda</title><p>The amazing case of the Antarctic pelagic slug <italic>Clione limacina</italic> is worth mentioning here. <italic>C. limacina</italic> possesses a polypropionate-derived compound, pteroenone (<bold>106</bold>), which is a strong feeding deterrent against fish predators, such as <italic>Pagothenia borchgrevincki</italic> and <italic>Pseudotrematomas bernachii</italic> [<xref rid="B313-marinedrugs-18-00657" ref-type="bibr">313</xref>]. Pteroenone seems to be de novo biosynthesized, since it is not found in the prey of <italic>C. limacina</italic>, the thecosomate <italic>Limacina helicina</italic> [<xref rid="B314-marinedrugs-18-00657" ref-type="bibr">314</xref>]. The pelagic hyperiid crustacean <italic>Hyperiella dilatata</italic> captures and carries the chemically protected pteropods on its dorsum, thus increasing its chances of survival [<xref rid="B315-marinedrugs-18-00657" ref-type="bibr">315</xref>].</p></sec><sec id="sec2dot1dot7-marinedrugs-18-00657"><title>2.1.7. Sacoglossa </title><p>Despite the fact that the variety of compounds described in sacoglossa is huge [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>], very few studies have tested deterrence at natural concentrations and against sympatric predators. The shelled sacoglossa <italic>Ascobulla ulla</italic> presents ascobullin A (<bold>107</bold>) and B, structurally related to oxytoxins (see below), but with less reactive molecules [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>]. <italic>Elysia crispata</italic> from Venezuela contains, among other compounds, crispatenine and onchidal (<bold>108</bold>), the latter also found in the pulmonate <italic>Onchidella</italic> (see below) where it is presumably used to deter potential predators in its active form, ancistrodial (<bold>109</bold>) [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B317-marinedrugs-18-00657" ref-type="bibr">317</xref>,<xref rid="B318-marinedrugs-18-00657" ref-type="bibr">318</xref>,<xref rid="B319-marinedrugs-18-00657" ref-type="bibr">319</xref>]. <italic>Elysia translucens</italic> contains udoteal as a main component from the green algae <italic>Udotea petiolata</italic>, which induces significant avoidance in the fish <italic>Pomacentrus coeruleus</italic> at 800 ppm [<xref rid="B320-marinedrugs-18-00657" ref-type="bibr">320</xref>].</p><p>Among the shell-less sacoglossans, the Mediterranean <italic>Thuridilla hopei</italic> contains the diterpenoids thuridillins (<bold>110</bold>), possessing a central &#x003b1;,&#x003b2;-epoxy-&#x003b4;-lactone ring which is substituted by an uncyclized or cyclized isoprenoid chain and a 2,5-diacetoxy-2,5-dihydrofuran unit [<xref rid="B321-marinedrugs-18-00657" ref-type="bibr">321</xref>,<xref rid="B322-marinedrugs-18-00657" ref-type="bibr">322</xref>]. <italic>T. hopei</italic> also possesses <italic>nor</italic>-thuridillonal (<bold>111</bold>), the epoxylactone from the algae <italic>Pseudochlorodesmis furcellata</italic> [<xref rid="B323-marinedrugs-18-00657" ref-type="bibr">323</xref>], considered the putative precursor of thuridillins (<bold>110</bold>), and which is active in laboratory feeding deterrence tests against the shrimp <italic>Palaemon elegans</italic> at a concentration of 5.0 mg/mL [<xref rid="B322-marinedrugs-18-00657" ref-type="bibr">322</xref>]. <italic>Thuridilla splendens</italic> from Australia also presents thuridillins (<bold>110</bold>), but contrastingly, these thuridillins did not deter feeding by the sympatric shrimp <italic>Palaemon serenus</italic> in the laboratory [<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>,<xref rid="B324-marinedrugs-18-00657" ref-type="bibr">324</xref>].</p><p>The Caribbean <italic>Costasiella ocellifera</italic> (<italic>C. lilianae</italic>) contains avrainvilleol (<bold>112</bold>), a brominated diphenylmethane dietary algal derivative, from feeding on the algae <italic>Avrainvillea longicaulis</italic> [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>]. Avrainvilleol (<bold>112</bold>) possesses deterrent properties against the tropical damselfish <italic>Pomatocentrus coeruleus</italic> at 100 ppm [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>].</p><p>The Mediterranean <italic>Cyerce cristallina</italic> presents cyercene polypropionates (<bold>113</bold>) [<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>]. This slug has unknown feeding habits and may autotomize its cerata [<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>]. Cyercenes (<bold>113</bold>) are also found in the Australian <italic>C. nigricans</italic>, which feeds on <italic>Chlorodesmis</italic> algae and presents the algal diterpenoid chlorodesmin (<bold>114</bold>) [<xref rid="B328-marinedrugs-18-00657" ref-type="bibr">328</xref>]. The Atlantic <italic>Mourgona germaineae</italic> secrets a toxic mucus when disturbed and may also autotomize the cerata [<xref rid="B329-marinedrugs-18-00657" ref-type="bibr">329</xref>]. <italic>M. germaineae</italic> retains active chloroplasts form its algal diet, the calcareous green alga <italic>Cymopolia barbata,</italic> from which it also accumulates prenylated bromohydroquinones, such as cyclocymopol (<bold>115</bold>) [<xref rid="B330-marinedrugs-18-00657" ref-type="bibr">330</xref>]. Cyclocymopol (<bold>115</bold>) is similar to the deterrent avrainvilleol (<bold>112</bold>) mentioned above [<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>]. <italic>Caliphylla mediterranea</italic>, instead, seems to rely only on a defensive cryptic behavior to avoid predators, lacking propionates or other defensive chemistry [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>]. This species captures chloroplasts from the algae <italic>Bryopsis plumula</italic> for camouflage and does not autotomize [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>]. Contrastingly, <italic>Placida dendritica</italic> possesses polypropionate &#x003b3;-pyrones such as <italic>iso</italic>-placidene A (<bold>116</bold>) that are probably used for deterrence; this species also uses crypsis as a defensive mechanism but does not autotomize [<xref rid="B332-marinedrugs-18-00657" ref-type="bibr">332</xref>]. </p></sec><sec id="sec2dot1dot8-marinedrugs-18-00657"><title>2.1.8. Pulmonata</title><p>While many different compounds have been described in pulmonates, very few have been appropriately tested using natural concentrations and against sympatric predators [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. <italic>Trimusculus costatus</italic> from South Africa presents the diterpenoid labdanes 6&#x003b2;,7a-diacetoxylab-8,13-dien-15-ol (<bold>117</bold>) and 2&#x003b1;,6&#x003b2;,7a-triacetoxylabda-8,13-dien-15-ol (<bold>118</bold>), which produce feeding deterrence against the predatory fish <italic>Pomadasys commersonnii</italic> [<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>]. <italic>T. reticulatus</italic> from New Zealand, instead, possesses some deterrent diterpenes, such as 6&#x003b2;-<italic>iso</italic>valeroxylabda-8,13-dien-7&#x003b1;,15-diol and 2&#x003b1;,7&#x003b1;-diacetoxy-6/3-<italic>iso</italic>valeroxylabda-8,13-dien-15-ol, which are located in the mantle and foot are effective against sea star predators [<xref rid="B334-marinedrugs-18-00657" ref-type="bibr">334</xref>]. Other species of this genus also display antifeeding activities, such as <italic>T. costatus</italic> from Chile and <italic>T. peruvianus</italic> from South Africa [<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>,<xref rid="B335-marinedrugs-18-00657" ref-type="bibr">335</xref>,<xref rid="B336-marinedrugs-18-00657" ref-type="bibr">336</xref>,<xref rid="B337-marinedrugs-18-00657" ref-type="bibr">337</xref>].</p><p>Contrastingly, species of the genus <italic>Siphonaria</italic> present two different classes of polypropionates, some of which are found in the mucus and mantle border, thus indicating some sort of deterrent role, and are considered to be de novo biosynthesized [<xref rid="B338-marinedrugs-18-00657" ref-type="bibr">338</xref>,<xref rid="B339-marinedrugs-18-00657" ref-type="bibr">339</xref>]. The first type of polypropionates is represented by acyclic compounds with a 2-pyrone and furanone rings, such as siphonarienolone (<bold>119</bold>), structurally related to the polypropionates of the cephalaspideans (see above). This type of polypropionate is found in some species from Australia, Atlantic Ocean, and South Africa [<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B345-marinedrugs-18-00657" ref-type="bibr">345</xref>,<xref rid="B346-marinedrugs-18-00657" ref-type="bibr">346</xref>]. The second type possesses variable lengths in the alkyl chain, producing a polyoxygenated network that often cyclizes, for example siphonarin A (<bold>120</bold>), similar to polypropionates from actinomycetes, and found in <italic>Siphonaria</italic> from Australia, New Zealand, Pacific Ocean, and South Africa [<xref rid="B347-marinedrugs-18-00657" ref-type="bibr">347</xref>,<xref rid="B348-marinedrugs-18-00657" ref-type="bibr">348</xref>,<xref rid="B349-marinedrugs-18-00657" ref-type="bibr">349</xref>,<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>,<xref rid="B351-marinedrugs-18-00657" ref-type="bibr">351</xref>,<xref rid="B352-marinedrugs-18-00657" ref-type="bibr">352</xref>]. The species that have been analyzed to date include <italic>S. capensis</italic>, <italic>S. concinna</italic>, <italic>S. cristatus</italic>, and <italic>S. serrata</italic>, and some of their polypropionates are deterrents against fish [<xref rid="B353-marinedrugs-18-00657" ref-type="bibr">353</xref>]. </p><p>The Onchidiidae possess repugnatorial glands which may contain sesquiterpenoids, depsipeptide acetates, or propionates. <italic>Onchidella binneyi</italic> presents onchidal (<bold>108</bold>), which is secreted as ancistrodial (<bold>109</bold>), its active form, to deter potential predators [<xref rid="B319-marinedrugs-18-00657" ref-type="bibr">319</xref>]. Many species of <italic>Onchidella</italic> present variable amounts of natural products at different geographical locations, all of them being deterrent for sea stars, such as the sympatric <italic>Leptasterias hexactis</italic> for <italic>Onchidella borealis</italic> [<xref rid="B354-marinedrugs-18-00657" ref-type="bibr">354</xref>,<xref rid="B355-marinedrugs-18-00657" ref-type="bibr">355</xref>]. <italic>Peronia peronii</italic> and several <italic>Onchidium</italic> species present polypropionates similar to those of <italic>Siphonaria</italic> mentioned above [<xref rid="B356-marinedrugs-18-00657" ref-type="bibr">356</xref>,<xref rid="B357-marinedrugs-18-00657" ref-type="bibr">357</xref>], as well as some depsipeptides, such as onchidin (<bold>121</bold>) [<xref rid="B358-marinedrugs-18-00657" ref-type="bibr">358</xref>,<xref rid="B359-marinedrugs-18-00657" ref-type="bibr">359</xref>]. Finally, <italic>Onchidium</italic> sp. From China presents onchidione (<bold>122</bold>) in the mucus and mantle [<xref rid="B360-marinedrugs-18-00657" ref-type="bibr">360</xref>], with a potential defensive role, as well as onchidiol and 4-<italic>epi</italic>-onchidiol (see below) [<xref rid="B361-marinedrugs-18-00657" ref-type="bibr">361</xref>,<xref rid="B362-marinedrugs-18-00657" ref-type="bibr">362</xref>]. </p></sec></sec><sec id="sec2dot2-marinedrugs-18-00657"><title>2.2. Toxicity</title><p>Toxicity was the first described activity in heterobranch molluscs, when the mucus secretion of <italic>Phyllidia varicosa</italic> was reported to be toxic to fish and crustaceans [<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>,<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. All nudibranchs except aeolidids, and all the other groups except pleurobranchoideans and pteropods, have been described to use toxic compounds for protection and survival (<xref ref-type="fig" rid="marinedrugs-18-00657-f006">Figure 6</xref> and <xref ref-type="fig" rid="marinedrugs-18-00657-f007">Figure 7</xref>). Toxicity may affect putative macropredators, such as fish, crabs, or others; small micropredators, such as amphipods or other crustaceans; and even gametes and early embryos of potential competitors or predators (<xref rid="marinedrugs-18-00657-t003" ref-type="table">Table 3</xref>). As mentioned above, the problem of assays that use species that are not sympatric puts in question the ecological validity of some of the results.</p><sec id="sec2dot2dot1-marinedrugs-18-00657"><title>2.2.1. Nudibranchia</title><sec><title>Doridacea</title><p>Species of the genus <italic>Archidoris</italic> present de novo biosynthesized ichthyotoxic diterpene glycerides (<bold>123</bold>) [<xref rid="B71-marinedrugs-18-00657" ref-type="bibr">71</xref>,<xref rid="B363-marinedrugs-18-00657" ref-type="bibr">363</xref>,<xref rid="B364-marinedrugs-18-00657" ref-type="bibr">364</xref>,<xref rid="B365-marinedrugs-18-00657" ref-type="bibr">365</xref>,<xref rid="B366-marinedrugs-18-00657" ref-type="bibr">366</xref>,<xref rid="B367-marinedrugs-18-00657" ref-type="bibr">367</xref>]. In the Atlantic, <italic>A. pseudoargus</italic> locates them in the mantle and egg masses [<xref rid="B363-marinedrugs-18-00657" ref-type="bibr">363</xref>]. Their compounds include a wide variety of terpenoids and related compounds (sesquiterpenoic and diterpenoic acid glycerides and glyceryl ether), although not all of them have been tested for ichthyotoxicity [<xref rid="B367-marinedrugs-18-00657" ref-type="bibr">367</xref>,<xref rid="B368-marinedrugs-18-00657" ref-type="bibr">368</xref>,<xref rid="B369-marinedrugs-18-00657" ref-type="bibr">369</xref>,<xref rid="B370-marinedrugs-18-00657" ref-type="bibr">370</xref>,<xref rid="B371-marinedrugs-18-00657" ref-type="bibr">371</xref>,<xref rid="B372-marinedrugs-18-00657" ref-type="bibr">372</xref>,<xref rid="B373-marinedrugs-18-00657" ref-type="bibr">373</xref>]. <italic>Doris verrucosa</italic> also presents ichthyotoxic diterpenoid acid glycerides, the verrucosins (<bold>124</bold>), active in the laboratory against <italic>Gambusia affinis</italic>, and most probably biosynthesized [<xref rid="B370-marinedrugs-18-00657" ref-type="bibr">370</xref>,<xref rid="B371-marinedrugs-18-00657" ref-type="bibr">371</xref>,<xref rid="B372-marinedrugs-18-00657" ref-type="bibr">372</xref>].</p><p><italic>Phyllidia varicosa</italic> accumulates sponge compounds and secretes them in the mucus, producing toxicity in fish and crustaceans [<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>,<xref rid="B109-marinedrugs-18-00657" ref-type="bibr">109</xref>]. Among several other bioactive compounds, 9-<italic>iso</italic>cyanopupukeanane (<bold>21</bold>) and 2-<italic>iso</italic>cyanopupukeanane (<bold>22</bold>) are obtained from the demosponge <italic>Ciocalypta</italic> (<italic>Hymeniacidon)</italic> [<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>,<xref rid="B107-marinedrugs-18-00657" ref-type="bibr">107</xref>]. When 9-<italic>iso</italic>cyanopupukanane (<bold>21</bold>) was tested using the killifish <italic>Oryzias latipes</italic>, it was more toxic than its 9-epi-isomer, while 2-<italic>iso</italic>cyanoallopupukeanane (<bold>125</bold>) was toxic at 10 &#x003bc;g/mL [<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B185-marinedrugs-18-00657" ref-type="bibr">185</xref>]. In Indonesia, <italic>P. varicosa</italic> feeds on <italic>Axinyssa aculeata</italic> sequestering two epimeric 9-thiocyanatopupekeanane sesquiterpenes (<bold>126</bold>), which, together with 9-<italic>iso</italic>cyanopupukeanane (<bold>21</bold>), are mildly toxic to brine shrimp (LC<sub>50</sub> 5 ppm) in the laboratory [<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>]. <italic>P. pulitzeri</italic> and its sponge food, <italic>Axinella cannabina</italic>, possess axisonitrile-1 (<bold>127</bold>), which was toxic against the marine fish <italic>Chromis chromis</italic> and the freshwater fish <italic>Carassius carassius</italic> [<xref rid="B184-marinedrugs-18-00657" ref-type="bibr">184</xref>]. Many other phyllidid species (<italic>P. rosans (P. bourguini)</italic>, <italic>P. coelestis</italic>, <italic>P. ocellata</italic>, <italic>Phyllidia</italic> sp, <italic>Phyllidiella pustulosa</italic>, <italic>Phyllidiopsis krempfi</italic>, etc.) contain a wide variety of these and other nitrogenated compounds, but these have not been tested for toxicity [<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>,<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>,<xref rid="B373-marinedrugs-18-00657" ref-type="bibr">373</xref>,<xref rid="B374-marinedrugs-18-00657" ref-type="bibr">374</xref>,<xref rid="B375-marinedrugs-18-00657" ref-type="bibr">375</xref>,<xref rid="B376-marinedrugs-18-00657" ref-type="bibr">376</xref>,<xref rid="B377-marinedrugs-18-00657" ref-type="bibr">377</xref>].</p><p>Within chromodoridids, <italic>Cadlina luteomarginata</italic> presents three isocyanides (<bold>30</bold>) and three isothiocyanates (<bold>128</bold>) obtained from its sponge diet [<xref rid="B126-marinedrugs-18-00657" ref-type="bibr">126</xref>,<xref rid="B127-marinedrugs-18-00657" ref-type="bibr">127</xref>]. These metabolites resulted toxic in laboratory at 100 &#x003bc;g/mL, but no studies at natural concentrations and sympatric species are reported [<xref rid="B126-marinedrugs-18-00657" ref-type="bibr">126</xref>,<xref rid="B127-marinedrugs-18-00657" ref-type="bibr">127</xref>]. Further, as previously mentioned, the well-studied genus <italic>Chromodoris</italic> possess toxic compounds [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>]. Kurospongin (<bold>36</bold>), a furanoterpene found in <italic>C. africana</italic> from the Red Sea, was obtained from an Okinawan <italic>Spongia</italic> sp. and reported to be strongly ichthyotoxic to the freshwater goldfish (<italic>C. auratus</italic>) at 5 &#x003bc;g/mL [<xref rid="B167-marinedrugs-18-00657" ref-type="bibr">167</xref>]. <italic>C. hamiltoni</italic> from South Africa and Mozambique presents one or both latrunculins A and B (<bold>38,37</bold>), among other compounds, as does <italic>C. africana</italic> from the Red Sea, and <italic>C. quadricolor</italic> (<italic>Glossodoris quadricolor</italic>) [<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>,<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]. Latrunculin B (<bold>37</bold>) has been reported to be ichthyotoxic and was described from the sponge <italic>Latrunculia</italic> magnifica [<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>]. The Mediterranean <italic>Felimida (Chromodoris) luteorosea</italic> contains many ichthyotoxic sponge-derived diterpenes tested in the laboratory, including norrisolide (<bold>130</bold>), polyrhaphin C (<bold>131</bold>), chelonaplysin C (<bold>132</bold>), luteorosin (<bold>133</bold>), macfarlandin A (<bold>134</bold>), and closely related compounds [<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>]. Although many other <italic>Chromodoris</italic> species possess interesting chemicals, they have not been tested for toxicity.</p><p>Among the scalarane sesterterpenes described in <italic>Doriprismatica (Glossodoris) sedna</italic> from Costa Rica, 12-deacetyl-23-acetoxy-20-methyl-12-<italic>epi</italic>-scalaradial (<bold>135</bold>) was ichthyotoxic to the allopatric fish <italic>Gambusia affinis</italic> at 0.1 ppm [<xref rid="B183-marinedrugs-18-00657" ref-type="bibr">183</xref>]. <italic>Goniobranchus splendidus</italic> from Australia contains many sponge compounds, mainly spongian diterpenes, rearranged diterpenes, and nor-diterpenes [<xref rid="B187-marinedrugs-18-00657" ref-type="bibr">187</xref>]. Its chemical extracts have been proven to be toxic to brine shrimp (<italic>Artemia</italic> sp.) at natural concentrations, with potency depending on the mixture of chemicals present in each population analyzed, from no activity to toxicity [<xref rid="B187-marinedrugs-18-00657" ref-type="bibr">187</xref>]. <italic>Doriprismatica (Glossodoris) atromarginata</italic> presents furanoditerpenoids and scalarane sesterterpenes from its dietary sponges <italic>Spongia</italic> (<italic>Hyatella</italic>) sp. and <italic>Hyrtios</italic> spp., and these compounds display ichthyotoxicity against the mosquito fish, <italic>G. affinis</italic>&#x02014;particularly, the activity of 12-deacetoxy-12-oxodeoxoscalarin (<bold>136</bold>) is noticeable [<xref rid="B92-marinedrugs-18-00657" ref-type="bibr">92</xref>,<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B378-marinedrugs-18-00657" ref-type="bibr">378</xref>,<xref rid="B379-marinedrugs-18-00657" ref-type="bibr">379</xref>,<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B382-marinedrugs-18-00657" ref-type="bibr">382</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>,<xref rid="B384-marinedrugs-18-00657" ref-type="bibr">384</xref>,<xref rid="B385-marinedrugs-18-00657" ref-type="bibr">385</xref>,<xref rid="B386-marinedrugs-18-00657" ref-type="bibr">386</xref>]. Other NPs from chromodoridids were analyzed for ichthyotoxicity against <italic>G. affinis</italic>, including homoscalarane and scalarane compounds from <italic>Felimida (Glossodoris) dalli</italic>, <italic>Glossodoris rufomarginata</italic>, <italic>Glossodoris pallida</italic>, <italic>Glossodoris vespa</italic>, and <italic>Ardeadoris (Glossodoris) averni</italic>, and 12-deacetyl-23-acetoxy-20-methyl-12-<italic>epi-</italic>scalaradial (<bold>135</bold>) was the most potent of them [<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B183-marinedrugs-18-00657" ref-type="bibr">183</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>].</p><p><italic>Ceratosoma trilobatum</italic> and <italic>C. gracillimum</italic> from China contain the furanosesquiterpenes pallescensin B (<bold>47</bold>), (&#x02013;)-furodysinin (<bold>48</bold>), (&#x02013;)-dehydroherbadysidolide (<bold>49</bold>), and (&#x02013;)-herbadysidolide (<bold>50</bold>), previously found in <italic>Dysidea</italic> sponges. These were tested for toxicity in the laboratory against mosquito fish and were all observed to be non-toxic except (&#x02013;)-furodysinin (<bold>48</bold>) [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B193-marinedrugs-18-00657" ref-type="bibr">193</xref>].</p></sec><sec><title>Dendronotida</title><p>The Mediterranean species <italic>Tethys fimbria</italic> contains a variety of de novo synthesized prostaglandins with diverse functions [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>], among which is a prostaglandin lactone, PGE<sub>2</sub>-1,15-lactone (<bold>80</bold>), later also found in <italic>Melibe viridis</italic> [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]. This prostaglandin lactone (<bold>80</bold>) is located in the mucus and cerata of <italic>T. fimbria</italic> and is ichthyotoxic in the laboratory against the mosquito fish [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>].</p></sec><sec><title>Euarminida</title><p>Two euarminid species are reported to present toxic compounds. In China, <italic>Dermatobranchus ornatus</italic> has been reported to possess compounds inhibiting cell division in fertilized starfish eggs [<xref rid="B9-marinedrugs-18-00657" ref-type="bibr">9</xref>]. <italic>D. ornatus</italic> possesses four diterpenoids of the eunicellin class in the mantle, ophirin (<bold>137</bold>), calicophirin B, 13-deacetoxyl calicophirin B, and 13-deacetoxyl-3-deacetyl calicophirin B, two of them probably from its diet on the gorgonian <italic>Muricella sinensis</italic>, and another one previously found in an unidentified soft coral from the Pacific Ocean [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B387-marinedrugs-18-00657" ref-type="bibr">387</xref>]. Among them, ophirin (<bold>137</bold>) is reported to induce brine shrimp (<italic>Artemia</italic> sp.) lethality. The second case is that of <italic>Janolus cristatus</italic>, which possesses janolusimide (<bold>138</bold>), a toxic tripeptide which is toxic to mice at LD 5 mg/kg [<xref rid="B388-marinedrugs-18-00657" ref-type="bibr">388</xref>,<xref rid="B389-marinedrugs-18-00657" ref-type="bibr">389</xref>]. The N-methyl analogue, janolusimide B, has been further isolated from <italic>Bugula flabellata</italic>, a bryozoan from New Zealand, thus suggesting a putative dietary origin for janolusimide (<bold>138</bold>) [<xref rid="B390-marinedrugs-18-00657" ref-type="bibr">390</xref>].</p></sec></sec><sec id="sec2dot2dot2-marinedrugs-18-00657"><title>2.2.2. Tylodinoidea</title><p>The Mediterranean <italic>Umbraculum mediterraneum</italic> contains diacylglycerid fatty acid esters that are ichthyotoxic to the mosquito fish in the laboratory [<xref rid="B391-marinedrugs-18-00657" ref-type="bibr">391</xref>,<xref rid="B392-marinedrugs-18-00657" ref-type="bibr">392</xref>,<xref rid="B393-marinedrugs-18-00657" ref-type="bibr">393</xref>]. These natural products, umbraculumins A, B, and C (<bold>139</bold>), are suggested to be obtained from their sponge prey [<xref rid="B263-marinedrugs-18-00657" ref-type="bibr">263</xref>].</p></sec><sec id="sec2dot2dot3-marinedrugs-18-00657"><title>2.2.3. Cephalaspidea</title><p>Several compounds from <italic>Bulla</italic> species, such as niuhinone-B, isopulo&#x02019;upone (<bold>140</bold>), and 5,6-dehydroaglajne-3 (<bold>141</bold>), are polypronionates described to be toxic to fish and shrimp [<xref rid="B274-marinedrugs-18-00657" ref-type="bibr">274</xref>,<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]. Niuhinone-B is found in the Pacific <italic>B. gouldiana</italic> and the Mexican <italic>B. occidentalis</italic> [<xref rid="B274-marinedrugs-18-00657" ref-type="bibr">274</xref>,<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]. In the Pacific Ocean, <italic>Navanax inermis</italic> also uses these compounds after ingesting <italic>B. gouldiana</italic> specimens, while in Hawai&#x02019;i, <italic>Philinopsis depicta</italic> probably obtains niuhinone-B from other cephalaspideans [<xref rid="B272-marinedrugs-18-00657" ref-type="bibr">272</xref>,<xref rid="B273-marinedrugs-18-00657" ref-type="bibr">273</xref>,<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]. <italic>N. inermis</italic> also contains <italic>iso</italic>pulo&#x02019;upone (<bold>140</bold>), which is reported to be a strong ichthyotoxin that significantly affects the mosquito fish <italic>Gambusia affinis</italic> at 10 ppm and <italic>Artemia salina</italic> at 2 ppm in the laboratory [<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B394-marinedrugs-18-00657" ref-type="bibr">394</xref>]. The Mediterranean <italic>P. depicta</italic> contains aglajne-3 (<bold>88</bold>), a polypropionate toxic to <italic>Artemia salina</italic> (LD<sub>50</sub> &#x0003c; 35 ppm) and <italic>Gambusia affinis</italic> [<xref rid="B270-marinedrugs-18-00657" ref-type="bibr">270</xref>].</p><p><italic>Haminoea</italic> species also possess some toxic compounds. In the Mediterranean, <italic>H. cyanomarginata</italic> presents a brominated tetrahydropyran (<bold>142</bold>) reported to be highly toxic to the mosquito fish <italic>G. affinis</italic> at 1 ppm in the laboratory [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]. This tetrahydropyran (<bold>142</bold>) was also found in the Indian <italic>H. cymbalum</italic>, where it could play the same role, and it is structurally similar to kumepaloxane (<bold>91</bold>) from conspecifics of Guam [<xref rid="B280-marinedrugs-18-00657" ref-type="bibr">280</xref>].</p></sec><sec id="sec2dot2dot4-marinedrugs-18-00657"><title>2.2.4. Anaspidea</title><p>Several sea hares are reported to use toxic compounds. In the Mediterranean, <italic>Aplysia fasciata</italic> presents different compounds in different locations, with polyhalogenated monoterpenes similar to those of <italic>Plocamium</italic> red algae in some places [<xref rid="B395-marinedrugs-18-00657" ref-type="bibr">395</xref>], but some degraded sterols in other localities, such as 4-acetylaplykurodin-B (<bold>143</bold>), aplykurodinone B (<bold>144</bold>), and 3-<italic>epi</italic>-aplykurodinone B (<bold>145</bold>), which are located in the mantle and are described to be ichthyotoxic to the mosquito fish <italic>G. affinis</italic> in the laboratory [<xref rid="B396-marinedrugs-18-00657" ref-type="bibr">396</xref>]. These compounds are also related to the steroids found in the Atlantic <italic>A. fasciata</italic> [<xref rid="B397-marinedrugs-18-00657" ref-type="bibr">397</xref>] and to aplykurodin B (<bold>146</bold>) from the Pacific <italic>A. kurodai</italic> [<xref rid="B398-marinedrugs-18-00657" ref-type="bibr">398</xref>]. In Japan, instead, <italic>A. parvula</italic> possesses the ichthyotoxic brominated acetogenin dicyclic ether, aplyparvunin (<bold>147</bold>), which possesses strong activity (LC<sub>100</sub> 3 ppm in 24h) against <italic>G. affinis</italic> in the laboratory [<xref rid="B399-marinedrugs-18-00657" ref-type="bibr">399</xref>], while specimens from South East Africa present (3<italic>Z</italic>)-bromofucin (<bold>148</bold>), a halogenated cyclic acetogenin obtained from its red algal food, <italic>Laurencia implicata</italic> [<xref rid="B400-marinedrugs-18-00657" ref-type="bibr">400</xref>]. <italic>A. vaccaria</italic> from the Pacific Ocean presents also ichthyotoxic compounds, in this case, the crenulides (<bold>149</bold>), non-halogenated diterpenoids obtained from its brown algal food, <italic>Dictyota crenulata,</italic> and located in their digestive gland [<xref rid="B401-marinedrugs-18-00657" ref-type="bibr">401</xref>,<xref rid="B402-marinedrugs-18-00657" ref-type="bibr">402</xref>]. Crenulides (<bold>149</bold>) are toxic to the reef-dwelling fish <italic>Eupomacentrus leucosticus</italic> at 10 &#x000b5;g/mL [<xref rid="B401-marinedrugs-18-00657" ref-type="bibr">401</xref>,<xref rid="B402-marinedrugs-18-00657" ref-type="bibr">402</xref>]. <italic>A. depilans</italic> also possesses ichthyotoxic fatty acid lactones, the aplyolides A&#x02212;E (<bold>150,151</bold>), which are toxic in the laboratory to the mosquito fish <italic>G. affinis</italic> at 10 ppm [<xref rid="B403-marinedrugs-18-00657" ref-type="bibr">403</xref>]. In the Caribbean, <italic>A. argus</italic> presents ichthyotoxic biotransformed compounds from its diet, the brown algae <italic>Stypopodium zonale</italic>, but it possesses the bioactive diphenyl ether 2-(2&#x02032;,4&#x02032;dibromophenoxy)-dibromoanisole from the green alga <italic>Cladophora vagabunda</italic> in the digestive gland when it feeds on it [<xref rid="B404-marinedrugs-18-00657" ref-type="bibr">404</xref>,<xref rid="B405-marinedrugs-18-00657" ref-type="bibr">405</xref>].</p><p>Several bioactive compounds have also been isolated from <italic>Stylocheilus</italic>, mostly related to cyanobacterial metabolites [<xref rid="B301-marinedrugs-18-00657" ref-type="bibr">301</xref>,<xref rid="B302-marinedrugs-18-00657" ref-type="bibr">302</xref>,<xref rid="B303-marinedrugs-18-00657" ref-type="bibr">303</xref>,<xref rid="B304-marinedrugs-18-00657" ref-type="bibr">304</xref>,<xref rid="B305-marinedrugs-18-00657" ref-type="bibr">305</xref>,<xref rid="B306-marinedrugs-18-00657" ref-type="bibr">306</xref>,<xref rid="B307-marinedrugs-18-00657" ref-type="bibr">307</xref>,<xref rid="B308-marinedrugs-18-00657" ref-type="bibr">308</xref>,<xref rid="B309-marinedrugs-18-00657" ref-type="bibr">309</xref>,<xref rid="B310-marinedrugs-18-00657" ref-type="bibr">310</xref>]. However, only the related acetyl malyngamide I (<bold>152</bold>) from the Hawaiian <italic>Lyngbya majuscula</italic> was found to be ichthyotoxic [<xref rid="B306-marinedrugs-18-00657" ref-type="bibr">306</xref>], being structurally similar to stylocheilamide (<bold>98</bold>), a non-toxic amide from the Hawaiian <italic>S. longicauda</italic> [<xref rid="B304-marinedrugs-18-00657" ref-type="bibr">304</xref>].</p></sec><sec id="sec2dot2dot5-marinedrugs-18-00657"><title>2.2.5. Sacoglossa </title><p>The first toxic species reported in this group was <italic>Oxynoe panamensis</italic> from California, containing caulerpicin (<bold>153</bold>) and caulerpin (<bold>154</bold>) from its green algal food, <italic>Caulerpa sertularioides</italic> [<xref rid="B406-marinedrugs-18-00657" ref-type="bibr">406</xref>]. Later, in the Mediterranean, the shelled sacoglossans <italic>Oxynoe olivacea</italic> and <italic>Ascobulla</italic> (<italic>Cylindrobulla</italic>) <italic>fragilis</italic> were described to biotransform the sesquiterpenoid caulerpenyne (<bold>155</bold>) from its green algal food (<italic>Caulerpa prolifera</italic>) into the more potent ichthyotoxic aldehydes, oxytoxin-1 (<bold>156</bold>) and oxytoxin-2 [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B407-marinedrugs-18-00657" ref-type="bibr">407</xref>]. In particular, oxytoxin-1 (<bold>156</bold>) is toxic to the mosquito fish <italic>G. affinis</italic> at &#x0003e;10 &#x000b5;g/mL in the laboratory, while oxytoxin-2 is toxic at 1 &#x000b5;g/mL. These animals are able to transport the compounds from the digestive gland to the mantle and secrete them into toxic whitish mucus [<xref rid="B407-marinedrugs-18-00657" ref-type="bibr">407</xref>]. Similarly, <italic>Lobiger serradifalci</italic>, also feeding on <italic>C. prolifera,</italic> presents only oxytoxin-1 (<bold>156</bold>) in its parapodial lobes and defensive secretion [<xref rid="B407-marinedrugs-18-00657" ref-type="bibr">407</xref>,<xref rid="B408-marinedrugs-18-00657" ref-type="bibr">408</xref>]. In the Caribbean species <italic>Ascobulla ulla</italic> (eating <italic>Caulerpa fastigiata</italic>), <italic>Oxynoe antillarum</italic> (eating <italic>Caulerpa</italic> sp.), and <italic>Lobiger souberveii</italic> (eating <italic>Caulerpa racemosa</italic>), also caulerpenyne (<bold>155</bold>) is also found [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>]. In fact, only caulerpenyne (<bold>155</bold>) is detected in <italic>L. souberveii</italic>, while the rest of species modify it to oxytoxins (<bold>156</bold>) [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>]. Caulerpenyne (<bold>155</bold>) is also found in <italic>Volvatella</italic> sp. in India [<xref rid="B409-marinedrugs-18-00657" ref-type="bibr">409</xref>].</p><p>Some shell-less species use the same system, transforming caulerpenyne (<bold>155</bold>) from <italic>Caulerpa</italic> species into oxytoxins (<bold>156</bold>) [<xref rid="B410-marinedrugs-18-00657" ref-type="bibr">410</xref>]. The Caribbean <italic>Elysia subornata</italic> feeds on <italic>Caulerpa prolifera</italic>, while <italic>E. patina</italic> and <italic>E. nisbeti</italic> feed on <italic>Caulerpa</italic> sp., and they all present caulerpenyne (<bold>155</bold>) and oxytoxin-1 (<bold>156</bold>) [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>]. In India, <italic>E.</italic> cf. <italic>expansa</italic> also contains caulerpenyne (<bold>155</bold>), along with dihydrocaulerpenyne and expansinol, some minor reduced derivatives, similar to <italic>Ascobulla ulla</italic> compounds (see above) [<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>]. In <italic>A. ulla,</italic> ascobullin A (<bold>107</bold>) and ascobullin B have replaced oxytoxins, being structurally related but less reactive compounds detoxification process [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>]. </p><p>Avrainvilleol (<bold>112</bold>) from <italic>Costasiella ocellifera</italic> (<italic>C. lilianae</italic>) from the Caribbean is toxic to sympatric reef fishes at 10 &#x000b5;g/mL [<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>].</p><p>Cyercenes (<bold>113</bold>) are pyrone compounds found in several shell-less sacoglossans, displaying a very strong ichthyotoxicity against the mosquito fish, <italic>G. affinis</italic> in the laboratory [<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>]. The Mediterranean <italic>Cyerce cristallina</italic> de novo biosynthesizes the <italic>&#x003b1;</italic>- and <italic>&#x003b3;</italic>-pyrones cyercene A (<bold>157</bold>) and B, as well as cyercenes 1&#x02013;5 (<bold>158,159</bold>) [<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>]. In the toxicity assays, the most active compounds were cyercene A (<bold>157</bold>), cyercene-3 (<bold>158</bold>), and cyercene-4 (<bold>159</bold>), all at 10 &#x000b5;g/mL [<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>]. Although many other compounds of interest have been described in this group [<xref rid="B19-marinedrugs-18-00657" ref-type="bibr">19</xref>,<xref rid="B412-marinedrugs-18-00657" ref-type="bibr">412</xref>,<xref rid="B413-marinedrugs-18-00657" ref-type="bibr">413</xref>,<xref rid="B414-marinedrugs-18-00657" ref-type="bibr">414</xref>,<xref rid="B415-marinedrugs-18-00657" ref-type="bibr">415</xref>,<xref rid="B416-marinedrugs-18-00657" ref-type="bibr">416</xref>,<xref rid="B417-marinedrugs-18-00657" ref-type="bibr">417</xref>,<xref rid="B418-marinedrugs-18-00657" ref-type="bibr">418</xref>,<xref rid="B419-marinedrugs-18-00657" ref-type="bibr">419</xref>], they have not been proven to be toxic against sympatric species.</p></sec><sec id="sec2dot2dot6-marinedrugs-18-00657"><title>2.2.6. Pulmonata</title><p><italic>Trimusculus costatus</italic> from South Africa presents the labdanes 6&#x003b2;,7a-diacetoxylab-8,13-dien-15-ol (<bold>117</bold>) and 2&#x003b1;,6&#x003b2;,7a-triacetoxylabda-8,13-dien-15-ol (<bold>118</bold>), both toxic to the brine shrimp <italic>Artemia salina</italic> in the laboratory [<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>]. <italic>Siphonaria</italic> species present two different types of polypropionates, some of them located in the mucus and mantle border and reported to be ichthyotoxic [<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>]. <italic>Siphonaria maura</italic> from Mexico presents Vallartanone B, which in laboratory assays was rejected when applied to krill at 100 &#x000b5;g/mg and offered to the fish <italic>Thallasoma lunare</italic> [<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>].</p></sec></sec><sec id="sec2dot3-marinedrugs-18-00657"><title>2.3. Antimicrobials</title><p>Many marine organisms possess compounds to avoid microbial infections, and heterobranchs are no exception. Antimicrobial compounds against marine microorganisms described in heterobranchs are reported here (<xref ref-type="fig" rid="marinedrugs-18-00657-f008">Figure 8</xref>, <xref rid="marinedrugs-18-00657-t004" ref-type="table">Table 4</xref>). To the best of our knowledge, however, euarminids, pleurobranchoids, tylodinoids, pteropods, and sacoglossans have not been studied for this activity to date.</p><sec id="sec2dot3dot1-marinedrugs-18-00657"><title>2.3.1. Nudibranchia</title><sec><title>Doridacea</title><p><italic>Notodoris citrina</italic> from the Red Sea presents several imidazole alkaloids, among which <italic>iso</italic>naamidine-A (<bold>160</bold>) has been reported to strongly inhibit the AI-2 channel of the marine pathogen <italic>Vibrio harveyi</italic>, acting as a quorum sensing inhibitor [<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B425-marinedrugs-18-00657" ref-type="bibr">425</xref>]. Some of the compounds of <italic>N. citrina</italic> have been also found in the calcareous sponge <italic>Leucetta chagosensis,</italic> which is the slug diet at different geographical localities [<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B425-marinedrugs-18-00657" ref-type="bibr">425</xref>]. <italic>Iso</italic>naamidine-A (<bold>160</bold>) has also been found in <italic>Notodoris gardineri</italic> from the Philippines [<xref rid="B426-marinedrugs-18-00657" ref-type="bibr">426</xref>].</p><p>Several species of the colorful Phyllidids have been reported to contain isocyanate compounds with diverse bioactive properties [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B104-marinedrugs-18-00657" ref-type="bibr">104</xref>,<xref rid="B105-marinedrugs-18-00657" ref-type="bibr">105</xref>]. As previously mentioned, this is a particularly difficult group to study since many species and genera are similar in shape and color, resulting in many misidentifications over the years [<xref rid="B99-marinedrugs-18-00657" ref-type="bibr">99</xref>], although some species have been studied in depth [<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B104-marinedrugs-18-00657" ref-type="bibr">104</xref>,<xref rid="B105-marinedrugs-18-00657" ref-type="bibr">105</xref>,<xref rid="B427-marinedrugs-18-00657" ref-type="bibr">427</xref>]. <italic>Phyllidiella pustulosa</italic> presents compounds obtained from the sponge <italic>Acanthella cavernosa</italic> [<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>]. <italic>Acanthella</italic> sponges are the dietary origin for different sesquiterpene isocyanides and related compounds in specimens from China and Vietnam [<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B121-marinedrugs-18-00657" ref-type="bibr">121</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>]. Recent chemical analysis of the South China Sea nudibranchs, <italic>P. pustulosa</italic> and <italic>Phyllidia coelestis</italic>, as well as <italic>A. cavernosa</italic>, reported a nitrogenous cadinane-type sesquiterpenoid, xidaoisocyanate A (<bold>24</bold>), among other sesqui- and di-terpenoids [<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. Moreover, axisonitrile-3 (<bold>25</bold>) and several minor related sesquiterpenes were isolated from the same species, <italic>P. pustulosa,</italic> from Fiji [<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>]. Moreover, <italic>P. pustulosa</italic> and <italic>Phyllidia ocellata</italic> from Australia also present some stereoisomers of 4-isocyano-9-amorphene and of 10-isocyano-4-amorphene, respectively, while <italic>Phyllidia picta</italic> from Bali contains the axane sesquiterpenoids pictaisonitrile-1 (<bold>23</bold>) and pictaisonitrile-2 [<xref rid="B112-marinedrugs-18-00657" ref-type="bibr">112</xref>]. <italic>Phyllidia</italic> sp. from Sri Lanka contains 3-<italic>iso</italic>cyano-theonellin (<bold>161</bold>), closely related to a cyanide obtained from the demosponge <italic>Axinyssa</italic> [<xref rid="B113-marinedrugs-18-00657" ref-type="bibr">113</xref>]. <italic>P. varicosa</italic> presents two 9-thiocyanatopupukeanane sesquiterpenes (<bold>126</bold>), found also in its demosponge prey <italic>Axinyssa aculeata</italic> [<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>]. Several of these compounds are reported to have an antimicrobial role. </p></sec><sec><title>Dendronotida</title><p>Only homarine (<bold>79</bold>) has been described in this group as a potential antimicrobial [<xref rid="B428-marinedrugs-18-00657" ref-type="bibr">428</xref>], and it is found in the species <italic>Marionia blainvillea</italic> [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]. </p></sec><sec><title>Aeolidida</title><p>Again, homarine (<bold>79</bold>) has been found in nine aeolid species as mentioned above (<xref rid="marinedrugs-18-00657-t002" ref-type="table">Table 2</xref>), and it has been reported as a potential antimicrobial, probably derived from their cnidarian food sources [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B428-marinedrugs-18-00657" ref-type="bibr">428</xref>]. </p></sec></sec><sec id="sec2dot3dot2-marinedrugs-18-00657"><title>2.3.2. Cephalaspidea</title><p>In cephalaspideans, homarine (<bold>79</bold>) has also been described in <italic>Aglaja tricolorata</italic>, originating probably from their diet of other heterobranchs [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>].</p></sec><sec id="sec2dot3dot3-marinedrugs-18-00657"><title>2.3.3. Anaspidea</title><p>Regarding sea hares, <italic>Aplysia punctata</italic> possesses three brominated diterpenes, glandulaurencianols A&#x02013;C (<bold>162,163</bold>), obtained from the red algae <italic>Laurencia glandulifera</italic>, along with punctatol (<bold>164</bold>) [<xref rid="B429-marinedrugs-18-00657" ref-type="bibr">429</xref>,<xref rid="B430-marinedrugs-18-00657" ref-type="bibr">430</xref>]. All these compounds showed a laurencianol skeleton, known for its antibacterial activity and a common algal dietary source [<xref rid="B431-marinedrugs-18-00657" ref-type="bibr">431</xref>]. Moreover, the cosmopolitan <italic>Aplysia juliana</italic> presents two toxic chlorophyll derivatives, pyropheophorbides <italic>a</italic> and <italic>b,</italic> and a halogenated diterpenoid lactone, while its purple secretion also includes an antibacterial and cytotoxic peptide, julianin-S, and their egg masses are protected from microbial infections by unsaturated fatty acids [<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>,<xref rid="B432-marinedrugs-18-00657" ref-type="bibr">432</xref>,<xref rid="B433-marinedrugs-18-00657" ref-type="bibr">433</xref>,<xref rid="B434-marinedrugs-18-00657" ref-type="bibr">434</xref>].</p><p><italic>Dolabella auricularia</italic> is another anaspidean known for protecting their eggs from bacterial pathogens, with a de novo biosynthesized glycoprotein, dolabellanin A, located in the albumen gland, showing antibacterial activity [<xref rid="B435-marinedrugs-18-00657" ref-type="bibr">435</xref>].</p></sec><sec id="sec2dot3dot4-marinedrugs-18-00657"><title>2.3.4. Pulmonata</title><p>Some <italic>Siphonaria</italic> species possess polypropionates in their mucus and mantle border [<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>]. Compounds with a 2-pyrone and furanone rings, such as siphonarienolone (<bold>119</bold>), structurally related to the polypropionates of cephalaspideans, are present in several species from Australia, the West and East Atlantic, and South Africa [<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>]. Both <italic>S. diemenensis</italic> and <italic>S. pectinata</italic> display antimicrobial activity due to the presence of diemenensin-A (<bold>165</bold>) and pectinatone (<bold>166</bold>), respectively [<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>].</p></sec></sec><sec id="sec2dot4-marinedrugs-18-00657"><title>2.4. Antifouling</title><p>Potentially, all surfaces under water are possible substrates for fouling colonization. Marine organisms have developed an amazing array of mechanisms to avoid fouling, and these include the use of chemicals [<xref rid="B436-marinedrugs-18-00657" ref-type="bibr">436</xref>]. In heterobranch molluscs, all nudibranchs except euarminids, as well as cephalaspideans, have been reported to possess antifouling compounds (<xref ref-type="fig" rid="marinedrugs-18-00657-f009">Figure 9</xref>, <xref rid="marinedrugs-18-00657-t005" ref-type="table">Table 5</xref>).</p><sec id="sec2dot4dot1-marinedrugs-18-00657"><title>2.4.1. Nudibranchia</title><sec><title>Doridacea</title><p>Since the isolation of 9-<italic>iso</italic>cyanopupukeanane (<bold>21</bold>) from <italic>Phillidia varicosa</italic> [<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>], phyllidids have been shown to be chemically rich, presenting many nitrogenous mono-, bi- and tri-cyclic sesquiterpenes, usually traced back to their sponge prey [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>,<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B104-marinedrugs-18-00657" ref-type="bibr">104</xref>,<xref rid="B105-marinedrugs-18-00657" ref-type="bibr">105</xref>,<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>,<xref rid="B107-marinedrugs-18-00657" ref-type="bibr">107</xref>,<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>,<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>,<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B116-marinedrugs-18-00657" ref-type="bibr">116</xref>,<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>,<xref rid="B374-marinedrugs-18-00657" ref-type="bibr">374</xref>,<xref rid="B375-marinedrugs-18-00657" ref-type="bibr">375</xref>,<xref rid="B376-marinedrugs-18-00657" ref-type="bibr">376</xref>,<xref rid="B377-marinedrugs-18-00657" ref-type="bibr">377</xref>,<xref rid="B437-marinedrugs-18-00657" ref-type="bibr">437</xref>]. Some of these compounds are potent antifouling agents, effective against barnacle larvae, such as the bisabolene 3-<italic>iso</italic>cyanotheonellin (<bold>161</bold>) of <italic>P. varicosa</italic> from Sri Lanka, and a sesquiterpene isonitrile from the Japanese <italic>Phyllidiella pustulosa</italic> [<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B115-marinedrugs-18-00657" ref-type="bibr">115</xref>,<xref rid="B116-marinedrugs-18-00657" ref-type="bibr">116</xref>,<xref rid="B437-marinedrugs-18-00657" ref-type="bibr">437</xref>]. Moreover, from <italic>Phyllidia</italic> sp. collected at Sri Lanka, some nitrogenous bisabolene sesquiterpenes exhibited a potent in vitro antifouling activity against barnacle larvae [<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B115-marinedrugs-18-00657" ref-type="bibr">115</xref>]. Different studies on <italic>Phyllidia ocelata</italic>, <italic>P. varicosa</italic>, <italic>Phyllidiella pustulosa</italic>, and <italic>Phillidiopsis krempfi</italic> with the aim of identifying antifouling activity reported three sesquiterpene isonitriles, namely, 10-<italic>epi</italic>-axisonitrile-3, 10-<italic>iso</italic>cyano-4-cadinene, and 2-<italic>iso</italic>cyanotrachyopsane, as well as a peroxide, 1,7-<italic>epi</italic>dioxy-5-cadinene, among others [<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B116-marinedrugs-18-00657" ref-type="bibr">116</xref>]. These molecules display potent antifouling activity against larvae of the barnacle <italic>Balanus amphitrite</italic> (EC<sub>50</sub> = 0.14 &#x003bc;g/mL), while axisonitrile-3 (<bold>25</bold>) has an EC<sub>50</sub> value of 3,2 &#x003bc;g/mL [<xref rid="B437-marinedrugs-18-00657" ref-type="bibr">437</xref>]. In fact, these natural products are present in many phyllidid species, such as <italic>P. varicosa</italic>, <italic>P. coelestis</italic>, <italic>P. ocellata</italic>, <italic>P. picta</italic>, <italic>Phyllidia</italic> sp., <italic>Phillidiopsis krempfi</italic>, <italic>Phyllidiella pustulosa,</italic> and <italic>P. rosans (P. bourguini)</italic> [<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B116-marinedrugs-18-00657" ref-type="bibr">116</xref>,<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B121-marinedrugs-18-00657" ref-type="bibr">121</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>,<xref rid="B373-marinedrugs-18-00657" ref-type="bibr">373</xref>,<xref rid="B437-marinedrugs-18-00657" ref-type="bibr">437</xref>]. Moreover, <italic>Reticulidia fungia</italic> presents sesquiterpenes such as reticulidin A (<bold>215</bold>) with antifouling activity [<xref rid="B438-marinedrugs-18-00657" ref-type="bibr">438</xref>].</p></sec><sec><title>Dendronotida</title><p>As reported above, some species present homarine (<bold>79</bold>), such as the Mediterranean <italic>Marionia blainvillea</italic>, a compound that has also been proven to display potent antifouling activity [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B428-marinedrugs-18-00657" ref-type="bibr">428</xref>,<xref rid="B439-marinedrugs-18-00657" ref-type="bibr">439</xref>]. This activity was previously reported for the gorgonian <italic>Eunicella singularis</italic> and the soft coral <italic>Gersemia antarctica,</italic> and homarine (<bold>79</bold>) has been suggested to be incorporated in dendronotids from their octocoral cnidarian food prey [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B428-marinedrugs-18-00657" ref-type="bibr">428</xref>,<xref rid="B439-marinedrugs-18-00657" ref-type="bibr">439</xref>]. The presence of homarine (<bold>79</bold>) in the mucus secretion of the slugs would inhibit the growth of microorganisms in the mucus [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>].</p></sec><sec><title>Aeolidida</title><p>Homarine (<bold>79</bold>) is also found in this group, particularly in <italic>Cratena pilata</italic> and <italic>Cuthona gymnota</italic> from the Atlantic, <italic>Hermissenda crassicornis</italic> from the Pacific (locations mistaken in [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]), <italic>Cuthona coerulea</italic> from the Mediterranean, and <italic>Phestilla lugubris</italic> from Australia [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B440-marinedrugs-18-00657" ref-type="bibr">440</xref>]. In this case, homarine (<bold>79</bold>) is originated from their hydrozan cnidarian prey and may also be used to avoid microbial colonization of the slug mucus [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B441-marinedrugs-18-00657" ref-type="bibr">441</xref>,<xref rid="B442-marinedrugs-18-00657" ref-type="bibr">442</xref>]. </p></sec></sec><sec id="sec2dot4dot2-marinedrugs-18-00657"><title>2.4.2. Cephalaspidea</title><p>Again, homarine (<bold>79</bold>) is reported here, although in a different context. The Mediterranean <italic>Aglaja tricolorata</italic> feeds on other heterobranchs, and may, therefore, accumulate their natural products, in this case homarine (<bold>79</bold>) [<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B442-marinedrugs-18-00657" ref-type="bibr">442</xref>]. </p><p>Another compound has been reported to present antifouling activity in the mantle of <italic>Sagaminopteron nigropunctatum</italic> and <italic>S. psychedelicum</italic> [<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>]. This is the polybrominated diphenyl ether 3,5-dibromo-2-(2&#x02032;,4&#x02032;-dibromo-phenoxy)-phenol (<bold>92</bold>), which is also found in their prey, the demosponge <italic>Dysidea granulosa</italic>, together with other polybrominated diphenyl ethers [<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>]. This compound (<bold>92</bold>) is selectively accumulated in the parapodia of the slugs at a concentration of 8&#x02013;10%, while it is present in other tissues of the slug and in the sponge at only 2&#x02013;4% [<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>]. Its antifouling activity has been reported to be very high against marine bacteria, diatoms, barnacle larvae, and mussel juveniles [<xref rid="B443-marinedrugs-18-00657" ref-type="bibr">443</xref>].</p><p><italic>Haminoea cyanomarginata</italic> from the Mediterranean is also protected against fouling by a brominated tetrahydropyran (<bold>142</bold>) [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]. This compound was previously found in an Australian sponge and later reported in <italic>H. cymbalum</italic> from India [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]. Haminols are 3-alkylpyridines also found in <italic>Haminoea</italic> species, which, among other activities, have been tested as antifouling molecules. These compounds include haminols A&#x02013;C (<bold>167&#x02013;168</bold>) and haminols 1&#x02013;6 (<bold>169</bold>) [<xref rid="B444-marinedrugs-18-00657" ref-type="bibr">444</xref>], which are structurally related to the navenones (<bold>170</bold>) mentioned below. Haminol 2 (<bold>169</bold>) was the most potent compound, with low toxicity and strong activity against larvae of the barnacle <italic>Amphibalanus amphitrite</italic> [<xref rid="B445-marinedrugs-18-00657" ref-type="bibr">445</xref>]. De novo biosynthesis of haminols was proven in the Mediterranean <italic>H. orbignyana</italic> [<xref rid="B446-marinedrugs-18-00657" ref-type="bibr">446</xref>].</p></sec></sec><sec id="sec2dot5-marinedrugs-18-00657"><title>2.5. Trail Following and Alarm Pheromones</title><p>In nature, behavioral and chemical defenses of heterobranchs are often combined to increase survival chances [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Heterobranchs display a high number of strategies, among which alarm pheromones are used to communicate and induce behavioral changes (<xref ref-type="fig" rid="marinedrugs-18-00657-f009">Figure 9</xref>, <xref rid="marinedrugs-18-00657-t006" ref-type="table">Table 6</xref>) [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Doridacean nudibranchs and cephalaspideans, and perhaps some anaspideans, display trail-following behavior, which also implies some chemoreception mechanisms.</p><sec id="sec2dot5dot1-marinedrugs-18-00657"><title>2.5.1. Nudibranchia</title><sec><title>Doridacea</title><p>A trail-following behavior has been reported in some chromodoridids, such as <italic>Hypselodoris</italic> (<italic>Risbecia) tryoni</italic>, but the potential chemicals involved have not yet been described [<xref rid="B447-marinedrugs-18-00657" ref-type="bibr">447</xref>]. Whether this is related to defense or to reproduction remains to be further investigated.</p><p><italic>Tambja</italic> and <italic>Roboastra</italic> are protected by the potent alkaloids tambjamines (<bold>65&#x02013;70</bold>), which are obtained from their prey, for example, the bryozoan <italic>Sessibugula translucens</italic> for <italic>Tambja abdere</italic> and <italic>T. eliora</italic>, and these two slug species in turn for the voracious <italic>Roboastra tigris</italic> [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>,<xref rid="B227-marinedrugs-18-00657" ref-type="bibr">227</xref>,<xref rid="B228-marinedrugs-18-00657" ref-type="bibr">228</xref>]. All these slugs are able to detect the tambjamines (<bold>65&#x02013;70</bold>) secreted in mucous trails through chemoreception mechanisms, thus being able to find conspecifics and food (bryozoan) for <italic>Tambja</italic> species or detect food (slugs) for <italic>Roboastra</italic> [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>]. When <italic>Tambja abdere</italic> specimens are disturbed, they release higher amounts of tambjamines (<bold>65&#x02013;70</bold>), and, thus, they are also considered to be alarm pheromones [<xref rid="B61-marinedrugs-18-00657" ref-type="bibr">61</xref>,<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>]. Similar examples include <italic>Tambja ceutae</italic> and the bryozoan <italic>Bugula dentata</italic>, <italic>Tambja stegosauriformis</italic> and <italic>B. dentata</italic>, as well as some <italic>Nembrotha</italic> species and their ascidian prey, <italic>Atapozoa</italic> sp. [<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>,<xref rid="B229-marinedrugs-18-00657" ref-type="bibr">229</xref>,<xref rid="B230-marinedrugs-18-00657" ref-type="bibr">230</xref>,<xref rid="B231-marinedrugs-18-00657" ref-type="bibr">231</xref>]. </p></sec></sec><sec id="sec2dot5dot2-marinedrugs-18-00657"><title>2.5.2. Cephalaspidea</title><p>Several genera in this group have been reported to secrete alarm pheromones and display trail-following behavior. Navenones A&#x02013;C (<bold>170</bold>) were isolated long ago from <italic>Navanax inermis</italic> and reported to be used as alarm signals [<xref rid="B394-marinedrugs-18-00657" ref-type="bibr">394</xref>]. Navenones (<bold>170</bold>) are accumulated in a specialized ventral gland and are released within its yellow slime trail when the animals are disturbed, inducing an avoidance alarm response in the conspecifics that follow them [<xref rid="B269-marinedrugs-18-00657" ref-type="bibr">269</xref>,<xref rid="B394-marinedrugs-18-00657" ref-type="bibr">394</xref>,<xref rid="B448-marinedrugs-18-00657" ref-type="bibr">448</xref>]. Navenones (<bold>170</bold>) are suggested to be de novo biosynthesized [<xref rid="B448-marinedrugs-18-00657" ref-type="bibr">448</xref>]. These slugs may also be cannibalistic, but, interestingly, the secretion is not released when a small slug is attacked by a larger conspecific [<xref rid="B318-marinedrugs-18-00657" ref-type="bibr">318</xref>]. </p><p><italic>Haminoea</italic> species similarly release alarm pheromones that induce escape behavior in the trail-following conspecifics [<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B449-marinedrugs-18-00657" ref-type="bibr">449</xref>]. The Mediterranean species <italic>H. exigua, H. fusari</italic>, <italic>H. orbignyana</italic>, <italic>H. orteai</italic>, and <italic>H. navicula</italic> present haminols (<bold>167&#x02013;169</bold>), oxygenated 3-alkylpyridines that are secreted in their mucous trail [<xref rid="B19-marinedrugs-18-00657" ref-type="bibr">19</xref>,<xref rid="B446-marinedrugs-18-00657" ref-type="bibr">446</xref>]. Haminols (<bold>167&#x02013;169</bold>) are biosynthesized through sequential addition of acetic acid units to nicotinic acid [<xref rid="B446-marinedrugs-18-00657" ref-type="bibr">446</xref>,<xref rid="B450-marinedrugs-18-00657" ref-type="bibr">450</xref>]. Haminols consist of several structures similar to navenones (<bold>170</bold>), the haminols A&#x02013;C (<bold>167&#x02013;168</bold>) and the haminols 1&#x02013;6 (<bold>169</bold>) [<xref rid="B444-marinedrugs-18-00657" ref-type="bibr">444</xref>]. Similarly, <italic>H callidegenita</italic> presents haminols 7&#x02013;11, which are also suggested to act as alarm pheromones [<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B451-marinedrugs-18-00657" ref-type="bibr">451</xref>]. The Pacific <italic>H. japonica</italic> also presents a series of alkylphenols, which are structurally similar to navenone-C and are suggested to act as alarm pheromones [<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B451-marinedrugs-18-00657" ref-type="bibr">451</xref>].</p><p>The widespread <italic>Scaphander lignarius</italic> lives in sandy bottoms, feeding usually on foraminiferans [<xref rid="B452-marinedrugs-18-00657" ref-type="bibr">452</xref>,<xref rid="B453-marinedrugs-18-00657" ref-type="bibr">453</xref>]. This species presents the &#x003c9;-arylmethylketones, lignarenones (<bold>171</bold>), de novo biosynthesized through a polyketide pathway from benzoic acid and accumulated in the Blochmann&#x02019;s gland [<xref rid="B454-marinedrugs-18-00657" ref-type="bibr">454</xref>,<xref rid="B455-marinedrugs-18-00657" ref-type="bibr">455</xref>,<xref rid="B456-marinedrugs-18-00657" ref-type="bibr">456</xref>]. Lignarenones (<bold>171</bold>) are released within the bright yellow slime that <italic>S. lignarius</italic> secretes when disturbed and are also suggested to be used as alarm pheromones [<xref rid="B454-marinedrugs-18-00657" ref-type="bibr">454</xref>,<xref rid="B455-marinedrugs-18-00657" ref-type="bibr">455</xref>,<xref rid="B456-marinedrugs-18-00657" ref-type="bibr">456</xref>].</p></sec><sec id="sec2dot5dot3-marinedrugs-18-00657"><title>2.5.3. Anaspidea</title><p>Mycosporine-like amino acids (MAAs) have been suggested to act as alarm cues in the sea hare <italic>Aplysia californica</italic> [<xref rid="B457-marinedrugs-18-00657" ref-type="bibr">457</xref>]. </p></sec></sec><sec id="sec2dot6-marinedrugs-18-00657"><title>2.6. Sunscreens and UV Protection</title><p>Avoiding UV radiation (UVR) is very relevant for marine organisms that live in shallow waters, since the damaging effects of UVR on cells and tissues are potentially huge [<xref rid="B459-marinedrugs-18-00657" ref-type="bibr">459</xref>]. In heterobranch molluscs, those living close to the surface (plankton and pteropods) or living on algae (for food and camouflage; sea hares and sacoglossans) are the most susceptible to UVR, and UV-protecting compounds have indeed been described in anaspideans, pteropods, and sacoglossa (<xref ref-type="fig" rid="marinedrugs-18-00657-f009">Figure 9</xref>, <xref rid="marinedrugs-18-00657-t007" ref-type="table">Table 7</xref>).</p><sec id="sec2dot6dot1-marinedrugs-18-00657"><title>2.6.1. Anaspidea</title><p>As mentioned above, sea hares are generalist herbivores. Among them, <italic>Aplysia</italic> species possess many dietary compounds from their algal food, such as many halogenated terpenoids and some carotenoids, which may provide UVR protection [<xref rid="B459-marinedrugs-18-00657" ref-type="bibr">459</xref>,<xref rid="B460-marinedrugs-18-00657" ref-type="bibr">460</xref>]. Furthermore, <italic>A. californica</italic> contains mycosporine-like amino acids (MAAs), the most common photoprotective molecules reported in marine organisms [<xref rid="B457-marinedrugs-18-00657" ref-type="bibr">457</xref>,<xref rid="B459-marinedrugs-18-00657" ref-type="bibr">459</xref>].</p></sec><sec id="sec2dot6dot2-marinedrugs-18-00657"><title>2.6.2. Pteropoda</title><p>The sea butterflies <italic>Limacina helicina</italic> and <italic>Clione limacina</italic> also possess MAAs originated from phytoplanktonic microalgal species, which provide them with UV protection [<xref rid="B461-marinedrugs-18-00657" ref-type="bibr">461</xref>].</p></sec><sec id="sec2dot6dot3-marinedrugs-18-00657"><title>2.6.3. Sacoglossa </title><p>Polypropionates from sacoglossans have been reported to be used as sunscreens in several species [<xref rid="B412-marinedrugs-18-00657" ref-type="bibr">412</xref>,<xref rid="B461-marinedrugs-18-00657" ref-type="bibr">461</xref>]. These compounds are de novo biosynthesized by the slugs, and their biosynthesis is affected by UVR [<xref rid="B462-marinedrugs-18-00657" ref-type="bibr">462</xref>,<xref rid="B463-marinedrugs-18-00657" ref-type="bibr">463</xref>]. <italic>Elysia</italic> species possess &#x003b3;-pyrone propionates, such as phototridachiapyrone J (<bold>172</bold>) in the Atlantic <italic>E. patagonica</italic> [<xref rid="B412-marinedrugs-18-00657" ref-type="bibr">412</xref>], and tridachiahydropyrone (<bold>173</bold>) and phototridachiahydropyrone (<bold>174</bold>) in the Caribbean <italic>Elysia crispata</italic> [<xref rid="B78-marinedrugs-18-00657" ref-type="bibr">78</xref>,<xref rid="B317-marinedrugs-18-00657" ref-type="bibr">317</xref>]. Phototridachiahydropyrone (<bold>174</bold>) seems to originate from a rearrangement mechanism during the photochemical electrocyclic formation of tridachiahydropyrone (<bold>173</bold>) under prolonged UVR exposition [<xref rid="B464-marinedrugs-18-00657" ref-type="bibr">464</xref>]. Similar &#x003b3;-pyrone compounds, tridachiapyrones A&#x02013;F (<bold>175,176</bold>), as well as elysiapyrones (<bold>177</bold>), along with other compounds, were found in the Pacific <italic>E. (Tridachiella) diomedea</italic> [<xref rid="B413-marinedrugs-18-00657" ref-type="bibr">413</xref>,<xref rid="B415-marinedrugs-18-00657" ref-type="bibr">415</xref>,<xref rid="B416-marinedrugs-18-00657" ref-type="bibr">416</xref>,<xref rid="B417-marinedrugs-18-00657" ref-type="bibr">417</xref>,<xref rid="B418-marinedrugs-18-00657" ref-type="bibr">418</xref>,<xref rid="B419-marinedrugs-18-00657" ref-type="bibr">419</xref>]. <italic>E. viridis</italic> feeds on the green algae <italic>Codium vermiliara</italic> and biosynthesizes the polypropionate (+) elysione (<bold>178</bold>) [<xref rid="B463-marinedrugs-18-00657" ref-type="bibr">463</xref>,<xref rid="B465-marinedrugs-18-00657" ref-type="bibr">465</xref>]. Elysione (<bold>178</bold>) is also found in <italic>E. chlorotica</italic>, which feeds on <italic>Cladophora</italic> algae [<xref rid="B414-marinedrugs-18-00657" ref-type="bibr">414</xref>]. Tridachiapyrone A (<bold>175</bold>) is the enantiomer of (+) elysione (<bold>178</bold>), and like tridachiapyrone C (<bold>176</bold>) and crispatene, it has been suggested that these metabolites represent the protected forms of (+) elysione (<bold>178</bold>) under strong light irradiation [<xref rid="B414-marinedrugs-18-00657" ref-type="bibr">414</xref>,<xref rid="B466-marinedrugs-18-00657" ref-type="bibr">466</xref>]. All of these polyene &#x003b3;-pyrone compounds are localized in cell membranes, where they may act as sunscreens, thus protecting the photosynthetic apparatus of the chloroplasts [<xref rid="B466-marinedrugs-18-00657" ref-type="bibr">466</xref>,<xref rid="B467-marinedrugs-18-00657" ref-type="bibr">467</xref>]. </p><p><italic>Placobranchus ocellatus</italic> and <italic>Placobranchus</italic> sp. from the Pacific Ocean also present propionate-derived &#x003b3;-pyrones, such as 9,10-deoxytridachione (<bold>179</bold>), photodeoxytridachione (<bold>180</bold>), tridachiahydropyrone B and C (<bold>181</bold>), and <italic>iso</italic>-9,10-deoxy-tridachione, probably also used as sunscreens [<xref rid="B19-marinedrugs-18-00657" ref-type="bibr">19</xref>,<xref rid="B412-marinedrugs-18-00657" ref-type="bibr">412</xref>,<xref rid="B466-marinedrugs-18-00657" ref-type="bibr">466</xref>,<xref rid="B468-marinedrugs-18-00657" ref-type="bibr">468</xref>,<xref rid="B469-marinedrugs-18-00657" ref-type="bibr">469</xref>]. In specimens from India, the elysiapyrone-related compounds ocellapyrones (<bold>182</bold>) were also found [<xref rid="B468-marinedrugs-18-00657" ref-type="bibr">468</xref>].</p></sec></sec><sec id="sec2dot7-marinedrugs-18-00657"><title>2.7. Tissue Regeneration</title><p>As in terrestrial organisms, vagile marine organisms, as well as heterobranchs, may use autotomy and tissue regeneration as a mechanism to distract predators and escape [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. In fact, many nudibranchs and sacoglossa may lose part of their mantle or their cerata [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. The known compounds involved in these mechanisms are reported here (<xref ref-type="fig" rid="marinedrugs-18-00657-f009">Figure 9</xref>, <xref rid="marinedrugs-18-00657-t008" ref-type="table">Table 8</xref>).</p><sec id="sec2dot7dot1-marinedrugs-18-00657"><title>2.7.1. Nudibranchia</title><sec><title>Doridacea</title><p><italic>Peltodoris atromaculata</italic> feeds on the sponge <italic>Petrosia ficiformis,</italic> accumulating polyacetylenes, petroformynes, and other compounds, although the autotomy mechanism of the slug does not seem to be related with this chemistry, and, in fact, may be related to stress or senescence instead [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B210-marinedrugs-18-00657" ref-type="bibr">210</xref>,<xref rid="B470-marinedrugs-18-00657" ref-type="bibr">470</xref>].</p></sec><sec><title>Dendronotida</title><p><italic>Tethys fimbria</italic> presents de novo biosynthesized prostaglandin (PG) lactones (<bold>80&#x02013;81</bold>) involved in predator distraction by the release of their cerata [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>,<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>]. When <italic>T. fimbria</italic> is molested, cerata are detached together with a copious amount of mucus and continue to move for some time. Although PGEs and PGFs have been suggested to be involved in defense and reproduction, respectively, a role in tissue regeneration has also been suggested, since they are common hormonal compounds [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>,<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>,<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>,<xref rid="B471-marinedrugs-18-00657" ref-type="bibr">471</xref>,<xref rid="B472-marinedrugs-18-00657" ref-type="bibr">472</xref>]. In fact, PGE<sub>2</sub>-1,15-lactone (<bold>80</bold>) and PGE<sub>3</sub>-1,15-lactone (<bold>81</bold>) are found in the cerata, detached when disturbed to distract potential predators and reverting to the free acid forms, PGE<sub>2</sub> and PGE<sub>3</sub>, which are suggested to be the defensive compounds [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>].</p></sec></sec><sec id="sec2dot7dot2-marinedrugs-18-00657"><title>2.7.2. Sacoglossa </title><p>Many sacoglossans also release their cerata when disturbed. Among them, the Mediterranean <italic>Ercolania viridis</italic> presents &#x003b3;- and &#x003b1;-pyrone polypropionates, including cyercenes (<bold>113, 157&#x02013;159</bold>) [<xref rid="B473-marinedrugs-18-00657" ref-type="bibr">473</xref>]. Cyercene polypropionates (<bold>113, 157&#x02013;159</bold>) are also found in the Mediterranean <italic>Cyerce cristallina</italic>, which also displays cerata autotomy [<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>], as well as in <italic>C. nigricans</italic> from Australia [<xref rid="B328-marinedrugs-18-00657" ref-type="bibr">328</xref>]. Moreover, in <italic>Aplysiopsis formosa</italic> from the Atlantic Ocean, the &#x003b1;-pyrones aplysiopsenes A&#x02013;D (<bold>183,184</bold>) have been found [<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>]. The implication of polypropionates in autotomy and further cerata regeneration has been further demonstrated by experiments with <italic>Hydra</italic> [<xref rid="B474-marinedrugs-18-00657" ref-type="bibr">474</xref>]. However, some sacoglossa may also present cerata autotomy without possessing polypropionates, such as the Atlantic <italic>Mourgona germaineae</italic>, which instead possesses prenylated bromohydroquinones obtained from the calcareous green alga <italic>Cymopolia barbata</italic> [<xref rid="B330-marinedrugs-18-00657" ref-type="bibr">330</xref>], similarly to <italic>Costasiella ocellifera</italic> from <italic>Avrainvillea longicaulis</italic> [<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>]. In contrast, some species may present polypropionates without displaying autotomy behavior, such as <italic>Placida dendritica</italic>, which possesses polypropionate &#x003b3;-pyrones (<bold>116</bold>) with no regenerative activity on the <italic>Hydra</italic> assay [<xref rid="B332-marinedrugs-18-00657" ref-type="bibr">332</xref>]. Evolutionary trends are probably behind this behavioral and chemical variability [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>].</p></sec></sec><sec id="sec2dot8-marinedrugs-18-00657"><title>2.8. Other Ecological Activities</title><p>Some nudibranchs have been reported to display activities other than those mentioned above [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. These may include metabolites that may be considered stress metabolites, as well as compounds involved in reproduction or in hormonal responses, as reported below (<xref ref-type="fig" rid="marinedrugs-18-00657-f009">Figure 9</xref>, <xref rid="marinedrugs-18-00657-t009" ref-type="table">Table 9</xref>).</p><sec id="sec2dot8dot1-marinedrugs-18-00657"><title>2.8.1. Nudibranchia</title><sec><title>Doridacea</title><p>The Antarctic slug <italic>Doris kerguelenensis</italic> possesses diterpenoid glycerols (<bold>2</bold>) and terpenoid glyceryl esters of different types (<italic>ent</italic>-labdane, halimane, isocopalane diterpenoids) in its mantle many [<xref rid="B59-marinedrugs-18-00657" ref-type="bibr">59</xref>,<xref rid="B62-marinedrugs-18-00657" ref-type="bibr">62</xref>,<xref rid="B64-marinedrugs-18-00657" ref-type="bibr">64</xref>,<xref rid="B370-marinedrugs-18-00657" ref-type="bibr">370</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B476-marinedrugs-18-00657" ref-type="bibr">476</xref>]. <italic>D. kerguelenensis</italic> may also present some nor-sesquiterpenes in its mantle, austrodoral (<bold>185</bold>) and its oxidized derivative austrodoric acid (<bold>186</bold>), which have been detected in higher amounts after the animals were kept in aquarium for 15 days before freezing [<xref rid="B64-marinedrugs-18-00657" ref-type="bibr">64</xref>]. This is the reason why austrodoral (<bold>185</bold>) has been suggested to be a stress metabolite, although perhaps some physiological alterations may also be behind these higher amounts of austrodoral (<bold>185</bold>) [<xref rid="B64-marinedrugs-18-00657" ref-type="bibr">64</xref>].</p></sec><sec><title>Dendronotida</title><p>Prostaglandins (PGs) (<bold>80&#x02013;81</bold>) from <italic>Tethys fimbria</italic> have been reported to be de novo biosynthesized, having different roles in the species, and being located in different body parts of the slug [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>,<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>]. As previously mentioned, PGE<sub>2</sub>-1,15-lactone (<bold>80</bold>) and PGE<sub>3</sub>-1,15-lactone (<bold>81</bold>) are found in the cerata, reverting to the free acid forms PGE<sub>2</sub> and PGE<sub>3</sub> probably for defense [<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>]. In their reproductive system, instead, PGF&#x02013;lactones are found, and these have been suggested to have a role in reproduction [<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>].</p></sec><sec><title>Euarminida</title><p>Some species have been reported to inhibit cell division in embryos or eggs of sympatric species to avoid competition and/or further predation by their adults, for example, against sea urchins or sea stars [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. An example is <italic>Dermatobranchus ornatus</italic> from China, which presents several types of diterpenes that inhibit cell division in fertilized starfish eggs [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>]. These compounds include four eunicellin diterpenes, such as ophirin (<bold>187</bold>). In fact, two of these compounds are probably taken from its gorgonian prey, <italic>Muricella sinensis</italic> [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>], while another one was previously found in an unidentified Pacific soft coral [<xref rid="B387-marinedrugs-18-00657" ref-type="bibr">387</xref>]. Furthermore, <italic>D. ornatus</italic> possesses a calicophirin diterpenoid (<bold>188</bold>) probably from a gorgonian prey, <italic>Muricella</italic> sp. [<xref rid="B477-marinedrugs-18-00657" ref-type="bibr">477</xref>].</p></sec></sec></sec></sec><sec id="sec3-marinedrugs-18-00657"><title>3. Pharmacological Activity</title><p>Marine natural products may have many diverse applications that are beneficial for humans and, thus, may become potentially very useful drugs [<xref rid="B5-marinedrugs-18-00657" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-18-00657" ref-type="bibr">6</xref>,<xref rid="B8-marinedrugs-18-00657" ref-type="bibr">8</xref>,<xref rid="B10-marinedrugs-18-00657" ref-type="bibr">10</xref>,<xref rid="B29-marinedrugs-18-00657" ref-type="bibr">29</xref>,<xref rid="B30-marinedrugs-18-00657" ref-type="bibr">30</xref>,<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B33-marinedrugs-18-00657" ref-type="bibr">33</xref>]. Some recent reviews offer wide summaries of the different compounds and activities, as well as a historical perspective [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B32-marinedrugs-18-00657" ref-type="bibr">32</xref>,<xref rid="B33-marinedrugs-18-00657" ref-type="bibr">33</xref>,<xref rid="B35-marinedrugs-18-00657" ref-type="bibr">35</xref>,<xref rid="B36-marinedrugs-18-00657" ref-type="bibr">36</xref>,<xref rid="B37-marinedrugs-18-00657" ref-type="bibr">37</xref>,<xref rid="B38-marinedrugs-18-00657" ref-type="bibr">38</xref>,<xref rid="B39-marinedrugs-18-00657" ref-type="bibr">39</xref>,<xref rid="B40-marinedrugs-18-00657" ref-type="bibr">40</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>,<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B480-marinedrugs-18-00657" ref-type="bibr">480</xref>,<xref rid="B481-marinedrugs-18-00657" ref-type="bibr">481</xref>,<xref rid="B482-marinedrugs-18-00657" ref-type="bibr">482</xref>]. Overall, it remains clear that natural products are still the best option to find novel bioactive entities and potentially be modified to find leads to fight several human diseases. </p><sec id="sec3dot1-marinedrugs-18-00657"><title>3.1. Cytotoxicity and Antitumoral Activity</title><p>Many reviews have dealt with this topic in depth, and, therefore, we include here only a brief summary of all the activities described [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>]. Among the most active compounds, it is worth mentioning jorumycin (<bold>189</bold>) from the doridacean <italic>Jorunna funebris</italic>, ulapualides (<bold>190</bold>) from <italic>Hexabranchus sanguineus</italic>, kabiramides (<bold>62</bold>) from <italic>Hexabranchus</italic> sp., aplyronines (<bold>191</bold>) and dolastatins (<bold>192</bold>) from the anaspidean <italic>Dolabella auricularia</italic>, and bursatellanins (<bold>193</bold>) from <italic>Bursatella leachii</italic>, as well as kahalalides (<bold>194</bold>) from the sacoglossan <italic>Elysia rufescens</italic>, all of which are under clinical trials for antitumoral activity [<xref rid="B36-marinedrugs-18-00657" ref-type="bibr">36</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>,<xref rid="B45-marinedrugs-18-00657" ref-type="bibr">45</xref>,<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>]. It is important to remember that cytotoxic, anticancer, and antitumoral compounds are strongly needed, since cancer remains one of the deadliest diseases worldwide [<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>]. In 2018, about 18 million new cancer cases were reported globally, producing around 10 million deaths [<xref rid="B483-marinedrugs-18-00657" ref-type="bibr">483</xref>]. Thus, many studies are being developed to find new compounds with novel modes of action, and marine organisms, such as heterobranch molluscs, are considered to be reservoirs of new bioactive compounds that are potentially useful [<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>]. In fact, about 30% of the top twenty drugs currently on the market originate from a natural source (mostly plants), while approximately 50% of the marketed drugs are naturally derived or based on natural compounds [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B480-marinedrugs-18-00657" ref-type="bibr">480</xref>,<xref rid="B484-marinedrugs-18-00657" ref-type="bibr">484</xref>]. Comparing marine and terrestrial natural products, it has been reported by the NCI (USA) that more than 1% of marine compounds present antitumoral activity compared to the 0.01% for terrestrial compounds [<xref rid="B481-marinedrugs-18-00657" ref-type="bibr">481</xref>]. Many natural compounds present cytotoxic effects against macromolecules expressed by cancer cells, such as in oncogenic signal transduction pathways, and display growth inhibition of human tumor cells [<xref rid="B39-marinedrugs-18-00657" ref-type="bibr">39</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>,<xref rid="B482-marinedrugs-18-00657" ref-type="bibr">482</xref>]. Moreover, many studies on the mechanism of action of marine natural compounds inhibiting tumor growth indicate that it involves processes of apoptosis, necrosis, and lysis of the tumor cells, both in vitro and in vivo [<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B485-marinedrugs-18-00657" ref-type="bibr">485</xref>]. All heterobranch groups reviewed here possess some anticancer, antitumoral, and/or cytotoxic compounds, except pteropods (<xref ref-type="fig" rid="marinedrugs-18-00657-f010">Figure 10</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f011">Figure 11</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f012">Figure 12</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f013">Figure 13</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f014">Figure 14</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f015">Figure 15</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f016">Figure 16</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f017">Figure 17</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f018">Figure 18</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f019">Figure 19</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f020">Figure 20</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f021">Figure 21</xref>, <xref ref-type="fig" rid="marinedrugs-18-00657-f022">Figure 22</xref> and <xref ref-type="fig" rid="marinedrugs-18-00657-f023">Figure 23</xref>, <xref rid="marinedrugs-18-00657-t010" ref-type="table">Table 10</xref>). The natural products described include a wide variety of compounds, from terpenoids and steroids, to peptides, polyketides, as well as nitrogen-containing metabolites.</p><sec id="sec3dot1dot1-marinedrugs-18-00657"><title>3.1.1. Nudibranchia</title><sec><title>Doridacea</title><p>The Antarctic slug <italic>Doris kerguelenensis</italic> presents clerodane and labdane diterpenes, such as palmadorins (<bold>195&#x02013;200</bold>), among other compounds [<xref rid="B66-marinedrugs-18-00657" ref-type="bibr">66</xref>,<xref rid="B67-marinedrugs-18-00657" ref-type="bibr">67</xref>]. Palmadorins A (<bold>195</bold>), B (<bold>196</bold>), D (<bold>197</bold>), M (<bold>198</bold>), N (<bold>199</bold>), and O (<bold>200</bold>) have been described to inhibit human erythroleukemia cells (HEL) at low IC<sub>50</sub> (micromolar), and palmadorin M (<bold>198</bold>) has been reported to inhibit Jak2, STAT5, and Erk1/2 activation in HEL cells, producing apoptosis at 5 &#x003bc;M [<xref rid="B67-marinedrugs-18-00657" ref-type="bibr">67</xref>]. The Mediterranean and Atlantic <italic>Doris verrucosa</italic>, contains the de novo biosynthesized verrucosins, diterpenoid acid glycerides, among which verrucosins A (<bold>124</bold>) and B are potent activators of protein kinase C, and they promote tentacle regeneration in the freshwater hydrozoan <italic>Hydra vulgaris</italic> [<xref rid="B370-marinedrugs-18-00657" ref-type="bibr">370</xref>,<xref rid="B371-marinedrugs-18-00657" ref-type="bibr">371</xref>,<xref rid="B486-marinedrugs-18-00657" ref-type="bibr">486</xref>]. <italic>Notodoris</italic> nudibranchs feed on <italic>Leucetta</italic> calcareous sponges, presenting sponge-derived imidazole alkaloids [<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B426-marinedrugs-18-00657" ref-type="bibr">426</xref>,<xref rid="B487-marinedrugs-18-00657" ref-type="bibr">487</xref>,<xref rid="B488-marinedrugs-18-00657" ref-type="bibr">488</xref>]. In the Red Sea, <italic>N. citrina</italic> and <italic>N. gardineri</italic> obtain their chemicals from <italic>Leucetta chagosensis</italic>, presenting among others, naamidine A (<bold>201</bold>) and <italic>iso</italic>-naamidine-A (<bold>160</bold>) [<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B426-marinedrugs-18-00657" ref-type="bibr">426</xref>]. Naamidine A (<bold>201</bold>) was later tested from the sponge (from different localities) as a selective inhibitor of the epidermal growth factor (EGF) and was found to inhibit human tumor xenografts in mice, as well as displaying antitumour activity that promotes caspase-dependent apoptosis in tumor cells [<xref rid="B489-marinedrugs-18-00657" ref-type="bibr">489</xref>,<xref rid="B490-marinedrugs-18-00657" ref-type="bibr">490</xref>].</p><p><italic>Adalaria loveni</italic> from the North Sea presents lovenone (<bold>202</bold>), a degraded triterpenoid suggested to come from an unidentified bryozoan prey [<xref rid="B491-marinedrugs-18-00657" ref-type="bibr">491</xref>]. Lovenone (<bold>202</bold>) was reported to present modest cytotoxicity to two HTCLs (human tumor cell lines) [<xref rid="B491-marinedrugs-18-00657" ref-type="bibr">491</xref>]. Another bryozoan-feeder, <italic>Polycera atra</italic> accumulates bryostatins (<bold>203</bold>) from <italic>Bugula neritina</italic>, also including them in their spawn [<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B492-marinedrugs-18-00657" ref-type="bibr">492</xref>,<xref rid="B493-marinedrugs-18-00657" ref-type="bibr">493</xref>,<xref rid="B494-marinedrugs-18-00657" ref-type="bibr">494</xref>]. Bryostatins (<bold>203</bold>) are polyketide macrolides known to be biosynthesized by a microbial symbiont, <italic>Endobugula sertula</italic> [<xref rid="B495-marinedrugs-18-00657" ref-type="bibr">495</xref>]. Bryostatins (<bold>203</bold>) are highly bioactive compounds, with bryostatin 1 (<bold>203</bold>), for example, being investigated in more than 20 clinical trials (two phase I trials) against multiple carcinomas and Alzheimer&#x02019;s disease [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B42-marinedrugs-18-00657" ref-type="bibr">42</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>,<xref rid="B496-marinedrugs-18-00657" ref-type="bibr">496</xref>,<xref rid="B497-marinedrugs-18-00657" ref-type="bibr">497</xref>]. Bryostatin 1 (<bold>203</bold>) modulates the Bcl-2 and p53 oncoproteins in human diffuse large-cell lymphoma WSU-DLCL2, inducing a decrease in the expression of Bcl-2 [<xref rid="B498-marinedrugs-18-00657" ref-type="bibr">498</xref>]. Furthermore, bryostatin 1 (<bold>203</bold>) showed a notable activity of modulating the paclitaxel inhibitor of protein kinase C (PKC) [<xref rid="B499-marinedrugs-18-00657" ref-type="bibr">499</xref>,<xref rid="B500-marinedrugs-18-00657" ref-type="bibr">500</xref>,<xref rid="B501-marinedrugs-18-00657" ref-type="bibr">501</xref>], as well as inducing ubiquitination and proteasome degradation of Bcl-2 in lymphoblastic leukemia, allowing for the growth of progenitor cells from bone marrow [<xref rid="B502-marinedrugs-18-00657" ref-type="bibr">502</xref>]. Moreover, bryostatins (<bold>203</bold>) are strong activators of PKC, regulating the activation, growth, and differentiation of cells [<xref rid="B503-marinedrugs-18-00657" ref-type="bibr">503</xref>].</p><p>Another interesting species is the Chinese <italic>Actinocyclus papillatus</italic>, which presents the mildly cytotoxic (&#x02013;)-actisonitrile (<bold>204</bold>) in its mantle, along with actinofide (<bold>205</bold>), a terpenoid diacylguanidine [<xref rid="B361-marinedrugs-18-00657" ref-type="bibr">361</xref>,<xref rid="B504-marinedrugs-18-00657" ref-type="bibr">504</xref>,<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>]. Both enantiomers, (&#x02013;)- and (+)-actisonitrile (<bold>204</bold>), were tested for cytotoxicity against tumor and non-tumor mammalian cells, resulting in a parallel concentration-dependent toxic profile at a micromolar concentration [<xref rid="B504-marinedrugs-18-00657" ref-type="bibr">504</xref>]. On the other hand, actinofide (<bold>205</bold>), a guanidine moiety acylated by two terpenoid acid units, allowed for the synthesis of a series of structural analogues which were tested for growth inhibitory activity against some cancer cell lines in vitro [<xref rid="B506-marinedrugs-18-00657" ref-type="bibr">506</xref>,<xref rid="B507-marinedrugs-18-00657" ref-type="bibr">507</xref>,<xref rid="B508-marinedrugs-18-00657" ref-type="bibr">508</xref>]. Actinofide (<bold>205</bold>) and some of its analogues were tested against six cancer cell lines: two human carcinoma cancer cell lines (MCF-7 (breast) and A549 (non&#x02013;small-cell lung cancer, NSCLC)) of epithelial origin, two human cancer cell lines from glial origin (Hs683 oligodendroglioma and U373 glioblastoma of astrocytic origin), and two melanoma models (mouse B16F10 and human SKMEL-28 cell lines), resulting in many relevant activities [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>]. Actinofide (<bold>205</bold>) presents GI<sub>50</sub> values of 8.3 &#x000b1; 1.8 for Hs683, 15.7 &#x000b1; 10.1 for U373, 23.4 &#x000b1; 5.5 for A549, 23.4 &#x000b1; 5.9 for MCF-7, 24.2 &#x000b1; 8.2 for SKMEL-28, and 7.5 &#x000b1; 3.1 for B16F10 [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>]. The most active compounds are reported to be those with one or two N-C<sub>15</sub> residues, and a preliminary correlation between structure and activity was proposed [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>].</p><p><italic>Aldisa andersoni</italic> from the Indo-Pacific contains some phorbazoles, peculiar chlorinated phenyl-pyrrolyloxazoles, such as 9-chloro-phorbazole D (<bold>5</bold>) and <italic>N</italic>1-methyl-phorbazole A (<bold>6</bold>), along with phorbazoles A (<bold>7</bold>), B (<bold>8</bold>), and C described in the sponge <italic>Phorbas</italic> aff. <italic>clathrata</italic> [<xref rid="B55-marinedrugs-18-00657" ref-type="bibr">55</xref>,<xref rid="B56-marinedrugs-18-00657" ref-type="bibr">56</xref>,<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-18-00657" ref-type="bibr">76</xref>]. Both 9-chloro-phorbazole D (<bold>5</bold>) and <italic>N</italic>1-methyl-phorbazole A (<bold>6</bold>) produce cytostatic effects in vitro against several HTCLs [<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>]. More specifically, <italic>N</italic>1-methyl-phorbazole A (<bold>6</bold>) inhibits human SKMEL-28 melanoma and U373 glioblastoma cells [<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>].</p><p><italic>Dendrodoris carbunculosa</italic> from Japan possesses drimane sesquiterpenoids, the dendocarbins A&#x02013;N (<bold>16,206</bold>), along with <italic>iso</italic>drimeninol (<bold>207</bold>) and 11-<italic>epi</italic>valdiviolide (<bold>208</bold>), some of them displaying cytotoxicity against murine leukemia P388 cell lines [<xref rid="B87-marinedrugs-18-00657" ref-type="bibr">87</xref>]. In particular, the IC<sub>50</sub> values against adriamycin (ADR)- and vincristine (VCR)-resistant P388 cells (P388/ADR and P388/VCR, respectively), as well as those against sensitive P388 strain (P388/S) were reported for all compounds, with dendocarbin J (<bold>206</bold>) and 11-<italic>epi</italic>valdiviolide (<bold>208</bold>) showing moderate cytotoxicity against both sensitive and resistant cell strains [<xref rid="B86-marinedrugs-18-00657" ref-type="bibr">86</xref>]. The IC<sub>50</sub> values for dendocarbin J (<bold>206</bold>) were 17 &#x000b5;g/mL for P388/S, 4 &#x000b5;g/mL for P388/VCR(-), 4 &#x000b5;g/mL for P388/VCR(+), 11 &#x000b5;g/mL for P388/ADR(-), and 8 &#x000b5;g/mL for P388/ADR(+), while for 11-<italic>epi</italic>valdiviolide (<bold>208</bold>) the values were 3.2, 2.5, 2.5, 2.5, and 2.5 &#x000b5;g/mL, respectively [<xref rid="B86-marinedrugs-18-00657" ref-type="bibr">86</xref>]. The origin of 11-<italic>epi</italic>valdiviolide (<bold>208</bold>) could be dietary, since it was first described in the sponge <italic>Dysidea fusca</italic> [<xref rid="B509-marinedrugs-18-00657" ref-type="bibr">509</xref>].</p><p>Regarding phyllidids, several species are described to present bioactive compounds. In Thailand, <italic>Phyllidia coelestis</italic> presents two cytotoxic pupukeanane sesquiterpenoids, 1-formamido-10(1,2)-abeopupukeanane (<bold>209</bold>) and 2-formamidopupukeanane (<bold>210</bold>), which show in vitro growth inhibitory activity against four human cancer cell lines [<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>]. In particular, this activity was tested against HeLa (cervical), MCF-7 (breast), KB (oral cavity), and HT-29 (colon) cancer cell lines with IC<sub>50</sub> values between 0.05 and 10 &#x003bc;M [<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>,<xref rid="B510-marinedrugs-18-00657" ref-type="bibr">510</xref>]. Furthermore, both molecules (<bold>209,210</bold>) present selectivity, weakly inhibiting the growth of human gingival fibroblasts by 65 and 25% at 20 &#x003bc;M, respectively [<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>,<xref rid="B510-marinedrugs-18-00657" ref-type="bibr">510</xref>]. <italic>Phyllidiella pustulosa</italic> also contains many sesquiterpenoids, as abovementioned, and specimens from Okinawa, for example, possess the moderately cytotoxic substituted axinisothiocyanate K derivative (<bold>211</bold>) and an isocyano compound [<xref rid="B377-marinedrugs-18-00657" ref-type="bibr">377</xref>]. In Fiji, <italic>P. pustulosa</italic> contains the isothiocyanate axisonitrile-3 (<bold>25</bold>), which is weakly cytotoxic (IC<sub>50</sub> &#x0003e; 20 &#x003bc;g/mL), in addition to some related sesquiterpenes [<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B427-marinedrugs-18-00657" ref-type="bibr">427</xref>]. In southern China, both <italic>P. coelestis</italic> and <italic>P. pustulosa</italic> present several nitrogenous terpenoids from their demosponge prey, <italic>Acanthella cavernosa</italic> [<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. Among these compounds, a bisabolane-type sesquiterpenoid (<bold>212</bold>), a theonellin <italic>iso</italic>thiocyanate (<bold>213</bold>), and 7-<italic>iso</italic>cyano-7,8-dihydro-&#x0221d;-bisabolene (<bold>214</bold>) display cytotoxicity against several HCCLs [<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. In particular, they all show strong cytotoxicity against HCCL SNU-398 with IC<sub>50</sub> values of 0.50, 2.15, and 0.50 &#x000b5;M, respectively [<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. Furthermore, the bisabolane sesquiterpenoid (<bold>212</bold>) presents broad cytotoxicity, being active against HCCLs A549, HT-29, and Capan-1, with IC<sub>50</sub> values of 8.60, 3.35, and 1.98 &#x000b5;M, respectively [<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. Contrastingly, <italic>Reticulidia fungia</italic> from Okinawa presents the cytotoxic carbonimidic dichlorides, reticulidins A (<bold>215</bold>) and B, which are two uncommon sponge sesquiterpenes, probably obtained from their diet of <italic>Pseudaxinyssa</italic> sponges [<xref rid="B438-marinedrugs-18-00657" ref-type="bibr">438</xref>,<xref rid="B511-marinedrugs-18-00657" ref-type="bibr">511</xref>,<xref rid="B512-marinedrugs-18-00657" ref-type="bibr">512</xref>]. Both compounds are moderately cytotoxic in vitro against KB cells, with IC<sub>50</sub> values of ~1 &#x003bc;M for both, and against mouse L1210 leukemia cells, with IC<sub>50</sub> values of ~2 and ~0.3 &#x003bc;M, respectively [<xref rid="B438-marinedrugs-18-00657" ref-type="bibr">438</xref>]. </p><p>Chromodoridids are also reported to possess cytotoxic and anticancer compounds. In the Paficic, <italic>Cadlina luteomarginata</italic> and its sponge prey <italic>Phorbas</italic> sp. Contain, among other compounds, ansellone A (<bold>216</bold>), a sesterterpenoid that moderately activates the cyclic adenosine monophosphate (cAMP) signaling pathway, with an EC<sub>50</sub> value of 14 mM in the HEK293 cell-based test [<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>]. The modulation of the cAMP signaling pathway is used in stem cell techniques, and it is relevant to treat diseases such as cancer, heart failure, and neurodegenerative diseases [<xref rid="B514-marinedrugs-18-00657" ref-type="bibr">514</xref>]. On the other hand, several <italic>Chromodoris</italic> species possess latrunculin A (<bold>38</bold>), a PKS-NRPS-derived macrolide, reported to be cytotoxic [<xref rid="B141-marinedrugs-18-00657" ref-type="bibr">141</xref>]. Latrunculin A (<bold>38</bold>) was found in <italic>C. lochi</italic> and its sponge prey <italic>Spongia</italic> (<italic>Cacospongia</italic>) <italic>mycofijiensis</italic> in Fiji [<xref rid="B141-marinedrugs-18-00657" ref-type="bibr">141</xref>]. In fact, latrunculins A (<bold>38</bold>) and B (<bold>37</bold>) were first described from the Red Sea <italic>Negombata</italic> (<italic>Latrunculia</italic>) <italic>magnifica</italic> and later in other sponges (<italic>Hyattela</italic> sp.) [<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>]. Latrunculins (<bold>37,38</bold>) were then reported in several <italic>Chromodoris</italic> species at different localities, including <italic>C. africana, C. annae</italic>, <italic>C. elisabethina</italic>, <italic>C. hamiltoni</italic>, <italic>C. kuiteri</italic>, <italic>C. magnifica</italic>, and <italic>C. quadricolor</italic> [<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>,<xref rid="B164-marinedrugs-18-00657" ref-type="bibr">164</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>,<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]. <italic>C.</italic> (<italic>Glossodoris</italic>) also obtains latrunculin B (<bold>37</bold>) from the demosponge <italic>Latrunculia magnifica</italic> [<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]. Latrunculins (<bold>37,38</bold>) interfere with the cytoskeleton, disrupting the organization of cell microfilaments, and inhibit the proliferation of cancer cells due to their strong actin binding properties [<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B164-marinedrugs-18-00657" ref-type="bibr">164</xref>,<xref rid="B515-marinedrugs-18-00657" ref-type="bibr">515</xref>,<xref rid="B516-marinedrugs-18-00657" ref-type="bibr">516</xref>,<xref rid="B517-marinedrugs-18-00657" ref-type="bibr">517</xref>]. A PKS-NRPS-derived mycothiazole (<bold>129</bold>) found in <italic>C. lochi</italic> from Vanuatu and its prey sponge (see above) possesses selective cytotoxicity, inhibits the hypoxia-inducible factor-1 (HIF-1), and also suppresses the mitochondrial respiration at complex I in sensitive cell lines (IC<sub>50</sub> values of 0.36&#x02013;13.8 nM for HeLa, P815, RAW 264.7, MDCK, HeLa S3, 4T1, B16, and CD4/CD8 T cells) [<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B104-marinedrugs-18-00657" ref-type="bibr">104</xref>,<xref rid="B105-marinedrugs-18-00657" ref-type="bibr">105</xref>,<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>]. Latrunculins A (<bold>38</bold>) and B (<bold>37</bold>) display antimigratory activity against highly metastatic human prostate cancer PC-3M-CT<sup>+</sup> cells and murine brain-metastatic melanoma B16B15b cells [<xref rid="B515-marinedrugs-18-00657" ref-type="bibr">515</xref>,<xref rid="B518-marinedrugs-18-00657" ref-type="bibr">518</xref>]. Latrunculin A (<bold>38</bold>) presented IC<sub>50</sub> values of ~0.5 &#x003bc;M against murine P388 leukemia, human HT-29 colon cancer, and human A549 NSCLC, with more than a fivefold in vitro growth inhibitory effects against A549 NSCLC than to P388 leukemia [<xref rid="B519-marinedrugs-18-00657" ref-type="bibr">519</xref>]. Latrunculin A (<bold>38</bold>), coded NSC613011 on the NCI database, has an IC<sub>50</sub> mean value of ~0.7 &#x003bc;M in the 60 cancer cell line panel, with a more than twofold log magnitude difference between the most sensitive and the most resistant cancer cell lines, being as active against MDR NCI/ADR-RES as against cells without the MDR phenotype [<xref rid="B47-marinedrugs-18-00657" ref-type="bibr">47</xref>]. Finally, latrunculin A (<bold>38</bold>) induces apoptosis in cancer cells via activation of the caspase-3/caspase-7 pathway and displays strong anticancer effects in peritoneal dissemination models of MKN45 and NUGC-4 human gastric cancer in mice [<xref rid="B455-marinedrugs-18-00657" ref-type="bibr">455</xref>]. In vivo anticancer assays using A549 NSCLC xenografts also show that latrunculin A (<bold>38</bold>) increased the life span of treated tumor-bearing mice by 46% compared to controls [<xref rid="B520-marinedrugs-18-00657" ref-type="bibr">520</xref>].</p><p><italic>Chromodoris lochi</italic> from Indonesia, instead, presents sponge-derived polyketides, such as laulimalide (<bold>39</bold>) and <italic>iso</italic>laulimalide (<bold>40</bold>) from the sponge <italic>Hyattella</italic> sp., both compounds being cytotoxic due to their microtubule-stabilizing action at a different binding site to taxanes, located on two adjacent &#x003b2;-tubulin units between tubulin protofilaments of a microtubule [<xref rid="B521-marinedrugs-18-00657" ref-type="bibr">521</xref>,<xref rid="B522-marinedrugs-18-00657" ref-type="bibr">522</xref>]. Therefore, these compounds (<bold>39&#x02013;40</bold>), with IC<sub>50</sub> values of 15 ng/mL in the KB cell line, are being tested as potential antitumor agents [<xref rid="B142-marinedrugs-18-00657" ref-type="bibr">142</xref>,<xref rid="B523-marinedrugs-18-00657" ref-type="bibr">523</xref>,<xref rid="B524-marinedrugs-18-00657" ref-type="bibr">524</xref>]. Laulimalide (<bold>39</bold>) inhibits growth in more than ten cancer cell lines at low nanomolar concentrations, while <italic>iso</italic>laulimalide (<bold>40</bold>) is effective at low micromolar values [<xref rid="B142-marinedrugs-18-00657" ref-type="bibr">142</xref>,<xref rid="B525-marinedrugs-18-00657" ref-type="bibr">525</xref>,<xref rid="B526-marinedrugs-18-00657" ref-type="bibr">526</xref>]. As previously mentioned, laulimalide (<bold>39</bold>) is a microtubule stabilizer, like the plant compounds taccalonolide and paclitaxel, but laulimalide (<bold>39</bold>) has been reported to cause the formation of aberrant, structurally distinct mitotic spindles, differently from the other two molecules [<xref rid="B527-marinedrugs-18-00657" ref-type="bibr">527</xref>]. Moreover, laulimalide (<bold>39</bold>) has an effect in P-gp-overexpressing cancer cells and against cell lines resistant to paclitaxel and epothilones [<xref rid="B525-marinedrugs-18-00657" ref-type="bibr">525</xref>,<xref rid="B528-marinedrugs-18-00657" ref-type="bibr">528</xref>]. Further studies have shown that in ovarian cancer cells, the increased expression of &#x003b2;II- and &#x003b2;III tubulin isotypes induces resistance to laulimalide (<bold>39</bold>), as does the downregulation of vimentin expression in human ovarian carcinoma cells [<xref rid="B529-marinedrugs-18-00657" ref-type="bibr">529</xref>,<xref rid="B530-marinedrugs-18-00657" ref-type="bibr">530</xref>]. Moreover, assays in vivo tested the anticancer activity of laulimalide (<bold>39</bold>) in two xenograft models, the human MDA-MB-435 breast cancer and the human HT-1080 fibrosarcoma models, describing little tumor growth inhibition accompanied by a strong toxicity and mortality, contrasting to paclitaxel [<xref rid="B525-marinedrugs-18-00657" ref-type="bibr">525</xref>]. </p><p>Furthermore, inorolides A&#x02013;C (<bold>217</bold>), sesquiterpenoids found in the Japanese <italic>Chromodoris inornata</italic> (<italic>C. aspersa</italic>) and other scalarane terpenoids are cytotoxic against murine L1210 leukemia and human epidermoid carcinoma KB cell lines [<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>]. Particularly, inorolides A&#x02013;C (<bold>217</bold>) display IC<sub>50</sub> values of ~7, ~5, and ~4 &#x003bc;M, respectively, while sesterterpenoids like deoxoscalarin (<bold>46</bold>) and its analogues, deoxoscalarin-3-one, 21-hydroxydeoxoscalarin, 21-acetoxydeoxoscalarin, and 12-O-acetyl-16-O-deacetyl-12,16-episcalarolbutenolide, display values of ~3, ~2, ~9, ~1, and ~5 &#x003bc;M, respectively [<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>]. Some of these metabolites have been reported also in <italic>Hyrtios</italic> sponges and reviewed for their bioactivity [<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>,<xref rid="B531-marinedrugs-18-00657" ref-type="bibr">531</xref>]. </p><p>Similarly, cytoxicity has been reported in several compounds from other <italic>Chromodoris</italic> species, such as a sponge diterpene found in <italic>C. petechialis</italic> from Hawai&#x02019;i, puupehenone (<bold>218</bold>), an oxygenated diterpene of <italic>C. elisabethina</italic> from Australia, a spongian diterpene of <italic>C. kunei</italic> from Okinawa, furanoditerpenoids found in <italic>C. reticulata</italic> from China, and the mildly toxic diterpenes from a <italic>Chromodoris</italic> sp. from Australia [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B158-marinedrugs-18-00657" ref-type="bibr">158</xref>,<xref rid="B160-marinedrugs-18-00657" ref-type="bibr">160</xref>,<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]. Puupehenone (<bold>218</bold>) is active at IC<sub>50</sub> values of 1 &#x003bc;g/mL to P388, 0.1&#x02013;1 &#x003bc;g/mL to A-549 and MCF-7, as well as 1&#x02013;10 &#x003bc;g/mL to HCT-8 [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B158-marinedrugs-18-00657" ref-type="bibr">158</xref>,<xref rid="B160-marinedrugs-18-00657" ref-type="bibr">160</xref>,<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>].</p><p><italic>Goniobranchus</italic> species also possess some cytotoxic compounds. In Australia, <italic>G. splendidus</italic> has a cytotoxic spiroepoxide lactone, epoxygoniolide-1 (<bold>219</bold>), suspected to originate from its dietary sponge prey [<xref rid="B532-marinedrugs-18-00657" ref-type="bibr">532</xref>]. Epoxygoniolide-1 (<bold>219</bold>) shows moderate cytotoxicity to NCIH-460, SW60, and HepG2 cancer cells [<xref rid="B532-marinedrugs-18-00657" ref-type="bibr">532</xref>]. <italic>G. (Chromodoris) sinensis</italic> from China presents aplyroseol-2 (<bold>220</bold>) [<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>]. <italic>G. reticulatus</italic> from Australia presents a dialdehyde sesquiterpene, together with the ring-closed acetal, both bioactive against P388 mouse leukemia cells [<xref rid="B161-marinedrugs-18-00657" ref-type="bibr">161</xref>,<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]. <italic>G. reticulatus</italic> contains spongian-16-one (<bold>221</bold>), aplytandiene-3 (<bold>222</bold>), aplysulfurin (<bold>223</bold>), aplyroseol-2 (<bold>220</bold>), and gracilins A (<bold>224</bold>), B (<bold>225</bold>), C (<bold>226</bold>), G (<bold>227</bold>), and M (<bold>228</bold>), all of which display cytotoxicity against HeLa S3 cells [<xref rid="B190-marinedrugs-18-00657" ref-type="bibr">190</xref>]. Moreover, gracilins B (<bold>225</bold>) and C (<bold>226</bold>), as well as some isomers, obtained from the demosponge <italic>Spongionella</italic> sp. are cytotoxic against a wider panel of HTCLs, and have also been reported as cyclosporine A mimics and BACE1 and ERK inhibitors (see below) [<xref rid="B533-marinedrugs-18-00657" ref-type="bibr">533</xref>,<xref rid="B534-marinedrugs-18-00657" ref-type="bibr">534</xref>]. Gracilins M&#x02013;Q (<bold>228</bold>) showed a significant potency against the HeLa S3 cell line [<xref rid="B113-marinedrugs-18-00657" ref-type="bibr">113</xref>]. In Japan, <italic>G. (Chromodoris) obsoletus</italic> contains dorisenones A&#x02013;D (<bold>229</bold>), cytotoxic sponge diterpenoids, along with related compounds, such as 11<italic>&#x003b2;</italic>-hydroxyspongi-12-en-16-one (<bold>230</bold>), spongian-16-one (<bold>221</bold>) [<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>]. All of these compounds are active against murine lymphoma L1210 and human epidermoid carcinoma KB cells at IC<sub>50</sub> submicromolar (as low as IC<sub>50</sub> 0.2 &#x003bc;g/mL) and low micromolar values, respectively, and although dorisenone D and a related compound have also been tested in vivo against P388 leukemia, they show no activity [<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>]. Similarly, in <italic>G. collingwoodii</italic>, some spongian-16-one diterpenes are reported to be inactive to a range of HTCLs [<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>].</p><p>The spongian diterpenes of <italic>Glossodoris cincta</italic> from Egypt and Sri Lanka have also been reported to be cytotoxic [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>,<xref rid="B536-marinedrugs-18-00657" ref-type="bibr">536</xref>,<xref rid="B537-marinedrugs-18-00657" ref-type="bibr">537</xref>]. The compound 12-<italic>epi</italic>-scalaradial found in <italic>G. cincta</italic> and <italic>G. hikuerensis</italic> is the most active, inhibiting the epidermal growth factor receptor (EGFR) implicated in many cancers, and also inhibiting the human recombinant PLA2 at 0.02 &#x003bc;M. <italic>Doriprismatica (Glossodoris) atromarginata</italic> presents furanoditerpenoids and scalarane sesterterpenes originating from its dietary sponges <italic>Spongia</italic> (<italic>Hyatella</italic>) sp. and <italic>Hyrtios</italic> spp., depending on the geographical location (Australia, Sri Lanka, India) [<xref rid="B93-marinedrugs-18-00657" ref-type="bibr">93</xref>,<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B181-marinedrugs-18-00657" ref-type="bibr">181</xref>,<xref rid="B386-marinedrugs-18-00657" ref-type="bibr">386</xref>,<xref rid="B387-marinedrugs-18-00657" ref-type="bibr">387</xref>,<xref rid="B388-marinedrugs-18-00657" ref-type="bibr">388</xref>]. The most active metabolites were spongiadiol (<bold>35</bold>), spongiadiol diacetate (<bold>231</bold>), <italic>epi</italic>-spongiadiol (<bold>232</bold>), 12-deacetoxy-12-oxodeoxoscalarin (<bold>136</bold>), heteronemin (<bold>233</bold>), and mooloolabene D (<bold>234</bold>) [<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>,<xref rid="B384-marinedrugs-18-00657" ref-type="bibr">384</xref>,<xref rid="B385-marinedrugs-18-00657" ref-type="bibr">385</xref>,<xref rid="B386-marinedrugs-18-00657" ref-type="bibr">386</xref>,<xref rid="B519-marinedrugs-18-00657" ref-type="bibr">519</xref>,<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>,<xref rid="B538-marinedrugs-18-00657" ref-type="bibr">538</xref>,<xref rid="B539-marinedrugs-18-00657" ref-type="bibr">539</xref>,<xref rid="B540-marinedrugs-18-00657" ref-type="bibr">540</xref>]. In particular, spongiadiol (<bold>35</bold>) is active against P388 murine leukemia cells at an IC<sub>50</sub> of 0.5 &#x003bc;g/mL. Other species, such as <italic>Felimida (Glossodoris) dalli</italic>, <italic>Doriprismatica (Glossodoris) sedna</italic>, <italic>Glossodoris rufomarginata</italic>, <italic>Glossodoris pallida</italic>, <italic>Glossodoris vespa</italic>, and <italic>Ardeadoris (Glossodoris) averni</italic>, also present homoscalarane and scalarane metabolites, among which 12-deacetyl-23-acetoxy-20-methyl-12<italic>-epi</italic>-scalaradial (<bold>135</bold>) moderately inhibits mammalian phospholipase A2 (IC<sub>50</sub> = 18 &#x003bc;M) [<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B183-marinedrugs-18-00657" ref-type="bibr">183</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>]. Heteronemin (<bold>233</bold>), also found in several chromodoridid species and derived from dietary sponges, such as <italic>Heteronema erecta,</italic> blocks tumor cell intravasation through the lymph-endothelial barrier in a three-dimensional (3D) cell culture model, using spheroids of the MCF-7 breast cancer cell [<xref rid="B541-marinedrugs-18-00657" ref-type="bibr">541</xref>,<xref rid="B542-marinedrugs-18-00657" ref-type="bibr">542</xref>].</p><p><italic>Hypselodoris infucata</italic> from Bali presents (&#x02013;)-furodysinin (<bold>48</bold>), which is active against the HeLa cell line with an IC<sub>50</sub> of 102.7 &#x003bc;g/mL [<xref rid="B214-marinedrugs-18-00657" ref-type="bibr">214</xref>]. <italic>Felimida (Chromodoris) macfarlandi</italic> from California presents macfarlandines A&#x02013;E (<bold>134,235</bold>), from which macfarlandin E (<bold>235</bold>) displays unique Golgi-modifying properties [<xref rid="B139-marinedrugs-18-00657" ref-type="bibr">139</xref>,<xref rid="B140-marinedrugs-18-00657" ref-type="bibr">140</xref>,<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>,<xref rid="B543-marinedrugs-18-00657" ref-type="bibr">543</xref>].</p><p><italic>Hexabranchus sanguineus</italic> is a chemically rich species, transferring several compounds to their egg masses, including the macrolides ulapualides A (<bold>190</bold>) and B (<bold>236</bold>) in Hawai&#x02019;i, presenting three contiguous oxazole rings with the attached lipid-like side chain ending in the N-methyl-N-alkenylformamide group [<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>]. Ulapualide A (<bold>190</bold>) has also been found in sponges and, thus, is suggested to be of dietary origin in the slug [<xref rid="B544-marinedrugs-18-00657" ref-type="bibr">544</xref>]. Both compounds are reported to display activity against murine L1210 leukemia cells, with IC<sub>50</sub> values of ~10 and ~30 nM, respectively [<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>]. Ulapualide A (<bold>190</bold>) has been described to be a potent actin-depolymerizer [<xref rid="B545-marinedrugs-18-00657" ref-type="bibr">545</xref>]. Later, ulapualides C&#x02013;E (<bold>237</bold>) have been found in egg masses from Hawai&#x02019;i, and ulapualide C (<bold>237</bold>) is reported to display cytotoxicity against several HTCLs, although it is 2&#x02013;4 times less potent than ulapualides A (<bold>190</bold>) and B (<bold>236</bold>) [<xref rid="B546-marinedrugs-18-00657" ref-type="bibr">546</xref>]. A different study found several kabiramides, including kabiramide A (<bold>238</bold>), B (<bold>239</bold>), D (<bold>240</bold>), and E (<bold>241</bold>), along with the halichondramide derivatives, dihydrohalichondramide (<bold>63</bold>) and 33-methylhalichondramide (<bold>242</bold>), in egg masses of the same species from a different locality [<xref rid="B217-marinedrugs-18-00657" ref-type="bibr">217</xref>,<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>,<xref rid="B220-marinedrugs-18-00657" ref-type="bibr">220</xref>,<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>]. Kabiramides (<bold>238&#x02013;241</bold>) contain a macrolide ring with contiguous trisoxazole rings [<xref rid="B547-marinedrugs-18-00657" ref-type="bibr">547</xref>]. Kabiramide C (<bold>62</bold>) was traced to a <italic>Halichondria</italic> sponge and further reported in the sponge <italic>Pachastrissa nux</italic> together with other kabiramides, as well as to some adult slug specimens at a lower concentration [<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>,<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>,<xref rid="B548-marinedrugs-18-00657" ref-type="bibr">548</xref>]. Kabiramide C (<bold>62</bold>) presents growth inhibitory effects in vitro against human MCF-7 breast cancer cells (IC<sub>50</sub> ~0.5 &#x003bc;M), ten times higher than for human fibroblasts (IC<sub>50</sub> ~8 &#x003bc;M), displaying bioselectivity [<xref rid="B548-marinedrugs-18-00657" ref-type="bibr">548</xref>]. The mechanism of action has been described as kabiramide C (<bold>62</bold>) binding to actin and its actin complex, which is achieved through a two-step binding reaction and forms a very stable and long-lived complex [<xref rid="B549-marinedrugs-18-00657" ref-type="bibr">549</xref>]. Kabiramide G (<bold>243</bold>) presents an even stronger bioselectivity, with IC<sub>50</sub> values of 0.02 &#x003bc;M against MCF-7 cancer cells and &#x0003e;2 &#x003bc;M for human fibroblasts [<xref rid="B548-marinedrugs-18-00657" ref-type="bibr">548</xref>]. Kabiramides A (<bold>238</bold>) and B (<bold>239</bold>) were active with IC<sub>50</sub> values of ~10 nM, and kabiramides D (<bold>240</bold>) and E (<bold>241</bold>) with IC<sub>50</sub> values of ~30 nM, against the murine L1210 leukemia cell line [<xref rid="B220-marinedrugs-18-00657" ref-type="bibr">220</xref>]. On the other hand, dihydrohalichondramide (<bold>63</bold>) and 33-methylhalichondramide (<bold>242</bold>) inhibit growth in the murine L1210 leukemia cell line with IC<sub>50</sub> values of ~40 and ~60 nM, respectively, in this case by disrupting actin microfilaments [<xref rid="B220-marinedrugs-18-00657" ref-type="bibr">220</xref>,<xref rid="B550-marinedrugs-18-00657" ref-type="bibr">550</xref>]. Halichondramide (<bold>244</bold>) presents also a wide array of bioactivities, including cytotoxic and cytostatic activities and antiproliferative and antimigratory effects in vitro, as reported elsewhere [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B551-marinedrugs-18-00657" ref-type="bibr">551</xref>,<xref rid="B552-marinedrugs-18-00657" ref-type="bibr">552</xref>]. Most of these compounds probably originate from a sponge diet [<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>]. A mechanism of detoxification has been suggested for the slug to deal with halichondramide and transform it into less toxic compounds [<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>].</p><p>Another interesting species is <italic>Jorunna funebris</italic>, which in India presents the cytotoxic isoquinoline alkaloid jorumycin (<bold>189</bold>) [<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B553-marinedrugs-18-00657" ref-type="bibr">553</xref>,<xref rid="B554-marinedrugs-18-00657" ref-type="bibr">554</xref>]. Jorumycin (<bold>189</bold>) is cytotoxic at very low concentrations, with an IC<sub>50</sub> of 12.5 ng/mL against some cancer cell lines, such as P388, A549, HT29, and MEL28, including cells resistant to apopototic stimuli, and having a saframycin-like structure similar to ecteinascidin 743, one of the most active marine-derived antitumor agents isolated from the tunicate <italic>Ecteinascidia turbinata</italic> and an approved drug already on the market [<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>,<xref rid="B553-marinedrugs-18-00657" ref-type="bibr">553</xref>,<xref rid="B555-marinedrugs-18-00657" ref-type="bibr">555</xref>,<xref rid="B556-marinedrugs-18-00657" ref-type="bibr">556</xref>,<xref rid="B557-marinedrugs-18-00657" ref-type="bibr">557</xref>]. A synthetic compound derived from jorumycin (<bold>189</bold>) is in phase II clinical studies for endometrial and cervical cancer, as well as solid human tumors and hematological diseases (Ewing sarcoma, urothelial carcinoma, and multiple myeloma) [<xref rid="B556-marinedrugs-18-00657" ref-type="bibr">556</xref>,<xref rid="B558-marinedrugs-18-00657" ref-type="bibr">558</xref>,<xref rid="B559-marinedrugs-18-00657" ref-type="bibr">559</xref>]. Specimens from Thailand, instead, present jorunnamycins A&#x02013;C (<bold>245</bold>), along with renieramycins (<bold>246</bold>), which are also cytotoxic, while specimens from Sri Lanka presented several isoquinoline&#x02013;quinone metabolites from the sponge <italic>Xestospongia</italic> sp. [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B560-marinedrugs-18-00657" ref-type="bibr">560</xref>]. Jorunnamycins A&#x02013;C (<bold>245</bold>) are reported to be obtained after treatment of the samples with potassium cyanide, yielding more stable compounds while still conserving high cytotoxicity against HTCLs [<xref rid="B560-marinedrugs-18-00657" ref-type="bibr">560</xref>]. Jorunnamycin C (<bold>245</bold>) and renieramycin M (<bold>246</bold>) present IC<sub>50</sub> values at low nanomolar ranges against human colon (HCT-116) and breast (MDA-MB-435) cancer cells [<xref rid="B561-marinedrugs-18-00657" ref-type="bibr">561</xref>]. Their mechanism of action has been reported as the downregulation of protein tyrosine phosphatase receptor type K (PTPRK) in vitro, since PTPRK is a tumor suppressor gene product that may be involved in colon cancer [<xref rid="B516-marinedrugs-18-00657" ref-type="bibr">516</xref>,<xref rid="B561-marinedrugs-18-00657" ref-type="bibr">561</xref>,<xref rid="B562-marinedrugs-18-00657" ref-type="bibr">562</xref>,<xref rid="B563-marinedrugs-18-00657" ref-type="bibr">563</xref>]. Some structurally related compounds were also found in specimens from South China, such as the fennebricins A and B, and other molecules, probably also from a <italic>Xestospongia</italic> sp. [<xref rid="B564-marinedrugs-18-00657" ref-type="bibr">564</xref>,<xref rid="B565-marinedrugs-18-00657" ref-type="bibr">565</xref>].</p><p>The Mediterranean <italic>Peltodoris atromaculata</italic>, and the sponges on which it feeds on, <italic>Petrosia ficiformis</italic> and <italic>Haliclona fulva</italic>, contain cytotoxic long-chain fulvinol-like polyacetylenes, namely, petroformynes (<bold>247</bold>) [<xref rid="B566-marinedrugs-18-00657" ref-type="bibr">566</xref>,<xref rid="B567-marinedrugs-18-00657" ref-type="bibr">567</xref>,<xref rid="B568-marinedrugs-18-00657" ref-type="bibr">568</xref>,<xref rid="B569-marinedrugs-18-00657" ref-type="bibr">569</xref>]. These compounds are structurally very similar to the sponge compounds neopetroformynes and are active against murine P388 leukemia cells with IC<sub>50</sub> values of 0.09&#x02013;0.45 &#x003bc;M [<xref rid="B570-marinedrugs-18-00657" ref-type="bibr">570</xref>]. Further metabolites from this slug include some other polyacetylenes, such as the hydroxy-dehydroisofulvinol (<bold>248</bold>), very similar to fulvinol, which is active against four cell lines, i.e., murine P388 leukemia, A549 NSCLC, HT-29 colon cancer, and SKMEL-28, at IC50 ~2 &#x003bc;M [<xref rid="B571-marinedrugs-18-00657" ref-type="bibr">571</xref>]. Hydroxy-dehydroisofulvinol (<bold>248</bold>) presents an IC<sub>50</sub> value of ~3 &#x003bc;M against the SKMEL28 melanoma cell line [<xref rid="B571-marinedrugs-18-00657" ref-type="bibr">571</xref>].</p><p>Finally, nembrothids also present some cytoxocity. The alkaloids tambjamines (<bold>65&#x02013;70</bold>), as mentioned above, are found in several <italic>Tambja</italic> species (<italic>T. capensis</italic>, <italic>T. ceutae, T. eliora</italic>, <italic>T. morosa</italic>, <italic>T. stegosauriformis, T. verconis</italic>) along with their bryozoan prey (<italic>Bugula dentata</italic> or <italic>Sessibugula translucens)</italic> in different geographical localities [<xref rid="B21-marinedrugs-18-00657" ref-type="bibr">21</xref>,<xref rid="B88-marinedrugs-18-00657" ref-type="bibr">88</xref>,<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>,<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>,<xref rid="B228-marinedrugs-18-00657" ref-type="bibr">228</xref>,<xref rid="B572-marinedrugs-18-00657" ref-type="bibr">572</xref>,<xref rid="B573-marinedrugs-18-00657" ref-type="bibr">573</xref>]. <italic>Roboastra</italic> species feeding on <italic>Tambja</italic> species also present tambjamines (<bold>65&#x02013;70</bold>), and <italic>R. tigris</italic> obtains them from <italic>T. abdere</italic> and <italic>T. eliora</italic> [<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]. Tambjamines (<bold>65&#x02013;70</bold>) have also been found in <italic>Nembrotha</italic> spp. and the tunicate <italic>Atapozoa</italic> sp. [<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>,<xref rid="B227-marinedrugs-18-00657" ref-type="bibr">227</xref>]. Some tambjamines (<bold>65&#x02013;70</bold>), which are similar to the bacterial compounds prodigiosins, have been described to cause DNA damage and induce apoptosis [<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>,<xref rid="B574-marinedrugs-18-00657" ref-type="bibr">574</xref>,<xref rid="B575-marinedrugs-18-00657" ref-type="bibr">575</xref>,<xref rid="B576-marinedrugs-18-00657" ref-type="bibr">576</xref>,<xref rid="B577-marinedrugs-18-00657" ref-type="bibr">577</xref>]. Tambjamine D (<bold>68</bold>) is active against several tumor cell lines by intercalating into DNA, as well as by promoting single-strand DNA oxidative cleavage, although a lack of selectivity was described [<xref rid="B228-marinedrugs-18-00657" ref-type="bibr">228</xref>,<xref rid="B578-marinedrugs-18-00657" ref-type="bibr">578</xref>,<xref rid="B579-marinedrugs-18-00657" ref-type="bibr">579</xref>,<xref rid="B580-marinedrugs-18-00657" ref-type="bibr">580</xref>,<xref rid="B581-marinedrugs-18-00657" ref-type="bibr">581</xref>,<xref rid="B582-marinedrugs-18-00657" ref-type="bibr">582</xref>,<xref rid="B583-marinedrugs-18-00657" ref-type="bibr">583</xref>,<xref rid="B584-marinedrugs-18-00657" ref-type="bibr">584</xref>,<xref rid="B585-marinedrugs-18-00657" ref-type="bibr">585</xref>,<xref rid="B586-marinedrugs-18-00657" ref-type="bibr">586</xref>]. Tambjamine K (<bold>249</bold>) and the tetrapyrrole (<bold>72</bold>) display concentration-dependent cytotoxicity against tumor and non-tumor mammalian cells, with IC<sub>50</sub> values between ~0.004 and 15 &#x003bc;M and IC<sub>50</sub> ~19 &#x003bc;M against mouse 3T3-L1 fibroblasts for tambjamine K (<bold>249</bold>) [<xref rid="B232-marinedrugs-18-00657" ref-type="bibr">232</xref>,<xref rid="B584-marinedrugs-18-00657" ref-type="bibr">584</xref>,<xref rid="B587-marinedrugs-18-00657" ref-type="bibr">587</xref>]. In fact, tambjamine K (<bold>249</bold>) is very selective, showing a ~4000-fold differential sensitivity between human Caco-2 colon cancer cells and HeLa cervix cancer cells [<xref rid="B229-marinedrugs-18-00657" ref-type="bibr">229</xref>]. Tambjamine C (<bold>67</bold>), instead, is a good transmembrane anion transporter, similar to prodigiosins, which are relevant in cancer cell biology and cancer cell migration, and they are expressed differently in diverse cancer cells [<xref rid="B581-marinedrugs-18-00657" ref-type="bibr">581</xref>,<xref rid="B582-marinedrugs-18-00657" ref-type="bibr">582</xref>,<xref rid="B583-marinedrugs-18-00657" ref-type="bibr">583</xref>,<xref rid="B584-marinedrugs-18-00657" ref-type="bibr">584</xref>,<xref rid="B585-marinedrugs-18-00657" ref-type="bibr">585</xref>,<xref rid="B586-marinedrugs-18-00657" ref-type="bibr">586</xref>]. </p></sec><sec><title>Dendronotida</title><p>Within this group, several species have been described to present cytotoxic compounds. Punaglandins (<bold>250</bold>) are cytotoxic PGs obtained by <italic>Tritonia</italic> sp. From its octocoral prey, <italic>Telesto riisei,</italic> active at an IC<sub>50</sub> of 0.03 &#x000b5;M to mouse leukemia cells [<xref rid="B587-marinedrugs-18-00657" ref-type="bibr">587</xref>]. Dotofide (<bold>251</bold>) is found in <italic>Doto pinnatifida</italic> and is active against several cell lines using the MTT colorimetric assay [<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>]. Against human glioma, dotofide (<bold>251</bold>) shows a GI<sub>50</sub> value of 18.1 &#x000b5;M for Hs683 oligodendroglioma (ATCC HTB-138), and of 28.8 &#x000b5;M for U373 glioblastoma (ECACC 08061901) [<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>]. For human carcinoma, dotofide (<bold>251</bold>) displays GI<sub>50</sub> values of 29.4 &#x000b5;M for A549 NSCLC (DSMZ ACC107), and 28.1 &#x000b5;M for MCF-7 breast carcinoma (DSMZ ACC115) [<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>]. Finally, for melanoma, it displays GI<sub>50</sub> values of 60.5 &#x000b5;M for human SKMEL-28 (ATCC HTB-72) and 9.6 &#x000b5;M for mouse B16F10 (ATCC CRL-6475) [<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>].</p><p>The sesquiterpenes tritoniopsins A&#x02013;D (<bold>75&#x02013;78</bold>) are found in <italic>Tritoniopsis elegans</italic> and its soft coral prey <italic>Cladiella krempfi</italic>, where the slug accumulates tritoniopsin A (<bold>75</bold>) in its mantle at higher concentrations than the coral or other slug tissues [<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>]. Rat cell lines were used to test the cytotoxicity of tritoniopsin A (<bold>75</bold>), resulting in a weak to moderated activity [<xref rid="B234-marinedrugs-18-00657" ref-type="bibr">234</xref>].</p></sec><sec><title>Euarminida</title><p>The previously mentioned eunicellin diterpenes (<bold>187</bold>) from <italic>Dermatobranchus ornatus</italic> display moderate cytotoxicity to A-549, SKOV-3, SK-MEL-2, and HCT-15, along with inhibition of cell division in fertilized starfish eggs [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>]. The South African slug <italic>Leminda millecra</italic> possesses sesquiterpenes and prenylquinones from its diet of octocorals, mainly of the genus <italic>Alcyonium</italic> and gorgonians such as <italic>Leptogorgia palma</italic> [<xref rid="B588-marinedrugs-18-00657" ref-type="bibr">588</xref>,<xref rid="B589-marinedrugs-18-00657" ref-type="bibr">589</xref>,<xref rid="B590-marinedrugs-18-00657" ref-type="bibr">590</xref>]. Among them, a prenylated hydroquinone (<bold>252</bold>) possesses moderate inhibitory activity, with values of GI<sub>50</sub> around 6&#x02013;9 &#x003bc;M against WHCO1 and WHCO6 esophageal cancer cell lines, inducing apoptosis via generation of reactive oxygen moieties [<xref rid="B589-marinedrugs-18-00657" ref-type="bibr">589</xref>,<xref rid="B590-marinedrugs-18-00657" ref-type="bibr">590</xref>].</p></sec><sec><title>Aeolidida</title><p><italic>Hermissenda crassicornis</italic> presents L-6-bromohypaphorine (<bold>253</bold>), reported to be an agonist of human a7 nicotinic acetylcholine receptor [<xref rid="B591-marinedrugs-18-00657" ref-type="bibr">591</xref>]. In <italic>Phyllodesmium briareum</italic>, brianthein W (<bold>254</bold>) is reported to have an ED<sub>50</sub> of 0.76 &#x003bc;g/mL against P-388, while excavatolide C (<bold>255</bold>) displays an ED<sub>50</sub> of 0.3&#x003bc;g/mL for P-388, and an ED<sub>50</sub> of 1.9&#x003bc;g/mL for KB, A-549, HT-29 [<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]. Both compounds were traced to the diet the octocoral <italic>Briareum</italic> sp. [<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]. Similarly, <italic>P. magnum</italic> possesses 11-<italic>epi</italic>sinulariolide acetate (<bold>256</bold>) with an ED<sub>50</sub> of 1.2&#x003bc;g/mL for P-388, ED<sub>50</sub> of 1.9&#x003bc;g/mL for HT-29, and ED<sub>50</sub> of 0.8&#x003bc;g/mL for HL-60 [<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]. Moreover, the previously mentioned diterpene trocheliophorol (<bold>84</bold>) from <italic>Phyllodesmium longicirrum</italic> has been reported as cytotoxic [<xref rid="B245-marinedrugs-18-00657" ref-type="bibr">245</xref>]. </p><p>Phidianidines A (<bold>257</bold>) and B are bromoindole alkaloids from the Chinese slug <italic>Phidiana militaris</italic> [<xref rid="B361-marinedrugs-18-00657" ref-type="bibr">361</xref>,<xref rid="B592-marinedrugs-18-00657" ref-type="bibr">592</xref>]. Phidianidines (<bold>257</bold>) are the only known marine source of the 1,2,4-oxadiazole system, and their interesting structure promoted their synthesis, as well as that of several analogues [<xref rid="B593-marinedrugs-18-00657" ref-type="bibr">593</xref>,<xref rid="B594-marinedrugs-18-00657" ref-type="bibr">594</xref>,<xref rid="B595-marinedrugs-18-00657" ref-type="bibr">595</xref>,<xref rid="B596-marinedrugs-18-00657" ref-type="bibr">596</xref>,<xref rid="B597-marinedrugs-18-00657" ref-type="bibr">597</xref>,<xref rid="B598-marinedrugs-18-00657" ref-type="bibr">598</xref>,<xref rid="B599-marinedrugs-18-00657" ref-type="bibr">599</xref>,<xref rid="B600-marinedrugs-18-00657" ref-type="bibr">600</xref>,<xref rid="B601-marinedrugs-18-00657" ref-type="bibr">601</xref>,<xref rid="B602-marinedrugs-18-00657" ref-type="bibr">602</xref>,<xref rid="B603-marinedrugs-18-00657" ref-type="bibr">603</xref>,<xref rid="B604-marinedrugs-18-00657" ref-type="bibr">604</xref>,<xref rid="B605-marinedrugs-18-00657" ref-type="bibr">605</xref>]. Phidianidines (<bold>257</bold>) show cytotoxicity against several cell lines, such as C6 and HeLa tumor cells at nanomolar concentrations [<xref rid="B592-marinedrugs-18-00657" ref-type="bibr">592</xref>]. Their IC<sub>50</sub> values stand from ~0.4 to &#x0003e;100 &#x003bc;M in three cancer cell lines, with no selectivity against mouse 3T3-L1 fibroblasts and rat H9c2 cardiomyocytes (IC<sub>50</sub>: ~0.1 and ~5 &#x003bc;M) [<xref rid="B592-marinedrugs-18-00657" ref-type="bibr">592</xref>,<xref rid="B606-marinedrugs-18-00657" ref-type="bibr">606</xref>]. Human HeLa cervix cancer cells are very sensitive to the growth inhibitory effects of phidianidines (<bold>257</bold>), contrarily to Caco-2 colon cancer cells [<xref rid="B606-marinedrugs-18-00657" ref-type="bibr">606</xref>]. Phidianidines (<bold>257</bold>) are also selective and potent ligands with partial agonist activity against the &#x003bc; opiod receptor (when compared to &#x003b4;- and &#x003ba;-opiod receptors), which is involved in cancer progression [<xref rid="B593-marinedrugs-18-00657" ref-type="bibr">593</xref>,<xref rid="B607-marinedrugs-18-00657" ref-type="bibr">607</xref>]. Virtual screening allowed for the identification of phidianidine A (<bold>257</bold>) as a potential ligand for CXCR4, a chemokine receptor involved in several diseases, including cancer progression, metastasis, and immunodeficiency disorders, and competing with natural ligand CXCL12 as observed by molecular docking, proving that it is a CXCR4 antagonist [<xref rid="B608-marinedrugs-18-00657" ref-type="bibr">608</xref>]. Moreover, phidianidine A (<bold>257</bold>) significantly reduced the CXCL12-induced migration at 50 &#x003bc;M in a rat cell line of pituitary adenoma [<xref rid="B609-marinedrugs-18-00657" ref-type="bibr">609</xref>].</p></sec></sec><sec id="sec3dot1dot2-marinedrugs-18-00657"><title>3.1.2. Pleurobranchoidea </title><p><italic>Pleurobranchus albiguttatus</italic> and <italic>P. forskalii</italic> from the Philippines contain the cytotoxic chlorinated diterpenes chlorolissoclimide (<bold>258</bold>), dichlorolissoclimide (<bold>259</bold>), haterumaimides (<bold>260</bold>), and 3&#x003b2;-hydroxychlorolissoclimide (<bold>261</bold>), which are acquired from its tunicate prey <italic>Lissoclinum</italic> [<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>]. These were tested against the NCI panel of 60 tumor cell lines [<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>]. In Indonesia, <italic>P. forskalii</italic> presents a cyclic hexapeptide instead, keenamide A (<bold>262</bold>), containing a thiazoline and an isoprene residue, which has been reported active against four cancer cell lines (P388, A549, MEL20, and HT29) with IC<sub>50</sub> values of 2.5&#x02013;8 &#x003bc;M [<xref rid="B611-marinedrugs-18-00657" ref-type="bibr">611</xref>,<xref rid="B612-marinedrugs-18-00657" ref-type="bibr">612</xref>]. In Japan, <italic>P. forskalii</italic> contains a macrocyclic dodecapeptide, cycloforskamide (<bold>263</bold>), contaning three thiazoline heterocycles [<xref rid="B612-marinedrugs-18-00657" ref-type="bibr">612</xref>]. Cycloforskamide (<bold>263</bold>) displays an IC<sub>50</sub> value of 5.8 &#x003bc;M against murine P388 leukemia cells [<xref rid="B387-marinedrugs-18-00657" ref-type="bibr">387</xref>]. Unfortunately, the low sensitivity of this model resulted in the NCI not pursuing this compound further [<xref rid="B613-marinedrugs-18-00657" ref-type="bibr">613</xref>,<xref rid="B614-marinedrugs-18-00657" ref-type="bibr">614</xref>]. In Japan, <italic>P. forskalii</italic> also presented ergosinine (<bold>264</bold>), an alkaloid only described previously in terrestrial higher plants and fungi, which is a known activator of caspase-3 [<xref rid="B615-marinedrugs-18-00657" ref-type="bibr">615</xref>,<xref rid="B616-marinedrugs-18-00657" ref-type="bibr">616</xref>]. The tunicate-derived compounds chlorolissoclimide (<bold>258</bold>) and dichlorolissoclimide (<bold>259</bold>) have been further tested, resulting in IC<sub>50</sub> values of 0.7 and 1.25 &#x003bc;M against the NCI 60 cell lines panel, respectively, and also displaying selectivity toward melanoma cell lines [<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>,<xref rid="B613-marinedrugs-18-00657" ref-type="bibr">613</xref>,<xref rid="B617-marinedrugs-18-00657" ref-type="bibr">617</xref>,<xref rid="B618-marinedrugs-18-00657" ref-type="bibr">618</xref>]. Furthermore, both compounds (<bold>258,259</bold>) inhibit growth in the Corbett&#x02013;Valeriote soft agar disk diffusion test, but with no selectivity for solid tumors, while the related 3&#x003b2;-hydroxychlorolissoclimide (<bold>261</bold>) presents some selectivity for solid tumors in the same test [<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>]. In particular, chlorolissoclimide (<bold>258</bold>) and dichlorolissoclimide (<bold>259</bold>) were active against murine P388 leukemia cells resistant to adriamycin by blocking the translation elongation via inhibition of translocation, thus producing an accumulation of ribosomes on mRNA [<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>,<xref rid="B618-marinedrugs-18-00657" ref-type="bibr">618</xref>,<xref rid="B619-marinedrugs-18-00657" ref-type="bibr">619</xref>]. On the other hand, haterumaimides A&#x02013;Q (<bold>260,265&#x02013;269</bold>) also present interesting activities, as do their synthetic derivatives, against the NCI 60 cell lines panel, with IC<sub>50</sub> values of 0.08&#x02013;1 &#x003bc;M for haterumaimide D, and from 0.5 nM to &#x0003e;20 &#x003bc;M for haterumaimides J (<bold>265</bold>) and K (<bold>266</bold>) and haterumaimides C (<bold>267</bold>), G (<bold>268</bold>), and I (<bold>269</bold>), respectively [<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>,<xref rid="B617-marinedrugs-18-00657" ref-type="bibr">617</xref>,<xref rid="B620-marinedrugs-18-00657" ref-type="bibr">620</xref>,<xref rid="B621-marinedrugs-18-00657" ref-type="bibr">621</xref>,<xref rid="B622-marinedrugs-18-00657" ref-type="bibr">622</xref>,<xref rid="B623-marinedrugs-18-00657" ref-type="bibr">623</xref>,<xref rid="B624-marinedrugs-18-00657" ref-type="bibr">624</xref>].</p></sec><sec id="sec3dot1dot3-marinedrugs-18-00657"><title>3.1.3. Tylodinoidea</title><p>As previously mentioned, <italic>Tylodina perversa</italic> obtains brominated isoxazoline alkaloids from sponges of the genus <italic>Aplysina</italic> [<xref rid="B257-marinedrugs-18-00657" ref-type="bibr">257</xref>,<xref rid="B625-marinedrugs-18-00657" ref-type="bibr">625</xref>]. Among them, <italic>iso</italic>-fistularin-3 (<bold>270</bold>) presents a IC<sub>50</sub> value of ~9 &#x003bc;M against human HeLa cervix carcinoma cells [<xref rid="B625-marinedrugs-18-00657" ref-type="bibr">625</xref>].</p></sec><sec id="sec3dot1dot4-marinedrugs-18-00657"><title>3.1.4. Cephalaspidea</title><p>The most active species in this group is <italic>Philinopsis speciosa</italic>. Because its molecules are structurally similar to cyanobacterial compounds, it has been hypothesized that <italic>P. speciosa</italic> obtains them through its diet of the sea hares <italic>Stylocheilus longicauda</italic> and <italic>Dolabella auricularia,</italic> which in turn feed on cyanobacteria [<xref rid="B276-marinedrugs-18-00657" ref-type="bibr">276</xref>]. In Hawai&#x02019;i, <italic>P. speciosa</italic> presents the cyclodepsipeptide kulolide-1 (<bold>271</bold>), which displays potent antitumoral activity against L-1210 leukemia and P388 murine leukemia cell lines, with IC<sub>50</sub> values of 0.7 and 2.1 &#x003bc;g/mL, respectively, although these assays are highly sensitive to proapoptotic stimuli [<xref rid="B277-marinedrugs-18-00657" ref-type="bibr">277</xref>,<xref rid="B614-marinedrugs-18-00657" ref-type="bibr">614</xref>]. Kulolide-1 (<bold>271</bold>) also produced morphological changes in rat 3Y1 fibroblast cells at 50 &#x003bc;M [<xref rid="B277-marinedrugs-18-00657" ref-type="bibr">277</xref>]. Further chemical analysis of the species yielded some more related peptides, such as kulolide-2 (<bold>272</bold>), kulolide-3 (<bold>273</bold>), kulokainalide-1 (<bold>274</bold>) and the bidepsipeptides kulokekahilide-1 (<bold>275</bold>) and kulokekahilide-2 (<bold>276</bold>) [<xref rid="B276-marinedrugs-18-00657" ref-type="bibr">276</xref>,<xref rid="B626-marinedrugs-18-00657" ref-type="bibr">626</xref>,<xref rid="B627-marinedrugs-18-00657" ref-type="bibr">627</xref>]. Kulokainalide-1 (<bold>274</bold>) and kulokekahilide-1 (<bold>275</bold>) are reported to be moderately cytotoxic, while kulokekahilide-2 (<bold>276</bold>) is highly effective. Kulokekahilide-1 (<bold>275</bold>) shows growth inhibitory effects with an IC<sub>50</sub> of ~2 &#x003bc;M in murine P388 leukemia cells, while kulokekahilide-2 (<bold>276</bold>) presents a higher potency with an IC<sub>50</sub> of 4.2 nM [<xref rid="B626-marinedrugs-18-00657" ref-type="bibr">626</xref>,<xref rid="B627-marinedrugs-18-00657" ref-type="bibr">627</xref>]. Kulokekahilide-2 (<bold>276</bold>) also displays activity against human SK-OV-3 ovarian and tMDA-MB-435 breast cancer cell lines, with IC<sub>50</sub> values of 7.5 and 14.6 nM, respectively [<xref rid="B627-marinedrugs-18-00657" ref-type="bibr">627</xref>]. For A-10 (non-transformed rat (<italic>Rattus norvegicus</italic>) aortic cells), kulokekahilide-2 (<bold>276</bold>) shows an IC<sub>50</sub> of 59.1 nM, acting selectively [<xref rid="B627-marinedrugs-18-00657" ref-type="bibr">627</xref>]. In other cancer cell lines, namely, human A549 NSCLC, K562 chronic myelogenous leukemia, and MCF-7 breast cancer, kulokekahilide-2 (<bold>276</bold>) shows IC<sub>50</sub> values of ~0.2 nM [<xref rid="B628-marinedrugs-18-00657" ref-type="bibr">628</xref>]. In a methodologically different study, the IC<sub>50</sub> values for kulokekahilide-2 (<bold>276</bold>) were not the same, with ~19 and ~4 nM for murine P388 leukemia and human HeLa cervix carcinoma cells, respectively [<xref rid="B629-marinedrugs-18-00657" ref-type="bibr">629</xref>]. Some very potent analogues have also been synthesized, with IC<sub>50</sub> values of ~0.001 and ~0.008 nM, respectively, allowing the authors to ascertain the best substituents for cytotoxic activity [<xref rid="B628-marinedrugs-18-00657" ref-type="bibr">628</xref>].</p><p>Moreover, several polyunsaturated fatty acids with cytotoxic activity against a range of human cancer cells lines, including HT-29, MCF7, and A2058, were described from Arctic specimens of <italic>Scaphander lignarius</italic> [<xref rid="B630-marinedrugs-18-00657" ref-type="bibr">630</xref>].</p></sec><sec id="sec3dot1dot5-marinedrugs-18-00657"><title>3.1.5. Anaspidea</title><p>Sea hares have been proven to contain many interesting cytotoxic compounds, many of them derived from the algae or the cyanobacteria that they feed on [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Within the genus <italic>Aplysia</italic>, many species have been studied, including <italic>A. angasi, A. dactylomela, A. depilans, A. fasciata, A. juliana, A. kurodai, A. oculifera</italic>, and <italic>A. punctata</italic> [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. <italic>A. angasi</italic> (also reported as <italic>A. dactylomela</italic>), which showed growth inhibitory activity against murine lymphocytic leukemia P338 cells due to the presence of the brominated tricyclic 6-7-5-fused sesquiterpene, aplysistatin (<bold>277</bold>) [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>]. Aplysistatin (<bold>277</bold>) showed an IC<sub>50</sub> value of ~8 &#x003bc;M for P388 leukemia cells and human KB cancer cells [<xref rid="B613-marinedrugs-18-00657" ref-type="bibr">613</xref>,<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>].</p><p><italic>A. dactylomela</italic> presents a wide variety of metabolites [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>,<xref rid="B632-marinedrugs-18-00657" ref-type="bibr">632</xref>,<xref rid="B633-marinedrugs-18-00657" ref-type="bibr">633</xref>,<xref rid="B634-marinedrugs-18-00657" ref-type="bibr">634</xref>]. Some dietary halogenated chamigrene sesquiterpenes were described in specimens from the Canary Islands, such as elatol (<bold>278</bold>) and obtusol (<bold>279</bold>), previously found in the red algae <italic>Laurencia elata</italic> and <italic>L. microcladia,</italic> while <italic>iso</italic>-obtusol (<bold>280</bold>) was found in <italic>L. obtusa</italic> [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>,<xref rid="B632-marinedrugs-18-00657" ref-type="bibr">632</xref>,<xref rid="B633-marinedrugs-18-00657" ref-type="bibr">633</xref>,<xref rid="B634-marinedrugs-18-00657" ref-type="bibr">634</xref>]. Elatol (<bold>278</bold>) is a potent, non-selective, cytotoxic natural product, with IC<sub>50</sub> values between 1&#x02013;10 &#x003bc;M against ten cancer cell lines in several studies [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>,<xref rid="B635-marinedrugs-18-00657" ref-type="bibr">635</xref>,<xref rid="B636-marinedrugs-18-00657" ref-type="bibr">636</xref>]. Remarkably, elatol (<bold>278</bold>) is proapoptotic in murine B16F10 melanoma cells by decreasing Bcl-x and increasing Bak, caspase-9 and p53 expression, although it is known that B16F10 melanoma cells are very sensitive to these stimuli [<xref rid="B636-marinedrugs-18-00657" ref-type="bibr">636</xref>,<xref rid="B637-marinedrugs-18-00657" ref-type="bibr">637</xref>,<xref rid="B638-marinedrugs-18-00657" ref-type="bibr">638</xref>]. Obtusol (<bold>279</bold>) and <italic>iso</italic>-obtusol (<bold>280</bold>) show a much weaker effect inhibiting growth in vitro [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>,<xref rid="B633-marinedrugs-18-00657" ref-type="bibr">633</xref>,<xref rid="B635-marinedrugs-18-00657" ref-type="bibr">635</xref>]. A linear halogenated monoterpene (<bold>281</bold>) was also found, showing growth inhibitory effects towards HM02 (gastric carcinoma), HEP-G2 (liver carcinoma), and MCF-7 (breast carcinoma) cancer cells with IC<sub>50</sub> values of ~1 &#x003bc;M [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>]. Some tricyclic monobromoditerpenes were also found in <italic>A. dactylomela</italic> specimens, such as parguerol (<bold>282</bold>), parguerol-16-acetate (<bold>283</bold>), <italic>iso</italic>-parguerol (<bold>284</bold>), <italic>iso</italic>-parguerol-16-acetate (<bold>285</bold>), and deoxyparguerol (<bold>286</bold>), which were also present in red algae, such as <italic>Jania rubens</italic> [<xref rid="B639-marinedrugs-18-00657" ref-type="bibr">639</xref>,<xref rid="B640-marinedrugs-18-00657" ref-type="bibr">640</xref>]. In Bahamas and Puerto Rico, however, specimens of this sea hare contain different chemistry [<xref rid="B639-marinedrugs-18-00657" ref-type="bibr">639</xref>]. Parguerol (<bold>282</bold>) and the previously mentioned related compounds present in vitro growth inhibitory effects at low micromolar values on murine P388 leukemia, are highly sensitive to proapoptotic stimuli as previously discussed, and are also significantly sensitive to Ehrlich ascite carcinoma [<xref rid="B614-marinedrugs-18-00657" ref-type="bibr">614</xref>,<xref rid="B639-marinedrugs-18-00657" ref-type="bibr">639</xref>,<xref rid="B640-marinedrugs-18-00657" ref-type="bibr">640</xref>]. These activities were more potent with <italic>iso</italic>-parguerol (<bold>284</bold>) derivatives [<xref rid="B639-marinedrugs-18-00657" ref-type="bibr">639</xref>,<xref rid="B640-marinedrugs-18-00657" ref-type="bibr">640</xref>]. In the Caribbean, some other compounds are present, such as the bromotriterpene polyether aplysqualenol A (<bold>287</bold>), which displays potent IC<sub>50</sub> values in the NCI assay (60 cancer cell lines panel), particularly an IC<sub>50</sub> of ~0.4 &#x003bc;M in human SNB-19 central nervous system cancer and T-47D breast cancer cells [<xref rid="B641-marinedrugs-18-00657" ref-type="bibr">641</xref>]. Aplysqualenol A (<bold>287</bold>) has been described to be a ligand for DYNLL1 (light chain of dynein type 1), also indicating some anticancer potential [<xref rid="B642-marinedrugs-18-00657" ref-type="bibr">642</xref>,<xref rid="B643-marinedrugs-18-00657" ref-type="bibr">643</xref>,<xref rid="B644-marinedrugs-18-00657" ref-type="bibr">644</xref>,<xref rid="B645-marinedrugs-18-00657" ref-type="bibr">645</xref>]. In China, specimens of <italic>A. dactylomela</italic> also present a brominated triterpene polyether, thyrsiferol (<bold>288</bold>), previously reported in the red algae <italic>Laurencia thyrsifera</italic> [<xref rid="B646-marinedrugs-18-00657" ref-type="bibr">646</xref>,<xref rid="B647-marinedrugs-18-00657" ref-type="bibr">647</xref>]. Thyrsiferol (<bold>288</bold>) has been reported to display a strong growth inhibitory in vitro activity against mouse P388 leukemia cells, and only moderate activity in solid tumors cell lines, with IC<sub>50</sub> values of ~0.02 and ~17 &#x003bc;M for P388 and A549 NSCLC cancer cell lines, respectively [<xref rid="B614-marinedrugs-18-00657" ref-type="bibr">614</xref>,<xref rid="B648-marinedrugs-18-00657" ref-type="bibr">648</xref>,<xref rid="B649-marinedrugs-18-00657" ref-type="bibr">649</xref>]. Apparently, thyrsiferol (<bold>288</bold>) inhibits hypoxia-induced HIF-1 activation in T47D human breast tumor cells and suppresses hypoxic induction of HIF-1 target genes (VEGF and GLUT-1) at the mRNA level, also suppressing mitochondrial respiration in complex I [<xref rid="B648-marinedrugs-18-00657" ref-type="bibr">648</xref>].</p><p><italic>A. depilans</italic> presents an endoperoxide sterol (<bold>289</bold>) with an IC<sub>50</sub> value of 2.5 &#x003bc;M for human HCT-116 colorectal cancer cells [<xref rid="B606-marinedrugs-18-00657" ref-type="bibr">606</xref>,<xref rid="B650-marinedrugs-18-00657" ref-type="bibr">650</xref>,<xref rid="B651-marinedrugs-18-00657" ref-type="bibr">651</xref>]. <italic>A. fasciata</italic> from Spain presents a degraded sterol, 3-<italic>epi</italic>-aplykurodinone B (<bold>145</bold>) with an IC<sub>50</sub> value of ~8 &#x003bc;M against mouse P388 leukemia, human A549 NSCLC, HT-29 colon cancer, and SKMEl-28 melanoma [<xref rid="B397-marinedrugs-18-00657" ref-type="bibr">397</xref>]. <italic>A. juliana</italic> contains two chlorophyll derivatives, pyropheophorbides a and b, and a halogenated diterpenoid lactone, derived from its diet of green algae, as well as a cytotoxic peptide, julianin-S, which is secreted within its purple ink [<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>,<xref rid="B432-marinedrugs-18-00657" ref-type="bibr">432</xref>,<xref rid="B433-marinedrugs-18-00657" ref-type="bibr">433</xref>,<xref rid="B434-marinedrugs-18-00657" ref-type="bibr">434</xref>].</p><p><italic>A. kurodai</italic> has been widely studied over the years, containing a series of compounds that include polyketide macrolides, halogenated and brominated mono- and di-terpenes, brominated sesquiterpenoids, sterols, alkaloids, peptides, and others [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Aplyronines A&#x02013;H (<bold>191,290&#x02013;293</bold>) are polyketide macrolides found in Pacific specimens along with aplaminal (<bold>294</bold>), some of them being tested in antitumor clinical trials [<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>,<xref rid="B652-marinedrugs-18-00657" ref-type="bibr">652</xref>,<xref rid="B653-marinedrugs-18-00657" ref-type="bibr">653</xref>,<xref rid="B654-marinedrugs-18-00657" ref-type="bibr">654</xref>,<xref rid="B655-marinedrugs-18-00657" ref-type="bibr">655</xref>,<xref rid="B656-marinedrugs-18-00657" ref-type="bibr">656</xref>]. For human HeLa-S3 cancer cells, IC<sub>50</sub> values were 0.5 nM for aplyronine A (<bold>191</bold>), 3 nM for aplyronine B (<bold>290</bold>), 22 nM for aplyronine C (<bold>291</bold>), 0.08 nM for aplyronine D (<bold>292</bold>), and 10 nM for aplyronine H (<bold>293</bold>) [<xref rid="B653-marinedrugs-18-00657" ref-type="bibr">653</xref>,<xref rid="B657-marinedrugs-18-00657" ref-type="bibr">657</xref>,<xref rid="B658-marinedrugs-18-00657" ref-type="bibr">658</xref>]. However, in a different study with the same cell line, IC<sub>50</sub> values were ~0.4 nM for aplyronine A (<bold>191</bold>), ~4 nM for aplyronine B (<bold>290</bold>), and ~20 nM for aplyronine C (<bold>291</bold>) [<xref rid="B652-marinedrugs-18-00657" ref-type="bibr">652</xref>]. It has been suggested that the methylated amino acids (<italic>N</italic>,<italic>N</italic>,O-trimethyl-serine or <italic>N</italic>,<italic>N</italic>-dimethyl-alanine) in position 22 are important for the inhibition activity of these compounds [<xref rid="B653-marinedrugs-18-00657" ref-type="bibr">653</xref>]. Aplyronine A (<bold>191</bold>) is registered at the NCI database as NSC687160, with a mean IC<sub>50</sub> value of ~0.2 nM in the 60 cancer cell lines, but being selective against some cell lines and most active against MDR cancer cell line NCI/ADR-RES, with an IC<sub>50</sub> value of ~0.2 nM, as well as for P388 murine leukemia, Lewis murine lung carcinoma, Erhlich murine carcinoma, colon 26 murine carcinoma, and B16 murine melanoma, but very moderated against HOP-92 (NSCLC), OVCAR-4 (ovarian cancer), TK-10 and UO-31 (renal cancers), and BT-549 and T47-D (breast cancers) [<xref rid="B652-marinedrugs-18-00657" ref-type="bibr">652</xref>]. Aplyronine A (<bold>191</bold>) also presents proapoptotic effects in cancer cells [<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>]. Aplyronine A (<bold>191</bold>) was in fact suggested to inhibit the actin microfilaments, since it can depolymerize F-actin and inhibit actin polymerization, forming a complex with monomeric actin (1:1), in a similar way to the well-known tubulin inhibitors vincristine and vinblastine currently employed in some cancer treatments [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B659-marinedrugs-18-00657" ref-type="bibr">659</xref>,<xref rid="B660-marinedrugs-18-00657" ref-type="bibr">660</xref>]. Later, other studies suggested that aplyronine A (<bold>191</bold>) forms a 1:1:1 heterotrimeric complex with actin and tubulin, and this is what actually inhibits tubulin polymerization; thus, synthesis is being carried out [<xref rid="B661-marinedrugs-18-00657" ref-type="bibr">661</xref>,<xref rid="B662-marinedrugs-18-00657" ref-type="bibr">662</xref>,<xref rid="B663-marinedrugs-18-00657" ref-type="bibr">663</xref>,<xref rid="B664-marinedrugs-18-00657" ref-type="bibr">664</xref>]. Furthermore, an analogue of aplyronine D (<bold>292</bold>) is being analyzed as an antibody&#x02013;drug conjugate (ADC) and for bearing a linker suitable for bioconjugation [<xref rid="B665-marinedrugs-18-00657" ref-type="bibr">665</xref>]. Overall, aplyronines (<bold>191,290&#x02013;293</bold>) are extremely toxic molecules with huge potential as leads, but they are not yet known to be attached to a suitable mAb [<xref rid="B666-marinedrugs-18-00657" ref-type="bibr">666</xref>]. Aplaminal (<bold>294</bold>) is a triazabicyclo-[3.2.1]-octane, displaying an IC<sub>50</sub> value of ~2 &#x003bc;M against human HeLa S3 cervix carcinoma cells [<xref rid="B654-marinedrugs-18-00657" ref-type="bibr">654</xref>]. </p><p>In Japan, <italic>A. kurodai</italic> presents aplaminone (<bold>295</bold>), neoaplaminone (<bold>296</bold>), and neoaplaminone sulfate (<bold>297</bold>), formed from a bromine-containing dopamine and a sesquiterpenoid [<xref rid="B667-marinedrugs-18-00657" ref-type="bibr">667</xref>]. Both aplaminone (<bold>295</bold>) and neoaplaminone sulfate (<bold>297</bold>) show IC<sub>50</sub> values of ~1 &#x003bc;M for human HeLa cervix cancer cells, while neoaplaminone (<bold>296</bold>) is active at IC<sub>50</sub> ~1 nM [<xref rid="B667-marinedrugs-18-00657" ref-type="bibr">667</xref>]. In Japan, <italic>A. kurodai</italic> specimens also contain aplysiaterpenoid A (<bold>298</bold>) and aplysiapyranoids A&#x02013;D (<bold>299</bold>), displaying moderate cytotoxicities against Vero, MDCK, and B16 cell lines (IC<sub>50</sub> 19&#x02013;96 &#x003bc;g/mL) [<xref rid="B668-marinedrugs-18-00657" ref-type="bibr">668</xref>,<xref rid="B669-marinedrugs-18-00657" ref-type="bibr">669</xref>]. Moreover, mono- and di-terpenes, such as kurodainol (<bold>300</bold>), aplysiaterpenoids A&#x02013;D (<bold>298</bold>), aplysin-20 (<bold>301</bold>), <italic>iso</italic>-aplysin-20, aplysiadiol (<bold>302</bold>), <italic>epi</italic>-aplysin-20, and <italic>ent</italic>-isoconcinndiol (<bold>303</bold>), are found in <italic>A. kurodai</italic> specimens and are suggested to originate from isoconncindiol of the red algae <italic>Laurencia snyderae</italic> [<xref rid="B668-marinedrugs-18-00657" ref-type="bibr">668</xref>,<xref rid="B669-marinedrugs-18-00657" ref-type="bibr">669</xref>,<xref rid="B670-marinedrugs-18-00657" ref-type="bibr">670</xref>,<xref rid="B671-marinedrugs-18-00657" ref-type="bibr">671</xref>,<xref rid="B672-marinedrugs-18-00657" ref-type="bibr">672</xref>,<xref rid="B673-marinedrugs-18-00657" ref-type="bibr">673</xref>,<xref rid="B674-marinedrugs-18-00657" ref-type="bibr">674</xref>]. <italic>A. kurodai</italic> also contains other compounds, including aplydilactone, a dieicosanoid lactone, aplysepsine, and a 1,4-benzoidiasepine alkaloid [<xref rid="B675-marinedrugs-18-00657" ref-type="bibr">675</xref>,<xref rid="B676-marinedrugs-18-00657" ref-type="bibr">676</xref>]. The egg masses and albumen gland moreover contain cytotoxic peptides, such as aplysianin A or aplysianin E, the latter highly tumor-lytic at 10 ng/mL against MM 46 and MM 48 mice tumor cells [<xref rid="B294-marinedrugs-18-00657" ref-type="bibr">294</xref>,<xref rid="B677-marinedrugs-18-00657" ref-type="bibr">677</xref>,<xref rid="B678-marinedrugs-18-00657" ref-type="bibr">678</xref>,<xref rid="B679-marinedrugs-18-00657" ref-type="bibr">679</xref>].</p><p>Furthermore, <italic>A. kurodai</italic> presents some brominated sesquiterpenoids, such as (-)-aplysin (<bold>304</bold>), aplysinol (<bold>305</bold>), and aplykurodin A (<bold>306</bold>) and B (<bold>146</bold>) [<xref rid="B398-marinedrugs-18-00657" ref-type="bibr">398</xref>,<xref rid="B680-marinedrugs-18-00657" ref-type="bibr">680</xref>]. (-)-Aplysin (<bold>304</bold>), originating from its diet on algae, was in fact one of the first halogenated compounds found in marine organisms, and it shows IC<sub>50</sub> values of 4&#x02013;8 &#x003bc;M for several cancer cells, with a mean IC<sub>50</sub> value of ~30 &#x003bc;M at the NCI 60 cell line panel and no selectivity [<xref rid="B680-marinedrugs-18-00657" ref-type="bibr">680</xref>,<xref rid="B681-marinedrugs-18-00657" ref-type="bibr">681</xref>]. (-)-Aplysin (<bold>304</bold>) was active against the human A549 NSCLC xenograft with 18% of tumor growth reduction in vivo as compared to the control, supposedly by acting as a sensitizer for tumor necrosis factor-related apoptosis, producing TRAIL-induced apoptosis in cancer cells via the P38 MAPK/survivin pathway [<xref rid="B682-marinedrugs-18-00657" ref-type="bibr">682</xref>]. (-)-Aplysin (<bold>304</bold>) is also effective against human glioma cells by increasing miR-181 expression, sensitizing the cytotoxic effects of the alkylating drug temozolomide, and inducing cell cycle arrest and apoptosis through the inhibition of the PI3K/Akt signaling, which is relevant in the survival of glioma cells [<xref rid="B683-marinedrugs-18-00657" ref-type="bibr">683</xref>]. </p><p>In Egypt, <italic>A. oculifera</italic> contains two halogenated sesquiterpenes, oculiferane (<bold>307</bold>) and <italic>epi</italic>-obtusane (<bold>308</bold>), which displayed IC<sub>50</sub> values between 2 and 8 &#x003bc;M against human PC-3 prostate cancer, A549 NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and HCT116 colon cancer [<xref rid="B684-marinedrugs-18-00657" ref-type="bibr">684</xref>]. <italic>A. punctata</italic> from Spanish coasts present atypical acetates of halogenated monoterpenes, among which three compounds (<bold>309&#x02013;311</bold>) show IC<sub>50</sub> values between 1.5 and 2.5 &#x003bc;M against P388, HT-29, A-549, and MEL-28 cancer cell lines [<xref rid="B685-marinedrugs-18-00657" ref-type="bibr">685</xref>]. </p><p>Another sea hare, <italic>Dolabella auricularia,</italic> is one of the most studied marine invertebrates, with many bioactive natural products, including polyketides, halogenated terpenes, and peptides, along a wide geographical range [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. Several excellent reviews deal with <italic>D. auricularia</italic> most bioactive compounds [<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>,<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>], and, therefore, only a brief summary will be included here. This sea hare is able to modify dietary molecules from brown and red algae and also to de novo biosynthesize peptides and polypropionates, while it may also contain cyanobacterial metabolites [<xref rid="B686-marinedrugs-18-00657" ref-type="bibr">686</xref>]. We will summarize the cytotoxic activities of aurisides A and B (<bold>312,313</bold>), aurilol (<bold>314</bold>), doliculols A and B (<bold>315,316</bold>), dolabellin (<bold>317</bold>), auripyrones A and B (<bold>318,319</bold>), dolabelides A&#x02013;D (<bold>320&#x02013;323</bold>), aurilide (<bold>324</bold>), doliculide (<bold>325</bold>), auristatins (<bold>339&#x02013;344</bold>), and finally, dolastatins (<bold>192,326&#x02013;338,346&#x02013;348</bold>). In Japan, among the dietary compounds from red algae, the macrolide glycosides aurisides A and B (<bold>312,313</bold>) and aurilol (<bold>314</bold>), a polyether bromotriterpene, are cytotoxic to HeLa tumor cell line [<xref rid="B687-marinedrugs-18-00657" ref-type="bibr">687</xref>,<xref rid="B688-marinedrugs-18-00657" ref-type="bibr">688</xref>]. Aurisides A and B (<bold>312,313</bold>) present a carbon backbone 5,7,13-trihydroxy-3,9-dioxoheptadecanoic acid with a bromine-substituted conjugated diene moiety, a cyclic hemiacetal, and a 14-membered lactone [<xref rid="B688-marinedrugs-18-00657" ref-type="bibr">688</xref>]. Auriside A (<bold>312</bold>) displays IC<sub>50</sub> values of ~0.2 &#x003bc;M against human HeLa S3 cervix cancer cells, while auriside B (<bold>313</bold>) is less potent (IC<sub>50</sub> 2 &#x003bc;M), and both are being studied for their synthesis [<xref rid="B688-marinedrugs-18-00657" ref-type="bibr">688</xref>,<xref rid="B689-marinedrugs-18-00657" ref-type="bibr">689</xref>,<xref rid="B690-marinedrugs-18-00657" ref-type="bibr">690</xref>]. Aurilol (<bold>314</bold>) presents IC<sub>50</sub> values of ~7 &#x003bc;M against human HeLa S3 cancer cells, and it is structurally similar to enshuol, a bromo triterpenic polyether with a dioxabicyclo-(5.4.0)-undecane ring system described in <italic>Laurencia</italic>, thus supporting a dietary origin in the slug [<xref rid="B687-marinedrugs-18-00657" ref-type="bibr">687</xref>]. Doliculols A and B (<bold>315,316</bold>), non-halogenated acetylenic cyclic ethers similar to <italic>Laurencia</italic> ethers, are moderately cytotoxic macrolides [<xref rid="B691-marinedrugs-18-00657" ref-type="bibr">691</xref>,<xref rid="B692-marinedrugs-18-00657" ref-type="bibr">692</xref>,<xref rid="B693-marinedrugs-18-00657" ref-type="bibr">693</xref>,<xref rid="B694-marinedrugs-18-00657" ref-type="bibr">694</xref>]. Dolabellin (<bold>317</bold>), a bisthiazole metabolite found in Indian specimens, showed IC<sub>50</sub> values of ~10 &#x003bc;M against human HeLa S3 cervix carcinoma cells [<xref rid="B695-marinedrugs-18-00657" ref-type="bibr">695</xref>]. </p><p>In <italic>D. auricularia</italic> from Japan, auripyrones A and B (<bold>318,319</bold>) were described to have IC<sub>50</sub> values of ~0.5 &#x003bc;M against human HeLa S3 carcinoma cells and are being synthesized [<xref rid="B696-marinedrugs-18-00657" ref-type="bibr">696</xref>,<xref rid="B697-marinedrugs-18-00657" ref-type="bibr">697</xref>,<xref rid="B698-marinedrugs-18-00657" ref-type="bibr">698</xref>,<xref rid="B699-marinedrugs-18-00657" ref-type="bibr">699</xref>,<xref rid="B700-marinedrugs-18-00657" ref-type="bibr">700</xref>]. Furthermore, Japanese specimens contain the macrolides dolabelides A&#x02013;D (<bold>320&#x02013;323</bold>), displaying IC<sub>50</sub> values of ~8 and ~2 &#x003bc;M, for dolabelides A and B (<bold>320,321</bold>) respectively, while dolabelides C and D (<bold>322,323</bold>) showed both values of ~2 &#x003bc;M against human HeLa S3 cervix cancer cells, and synthesis studies are being carried out [<xref rid="B692-marinedrugs-18-00657" ref-type="bibr">692</xref>,<xref rid="B693-marinedrugs-18-00657" ref-type="bibr">693</xref>,<xref rid="B701-marinedrugs-18-00657" ref-type="bibr">701</xref>,<xref rid="B702-marinedrugs-18-00657" ref-type="bibr">702</xref>]. </p><p>The cyclic depsipeptide aurilide (<bold>324</bold>) was found in Japanese <italic>D. auricularia</italic> specimens, while aurilides B and C were found in the cyanobacterium <italic>Lyngbya majuscula</italic> from Papua New Guinea [<xref rid="B703-marinedrugs-18-00657" ref-type="bibr">703</xref>,<xref rid="B704-marinedrugs-18-00657" ref-type="bibr">704</xref>,<xref rid="B705-marinedrugs-18-00657" ref-type="bibr">705</xref>]. Aurilide (<bold>324</bold>) displayed an IC<sub>50</sub> mean value of ~0.01 &#x003bc;M in the NCI 60 cell line panel and was selective for renal, ovarian, and prostate cancer cell lines. It was active in the in vivo NCI hollow fiber assay, but inactive due to high toxicity in a xenograft model [<xref rid="B705-marinedrugs-18-00657" ref-type="bibr">705</xref>,<xref rid="B706-marinedrugs-18-00657" ref-type="bibr">706</xref>]. The mechanism of action of aurilide (<bold>324</bold>) seems to involve microtubule stabilization, since it does not interact with tubulin, thus being different from taxol [<xref rid="B705-marinedrugs-18-00657" ref-type="bibr">705</xref>]. Furthermore, aurilide (<bold>324</bold>) has been reported to selectively bind to prohibitin 1 (PHB1) in the mitochondria, activating the proteolytic processing of optic atrophy 1 (OPA1) and resulting in mitochondria-induced apoptosis [<xref rid="B707-marinedrugs-18-00657" ref-type="bibr">707</xref>]. </p><p>Doliculide (<bold>325</bold>) is a mixed peptide&#x02013;polyketide-originated compound found in Japanese specimens of <italic>D. auricularia</italic>, possessing an iodo-N-Me-tyrosine and a glycine, which inhibits growth of human HeLa S3 cervix carcinoma cells (IC<sub>50</sub> ~2 nM) [<xref rid="B708-marinedrugs-18-00657" ref-type="bibr">708</xref>]. Its action mechanism consists of binding to actin and stopping cancer cells at the G2/M phase of the cell cycle, thus interfering in normal actin assemblage and producing the hyperassemblage of purified actin in the form of F-actin [<xref rid="B709-marinedrugs-18-00657" ref-type="bibr">709</xref>]. Synthesis and computational studies are being developed [<xref rid="B710-marinedrugs-18-00657" ref-type="bibr">710</xref>,<xref rid="B711-marinedrugs-18-00657" ref-type="bibr">711</xref>,<xref rid="B712-marinedrugs-18-00657" ref-type="bibr">712</xref>]. Doliculide (<bold>325</bold>) inhibits proliferation and impairs the migratory potential of human MCF-7 and MDA-MB-231 breast cancer cells, while modifying senescence-related genes at non-toxic concentrations in p53 wild-type cancer cells by up to 13% [<xref rid="B713-marinedrugs-18-00657" ref-type="bibr">713</xref>].</p><p>The most famous compounds of all heterobranchs are the diverse cytotoxic linear and cyclic peptides of <italic>D. auricularia</italic>, the dolastatins (<bold>192,326</bold>&#x02013;<bold>338,346</bold>&#x02013;<bold>348</bold>), which were probably used by the Romans [<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>,<xref rid="B197-marinedrugs-18-00657" ref-type="bibr">197</xref>]. Dolastatins (<bold>192,326</bold>&#x02013;<bold>338,346</bold>&#x02013;<bold>348</bold>) include many different active molecules, including linear and cyclic peptides, depsipeptides, peptides containing thiazole and oxazole heterocycles, and macrolides [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>]. Dolastatins (<bold>192,326</bold>&#x02013;<bold>338,346</bold>&#x02013;<bold>348</bold>) are found in small amounts in sea hares and are suggested to originate from their diet, particularly from cyanobacteria of the genera <italic>Symploca, Caldora</italic> and <italic>Lyngbya</italic> [<xref rid="B714-marinedrugs-18-00657" ref-type="bibr">714</xref>,<xref rid="B715-marinedrugs-18-00657" ref-type="bibr">715</xref>,<xref rid="B716-marinedrugs-18-00657" ref-type="bibr">716</xref>]. Among the most known dolastatins, dolastatin 3 (<bold>192</bold>) and dolastatins 10&#x02013;15 (<bold>326</bold>&#x02013;<bold>331</bold>) display mild to strong biological activities and were further studied, such as the macrocyclic lactone dolastatin 19 (<bold>332</bold>); dolastatins C (<bold>333</bold>), D (<bold>334</bold>), H (<bold>335</bold>) and <italic>iso</italic>-dolastatin H (<bold>336</bold>); dolastatin G (<bold>337</bold>); and <italic>nor</italic>-dolastatin G (<bold>338</bold>) [<xref rid="B694-marinedrugs-18-00657" ref-type="bibr">694</xref>,<xref rid="B717-marinedrugs-18-00657" ref-type="bibr">717</xref>,<xref rid="B718-marinedrugs-18-00657" ref-type="bibr">718</xref>,<xref rid="B719-marinedrugs-18-00657" ref-type="bibr">719</xref>,<xref rid="B720-marinedrugs-18-00657" ref-type="bibr">720</xref>,<xref rid="B721-marinedrugs-18-00657" ref-type="bibr">721</xref>,<xref rid="B722-marinedrugs-18-00657" ref-type="bibr">722</xref>,<xref rid="B723-marinedrugs-18-00657" ref-type="bibr">723</xref>,<xref rid="B724-marinedrugs-18-00657" ref-type="bibr">724</xref>]. Dolastatin G (<bold>337</bold>) and <italic>nor</italic>-dolastatin G (<bold>338</bold>) show moderate cytotoxicity and are analogs of lyngbyastatin 2 and <italic>nor</italic>-lyngbyastatin 2 described in the cyanobacterium <italic>Lyngbya majuscula</italic> from Guam [<xref rid="B725-marinedrugs-18-00657" ref-type="bibr">725</xref>]. Dolastatin 19 (<bold>332</bold>) is structurally similar to the previously mentioned aurisides A (<bold>312</bold>) and B (<bold>313</bold>). In general, these compounds did not pass phase II trials alone, and several studies are being developed to use them in combination with other structures [<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>]. </p><p>Dolastatin 3 (<bold>192</bold>), a cyclic peptide with two thiazole rings, was also found in <italic>D. auricularia</italic> from Japan, and further synthesized, showing an IC<sub>50</sub> &#x0003c; 1 &#x003bc;M in P388 murine leukemia cells [<xref rid="B718-marinedrugs-18-00657" ref-type="bibr">718</xref>,<xref rid="B727-marinedrugs-18-00657" ref-type="bibr">727</xref>]. Dolastatin 3 (<bold>192</bold>) was also found in <italic>Lyngbya majuscula</italic> from Palau [<xref rid="B728-marinedrugs-18-00657" ref-type="bibr">728</xref>]. Dolastatin 3 (<bold>192</bold>) induces a 78% life extension in vivo in the murine P388 lymphocytic leukemia model, and a 52% life extension in murine colon carcinoma 38 [<xref rid="B728-marinedrugs-18-00657" ref-type="bibr">728</xref>].</p><p>Dolastatin 10 (<bold>326</bold>) is a linear pentapeptide with four unique residues described in 1987 from <italic>D. auricularia</italic> collected at the Indian Ocean, and later found in the cyanobacterium <italic>Symploca hydnoides</italic> together with its methyl derivative, symplostatin 1, and has been often reviewed in the literature [<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B714-marinedrugs-18-00657" ref-type="bibr">714</xref>,<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>,<xref rid="B729-marinedrugs-18-00657" ref-type="bibr">729</xref>,<xref rid="B730-marinedrugs-18-00657" ref-type="bibr">730</xref>,<xref rid="B731-marinedrugs-18-00657" ref-type="bibr">731</xref>]. Dolastatin 10 (<bold>326</bold>) was tested in phase I trials by the NCI but failed later in phase II for advanced and metastatic soft tissue sarcoma, advanced hepatobiliary cancers, pancreatic cancers, and others because of its side effects [<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>,<xref rid="B731-marinedrugs-18-00657" ref-type="bibr">731</xref>,<xref rid="B732-marinedrugs-18-00657" ref-type="bibr">732</xref>]. However, in 2011, brentuximab vedotin (Adcetris<sup>&#x000ae;</sup>), an antibody-dolastatin 10 conjugate (ADC), was approved by the FDA (Food and Drugs Administration) for the treatment of Hodgkin&#x02019;s lymphoma [<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>]. This ADC is composed of a highly toxic &#x0201c;warhead&#x0201d; derived from dolastatin 10 (<bold>326</bold>) which is attached to a specific targeting moiety, a monoclonal antibody (mAb) directed to a particular epitope on the cancer cell [<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>]. Dolastatin 10 (<bold>326</bold>) inhibits microtubule assembly, causing cells to accumulate in metaphase, but it produced bone marrow toxicity in initial trials, local irritation at the injection site, and some mild peripheral neuropathy [<xref rid="B733-marinedrugs-18-00657" ref-type="bibr">733</xref>,<xref rid="B734-marinedrugs-18-00657" ref-type="bibr">734</xref>]. Dolastatin 10 (<bold>326</bold>) exhibits cytotoxic effects against human lung and breast cancer cell lines via both Bcl-2 phosphorylation and caspase-3 protein activation, and it modulates p53 oncoproteins in human diffuse large-cell lymphoma [<xref rid="B735-marinedrugs-18-00657" ref-type="bibr">735</xref>,<xref rid="B736-marinedrugs-18-00657" ref-type="bibr">736</xref>]. Other studies describe dolastatin 10 (<bold>326</bold>) activity against ovarian carcinoma xenografts as well as mouse P388 and L1210 leukemia, B16 melanoma, M5076 sarcoma, human LOX melanoma, and MX-1 breast cancer xenografts [<xref rid="B736-marinedrugs-18-00657" ref-type="bibr">736</xref>,<xref rid="B737-marinedrugs-18-00657" ref-type="bibr">737</xref>,<xref rid="B738-marinedrugs-18-00657" ref-type="bibr">738</xref>]. Dolastatin 10 (<bold>326</bold>) is not only an inhibitor of tubulin polymerization, it also inhibits tubulin-dependent GTP hydrolysis as well as the binding of vinblastine, maytansine, and vincristine to tubulin, although the binding site on tubulin is not the same as that of the vinca alkaloids [<xref rid="B733-marinedrugs-18-00657" ref-type="bibr">733</xref>,<xref rid="B739-marinedrugs-18-00657" ref-type="bibr">739</xref>].</p><p>Auristatins (<bold>339&#x02013;344</bold>) are peptides related to dolastatin 10 (<bold>326</bold>) (see below), approved by the FDA as microtubule-destabilizing agents (MDA), and used as antibody&#x02013;drug conjugates (ADCs) [<xref rid="B740-marinedrugs-18-00657" ref-type="bibr">740</xref>,<xref rid="B741-marinedrugs-18-00657" ref-type="bibr">741</xref>,<xref rid="B742-marinedrugs-18-00657" ref-type="bibr">742</xref>,<xref rid="B743-marinedrugs-18-00657" ref-type="bibr">743</xref>]. Auristatins (<bold>339</bold>&#x02013;<bold>344</bold>) were synthesized by Pettit&#x02019;s group in the 1990s while working on dolastatins, and they included auristatin E (<bold>339</bold>), auristatin PHE (<bold>340</bold>), auristatin PYE (<bold>341</bold>), and two aminoquinoline derivatives, auristatin -2-AQ (<bold>342</bold>) and auristatin-6-AQ (<bold>343</bold>), all active against tumor lines (between 10&#x02013;100 pM) [<xref rid="B32-marinedrugs-18-00657" ref-type="bibr">32</xref>,<xref rid="B744-marinedrugs-18-00657" ref-type="bibr">744</xref>,<xref rid="B745-marinedrugs-18-00657" ref-type="bibr">745</xref>,<xref rid="B746-marinedrugs-18-00657" ref-type="bibr">746</xref>]. Several derivatives of auristatins are (or are expected to be soon) in preclinical trials as &#x0201c;ADC warheads&#x0201d;, some reaching phase I, such as DZ-2384 [<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>]. Auristatin PE (<bold>344</bold>), also named soblidotin, TZT-1027, or YHI-501, is a microtubule active drug that exerts a considerable antivascular effect along with a potent cytotoxic effect in several models, including murine P388 leukemia, colon 26 cancer, Lewis lung carcinoma, B16 melanoma, and M5076 sarcoma, as well as human MX-1 breast cancer and LX-1 and SBC-3 SCLC xenografts [<xref rid="B747-marinedrugs-18-00657" ref-type="bibr">747</xref>,<xref rid="B748-marinedrugs-18-00657" ref-type="bibr">748</xref>]. Auristatin PE (<bold>344</bold>) entered clinical trials for advanced and metastatic soft tissue sarcomas, NSCLCs, and others, but did not proceeded beyond phase II due to toxicity and/or a lack of efficacy in the trials [<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>]. More than 30 ADCs in clinical trials are based on auristatins [<xref rid="B43-marinedrugs-18-00657" ref-type="bibr">43</xref>,<xref rid="B555-marinedrugs-18-00657" ref-type="bibr">555</xref>,<xref rid="B717-marinedrugs-18-00657" ref-type="bibr">717</xref>,<xref rid="B749-marinedrugs-18-00657" ref-type="bibr">749</xref>].</p><p>Several excellent reviews, such as those of Newman, have dealt with dolastatin-10 (<bold>326</bold>) and all its derivatives, their evolution as ADC warheads, the auristatin-based ADCs, and the approved and/or tested drugs, such as brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, ladiratuzumab vedotin, lifastuzumab vedotin, PSMA-ADC, RC-48, telisotuzumab vedotin, tisotumab vedotin, BA-3021, CX-2029, HuMax-AXL-107 (enapotamab vedotin), pinatuzumab vedotin, ABBV-085, AGS67E, ALT-P7, CDX-014, losatuxizumab vedotin, SGN-CD48A, rituximab-MC-vc-MMAE (TRS-005), GM-103, HT-1511, OBI-999, depatuxizumab mafadotin, AGS-16C3F, GSK-2857916 (belantamab mafodotin), W-0101, cofetuzumab pelidotin, NG-HER2 ADC, XMT-1536, ASN-004, ARX-788, lupartumab amadotin, AGS-62P1, and ZW-49, among others [<xref rid="B478-marinedrugs-18-00657" ref-type="bibr">478</xref>,<xref rid="B666-marinedrugs-18-00657" ref-type="bibr">666</xref>,<xref rid="B726-marinedrugs-18-00657" ref-type="bibr">726</xref>]. We strongly recommend these reviews for further details on the different status of the many derivatives that are currently being tested and those that are in clinical trials. </p><p>Dolastatin 11 (<bold>327</bold>), 12 (<bold>328</bold>), 13 (<bold>329</bold>), and 14 (<bold>330</bold>) are further depsipeptides isolated from <italic>D. auricularia</italic>, while dolastatin 12 (<bold>328</bold>) was also reported in <italic>Lyngbya majuscula</italic>&#x02013;<italic>Schizothrix calcicola</italic> cyanobacterial assemblages [<xref rid="B750-marinedrugs-18-00657" ref-type="bibr">750</xref>,<xref rid="B751-marinedrugs-18-00657" ref-type="bibr">751</xref>,<xref rid="B752-marinedrugs-18-00657" ref-type="bibr">752</xref>,<xref rid="B753-marinedrugs-18-00657" ref-type="bibr">753</xref>]. In the NCI cell line panel, dolastatin 11 (<bold>327</bold>) showed an IC<sub>50</sub> mean value of ~0.07 &#x003bc;M, while dolastatin 12 (<bold>328</bold>) displayed different IC<sub>50</sub> values in several assays, such as 1 nM for human NCI-H460 NSCLC, 30 nM for human SF-295 CNS cancer, ~0.1 &#x003bc;M for mouse neuro-2a neuroblastoma and 1 &#x003bc;M for P388 leukemia cells [<xref rid="B750-marinedrugs-18-00657" ref-type="bibr">750</xref>,<xref rid="B754-marinedrugs-18-00657" ref-type="bibr">754</xref>,<xref rid="B755-marinedrugs-18-00657" ref-type="bibr">755</xref>]. Dolastatin 11 (<bold>327</bold>) produces a massive rearrangement of the actin filament network in cells, inducing a cytoplasmic retraction and further cell division arrest at the level of cytokinesis [<xref rid="B239-marinedrugs-18-00657" ref-type="bibr">239</xref>,<xref rid="B241-marinedrugs-18-00657" ref-type="bibr">241</xref>]. Dolastatin 12 (<bold>328</bold>) also targets actin microfilaments [<xref rid="B753-marinedrugs-18-00657" ref-type="bibr">753</xref>]. The values of IC<sub>50</sub> for dolastatin 13 (<bold>329</bold>) and 14 (<bold>330</bold>) against the murine P388 leukemia cell line are reported to be 14 and 20 nM, respectively [<xref rid="B751-marinedrugs-18-00657" ref-type="bibr">751</xref>,<xref rid="B752-marinedrugs-18-00657" ref-type="bibr">752</xref>]. </p><p>Dolastatin 15 (<bold>331</bold>) is another linear peptide from <italic>D. auricularia</italic> widely used as a potential warhead, with an IC<sub>50</sub> of 3&#x02212;5 nM, and with many derivatives being tested after chemical modifications, for example, replacing the C-terminal (S)-dolapyrrolidinone unit with some diverse amides while maintaining its anti-tubulin activity [<xref rid="B756-marinedrugs-18-00657" ref-type="bibr">756</xref>,<xref rid="B757-marinedrugs-18-00657" ref-type="bibr">757</xref>,<xref rid="B758-marinedrugs-18-00657" ref-type="bibr">758</xref>,<xref rid="B759-marinedrugs-18-00657" ref-type="bibr">759</xref>,<xref rid="B760-marinedrugs-18-00657" ref-type="bibr">760</xref>,<xref rid="B761-marinedrugs-18-00657" ref-type="bibr">761</xref>]. Dolastatin 15 (<bold>331</bold>) also produces microtubule depolymerization in vitro, possibly binding to the vinca domain of tubulin, and it is a classical inducer of apoptosis in cancer cells, acting as a conventional proapoptotic cytotoxic agent [<xref rid="B762-marinedrugs-18-00657" ref-type="bibr">762</xref>,<xref rid="B763-marinedrugs-18-00657" ref-type="bibr">763</xref>,<xref rid="B764-marinedrugs-18-00657" ref-type="bibr">764</xref>]. Dolastatin 15 (<bold>331</bold>) presents an IC<sub>50</sub> against the NCI panel about ten times higher than that of dolastatin 10 (<bold>326</bold>), that is, 2 vs. 0.2 nM, and it is three to four times more potent than vincristine, a clinically used common antiproliferative agent [<xref rid="B765-marinedrugs-18-00657" ref-type="bibr">765</xref>]. Tasidotin (<bold>345</bold>), an analog of dolastatin 15 (<bold>331</bold>) where the carboxyl-terminal ester group is replaced by a tert-butyl amide, is also a proapoptotic cytotoxic compound, tested against many different cancer lines, but it did not go beyond phase II clinical trials because of its lack of efficacy [<xref rid="B766-marinedrugs-18-00657" ref-type="bibr">766</xref>,<xref rid="B767-marinedrugs-18-00657" ref-type="bibr">767</xref>,<xref rid="B768-marinedrugs-18-00657" ref-type="bibr">768</xref>].</p><p>Dolastatin 16 (<bold>346</bold>), instead, is a cyclic depsipeptide with two amino acids, dolamethylleuine and dolaphenvaline, described in <italic>D. auricularia</italic> from Papua New Guinea, and found also in <italic>Lyngbya majuscula</italic> from Madagascar and <italic>Symploca</italic> cf. <italic>hydnoides</italic> from Guam [<xref rid="B769-marinedrugs-18-00657" ref-type="bibr">769</xref>,<xref rid="B770-marinedrugs-18-00657" ref-type="bibr">770</xref>,<xref rid="B771-marinedrugs-18-00657" ref-type="bibr">771</xref>]. In the NCI cell line panel, dolastatin 16 (<bold>346</bold>) displayed an IC<sub>50</sub> mean value of ~0.3 &#x003bc;M [<xref rid="B770-marinedrugs-18-00657" ref-type="bibr">770</xref>,<xref rid="B772-marinedrugs-18-00657" ref-type="bibr">772</xref>]. Specimens of <italic>D. auricularia</italic> from Papua New Guinea also contained dolastatin 17 (<bold>347</bold>), another cyclodepsipeptide with a novel acetylenic &#x003b2;-amino acid named dolayne (Doy), similar to that of onchidin (<bold>121</bold>), which has submicromolar values of IC<sub>50</sub> against four cancer cell lines [<xref rid="B773-marinedrugs-18-00657" ref-type="bibr">773</xref>,<xref rid="B774-marinedrugs-18-00657" ref-type="bibr">774</xref>]. Dolastatin 18 (<bold>348</bold>) was found in <italic>D. auricularia</italic> from the Indian Ocean, contains a thiazole ring, and shows submicromolar values of IC<sub>50</sub> against mouse P388 lymphocytic leukemia and human NCI-H460 NSCLC cell lines [<xref rid="B775-marinedrugs-18-00657" ref-type="bibr">775</xref>]. <italic>D. auricularia</italic> from California contains dolastatin 19 (<bold>332</bold>), a macrocyclic lactone related to the previously mentioned aurisides (<bold>312,313</bold>), showing in vitro growth inhibition for breast MCF-7 and colon KM20L2 cancer cells with IC<sub>50</sub> values of ~1 &#x003bc;M [<xref rid="B776-marinedrugs-18-00657" ref-type="bibr">776</xref>]. Similarly, other dolastatins from specimens from Japan and the Indian Ocean, such as dolastatin D (<bold>334</bold>), dolastatin G (<bold>337</bold>), <italic>nor</italic>-dolastatin G (<bold>338</bold>), dolastatin H (<bold>335</bold>), and <italic>iso</italic>-dolastatin H (<bold>336</bold>), also display activity against some cancer cell lines, such as human HeLa S3 cancer cells [<xref rid="B721-marinedrugs-18-00657" ref-type="bibr">721</xref>,<xref rid="B723-marinedrugs-18-00657" ref-type="bibr">723</xref>,<xref rid="B724-marinedrugs-18-00657" ref-type="bibr">724</xref>].</p><p><italic>Stylocheilus</italic> and <italic>Bursatella</italic> are also cyanobacterial feeders containing interesting cytotoxic compounds [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>]. Aplysiatoxin (<bold>96</bold>) and debromoaplysiatoxin (<bold>97</bold>) were found in <italic>S. longicauda</italic> from Hawai&#x02019;i, originating from <italic>Lyngbya majuscula</italic> [<xref rid="B302-marinedrugs-18-00657" ref-type="bibr">302</xref>,<xref rid="B303-marinedrugs-18-00657" ref-type="bibr">303</xref>,<xref rid="B777-marinedrugs-18-00657" ref-type="bibr">777</xref>]. The mixture of these two compounds was toxic to mice (LD<sub>100</sub> 0.3 mg/kg), and both compounds are potent PKC activators that are being tested as anticancer lead structures (along with some derivatives) based on their anti-proliferative activity while removing their tumor-promoting activities [<xref rid="B778-marinedrugs-18-00657" ref-type="bibr">778</xref>,<xref rid="B779-marinedrugs-18-00657" ref-type="bibr">779</xref>,<xref rid="B780-marinedrugs-18-00657" ref-type="bibr">780</xref>]. Further studies on different populations of <italic>S. longicauda</italic> also from Hawai&#x02019;i reported complex proline esters, makalika (<bold>99</bold>) and makalikone (<bold>100</bold>), together with lyngbyatoxin A (<bold>349</bold>) with antitumor properties, again from a diet of <italic>L. majuscula</italic> [<xref rid="B304-marinedrugs-18-00657" ref-type="bibr">304</xref>,<xref rid="B305-marinedrugs-18-00657" ref-type="bibr">305</xref>]. Makalikone (<bold>100</bold>) shows moderate activity against P388, A549, and HTB38 cancer cell lines, with IC<sub>50</sub> values between 2.5 and 5 &#x003bc;g/mL [<xref rid="B305-marinedrugs-18-00657" ref-type="bibr">305</xref>]. Lyngbyatoxin A (<bold>349</bold>) is toxic to mice (LD<sub>100</sub> 0.3 mg/kg), and it has been reported to act as a tumor promoter [<xref rid="B781-marinedrugs-18-00657" ref-type="bibr">781</xref>]. Lyngbyatoxin A acetate (<bold>101</bold>), also found in the sea hare and its cyanobacterial prey in Hawai&#x02019;i, displays very potent toxicity against several cancer cell lines, with IC<sub>50</sub> values ~0.05 &#x003bc;g/mL [<xref rid="B305-marinedrugs-18-00657" ref-type="bibr">305</xref>]. Furthermore, some alkaloids such as malyngamides O (<bold>102</bold>) and P (<bold>103</bold>) were found in <italic>S. longicauda</italic> and <italic>L. majuscula</italic> [<xref rid="B307-marinedrugs-18-00657" ref-type="bibr">307</xref>,<xref rid="B781-marinedrugs-18-00657" ref-type="bibr">781</xref>,<xref rid="B782-marinedrugs-18-00657" ref-type="bibr">782</xref>]. Malyngamide O (<bold>102</bold>) shows IC<sub>50</sub> values of 2 &#x003bc;g/mL against the cancer cell lines P388, A549, and HT29 [<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>]. In Guam, <italic>S. longicauda</italic> accumulates malyngamydes and transforms malyngamyde B into an acetate [<xref rid="B307-marinedrugs-18-00657" ref-type="bibr">307</xref>]. In fact, more than 30 malyngamides have been isolated from cyanobacteria and sea hares, and they have been observed to be N-substituted amides of long-chain methoxylated fatty acids, which are characterized by presenting a trans double bond and a 7S configuration of the oxygen-bearing carbon [<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>].</p><p><italic>Bursatella leachii</italic> also feeds on &#x0201c;<italic>Lyngbya</italic>&#x0201d;, accumulating lyngbyatoxin A (<bold>349</bold>) and debromoaplysiatoxin (<bold>97</bold>) in the digestive gland [<xref rid="B783-marinedrugs-18-00657" ref-type="bibr">783</xref>]. In New Zealand, <italic>B. leachii</italic> presents an alkaloid derived also from cyanobacteria, malyngamide S (<bold>350</bold>), with cytotoxic properties, while in Thailand, it presents hectochlorin (<bold>351</bold>) and deacetylhectochlorin (<bold>352</bold>), which are also cytotoxic compounds previously isolated from <italic>Lyngbya majuscula</italic> and structurally similar to dolabellin from <italic>Dolabella auricularia</italic> [<xref rid="B784-marinedrugs-18-00657" ref-type="bibr">784</xref>,<xref rid="B785-marinedrugs-18-00657" ref-type="bibr">785</xref>,<xref rid="B786-marinedrugs-18-00657" ref-type="bibr">786</xref>]. Malyngamide S (<bold>350</bold>) and malyngamide X (<bold>353</bold>), both found in <italic>B. leachii,</italic> possess in vitro growth inhibitory properties against several cancer cell lines, with IC<sub>50</sub> values between ~4 and ~8 &#x003bc;M against murine P388 leukemia and human A549 NSCLC, NCI-H187 (SCLC), HT-29 colon cancer, HL60 leukemia, KB and BC breast cancer lines [<xref rid="B307-marinedrugs-18-00657" ref-type="bibr">307</xref>,<xref rid="B786-marinedrugs-18-00657" ref-type="bibr">786</xref>,<xref rid="B787-marinedrugs-18-00657" ref-type="bibr">787</xref>]. Hectochlorin (<bold>351</bold>) and deacetylhectochlorin (<bold>352</bold>) show growth inhibitory effects in vitro against human KB, NCI-H187 SCLCL, and BC breast cancer cell lines, with deacetylhectochlorin (<bold>352</bold>) displaying a mean IC<sub>50</sub> value of ~1 &#x003bc;M, and hectochlorin (<bold>351</bold>) a mean IC<sub>50</sub> value of ~5 &#x003bc;Min the NCI cell panel (being more potent against colon, melanoma, ovarian, and renal cell lines) [<xref rid="B784-marinedrugs-18-00657" ref-type="bibr">784</xref>,<xref rid="B785-marinedrugs-18-00657" ref-type="bibr">785</xref>]. Additionally, hectochlorin (<bold>351</bold>) seems to be cytostatic rather than cytotoxic in regard to the obtained dose&#x02013;response curves [<xref rid="B785-marinedrugs-18-00657" ref-type="bibr">785</xref>].</p></sec><sec id="sec3dot1dot6-marinedrugs-18-00657"><title>3.1.6. Sacoglossa </title><p>Within this group, caulerpenyne (<bold>155</bold>)&#x02014;a sesquiterpene found in <italic>Elysia</italic> spp. and other species (see above), as well as in its diet of the green algae <italic>Caulerpa</italic>&#x02014;is active against several cancer cell lines at IC<sub>50</sub> ~10 &#x003bc;M, while it has an IC<sub>50</sub> ~40 &#x003bc;M in the NCI panel [<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>,<xref rid="B788-marinedrugs-18-00657" ref-type="bibr">788</xref>,<xref rid="B789-marinedrugs-18-00657" ref-type="bibr">789</xref>,<xref rid="B790-marinedrugs-18-00657" ref-type="bibr">790</xref>]. Caulerpenyne (<bold>155</bold>) is not selective for normal (hamster fibroblasts, human keratinocytes, and melanocytes) and cancer cells [<xref rid="B790-marinedrugs-18-00657" ref-type="bibr">790</xref>,<xref rid="B791-marinedrugs-18-00657" ref-type="bibr">791</xref>]. Caulerpenyne (<bold>155</bold>) induces tubulin aggregation, inhibiting the polymerization of tubulin and bundling of the residual microtubules, but it does not bind to colchicine, taxol, or vinca-alkaloid binding domains [<xref rid="B790-marinedrugs-18-00657" ref-type="bibr">790</xref>,<xref rid="B792-marinedrugs-18-00657" ref-type="bibr">792</xref>]. It has been shown that caulerpenyne (<bold>155</bold>) may block the stimulation of mitogen-activated protein kinase (MAPK), thus affecting the control of cell proliferation, differentiation, or death [<xref rid="B790-marinedrugs-18-00657" ref-type="bibr">790</xref>,<xref rid="B793-marinedrugs-18-00657" ref-type="bibr">793</xref>].</p><p>Kahalalides (<bold>194,354&#x02013;356</bold>) are cyclodepsipeptides found in <italic>Elysia</italic> species (<italic>E. rufescens, E. ornata, and E. grandifolia</italic>) and their algal food, <italic>Bryopsis pennata</italic> [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B796-marinedrugs-18-00657" ref-type="bibr">796</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>]. Kahalalides (<bold>194,354&#x02013;356</bold>) include more than 20 structurally diverse molecules, ranging from a C-31 tripeptide to a C-77 tridecapeptide, where each peptide contains a different fatty acid chain [<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>]. Among them, kahalalide F (<bold>194</bold>), a cyclic peptide connected by an amidic bond to a short fatty acid chain, is the most potent, being reported to show antitumour activity and tested in phase I trials in patients with hormone-refractory prostate cancer [<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>,<xref rid="B798-marinedrugs-18-00657" ref-type="bibr">798</xref>]. Treating cancer cells with kahalalide F (<bold>194</bold>) resulted in critical changes in lysosomal membranes and large vacuoles, producing cell swelling, while it is also reported to display specific interactions with cell membrane proteins [<xref rid="B482-marinedrugs-18-00657" ref-type="bibr">482</xref>,<xref rid="B799-marinedrugs-18-00657" ref-type="bibr">799</xref>]. Kahalalide F (<bold>194</bold>) inhibits the PI3K&#x02013;AKT signaling pathway in the breast cancer cell lines SKBR3 and BT474 [<xref rid="B800-marinedrugs-18-00657" ref-type="bibr">800</xref>]. The IC<sub>50</sub> values of kahalalide F (<bold>194</bold>) in the NCI 60 cell line panel were from 0.2 to 10 &#x003bc;M, with hormone-independent prostate cancer cells being the most sensitive [<xref rid="B267-marinedrugs-18-00657" ref-type="bibr">267</xref>]. Kahalalide F (<bold>194</bold>) also displays in vivo activity against human prostate hormone-independent xenograft models and in the hollow fiber test [<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B801-marinedrugs-18-00657" ref-type="bibr">801</xref>,<xref rid="B802-marinedrugs-18-00657" ref-type="bibr">802</xref>,<xref rid="B803-marinedrugs-18-00657" ref-type="bibr">803</xref>]. Kahalalide F (<bold>194</bold>) was tested in several oncological clinical trials and was taken to phase II, although it failed to be effective [<xref rid="B804-marinedrugs-18-00657" ref-type="bibr">804</xref>,<xref rid="B805-marinedrugs-18-00657" ref-type="bibr">805</xref>]. Kahalalide F (<bold>194</bold>) is found in nature as a mixture with <italic>iso</italic>-kahalalide F (<bold>354</bold>), also possessing interesting bioactivities [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B806-marinedrugs-18-00657" ref-type="bibr">806</xref>]. <italic>Iso</italic>-kahalalide F (<bold>354</bold>) also entered phase II clinical trials for liver cancer, melanoma, and NSCLC patients, but was also ineffective [<xref rid="B807-marinedrugs-18-00657" ref-type="bibr">807</xref>]. The origin of these compounds has been suggested to be <italic>Mycoplasma</italic> spp. Or <italic>Vibrio</italic> spp. Bacteria, since they are affiliated with <italic>E. rufescens</italic> and its mucus [<xref rid="B808-marinedrugs-18-00657" ref-type="bibr">808</xref>]. In <italic>E. ornata</italic> from India, two more compounds, kahalalide Z<sub>1</sub> (<bold>355</bold>) and kahalalide Z<sub>2</sub> (<bold>356</bold>), were found, differing from kahalalide F (<bold>194</bold>) in the <italic>N</italic>-terminal acid moiety and some aminoacid units of the peptide chain, and displaying a bioactivity profile comparable with kahalalide F (<bold>194</bold>) [<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>]. Furthermore, elisidepsin trifluoroacetate (PM02734, IrvalecR), a kahalalide-derived synthetic cyclic depsipeptide (<bold>357</bold>), displays cytotoxic activity, causing cell death by inhibiting the AKT/mTOR pathway [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B809-marinedrugs-18-00657" ref-type="bibr">809</xref>]. Elisidepsin (<bold>357</bold>) also underwent clinical development after showing IC<sub>50</sub> values between 0.4 and ~9 &#x003bc;M in a 23 cancer cell lines, including breast, colon, head and neck, lung, ovary, pancreas, prostate, and melanoma types [<xref rid="B810-marinedrugs-18-00657" ref-type="bibr">810</xref>,<xref rid="B811-marinedrugs-18-00657" ref-type="bibr">811</xref>,<xref rid="B812-marinedrugs-18-00657" ref-type="bibr">812</xref>]. Elisidepsin (<bold>357</bold>) acts at the cell membrane level, interacting directly with glycosylceramides in the membrane of cancer cells, while inducing necrosis-like cell death in the yeast <italic>Saccharomyces cerevisiae</italic> [<xref rid="B813-marinedrugs-18-00657" ref-type="bibr">813</xref>,<xref rid="B814-marinedrugs-18-00657" ref-type="bibr">814</xref>,<xref rid="B815-marinedrugs-18-00657" ref-type="bibr">815</xref>]. Elisidepsin (<bold>357</bold>) is active in vivo against human melanoma, liver, pancreas, breast, and prostate cancer xenografts [<xref rid="B816-marinedrugs-18-00657" ref-type="bibr">816</xref>]. However, in clinical trials, elisidepsin (<bold>357</bold>) has been ineffective to date [<xref rid="B811-marinedrugs-18-00657" ref-type="bibr">811</xref>,<xref rid="B817-marinedrugs-18-00657" ref-type="bibr">817</xref>].</p></sec><sec id="sec3dot1dot7-marinedrugs-18-00657"><title>3.1.7. Pulmonata</title><p><italic>Trimusculus</italic> species present a single type of labdane diterpenoids, such as <italic>T. costatus</italic> and <italic>T. reticulatus</italic> from different geographic localities [<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>,<xref rid="B334-marinedrugs-18-00657" ref-type="bibr">334</xref>,<xref rid="B818-marinedrugs-18-00657" ref-type="bibr">818</xref>]. In Chile and South Africa, <italic>T. costatus</italic> and <italic>T. peruvianus</italic> metabolites present cytotoxicity [<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>,<xref rid="B335-marinedrugs-18-00657" ref-type="bibr">335</xref>,<xref rid="B336-marinedrugs-18-00657" ref-type="bibr">336</xref>,<xref rid="B337-marinedrugs-18-00657" ref-type="bibr">337</xref>]. An atypical C-21 hydroxylated sterol (<bold>358</bold>) from <italic>T. peruvianus</italic> presented IC<sub>50</sub> values of ~6 &#x003bc;M when tested against human HCT-116 and HT29 colon cancer cells [<xref rid="B819-marinedrugs-18-00657" ref-type="bibr">819</xref>]. A secosterol (<bold>359</bold>) from <italic>T. costatus</italic> was also active, with an IC<sub>50</sub> value of ~3 &#x003bc;M against the WHCO1 esophageal cancer cell line [<xref rid="B337-marinedrugs-18-00657" ref-type="bibr">337</xref>]. </p><p><italic>Siphonaria</italic> species, <italic>S. capensis</italic>, <italic>S. concinna</italic>, <italic>S. cristatus</italic>, and <italic>S. serrata,</italic> contain de novo biosynthesized polypropionates, and some of which also present cytotoxic activity [<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B339-marinedrugs-18-00657" ref-type="bibr">339</xref>,<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B345-marinedrugs-18-00657" ref-type="bibr">345</xref>,<xref rid="B346-marinedrugs-18-00657" ref-type="bibr">346</xref>,<xref rid="B347-marinedrugs-18-00657" ref-type="bibr">347</xref>,<xref rid="B348-marinedrugs-18-00657" ref-type="bibr">348</xref>,<xref rid="B349-marinedrugs-18-00657" ref-type="bibr">349</xref>,<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>,<xref rid="B351-marinedrugs-18-00657" ref-type="bibr">351</xref>,<xref rid="B352-marinedrugs-18-00657" ref-type="bibr">352</xref>]. In particular, <italic>iso</italic>pectinatone, siphonarienolone (<bold>119</bold>) and others are active at 2.5 &#x003bc;g/mL against P388, A549, HT29, and MEL28, while pectinatone (<bold>166</bold>) and siphonarienfuranone are active at 5 &#x003bc;g/mL, and siphonarienedione, siphonarienone, and <italic>iso</italic>siphonarienolone are active at 10 &#x003bc;g/mL [<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B339-marinedrugs-18-00657" ref-type="bibr">339</xref>,<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B345-marinedrugs-18-00657" ref-type="bibr">345</xref>,<xref rid="B346-marinedrugs-18-00657" ref-type="bibr">346</xref>,<xref rid="B347-marinedrugs-18-00657" ref-type="bibr">347</xref>,<xref rid="B348-marinedrugs-18-00657" ref-type="bibr">348</xref>,<xref rid="B349-marinedrugs-18-00657" ref-type="bibr">349</xref>,<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>,<xref rid="B351-marinedrugs-18-00657" ref-type="bibr">351</xref>,<xref rid="B352-marinedrugs-18-00657" ref-type="bibr">352</xref>]. Onchidiidids present sesquiterpenoids, depsipeptide acetates, and propionates with 32 carbon atoms, two <italic>&#x003b3;</italic>-pyrone rings, and a number of hydroxyl groups [<xref rid="B12-marinedrugs-18-00657" ref-type="bibr">12</xref>]. <italic>Onchidium</italic> species possess cytotoxic cyclic depsipeptides, such as onchidin (<bold>121</bold>), and the tropical <italic>Onchidium</italic> sp. also possesses cytotoxic acetates and propionates [<xref rid="B358-marinedrugs-18-00657" ref-type="bibr">358</xref>,<xref rid="B359-marinedrugs-18-00657" ref-type="bibr">359</xref>,<xref rid="B820-marinedrugs-18-00657" ref-type="bibr">820</xref>]. Onchidin (<bold>121</bold>) and onchidin B (<bold>360</bold>) are active against murine P388 leukemia and human KB oral cancer cells at IC<sub>50</sub> values of ~ 7 &#x003bc;M [<xref rid="B358-marinedrugs-18-00657" ref-type="bibr">358</xref>,<xref rid="B359-marinedrugs-18-00657" ref-type="bibr">359</xref>]. In China, <italic>Onchidium</italic> sp. presents bis-&#x003b3;-pyrone polypropionates, such as onchidione (<bold>122</bold>) and related compounds, such as onchidiol (<bold>361</bold>) and ilikonapyrones (<bold>362,363</bold>) lacking the hemiketal ring, in different populations [<xref rid="B12-marinedrugs-18-00657" ref-type="bibr">12</xref>,<xref rid="B357-marinedrugs-18-00657" ref-type="bibr">357</xref>,<xref rid="B360-marinedrugs-18-00657" ref-type="bibr">360</xref>,<xref rid="B362-marinedrugs-18-00657" ref-type="bibr">362</xref>,<xref rid="B821-marinedrugs-18-00657" ref-type="bibr">821</xref>,<xref rid="B822-marinedrugs-18-00657" ref-type="bibr">822</xref>,<xref rid="B823-marinedrugs-18-00657" ref-type="bibr">823</xref>]. Both kinds of compounds were tested against HCCLs, resulting in 3-acetyl-11-(3-methylbutanoyl)-13-propanoyl-ilikonapyrone (<bold>362</bold>) being active, inhibiting growth in all tested cell lines with IC<sub>50</sub> between 3 and 9 &#x003bc;M (A549 NSCLC, MCF-7 breast cancer, PC-3 prostate cancer, Hs683 oligodendroglioma, U373 glioblastoma, and SKMEL-28 melanoma), and being comparable to etoposide and camptothecin [<xref rid="B357-marinedrugs-18-00657" ref-type="bibr">357</xref>]. This compound (<bold>362</bold>) seems to be active against cancer cells that present resistance to proapoptotic stimuli [<xref rid="B357-marinedrugs-18-00657" ref-type="bibr">357</xref>]. Moreover, onchidione (<bold>122</bold>) and the related 3-acetyl-onchidionol and 4-<italic>epi</italic>-onchidione were reported to have significant effects on the splicing of XBP1 mRNA, which is an important regulator of some genes related to the growth of tumors [<xref rid="B821-marinedrugs-18-00657" ref-type="bibr">821</xref>].</p></sec></sec><sec id="sec3dot2-marinedrugs-18-00657"><title>3.2. Antibiotic Activity</title><p>Most groups of heterobranchs present compounds with antibiotic activity, the exceptions being dendronotacean and aeolidacean nudibranchs, pleurobranchoideans, cephalaspideans, and pteropods (<xref ref-type="fig" rid="marinedrugs-18-00657-f023">Figure 23</xref>, <xref rid="marinedrugs-18-00657-t011" ref-type="table">Table 11</xref>) [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. This is an open field for research, since bacterial strains are becoming resistant or multiresistant to known antibiotics, and new molecules are strongly needed to target them [<xref rid="B31-marinedrugs-18-00657" ref-type="bibr">31</xref>,<xref rid="B830-marinedrugs-18-00657" ref-type="bibr">830</xref>]. </p><sec id="sec3dot2dot1-marinedrugs-18-00657"><title>3.2.1. Nudibranchia</title><sec><title>Doridacea</title><p>Both olepupuane (<bold>14</bold>) and polygodial (<bold>13</bold>), previously mentioned above, are found in different dendrodorid nudibranchs and show antifungal activity against <italic>Saccharomyces cerevisiae</italic> IFO 0203 and <italic>Hansenula anomala</italic> IFO 0136 [<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B831-marinedrugs-18-00657" ref-type="bibr">831</xref>]. Moreover, extracts of the egg masses of <italic>Dendrodoris fumata</italic> show antibacterial activity against <italic>Escherichia coli</italic>, <italic>Staphylococcus aureus</italic> and <italic>Pseudomonas aeruginosa</italic>, thus protecting embryos against bacterial infection [<xref rid="B832-marinedrugs-18-00657" ref-type="bibr">832</xref>].</p><p>Phyllidids, well-studied colorful nudibranchs, often contain isocyanate compounds [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. These isocyanates display a wide array of activities, including antibiotic activity, and have been well studied in recent years [<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B104-marinedrugs-18-00657" ref-type="bibr">104</xref>,<xref rid="B105-marinedrugs-18-00657" ref-type="bibr">105</xref>]. One of the best-known species is <italic>Phyllidiella pustulosa,</italic> with compounds obtained from its dietary sponges, mainly <italic>Acanthella cavernosa</italic>, from different geographical localities [<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B121-marinedrugs-18-00657" ref-type="bibr">121</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>]. <italic>P. pustulosa</italic> from Fiji presents axisonitrile-3 (<bold>25</bold>), displaying strong growth inhibition against <italic>Mycobacterium tuberculosis</italic> (MIC 2 &#x003bc;g/mL) [<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B427-marinedrugs-18-00657" ref-type="bibr">427</xref>]. Similarly, <italic>Phyllidia picta</italic> from Bali contains the axane sesquiterpenoids pictaisonitrile-1 (<bold>23</bold>) and pictaisonitrile-2, while <italic>Phyllidia coelestis</italic> and <italic>P. pustulosa</italic> from China, as well as their probable sponge prey <italic>A. cavernosa</italic>, present a nitrogenous cadinane-type sesquiterpenoid, xidaoisocyanate A (<bold>24</bold>), among other terpenoids [<xref rid="B112-marinedrugs-18-00657" ref-type="bibr">112</xref>,<xref rid="B113-marinedrugs-18-00657" ref-type="bibr">113</xref>,<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]. Furthermore, <italic>Phyllidia varicosa</italic> presents two 9-thiocyanatopupukeanane sesquiterpenes (<bold>126</bold>), sequestered from the sponge <italic>Axinyssa aculeata</italic> [<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>]. Altogether, 9-<italic>iso</italic>cyanopupukeanane (<bold>21</bold>) and <italic>epi</italic>-9-<italic>iso</italic>cyanopupukeanane, as well as their thiocyano derivatives, are moderately antibacterial against <italic>Bacillus subtilis</italic> and antifungal against <italic>Candida albicans,</italic> and they were also further isolated from <italic>Phyllidiella rosans</italic> (<italic>P. bourguini</italic>) [<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>,<xref rid="B373-marinedrugs-18-00657" ref-type="bibr">373</xref>].</p><p><italic>Doriprismatica (Glossodoris) atromarginata</italic> from Australia, Sri Lanka, and India, possesses different compounds from its demosponge preys (<italic>Spongia</italic> (<italic>Hyatella</italic>) sp., <italic>Hyrtios</italic> spp., and <italic>Hyattella cribriformis</italic>), two scalarane sesterterpenes in their MDFs, some pentacyclic scalaranes, and heteronemin (<bold>233</bold>) [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B92-marinedrugs-18-00657" ref-type="bibr">92</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B382-marinedrugs-18-00657" ref-type="bibr">382</xref>]. Heteronemin (<bold>233</bold>), a scalarin-skeleton sesterterpene first reported in the sponge <italic>Heteronema erecta</italic>, displays antibacterial activity towards <italic>M. tuberculosis</italic> H<sub>37</sub>Rv, with a MIC of 6.25 &#x003bc;g/mL [<xref rid="B85-marinedrugs-18-00657" ref-type="bibr">85</xref>,<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B833-marinedrugs-18-00657" ref-type="bibr">833</xref>]. Other <italic>Glossodoris</italic> species from Australia, <italic>G. hikuerensis</italic> and <italic>G. vespa,</italic> also contain heteronemin (<bold>233</bold>) in their viscera, along with scalaradial (<bold>44</bold>), 12-deacetoxy-12-oxoscalaradial (<bold>43</bold>), and 12-deacetoxy-12-oxo-deoxoscalarin (<bold>136</bold>) in their mantle [<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]. In particular, 12-<italic>epi</italic>-scalaradial of <italic>G. hikuerensis</italic> and <italic>G. cincta</italic> shows antimicrobial activity at 10 &#x003bc;g/disk against <italic>S. aureus</italic>, <italic>B. subtilis</italic>, and <italic>C. albicans</italic> [<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>].</p><p>Some compounds described in <italic>Chromodoris willani</italic> collected in Okinawa contain two sesterterpenes, deoximanoalide (<bold>364</bold>) and deoxysecomanoalide (<bold>365</bold>), biotransformed from manoalide and secomanoalide, respectively, possessing antimicrobial activity against <italic>E. coli</italic> and <italic>B. subtilis</italic>, and showing inhibition of snake venom phospholipase A2 at 0.2&#x02013;0.5 &#x000b5;g [<xref rid="B159-marinedrugs-18-00657" ref-type="bibr">159</xref>]. On the other hand, nakafuran-8 (<bold>54</bold>) and nakafuran-9 (<bold>51</bold>), found in several chromodorid species as reported above, were tested against <italic>E. coli</italic>, <italic>S. aureus</italic>, <italic>P. aeriginosa</italic> and <italic>B. subtilis</italic> in a disk diffusion assay, displaying no antibacterial activity [<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>]. In contrast, in <italic>Chromodoris petechialis</italic>, puupehenone (<bold>218</bold>) shows a MIC of 3 &#x003bc;g/mL against <italic>C. albicans</italic> [<xref rid="B158-marinedrugs-18-00657" ref-type="bibr">158</xref>].</p><p>Hawaiian specimens of the bright red &#x0201c;Spanish dancer&#x0201d; nudibranch, <italic>Hexabranchus sanguineus</italic>, yielded several bioactive macrolides (see above) [<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>]. Specimens of <italic>H. sanguineus</italic> from Fiji additionally yielded two thiazole cyclic peptides, sanguinamide A (<bold>64</bold>) and B (<bold>366</bold>) [<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>]. Both sanguinamide A (<bold>64</bold>) and B (<bold>366</bold>) were found at very low concentrations, 0.0023 and 0.011% dry weight, respectively [<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>]. Sanguinamide B (<bold>366</bold>) showed a moderate antibacterial activity against <italic>P. aeruginosa</italic>, reducing twitching motility [<xref rid="B834-marinedrugs-18-00657" ref-type="bibr">834</xref>,<xref rid="B835-marinedrugs-18-00657" ref-type="bibr">835</xref>]. <italic>H. sanguineus</italic> specimens from different locations showed different compounds, most of them probably from dietary sponges (<italic>Halichondria, Axinella,</italic> and <italic>Dysidea</italic>) [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>,<xref rid="B545-marinedrugs-18-00657" ref-type="bibr">545</xref>,<xref rid="B836-marinedrugs-18-00657" ref-type="bibr">836</xref>,<xref rid="B837-marinedrugs-18-00657" ref-type="bibr">837</xref>,<xref rid="B838-marinedrugs-18-00657" ref-type="bibr">838</xref>]. In Indonesia, Hawai&#x02019;i and Japan, <italic>H. sanguineus</italic> presents two trisoxazole macrolides, ulapualide A (<bold>190</bold>) and B (<bold>236</bold>), that inhibit the growth of <italic>C. albicans</italic>, while halichondramides (<bold>244</bold>) and kabiramides A&#x02013;E (<bold>62,238</bold>&#x02013;<bold>241,243</bold>) inhibited several fungi [<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>,<xref rid="B546-marinedrugs-18-00657" ref-type="bibr">546</xref>,<xref rid="B547-marinedrugs-18-00657" ref-type="bibr">547</xref>,<xref rid="B836-marinedrugs-18-00657" ref-type="bibr">836</xref>].</p><p>The Indian <italic>Jorunna funebris</italic> possesses, among other related metabolites, the isoquinoline alkaloid jorumycin (<bold>189</bold>), which is very similar to renieramycin E from the sponge <italic>Reniera</italic> sp. [<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B553-marinedrugs-18-00657" ref-type="bibr">553</xref>,<xref rid="B839-marinedrugs-18-00657" ref-type="bibr">839</xref>]. Jorumycin (<bold>189</bold>) presents antimicrobial activity against <italic>Bacillus subtilis</italic> and <italic>Staphylococcus aureus</italic> [<xref rid="B557-marinedrugs-18-00657" ref-type="bibr">557</xref>]. Jorumycin (<bold>189</bold>) was found in the mucus secretion, and, thus, a defensive role was proposed for it [<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>]. <italic>J. funebris</italic> and its prey, <italic>Xestospongia</italic> spp., present several isoquinolinequinones and bistetrahydroisoquinolines, among which some isoquinolinequinones also display antibacterial activity [<xref rid="B553-marinedrugs-18-00657" ref-type="bibr">553</xref>,<xref rid="B560-marinedrugs-18-00657" ref-type="bibr">560</xref>,<xref rid="B564-marinedrugs-18-00657" ref-type="bibr">564</xref>,<xref rid="B565-marinedrugs-18-00657" ref-type="bibr">565</xref>,<xref rid="B840-marinedrugs-18-00657" ref-type="bibr">840</xref>]. </p><p>Although the metabolites have not yet been described, the organic extract of <italic>Halgerda stricklandi</italic> displays modest activity against <italic>Staphylococcus aureus</italic>, but no activity against a range of several other bacteria and fungi [<xref rid="B840-marinedrugs-18-00657" ref-type="bibr">840</xref>]. <italic>Halgerda aurantiomaculata</italic> contains a tryptophane derivative called zooanemonin (<bold>367</bold>), previously isolated from several sponges and the sea anemone <italic>Anemonia sulcata</italic>, which is also reported to show antibacterial activity [<xref rid="B841-marinedrugs-18-00657" ref-type="bibr">841</xref>].</p><p>Finally, within the Nembrothidae, the previously mentioned alkaloids tambjamines (<bold>65</bold>&#x02013;<bold>70,249</bold>) also possess antimicrobial activity from their diet [<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]. Particularly, their blue tetrapyrrol (<bold>72</bold>), presumably derived from a diet of ascidians, is active against <italic>B. subtilis</italic> at 5 &#x000b5;g/disc [<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>].</p></sec><sec><title>Euarminida</title><p>Chemical studies of the South African <italic>Leminda millecra</italic> described some sesquiterpenes from dietary origin, including millecrones A and B (<bold>368,369</bold>) and millecrols A and B (<bold>370,371</bold>) [<xref rid="B588-marinedrugs-18-00657" ref-type="bibr">588</xref>,<xref rid="B589-marinedrugs-18-00657" ref-type="bibr">589</xref>]. Millecrone A (<bold>368</bold>), originating from the soft coral <italic>Alcyonium fauri</italic>, inhibited the growth of <italic>Candida albicans</italic> at 50 &#x000b5;g/disk, while millecrone B (<bold>369</bold>) from the gorgonian <italic>Leptogorgia palma</italic> was active against both <italic>Staphylococcus aureus</italic> and <italic>Bacillus subtilis</italic> at 50 &#x000b5;g/disk [<xref rid="B21-marinedrugs-18-00657" ref-type="bibr">21</xref>,<xref rid="B589-marinedrugs-18-00657" ref-type="bibr">589</xref>]. In contrast, millecrol B (<bold>371</bold>) was only active against <italic>B. subtilis</italic> at 50 &#x000b5;g/disk [<xref rid="B21-marinedrugs-18-00657" ref-type="bibr">21</xref>]. </p><p>Furthermore, <italic>Dermatobranchus otome</italic> from Japan presents the germacrane sesquiterpenoids DO1 (<bold>372</bold>), DO2 (<bold>373</bold>), and DO3 (<bold>374</bold>), displaying antibacterial activity against <italic>B. subtilis</italic> [<xref rid="B842-marinedrugs-18-00657" ref-type="bibr">842</xref>]. </p><p>Extracts of <italic>Armina babai</italic> also display antimicrobial activity against <italic>Pseudomonas</italic> sp. and <italic>Proteus mirabilis</italic>, although the compounds have not yet been described [<xref rid="B843-marinedrugs-18-00657" ref-type="bibr">843</xref>]. <italic>A. babai</italic> from India possesses a ceramide also found in the gorgonian <italic>Acabaria undulata</italic> [<xref rid="B842-marinedrugs-18-00657" ref-type="bibr">842</xref>,<xref rid="B844-marinedrugs-18-00657" ref-type="bibr">844</xref>].</p></sec></sec><sec id="sec3dot2dot2-marinedrugs-18-00657"><title>3.2.2. Tylodinoidea</title><p>As mentioned above, the Australian <italic>Tylodina corticalis</italic> selectively accumulates some bromotyrosine-derived alkaloids from the sponge <italic>Pseudoceratina purpurea</italic>, which contains a larger variety of these compounds [<xref rid="B258-marinedrugs-18-00657" ref-type="bibr">258</xref>]. Among them, hexadellin (<bold>375</bold>) and aplysamine 2 (<bold>376</bold>) display mild antibiotic activity against <italic>E. coli</italic> and <italic>S. aureus</italic> at concentrations of 125&#x02013;250 &#x000b5;g/mL [<xref rid="B262-marinedrugs-18-00657" ref-type="bibr">262</xref>]. </p></sec><sec id="sec3dot2dot3-marinedrugs-18-00657"><title>3.2.3. Anaspidea</title><p><italic>Aplysia</italic>, as mentioned above, is one of the most studied genera, with many NPs displaying a wide range of activities around the world [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. In particular, the brominated diterpenes, glandulaurencianols A&#x02013;C (<bold>162,163</bold>), as well as punctatol (<bold>164</bold>) from <italic>Aplysia punctata</italic>, probably from the red algae <italic>Laurencia glandulifera</italic>, possess the laurencianol skeleton, a known antibacterial diterpene from <italic>Laurencia glandulifera</italic> that is active against <italic>Escherichia coli</italic> and <italic>Bacillus subtilis</italic> [<xref rid="B429-marinedrugs-18-00657" ref-type="bibr">429</xref>,<xref rid="B430-marinedrugs-18-00657" ref-type="bibr">430</xref>,<xref rid="B431-marinedrugs-18-00657" ref-type="bibr">431</xref>]. Moreover, a purple secretion of the sea hare <italic>A. juliana</italic> contains julianin-S, an antibacterial peptide suggested to protect its egg masses from microbial infections, together with some unsaturated fatty acids [<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>,<xref rid="B434-marinedrugs-18-00657" ref-type="bibr">434</xref>]. Similarly, aplysianin E from <italic>A. kurodai</italic> eggs shows antifungal activity against <italic>C. albicans</italic> at IC<sub>50</sub> &#x0003e;16 &#x000b5;g/mL [<xref rid="B672-marinedrugs-18-00657" ref-type="bibr">672</xref>,<xref rid="B673-marinedrugs-18-00657" ref-type="bibr">673</xref>,<xref rid="B674-marinedrugs-18-00657" ref-type="bibr">674</xref>].</p><p>As mentioned above, <italic>Dolabella auricularia</italic>, possesses the glycoprotein dolabellanin A, probably de novo biosynthesized [<xref rid="B435-marinedrugs-18-00657" ref-type="bibr">435</xref>]. Besides its antineoplastic activity, dolabellanin A also shows antibacterial activity against <italic>E. coli</italic>, which may protect the egg masses from bacterial pathogens [<xref rid="B435-marinedrugs-18-00657" ref-type="bibr">435</xref>]. </p><p>Finally, bursatellin (<bold>105</bold>), a diol nitrile alkaloid found in <italic>Bursatella leachii plei</italic> from Puerto Rico, is structurally related to the well-known antibiotic chloramphenicol [<xref rid="B311-marinedrugs-18-00657" ref-type="bibr">311</xref>]. In the Mediterranean, both the + and &#x02013; isomers of bursatellin (<bold>105</bold>) are found in the external extracts of <italic>B. leachii leachii</italic> and <italic>B. leachii savignyana</italic> [<xref rid="B312-marinedrugs-18-00657" ref-type="bibr">312</xref>].</p></sec><sec id="sec3dot2dot4-marinedrugs-18-00657"><title>3.2.4. Sacoglossa </title><p>In this group, the previously mentioned cyclodepsipeptides kahalalides A (<bold>377</bold>) and F (<bold>194</bold>) from <italic>Elysia rufescens</italic> and its algal food, <italic>Bryopsis</italic> sp., are active against mycobacteria, with kahalalide A (<bold>377</bold>) inhibiting <italic>M. tuberculosis</italic> H37Rv by 83% at 12.5 &#x003bc;g/mL, and kahalalide F (<bold>194</bold>) by 67% at 12.5 &#x003bc;g/mL [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>,<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>]. Kahalalide F (<bold>194</bold>) also inhibited <italic>Mycobacterium intracellulare</italic> at a MIC of 25 &#x003bc;g/mL [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>]. Kahalalides (<bold>194,354&#x02013;356</bold>) are also found in <italic>E. rufescens</italic>, <italic>E. ornata</italic> and <italic>E. grandifolia,</italic> and their algal diet <italic>Bryopsis pennata</italic> [<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>], with kahalalide F (<bold>194</bold>) always being the most active compound [<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>]. Kahalalide F (<bold>194</bold>) is found in a mixture together with its isomer <italic>iso</italic>-kahalalide F (<bold>354</bold>), which also shows relevant bioactivities [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B806-marinedrugs-18-00657" ref-type="bibr">806</xref>]. Both compounds have been suggested to originate from bacterial symbionts, although more research is needed to prove this [<xref rid="B808-marinedrugs-18-00657" ref-type="bibr">808</xref>].</p><p>Chlorodesmin (<bold>114</bold>), from the Australian <italic>Cyerce nigricans</italic>, is a diterpenoid previously known from the green algae <italic>Chlorodesmis fastigiata</italic> with antibacterial and antifungal activity [<xref rid="B845-marinedrugs-18-00657" ref-type="bibr">845</xref>,<xref rid="B846-marinedrugs-18-00657" ref-type="bibr">846</xref>].</p></sec><sec id="sec3dot2dot5-marinedrugs-18-00657"><title>3.2.5. Pulmonata</title><p>Several species of <italic>Siphonaria</italic> (<italic>S. capensis</italic>, <italic>S. concinna</italic>, <italic>S. cristatus</italic>, and <italic>S. serrata</italic>) possess different types of polypropionates in their mantle and mucous secretion, affecting gramm + bacteria [<xref rid="B338-marinedrugs-18-00657" ref-type="bibr">338</xref>]. Species from Australia, West and East Atlantic, and South Africa displayed antimicrobial activity due to acyclic compounds with a 2-pyrone and furanone rings (type I), such as siphonarienolone (<bold>119</bold>), which were similar to the polypropionates of cephalaspideans [<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B345-marinedrugs-18-00657" ref-type="bibr">345</xref>,<xref rid="B346-marinedrugs-18-00657" ref-type="bibr">346</xref>]. On the other hand, polypropionates with a profuse polyoxygenated network that frequently cyclizes (Type II), such as siphonarin A (<bold>120</bold>), similar to those of actinomycetes, are found in <italic>Siphonaria</italic> species from Australia, New Zealand, North-East Pacific, Pacific Islands, and South Africa [<xref rid="B347-marinedrugs-18-00657" ref-type="bibr">347</xref>,<xref rid="B348-marinedrugs-18-00657" ref-type="bibr">348</xref>,<xref rid="B349-marinedrugs-18-00657" ref-type="bibr">349</xref>,<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>,<xref rid="B351-marinedrugs-18-00657" ref-type="bibr">351</xref>,<xref rid="B352-marinedrugs-18-00657" ref-type="bibr">352</xref>]. <italic>S. diemenensis</italic> and <italic>S. pectinata</italic> present diemenensin-A (<bold>165</bold>) and pectinatone (<bold>166</bold>) [<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>]. Diemenensin-A (<bold>165</bold>) inhibited <italic>S. aureus</italic> and <italic>B. subtilis</italic> at 1 &#x000b5;g/disc and 5 &#x000b5;g/disc, respectively, while pectinatone (<bold>166</bold>) inhibited <italic>S. aureus, B. subtilus</italic>, <italic>C. albicans</italic>, and <italic>S. cerevisiae</italic> [<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>]. </p></sec></sec><sec id="sec3dot3-marinedrugs-18-00657"><title>3.3. Antiparasitic Activity</title><p>Currently, another important need is to identify antiparasitic compounds, although the antiparasitic activities included here mainly comprise compounds related to antiplasmodial effects. Within heterobranchs, antimalarial compounds have been described in several doridacean nudibranchs, while only one species of sacoglossa has been cited to possess antileishmanial activity [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>] (<xref ref-type="fig" rid="marinedrugs-18-00657-f023">Figure 23</xref> and <xref ref-type="fig" rid="marinedrugs-18-00657-f024">Figure 24</xref>, <xref rid="marinedrugs-18-00657-t012" ref-type="table">Table 12</xref>).</p><sec id="sec3dot3dot1-marinedrugs-18-00657"><title>3.3.1. Nudibranchia</title><sec><title>Doridacea</title><p>The doridacean nudibranch <italic>Notodoris gardineri</italic> from the Philippines presents the imidazole alkaloids <italic>iso</italic>-naamidine-A (<bold>160</bold>) and dorimidazole-A (<bold>386</bold>), the latter exhibiting anthelminthic activity against the nematode parasite <italic>Nippostrongylus brasiliensis</italic> at 50 &#x003bc;g/mL [<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B426-marinedrugs-18-00657" ref-type="bibr">426</xref>]. Moreover, <italic>Chromodoris lochi</italic> from Vanuatu contains the PKS-NRPS-derived mycothiazole (<bold>129</bold>) which is described to possess anthelminthic activity against the nematode parasite <italic>N. brasiliensis</italic> at 50 &#x003bc;g/mL [<xref rid="B378-marinedrugs-18-00657" ref-type="bibr">378</xref>]. Mycothiazole (<bold>129</bold>) has also been found in the prey sponge of the slug, the sponge <italic>Spongia (Cacospongia) mycofijiensis</italic> [<xref rid="B379-marinedrugs-18-00657" ref-type="bibr">379</xref>].</p><p>Among the numerous nitrogenated compounds reported from phyllidid nudibranchs, mostly obtained from their sponge prey, several have been found to have antiplasmodial activity [<xref rid="B44-marinedrugs-18-00657" ref-type="bibr">44</xref>,<xref rid="B847-marinedrugs-18-00657" ref-type="bibr">847</xref>]. Axisonitrile-3 (<bold>25</bold>) shows an IC<sub>50</sub> towards <italic>Plasmodium falciparum</italic> of 16.5 ng/mL for chloroquine-resistant strain W2 and no associated cytotoxicity [<xref rid="B848-marinedrugs-18-00657" ref-type="bibr">848</xref>]. Axisonitrile-3 (<bold>25</bold>) has been reported to interfere with the detoxification of heme, a degradation product of hemoglobin digestion within infected erythrocytes, and to form a binary complex with iron in protoporphyrin IX, producing heme accumulation, which results in toxicity to the malaria parasite [<xref rid="B849-marinedrugs-18-00657" ref-type="bibr">849</xref>].</p><p>Pustulosaisonitrile-1 (<bold>378</bold>) from <italic>Phyllidiella pustulosa</italic> from Australia presents moderate levels of in vitro antimalarial activity [<xref rid="B850-marinedrugs-18-00657" ref-type="bibr">850</xref>]. Among the diverse nitrogenous mono-, bi- and tri-cyclic sesquiterpenes found in <italic>Phyllidia ocelata</italic> and <italic>Phyllidiella pustulosa</italic> from different geographical locations, several are reported to possess antimalarial activity against <italic>Plasmodium falciparum</italic> [<xref rid="B102-marinedrugs-18-00657" ref-type="bibr">102</xref>,<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B119-marinedrugs-18-00657" ref-type="bibr">119</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B122-marinedrugs-18-00657" ref-type="bibr">122</xref>,<xref rid="B375-marinedrugs-18-00657" ref-type="bibr">375</xref>,<xref rid="B376-marinedrugs-18-00657" ref-type="bibr">376</xref>,<xref rid="B377-marinedrugs-18-00657" ref-type="bibr">377</xref>]. In particular, in <italic>P. ocellata</italic> from Australia, 2-<italic>iso</italic>cyanoclovene (<bold>379</bold>), its dihydro analogue 2-<italic>iso</italic>cyanoclovane (<bold>380</bold>) and 4,5-<italic>epi</italic>-10-isocyanoisodauc-6-ene (<bold>381</bold>) present IC<sub>50</sub> values of 0.26&#x02013;0.30 &#x003bc;M, while 1-<italic>iso</italic>thiocyanatoepicaryolane (<bold>382</bold>) has an IC<sub>50</sub> &#x0003e; 10 &#x003bc;M [<xref rid="B376-marinedrugs-18-00657" ref-type="bibr">376</xref>]. In <italic>P. pustulosa</italic> from Fiji, 10-thiocyano-4-cadinene (<bold>383</bold>) shows moderate antiplasmodial activity [<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>]. </p></sec></sec><sec id="sec3dot3dot2-marinedrugs-18-00657"><title>3.3.2. Sacoglossa </title><p>The depsipeptides kahalalides (<bold>194,354&#x02013;356,377</bold>) found in different <italic>Elysia</italic> species, such as <italic>E. rufescens</italic>, <italic>E. ornata</italic>, <italic>E. grandifolia</italic>, and their algal food <italic>Bryopsis pennata</italic>, have been reported to possess antileishmanial properties [<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B796-marinedrugs-18-00657" ref-type="bibr">796</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>]. Kahalalides (<bold>194,354&#x02013;356,377</bold>) are active against <italic>Leishmania</italic> spp. At micromolar ranges, and their lethality is linked to the alteration of the plasmatic membrane of the protozoan [<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B796-marinedrugs-18-00657" ref-type="bibr">796</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>].</p></sec></sec><sec id="sec3dot4-marinedrugs-18-00657"><title>3.4. Antiviral Activity</title><p>Marine organisms are considered an underexplored source of antiviral compounds [<xref rid="B851-marinedrugs-18-00657" ref-type="bibr">851</xref>,<xref rid="B852-marinedrugs-18-00657" ref-type="bibr">852</xref>,<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]. Many of the drugs currently employed produce strong side effects and develop resistances [<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]. Viral diseases cause a huge number of deaths annually; for example, human immunodeficiency virus (HIV) is one of the top five most deadly diseases worldwide [<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]. Furthermore, new viruses are appearing with extreme virulence, such as COVID-19, with no known treatment to date [<xref rid="B854-marinedrugs-18-00657" ref-type="bibr">854</xref>]. Therefore, the need for new antiviral drugs is clear, and heterobranchs, with their amazing biodiversity and chemodiversity, may perhaps contribute to this. To date, only doridacean nudibranchs, sea hares, and sacoglossans have been reported to possess antiviral compounds (<xref ref-type="fig" rid="marinedrugs-18-00657-f024">Figure 24</xref>, <xref rid="marinedrugs-18-00657-t013" ref-type="table">Table 13</xref>).</p><sec id="sec3dot4dot1-marinedrugs-18-00657"><title>3.4.1. Nudibranchia</title><sec><title>Doridacea</title><p>The chromodoridid <italic>Cadlina luteomarginata</italic> presents compounds with the tricyclic ansellane carbon skeleton, among other compounds, obtained from its sponge prey <italic>Phorbas</italic> sp. [<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>]. Among them, ansellone A (<bold>216</bold>) from the sponge was tested for the &#x0201c;shock and kill&#x0201d; approach to a sterilizing HIV-1 cure [<xref rid="B855-marinedrugs-18-00657" ref-type="bibr">855</xref>]. Ansellone A (<bold>216</bold>), together with other sponge compounds, was found to activate the latent proviral HIV-1 gene expression, as well as to possess LRA profiles comparable to prostratin, which is in phase I as a potential HIV treatment [<xref rid="B855-marinedrugs-18-00657" ref-type="bibr">855</xref>].</p><p>Several chromodorid species contain spongiadiol (<bold>35</bold>) from the sponges they feed on, among other spongian diterpenes [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>,<xref rid="B536-marinedrugs-18-00657" ref-type="bibr">536</xref>]. This is the case of <italic>Chromodoris mandapamensis</italic> and <italic>Glossodoris cincta</italic> (<italic>G. atromarginata</italic>) specimens from different localities, which present these compounds in their mantle and digestive gland [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>,<xref rid="B536-marinedrugs-18-00657" ref-type="bibr">536</xref>]. Spongiadiol (<bold>35</bold>) is active against the herpes simplex virus, showing an IC<sub>50</sub> of 0.25 &#x003bc;g/mL against herpes simplex virus type I [<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>,<xref rid="B537-marinedrugs-18-00657" ref-type="bibr">537</xref>]. <italic>Chromodoris hamiltoni</italic> presents a wide arsenal of chemicals, among which the 2-thiazolidinone macrolides latrunculins A (<bold>38</bold>) and B (<bold>37</bold>) from its diet of sponges are found at different localities [<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>]. Latrunculin B (<bold>37</bold>) is also present in <italic>C. africana</italic> and <italic>C. quadricolor</italic> [<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>,<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]. Latrunculin B (<bold>37</bold>), a very active compound, as previously mentioned, was reported in the sponge <italic>Latrunculia magnifica</italic> [<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>]. The EC<sub>50</sub> of latrunculin B (<bold>37</bold>) against HIV-1 is 16.4 &#x003bc;M, thus showing a moderate activity while being non-cytotoxic [<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]. <italic>Doriprismatica (Glossodoris) atromarginata</italic> also presents furanoditerpenoids and scalarane sesterterpenes originating from its dietary sponges <italic>Spongia</italic> (<italic>Hyatella</italic>) sp. and <italic>Hyrtios</italic> spp., depending on the geographical location (Australia, Sri Lanka, and India) [<xref rid="B92-marinedrugs-18-00657" ref-type="bibr">92</xref>,<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B382-marinedrugs-18-00657" ref-type="bibr">382</xref>]. Some of these compounds are reported as antivirals, particularly spongiadiol (<bold>35</bold>) and <italic>epi</italic>-spongiadiol (<bold>232</bold>) [<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>,<xref rid="B384-marinedrugs-18-00657" ref-type="bibr">384</xref>,<xref rid="B385-marinedrugs-18-00657" ref-type="bibr">385</xref>,<xref rid="B386-marinedrugs-18-00657" ref-type="bibr">386</xref>,<xref rid="B519-marinedrugs-18-00657" ref-type="bibr">519</xref>,<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>,<xref rid="B539-marinedrugs-18-00657" ref-type="bibr">539</xref>]. Puupehenone (<bold>218</bold>) from <italic>Chromodoris petechialis</italic> is also active against HIV-1 [<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>].</p></sec></sec><sec id="sec3dot4dot2-marinedrugs-18-00657"><title>3.4.2. Anaspidea</title><p><italic>Dolabella auricularia</italic> presents some diet-derived cyclic depsipeptides reported to exhibit a wide range of activity against different stages of the HIV life cycle [<xref rid="B718-marinedrugs-18-00657" ref-type="bibr">718</xref>]. Dolastatin 3 (<bold>192</bold>) from <italic>D. auricularia</italic> was further isolated from the circumtropical cyanobacterium <italic>Lyngbya majuscula</italic> from Palau [<xref rid="B718-marinedrugs-18-00657" ref-type="bibr">718</xref>,<xref rid="B728-marinedrugs-18-00657" ref-type="bibr">728</xref>]. Dolastatin-3 (<bold>192</bold>) inhibits HIV-1 integrase at relatively high concentrations, with EC<sub>50</sub> of 5 mM for the terminal cleavage and 4.1 mM for the strand-transfer reactions [<xref rid="B728-marinedrugs-18-00657" ref-type="bibr">728</xref>]. The activity of dolastatin-3 (<bold>192</bold>) was lost after some time in the laboratory, since it was a difficult-to-handle molecule and also presented some cytotoxicity; therefore, it was not taken forward for further investigation [<xref rid="B728-marinedrugs-18-00657" ref-type="bibr">728</xref>]. </p></sec><sec id="sec3dot4dot3-marinedrugs-18-00657"><title>3.4.3. Sacoglossa </title><p>In this group, the previously mentioned depsipeptides kahalalides (<bold>194,354&#x02013;356,377</bold>) are found in <italic>Elysia rufescens</italic>, <italic>E. grandifolia</italic>, and <italic>E. ornata</italic>, as well as in the green algae <italic>Bryopsis pennata in</italic> their diet [<xref rid="B47-marinedrugs-18-00657" ref-type="bibr">47</xref>,<xref rid="B49-marinedrugs-18-00657" ref-type="bibr">49</xref>]. Among them, kahalalide F (<bold>194</bold>) is the most bioactive compound, although all kahalalides possess many activities as reported above. Kahalalide F (<bold>194</bold>) presents antiviral properties against herpes simplex virus II, while kahalalides A (<bold>377</bold>) and G (<bold>384</bold>) are inactive [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B796-marinedrugs-18-00657" ref-type="bibr">796</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>]. Kahalalide F (<bold>194</bold>) is found along with its isomer, <italic>iso</italic>-kahalalide F (<bold>354</bold>), both displaying a wide array of bioactivities and suggested to be of bacterial origin [<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B806-marinedrugs-18-00657" ref-type="bibr">806</xref>,<xref rid="B808-marinedrugs-18-00657" ref-type="bibr">808</xref>]. Kahalalide F (<bold>194</bold>) also exhibits moderate activity against HIV-1, with an EC<sub>50</sub> of 14.2 &#x003bc;M, while it is not cytotoxic against human peripheral blood mononuclear (PBM) cells [<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]. Kahalalides A (<bold>377</bold>) and G (<bold>384</bold>), contrastingly, are not active against HIV-1 [<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>].</p></sec></sec><sec id="sec3dot5-marinedrugs-18-00657"><title>3.5. Anti-Inflammatory Activity</title><p>Only a few nudibranchs and some sea hares are known to possess anti-inflammatory compounds, while there have been no studies to date regarding the remaining groups (<xref ref-type="fig" rid="marinedrugs-18-00657-f024">Figure 24</xref>, <xref rid="marinedrugs-18-00657-t014" ref-type="table">Table 14</xref>).</p><sec id="sec3dot5dot1-marinedrugs-18-00657"><title>3.5.1. Nudibranchia</title><sec><title>Doridacea</title><p>As reported above, several species of <italic>Glossodoris</italic> present scalaradial (<bold>44</bold>) and other scalarane compounds derived from the sponges they feed on [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>,<xref rid="B856-marinedrugs-18-00657" ref-type="bibr">856</xref>]. These include <italic>Glossodoris rufomarginata</italic>, <italic>G. pallida</italic>, <italic>G. vespa</italic>, <italic>G. averni</italic>, <italic>G. hikuerensis</italic>, <italic>G. atromarginata</italic>, and <italic>G. cincta</italic> from different geographical locations [<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>,<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>,<xref rid="B536-marinedrugs-18-00657" ref-type="bibr">536</xref>,<xref rid="B856-marinedrugs-18-00657" ref-type="bibr">856</xref>]. Scalaradial (<bold>44</bold>) is a potent anti-inflammatory compound [<xref rid="B856-marinedrugs-18-00657" ref-type="bibr">856</xref>], but it is also toxic to slugs, and, thus, after feeding, they quickly transform scalaradial (<bold>44</bold>) into its 12-deacetyl derivative or other related scalaranes in a detoxification process, locating them in MDFs in their mantle rims [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B4-marinedrugs-18-00657" ref-type="bibr">4</xref>,<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B177-marinedrugs-18-00657" ref-type="bibr">177</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>]. Scalaradial (<bold>44</bold>) was first found in the Mediterranean sponge <italic>Cacospongia mollior</italic> [<xref rid="B857-marinedrugs-18-00657" ref-type="bibr">857</xref>] and has been reported to display a potent inhibition of PLA<sub>2</sub> [<xref rid="B858-marinedrugs-18-00657" ref-type="bibr">858</xref>]. Similarly, <italic>Goniobranchus</italic> species usually present spongian cyclic diterpenes, which are often cytotoxic, as reported above, and obtained from their diet of <italic>Spongionella</italic> sponges [<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B190-marinedrugs-18-00657" ref-type="bibr">190</xref>,<xref rid="B533-marinedrugs-18-00657" ref-type="bibr">533</xref>]. Among these compounds, <italic>G. splendidus</italic> contains gracilins (<bold>224&#x02013;228</bold>), some of which have been tested from the sponge and possess a high anti-inflammatory potential, such as cyclosporine A mimics and as BACE1 and ERK inhibitors [<xref rid="B534-marinedrugs-18-00657" ref-type="bibr">534</xref>].</p></sec><sec><title>Dendronotida</title><p>The invasive species <italic>Melibe viridis</italic> presents a prostaglandin lactone in its mucus and cerata which had been previously reported in <italic>Tethys fimbria</italic> [<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>,<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>]. In fact, <italic>T. fimbria</italic>, presents a wide array of de novo biosynthesized prostaglandins (<bold>80,81</bold>) with different roles, which may include reducing inflammation in their tissues after autotomy and tissue regeneration [<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>]. </p><p>Moreover, punaglandins (<bold>250</bold>) from <italic>Tritonia</italic> sp. show anti-inflammatory activity, and a synthetic 10-thiomethyl derivative enhances in vivo mineralization in human osteoblasts [<xref rid="B587-marinedrugs-18-00657" ref-type="bibr">587</xref>].</p></sec></sec><sec id="sec3dot5dot2-marinedrugs-18-00657"><title>3.5.2. Anaspidea</title><p>Several species of sea hares have been studied to date for anti-inflammatory activity. <italic>Aplysia depilans</italic> presents 8 carotenoids and 22 polyunsaturated fatty acids obtained from their algal diet and found in the digestive gland which possess anti-inflammatory activity [<xref rid="B859-marinedrugs-18-00657" ref-type="bibr">859</xref>]. <italic>Aplysia dactylomela</italic> possesses dactyloditerpenol acetate (<bold>385</bold>); this is probably derived from laurenditerpenol from <italic>Laurencia intricata</italic>, which is reported to have a significant in vitro anti-neuroinflammatory activity [<xref rid="B860-marinedrugs-18-00657" ref-type="bibr">860</xref>,<xref rid="B861-marinedrugs-18-00657" ref-type="bibr">861</xref>].</p><p><italic>Bursatella leachii</italic> feeds on cyanobacteria and accumulates its natural products usually in its digestive gland, using them for its own defense as previously discussed [<xref rid="B311-marinedrugs-18-00657" ref-type="bibr">311</xref>,<xref rid="B312-marinedrugs-18-00657" ref-type="bibr">312</xref>,<xref rid="B783-marinedrugs-18-00657" ref-type="bibr">783</xref>,<xref rid="B784-marinedrugs-18-00657" ref-type="bibr">784</xref>]. Among these compounds, the alkaloid malyngamide S (<bold>350</bold>) from New Zealand specimens presents anti-inflammatory properties [<xref rid="B786-marinedrugs-18-00657" ref-type="bibr">786</xref>].</p></sec></sec><sec id="sec3dot6-marinedrugs-18-00657"><title>3.6. Against Neurodegenerative Diseases</title><p>Activity against neurodegenerative diseases has been described for several marine natural compounds [<xref rid="B862-marinedrugs-18-00657" ref-type="bibr">862</xref>]. In heterobranch molluscs, compounds from several species have been tested, providing some interesting results (<xref ref-type="fig" rid="marinedrugs-18-00657-f024">Figure 24</xref>, <xref rid="marinedrugs-18-00657-t015" ref-type="table">Table 15</xref>). The doridacean nudibranch <italic>Polycera atra</italic> feeds on the bryozoan <italic>Bugula neritina,</italic> accumulating the polyketide macrolides bryostatins (<bold>203</bold>) and transferring them to its spawn, as mentioned above [<xref rid="B492-marinedrugs-18-00657" ref-type="bibr">492</xref>,<xref rid="B493-marinedrugs-18-00657" ref-type="bibr">493</xref>,<xref rid="B494-marinedrugs-18-00657" ref-type="bibr">494</xref>]. Bryostatins (<bold>203</bold>) have been further traced to the symbiont Candidatus <italic>Endobugula sertula</italic>, where the biosynthetic genes have been described [<xref rid="B495-marinedrugs-18-00657" ref-type="bibr">495</xref>]. Among them, bryostatin 1 (<bold>203</bold>) is the most studied molecule as a potential treatment for many diseases, including cancer and Alzheimer disease (AD), and it is in phase I trials for AD [<xref rid="B495-marinedrugs-18-00657" ref-type="bibr">495</xref>,<xref rid="B497-marinedrugs-18-00657" ref-type="bibr">497</xref>].</p><p>The doridacean nudibranchs <italic>Goniobranchus obsoletus</italic> and <italic>G. splendidus</italic> from Australia possess many cyclic diterpenes of the spongian type, including gracilins (<bold>224&#x02013;228</bold>) which are accumulated from feeding on <italic>Spongiella</italic> sponges [<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>,<xref rid="B190-marinedrugs-18-00657" ref-type="bibr">190</xref>,<xref rid="B533-marinedrugs-18-00657" ref-type="bibr">533</xref>]. Gracilins (<bold>224&#x02013;228</bold>), as previously mentioned, possess several interesting properties as drug candidates and also show a potential role against neurodegenerative diseases, such as AD, which is also being tested [<xref rid="B534-marinedrugs-18-00657" ref-type="bibr">534</xref>,<xref rid="B863-marinedrugs-18-00657" ref-type="bibr">863</xref>].</p><p>The chromodoridid <italic>Cadlina luteomarginata</italic> obtains ansellone A (<bold>216</bold>) from its diet of the sponge <italic>Phorbas</italic> sp. [<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>]. Ansellone A (<bold>216</bold>) shows cAMP activation (EC<sub>50</sub> = 14 mM) comparable to that of forskolin in the HEK293 cell-based assay [<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>]. This activity is very useful in stem cell techniques, because modulating the cAMP signaling pathway is crucial for treating many diseases, such as cancer and heart failure, as well as neurodegenerative diseases [<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>].</p><p>In cephalaspideans, the cylichnidae <italic>Scaphander lignarius</italic> lives in soft bottom, muddy areas, usually feeding on foraminiferans [<xref rid="B229-marinedrugs-18-00657" ref-type="bibr">229</xref>,<xref rid="B231-marinedrugs-18-00657" ref-type="bibr">231</xref>]. As previously mentioned, <italic>S. lignarius</italic> specimens from the Mediterranean and East Atlantic present the so-called lignarenones (<bold>171</bold>), which are de novo biosynthesized and secreted in the Blochmann&#x02019;s gland [<xref rid="B245-marinedrugs-18-00657" ref-type="bibr">245</xref>]. These compounds are suggested to be used as alarm pheromones, similarly to other cephalaspidean species mentioned above. Interestingly, recent studies suggest that lignarenone B (<bold>171</bold>) could also be used as a possible therapeutic candidate for the treatment of GSK3&#x003b2;-involved pathologies, such as AD [<xref rid="B864-marinedrugs-18-00657" ref-type="bibr">864</xref>]. In silico binding studies revealed that lignarenone B (<bold>171</bold>) can act over the ATP and/or substrate binding regions of GSK3&#x003b2; [<xref rid="B864-marinedrugs-18-00657" ref-type="bibr">864</xref>]. The predicted inhibitory potential of lignarenone B (<bold>171</bold>) was experimentally validated by an in vitro assay showing a ~50% increase in Ser9 phosphorylation levels of GSK3&#x003b2;, while it also potentiates structural neuronal plasticity in vitro using neuronal primary cultures [<xref rid="B865-marinedrugs-18-00657" ref-type="bibr">865</xref>]. Future studies are aimed to test lignarenones in preclinical mouse models of AD.</p></sec><sec id="sec3dot7-marinedrugs-18-00657"><title>3.7. Other Pharmacological Activities</title><p>Other activities that were not included in the previous sections comprise those of a couple of nudibranch species and a pleurobranchoidea (<xref ref-type="fig" rid="marinedrugs-18-00657-f024">Figure 24</xref>, <xref rid="marinedrugs-18-00657-t016" ref-type="table">Table 16</xref>). No other activities have been described in the remaining groups.</p><p>Janolusimide (<bold>138</bold>) is a tripeptide described in the Mediterranean euarminid nudibranch <italic>Janolus cristatus</italic> [<xref rid="B388-marinedrugs-18-00657" ref-type="bibr">388</xref>]. Janolusimide (<bold>138</bold>) is toxic to mice (LD 5 mg/kg) and affects acetylcholine receptors, thus having a neurotoxic action at lower concentrations [<xref rid="B388-marinedrugs-18-00657" ref-type="bibr">388</xref>]. A N-methyl analogue, janolusimide B, was further described in the New Zealand bryozoan <italic>Bugula flabellata</italic> [<xref rid="B390-marinedrugs-18-00657" ref-type="bibr">390</xref>], suggesting a dietary origin for janolusimide (<bold>138</bold>), since <italic>J. cristatus</italic> has been reported to feed on bryozoans, including <italic>B. flabellata</italic> [<xref rid="B390-marinedrugs-18-00657" ref-type="bibr">390</xref>].</p><p>The pleurobranchoid genus <italic>Pleurobranchaea</italic> is often used as a model for neurobiology investigations because of its peculiar escape swimming behavior, which is achieved by alternating dorsal and ventral body flexions [<xref rid="B868-marinedrugs-18-00657" ref-type="bibr">868</xref>]. Furthermore, it is also interesting because <italic>P. maculata</italic> from New Zealand possesses tetrodotoxin (TTX) (<bold>387</bold>). TTX (<bold>387</bold>) is found in its adult tissues, gonads, and egg masses, thus suggesting a defensive role [<xref rid="B869-marinedrugs-18-00657" ref-type="bibr">869</xref>,<xref rid="B870-marinedrugs-18-00657" ref-type="bibr">870</xref>]. TTX (<bold>387</bold>) is a very potent neurotoxin that inhibits action potential in nerve cells, and it has been found in many poisonous animals, such as flatworms, arrow worms, ribbon worms, snails, blue-ringed octopus, xanthid crabs, sea stars, fish, and toads [<xref rid="B871-marinedrugs-18-00657" ref-type="bibr">871</xref>,<xref rid="B872-marinedrugs-18-00657" ref-type="bibr">872</xref>]. In some of these cases, it has been demonstrated that TTX (<bold>387</bold>) is produced by symbiotic bacteria from the <italic>Pseudoalteromonas</italic>, <italic>Pseudomonas</italic>, <italic>Vibrio</italic>, and other strains, and that it is bioaccumulated along the food chain. However, the bacterial origin of TTX (<bold>387</bold>) has not been proved in all cases [<xref rid="B871-marinedrugs-18-00657" ref-type="bibr">871</xref>,<xref rid="B872-marinedrugs-18-00657" ref-type="bibr">872</xref>].</p></sec></sec><sec id="sec4-marinedrugs-18-00657"><title>4. Concluding Remarks</title><p>Despite the fact that only a small proportion of heterobranch molluscs has been reported to date, they represent a particularly rich group of natural products. Their NPs display an astonishing variation in bioactivity, both ecological and pharmacological, reflecting the huge chemodiversity they possess (<xref ref-type="fig" rid="marinedrugs-18-00657-f025">Figure 25</xref>). Biodiversity and chemodiversity correlate here to offer a huge amount of bioactive molecules in these peculiar group of molluscs. Heterobranchs indeed comprise a very diverse group of organisms that present almost all classes of natural products described to date, but not all of these NPs have been tested for potential bioactivities [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B28-marinedrugs-18-00657" ref-type="bibr">28</xref>]. Thus, many more studies are expected to find not only new NPs but also their potential bioactivities. </p><p>Regarding ecological activity, in fact, very few compounds from the total NPs described have been tested, as described above, and this keeps the door open for many other ecological interactions to be identified in the future. NPs from heterobranchs have been shown to be ecologically relevant, as in the case of those from other marine organisms, although many experiments should still be performed to complete the available information. Some molecules are shown to display multiple roles, as is the case in other marine invertebrates, while similar structures are shown to display similar roles in geographically distant localities by phylogenetically related species [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. The most studied activity is feeding deterrence, followed by toxicity (<xref ref-type="fig" rid="marinedrugs-18-00657-f025">Figure 25</xref>), although the NPs are not usually tested against sympatric species, raising doubts about their real effects in the habitat where the molluscs live. Reliable field data are scarce, and, therefore, the ecological significance of many compounds remains to be demonstrated. </p><p>The pharmacological activity of heterobranch NPs is still underexplored because we are only aware of a small part of their chemical arsenal. However, their potential is obvious from the molecules reported above, which are proven to be of interest in many fields, with some compounds being promising drugs, such as dolastatins, ulapualides, kabiramides, latrunculins, doliculides, and others. Further research is needed to develop these compounds. Overall, the most studied activities are cytotoxicity and anticancer activity, followed by antibiotic activity (<xref ref-type="fig" rid="marinedrugs-18-00657-f025">Figure 25</xref>).</p><p>In this review, we discussed more than 450 metabolites isolated from ca. 400 species of heterobranch molluscs. Heterobranch molluscs are thus an important source of bioactive NPs, even if not all of them are produced by the molluscs themselves. John Faulkner once said that in order to find the most bioactive compounds in an ecosystem, heterobranchs would be the best shot to find them, because they have already selected them along evolution. This continues to appear to be true. While symbionts may be behind some of the NP syntheses, heterobranchs have evolved to use them for their own benefit [<xref rid="B1-marinedrugs-18-00657" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. In some cases, dietary cyanobacteria or other bacteria have been proven to be the source of compounds, but, in general, origin from symbionts remains difficult to prove [<xref rid="B481-marinedrugs-18-00657" ref-type="bibr">481</xref>]. In any case, if NPs can be traced to a microorganism, this may help to solve the supply problems for many of the bioactive NPs, either by culturing, by isolating the BGCs (biosynthetic gene clusters), or by using other metagenomic techniques [<xref rid="B873-marinedrugs-18-00657" ref-type="bibr">873</xref>,<xref rid="B874-marinedrugs-18-00657" ref-type="bibr">874</xref>]. Culturing the molluscs is a difficult-but-not-impossible task, which could also be useful for some heterobranch species. Moreover, possible strategies to improve MNP selection include many dereplication strategies described in the literature, in addition to the many chemical techniques used to obtain derivatives, as well as synthesis methods [<xref rid="B44-marinedrugs-18-00657" ref-type="bibr">44</xref>,<xref rid="B761-marinedrugs-18-00657" ref-type="bibr">761</xref>,<xref rid="B875-marinedrugs-18-00657" ref-type="bibr">875</xref>]. Furthermore, virtual screening, computational chemistry, as well as more studies on molecular targets are needed to overcome the limitations of studying MNPs. The use of nanotechnology to deliver drugs is also a promising field that requires further investigation; ADCs, for instance, show considerable potential [<xref rid="B481-marinedrugs-18-00657" ref-type="bibr">481</xref>]. As an example, kahalalide F (<bold>194</bold>) conjugated to 40 nm gold nanoparticles resulted in higher cell growth inhibition in HeLa cervical carcinoma cells than the compound alone [<xref rid="B481-marinedrugs-18-00657" ref-type="bibr">481</xref>,<xref rid="B876-marinedrugs-18-00657" ref-type="bibr">876</xref>]. Further research should also be devoted to this field. Overall, we have seen that heterobranch molluscs are extremely interesting in regard to the study of marine natural products in terms of both chemical ecology and biotechnology studies, providing many leads for further detailed research in these fields in the near future.</p></sec></body><back><ack><title>Acknowledgments</title><p>This is an AntECO (SCAR) contribution.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization and design C.A.; literature review, investigation, and data curation C.A. and C.A.-P.; writing&#x02014;original draft preparation, review and editing, C.A. and C.A.-P.; funding acquisition, C.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>Support for this work was provided by BLUEBIO grant to C.A. (CTM2016-78901/ANT) and the Ramon Areces Foundation to C.A.-P.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">AD</td><td align="left" valign="middle" rowspan="1" colspan="1">Alzheimer Disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADCs</td><td align="left" valign="middle" rowspan="1" colspan="1">Antibody-drug conjugates</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADMET</td><td align="left" valign="middle" rowspan="1" colspan="1">Absortion, Distribution, Metabolism, Excretion, and Toxicity</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADR</td><td align="left" valign="middle" rowspan="1" colspan="1">Adriamycin resistant</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BGCs</td><td align="left" valign="middle" rowspan="1" colspan="1">Biosynthetic Gene Clusters</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">cAMP</td><td align="left" valign="middle" rowspan="1" colspan="1">Cyclic Adenosine Monophosphate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Half maximal Effective Concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ED<sub>50</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Half effective dose</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EGF</td><td align="left" valign="middle" rowspan="1" colspan="1">Epidermal Groth Factor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EGFR</td><td align="left" valign="middle" rowspan="1" colspan="1">Epidermal Groth Factor Receptor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ERK</td><td align="left" valign="middle" rowspan="1" colspan="1">Extracellular signal-regulated kinases</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FDA</td><td align="left" valign="middle" rowspan="1" colspan="1">Food and Drugs Administration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GI<sub>50</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Maximal inhibition of cell proliferation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCCLs</td><td align="left" valign="middle" rowspan="1" colspan="1">Human Colon Cancer Cell Lines</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HEL</td><td align="left" valign="middle" rowspan="1" colspan="1">Human Erythroleukemia cells</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HeLa</td><td align="left" valign="middle" rowspan="1" colspan="1">Henrietta_Lacks cell line from cervical cancer cells</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HIF-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Hypoxia Inducible Factor 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HTCLs</td><td align="left" valign="middle" rowspan="1" colspan="1">Human Tumor Cell Lines</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KB</td><td align="left" valign="middle" rowspan="1" colspan="1">Subline of the KERATIN-forming tumor cell line HeLa</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Half minimal Inhibitory Concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LD</td><td align="left" valign="middle" rowspan="1" colspan="1">Lethal Dose</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LRA</td><td align="left" valign="middle" rowspan="1" colspan="1">Latency Reversal Agent</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAAs</td><td align="left" valign="middle" rowspan="1" colspan="1">Mycosporine-like Amino Acids</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAPK</td><td align="left" valign="middle" rowspan="1" colspan="1">Mitogen-Activated Protein Kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDA</td><td align="left" valign="middle" rowspan="1" colspan="1">Microtubule-Desestabilizing Agent</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDFs</td><td align="left" valign="middle" rowspan="1" colspan="1">Mantle Dermal Formations</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDR</td><td align="left" valign="middle" rowspan="1" colspan="1">Multidrug resistant variant</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MIC</td><td align="left" valign="middle" rowspan="1" colspan="1">Minimum Inhibitory Concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MNPs</td><td align="left" valign="middle" rowspan="1" colspan="1">Marine Natural Products</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MTT</td><td align="left" valign="middle" rowspan="1" colspan="1">Dimethyl Thiazolyl Diphenyl Tetrazolium Bromide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NCI</td><td align="left" valign="middle" rowspan="1" colspan="1">National Cancer Institute</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NPs</td><td align="left" valign="middle" rowspan="1" colspan="1">Natural Products</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NSCLC</td><td align="left" valign="middle" rowspan="1" colspan="1">Nonsmall Cell Lung Cancer</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PBM</td><td align="left" valign="middle" rowspan="1" colspan="1">Peripheral Blood Mononuclear</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PG</td><td align="left" valign="middle" rowspan="1" colspan="1">Prostaglandins</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PKC</td><td align="left" valign="middle" rowspan="1" colspan="1">Protein Kinase C</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PSMA-ADC</td><td align="left" valign="middle" rowspan="1" colspan="1">Prostate-specific membrane antigen antibody&#x02013;drug conjugate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PTPRK</td><td align="left" valign="middle" rowspan="1" colspan="1">Protein Tyrosine Phosphatase Receptor type K</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TRAIL</td><td align="left" valign="middle" rowspan="1" colspan="1">Tumor necrosis factor-related apoptosis-inducing ligand</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TTX</td><td align="left" valign="middle" rowspan="1" colspan="1">Tetrodotoxin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">UVR</td><td align="left" valign="middle" rowspan="1" colspan="1">Ultra-Violet Radiation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Vincristine resistant</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-marinedrugs-18-00657"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez-Pons</surname><given-names>L.</given-names></name><name><surname>Moles</surname><given-names>J.</given-names></name></person-group><article-title>From the tropics to the poles: Chemical defensive strategies in sea slugs (Mollusca: Heterobranchia)</article-title><source>Chemical Ecology: The Ecological Impacts of Marine Natural Products</source><person-group person-group-type="editor"><name><surname>Puglisi</surname><given-names>M.P.</given-names></name><name><surname>Becerro</surname><given-names>M.A.</given-names></name></person-group><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><publisher-name>Taylor and Francis</publisher-name><publisher-loc>Abingdon, UK</publisher-loc><year>2018</year></element-citation></ref><ref id="B2-marinedrugs-18-00657"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Natural products of opisthobranch molluscs: A biological review</article-title><source>Oceanogr. Mar. Biol. Annu. Rev.</source><year>1995</year><volume>33</volume><fpage>487</fpage><lpage>559</lpage></element-citation></ref><ref id="B3-marinedrugs-18-00657"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>A preliminary catalogue of natural substances of opistobranch molluscs from Western Mediterranean and near Atlantic</article-title><source>Sci. Mar.</source><year>1992</year><volume>56</volume><fpage>373</fpage><lpage>382</lpage></element-citation></ref><ref id="B4-marinedrugs-18-00657"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Terpenoids in Marine Heterobranch Molluscs</article-title><source>Mar. Drugs</source><year>2020</year><volume>8</volume><elocation-id>162</elocation-id><pub-id pub-id-type="doi">10.3390/md18030162</pub-id><?supplied-pmid 32183298?><pub-id pub-id-type="pmid">32183298</pub-id></element-citation></ref><ref id="B5-marinedrugs-18-00657"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Carroll</surname><given-names>A.R.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2018</year><volume>35</volume><fpage>8</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1039/C7NP00052A</pub-id><pub-id pub-id-type="pmid">29335692</pub-id></element-citation></ref><ref id="B6-marinedrugs-18-00657"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>A.R.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2020</year><volume>37</volume><fpage>175</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1039/C9NP00069K</pub-id><pub-id pub-id-type="pmid">32025684</pub-id></element-citation></ref><ref id="B7-marinedrugs-18-00657"><label>7.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Puglisi</surname><given-names>M.P.</given-names></name><name><surname>Becerro</surname><given-names>M.A.</given-names></name></person-group><source>Chemical Ecology: The Ecological Impacts of Marine Natural Products</source><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><publisher-name>Taylor and Francis</publisher-name><publisher-loc>Abingdon, UK</publisher-loc><year>2018</year></element-citation></ref><ref id="B8-marinedrugs-18-00657"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>P.J.</given-names></name></person-group><source>Marine Chemical Ecology</source><publisher-name>CRC Marine Science Series Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2001</year></element-citation></ref><ref id="B9-marinedrugs-18-00657"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ianora</surname><given-names>A.</given-names></name><name><surname>Boersma</surname><given-names>M.</given-names></name><name><surname>Casotti</surname><given-names>R.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Harder</surname><given-names>J.</given-names></name><name><surname>Hoffmann</surname><given-names>F.</given-names></name><name><surname>Pavia</surname><given-names>H.</given-names></name><name><surname>Potin</surname><given-names>P.</given-names></name><name><surname>Poulet</surname><given-names>S.A.</given-names></name><name><surname>Toth</surname><given-names>G.</given-names></name></person-group><article-title>New trends in marine chemical ecology</article-title><source>Estuar. Coasts</source><year>2006</year><volume>29</volume><fpage>531</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1007/BF02784281</pub-id></element-citation></ref><ref id="B10-marinedrugs-18-00657"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puglisi</surname><given-names>M.P.</given-names></name><name><surname>Sneed</surname><given-names>J.M.</given-names></name><name><surname>Sharp</surname><given-names>K.H.</given-names></name><name><surname>Ritson-Williams</surname><given-names>R.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Marine chemical ecology in benthic environments</article-title><source>Nat. Prod. Rep.</source><year>2014</year><volume>31</volume><fpage>1510</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1039/C4NP00017J</pub-id><pub-id pub-id-type="pmid">25070776</pub-id></element-citation></ref><ref id="B11-marinedrugs-18-00657"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.-L.</given-names></name><name><surname>Zhao</surname><given-names>F.-C.</given-names></name></person-group><article-title>Secondary metabolites from polar organisms</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.3390/md15030028</pub-id></element-citation></ref><ref id="B12-marinedrugs-18-00657"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><source>Progress in Molecular and Subcellular Biology</source><comment>Subseries Marine Molecular Biotechnology</comment><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume></element-citation></ref><ref id="B13-marinedrugs-18-00657"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkendorff</surname><given-names>K.</given-names></name></person-group><article-title>Molluscan biological and chemical diversity: Secondary metabolites and medicinal resources produced by marine molluscs</article-title><source>Biol. Rev.</source><year>2010</year><volume>85</volume><fpage>757</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1111/j.1469-185X.2010.00124.x</pub-id><pub-id pub-id-type="pmid">20105155</pub-id></element-citation></ref><ref id="B14-marinedrugs-18-00657"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandyuk</surname><given-names>R.P.</given-names></name></person-group><article-title>Sterols and their functional role in Mollusks (a review)</article-title><source>Hydrobiol. J.</source><year>2006</year><volume>42</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1615/HydrobJ.v42.i3.50</pub-id></element-citation></ref><ref id="B15-marinedrugs-18-00657"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garson</surname><given-names>M.</given-names></name></person-group><article-title>Marine natural products as antifeedants</article-title><source>Comprehensive Natural Products II. Chemistry and Biology</source><person-group person-group-type="editor"><name><surname>Mander</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>H.W.</given-names></name></person-group><publisher-name>Elsevier Science</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2010</year><fpage>503</fpage><lpage>537</lpage></element-citation></ref><ref id="B16-marinedrugs-18-00657"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name></person-group><article-title>Marine natural products chemistry as an evolutionary narrative</article-title><source>Marine Chemical Ecology</source><person-group person-group-type="editor"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>P.J.</given-names></name></person-group><publisher-name>CRC Marine Science Series Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2001</year><fpage>115</fpage><lpage>154</lpage></element-citation></ref><ref id="B17-marinedrugs-18-00657"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Amsler</surname><given-names>C.D.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Overview of the chemical ecology of benthic marine invertebrates along the Western Antarctic peninsula</article-title><source>Integr. Comp. Biol.</source><year>2010</year><volume>50</volume><fpage>967</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1093/icb/icq035</pub-id><?supplied-pmid 21558253?><pub-id pub-id-type="pmid">21558253</pub-id></element-citation></ref><ref id="B18-marinedrugs-18-00657"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000fa;&#x000f1;ez-Pons</surname><given-names>L.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Natural products mediating ecological interactions in Antarctic benthic communities: A mini-review of the known molecules</article-title><source>Nat. Prod. Rep.</source><year>2015</year><volume>32</volume><fpage>1114</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1039/C4NP00150H</pub-id><?supplied-pmid 25693047?><pub-id pub-id-type="pmid">25693047</pub-id></element-citation></ref><ref id="B19-marinedrugs-18-00657"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name></person-group><article-title>Chemical defense and the evolution of opisthobranch gastropods</article-title><source>Proc. Calif. Acad. Sci.</source><year>2009</year><volume>60</volume><fpage>175</fpage><lpage>422</lpage></element-citation></ref><ref id="B20-marinedrugs-18-00657"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Marine mollusks from Australia and New Zealand: Chemical and ecological studies</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>159</fpage><lpage>174</lpage></element-citation></ref><ref id="B21-marinedrugs-18-00657"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name></person-group><article-title>Secondary metabolites from the marine gastropod molluscs of Antarctica, Southern Africa and South America</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>133</fpage><lpage>157</lpage></element-citation></ref><ref id="B22-marinedrugs-18-00657"><label>22.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wahidulla</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Fakhr</surname><given-names>I.M.I.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name></person-group><article-title>Chemical diversity in opisthobranch molluscs from scarcely investigated Indo-Pacific areas</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>175</fpage><lpage>198</lpage></element-citation></ref><ref id="B23-marinedrugs-18-00657"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name></person-group><article-title>Selected bioactive compounds from Japanese anaspideans and nudibranchs</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>199</fpage><lpage>214</lpage></element-citation></ref><ref id="B24-marinedrugs-18-00657"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.R.</given-names></name><name><surname>He</surname><given-names>W.F.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Chemistry, chemoecology, and bioactivity of the South China Sea opisthobranch molluscs and their dietary organisms</article-title><source>J. Asian Nat. Prod. Res.</source><year>2013</year><volume>15</volume><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1080/10286020.2012.746960</pub-id><?supplied-pmid 23323746?><pub-id pub-id-type="pmid">23323746</pub-id></element-citation></ref><ref id="B25-marinedrugs-18-00657"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Desjardine</surname><given-names>K.</given-names></name><name><surname>Woods</surname><given-names>K.</given-names></name></person-group><article-title>Skin chemistry of nudibranchs from the West Coast of North America</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>277</fpage><lpage>301</lpage></element-citation></ref><ref id="B26-marinedrugs-18-00657"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>H.</given-names></name><name><surname>Sakai</surname><given-names>R.</given-names></name><name><surname>Jimbo</surname><given-names>M.</given-names></name></person-group><article-title>Bioactive molecules from sea hares</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>215</fpage><lpage>239</lpage></element-citation></ref><ref id="B27-marinedrugs-18-00657"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Darias</surname><given-names>J.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>D&#x000ed;az-Marrero</surname><given-names>A.R.</given-names></name></person-group><article-title>The chemistry of marine pulmonate gastropods</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>105</fpage><lpage>131</lpage></element-citation></ref><ref id="B28-marinedrugs-18-00657"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>L.J.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name></person-group><article-title>The chemistry and chemical ecology of nudibranchs</article-title><source>Nat. Prod. Rep.</source><year>2017</year><volume>34</volume><fpage>1359</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1039/C7NP00041C</pub-id><?supplied-pmid 29135002?><pub-id pub-id-type="pmid">29135002</pub-id></element-citation></ref><ref id="B29-marinedrugs-18-00657"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Taboada</surname><given-names>S.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez-Pons</surname><given-names>L.</given-names></name></person-group><article-title>Antarctic marine chemical ecology: What is next?</article-title><source>Mar. Ecol.</source><year>2008</year><volume>29</volume><fpage>1</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1111/j.1439-0485.2007.00215.x</pub-id></element-citation></ref><ref id="B30-marinedrugs-18-00657"><label>30.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><source>Ecological Roles of Marine Natural Products</source><publisher-name>Comstock Publishications Association</publisher-name><publisher-loc>Ithaka, NY, USA</publisher-loc><year>1992</year></element-citation></ref><ref id="B31-marinedrugs-18-00657"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Torres</surname><given-names>V.</given-names></name><name><surname>Encinar</surname><given-names>J.A.</given-names></name><name><surname>Herranz-L&#x000f3;pez</surname><given-names>M.</given-names></name><name><surname>P&#x000e9;rez-S&#x000e1;nchez</surname><given-names>A.</given-names></name><name><surname>Galiano</surname><given-names>V.</given-names></name><name><surname>Barraj&#x000f3;n-Catal&#x000e1;n</surname><given-names>E.</given-names></name><name><surname>Micol</surname><given-names>V.</given-names></name></person-group><article-title>An updated review on marine anticancer compounds: The use of virtual screening for the discovery of small-molecule cancer drugs</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1037</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22071037</pub-id></element-citation></ref><ref id="B32-marinedrugs-18-00657"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Marine natural products and related compounds in clinical and advanced preclinical trials</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1216</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1021/np040031y</pub-id><pub-id pub-id-type="pmid">15332835</pub-id></element-citation></ref><ref id="B33-marinedrugs-18-00657"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><source>Marine Biomedicine: From Beach to Bedside</source><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><publisher-name>Taylor and Francis</publisher-name><publisher-loc>Abingdon, UK</publisher-loc><year>2015</year></element-citation></ref><ref id="B34-marinedrugs-18-00657"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haefner</surname><given-names>B.</given-names></name></person-group><article-title>Drugs from the deep: Marine natural products as drug candidates</article-title><source>Drug Discov. Today</source><year>2003</year><volume>8</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/S1359-6446(03)02713-2</pub-id><pub-id pub-id-type="pmid">12821301</pub-id></element-citation></ref><ref id="B35-marinedrugs-18-00657"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clardy</surname><given-names>J.</given-names></name><name><surname>Walsh</surname><given-names>C.</given-names></name></person-group><article-title>Lessons from natural molecules</article-title><source>Nature</source><year>2004</year><volume>432</volume><fpage>829</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nature03194</pub-id><pub-id pub-id-type="pmid">15602548</pub-id></element-citation></ref><ref id="B36-marinedrugs-18-00657"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Dalisay</surname><given-names>D.S.</given-names></name><name><surname>Lievens</surname><given-names>S.L.</given-names></name><name><surname>Saludes</surname><given-names>J.P.</given-names></name></person-group><article-title>Drug development from marine natural products</article-title><source>Nature Rev. Drug Discov.</source><year>2009</year><volume>8</volume><fpage>69</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/nrd2487</pub-id><?supplied-pmid 19096380?><pub-id pub-id-type="pmid">19096380</pub-id></element-citation></ref><ref id="B37-marinedrugs-18-00657"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Grothaus</surname><given-names>P.G.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>New horizons for old drugs and drug leads</article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>703</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1021/np5000796</pub-id><?supplied-pmid 24499205?><pub-id pub-id-type="pmid">24499205</pub-id></element-citation></ref><ref id="B38-marinedrugs-18-00657"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudit</surname><given-names>M.</given-names></name><name><surname>El Sayed</surname><given-names>K.A.</given-names></name></person-group><article-title>Cancer control potential of marine natural product scaffolds through inhibition of tumor cell migration and invasion</article-title><source>Drug Discov. Today</source><year>2016</year><volume>21</volume><fpage>1745</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2016.06.032</pub-id><?supplied-pmid 27394962?><pub-id pub-id-type="pmid">27394962</pub-id></element-citation></ref><ref id="B39-marinedrugs-18-00657"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs over the 30 years from 1981 to 2010</article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>311</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1021/np200906s</pub-id><pub-id pub-id-type="pmid">22316239</pub-id></element-citation></ref><ref id="B40-marinedrugs-18-00657"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs from 1981 to 2014</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><?supplied-pmid 26852623?><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="B41-marinedrugs-18-00657"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>J.</given-names></name></person-group><article-title>Drug Addiction: From Basic Research to Therapy</article-title><source>Drug Alcohol. Rev.</source><year>2009</year><volume>28</volume><fpage>455</fpage><pub-id pub-id-type="doi">10.1111/j.1465-3362.2009.00088_1.x</pub-id></element-citation></ref><ref id="B42-marinedrugs-18-00657"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalifa</surname><given-names>S.A.</given-names></name><name><surname>Elias</surname><given-names>N.</given-names></name><name><surname>Farag</surname><given-names>M.A.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Saeed</surname><given-names>A.</given-names></name><name><surname>Hegazy</surname><given-names>M.E.</given-names></name><name><surname>Moustafa</surname><given-names>M.S.</given-names></name><name><surname>El-Wahed</surname><given-names>A.</given-names></name><name><surname>Al-Mousawi</surname><given-names>S.M.</given-names></name><name><surname>Musharraf</surname><given-names>S.G.</given-names></name><etal/></person-group><article-title>Marine natural products: A source of novel anticancer drugs</article-title><source>Mar. Drugs</source><year>2019</year><volume>17</volume><elocation-id>491</elocation-id><pub-id pub-id-type="doi">10.3390/md17090491</pub-id></element-citation></ref><ref id="B43-marinedrugs-18-00657"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>255</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.3390/md12010255</pub-id><pub-id pub-id-type="pmid">24424355</pub-id></element-citation></ref><ref id="B44-marinedrugs-18-00657"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Terpenoids from marine organisms: Unique structures and their pharmacological potential</article-title><source>Phytochem. Rev.</source><year>2006</year><volume>5</volume><fpage>115</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1007/s11101-005-5464-3</pub-id></element-citation></ref><ref id="B45-marinedrugs-18-00657"><label>45.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Faircloth</surname><given-names>G.</given-names></name><name><surname>Cuevas</surname><given-names>M.C.</given-names></name></person-group><article-title>Kahalalide F and ES285: Potent anticancer agents from marine molluscs</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>363</fpage><lpage>379</lpage></element-citation></ref><ref id="B46-marinedrugs-18-00657"><label>46.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Kita</surname><given-names>M.</given-names></name></person-group><article-title>Antitumor effects of sea hare-derived compounds in cancer</article-title><source>Handbook of Anticancer Drugs from Marine Origin</source><person-group person-group-type="editor"><name><surname>Kim</surname><given-names>S.K.</given-names></name></person-group><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2015</year><fpage>701</fpage><lpage>739</lpage></element-citation></ref><ref id="B47-marinedrugs-18-00657"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;dl</surname><given-names>M.</given-names></name><name><surname>J&#x000f6;rger</surname><given-names>K.M.</given-names></name><name><surname>Klussmann-Kolb</surname><given-names>A.</given-names></name><name><surname>Wilson</surname><given-names>N.G.</given-names></name></person-group><article-title>Bye bye &#x02018;Opisthobranchia&#x02019;! A review on the contribution of mesopsammic sea slugs to euthyneuran systematics</article-title><source>Thalassas</source><year>2011</year><volume>27</volume><fpage>101</fpage><lpage>112</lpage></element-citation></ref><ref id="B48-marinedrugs-18-00657"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>M.</given-names></name><name><surname>Lal</surname><given-names>S.</given-names></name><name><surname>Vall&#x000e8;s</surname><given-names>Y.</given-names></name><name><surname>Takaoka</surname><given-names>T.L.</given-names></name><name><surname>Dayrat</surname><given-names>B.A.</given-names></name><name><surname>Boore</surname><given-names>J.L.</given-names></name><name><surname>Gosliner</surname><given-names>T.</given-names></name></person-group><article-title>Crawling through time: Transition of snails to slugs dating back to the Paleozoic, based on mitochondrial phylogenomics</article-title><source>Mar. Genom.</source><year>2011</year><volume>4</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.margen.2010.12.006</pub-id><?supplied-pmid 21429465?><pub-id pub-id-type="pmid">21429465</pub-id></element-citation></ref><ref id="B49-marinedrugs-18-00657"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>Klussmann-Kolb</surname><given-names>A.</given-names></name><name><surname>Verbeek</surname><given-names>E.</given-names></name><name><surname>Schr&#x000f6;dl</surname><given-names>M.</given-names></name></person-group><article-title>Flashback and foreshadowing; a review of the taxon Opisthobranchia</article-title><source>Org. Div. Evol.</source><year>2014</year><volume>14</volume><fpage>133</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1007/s13127-013-0151-5</pub-id></element-citation></ref><ref id="B50-marinedrugs-18-00657"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapata</surname><given-names>F.</given-names></name><name><surname>Wilson</surname><given-names>N.G.</given-names></name><name><surname>Howison</surname><given-names>M.</given-names></name><name><surname>Andrade</surname><given-names>S.C.</given-names></name><name><surname>J&#x000f6;rger</surname><given-names>K.M.</given-names></name><name><surname>Schr&#x000f6;dl</surname><given-names>M.</given-names></name><name><surname>Goetz</surname><given-names>F.E.</given-names></name><name><surname>Giribet</surname><given-names>G.</given-names></name><name><surname>Dunn</surname><given-names>C.W.</given-names></name></person-group><article-title>Phylogenomic analyses of deep gastropod relationships reject Orthogastropoda</article-title><source>Proc. R. Soc. B Biol. Sci.</source><year>2014</year><volume>281</volume><fpage>20141739</fpage><pub-id pub-id-type="doi">10.1098/rspb.2014.1739</pub-id><?supplied-pmid 25232139?><pub-id pub-id-type="pmid">25232139</pub-id></element-citation></ref><ref id="B51-marinedrugs-18-00657"><label>51.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>WoRMS</collab></person-group><article-title>World Register of Marine Species, Database</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.marinespecies.org">http://www.marinespecies.org</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-11">(accessed on 11 November 2020)</date-in-citation></element-citation></ref><ref id="B52-marinedrugs-18-00657"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Molluscan natural products as biological models: Chemical ecology, histology, and laboratory culture</article-title><source>Progress in Molecular and Subcellular Biology</source><person-group person-group-type="editor"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><volume>Volume 43</volume><fpage>1</fpage><lpage>23</lpage></element-citation></ref><ref id="B53-marinedrugs-18-00657"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iken</surname><given-names>K.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Hodgsonal, a new drimane sesquiterpene from the mantle of the Antarctic nudibranch <italic>Bathydoris hodgsoni</italic></article-title><source>Tetrahedron Lett.</source><year>1998</year><volume>39</volume><fpage>5635</fpage><lpage>5638</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(98)01095-8</pub-id></element-citation></ref><ref id="B54-marinedrugs-18-00657"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Iken</surname><given-names>K.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical ecology of the Antarctic nudibranch <italic>Bathydoris hodgsoni</italic> Eliot, 1907: Defensive role and origin of its natural products</article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>2000</year><volume>252</volume><fpage>27</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0022-0981(00)00227-6</pub-id><pub-id pub-id-type="pmid">10962063</pub-id></element-citation></ref><ref id="B55-marinedrugs-18-00657"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loughlin</surname><given-names>W.A.</given-names></name><name><surname>Muderawan</surname><given-names>I.W.</given-names></name><name><surname>McCleary</surname><given-names>M.A.</given-names></name><name><surname>Volter</surname><given-names>K.E.</given-names></name><name><surname>King</surname><given-names>M.D.</given-names></name></person-group><article-title>Studies towards the synthesis of phorbazoles A&#x02013;D: Formation of the pyrrole oxazole skeleton</article-title><source>Aust. J. Chem.</source><year>1999</year><volume>52</volume><fpage>231</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1071/C98169</pub-id></element-citation></ref><ref id="B56-marinedrugs-18-00657"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radspieler</surname><given-names>A.</given-names></name><name><surname>Liebscher</surname><given-names>J.</given-names></name></person-group><article-title>Total synthesis of phorbazole C</article-title><source>Tetrahedron</source><year>2001</year><volume>57</volume><fpage>4867</fpage><lpage>4871</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)00425-2</pub-id></element-citation></ref><ref id="B57-marinedrugs-18-00657"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moles</surname><given-names>J.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Ballesteros</surname><given-names>M.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Giant embryos and hatchlings of Antarctic nudibranchs (Mollusca: Gastropoda: Heterobranchia)</article-title><source>Mar. Biol.</source><year>2017</year><volume>164</volume><fpage>114</fpage><pub-id pub-id-type="doi">10.1007/s00227-017-3143-8</pub-id></element-citation></ref><ref id="B58-marinedrugs-18-00657"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>De Napoli</surname><given-names>A.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Austrodorin-A and-B: First tricyclic diterpenoid 2&#x02032;-monoglyceryl esters from an Antarctic nudibranch</article-title><source>Tetrahedron Lett.</source><year>1999</year><volume>40</volume><fpage>8471</fpage><lpage>8475</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(99)01777-3</pub-id></element-citation></ref><ref id="B59-marinedrugs-18-00657"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>De Napoli</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Iken</surname><given-names>K.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Garcia</surname><given-names>F.J.</given-names></name></person-group><article-title>Absolute configuration of diterpenoid diacylglycerols from the Antarctic nudibranch <italic>Austrodoris kerguelenensis</italic></article-title><source>Tetrahedron Asym.</source><year>1999</year><volume>10</volume><fpage>2647</fpage><lpage>2650</lpage><pub-id pub-id-type="doi">10.1016/S0957-4166(99)00273-6</pub-id></element-citation></ref><ref id="B60-marinedrugs-18-00657"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iken</surname><given-names>K.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Chemical ecology and origin of defensive compounds in the Antarctic nudibranch <italic>Austrodoris kerguelenensis</italic> (Opisthobranchia: Gastropoda)</article-title><source>Mar. Biol.</source><year>2002</year><volume>141</volume><fpage>101</fpage><lpage>109</lpage></element-citation></ref><ref id="B61-marinedrugs-18-00657"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carte</surname><given-names>B.</given-names></name><name><surname>Faulkner</surname><given-names>D.</given-names></name></person-group><article-title>Role of Secondary Metabolites in Feeding Associations between a Predatory Nudibranch, 2 Grazing Nudibranchs, and a Bryozoan</article-title><source>J. Chem. Ecol.</source><year>1986</year><volume>12</volume><fpage>795</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1007/BF01012111</pub-id><?supplied-pmid 24306917?><pub-id pub-id-type="pmid">24306917</pub-id></element-citation></ref><ref id="B62-marinedrugs-18-00657"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>New diterpenoic acid glycerides from the Antarctic nudibranch <italic>Austrodoris kerguelensis</italic></article-title><source>Tetrahedron</source><year>1991</year><volume>47</volume><fpage>9743</fpage><lpage>9750</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)80714-6</pub-id></element-citation></ref><ref id="B63-marinedrugs-18-00657"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Cattaneo-Vietti</surname><given-names>R.</given-names></name></person-group><article-title>Glyceryl ester of a new halimane diterpenoic acid from the skin of the antarctic nudibranch <italic>Austrodoris kerguelenensis</italic></article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>7319</fpage><lpage>7322</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)01476-X</pub-id></element-citation></ref><ref id="B64-marinedrugs-18-00657"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Austrodoral and austrodoric acid: Nor-sesquiterpenes with a new carbon skeleton from the Antarctic nudibranch <italic>Austrodoris kerguelenensis</italic></article-title><source>Tetrahedron Lett.</source><year>2003</year><volume>44</volume><fpage>1495</fpage><lpage>1498</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(02)02849-6</pub-id></element-citation></ref><ref id="B65-marinedrugs-18-00657"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Further chemical studies on the Antarctic nudibranch <italic>Austrodoris kerguelenensis</italic>: New terpenoid acylglycerols and revision of the previous stereochemistry</article-title><source>Tetrahedron</source><year>2003</year><volume>59</volume><fpage>5579</fpage><lpage>5583</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(03)00775-0</pub-id></element-citation></ref><ref id="B66-marinedrugs-18-00657"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diyabalanage</surname><given-names>T.</given-names></name><name><surname>Iken</surname><given-names>K.B.</given-names></name><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Amsler</surname><given-names>C.D.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Palmadorins A&#x02212; C, diterpene glycerides from the Antarctic nudibranch <italic>Austrodoris kerguelenensis</italic></article-title><source>J. Nat. Prod.</source><year>2010</year><volume>73</volume><fpage>416</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1021/np900617m</pub-id><?supplied-pmid 20121160?><pub-id pub-id-type="pmid">20121160</pub-id></element-citation></ref><ref id="B67-marinedrugs-18-00657"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maschek</surname><given-names>J.A.</given-names></name><name><surname>Mevers</surname><given-names>E.</given-names></name><name><surname>Diyabalanage</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Amsler</surname><given-names>C.D.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Palmadorin chemodiversity from the Antarctic nudibranch <italic>Austrodoris kerguelenensis</italic> and inhibition of Jak2/STAT5-dependent HEL leukemia cells</article-title><source>Tetrahedron</source><year>2012</year><volume>68</volume><fpage>9095</fpage><lpage>9104</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2012.08.045</pub-id></element-citation></ref><ref id="B68-marinedrugs-18-00657"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Intrapopulation variability in the terpene metabolism of the Antarctic opisthobranch mollusc <italic>Austrodoris kerguelenensis</italic></article-title><source>Eur. J. Org. Chem.</source><year>2011</year><fpage>5383</fpage><lpage>5389</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201100552</pub-id></element-citation></ref><ref id="B69-marinedrugs-18-00657"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>N.G.</given-names></name><name><surname>Maschek</surname><given-names>J.A.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>A species flock driven by predation? Secondary metabolites support diversification of slugs in Antarctica</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e80277</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0080277</pub-id><pub-id pub-id-type="pmid">24303002</pub-id></element-citation></ref><ref id="B70-marinedrugs-18-00657"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical studies on Antarctic nudibranch molluscs</article-title><source>Italian J. Zool.</source><year>2000</year><volume>1</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1080/11250000009356363</pub-id></element-citation></ref><ref id="B71-marinedrugs-18-00657"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graziani</surname><given-names>E.I.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Krug</surname><given-names>P.J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Stable isotope incorporation evidence for the de novo biosynthesis of terpenoic acid glycerides by dorid nudibranchs</article-title><source>Tetrahedron</source><year>1996</year><volume>52</volume><fpage>6869</fpage><lpage>6878</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(96)00327-4</pub-id></element-citation></ref><ref id="B72-marinedrugs-18-00657"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granato</surname><given-names>A.C.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.S.</given-names></name><name><surname>Magalhaes</surname><given-names>A.</given-names></name><name><surname>Schefer</surname><given-names>A.B.</given-names></name><name><surname>Ferreira</surname><given-names>A.G.</given-names></name><name><surname>De Sanctis</surname><given-names>B.</given-names></name><name><surname>De Freitas</surname><given-names>J.C.</given-names></name><name><surname>Hajdu</surname><given-names>E.</given-names></name><name><surname>Migotto</surname><given-names>A.E.</given-names></name></person-group><article-title>Natural products from the marine sponges <italic>Aaptos</italic> sp. and <italic>Hymeniacidon</italic> aff. <italic>heliophila</italic>, and from the nudibranch <italic>Doris</italic> aff<italic>. verrucosa</italic></article-title><source>Quim. Nov.</source><year>2000</year><volume>23</volume><fpage>594</fpage><lpage>599</lpage></element-citation></ref><ref id="B73-marinedrugs-18-00657"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayer</surname><given-names>S.W.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Steroidal antifeedants from the dorid nudibranch <italic>Aldisa sanguinea cooperi</italic></article-title><source>Tetrahedron Lett.</source><year>1982</year><volume>23</volume><fpage>1039</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)87016-1</pub-id></element-citation></ref><ref id="B74-marinedrugs-18-00657"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Ungur</surname><given-names>N.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Templado</surname><given-names>J.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Structure and synthesis of a progesterone homologue from the skin of the dorid nudibranch <italic>Aldisa smaragdina</italic></article-title><source>Eur. J. Org. Chem.</source><year>2002</year><volume>9</volume><fpage>1500</fpage><lpage>1504</lpage><pub-id pub-id-type="doi">10.1002/1099-0690(200205)2002:9&#x0003c;1500::AID-EJOC1500&#x0003e;3.0.CO;2-D</pub-id></element-citation></ref><ref id="B75-marinedrugs-18-00657"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuzzo</surname><given-names>G.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Leclercqz</surname><given-names>H.</given-names></name><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Lefranc</surname><given-names>F.</given-names></name><name><surname>D'Souza</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Chemistry of the nudibranch <italic>Aldisa andersoni</italic>: Structure and biological activity of phorbazole metabolites</article-title><source>Mar. Drugs</source><year>2012</year><volume>10</volume><fpage>1799</fpage><lpage>1811</lpage><pub-id pub-id-type="doi">10.3390/md10081799</pub-id><pub-id pub-id-type="pmid">23015775</pub-id></element-citation></ref><ref id="B76-marinedrugs-18-00657"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudi</surname><given-names>A.</given-names></name><name><surname>Stein</surname><given-names>Z.</given-names></name><name><surname>Green</surname><given-names>S.</given-names></name><name><surname>Goldberg</surname><given-names>I.</given-names></name><name><surname>Kashman</surname><given-names>Y.</given-names></name><name><surname>Benayahu</surname><given-names>Y.</given-names></name><name><surname>Schleyer</surname><given-names>M.</given-names></name></person-group><article-title>Phorbazoles A&#x02013;D, novel chlorinated phenylpyrrolyloxazoles from the marine sponge <italic>Phorbas</italic> aff. <italic>clathrata</italic></article-title><source>Tetrahedron Lett.</source><year>1994</year><volume>35</volume><fpage>2589</fpage><lpage>2592</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)77179-6</pub-id></element-citation></ref><ref id="B77-marinedrugs-18-00657"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Pozone</surname><given-names>F.</given-names></name><name><surname>Roussis</surname><given-names>V.</given-names></name><name><surname>Templado</surname><given-names>J.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Factors promoting marine invasions: A chemoecological approach</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>4582</fpage><lpage>4586</lpage><pub-id pub-id-type="doi">10.1073/pnas.0709355105</pub-id><pub-id pub-id-type="pmid">18337492</pub-id></element-citation></ref><ref id="B78-marinedrugs-18-00657"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krug</surname><given-names>P.J.</given-names></name><name><surname>Boyd</surname><given-names>K.G.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Isolation and synthesis of tanyolides A and B, metabolites of the nudibranch <italic>Sclerodoris tanya</italic></article-title><source>Tetrahedron</source><year>1995</year><volume>51</volume><fpage>11063</fpage><lpage>11074</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(95)00679-3</pub-id></element-citation></ref><ref id="B79-marinedrugs-18-00657"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>L&#x000f3;pez-Belluga</surname><given-names>M.D.</given-names></name><name><surname>Scognamiglio</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Morphological and chemical camouflage of the Mediterranean nudibranch <italic>Discodoris indecora</italic> on the sponges <italic>Ircinia variabilis</italic> and <italic>Ircinia fasciculata</italic></article-title><source>J. Mollus. Stud.</source><year>1997</year><volume>63</volume><fpage>431</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1093/mollus/63.3.431</pub-id></element-citation></ref><ref id="B80-marinedrugs-18-00657"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name></person-group><article-title>Dorid nudibranch elaborates its own chemical defense</article-title><source>Science</source><year>1983</year><volume>219</volume><fpage>1237</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1126/science.219.4589.1237</pub-id><?supplied-pmid 17771309?><pub-id pub-id-type="pmid">17771309</pub-id></element-citation></ref><ref id="B81-marinedrugs-18-00657"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Can molluscs biosynthesize typical sponge metabolites? The case of the nudibranch <italic>Doriopsilla areolata</italic></article-title><source>Tetrahedron</source><year>2001</year><volume>57</volume><fpage>8913</fpage><lpage>8916</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)00876-6</pub-id></element-citation></ref><ref id="B82-marinedrugs-18-00657"><label>82.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>I.</given-names></name><name><surname>Nakanishi</surname><given-names>K.</given-names></name></person-group><article-title>Insect antifeedants and repellents from African plants</article-title><source>Host Plant Resistance to Pests</source><series>ACS Symposium Series</series><publisher-name>American Chemical Society</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>1977</year><volume>Volume 62</volume><fpage>165</fpage><lpage>178</lpage></element-citation></ref><ref id="B83-marinedrugs-18-00657"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Observations on the toxicity and metabolic relationships of polygodial, the chemical defense of the nudibranch <italic>Dendrodoris limbata</italic></article-title><source>Experientia</source><year>1985</year><volume>41</volume><fpage>1335</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1007/BF01952082</pub-id></element-citation></ref><ref id="B84-marinedrugs-18-00657"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name></person-group><article-title>Occurrence of olepupuane in two Mediterranean nudibranchs: A protected form of polygodial</article-title><source>J. Nat. Prod.</source><year>1988</year><volume>51</volume><fpage>1010</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1021/np50059a039</pub-id><?supplied-pmid 21401197?><pub-id pub-id-type="pmid">21401197</pub-id></element-citation></ref><ref id="B85-marinedrugs-18-00657"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Novel sesquiterpenoid esters from the nudibranch <italic>Dendrodoris limbata</italic></article-title><source>Tetrahedron Letters.</source><year>1981</year><volume>22</volume><fpage>1271</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)90293-X</pub-id></element-citation></ref><ref id="B86-marinedrugs-18-00657"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakio</surname><given-names>Y.</given-names></name><name><surname>Hirano</surname><given-names>Y.J.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Komiyama</surname><given-names>K.</given-names></name><name><surname>Ishibashi</surname><given-names>M.</given-names></name></person-group><article-title>Dendocarbins A&#x02013;N, new drimane sesquiterpenes from the nudibranch <italic>Dendrodoris carbunculosa</italic></article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>726</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1021/np000639g</pub-id><pub-id pub-id-type="pmid">11421732</pub-id></element-citation></ref><ref id="B87-marinedrugs-18-00657"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Biosynthesis of drimane terpenoids in dorid molluscs: Pivotal role of 7-deacetoxyolepupuane in two species of <italic>Dendrodoris</italic> nudibranchs</article-title><source>Tetrahedron</source><year>1999</year><volume>55</volume><fpage>5937</fpage><lpage>5946</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(99)00256-2</pub-id></element-citation></ref><ref id="B88-marinedrugs-18-00657"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grkovic</surname><given-names>T.</given-names></name><name><surname>Appleton</surname><given-names>D.R.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name></person-group><article-title>Chemistry and chemical ecology of some of the common opisthobranch molluscs found on the shores of NE New Zealand</article-title><source>Chem. N. Z.</source><year>2005</year><volume>69</volume><fpage>12</fpage><lpage>15</lpage></element-citation></ref><ref id="B89-marinedrugs-18-00657"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Fahey</surname><given-names>S.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical studies of porostome nudibranchs: Comparative and ecological aspects</article-title><source>Chemoecology</source><year>2001</year><volume>11</volume><fpage>131</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1007/PL00001843</pub-id></element-citation></ref><ref id="B90-marinedrugs-18-00657"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name></person-group><article-title>Drimane sesquiterpenoids in Mediterranean Dendrodoris nudibranchs: Anatomical distribution and biological role</article-title><source>Experientia</source><year>1991</year><volume>47</volume><fpage>306</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1007/BF01958169</pub-id></element-citation></ref><ref id="B91-marinedrugs-18-00657"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>R.K.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Walker</surname><given-names>R.P.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Sesquiterpenoid constituents of eight porostome nudibranchs</article-title><source>J. Org. Chem.</source><year>1983</year><volume>48</volume><fpage>1866</fpage><lpage>1869</lpage><pub-id pub-id-type="doi">10.1021/jo00159a014</pub-id></element-citation></ref><ref id="B92-marinedrugs-18-00657"><label>92.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Karuso</surname><given-names>P.</given-names></name></person-group><article-title>Chemical ecology of the nudibranchs</article-title><source>BioorganicMarine Chemistry</source><person-group person-group-type="editor"><name><surname>Scheuer</surname><given-names>P.P.J.</given-names></name></person-group><comment>Bioorganic Marine Chemistry</comment><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>1987</year><fpage>31</fpage><lpage>60</lpage></element-citation></ref><ref id="B93-marinedrugs-18-00657"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name></person-group><article-title>Chemical defense and evolutionary trends in biosynthetic capacity among Dorid nudibranchs (Mollusca: Gastropoda: Opisthobranchia)</article-title><source>Chemoecology</source><year>1999</year><volume>9</volume><fpage>187</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1007/s000490050052</pub-id></element-citation></ref><ref id="B94-marinedrugs-18-00657"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Marine Natural Products</article-title><source>Nat. Prod. Rep.</source><year>2001</year><volume>18</volume><fpage>1</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1039/b006897g</pub-id><?supplied-pmid 11245399?><pub-id pub-id-type="pmid">11245399</pub-id></element-citation></ref><ref id="B95-marinedrugs-18-00657"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Pelseneeriol-1 and-2: New furanosesquiterpene alcohols from porostome nudibranch <italic>Doriopsilla pelseneeri</italic></article-title><source>Tetrahedron</source><year>2005</year><volume>61</volume><fpage>11032</fpage><lpage>11037</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2005.08.096</pub-id></element-citation></ref><ref id="B96-marinedrugs-18-00657"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Tramice</surname><given-names>A.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>d&#x02019;Ippolito</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Terpene biosynthesis in the nudibranch <italic>Doriopsilla areolata</italic></article-title><source>J. Org. Chem.</source><year>2003</year><volume>68</volume><fpage>2405</fpage><lpage>2409</lpage><pub-id pub-id-type="doi">10.1021/jo026131v</pub-id><pub-id pub-id-type="pmid">12636409</pub-id></element-citation></ref><ref id="B97-marinedrugs-18-00657"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Alvarez</surname><given-names>L.A.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>New acetoxy-ent-pallescensin-A sesquiterpenoids from the skin of the porostome nudibranch <italic>Doriopsilla areolata</italic></article-title><source>Tetrahedron Lett.</source><year>1994</year><volume>35</volume><fpage>8665</fpage><lpage>8668</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)78466-8</pub-id></element-citation></ref><ref id="B98-marinedrugs-18-00657"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>J.D.</given-names></name><name><surname>Hay</surname><given-names>M.E.</given-names></name></person-group><article-title>Fishes learn aversions to a nudibranch&#x02019;s chemical defense</article-title><source>Mar. Ecol. Progr. Ser.</source><year>2006</year><volume>307</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.3354/meps307199</pub-id></element-citation></ref><ref id="B99-marinedrugs-18-00657"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Ferreira</surname><given-names>T.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Biosynthetic evidence supporting the generation of terpene chemodiversity in marine mollusks of the genus <italic>Doriopsilla</italic></article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>2053</fpage><lpage>2056</lpage><pub-id pub-id-type="doi">10.1021/np8004387</pub-id><pub-id pub-id-type="pmid">19053515</pub-id></element-citation></ref><ref id="B100-marinedrugs-18-00657"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunckhorst</surname><given-names>D.J.</given-names></name></person-group><article-title>The systematics and phylogeny of phyllidiid nudibranchs (Doridoidea)</article-title><source>Rec. Aust. Mus. Suppl.</source><year>1993</year><volume>16</volume><fpage>1</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.3853/j.0812-7387.16.1993.79</pub-id></element-citation></ref><ref id="B101-marinedrugs-18-00657"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Wolstenholme</surname><given-names>H.J.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Hirota</surname><given-names>H.</given-names></name></person-group><article-title>Two new sesquiterpene isonitriles from the nudibranch <italic>Phyllidia pustulosa</italic></article-title><source>Tetrahedron Lett.</source><year>1991</year><volume>32</volume><fpage>7291</fpage><lpage>7294</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(91)80501-V</pub-id></element-citation></ref><ref id="B102-marinedrugs-18-00657"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okino</surname><given-names>T.</given-names></name><name><surname>Yoshimura</surname><given-names>E.</given-names></name><name><surname>Hirota</surname><given-names>H.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>New antifouling sesquiterpenes from four nudibranchs of the family Phyllidiidae</article-title><source>Tetrahedron</source><year>1996</year><volume>52</volume><fpage>9447</fpage><lpage>9454</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(96)00481-4</pub-id></element-citation></ref><ref id="B103-marinedrugs-18-00657"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>H.</given-names></name><name><surname>Okino</surname><given-names>T.</given-names></name><name><surname>Yoshimura</surname><given-names>E.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>Five new antifouling sesquiterpenes from two marine sponges of the genus <italic>Axinyssa</italic> and the nudibranch <italic>Phyllidia pustulosa</italic></article-title><source>Tetrahedron</source><year>1998</year><volume>54</volume><fpage>13971</fpage><lpage>13980</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(98)00867-9</pub-id></element-citation></ref><ref id="B104-marinedrugs-18-00657"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Marine opisthobranch molluscs: Chemistry and ecology in sacoglossan and dorids</article-title><source>Curr. Org. Chem.</source><year>1999</year><volume>3</volume><fpage>327</fpage><lpage>372</lpage></element-citation></ref><ref id="B105-marinedrugs-18-00657"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Simpson</surname><given-names>J.S.</given-names></name></person-group><article-title>Marine isocyanides and related natural products&#x02014;Structure, biosynthesis and ecology</article-title><source>Nat. Prod. Rep.</source><year>2004</year><volume>21</volume><fpage>164</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1039/b302359c</pub-id><pub-id pub-id-type="pmid">15039841</pub-id></element-citation></ref><ref id="B106-marinedrugs-18-00657"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burreson</surname><given-names>B.J.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Finer</surname><given-names>J.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>9-Isocyanopupukeanane, a marine invertebrate allomone with a new sesquiterpene skeleton</article-title><source>J. Am. Chem. Soc.</source><year>1975</year><volume>97</volume><fpage>4763</fpage><lpage>4764</lpage><pub-id pub-id-type="doi">10.1021/ja00849a053</pub-id></element-citation></ref><ref id="B107-marinedrugs-18-00657"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagadone</surname><given-names>M.R.</given-names></name><name><surname>Burreson</surname><given-names>B.J.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Finer</surname><given-names>J.S.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Defense allomones of the nudibranch <italic>Phyllidia varicosa</italic> Lamarck 1801</article-title><source>Helv. Chim. Acta</source><year>1979</year><volume>62</volume><fpage>2484</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.1002/hlca.19790620742</pub-id></element-citation></ref><ref id="B108-marinedrugs-18-00657"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ungur</surname><given-names>N.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Absolute stereochemistry of natural sesquiterpenoid diacylglycerols</article-title><source>Tetrahedron Asymmetry</source><year>1999</year><volume>10</volume><fpage>1263</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1016/S0957-4166(99)00119-6</pub-id></element-citation></ref><ref id="B109-marinedrugs-18-00657"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritson-Williams</surname><given-names>R.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Marine benthic invertebrates use multimodal cues for defense against reef fish</article-title><source>Mar. Ecol. Progr. Ser.</source><year>2007</year><volume>340</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.3354/meps340029</pub-id></element-citation></ref><ref id="B110-marinedrugs-18-00657"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasman</surname><given-names>Y.</given-names></name><name><surname>Edrada</surname><given-names>R.A.</given-names></name><name><surname>Wray</surname><given-names>V.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>New 9-thiocyanatopupukeanane sesquiterpenes from the nudibranch <italic>Phyllidia varicosa</italic> and its sponge-prey <italic>Axinyssa aculeata</italic></article-title><source>J. Nat. Prod.</source><year>2003</year><volume>66</volume><fpage>1512</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1021/np030237j</pub-id><pub-id pub-id-type="pmid">14640531</pub-id></element-citation></ref><ref id="B111-marinedrugs-18-00657"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaisamut</surname><given-names>S.</given-names></name><name><surname>Prabpai</surname><given-names>S.</given-names></name><name><surname>Tancharoen</surname><given-names>C.</given-names></name><name><surname>Yuenyongsawad</surname><given-names>S.</given-names></name><name><surname>Hannongbua</surname><given-names>S.</given-names></name><name><surname>Kongsaeree</surname><given-names>P.</given-names></name><name><surname>Plubrukarn</surname><given-names>A.</given-names></name></person-group><article-title>Bridged tricyclic sesquiterpenes from the tubercle nudibranch <italic>Phyllidia coelestis</italic> Bergh</article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>2158</fpage><lpage>2161</lpage><pub-id pub-id-type="doi">10.1021/np4007074</pub-id><pub-id pub-id-type="pmid">24200393</pub-id></element-citation></ref><ref id="B112-marinedrugs-18-00657"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>D.C.-M.</given-names></name><name><surname>Mudianta</surname><given-names>I.W.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Martiningsih</surname><given-names>N.W.</given-names></name><name><surname>Loh</surname><given-names>J.J.M.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>New sesquiterpenoid isonitriles from three species of phyllidid nudibranchs</article-title><source>Fitoterapia</source><year>2018</year><volume>126</volume><fpage>69</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2017.10.003</pub-id><?supplied-pmid 29031559?><pub-id pub-id-type="pmid">29031559</pub-id></element-citation></ref><ref id="B113-marinedrugs-18-00657"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwashima</surname><given-names>M.</given-names></name><name><surname>Terada</surname><given-names>I.</given-names></name><name><surname>Iguchi</surname><given-names>K.</given-names></name><name><surname>Yamori</surname><given-names>T.</given-names></name></person-group><article-title>New biologically active marine sesquiterpenoid and steroid from the Okinawan sponge of the genus <italic>Axinyssa</italic></article-title><source>Chem. Pharm. Bull.</source><year>2002</year><volume>50</volume><fpage>1286</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1248/cpb.50.1286</pub-id><?supplied-pmid 12237556?><pub-id pub-id-type="pmid">12237556</pub-id></element-citation></ref><ref id="B114-marinedrugs-18-00657"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulavita</surname><given-names>N.K.</given-names></name><name><surname>De Silva</surname><given-names>E.D.</given-names></name><name><surname>Hagadone</surname><given-names>M.R.</given-names></name><name><surname>Karuso</surname><given-names>P.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>van Duyne</surname><given-names>G.D.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Nitrogenous bisabolene sesquiterpenes from marine invertebrates</article-title><source>J. Org. Chem.</source><year>1986</year><volume>51</volume><fpage>5136</fpage><lpage>5139</lpage><pub-id pub-id-type="doi">10.1021/jo00376a015</pub-id></element-citation></ref><ref id="B115-marinedrugs-18-00657"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitano</surname><given-names>Y.</given-names></name><name><surname>Ito</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Nogata</surname><given-names>Y.</given-names></name><name><surname>Shinshima</surname><given-names>K.</given-names></name><name><surname>Yoshimura</surname><given-names>E.</given-names></name><name><surname>Chiba</surname><given-names>K.</given-names></name><name><surname>Tada</surname><given-names>M.</given-names></name><name><surname>Sakaguchi</surname><given-names>I.</given-names></name></person-group><article-title>(2002) Synthesis and antifouling activity of 3-isocyanotheonellin and its analogues</article-title><source>J. Chem. Soc. Perkin Trans.</source><year>2002</year><volume>1</volume><fpage>2251</fpage><lpage>2255</lpage><pub-id pub-id-type="doi">10.1039/b206705f</pub-id></element-citation></ref><ref id="B116-marinedrugs-18-00657"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Hirota</surname><given-names>H.</given-names></name><name><surname>Okino</surname><given-names>T.</given-names></name><name><surname>Tomono</surname><given-names>Y.</given-names></name><name><surname>Yoshimura</surname><given-names>E.</given-names></name></person-group><article-title>Antifouling activity of isocyanoterpenoids and related compounds isolated from a marine sponge and nudibranchs</article-title><source>J. Nat. Toxins</source><year>1996</year><volume>5</volume><fpage>249</fpage><lpage>259</lpage></element-citation></ref><ref id="B117-marinedrugs-18-00657"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>W.-T.</given-names></name><name><surname>Li</surname><given-names>S.-W.</given-names></name><name><surname>Ye</surname><given-names>J.-Y.</given-names></name><name><surname>Huan</surname><given-names>X.-J.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Yao</surname><given-names>L.-G.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Miao</surname><given-names>Z.-H.</given-names></name><name><surname>Li</surname><given-names>X.-W.</given-names></name><etal/></person-group><article-title>Cytotoxic nitrogenous terpenoids from two South China Sea nudibranchs <italic>Phyllidiella pustulosa</italic>, <italic>Phyllidia coelestis</italic>, and their sponge-prey <italic>Acanthella cavernosa</italic></article-title><source>Mar. Drugs</source><year>2019</year><volume>17</volume><elocation-id>56</elocation-id><pub-id pub-id-type="doi">10.3390/md17010056</pub-id></element-citation></ref><ref id="B118-marinedrugs-18-00657"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>A.D.</given-names></name></person-group><article-title>GC-MS and NMR analysis of <italic>Phyllidiella pustulosa</italic> and one of its dietary sources, the sponge <italic>Phakellia carduus</italic></article-title><source>Comp. Biochem. Physiol.</source><year>2003</year><volume>134A</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/S1095-6433(02)00265-9</pub-id></element-citation></ref><ref id="B119-marinedrugs-18-00657"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumdei</surname><given-names>E.J.</given-names></name><name><surname>Flowers</surname><given-names>A.E.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Moore</surname><given-names>C.J.</given-names></name></person-group><article-title>The biosynthesis of sesquiterpene isocyanides and isothiocyanates in the marine sponge <italic>Acanthella cavernosa</italic> (Dendy); evidence for dietary transfer to the dorid nudibranch <italic>Phyllidiella pustulosa</italic></article-title><source>Comp. Biochem. Physiol.</source><year>1997</year><volume>118</volume><fpage>1385</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1016/S0300-9629(97)00051-0</pub-id></element-citation></ref><ref id="B120-marinedrugs-18-00657"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Isocyanide terpene metabolites of <italic>Phyllidiella pustulosa</italic>, a nudibranch from the South China Sea</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1701</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1021/np0400961</pub-id><pub-id pub-id-type="pmid">15497943</pub-id></element-citation></ref><ref id="B121-marinedrugs-18-00657"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimomura</surname><given-names>M.</given-names></name><name><surname>Miyaoka</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name></person-group><article-title>Absolute configuration of marine diterpenoid kalihinol A</article-title><source>Tetrahedron Lett.</source><year>1999</year><volume>40</volume><fpage>8015</fpage><lpage>8017</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(99)01664-0</pub-id></element-citation></ref><ref id="B122-marinedrugs-18-00657"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyakhova</surname><given-names>E.G.</given-names></name><name><surname>Kolesnikova</surname><given-names>S.A.</given-names></name><name><surname>Kalinovskii</surname><given-names>A.I.</given-names></name><name><surname>Stonik</surname><given-names>V.A.</given-names></name></person-group><article-title>Secondary metabolites of the Vietnamese nudibranch mollusc <italic>Phyllidiella pustulosa</italic></article-title><source>Chem. Nat. Comp.</source><year>2010</year><volume>46</volume><fpage>534</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1007/s10600-010-9670-x</pub-id></element-citation></ref><ref id="B123-marinedrugs-18-00657"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisch</surname><given-names>K.M.</given-names></name><name><surname>Hertzer</surname><given-names>C.</given-names></name><name><surname>B&#x000f6;hringer</surname><given-names>N.</given-names></name><name><surname>Wuisan</surname><given-names>Z.G.</given-names></name><name><surname>Schillo</surname><given-names>D.</given-names></name><name><surname>Bara</surname><given-names>R.</given-names></name><name><surname>Kaligis</surname><given-names>F.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name></person-group><article-title>The potential of Indonesian heterobranchs found around Bunaken Island for the production of bioactive compounds</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>384</elocation-id><pub-id pub-id-type="doi">10.3390/md15120384</pub-id><?supplied-pmid 29215579?><pub-id pub-id-type="pmid">29215579</pub-id></element-citation></ref><ref id="B124-marinedrugs-18-00657"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>Ballesteros</surname><given-names>M.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Defensive glandular structures in opisthobranch molluscs-from histology to ecology</article-title><source>Oceanogr. Mar. Biol.</source><year>2006</year><volume>44</volume><fpage>197</fpage></element-citation></ref><ref id="B125-marinedrugs-18-00657"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>R.F.</given-names></name><name><surname>Gosliner</surname><given-names>T.M.</given-names></name></person-group><article-title>Traditional taxonomic groupings mask evolutionary history: A molecular phylogeny and new classification of the chromodorid nudibranchs</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e33479</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0033479</pub-id><pub-id pub-id-type="pmid">22506002</pub-id></element-citation></ref><ref id="B126-marinedrugs-18-00657"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>J.E.</given-names></name><name><surname>Walker</surname><given-names>R.P.</given-names></name><name><surname>Wratten</surname><given-names>S.J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>A chemical defense mechanism for the nudibranch <italic>Cadlina luteomarginata</italic></article-title><source>Tetrahedron</source><year>1982</year><volume>38</volume><fpage>1865</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(82)80035-5</pub-id></element-citation></ref><ref id="B127-marinedrugs-18-00657"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Dumdei</surname><given-names>E.J.</given-names></name><name><surname>De Silva</surname><given-names>E.D.</given-names></name></person-group><article-title>Geographical variation in defensive chemicals from Pacific coast dorid nudibranchs and some related marine molluscs</article-title><source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source><year>1990</year><volume>97</volume><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/0742-8413(90)90133-T</pub-id></element-citation></ref><ref id="B128-marinedrugs-18-00657"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubanek</surname><given-names>J.</given-names></name><name><surname>Graziani</surname><given-names>E.I.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Investigations of terpenoid biosynthesis by the dorid nudibranch <italic>Cadlina luteomarginata</italic></article-title><source>J. Org. Chem.</source><year>1997</year><volume>62</volume><fpage>7239</fpage><lpage>7246</lpage><pub-id pub-id-type="doi">10.1021/jo970695v</pub-id><pub-id pub-id-type="pmid">11671835</pub-id></element-citation></ref><ref id="B129-marinedrugs-18-00657"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellou</surname><given-names>J.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Thompson</surname><given-names>J.E.</given-names></name></person-group><article-title>Terpenoids from the dorid nudibranch <italic>Cadlina luteomarginata</italic></article-title><source>Tetrahedron</source><year>1982</year><volume>38</volume><fpage>1875</fpage><lpage>1879</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(82)80036-7</pub-id></element-citation></ref><ref id="B130-marinedrugs-18-00657"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumdei</surname><given-names>E.J.</given-names></name><name><surname>Kubanek</surname><given-names>J.</given-names></name><name><surname>Coleman</surname><given-names>J.E.</given-names></name><name><surname>Pika</surname><given-names>J.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Steiner</surname><given-names>J.R.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>New terpenoid metabolites from the skin extracts, an egg mass, and dietary sponges of the Northeastern Pacific dorid nudibranch <italic>Cadlina luteomarginata</italic></article-title><source>Can. J. Chem.</source><year>1997</year><volume>75</volume><fpage>773</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1139/v97-094</pub-id></element-citation></ref><ref id="B131-marinedrugs-18-00657"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Haber</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Genta-Jouve</surname><given-names>G.</given-names></name><name><surname>Tsoukatou</surname><given-names>M.</given-names></name><name><surname>Rudman</surname><given-names>W.B.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Packaging and delivery of chemical weapons: A defensive trojan horse stratagem in Chromodorid nudibranchs</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e62075</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0062075</pub-id><pub-id pub-id-type="pmid">23620804</pub-id></element-citation></ref><ref id="B132-marinedrugs-18-00657"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Chemical constituents of the nudibranch <italic>Chromodoris marislae</italic></article-title><source>Tetrahedron Lett.</source><year>1981</year><volume>22</volume><fpage>271</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(81)80073-1</pub-id></element-citation></ref><ref id="B133-marinedrugs-18-00657"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte</surname><given-names>G.R.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Defense allomones of some marine mollusks</article-title><source>Tetrahedron</source><year>1982</year><volume>38</volume><fpage>1857</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(82)80034-3</pub-id></element-citation></ref><ref id="B134-marinedrugs-18-00657"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Matsumoto</surname><given-names>G.K.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Norrisolide, a novel diterpene from the dorid nudibranch <italic>Chromodoris norrisi</italic></article-title><source>J. Org. Chem.</source><year>1983</year><volume>48</volume><fpage>1141</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1021/jo00155a055</pub-id></element-citation></ref><ref id="B135-marinedrugs-18-00657"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergquist</surname><given-names>P.R.</given-names></name><name><surname>Bowden</surname><given-names>B.F.</given-names></name><name><surname>Cambie</surname><given-names>R.C.</given-names></name><name><surname>Craw</surname><given-names>P.A.</given-names></name><name><surname>Karuso</surname><given-names>P.</given-names></name><name><surname>Poiner</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>W.C.</given-names></name></person-group><article-title>The constituents of marine sponges. VI. Diterpenoid metabolites of the New Zealand sponge <italic>Chelonaplysilla violacea</italic></article-title><source>Aust. J. Chem.</source><year>1993</year><volume>46</volume><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1071/CH9930623</pub-id></element-citation></ref><ref id="B136-marinedrugs-18-00657"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>R.K.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Latrunculin-A, ichthyotoxic constituent of the nudibranch <italic>Chromodoris elisabethina</italic></article-title><source>Experientia</source><year>1985</year><volume>41</volume><fpage>1355</fpage><lpage>1356</lpage><pub-id pub-id-type="doi">10.1007/BF01952094</pub-id></element-citation></ref><ref id="B137-marinedrugs-18-00657"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carte</surname><given-names>B.</given-names></name><name><surname>Kernan</surname><given-names>M.R.</given-names></name><name><surname>Barrabee</surname><given-names>E.B.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Matsumoto</surname><given-names>G.K.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Metabolites of the nudibranch <italic>Chromodoris funerea</italic> and the singlet oxygen oxidation products of furodysin and furodysinin</article-title><source>J. Org. Chem.</source><year>1986</year><volume>51</volume><fpage>3528</fpage><lpage>3532</lpage><pub-id pub-id-type="doi">10.1021/jo00368a025</pub-id></element-citation></ref><ref id="B138-marinedrugs-18-00657"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>J.</given-names></name><name><surname>Hyosu</surname><given-names>M.</given-names></name></person-group><article-title>Two new sesterterpenes from the marine sponge, <italic>Coscinoderma mathewsi</italic></article-title><source>Chem. Lett.</source><year>1999</year><volume>28</volume><fpage>61</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1246/cl.1999.61</pub-id></element-citation></ref><ref id="B139-marinedrugs-18-00657"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Aromatic norditerpenes from the nudibranch <italic>Chromodoris macfarlandi</italic></article-title><source>J. Org. Chem.</source><year>1986</year><volume>51</volume><fpage>2601</fpage><lpage>2603</lpage><pub-id pub-id-type="doi">10.1021/jo00363a040</pub-id></element-citation></ref><ref id="B140-marinedrugs-18-00657"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>He</surname><given-names>C.H.</given-names></name><name><surname>Van Duyne</surname><given-names>G.D.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Three new rearranged spongian diterpenes from <italic>Chromodoris macfarlandi</italic>: Reappraisal of the structures of dendrillolides A and B</article-title><source>J. Org. Chem.</source><year>1986</year><volume>51</volume><fpage>4564</fpage><lpage>4567</lpage><pub-id pub-id-type="doi">10.1021/jo00374a014</pub-id></element-citation></ref><ref id="B141-marinedrugs-18-00657"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakou</surname><given-names>Y.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Bakus</surname><given-names>G.J.</given-names></name></person-group><article-title>Dendrolasin and latrunculin A from the Fijian sponge <italic>Spongia mycofijiensis</italic> and an associated nudibranch <italic>Chromodoris lochi</italic></article-title><source>J. Nat. Prod.</source><year>1987</year><volume>50</volume><fpage>482</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1021/np50051a023</pub-id></element-citation></ref><ref id="B142-marinedrugs-18-00657"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corley</surname><given-names>D.G.</given-names></name><name><surname>Herb</surname><given-names>R.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Laulimalides. New potent cytotoxic macrolides from a marine sponge and a nudibranch predator</article-title><source>J. Org. Chem.</source><year>1988</year><volume>53</volume><fpage>3644</fpage><lpage>3646</lpage><pub-id pub-id-type="doi">10.1021/jo00250a053</pub-id></element-citation></ref><ref id="B143-marinedrugs-18-00657"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernan</surname><given-names>M.R.</given-names></name><name><surname>Barrabee</surname><given-names>E.B.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Variation of the metabolites of <italic>Chromodoris funerea</italic>: Comparison of specimens from a Palauan marine lake with those from adjacent waters</article-title><source>Comp. Biochem. Physiol. B Comp. Biochem.</source><year>1988</year><volume>89</volume><fpage>275</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(88)90223-4</pub-id></element-citation></ref><ref id="B144-marinedrugs-18-00657"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobzin</surname><given-names>S.C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Diterpenes from the marine sponge <italic>Aplysilla polyrhaphis</italic> and the dorid nudibranch <italic>Chromodoris norrisi</italic></article-title><source>J. Org. Chem.</source><year>1989</year><volume>54</volume><fpage>3902</fpage><lpage>3907</lpage><pub-id pub-id-type="doi">10.1021/jo00277a029</pub-id></element-citation></ref><ref id="B145-marinedrugs-18-00657"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumdei</surname><given-names>E.J.</given-names></name><name><surname>De Silva</surname><given-names>E.D.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Choudhary</surname><given-names>M.I.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Chromodorolide A, a rearranged diterpene with a new carbon skeleton from the Indian ocean nudibranch <italic>Chromodoris cavae</italic></article-title><source>J. Am. Chem. Soc.</source><year>1989</year><volume>111</volume><fpage>2712</fpage><lpage>2713</lpage><pub-id pub-id-type="doi">10.1021/ja00189a055</pub-id></element-citation></ref><ref id="B146-marinedrugs-18-00657"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Diterpenes from the nudibranch <italic>Chromodoris luteorosea</italic></article-title><source>J. Nat. Prod.</source><year>1990</year><volume>53</volume><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1021/np50067a013</pub-id></element-citation></ref><ref id="B147-marinedrugs-18-00657"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Silva</surname><given-names>E.D.</given-names></name><name><surname>Morris</surname><given-names>S.A.</given-names></name><name><surname>Miao</surname><given-names>S.</given-names></name><name><surname>Dumdei</surname><given-names>E.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Terpenoid metabolites from skin extracts of four Sri Lankan Nudibranchs in the Genus <italic>Chromodoris</italic></article-title><source>J. Nat. Prod.</source><year>1991</year><volume>54</volume><fpage>993</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1021/np50076a011</pub-id></element-citation></ref><ref id="B148-marinedrugs-18-00657"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>S.A.</given-names></name><name><surname>Silva</surname><given-names>E.D.D.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Chromodorane diterpenes from the tropical dorid nudibranch <italic>Chromodoris cavae</italic></article-title><source>Can. J. Chem.</source><year>1991</year><volume>69</volume><fpage>768</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1139/v91-114</pub-id></element-citation></ref><ref id="B149-marinedrugs-18-00657"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name></person-group><article-title>Ichthyotoxic diterpenoids from the Cantabrian nudibranch <italic>Chromodoris luteorosea</italic></article-title><source>J. Nat. Prod.</source><year>1992</year><volume>55</volume><fpage>368</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1021/np50081a014</pub-id><pub-id pub-id-type="pmid">1593284</pub-id></element-citation></ref><ref id="B150-marinedrugs-18-00657"><label>150.</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>F.</given-names></name><name><surname>Nohara</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>M.</given-names></name><name><surname>Yoshizawa</surname><given-names>T.</given-names></name><name><surname>Yamashita</surname><given-names>M.</given-names></name><name><surname>Marubayashi</surname><given-names>N.</given-names></name></person-group><article-title>Tennen Yuki Kagobutsu Toronkai Koen Yoshishu</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.scienceopen.com/document?vid=294f7cd1-f803-4b53-907a-bc3edf8ab46e">https://www.scienceopen.com/document?vid=294f7cd1-f803-4b53-907a-bc3edf8ab46e</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-11">(accessed on 11 November 2020)</date-in-citation></element-citation></ref><ref id="B151-marinedrugs-18-00657"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Amano</surname><given-names>H.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group><article-title>Three new cytotoxic sesterterpenoids, inorolide A, B, and C from the nudibranch <italic>Chromodoris inornata</italic></article-title><source>Tetrahedron Lett.</source><year>1992</year><volume>33</volume><fpage>5811</fpage><lpage>5814</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(92)89038-E</pub-id></element-citation></ref><ref id="B152-marinedrugs-18-00657"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puliti</surname><given-names>R.A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.A.</given-names></name><name><surname>Cimino</surname><given-names>G.U.</given-names></name><name><surname>Mattia</surname><given-names>C.A.</given-names></name><name><surname>Mazzarella</surname><given-names>L.E.</given-names></name></person-group><article-title>Structure of chelonaplysin C: A spongian diterpenoid from nudibranch <italic>Chromodoris luteorosea</italic></article-title><source>Acta Crystallogr. C</source><year>1992</year><volume>48</volume><fpage>2145</fpage><lpage>2147</lpage><pub-id pub-id-type="doi">10.1107/S0108270192003196</pub-id></element-citation></ref><ref id="B153-marinedrugs-18-00657"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pika</surname><given-names>J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Unusual chlorinated homo-diterpenes from the South African nudibranch <italic>Chromodoris hamiltoni</italic></article-title><source>Tetrahedron</source><year>1995</year><volume>51</volume><fpage>8189</fpage><lpage>8198</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(95)00440-J</pub-id></element-citation></ref><ref id="B154-marinedrugs-18-00657"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Arao</surname><given-names>K.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group><article-title>Dorisenones, cytotoxic spongian diterpenoids, from the nudibranch <italic>Chromodoris obsoleta</italic></article-title><source>Tetrahedron</source><year>1996</year><volume>52</volume><fpage>8187</fpage><lpage>8198</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(96)00388-2</pub-id></element-citation></ref><ref id="B155-marinedrugs-18-00657"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPhail</surname><given-names>K.L.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name></person-group><article-title>New spongiane diterpenes from the East African nudibranch <italic>Chromodoris hamiltoni</italic></article-title><source>Tetrahedron</source><year>1997</year><volume>53</volume><fpage>4655</fpage><lpage>4660</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(97)00198-1</pub-id></element-citation></ref><ref id="B156-marinedrugs-18-00657"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Amano</surname><given-names>H.</given-names></name><name><surname>Arakawa</surname><given-names>Y.</given-names></name><name><surname>Nagarekawa</surname><given-names>Y.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group><article-title>New cytotoxic sesterterpenoids from the nudibranch <italic>Chromodoris inornata</italic></article-title><source>Tetrahedron</source><year>1999</year><volume>55</volume><fpage>9133</fpage><lpage>9142</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(99)00477-9</pub-id></element-citation></ref><ref id="B157-marinedrugs-18-00657"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karuso</surname><given-names>P.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Natural products from three nudibranchs: <italic>Nembrotha kubaryana</italic>, <italic>Hypselodoris infucata</italic> and <italic>Chromodoris petechialis</italic></article-title><source>Molecules</source><year>2002</year><volume>7</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3390/70100001-rev</pub-id></element-citation></ref><ref id="B158-marinedrugs-18-00657"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>K.W.</given-names></name><name><surname>Salim</surname><given-names>A.A.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>New oxygenated diterpenes from an Australian nudibranch of the genus <italic>Chromodoris</italic></article-title><source>Tetrahedron</source><year>2008</year><volume>64</volume><fpage>6733</fpage><lpage>6738</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2008.05.008</pub-id></element-citation></ref><ref id="B159-marinedrugs-18-00657"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.H.</given-names></name><name><surname>Otsuka</surname><given-names>M.</given-names></name><name><surname>Muroi</surname><given-names>T.</given-names></name><name><surname>Ono</surname><given-names>A.</given-names></name><name><surname>Hanif</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>J.</given-names></name></person-group><article-title>Deoxymanoalides from the nudibranch <italic>Chromodoris willani</italic></article-title><source>Chem. Pharm. Bull.</source><year>2009</year><volume>57</volume><fpage>885</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1248/cpb.57.885</pub-id></element-citation></ref><ref id="B160-marinedrugs-18-00657"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agena</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>C.</given-names></name><name><surname>Hanif</surname><given-names>N.</given-names></name><name><surname>Yasumoto-Hirose</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>J.</given-names></name></person-group><article-title>New cytotoxic spongian diterpenes from the sponge <italic>Dysidea</italic> cf</article-title><source>arenaria. Tetrahedron</source><year>2009</year><volume>65</volume><fpage>1495</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2008.11.101</pub-id></element-citation></ref><ref id="B161-marinedrugs-18-00657"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suciati</surname><given-names>S.</given-names></name><name><surname>Lambert</surname><given-names>L.K.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Structures and anatomical distribution of oxygenated diterpenes in the Australian nudibranch <italic>Chromodoris reticulata</italic></article-title><source>Aust. J. Chem.</source><year>2011</year><volume>64</volume><fpage>757</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1071/CH11036</pub-id></element-citation></ref><ref id="B162-marinedrugs-18-00657"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katavic</surname><given-names>P.L.</given-names></name><name><surname>Jumaryatno</surname><given-names>P.</given-names></name><name><surname>Hooper</surname><given-names>J.N.</given-names></name><name><surname>Blanchfield</surname><given-names>J.T.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Oxygenated terpenoids from the Australian sponges <italic>Coscinoderma matthewsi</italic> and <italic>Dysidea</italic> sp., and the nudibranch <italic>Chromodoris albopunctata</italic></article-title><source>Aust. J. Chem.</source><year>2012</year><volume>65</volume><fpage>531</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1071/CH12010</pub-id></element-citation></ref><ref id="B163-marinedrugs-18-00657"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katavic</surname><given-names>P.L.</given-names></name><name><surname>Jumaryatno</surname><given-names>P.</given-names></name><name><surname>Hooper</surname><given-names>J.N.</given-names></name><name><surname>Blanchfield</surname><given-names>J.T.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Note of clarification about: Oxygenated Terpenoids from the Australian Sponges <italic>Coscinoderma matthewsi</italic> and <italic>Dysidea</italic> sp., and the Nudibranch <italic>Chromodoris albopunctata</italic></article-title><source>Aust. J. Chem.</source><year>2013</year><volume>66</volume><fpage>1461</fpage></element-citation></ref><ref id="B164-marinedrugs-18-00657"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>White</surname><given-names>A.</given-names></name><name><surname>Mudianta</surname><given-names>I.W.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Quezada</surname><given-names>M.</given-names></name><name><surname>Capon</surname><given-names>R.J.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Choose your weaponry: Selective storage of a single toxic compound, latrunculin A, by closely related nudibranch molluscs</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0145134</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0145134</pub-id><pub-id pub-id-type="pmid">26788920</pub-id></element-citation></ref><ref id="B165-marinedrugs-18-00657"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte</surname><given-names>G.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>McConnell</surname><given-names>O.J.</given-names></name></person-group><article-title>Two furanosesquiterpene marine metabolites with antifeedant properties</article-title><source>Helv. Chim. Acta</source><year>1980</year><volume>63</volume><fpage>2159</fpage><lpage>2167</lpage><pub-id pub-id-type="doi">10.1002/hlca.19800630805</pub-id></element-citation></ref><ref id="B166-marinedrugs-18-00657"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>L.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Naik</surname><given-names>C.G.</given-names></name><name><surname>Parameswaran</surname><given-names>P.S.</given-names></name><name><surname>Wahidulla</surname><given-names>S.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Selected chemo-ecological studies of marine opisthobranchs from Indian coasts</article-title><source>J. Indian Inst. Sci.</source><year>2001</year><volume>81</volume><fpage>403</fpage><lpage>415</lpage></element-citation></ref><ref id="B167-marinedrugs-18-00657"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>J.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name></person-group><article-title>The absolute configuration of kurospongin a new furanoterpene from a marine sponge, <italic>Spongia</italic> sp.</article-title><source>Tetrahedron</source><year>1988</year><volume>44</volume><fpage>2805</fpage><lpage>2810</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(88)90016-6</pub-id></element-citation></ref><ref id="B168-marinedrugs-18-00657"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashman</surname><given-names>Y.</given-names></name><name><surname>Croweiss</surname><given-names>A.</given-names></name><name><surname>Shmueli</surname><given-names>U.</given-names></name></person-group><article-title>Latrunculin, a new 2-thiazolidinone macrolide from the marine sponge <italic>Latrunculia magnifica</italic></article-title><source>Tetrahedron Lett.</source><year>1980</year><volume>21</volume><fpage>3629</fpage><lpage>3632</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(80)80255-3</pub-id></element-citation></ref><ref id="B169-marinedrugs-18-00657"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashman</surname><given-names>Y.</given-names></name><name><surname>Croweiss</surname><given-names>A.</given-names></name><name><surname>Kidor</surname><given-names>R.</given-names></name><name><surname>Blasberger</surname><given-names>D.</given-names></name><name><surname>Carmelya</surname><given-names>S.</given-names></name></person-group><article-title>Latrunculins: NMR study, two new toxins and a synthetic approach</article-title><source>Tetrahedron</source><year>1985</year><volume>41</volume><fpage>1905</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)96553-6</pub-id></element-citation></ref><ref id="B170-marinedrugs-18-00657"><label>170.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Chemical Studies of the Novel Bioactive Secondary Metabolites from the Benthic Invertebrates: Isolation and Structure Characterization</article-title><source>Ph.D. Thesis</source><publisher-name>University of Naples</publisher-name><publisher-loc>Naples, Italy</publisher-loc><year>1997</year></element-citation></ref><ref id="B171-marinedrugs-18-00657"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mebs</surname><given-names>D.</given-names></name></person-group><article-title>Chemical defense of a dorid nudibranch, <italic>Glossodoris quadricolor</italic>, from the Red Sea</article-title><source>J. Chem. Ecol.</source><year>1985</year><volume>11</volume><fpage>713</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1007/BF00988300</pub-id><?supplied-pmid 24310217?><pub-id pub-id-type="pmid">24310217</pub-id></element-citation></ref><ref id="B172-marinedrugs-18-00657"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jefford</surname><given-names>C.W.</given-names></name><name><surname>Bernardinelli</surname><given-names>G.</given-names></name><name><surname>Tanaka</surname><given-names>J.I.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name></person-group><article-title>Structures and absolute configurations of the marine toxins, latrunculin A and laulimalide</article-title><source>Tetrahedron Lett.</source><year>1996</year><volume>37</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)02113-2</pub-id></element-citation></ref><ref id="B173-marinedrugs-18-00657"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A.K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Total synthesis of (&#x02212;)-laulimalide</article-title><source>J. Am. Chem. Soc.</source><year>2000</year><volume>122</volume><fpage>11027</fpage><lpage>11028</lpage><pub-id pub-id-type="doi">10.1021/ja0027416</pub-id><pub-id pub-id-type="pmid">30393384</pub-id></element-citation></ref><ref id="B174-marinedrugs-18-00657"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gollner</surname><given-names>A.</given-names></name><name><surname>Mulzer</surname><given-names>J.</given-names></name></person-group><article-title>Total synthesis of neolaulimalide and isolaulimalide</article-title><source>Organic Lett.</source><year>2008</year><volume>10</volume><fpage>4701</fpage><lpage>4704</lpage><pub-id pub-id-type="doi">10.1021/ol802075v</pub-id><?supplied-pmid 18816129?><pub-id pub-id-type="pmid">18816129</pub-id></element-citation></ref><ref id="B175-marinedrugs-18-00657"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Somerville</surname><given-names>M.J.</given-names></name><name><surname>Mao</surname><given-names>S.-C.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Schupp</surname><given-names>P.J.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Guo</surname><given-names>V.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemistry of <italic>Glossodoris</italic> nudibranchs: Specific occurrence of 12-keto scalaranes</article-title><source>J. Chem. Ecol.</source><year>2007</year><volume>33</volume><fpage>2325</fpage><lpage>2336</lpage><pub-id pub-id-type="doi">10.1007/s10886-007-9387-x</pub-id><?supplied-pmid 18000710?><pub-id pub-id-type="pmid">18000710</pub-id></element-citation></ref><ref id="B176-marinedrugs-18-00657"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>S.D.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Chemical defenses of three <italic>Glossodoris</italic> nudibranchs and their dietary <italic>Hyrtios</italic> sponges</article-title><source>Mar. Ecol. Progr. Ser.</source><year>1991</year><volume>77</volume><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.3354/meps077221</pub-id></element-citation></ref><ref id="B177-marinedrugs-18-00657"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Chemical ecology of the nudibranch <italic>Glossodoris pallida</italic>: Is the location of diet-derived metabolites important for defense?</article-title><source>Mar. Ecol. Progr. Ser.</source><year>1997</year><volume>150</volume><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.3354/meps150171</pub-id></element-citation></ref><ref id="B178-marinedrugs-18-00657"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Dewi</surname><given-names>A.S.</given-names></name><name><surname>Mudianta</surname><given-names>I.W.</given-names></name><name><surname>Wilson</surname><given-names>N.G.</given-names></name><name><surname>Forster</surname><given-names>L.C.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name></person-group><article-title>Distribution of defensive metabolites in nudibranch molluscs</article-title><source>J. Chem. Ecol.</source><year>2018</year><volume>44</volume><fpage>384</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1007/s10886-018-0941-5</pub-id><pub-id pub-id-type="pmid">29552702</pub-id></element-citation></ref><ref id="B179-marinedrugs-18-00657"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhukova</surname><given-names>N.V.</given-names></name></person-group><article-title>Lipids and fatty acids of nudibranch molluscs: Potential sources of bioactive compounds</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>4578</fpage><lpage>4592</lpage><pub-id pub-id-type="doi">10.3390/md12084578</pub-id><pub-id pub-id-type="pmid">25196731</pub-id></element-citation></ref><ref id="B180-marinedrugs-18-00657"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.L.</given-names></name><name><surname>Li</surname><given-names>S.W.</given-names></name><name><surname>Yao</surname><given-names>L.G.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>The chemical and chemo-ecological studies on Weizhou nudibranch Glossodoris atromarginata</article-title><source>Magn Reson Chem.</source><year>2019</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/mrc.4949</pub-id></element-citation></ref><ref id="B181-marinedrugs-18-00657"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somerville</surname><given-names>M.J.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Rungprom</surname><given-names>W.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Spongian diterpenes from Australian nudibranchs: An anatomically guided chemical study of <italic>Glossodoris atromarginata</italic></article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1836</fpage><pub-id pub-id-type="doi">10.1021/np070553o</pub-id></element-citation></ref><ref id="B182-marinedrugs-18-00657"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>K.W.</given-names></name><name><surname>Mudianta</surname><given-names>I.W.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name></person-group><article-title>: Blanchfield, J.T.; Garson, M.J. Isolation of norsesterterpenes and spongian diterpenes from <italic>Dorisprismatica</italic> (=<italic>Glossodoris</italic>) <italic>atromarginata</italic></article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>421</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1021/np500797b</pub-id><pub-id pub-id-type="pmid">25584880</pub-id></element-citation></ref><ref id="B183-marinedrugs-18-00657"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Scalarane and homoscalarane compounds from the nudibranchs <italic>Glossodoris sedna</italic> and <italic>Glossodoris dalli</italic>: Chemical and biological properties</article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>527</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1021/np990506z</pub-id><pub-id pub-id-type="pmid">10785432</pub-id></element-citation></ref><ref id="B184-marinedrugs-18-00657"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>The chemical defense of four Mediterranean nudibranchs</article-title><source>Comp. Biochem. Physiol. B Comp. Biochem.</source><year>1982</year><volume>73</volume><fpage>471</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(82)90061-X</pub-id></element-citation></ref><ref id="B185-marinedrugs-18-00657"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>L.C.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Dewapriya</surname><given-names>P.</given-names></name><name><surname>Capon</surname><given-names>R.J.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Spongian-16-one diterpenes and their anatomical distribution in the Australian nudibranch <italic>Goniobranchus collingwoodi</italic></article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>670</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00936</pub-id><?supplied-pmid 28032760?><pub-id pub-id-type="pmid">28032760</pub-id></element-citation></ref><ref id="B186-marinedrugs-18-00657"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudianta</surname><given-names>W.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Suciati</surname><given-names>P.L.K.</given-names></name><name><surname>Krishnaraj</surname><given-names>R.R.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Chemoecological studies on marine natural products: Terpene chemistry from marine mollusks</article-title><source>Pure Appl. Chem.</source><year>2014</year><volume>86</volume><fpage>995</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1515/pac-2013-1111</pub-id></element-citation></ref><ref id="B187-marinedrugs-18-00657"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Geographic variation in diterpene-based secondary metabolites and level of defence in an aposematic nudibranch, <italic>Goniobranchus splendidus</italic></article-title><source>J. Moll. Stud.</source><year>2019</year><volume>85</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1093/mollus/eyy057</pub-id></element-citation></ref><ref id="B188-marinedrugs-18-00657"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Green</surname><given-names>N.F.</given-names></name><name><surname>Wilson</surname><given-names>N.G.</given-names></name><name><surname>How</surname><given-names>M.J.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Marshall</surname><given-names>N.J.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name></person-group><article-title>Stabilizing selection on individual pattern elements of aposematic signals</article-title><source>Proc. R. Soc. B</source><year>2017</year><volume>284</volume><fpage>20170926</fpage><pub-id pub-id-type="doi">10.1098/rspb.2017.0926</pub-id><?supplied-pmid 28835556?><pub-id pub-id-type="pmid">28835556</pub-id></element-citation></ref><ref id="B189-marinedrugs-18-00657"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Dewi</surname><given-names>A.S.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Blanchfield</surname><given-names>J.T.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Oxygenated diterpenes from the Indo-Pacific nudibranchs <italic>Goniobranchus splendidus</italic> and <italic>Ardeadoris egretta</italic></article-title><source>Nat. Prod. Commun.</source><year>2016</year><volume>11</volume><fpage>921</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1177/1934578X1601100714</pub-id><pub-id pub-id-type="pmid">30452163</pub-id></element-citation></ref><ref id="B190-marinedrugs-18-00657"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirayama</surname><given-names>Y.</given-names></name><name><surname>Katavic</surname><given-names>P.L.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Pierens</surname><given-names>G.K.</given-names></name><name><surname>Lambert</surname><given-names>L.K.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Kita</surname><given-names>M.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>New cytotoxic norditerpenes from the Australian nudibranchs <italic>Goniobranchus splendidus</italic> and <italic>Goniobranchus daphne</italic></article-title><source>Aust. J. Chem.</source><year>2016</year><volume>69</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1071/CH15203</pub-id></element-citation></ref><ref id="B191-marinedrugs-18-00657"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudianta</surname><given-names>I.W.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Oxygenated Terpenes from Indo-Pacific nudibranchs: Scalarane sesterterpenes from <italic>Glossodoris hikuerensis</italic> and 12-Acetoxy dendrillolide A from <italic>Goniobranchus albonares</italic></article-title><source>Nat. Prod. Commun.</source><year>2015</year><volume>10</volume><fpage>865</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1177/1934578X1501000617</pub-id><pub-id pub-id-type="pmid">26197502</pub-id></element-citation></ref><ref id="B192-marinedrugs-18-00657"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Pierens</surname><given-names>G.K.</given-names></name><name><surname>Forster</surname><given-names>L.C.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Rearranged diterpenes and norditerpenes from three Australian <italic>Goniobranchus</italic> mollusks</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00866</pub-id><pub-id pub-id-type="pmid">26698272</pub-id></element-citation></ref><ref id="B193-marinedrugs-18-00657"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical studies on Indopacific <italic>Ceratosoma</italic> nudibranchs illuminate the protective role of their dorsal horn</article-title><source>Chemoecology</source><year>2005</year><volume>15</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s00049-005-0289-5</pub-id></element-citation></ref><ref id="B194-marinedrugs-18-00657"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Guerriero</surname><given-names>A.</given-names></name><name><surname>Minale</surname><given-names>L.</given-names></name></person-group><article-title>Furanosesquiterpenoids in sponges-III. Pallescensins AD from <italic>Disidea pallescens</italic>: New skeletal types</article-title><source>Tetrahedron Lett.</source><year>1975</year><volume>16</volume><fpage>1425</fpage><lpage>1428</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)72159-9</pub-id></element-citation></ref><ref id="B195-marinedrugs-18-00657"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazlauskas</surname><given-names>R.</given-names></name><name><surname>Murphy</surname><given-names>P.T.</given-names></name><name><surname>Wells</surname><given-names>R.J.</given-names></name><name><surname>Daly</surname><given-names>J.J.</given-names></name><name><surname>Sch&#x000f6;nholzer</surname><given-names>P.</given-names></name></person-group><article-title>Two sesquiterpene furans with new carbocyclic ring systems and related thiol acetates from a species of the sponge genus <italic>Dysidea</italic></article-title><source>Tetrahedron Lett.</source><year>1978</year><volume>19</volume><fpage>4951</fpage><lpage>4954</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)85779-8</pub-id></element-citation></ref><ref id="B196-marinedrugs-18-00657"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>G.M.</given-names></name><name><surname>Stapleton</surname><given-names>B.L.</given-names></name><name><surname>Simonsen</surname><given-names>S.M.</given-names></name><name><surname>Brecknell</surname><given-names>D.J.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>New sesquiterpene and brominated metabolites from the tropical marine sponge <italic>Dysidea</italic> sp.</article-title><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>5247</fpage><lpage>5252</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00434-8</pub-id></element-citation></ref><ref id="B197-marinedrugs-18-00657"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charles</surname><given-names>C.</given-names></name><name><surname>Braekman</surname><given-names>J.C.</given-names></name><name><surname>Daloze</surname><given-names>D.</given-names></name><name><surname>Tursch</surname><given-names>B.</given-names></name><name><surname>Declercq</surname><given-names>J.P.</given-names></name><name><surname>Germain</surname><given-names>G.</given-names></name><name><surname>Van Meerssche</surname><given-names>M.</given-names></name></person-group><article-title>Chemical studies of marine invertebrates. XXXIV. Herbadysidolide and herbasolide, two unusual sesquiterpenoids from the sponge <italic>Dysidea herbacea</italic></article-title><source>Bull. Soc. Chim. Belg.</source><year>1978</year><volume>87</volume><fpage>481</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1002/bscb.19780870609</pub-id></element-citation></ref><ref id="B198-marinedrugs-18-00657"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Martinez</surname><given-names>E.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Defensive allomones in three species of <italic>Hypselodoris</italic> (gastropoda: Nudibranchia) from the Cantabrian sea</article-title><source>J. Chem. Ecol.</source><year>1993</year><volume>19</volume><fpage>339</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1007/BF00993700</pub-id><pub-id pub-id-type="pmid">24248879</pub-id></element-citation></ref><ref id="B199-marinedrugs-18-00657"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Walker</surname><given-names>R.P.</given-names></name><name><surname>Ireland</surname><given-names>C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Metabolites of four nudibranchs of the genus <italic>Hypselodoris</italic></article-title><source>J. Org. Chem.</source><year>1982</year><volume>47</volume><fpage>88</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1021/jo00340a018</pub-id></element-citation></ref><ref id="B200-marinedrugs-18-00657"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grode</surname><given-names>S.H.</given-names></name><name><surname>Cardellina</surname><given-names>J.H.</given-names></name></person-group><article-title>Sesquiterpenes from the sponge <italic>Dysidea etheria</italic> and the nudibranch <italic>Hypselodoris zebra</italic></article-title><source>J. Nat. Prod.</source><year>1984</year><volume>47</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1021/np50031a009</pub-id></element-citation></ref><ref id="B201-marinedrugs-18-00657"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-G&#x000f3;mez</surname><given-names>J.C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Medina</surname><given-names>A.</given-names></name></person-group><article-title>Studies on the defensive behaviour of <italic>Hypselodoris</italic> species (Gastropoda: Nudibranchia): Ultrastructure and chemical analysis of mantle dermal formations (MDFs)</article-title><source>Mar. Biol.</source><year>1990</year><volume>106</volume><fpage>245</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1007/BF01314807</pub-id></element-citation></ref><ref id="B202-marinedrugs-18-00657"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name></person-group><article-title>Defensive strategy of two <italic>Hypselodoris</italic> nudibranchs from Italian and Spanish coasts</article-title><source>J. Chem. Ecol.</source><year>1991</year><volume>17</volume><fpage>625</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1007/BF00982131</pub-id><pub-id pub-id-type="pmid">24258811</pub-id></element-citation></ref><ref id="B203-marinedrugs-18-00657"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Gim&#x000e9;nez</surname><given-names>F.</given-names></name><name><surname>Marin</surname><given-names>A.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Zubia</surname><given-names>E.</given-names></name></person-group><article-title>Biotransformation of a dietary sesterterpenoid in the Mediterranean nudibranch <italic>Hypselodoris orsini</italic></article-title><source>Experientia</source><year>1993</year><volume>49</volume><fpage>582</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1007/BF01955168</pub-id></element-citation></ref><ref id="B204-marinedrugs-18-00657"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Martinez</surname><given-names>E.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name></person-group><article-title>Further chemical studies of Mediterranean and Atlantic <italic>Hypselodoris</italic> nudibranchs: A new furanosesquiterpenoid from <italic>Hypsdodoris webbi</italic></article-title><source>J. Nat. Prod.</source><year>1994</year><volume>57</volume><fpage>510</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1021/np50106a011</pub-id></element-citation></ref><ref id="B205-marinedrugs-18-00657"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>M.</given-names></name><name><surname>Cerfeda</surname><given-names>S.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Neves</surname><given-names>R.</given-names></name><name><surname>Maharajan</surname><given-names>V.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name><etal/></person-group><article-title>Coloration and defense in the nudibranch gastropod <italic>Hypselodoris fontandraui</italic></article-title><source>Biol. Bull.</source><year>2010</year><volume>218</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1086/BBLv218n2p181</pub-id><?supplied-pmid 20413794?><pub-id pub-id-type="pmid">20413794</pub-id></element-citation></ref><ref id="B206-marinedrugs-18-00657"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Cruz</surname><given-names>J.F.</given-names></name><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name></person-group><article-title>Turning the game around: Toxicity in a nudibranch-sponge predator-prey association</article-title><source>Chemoecology</source><year>2012</year><volume>22</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1007/s00049-011-0097-z</pub-id></element-citation></ref><ref id="B207-marinedrugs-18-00657"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>F.R.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.S.</given-names></name><name><surname>Rodrigues Filho</surname><given-names>E.</given-names></name><name><surname>Veloso</surname><given-names>K.</given-names></name><name><surname>Ferreira</surname><given-names>A.G.</given-names></name><name><surname>Padula</surname><given-names>V.</given-names></name></person-group><article-title>Metab&#x000f3;litos secund&#x000e1;rios dos nudibr&#x000e2;nquios <italic>Tambja stegosauriformis</italic>, <italic>Hypselodoris lajensis</italic> e <italic>Okenia zoobotryon</italic> e dos briozo&#x000e1;rios <italic>Zoobotryon verticillatum</italic> e <italic>Bugula dentata</italic> da costa do Brasil</article-title><source>Quim. Nova</source><year>2012</year><volume>35</volume><fpage>2194</fpage><lpage>2201</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422012001100018</pub-id></element-citation></ref><ref id="B208-marinedrugs-18-00657"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Minale</surname><given-names>L.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name></person-group><article-title>Furanosesquiterpenoids in sponges-V: Spiniferins from <italic>Pleraplysilla spinifera</italic></article-title><source>Tetrahedron Lett.</source><year>1975</year><volume>16</volume><fpage>3727</fpage><lpage>3730</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)91320-0</pub-id></element-citation></ref><ref id="B209-marinedrugs-18-00657"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudianta</surname><given-names>I.W.</given-names></name><name><surname>Challinor</surname><given-names>V.L.</given-names></name><name><surname>Winters</surname><given-names>A.E.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>De Voss</surname><given-names>J.J.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Synthesis and determination of the absolute configuration of (&#x02212;)-(5R, 6Z)-dendrolasin-5-acetate from the nudibranch <italic>Hypselodoris jacksoni</italic></article-title><source>Beilstein J. Org. Chem.</source><year>2013</year><volume>9</volume><fpage>2925</fpage><lpage>2933</lpage><pub-id pub-id-type="doi">10.3762/bjoc.9.329</pub-id><pub-id pub-id-type="pmid">24454572</pub-id></element-citation></ref><ref id="B210-marinedrugs-18-00657"><label>210.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Substancias Naturales de Moluscos Opistobranquios: Estudio de su Estructura, Origen y Funci&#x000f3;n en Ecosistemas Bent&#x000f3;nicos</article-title><source>Ph.D. Thesis</source><publisher-name>University of Barcelona</publisher-name><publisher-loc>Barcelona, Catalonia, Spain</publisher-loc><year>1993</year></element-citation></ref><ref id="B211-marinedrugs-18-00657"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Durfort</surname><given-names>M.</given-names></name></person-group><article-title>Histology of epithelia and mantle glands of selected species of doridacean mollusks with chemical defensive strategies</article-title><source>Veliger</source><year>1996</year><volume>39</volume><fpage>148</fpage><lpage>163</lpage></element-citation></ref><ref id="B212-marinedrugs-18-00657"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Rodrigues</surname><given-names>A.I.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name></person-group><article-title>Comparative study of chemical defences from two allopatric north Atlantic subspecies of <italic>Hypselodoris picta</italic> (Mollusca: Opisthobranchia)</article-title><source>A&#x000e7;oreana</source><year>2009</year><volume>6</volume><fpage>137</fpage><lpage>143</lpage></element-citation></ref><ref id="B213-marinedrugs-18-00657"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPhail</surname><given-names>K.L.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name><name><surname>Coetzee</surname><given-names>P.</given-names></name></person-group><article-title>A new furanosesterterpene from the South African nudibranch <italic>Hypselodoris capensis</italic> and a Dictyoceratida sponge</article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>961</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1021/np980051y</pub-id><pub-id pub-id-type="pmid">9677286</pub-id></element-citation></ref><ref id="B214-marinedrugs-18-00657"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudianta</surname><given-names>W.I.</given-names></name><name><surname>Martiningsih</surname><given-names>N.W.</given-names></name><name><surname>Dodik Prasetia</surname><given-names>I.N.</given-names></name><name><surname>Nursid</surname><given-names>M.</given-names></name></person-group><article-title>Bioactive terpenoid from the balinese nudibranch <italic>Hypselodoris infucata</italic></article-title><source>Indones. J. Pharm.</source><year>2016</year><volume>27</volume><fpage>104</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.14499/indonesianjpharm27iss2pp104</pub-id></element-citation></ref><ref id="B215-marinedrugs-18-00657"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guella</surname><given-names>G.</given-names></name><name><surname>Mancini</surname><given-names>I.</given-names></name><name><surname>Guerriero</surname><given-names>A.</given-names></name><name><surname>Pietra</surname><given-names>F.</given-names></name></person-group><article-title>New furano-sesquiterpenoids from Mediterranean sponges</article-title><source>Helv. Chim. Acta</source><year>1985</year><volume>68</volume><fpage>1276</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1002/hlca.19850680523</pub-id></element-citation></ref><ref id="B216-marinedrugs-18-00657"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Munia&#x000ed;n</surname><given-names>C.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>First chemical study of patagonian nudibranchs: A new seco-11, 12-spongiane, tyrinnal, from the defensive organs of <italic>Tyrinna nobilis</italic></article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>1027</fpage><lpage>1029</lpage><pub-id pub-id-type="doi">10.1021/np980073k</pub-id><?supplied-pmid 9722492?><pub-id pub-id-type="pmid">9722492</pub-id></element-citation></ref><ref id="B217-marinedrugs-18-00657"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Koseki</surname><given-names>K.</given-names></name><name><surname>Noma</surname><given-names>M.</given-names></name></person-group><article-title>Bioactive marine metabolites</article-title><source>J. Ame. Chem. Soc.</source><year>1986</year><volume>13</volume><fpage>847</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1021/ja00264a053</pub-id></element-citation></ref><ref id="B218-marinedrugs-18-00657"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlik</surname><given-names>J.R.</given-names></name><name><surname>Kernan</surname><given-names>M.R.</given-names></name><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Harper</surname><given-names>M.K.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Defensive chemicals of the Spanish dancer nudibranch <italic>Hexabranchus sanguineus</italic> and its egg ribbons: Macrolides derived from a sponge diet</article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>1988</year><volume>119</volume><fpage>99</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/0022-0981(88)90225-0</pub-id></element-citation></ref><ref id="B219-marinedrugs-18-00657"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalisay</surname><given-names>D.S.</given-names></name><name><surname>Rogers</surname><given-names>E.W.</given-names></name><name><surname>Edison</surname><given-names>A.S.</given-names></name><name><surname>Molinski</surname><given-names>T.F.</given-names></name></person-group><article-title>Trisoxazole macrolides and thiazole-containing cyclic peptides from the nudibranch <italic>Hexabranchus sanguineus</italic></article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>732</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1021/np8007649</pub-id><?supplied-pmid 19254038?><pub-id pub-id-type="pmid">19254038</pub-id></element-citation></ref><ref id="B220-marinedrugs-18-00657"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Koseki</surname><given-names>K.</given-names></name><name><surname>Noguchi</surname><given-names>H.</given-names></name><name><surname>Noma</surname><given-names>M.</given-names></name><name><surname>Sankawa</surname><given-names>U.</given-names></name></person-group><article-title>Bioactive marine metabolites, part 25. Further kabiramides and halichondramides cytotoxic peptides from <italic>Hexabranchus</italic> egg masses</article-title><source>J. Org. Chem.</source><year>1989</year><volume>54</volume><fpage>1360</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1021/jo00267a024</pub-id></element-citation></ref><ref id="B221-marinedrugs-18-00657"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernan</surname><given-names>M.R.</given-names></name><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Macrocyclic antifungal metabolites from the Spanish dancer nudibranch <italic>Hexabranchus sanguineus</italic> and sponges of the genus <italic>Halichondria</italic></article-title><source>J. Org. Chem.</source><year>1988</year><volume>53</volume><fpage>5014</fpage><lpage>5020</lpage><pub-id pub-id-type="doi">10.1021/jo00256a021</pub-id></element-citation></ref><ref id="B222-marinedrugs-18-00657"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roesener</surname><given-names>J.A.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Ulapualide A and B, extraordinary antitumor macrolides from nudibranch eggmasses</article-title><source>J. Am. Chem. Soc.</source><year>1986</year><volume>108</volume><fpage>846</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1021/ja00264a052</pub-id></element-citation></ref><ref id="B223-marinedrugs-18-00657"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cart&#x000e9;</surname><given-names>B.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Defensive metabolites from three nembrothid nudibranchs</article-title><source>J. Org. Chem.</source><year>1983</year><volume>48</volume><fpage>2314</fpage><lpage>2318</lpage><pub-id pub-id-type="doi">10.1021/jo00162a003</pub-id></element-citation></ref><ref id="B224-marinedrugs-18-00657"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granato</surname><given-names>A.C.</given-names></name><name><surname>de Oliveira</surname><given-names>J.H.</given-names></name><name><surname>Seleghim</surname><given-names>M.H.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.</given-names></name><name><surname>Macedo</surname><given-names>M.L.</given-names></name><name><surname>Ferreira</surname><given-names>A.G.</given-names></name><name><surname>Rocha</surname><given-names>R.M.D.</given-names></name><name><surname>Hajdu</surname><given-names>E.</given-names></name><name><surname>Peixinho</surname><given-names>S.</given-names></name><name><surname>Pessoa</surname><given-names>C.O.</given-names></name><etal/></person-group><article-title>Produtos naturais da ascidia <italic>Botrylloides giganteum</italic>, das esponjas <italic>Verongula gigantea</italic>, <italic>Ircinia felix</italic>, <italic>Cliona delitrix</italic> e do nudibr&#x000e2;nquio <italic>Tambja eliora</italic>, da costa do Brasil</article-title><source>Quim. Nova</source><year>2005</year><volume>28</volume><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422005000200005</pub-id></element-citation></ref><ref id="B225-marinedrugs-18-00657"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackman</surname><given-names>A.J.</given-names></name><name><surname>Li</surname><given-names>C.P.</given-names></name></person-group><article-title>New tambjamine alkaloids from the marine bryozoan <italic>Bugula dentata</italic></article-title><source>Aust. J. Chem.</source><year>1994</year><volume>47</volume><fpage>1625</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1071/CH9941625</pub-id></element-citation></ref><ref id="B226-marinedrugs-18-00657"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.</given-names></name><name><surname>Lindquist</surname><given-names>N.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Chemical defenses of the tropical ascidian <italic>Atapozoa</italic> sp. and its nudibranch predators <italic>Nembrotha</italic> spp<italic/></article-title><source>Mar. Ecol. Prog. Ser.</source><year>1990</year><volume>59</volume><fpage>109</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.3354/meps059109</pub-id></element-citation></ref><ref id="B227-marinedrugs-18-00657"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindquist</surname><given-names>N.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>New tamjamine class alkaloids from the marine ascidian <italic>Atapozoa</italic> sp. and its nudibranch predators. Origin of the tambjamines in <italic>Atapozoa</italic></article-title><source>Experientia</source><year>1991</year><volume>47</volume><fpage>504</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1007/BF01959957</pub-id></element-citation></ref><ref id="B228-marinedrugs-18-00657"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Irace</surname><given-names>C.</given-names></name><name><surname>Costagliola</surname><given-names>F.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Padula</surname><given-names>V.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Cervera</surname><given-names>J.L.</given-names></name><name><surname>Santamaria</surname><given-names>R.</given-names></name><etal/></person-group><article-title>A new cytotoxic tambjamine alkaloid from the Azorean nudibranch <italic>Tambja ceutae</italic></article-title><source>Bioorg. Med. Chem. Lett.</source><year>2010</year><volume>20</volume><fpage>2668</fpage><lpage>2670</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.02.020</pub-id><?supplied-pmid 20227875?><pub-id pub-id-type="pmid">20227875</pub-id></element-citation></ref><ref id="B229-marinedrugs-18-00657"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronin</surname><given-names>G.</given-names></name><name><surname>Hay</surname><given-names>M.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Lindquist</surname><given-names>N.</given-names></name></person-group><article-title>Distribution, density, and sequestration of host chemical defenses by the specialist nudibranch <italic>Tritonia hamnerorum</italic> found at high densities on the sea fan <italic>Gorgonia ventalina</italic></article-title><source>Mar. Ecol. Prog. Ser.</source><year>1995</year><volume>119</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.3354/meps119177</pub-id></element-citation></ref><ref id="B230-marinedrugs-18-00657"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Bryan</surname><given-names>P.J.</given-names></name><name><surname>Slattery</surname><given-names>M.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Hamann</surname><given-names>M.</given-names></name><name><surname>Heine</surname><given-names>J.N.</given-names></name></person-group><article-title>Chemical ecology of three Antarctic gastropods</article-title><source>Antarct. J.</source><year>1994</year><volume>29</volume><fpage>151</fpage><lpage>154</lpage></element-citation></ref><ref id="B231-marinedrugs-18-00657"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name><name><surname>Slattery</surname><given-names>M.</given-names></name><name><surname>Heine</surname><given-names>J.N.</given-names></name><name><surname>Bryan</surname><given-names>P.J.</given-names></name><name><surname>Yoshida</surname><given-names>W.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Chemical defense of common Antarctic shallow-water nudibranch <italic>Tritoniella belli</italic> Eliot (Mollusca: Tritonidae) and its prey, <italic>Clavularia frankliniana</italic> Rouel (Cnidaria: Octocorallia)</article-title><source>J. Chem. Ecol.</source><year>1994</year><volume>20</volume><fpage>3361</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.1007/BF02033732</pub-id><pub-id pub-id-type="pmid">24241998</pub-id></element-citation></ref><ref id="B232-marinedrugs-18-00657"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>P.J.</given-names></name><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Population biology and antipredator defenses of the shallow-water Antarctic nudibranch <italic>Tritoniella belli</italic></article-title><source>Mar. Biol.</source><year>1998</year><volume>132</volume><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1007/s002270050391</pub-id></element-citation></ref><ref id="B233-marinedrugs-18-00657"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Palatability and chemical defense in the eggs, embryos and larvae of shallow-water Antarctic marine invertebrates</article-title><source>Mar. Ecol. Progr. Ser.</source><year>1997</year><volume>154</volume><fpage>121</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.3354/meps154121</pub-id></element-citation></ref><ref id="B234-marinedrugs-18-00657"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Mattia</surname><given-names>C.A.</given-names></name><name><surname>Tedesco</surname><given-names>C.</given-names></name><name><surname>Irace</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Li</surname><given-names>X.-B.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Tritoniopsins A&#x02013;D, cladiellane-based diterpenes from the south china sea nudibranch <italic>Tritoniopsis elegans</italic> and its prey <italic>Cladiella krempfi</italic></article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1902</fpage><lpage>1907</lpage><pub-id pub-id-type="doi">10.1021/np200342k</pub-id><pub-id pub-id-type="pmid">21861494</pub-id></element-citation></ref><ref id="B235-marinedrugs-18-00657"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Affeld</surname><given-names>S.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Kehraus</surname><given-names>S.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Distribution of homarine in some Opisthobranchia (Gastropoda: Mollusca)</article-title><source>Bonn. Zool. Beitr.</source><year>2007</year><volume>55</volume><fpage>181</fpage><lpage>190</lpage></element-citation></ref><ref id="B236-marinedrugs-18-00657"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Yoshida</surname><given-names>W.</given-names></name><name><surname>Slattery</surname><given-names>M.</given-names></name><name><surname>Heine</surname><given-names>J.N.</given-names></name><name><surname>Bryan</surname><given-names>P.J.</given-names></name><name><surname>Jayatilake</surname><given-names>G.S.</given-names></name><name><surname>Moon</surname><given-names>B.H.</given-names></name></person-group><article-title>Homarine as a feeding deterrent in common shallow-water antarctic lamellarian gastropod <italic>Marseniopsis mollis</italic>: A rare example of chemical defense in a marine prosobranch</article-title><source>J. Chem. Ecol.</source><year>1994</year><volume>20</volume><fpage>2539</fpage><lpage>2549</lpage><pub-id pub-id-type="doi">10.1007/BF02036190</pub-id><?supplied-pmid 24241830?><pub-id pub-id-type="pmid">24241830</pub-id></element-citation></ref><ref id="B237-marinedrugs-18-00657"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name></person-group><article-title>A marine mollusc provides the first example of in vivo storage of prostaglandins: Prostaglandin-1, 15-lactones</article-title><source>Experientia</source><year>1991</year><volume>47</volume><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/BF02041252</pub-id><?supplied-pmid 1999245?><pub-id pub-id-type="pmid">1999245</pub-id></element-citation></ref><ref id="B238-marinedrugs-18-00657"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Naturally occurring prostaglandin-1, 15-lactones</article-title><source>Tetrahedron Lett.</source><year>1989</year><volume>30</volume><fpage>3589</fpage><lpage>3592</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)99449-8</pub-id></element-citation></ref><ref id="B239-marinedrugs-18-00657"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Prostaglandin 1, 15-lactones of the F series from the nudibranch mollusk <italic>Tethys fimbria</italic></article-title><source>J. Org. Chem.</source><year>1991</year><volume>56</volume><fpage>2907</fpage><lpage>2911</lpage><pub-id pub-id-type="doi">10.1021/jo00008a056</pub-id></element-citation></ref><ref id="B240-marinedrugs-18-00657"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Minardi</surname><given-names>C.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name></person-group><article-title>A novel multifunctional metabolic pathway in a marine mollusc leads to unprecedented prostaglandin derivatives (prostaglandin 1, 15-lactones)</article-title><source>Biochem. J.</source><year>1991</year><volume>273</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1042/bj2730593</pub-id><pub-id pub-id-type="pmid">1899996</pub-id></element-citation></ref><ref id="B241-marinedrugs-18-00657"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Moles</surname><given-names>J.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Granuloside, a unique linear homosesterterpene from the Antarctic nudibranch <italic>Charcotia granulosa</italic></article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>1761</fpage><lpage>1764</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00378</pub-id><pub-id pub-id-type="pmid">26177282</pub-id></element-citation></ref><ref id="B242-marinedrugs-18-00657"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moles</surname><given-names>J.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Distribution of granuloside in the Antarctic nudibranch <italic>Charcotia granulosa</italic> (Gastropoda: Heterobranchia: Charcotiidae)</article-title><source>Mar. Biol.</source><year>2016</year><volume>163</volume><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/s00227-016-2831-0</pub-id></element-citation></ref><ref id="B243-marinedrugs-18-00657"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putz</surname><given-names>A.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name></person-group><article-title>Defensive strategies of Cladobranchia (Gastropoda, Opisthobranchia)</article-title><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>1386</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1039/b923849m</pub-id><pub-id pub-id-type="pmid">20714466</pub-id></element-citation></ref><ref id="B244-marinedrugs-18-00657"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Affeld</surname><given-names>S.</given-names></name><name><surname>Kehraus</surname><given-names>S.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Dietary derived sesquiterpenes from <italic>Phyllodesmium lizardensis</italic></article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>298</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1021/np800583e</pub-id><pub-id pub-id-type="pmid">19173621</pub-id></element-citation></ref><ref id="B245-marinedrugs-18-00657"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coll</surname><given-names>J.</given-names></name><name><surname>Bowden</surname><given-names>B.</given-names></name><name><surname>Tapiolas</surname><given-names>D.</given-names></name><name><surname>Willis</surname><given-names>R.</given-names></name><name><surname>Djura</surname><given-names>P.</given-names></name><name><surname>Streamer</surname><given-names>M.</given-names></name><name><surname>Trott</surname><given-names>L.</given-names></name></person-group><article-title>Studies of Australian soft corals XXXV: The terpenoid chemistry of soft corals and its implications</article-title><source>Tetrahedron</source><year>1985</year><volume>41</volume><fpage>1085</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)96476-2</pub-id></element-citation></ref><ref id="B246-marinedrugs-18-00657"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>M.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Starmer</surname><given-names>J.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>A sequestered soft coral diterpene in the aeolid nudibranch <italic>Phyllodesmium guamensis</italic></article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>1998</year><volume>226</volume><fpage>33</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/S0022-0981(97)00240-2</pub-id></element-citation></ref><ref id="B247-marinedrugs-18-00657"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edrada</surname><given-names>R.A.</given-names></name><name><surname>Wray</surname><given-names>V.</given-names></name><name><surname>Witte</surname><given-names>L.</given-names></name><name><surname>van Ofwegen</surname><given-names>L.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Bioactive terpenes from the soft coral <italic>Heteroxenia</italic> sp. from Mindoro, Philippines</article-title><source>Z. Naturforsch.</source><year>2000</year><volume>55</volume><fpage>82</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1515/znc-2000-1-216</pub-id><?supplied-pmid 10739105?><pub-id pub-id-type="pmid">10739105</pub-id></element-citation></ref><ref id="B248-marinedrugs-18-00657"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanov</surname><given-names>A.</given-names></name><name><surname>Kehraus</surname><given-names>S.</given-names></name><name><surname>Bleidissel</surname><given-names>S.</given-names></name><name><surname>Preisfeld</surname><given-names>G.</given-names></name><name><surname>Schillo</surname><given-names>D.</given-names></name><name><surname>Piel</surname><given-names>J.</given-names></name><name><surname>Brachmann</surname><given-names>A.O.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Defense in the Aeolidoidean Genus <italic>Phyllodesmium</italic> (Gastropoda)</article-title><source>J. Chem. Ecol.</source><year>2014</year><volume>40</volume><fpage>1013</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1007/s10886-014-0496-z</pub-id><pub-id pub-id-type="pmid">25244950</pub-id></element-citation></ref><ref id="B249-marinedrugs-18-00657"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>S.C.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name></person-group><article-title>A new rare asteriscane sesquiterpene and other related derivatives from the Hainan aeolid nudibranch <italic>Phyllodesmium magnum</italic></article-title><source>Biochem. System. Ecol.</source><year>2011</year><volume>39</volume><fpage>408</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2011.05.018</pub-id></element-citation></ref><ref id="B250-marinedrugs-18-00657"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanov</surname><given-names>A.</given-names></name><name><surname>Hertzer</surname><given-names>C.</given-names></name><name><surname>Kehraus</surname><given-names>S.</given-names></name><name><surname>Nietzer</surname><given-names>S.</given-names></name><name><surname>Rohde</surname><given-names>S.</given-names></name><name><surname>Schupp</surname><given-names>P.J.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Defensive diterpene from the Aeolidoidean <italic>Phyllodesmium longicirrum</italic></article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>611</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00860</pub-id><pub-id pub-id-type="pmid">26649919</pub-id></element-citation></ref><ref id="B251-marinedrugs-18-00657"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanov</surname><given-names>A.</given-names></name><name><surname>Hertzer</surname><given-names>C.</given-names></name><name><surname>Kehraus</surname><given-names>S.</given-names></name><name><surname>Nietzer</surname><given-names>S.</given-names></name><name><surname>Rohde</surname><given-names>S.</given-names></name><name><surname>Schupp</surname><given-names>P.J.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Secondary metabolome and its defensive role in the aeolidoidean <italic>Phyllodesmium longicirrum</italic> (Gastropoda, Heterobranchia, Nudibranchia)</article-title><source>Beilstein J. Org. Chem.</source><year>2017</year><volume>13</volume><fpage>502</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.3762/bjoc.13.50</pub-id><pub-id pub-id-type="pmid">28405231</pub-id></element-citation></ref><ref id="B252-marinedrugs-18-00657"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillette</surname><given-names>R.</given-names></name><name><surname>Saeki</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>R.C.</given-names></name></person-group><article-title>Defensive mechanisms in notaspid snails: Acid humor and evasiveness</article-title><source>J. Exp. Biol.</source><year>1991</year><volume>156</volume><fpage>335</fpage><lpage>347</lpage></element-citation></ref><ref id="B253-marinedrugs-18-00657"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willan</surname><given-names>R.C.</given-names></name></person-group><article-title>A review of the diets in the Notaspidea (Mollusca: Opisthobranchia)</article-title><source>J. Malacol. Soc. Aust.</source><year>1984</year><volume>6</volume><fpage>125</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1080/00852988.1984.10673965</pub-id></element-citation></ref><ref id="B254-marinedrugs-18-00657"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taboada</surname><given-names>S.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez-Pons</surname><given-names>L.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Feeding repellence of Antarctic and sub-Antarctic benthic invertebrates against the omnivorous sea star <italic>Odontaster validus</italic> Koehler, 1906</article-title><source>Pol. Biol.</source><year>2013</year><volume>36</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/s00300-012-1234-z</pub-id></element-citation></ref><ref id="B255-marinedrugs-18-00657"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moles</surname><given-names>J.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez-Pons</surname><given-names>L.</given-names></name><name><surname>Taboada</surname><given-names>S.</given-names></name><name><surname>Figuerola</surname><given-names>B.</given-names></name><name><surname>Cristobo</surname><given-names>J.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>Anti-predatory chemical defences in Antarctic benthic fauna</article-title><source>Mar. Biol.</source><year>2015</year><volume>162</volume><fpage>1813</fpage><lpage>1821</lpage><pub-id pub-id-type="doi">10.1007/s00227-015-2714-9</pub-id></element-citation></ref><ref id="B256-marinedrugs-18-00657"><label>256.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Antibiotics from marine organisms of the Gulf of California</article-title><source>Proceedings of the Abstracts from 3rd Conference on Food and Drugs from the Sea</source><conf-loc>Kingston, RI, USA</conf-loc><conf-date>20&#x02013;23 August 1972</conf-date><fpage>111</fpage><lpage>115</lpage></element-citation></ref><ref id="B257-marinedrugs-18-00657"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teeyapant</surname><given-names>R.</given-names></name><name><surname>Kreis</surname><given-names>P.</given-names></name><name><surname>Wray</surname><given-names>V.</given-names></name><name><surname>Witte</surname><given-names>L.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Brominated secondary compounds from the marine sponge <italic>Verongia aerophoba</italic> and the sponge feeding gastropod <italic>Tylodina perversa</italic></article-title><source>Z. Naturforsch.</source><year>1993</year><volume>48</volume><fpage>630</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1515/znc-1993-7-818</pub-id></element-citation></ref><ref id="B258-marinedrugs-18-00657"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotsbacher</surname><given-names>M.P.</given-names></name><name><surname>Karuso</surname><given-names>P.</given-names></name></person-group><article-title>New antimicrobial bromotyrosine analogues from the sponge <italic>Pseudoceratina purpurea</italic> and its predator <italic>Tylodina corticalis</italic></article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>1389</fpage><lpage>1409</lpage><pub-id pub-id-type="doi">10.3390/md13031389</pub-id><?supplied-pmid 25786066?><pub-id pub-id-type="pmid">25786066</pub-id></element-citation></ref><ref id="B259-marinedrugs-18-00657"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Marin</surname><given-names>A.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Organ-specific distribution of dietary alkaloids in the marine opisthobranch <italic>Tylodina perversa</italic></article-title><source>Biochem. System. Ecol.</source><year>1999</year><volume>27</volume><fpage>769</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1016/S0305-1978(99)00024-1</pub-id></element-citation></ref><ref id="B260-marinedrugs-18-00657"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoms</surname><given-names>C.</given-names></name><name><surname>Wolff</surname><given-names>M.</given-names></name><name><surname>Padmakumar</surname><given-names>K.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Chemical defense of Mediterranean sponges <italic>Aplysina cavernicola</italic> and <italic>Aplysina aerophoba</italic></article-title><source>Z. Naturforsch.</source><year>2004</year><volume>59</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1515/znc-2004-1-222</pub-id><?supplied-pmid 15018063?><pub-id pub-id-type="pmid">15018063</pub-id></element-citation></ref><ref id="B261-marinedrugs-18-00657"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becerro</surname><given-names>M.A.</given-names></name><name><surname>Turon</surname><given-names>X.</given-names></name><name><surname>Uriz</surname><given-names>M.J.</given-names></name><name><surname>Templado</surname><given-names>J.</given-names></name></person-group><article-title>Can a sponge feeder be an herbivore? Tylodina perversa (Gastropoda) feeding on <italic>Aplysina aerophoba</italic></article-title><source>Biol. J. Linn. Soc.</source><year>2003</year><volume>78</volume><fpage>429</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1046/j.0024-4066.2002.00165.x</pub-id></element-citation></ref><ref id="B262-marinedrugs-18-00657"><label>262.</label><element-citation publication-type="journal"><article-title>Cimino G, De Rosa S, De Stefano S, Spinella A, Sodano G The zoochrome of the sponge <italic>Verongia aerophoba</italic> (&#x0201c;Uranidine&#x0201d;)</article-title><source>Tetrahedron Lett.</source><year>1984</year><volume>25</volume><fpage>2925</fpage><lpage>2928</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)81328-9</pub-id></element-citation></ref><ref id="B263-marinedrugs-18-00657"><label>263.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Transfer of sponge secondary metabolites to predators</article-title><source>Sponges in Time and Space: Biology, Chemistry, Paleontology</source><person-group person-group-type="editor"><name><surname>van Soest</surname><given-names>R.W.M.</given-names></name><name><surname>van Kempen</surname><given-names>T.M.G.</given-names></name><name><surname>Braekman</surname><given-names>J.-C.</given-names></name></person-group><publisher-name>AA</publisher-name><publisher-loc>Balkema, Rotterdam</publisher-loc><year>1994</year><fpage>459</fpage><lpage>472</lpage></element-citation></ref><ref id="B264-marinedrugs-18-00657"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>T.E.</given-names></name></person-group><article-title>Defensive acid-secretion in marine gastropods</article-title><source>J. Mar. Biolog. Assoc.</source><year>1960</year><volume>39</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1017/S0025315400013151</pub-id></element-citation></ref><ref id="B265-marinedrugs-18-00657"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>T.E.</given-names></name></person-group><article-title>Investigation of the acidic allomone of the gastropod mollusc <italic>Philine aperta</italic> by means of ion chromatography and histochemical localisation of sulphate and chloride ions</article-title><source>J. Mollus. Stud.</source><year>1986</year><volume>52</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1093/mollus/52.1.38</pub-id></element-citation></ref><ref id="B266-marinedrugs-18-00657"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moles</surname><given-names>J.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Malaquias</surname><given-names>M.A.E.</given-names></name></person-group><article-title>Unmasking Antarctic mollusc lineages: Novel evidence from philinoid snails (Gastropoda: Cephalaspidea)</article-title><source>Cladistics</source><year>2019</year><volume>35</volume><fpage>487</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1111/cla.12364</pub-id></element-citation></ref><ref id="B267-marinedrugs-18-00657"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>R.</given-names></name><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name></person-group><article-title>Does a shell matter for defence? Chemical deterrence in two cephalaspidean gastropods with calcified shells</article-title><source>J. Mollus. Stud.</source><year>2009</year><volume>75</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1093/mollus/eyp004</pub-id></element-citation></ref><ref id="B268-marinedrugs-18-00657"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Giordano</surname><given-names>A.</given-names></name><name><surname>Coll</surname><given-names>A.D.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Biosynthesis of aglajnes, polypropionate allomones of the opisthobranch mollusc <italic>Bulla striata</italic></article-title><source>Tetrahedron Lett.</source><year>2004</year><volume>45</volume><fpage>6847</fpage><lpage>6850</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2004.07.115</pub-id></element-citation></ref><ref id="B269-marinedrugs-18-00657"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name></person-group><article-title>Aglajne-1, a polypropionate metabolite from the opisthobranch mollusk <italic>Aglaja depicta</italic></article-title><source>Tetrahedron Lett.</source><year>1985</year><volume>26</volume><fpage>3389</fpage><lpage>3392</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)98305-9</pub-id></element-citation></ref><ref id="B270-marinedrugs-18-00657"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name></person-group><article-title>New propionate-derived metabolites from <italic>Aglaja depicta</italic> and from its prey <italic>Bulla striata</italic> (opisthobranch mollusks)</article-title><source>J. Org. Chem.</source><year>1987</year><volume>52</volume><fpage>5326</fpage><lpage>5331</lpage><pub-id pub-id-type="doi">10.1021/jo00233a005</pub-id></element-citation></ref><ref id="B271-marinedrugs-18-00657"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>L.A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name></person-group><article-title>Chemical defence in cephalaspidean gastropods: Origin, anatomical location and ecological roles</article-title><source>J. Mollus. Stud.</source><year>1999</year><volume>65</volume><fpage>121</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1093/mollus/65.1.121</pub-id></element-citation></ref><ref id="B272-marinedrugs-18-00657"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coval</surname><given-names>S.J.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>An intriguing C16-alkadienone-substituted 2-pyridine from a marine mollusk</article-title><source>J. Org. Chem.</source><year>1985</year><volume>50</volume><fpage>3024</fpage><lpage>3025</lpage><pub-id pub-id-type="doi">10.1021/jo00216a052</pub-id></element-citation></ref><ref id="B273-marinedrugs-18-00657"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coval</surname><given-names>S.J.</given-names></name><name><surname>Schulte</surname><given-names>G.R.</given-names></name><name><surname>Matsumoto</surname><given-names>G.K.</given-names></name><name><surname>Roll</surname><given-names>D.M.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Two polypropionate metabolites from the cephalaspidean mollusk <italic>Philinopsis speciosa</italic></article-title><source>Tetrahedron Lett.</source><year>1985</year><volume>26</volume><fpage>5359</fpage><lpage>5362</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)98207-8</pub-id></element-citation></ref><ref id="B274-marinedrugs-18-00657"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Calado</surname><given-names>G.</given-names></name><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Polypropionates from <italic>Bulla occidentalis</italic>: Chemical markers and trophic relationships in cephalaspidean molluscs</article-title><source>Tetrahedron Lett.</source><year>2011</year><volume>52</volume><fpage>4595</fpage><lpage>4597</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2011.06.104</pub-id></element-citation></ref><ref id="B275-marinedrugs-18-00657"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Pupukeamide, a linear tetrapeptide from a cephalaspidean mollusk <italic>Philinopsis speciosa</italic></article-title><source>Tetrahedron Lett.</source><year>1996</year><volume>37</volume><fpage>8993</fpage><lpage>8996</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(96)02111-9</pub-id></element-citation></ref><ref id="B276-marinedrugs-18-00657"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Szabo</surname><given-names>C.M.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>More peptides and other diverse constituents of the marine mollusk <italic>Philinopsis speciosa</italic></article-title><source>J. Org. Chem.</source><year>1998</year><volume>63</volume><fpage>3272</fpage><lpage>3280</lpage><pub-id pub-id-type="doi">10.1021/jo9719867</pub-id></element-citation></ref><ref id="B277-marinedrugs-18-00657"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reese</surname><given-names>M.T.</given-names></name><name><surname>Gulavita</surname><given-names>N.K.</given-names></name><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Coval</surname><given-names>S.J.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Kulolide: A cytotoxic depsipeptide from a cephalaspidean mollusk, <italic>Philinopsis speciosa</italic></article-title><source>J. Am. Chem. Soc.</source><year>1996</year><volume>118</volume><fpage>11081</fpage><lpage>11084</lpage><pub-id pub-id-type="doi">10.1021/ja9620301</pub-id></element-citation></ref><ref id="B278-marinedrugs-18-00657"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>L.A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Predator-prey relationship between <italic>Navanax inermis</italic> and <italic>Bulla gouldiana</italic>: A chemical approach</article-title><source>Tetrahedron</source><year>1993</year><volume>49</volume><fpage>3203</fpage><lpage>3210</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)89902-6</pub-id></element-citation></ref><ref id="B279-marinedrugs-18-00657"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Rivera</surname><given-names>E.</given-names></name></person-group><article-title>Evidence for chemical defence in the Cephalaspidean <italic>Nakamigawaia spiralis</italic> Kuroda and Habe, 1961</article-title><source>J. Mollus. Stud.</source><year>2011</year><volume>77</volume><fpage>95</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1093/mollus/eyq036</pub-id></element-citation></ref><ref id="B280-marinedrugs-18-00657"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poiner</surname><given-names>A.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Kumepaloxane, a rearranged trisnor sesquiterpene from the bubble shell <italic>Haminoea cymbalum</italic></article-title><source>Tetrahedron</source><year>1989</year><volume>45</volume><fpage>617</fpage><lpage>622</lpage></element-citation></ref><ref id="B281-marinedrugs-18-00657"><label>281.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>E.S.</given-names></name></person-group><source>Possible Anti-Predation Properties of the Egg Masses of the Marine Gastropods Dialula sandiegensis, Doris montereyensis and Haminoea virescens (Mollusca, Gastropoda)</source><comment>Friday Harbor Laboratories Student Research Papers</comment><publisher-name>Friday Harbor Laboratories</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>2014</year><fpage>528</fpage></element-citation></ref><ref id="B282-marinedrugs-18-00657"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becerro</surname><given-names>M.A.</given-names></name><name><surname>Starmer</surname><given-names>J.A.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Chemical defenses of cryptic and aposematic gastropterid molluscs feeding on their host sponge <italic>Dysidea granulosa</italic></article-title><source>J. Chem. Ecol.</source><year>2006</year><volume>32</volume><fpage>1491</fpage><lpage>1500</lpage><pub-id pub-id-type="doi">10.1007/s10886-006-9064-5</pub-id><pub-id pub-id-type="pmid">16718562</pub-id></element-citation></ref><ref id="B283-marinedrugs-18-00657"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>R.B.</given-names></name><name><surname>Andrade</surname><given-names>P.B.</given-names></name><name><surname>Valent&#x000e3;o</surname><given-names>P.</given-names></name></person-group><article-title>Chemical diversity and biological properties of secondary metabolites from sea hares of <italic>Aplysia</italic> genus</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>39</elocation-id><pub-id pub-id-type="doi">10.3390/md14020039</pub-id></element-citation></ref><ref id="B284-marinedrugs-18-00657"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellingson</surname><given-names>R.A.</given-names></name><name><surname>Krug</surname><given-names>P.J.</given-names></name></person-group><article-title>Evolution of poecilogony from planktotrophy: Cryptic speciation, phylogeography, and larval development in the gastropod genus <italic>Alderia</italic></article-title><source>Evolution</source><year>2006</year><volume>60</volume><fpage>2293</fpage><lpage>2310</lpage><pub-id pub-id-type="doi">10.1111/j.0014-3820.2006.tb01866.x</pub-id><pub-id pub-id-type="pmid">17236422</pub-id></element-citation></ref><ref id="B285-marinedrugs-18-00657"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>B.P.V.</given-names></name><name><surname>Pakhomov</surname><given-names>E.A.</given-names></name><name><surname>Hosie</surname><given-names>G.W.</given-names></name><name><surname>Siegel</surname><given-names>V.</given-names></name><name><surname>Ward</surname><given-names>P.</given-names></name><name><surname>Bernard</surname><given-names>K.</given-names></name></person-group><article-title>Pteropods in Southern Ocean ecosystems</article-title><source>Prog. Oceanogr.</source><year>2008</year><volume>78</volume><fpage>193</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.pocean.2008.06.001</pub-id></element-citation></ref><ref id="B286-marinedrugs-18-00657"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000f6;rger</surname><given-names>K.M.</given-names></name><name><surname>Norenburg</surname><given-names>J.L.</given-names></name><name><surname>Wilson</surname><given-names>N.G.</given-names></name><name><surname>Schr&#x000f6;dl</surname><given-names>M.</given-names></name></person-group><article-title>Barcoding against a paradox? Combined molecular species delineations reveal multiple cryptic lineages in elusive meiofaunal sea slugs</article-title><source>BMC Evol. Biol.</source><year>2012</year><volume>12</volume><elocation-id>245</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2148-12-245</pub-id><pub-id pub-id-type="pmid">23244441</pub-id></element-citation></ref><ref id="B287-marinedrugs-18-00657"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnel</surname><given-names>R.B.</given-names></name><name><surname>Dieter</surname><given-names>R.K.</given-names></name><name><surname>Meinwald</surname><given-names>J.</given-names></name><name><surname>Van Engen</surname><given-names>D.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name><name><surname>Eisner</surname><given-names>T.</given-names></name><name><surname>Stallard</surname><given-names>M.O.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Brasilenyne and cis-dihydrorhodophytin: Antifeedant medium-ring haloethers from a sea hare (<italic>Aplysia brasiliana</italic>)</article-title><source>PNAS</source><year>1979</year><volume>76</volume><fpage>3576</fpage><lpage>3579</lpage><pub-id pub-id-type="doi">10.1073/pnas.76.8.3576</pub-id><pub-id pub-id-type="pmid">16592687</pub-id></element-citation></ref><ref id="B288-marinedrugs-18-00657"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>H.</given-names></name><name><surname>Muramoto</surname><given-names>K.</given-names></name><name><surname>Goto</surname><given-names>R.</given-names></name><name><surname>Sakai</surname><given-names>M.</given-names></name><name><surname>Endo</surname><given-names>Y.</given-names></name><name><surname>Yamazaki</surname><given-names>M.</given-names></name></person-group><article-title>Purification and characterization of an antibacterial and antineoplastic protein secretion of a sea hare, <italic>Aplysia juliana</italic></article-title><source>Toxicon</source><year>1989</year><volume>27</volume><fpage>1269</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(89)90058-5</pub-id><pub-id pub-id-type="pmid">2697958</pub-id></element-citation></ref><ref id="B289-marinedrugs-18-00657"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamio</surname><given-names>M.</given-names></name><name><surname>Grimes</surname><given-names>T.V.</given-names></name><name><surname>Hutchins</surname><given-names>M.H.</given-names></name><name><surname>van Dam</surname><given-names>R.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>The purple pigment aplysioviolin in sea hare ink deters predatory blue crabs through their chemical senses</article-title><source>Anim. Behav.</source><year>2010</year><volume>80</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.anbehav.2010.04.003</pub-id></element-citation></ref><ref id="B290-marinedrugs-18-00657"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamio</surname><given-names>M.</given-names></name><name><surname>Nguyen</surname><given-names>L.</given-names></name><name><surname>Yaldiz</surname><given-names>S.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>How to produce a chemical defense: Structural elucidation and anatomical distribution of aplysioviolin and phycoerythrobilin in the sea hare <italic>Aplysia californica</italic></article-title><source>Chem. Biodivers.</source><year>2010</year><volume>7</volume><fpage>1183</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201000006</pub-id><?supplied-pmid 20491075?><pub-id pub-id-type="pmid">20491075</pub-id></element-citation></ref><ref id="B291-marinedrugs-18-00657"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Escape by inking and secreting: Marine molluscs avoid predators through a rich array of chemicals and mechanisms</article-title><source>Biol. Bull.</source><year>2007</year><volume>213</volume><fpage>274</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.2307/25066645</pub-id><pub-id pub-id-type="pmid">18083967</pub-id></element-citation></ref><ref id="B292-marinedrugs-18-00657"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kicklighter</surname><given-names>C.E.</given-names></name><name><surname>Shabani</surname><given-names>S.</given-names></name><name><surname>Johnson</surname><given-names>P.M.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Sea hares use novel antipredatory chemical defenses</article-title><source>Curr. Biol.</source><year>2005</year><volume>15</volume><fpage>549</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.01.057</pub-id><pub-id pub-id-type="pmid">15797024</pub-id></element-citation></ref><ref id="B293-marinedrugs-18-00657"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheybani</surname><given-names>A.</given-names></name><name><surname>Nusnbaum</surname><given-names>M.</given-names></name><name><surname>Caprio</surname><given-names>J.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Responses of the sea catfish Ariopsis felis to chemical defenses from the sea hare <italic>Aplysia californica</italic></article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>2009</year><volume>368</volume><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.jembe.2008.09.024</pub-id></element-citation></ref><ref id="B294-marinedrugs-18-00657"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>P.M.</given-names></name><name><surname>Kicklighter</surname><given-names>C.E.</given-names></name><name><surname>Schmidt</surname><given-names>M.</given-names></name><name><surname>Kamio</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Elkin</surname><given-names>D.</given-names></name><name><surname>Michel</surname><given-names>W.C.</given-names></name><name><surname>Tai</surname><given-names>P.C.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Packaging of chemicals in the defensive secretory glands of the sea hare <italic>Aplysia californica</italic></article-title><source>J. Exp. Biol.</source><year>2006</year><volume>209</volume><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1242/jeb.01972</pub-id><pub-id pub-id-type="pmid">16354780</pub-id></element-citation></ref><ref id="B295-marinedrugs-18-00657"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusnbaum</surname><given-names>M.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Effects of sea hare ink secretion and its escapin-generated components on a variety of predatory fishes</article-title><source>Biol. Bull.</source><year>2010</year><volume>218</volume><fpage>282</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1086/BBLv218n3p282</pub-id><pub-id pub-id-type="pmid">20570851</pub-id></element-citation></ref><ref id="B296-marinedrugs-18-00657"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kicklighter</surname><given-names>C.E.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Multiple components in ink of the sea hare <italic>Aplysia californica</italic> are aversive to the sea anemone <italic>Anthopleura sola</italic></article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>2006</year><volume>334</volume><fpage>256</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.jembe.2006.02.002</pub-id></element-citation></ref><ref id="B297-marinedrugs-18-00657"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamio</surname><given-names>M.</given-names></name><name><surname>Ko</surname><given-names>K.C.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Collins</surname><given-names>S.L.</given-names></name><name><surname>Gadda</surname><given-names>G.</given-names></name><name><surname>Tai</surname><given-names>P.C.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>The chemistry of escapin: Identification and quantification of the components in the complex mixture generated by an L-amino acid oxidase in the defensive secretion of the sea snail <italic>Aplysia californica</italic></article-title><source>Chem. Eur. J.</source><year>2009</year><volume>15</volume><fpage>1597</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1002/chem.200801696</pub-id><pub-id pub-id-type="pmid">19130530</pub-id></element-citation></ref><ref id="B298-marinedrugs-18-00657"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennings</surname><given-names>S.C.</given-names></name></person-group><article-title>Multiple factors promoting narrow host range in the sea hare, <italic>Aplysia californica</italic></article-title><source>Oecologia</source><year>1990</year><volume>82</volume><fpage>192</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/BF00323535</pub-id><?supplied-pmid 28312665?><pub-id pub-id-type="pmid">28312665</pub-id></element-citation></ref><ref id="B299-marinedrugs-18-00657"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsburg</surname><given-names>D.W.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Chemical defenses in the sea hare <italic>Aplysia parvula</italic>: Importance of diet and sequestration of algal secondary metabolites</article-title><source>Mar. Ecol. Progr. Ser.</source><year>2001</year><volume>215</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.3354/meps215261</pub-id></element-citation></ref><ref id="B300-marinedrugs-18-00657"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stierle</surname><given-names>D.B.</given-names></name><name><surname>Wing</surname><given-names>R.M.</given-names></name><name><surname>Sims</surname><given-names>J.J.</given-names></name></person-group><article-title>Marine natural products, XI Costatone and costatolide, new halogenated monoterpenes from the red seaweed, <italic>Plocamium costatum</italic></article-title><source>Tetrahedron Lett.</source><year>1976</year><volume>49</volume><fpage>4455</fpage><lpage>4458</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(76)80141-4</pub-id></element-citation></ref><ref id="B301-marinedrugs-18-00657"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Arthur</surname><given-names>K.E.</given-names></name><name><surname>Ritson-Williams</surname><given-names>R.</given-names></name><name><surname>Ross</surname><given-names>C.</given-names></name><name><surname>Sharp</surname><given-names>K.</given-names></name></person-group><article-title>Chemical defenses: From compounds to communities</article-title><source>Biol. Bull.</source><year>2007</year><volume>213</volume><fpage>226</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.2307/25066642</pub-id><?supplied-pmid 18083964?><pub-id pub-id-type="pmid">18083964</pub-id></element-citation></ref><ref id="B302-marinedrugs-18-00657"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Aplysiatoxin and debromoaplysiatoxin, constituents of the marine mollusk <italic>Stylocheilus longicauda</italic> (Quoy and Gaimard, 1824)</article-title><source>J. Am. Chem. Soc.</source><year>1974</year><volume>96</volume><fpage>2245</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1021/ja00814a041</pub-id><?supplied-pmid 4833645?><pub-id pub-id-type="pmid">4833645</pub-id></element-citation></ref><ref id="B303-marinedrugs-18-00657"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>The aplysiatoxins</article-title><source>Pure Appl. Chem.</source><year>1975</year><volume>41</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1351/pac197541010001</pub-id></element-citation></ref><ref id="B304-marinedrugs-18-00657"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>A.F.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Springer</surname><given-names>J.P.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Stylocheilamide, an unusual constituent of the sea hare <italic>Stylocheilus longicauda</italic></article-title><source>J. Am. Chem. Soc.</source><year>1978</year><volume>100</volume><fpage>7665</fpage><lpage>7670</lpage><pub-id pub-id-type="doi">10.1021/ja00492a039</pub-id></element-citation></ref><ref id="B305-marinedrugs-18-00657"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallimore</surname><given-names>W.A.</given-names></name><name><surname>Galario</surname><given-names>D.L.</given-names></name><name><surname>Lacy</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Two complex proline esters from the sea hare <italic>Stylocheilus longicauda</italic></article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>1022</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1021/np990640j</pub-id><pub-id pub-id-type="pmid">10924193</pub-id></element-citation></ref><ref id="B306-marinedrugs-18-00657"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>J.S.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Malyngamide I from the tropical marine cyanobacterium <italic>Lyngbya majuscula</italic> and the probable structure revision of stylocheilamide</article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>7837</fpage><lpage>7840</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)01662-2</pub-id></element-citation></ref><ref id="B307-marinedrugs-18-00657"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallimore</surname><given-names>W.A.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Malyngamides O and P from the sea hare <italic>Stylocheilus longicauda</italic></article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>1422</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1021/np0000365</pub-id><pub-id pub-id-type="pmid">11076568</pub-id></element-citation></ref><ref id="B308-marinedrugs-18-00657"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennings</surname><given-names>S.C.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Sequestration of dietary secondary metabolites by three species of sea hares: Location, specificity and dynamics</article-title><source>Mar. Biol.</source><year>1993</year><volume>117</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1007/BF00349763</pub-id></element-citation></ref><ref id="B309-marinedrugs-18-00657"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Pennings</surname><given-names>S.C.</given-names></name></person-group><article-title>Diet-derived chemical defenses in the sea hare <italic>Stylocheilus longicauda</italic> (Quoy et Gaimard 1824)</article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>1991</year><volume>151</volume><fpage>227</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/0022-0981(91)90126-H</pub-id></element-citation></ref><ref id="B310-marinedrugs-18-00657"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capper</surname><given-names>A.</given-names></name><name><surname>Cruz-Rivera</surname><given-names>E.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Tibbetts</surname><given-names>I.R.</given-names></name></person-group><article-title>Chemical deterrence of a marine cyanobacterium against sympatric and non-sympatric consumers</article-title><source>Hydrobiologia</source><year>2006</year><volume>553</volume><fpage>319</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1007/s10750-005-1129-x</pub-id></element-citation></ref><ref id="B311-marinedrugs-18-00657"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopichand</surname><given-names>Y.</given-names></name><name><surname>Schmitz</surname><given-names>F.J.</given-names></name></person-group><article-title>Bursatellin: A new diol dinitrile from the sea hare <italic>Bursatella leachii pleii</italic></article-title><source>J. Org. Chem.</source><year>1980</year><volume>45</volume><fpage>5383</fpage><lpage>5385</lpage><pub-id pub-id-type="doi">10.1021/jo01314a040</pub-id></element-citation></ref><ref id="B312-marinedrugs-18-00657"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Strazzullo</surname><given-names>G.</given-names></name></person-group><article-title>Revised structure of Bursatellin</article-title><source>J. Org. Chem.</source><year>1987</year><volume>52</volume><fpage>2303</fpage><lpage>2306</lpage><pub-id pub-id-type="doi">10.1021/jo00387a037</pub-id></element-citation></ref><ref id="B313-marinedrugs-18-00657"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Bryan</surname><given-names>P.J.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name><name><surname>Mcclintock</surname><given-names>J.B.</given-names></name></person-group><article-title>Pteroenone: A defensive metabolite of the abducted Antarctic pteropod <italic>Clione antarctica</italic></article-title><source>J. Org. Chem.</source><year>1995</year><volume>60</volume><fpage>780</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1021/jo00108a057</pub-id></element-citation></ref><ref id="B314-marinedrugs-18-00657"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>P.J.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Ecological role for pteroenone, a novel antifeedant from the conspicuous Antarctic pteropod <italic>Clione antarctica</italic> (Gymnosomata: Gastropoda)</article-title><source>Mar. Biol.</source><year>1995</year><volume>122</volume><fpage>271</fpage><lpage>277</lpage></element-citation></ref><ref id="B315-marinedrugs-18-00657"><label>315.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Janssen</surname><given-names>J.</given-names></name></person-group><article-title>Pteropod abduction as a chemical defence in a pelagic Antarctic amphipod</article-title><source>Nature</source><year>1990</year><volume>346</volume><fpage>462</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/346462a0</pub-id></element-citation></ref><ref id="B316-marinedrugs-18-00657"><label>316.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Montanaro</surname><given-names>D.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical studies of Caribbean sacoglossans: Dietary relationships with green algae and ecological implications</article-title><source>J. Chem. Ecol.</source><year>2000</year><volume>26</volume><fpage>1563</fpage><lpage>1578</lpage><pub-id pub-id-type="doi">10.1023/A:1005526526884</pub-id></element-citation></ref><ref id="B317-marinedrugs-18-00657"><label>317.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name></person-group><article-title>A new &#x003b3;-dihydropyrone-propionate from the Caribbean sascoglossan <italic>Tridachia crispata</italic></article-title><source>Tetrahedron Lett.</source><year>1996</year><volume>37</volume><fpage>4259</fpage><lpage>4262</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(96)00811-8</pub-id></element-citation></ref><ref id="B318-marinedrugs-18-00657"><label>318.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Montanaro</surname><given-names>D.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>A novel dietary sesquiterpene from the marine sacoglossan <italic>Tridachia crispata</italic></article-title><source>Nat. Prod. Lett.</source><year>1997</year><volume>10</volume><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1080/10575639708043731</pub-id></element-citation></ref><ref id="B319-marinedrugs-18-00657"><label>319.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>The defensive secretion of the opisthobranch mollusc <italic>Onchidella binneyi</italic></article-title><source>Bioorg. Chem.</source><year>1978</year><volume>7</volume><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/0045-2068(78)90043-3</pub-id></element-citation></ref><ref id="B320-marinedrugs-18-00657"><label>320.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Sun</surname><given-names>H.H.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Udoteal, a linear diterpenoid feeding deterrent from the tropical green alga <italic>Udotea flabellum</italic></article-title><source>Phytochemistry</source><year>1982</year><volume>21</volume><fpage>468</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)95295-6</pub-id></element-citation></ref><ref id="B321-marinedrugs-18-00657"><label>321.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Epifanio</surname><given-names>R.D.A.</given-names></name><name><surname>Marn</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical-components of the Mediterranean ascoglossan <italic>Thuridilla hopei</italic></article-title><source>Gazz. Chim. Ital.</source><year>1993</year><volume>123</volume><fpage>205</fpage><lpage>208</lpage></element-citation></ref><ref id="B322-marinedrugs-18-00657"><label>322.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>De Rinaldis</surname><given-names>G.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Identification of thuridillin-related aldehydes from Mediterranean ascoglossan mollusk <italic>Thuridilla hopei</italic></article-title><source>Tetrahedron</source><year>2014</year><volume>70</volume><fpage>3770</fpage><lpage>3773</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2014.04.046</pub-id></element-citation></ref><ref id="B323-marinedrugs-18-00657"><label>323.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.</given-names></name><name><surname>Ciminiello</surname><given-names>P.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Diterpenoid feeding deterrents from the Pacific green-alga <italic>Pseudochlorodesmis furcellata</italic></article-title><source>Phytochemistry</source><year>1988</year><volume>27</volume><fpage>1011</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(88)80262-0</pub-id></element-citation></ref><ref id="B324-marinedrugs-18-00657"><label>324.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somerville</surname><given-names>M.J.</given-names></name><name><surname>Katavic</surname><given-names>P.L.</given-names></name><name><surname>Lambert</surname><given-names>L.K.</given-names></name><name><surname>Pierens</surname><given-names>G.K.</given-names></name><name><surname>Blanchfield</surname><given-names>J.T.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Banwell</surname><given-names>M.G.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Isolation of thuridillins D-F, diterpene metabolites from the Australian sacoglossan mollusk <italic>Thuridilla splendens</italic>; relative configuration of the epoxylactone ring</article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>1618</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1021/np300442s</pub-id><pub-id pub-id-type="pmid">22988884</pub-id></element-citation></ref><ref id="B325-marinedrugs-18-00657"><label>325.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>M.E.</given-names></name><name><surname>Duffy</surname><given-names>J.E.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Renaud</surname><given-names>P.E.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Specialist herbivores reduce their susceptibility to predation by feeding on the chemically defended seaweed <italic>Avrainvillea longicaulis</italic></article-title><source>Limnol. Oceanogr.</source><year>1990</year><volume>35</volume><fpage>1734</fpage><lpage>1747</lpage><pub-id pub-id-type="doi">10.4319/lo.1990.35.8.1734</pub-id></element-citation></ref><ref id="B326-marinedrugs-18-00657"><label>326.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Cyercenes, novel polypropionate pyrones from the autotomizing Mediterranean mollusc <italic>Cyerce cristallina</italic></article-title><source>Tetrahedron</source><year>1991</year><volume>47</volume><fpage>5569</fpage><lpage>5576</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)80988-1</pub-id></element-citation></ref><ref id="B327-marinedrugs-18-00657"><label>327.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>De Petrocellis</surname><given-names>L.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Minei</surname><given-names>R.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Cyercenes, novel pyrones from the ascoglossan mollusc <italic>Cyerce cristallina</italic>. Tissue distribution, biosynthesis and possible involvement in defense and regenerative processes</article-title><source>Experientia</source><year>1991</year><volume>47</volume><fpage>1221</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1007/BF01918390</pub-id></element-citation></ref><ref id="B328-marinedrugs-18-00657"><label>328.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roussis</surname><given-names>V.</given-names></name><name><surname>Pawlik</surname><given-names>J.R.</given-names></name><name><surname>Hay</surname><given-names>M.E.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Secondary metabolites of the chemically rich ascoglossan <italic>Cyerce nigricans</italic></article-title><source>Experientia</source><year>1990</year><volume>49</volume><fpage>327</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1007/BF01951780</pub-id></element-citation></ref><ref id="B329-marinedrugs-18-00657"><label>329.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>K.R.</given-names></name></person-group><article-title>Defensive behavior and toxicity of the ascoglossan opisthobranch <italic>Mourgona germaineae</italic> Marcus</article-title><source>J. Chem. Ecol.</source><year>1984</year><volume>10</volume><fpage>475</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1007/BF00988093</pub-id><?supplied-pmid 24318552?><pub-id pub-id-type="pmid">24318552</pub-id></element-citation></ref><ref id="B330-marinedrugs-18-00657"><label>330.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;gberg</surname><given-names>H.E.</given-names></name><name><surname>Thompson</surname><given-names>R.H.</given-names></name><name><surname>King</surname><given-names>T.J.</given-names></name></person-group><article-title>The cymopols, a group of prenylated bromohydroquinones from the green calcareous alga <italic>Cymopolia barbata</italic></article-title><source>J. Chem. Soc. Perkin Trans. I</source><year>1976</year><volume>1</volume><fpage>1696</fpage><lpage>1701</lpage><pub-id pub-id-type="doi">10.1039/P19760001696</pub-id></element-citation></ref><ref id="B331-marinedrugs-18-00657"><label>331.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Otto</surname><given-names>C.S.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Dunbar</surname><given-names>D.C.</given-names></name></person-group><article-title>Kahalalides: Bioactive peptides from a marine mollusk <italic>Elysia rufescens</italic> and its algal diet <italic>Bryopsis</italic> sp.</article-title><source>J. Org. Chem.</source><year>1996</year><volume>61</volume><fpage>6594</fpage><lpage>6600</lpage><pub-id pub-id-type="doi">10.1021/jo960877+</pub-id><?supplied-pmid 11667527?><pub-id pub-id-type="pmid">11667527</pub-id></element-citation></ref><ref id="B332-marinedrugs-18-00657"><label>332.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Placidenes: Cyercene-like polypropionate &#x003b3;-pyrones from the Mediterranean ascoglossan mollusc <italic>Placida dendritica</italic></article-title><source>Tetrahedron Lett.</source><year>1992</year><volume>33</volume><fpage>2875</fpage><lpage>2878</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)78884-8</pub-id></element-citation></ref><ref id="B333-marinedrugs-18-00657"><label>333.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>C.A.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name><name><surname>McQuaid</surname><given-names>C.</given-names></name></person-group><article-title>Labdane diterpenes from the South African marine pulmonate <italic>Trimusculus costatus</italic></article-title><source>Nat. Prod. Lett.</source><year>1998</year><volume>12</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1080/10575639808048870</pub-id></element-citation></ref><ref id="B334-marinedrugs-18-00657"><label>334.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manker</surname><given-names>D.C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Investigation of the role of diterpenes produced by marine pulmonates <italic>Trimusculus reticulatus</italic> and <italic>T. conica</italic></article-title><source>J. Chem. Ecol.</source><year>1996</year><volume>22</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/BF02040197</pub-id><pub-id pub-id-type="pmid">24226980</pub-id></element-citation></ref><ref id="B335-marinedrugs-18-00657"><label>335.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Marrero</surname><given-names>A.R.</given-names></name><name><surname>Dorta</surname><given-names>E.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>Rovirosa</surname><given-names>J.</given-names></name><name><surname>San-Mart&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Loyola</surname><given-names>A.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name></person-group><article-title>Labdane diterpenes with a new oxidation pattern from the marine pulmonate <italic>Trimusculus peruvianus</italic></article-title><source>Tetrahedron</source><year>2003</year><volume>59</volume><fpage>4805</fpage><lpage>4809</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(03)00731-2</pub-id></element-citation></ref><ref id="B336-marinedrugs-18-00657"><label>336.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovirosa</surname><given-names>J.</given-names></name><name><surname>Quezada</surname><given-names>E.</given-names></name><name><surname>San-Martin</surname><given-names>A.</given-names></name></person-group><article-title>New diterpene from the mollusc <italic>Trimusculus peruvianus</italic></article-title><source>Bol. Soc. Chil. Quim.</source><year>1992</year><volume>37</volume><fpage>143</fpage><lpage>145</lpage></element-citation></ref><ref id="B337-marinedrugs-18-00657"><label>337.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Wyk</surname><given-names>A.W.W.</given-names></name><name><surname>Gray</surname><given-names>C.A.</given-names></name><name><surname>Whibley</surname><given-names>C.E.</given-names></name><name><surname>Osoniyi</surname><given-names>O.</given-names></name><name><surname>Hendricks</surname><given-names>D.T.</given-names></name><name><surname>Caira-Mino</surname><given-names>R.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name></person-group><article-title>Bioactive metabolites from the South African marine mollusk <italic>Trimusculus costatus</italic></article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1021/np070612y</pub-id><pub-id pub-id-type="pmid">18288809</pub-id></element-citation></ref><ref id="B338-marinedrugs-18-00657"><label>338.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiggering</surname><given-names>B.</given-names></name><name><surname>Neiber</surname><given-names>M.T.</given-names></name><name><surname>Gebauer</surname><given-names>K.</given-names></name><name><surname>Glaubrecht</surname><given-names>M.</given-names></name></person-group><article-title>One species, two developmental modes: a case of geographic poecilogony in marine gastropods</article-title><source>BMC Evol. Biol.</source><year>2020</year><volume>20</volume><elocation-id>76</elocation-id><pub-id pub-id-type="doi">10.1186/s12862-020-01644-1</pub-id><?supplied-pmid 32591013?><pub-id pub-id-type="pmid">32591013</pub-id></element-citation></ref><ref id="B339-marinedrugs-18-00657"><label>339.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manker</surname><given-names>D.C.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title><italic>De novo</italic> biosynthesis of polypropionate metabolites in the marine pulmonate <italic>Siphonaria denticulata</italic></article-title><source>J. Chem. Soc. Chem. Commun.</source><year>1988</year><volume>16</volume><fpage>1061</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1039/c39880001061</pub-id></element-citation></ref><ref id="B340-marinedrugs-18-00657"><label>340.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>M.C.</given-names></name><name><surname>Zub&#x000ed;a</surname><given-names>E.</given-names></name><name><surname>Ortega</surname><given-names>M.J.</given-names></name><name><surname>Salv&#x000e1;</surname><given-names>J.</given-names></name></person-group><article-title>New polypropionates from <italic>Siphonaria pectinata</italic></article-title><source>Tetrahedron</source><year>1997</year><volume>53</volume><fpage>2303</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(96)01131-3</pub-id></element-citation></ref><ref id="B341-marinedrugs-18-00657"><label>341.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Antibiotics from the marine pulmonate <italic>Siphonaria diemenensis</italic></article-title><source>Tetrahedron Lett.</source><year>1983</year><volume>24</volume><fpage>1917</fpage><lpage>1920</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)81805-5</pub-id></element-citation></ref><ref id="B342-marinedrugs-18-00657"><label>342.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Metabolites of the marine pulmonate <italic>Siphonaria australis</italic></article-title><source>J. Org. Chem.</source><year>1984</year><volume>49</volume><fpage>3838</fpage><lpage>3840</lpage><pub-id pub-id-type="doi">10.1021/jo00194a036</pub-id></element-citation></ref><ref id="B343-marinedrugs-18-00657"><label>343.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biskupiak</surname><given-names>J.E.</given-names></name><name><surname>Ireland</surname><given-names>C.M.</given-names></name></person-group><article-title>Pectinatone, a new antibiotic from the mollusc <italic>Siphonaria pectinata</italic></article-title><source>Tetrahedron Lett.</source><year>1983</year><volume>24</volume><fpage>3055</fpage><lpage>3058</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)88093-4</pub-id></element-citation></ref><ref id="B344-marinedrugs-18-00657"><label>344.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norte</surname><given-names>M.</given-names></name><name><surname>Cataldo</surname><given-names>F.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>A.G.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>M.L.</given-names></name><name><surname>Ruiz-P&#x000e9;rez</surname><given-names>C.</given-names></name></person-group><article-title>New metabolites from the marine mollusc <italic>Siphonaria grisea</italic></article-title><source>Tetrahedron</source><year>1990</year><volume>46</volume><fpage>1669</fpage><lpage>1678</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)81974-8</pub-id></element-citation></ref><ref id="B345-marinedrugs-18-00657"><label>345.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norte</surname><given-names>M.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>J.J.</given-names></name><name><surname>Padilla</surname><given-names>A.</given-names></name></person-group><article-title>Isolation and synthesis of siphonarienal a new polypropionate from <italic>Siphonaria grisea</italic></article-title><source>Tetrahedron Lett.</source><year>1994</year><volume>35</volume><fpage>3413</fpage><lpage>3416</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)76923-1</pub-id></element-citation></ref><ref id="B346-marinedrugs-18-00657"><label>346.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beukes</surname><given-names>D.R.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name></person-group><article-title>Novel polypropionates from the South African marine mollusc <italic>Siphonaria capensis</italic></article-title><source>Tetrahedron</source><year>1999</year><volume>55</volume><fpage>4051</fpage><lpage>4056</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(99)00093-9</pub-id></element-citation></ref><ref id="B347-marinedrugs-18-00657"><label>347.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Matsumoto</surname><given-names>G.K.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>The denticulatins, two propionate metabolites from the pulmonate <italic>Siphonaria denticulata</italic></article-title><source>J. Am. Chem. Soc.</source><year>1983</year><volume>105</volume><fpage>7413</fpage><lpage>7415</lpage><pub-id pub-id-type="doi">10.1021/ja00363a034</pub-id></element-citation></ref><ref id="B348-marinedrugs-18-00657"><label>348.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.</given-names></name><name><surname>Coll</surname><given-names>J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Novel metabolites of four <italic>Siphonaria</italic> species</article-title><source>J. Am. Chem. Soc.</source><year>1984</year><volume>106</volume><fpage>6748</fpage><lpage>6750</lpage><pub-id pub-id-type="doi">10.1021/ja00334a046</pub-id></element-citation></ref><ref id="B349-marinedrugs-18-00657"><label>349.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roll</surname><given-names>D.M.</given-names></name><name><surname>Biskupiak</surname><given-names>J.E.</given-names></name><name><surname>Mayne</surname><given-names>C.L.</given-names></name><name><surname>Ireland</surname><given-names>C.M.</given-names></name></person-group><article-title>Muamvatin, a novel tricyclic spiro ketal from the Fijian mollusk <italic>Siphonaria normalis</italic></article-title><source>J. Am. Chem. Soc.</source><year>1986</year><volume>108</volume><fpage>6680</fpage><lpage>6682</lpage><pub-id pub-id-type="doi">10.1021/ja00281a039</pub-id></element-citation></ref><ref id="B350-marinedrugs-18-00657"><label>350.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manker</surname><given-names>D.C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Vallartanones A and B, polypropionate metabolites of <italic>Siphonaria maura</italic> from Mexico</article-title><source>J. Org. Chem.</source><year>1989</year><volume>54</volume><fpage>5374</fpage><lpage>5377</lpage><pub-id pub-id-type="doi">10.1021/jo00283a037</pub-id></element-citation></ref><ref id="B351-marinedrugs-18-00657"><label>351.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manker</surname><given-names>D.C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Stout</surname><given-names>T.J.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>The baconipyrones. Novel polypropionates from the pulmonate <italic>Siphonaria baconi</italic></article-title><source>J. Org. Chem.</source><year>1989</year><volume>54</volume><fpage>5371</fpage><lpage>5374</lpage><pub-id pub-id-type="doi">10.1021/jo00283a036</pub-id></element-citation></ref><ref id="B352-marinedrugs-18-00657"><label>352.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brecknell</surname><given-names>D.J.</given-names></name><name><surname>Collett</surname><given-names>L.A.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Jones</surname><given-names>D.D.</given-names></name></person-group><article-title>New non-contiguous polypropionates from marine molluscs: A comment on their natural product status</article-title><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>2497</fpage><lpage>2502</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00095-8</pub-id></element-citation></ref><ref id="B353-marinedrugs-18-00657"><label>353.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mary J.</surname><given-names>G.</given-names></name></person-group><article-title>The biosynthesis of marine natural products</article-title><source>Chem. Rev.</source><year>1993</year><volume>93</volume><fpage>1699</fpage><lpage>1733</lpage></element-citation></ref><ref id="B354-marinedrugs-18-00657"><label>354.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>S.N.</given-names></name><name><surname>Radic</surname><given-names>Z.</given-names></name><name><surname>Manker</surname><given-names>D.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Taylor</surname><given-names>P.</given-names></name></person-group><article-title>Onchidal: A naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action</article-title><source>Mol. Pharm.</source><year>1989</year><volume>36</volume><fpage>349</fpage><lpage>354</lpage></element-citation></ref><ref id="B355-marinedrugs-18-00657"><label>355.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>C.M.</given-names></name><name><surname>Greenwood</surname><given-names>P.G.</given-names></name><name><surname>Powell</surname><given-names>C.J.</given-names></name></person-group><article-title>The ecological role of defensive secretions in the intertidal pulmonate <italic>Onchidella borealis</italic></article-title><source>Biol. Bull.</source><year>1986</year><volume>171</volume><fpage>391</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.2307/1541681</pub-id></element-citation></ref><ref id="B356-marinedrugs-18-00657"><label>356.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biskupiak</surname><given-names>J.E.</given-names></name><name><surname>Ireland</surname><given-names>C.M.</given-names></name></person-group><article-title>Cytotoxic metabolites from the mollusc <italic>Peronia peronii</italic></article-title><source>Tetrahedron Lett.</source><year>1985</year><volume>26</volume><fpage>4307</fpage><lpage>4310</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)98720-3</pub-id></element-citation></ref><ref id="B357-marinedrugs-18-00657"><label>357.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Wang</surname><given-names>J.R.</given-names></name><name><surname>Cirillo</surname><given-names>I.</given-names></name><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Extending the record of bis-&#x003b3;-pyrone polypropionates from marine pulmonate mollusks</article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>2065</fpage><lpage>2073</lpage><pub-id pub-id-type="doi">10.1021/np400483c</pub-id><pub-id pub-id-type="pmid">24180210</pub-id></element-citation></ref><ref id="B358-marinedrugs-18-00657"><label>358.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>J.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name><name><surname>Qui&#x000f1;o&#x000e1;</surname><given-names>E.</given-names></name><name><surname>Riguera</surname><given-names>R.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Bouchet</surname><given-names>P.</given-names></name></person-group><article-title>Onchidin: A cytotoxic depsipeptide with C 2 symmetry from a marine mollusc</article-title><source>Tetrahedron Lett.</source><year>1994</year><volume>35</volume><fpage>9239</fpage><lpage>9242</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(94)88477-3</pub-id></element-citation></ref><ref id="B359-marinedrugs-18-00657"><label>359.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>J.</given-names></name><name><surname>Qui&#x000f1;o&#x000e1;</surname><given-names>E.</given-names></name><name><surname>Riguera</surname><given-names>R.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>L.</given-names></name><name><surname>Fern&#x000e1;ndez-Su&#x000e1;rez</surname><given-names>M.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name></person-group><article-title>Onchidin B: A new cyclodepsipeptide from the mollusc <italic>Onchidium</italic> sp.</article-title><source>J. Am. Chem. Soc.</source><year>1996</year><volume>118</volume><fpage>11635</fpage><lpage>11643</lpage><pub-id pub-id-type="doi">10.1021/ja961314i</pub-id></element-citation></ref><ref id="B360-marinedrugs-18-00657"><label>360.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mattia</surname><given-names>C.A.</given-names></name><name><surname>Lotti</surname><given-names>C.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Pagano</surname><given-names>B.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Structure of onchidione, a bis-&#x003b3;-pyrone polypropionate from a marine pulmonate mollusk</article-title><source>Tetrahedron</source><year>2009</year><volume>65</volume><fpage>4404</fpage><lpage>4409</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2009.03.052</pub-id></element-citation></ref><ref id="B361-marinedrugs-18-00657"><label>361.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Recent Sino-Italian collaborative studies on marine organisms from the South China Sea</article-title><source>Pure Appl. Chem.</source><year>2012</year><volume>84</volume><fpage>1391</fpage><lpage>1405</lpage><pub-id pub-id-type="doi">10.1351/PAC-CON-11-09-04</pub-id></element-citation></ref><ref id="B362-marinedrugs-18-00657"><label>362.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.R.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>M&#x000e1;ndi</surname><given-names>A.</given-names></name><name><surname>Antus</surname><given-names>S.</given-names></name><name><surname>Yao</surname><given-names>L.G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Kurt&#x000e1;n</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Assignment of absolute configuration of bis-&#x003b3;-pyrone polypropionates from marine pulmonate molluscs</article-title><source>Eur. J. Org. Chem.</source><year>2012</year><volume>6</volume><fpage>1107</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201101587</pub-id></element-citation></ref><ref id="B363-marinedrugs-18-00657"><label>363.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>R.M.</given-names></name><name><surname>Baker</surname><given-names>B.J.</given-names></name></person-group><article-title>Defensive chemistry of the Irish nudibranch <italic>Archidoris psuedoargus</italic> (Gastropoda opisthobranchia)</article-title><source>Planta Med.</source><year>2016</year><volume>82</volume><fpage>597</fpage><pub-id pub-id-type="doi">10.1055/s-0036-1596656</pub-id></element-citation></ref><ref id="B364-marinedrugs-18-00657"><label>364.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zubia</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Martinez</surname><given-names>E.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Diasteroisomeric ichthyotoxic acylglycerols from the dorsum of two geographically distinct populations of <italic>Archidoris</italic> nudibranchs</article-title><source>Experientia</source><year>1993</year><volume>49</volume><fpage>268</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1007/BF01923538</pub-id></element-citation></ref><ref id="B365-marinedrugs-18-00657"><label>365.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafson</surname><given-names>K.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Chemical studies of British Columbia nudibranchs</article-title><source>Tetrahedron</source><year>1985</year><volume>41</volume><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)96478-6</pub-id></element-citation></ref><ref id="B366-marinedrugs-18-00657"><label>366.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriente</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Reed</surname><given-names>K.C.</given-names></name><name><surname>Todd</surname><given-names>C.</given-names></name></person-group><article-title>A new ichthyotoxic diacylglycerol from the nudibranch <italic>Archidoris pseudoargus</italic></article-title><source>Nat. Prod. Lett.</source><year>1993</year><volume>3</volume><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1080/10575639308043834</pub-id></element-citation></ref><ref id="B367-marinedrugs-18-00657"><label>367.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Zub&#x000ed;a</surname><given-names>E.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>E.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name></person-group><article-title>Archidorin: A new ichthyotoxic diacylglycerol from the Atlantic dorid nudibranch <italic>Archidoris tuberculata</italic></article-title><source>J. Nat. Prod.</source><year>1993</year><volume>56</volume><fpage>1642</fpage><lpage>1646</lpage><pub-id pub-id-type="doi">10.1021/np50099a033</pub-id></element-citation></ref><ref id="B368-marinedrugs-18-00657"><label>368.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Sum</surname><given-names>F.W.</given-names></name></person-group><article-title>Farnesic acid glycerides from the nudibranch <italic>Archidoris odhneri</italic></article-title><source>Tetrahedron Lett.</source><year>1980</year><volume>21</volume><fpage>797</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)71508-5</pub-id></element-citation></ref><ref id="B369-marinedrugs-18-00657"><label>369.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafson</surname><given-names>K.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Chen</surname><given-names>M.H.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name></person-group><article-title>Terpenoic acid glycerides from the dorid nudibranch <italic>Archidoris montereyensis</italic></article-title><source>Tetrahedron Lett.</source><year>1984</year><volume>25</volume><fpage>11</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)91135-9</pub-id></element-citation></ref><ref id="B370-marinedrugs-18-00657"><label>370.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Ungur</surname><given-names>N.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Novel verrucosins from the skin of the Mediterranean nudibranch <italic>Doris verrucosa</italic></article-title><source>Tetrahedron</source><year>1997</year><volume>53</volume><fpage>1491</fpage><lpage>1504</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(96)01083-6</pub-id></element-citation></ref><ref id="B371-marinedrugs-18-00657"><label>371.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Puliti</surname><given-names>R.</given-names></name><name><surname>Mattia</surname><given-names>C.A.</given-names></name><name><surname>Mazzarella</surname><given-names>L.</given-names></name></person-group><article-title>Verrucosin-A and-B, ichthyotoxic diterpenoic acid glycerides with a new carbon skeleton from the dorid nudibranch <italic>Doris verrucosa</italic></article-title><source>Tetrahedron</source><year>1988</year><volume>44</volume><fpage>2301</fpage><lpage>2310</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)81739-7</pub-id></element-citation></ref><ref id="B372-marinedrugs-18-00657"><label>372.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Ballesteros</surname><given-names>M.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Biosynthetic origin and anatomical distribution of the main secondary metabolites in the nudibranch mollusc <italic>Doris verrucosa</italic></article-title><source>Comp. Biochem. Physiol. B Comp. Biochem.</source><year>1990</year><volume>97</volume><fpage>363</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(90)90294-4</pub-id></element-citation></ref><ref id="B373-marinedrugs-18-00657"><label>373.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Wolstenholme</surname><given-names>H.J.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name></person-group><article-title>Co-occurrence of 9-isocyanopupukeanane and its C-9 epimer in the nudibranch <italic>Phyllidia bourguini</italic></article-title><source>Tetrahedron Lett.</source><year>1990</year><volume>31</volume><fpage>5623</fpage><lpage>5624</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)97915-2</pub-id></element-citation></ref><ref id="B374-marinedrugs-18-00657"><label>374.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassuhlke</surname><given-names>K.E.</given-names></name><name><surname>Potts</surname><given-names>B.C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>New nitrogenous sesquiterpenes from two Philippine nudibranchs, <italic>Phyllidia pustulosa</italic> and <italic>P. varicosa</italic>, and from a Palauan sponge, <italic>Halichondria</italic> cf. <italic>lendenfeldi</italic></article-title><source>J. Org. Chem.</source><year>1991</year><volume>56</volume><fpage>3747</fpage><lpage>3750</lpage><pub-id pub-id-type="doi">10.1021/jo00011a065</pub-id></element-citation></ref><ref id="B375-marinedrugs-18-00657"><label>375.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Wolstenholme</surname><given-names>H.J.</given-names></name><name><surname>Shinoda</surname><given-names>K.</given-names></name><name><surname>Asai</surname><given-names>N.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Onuki</surname><given-names>H.</given-names></name><name><surname>Hirota</surname><given-names>H.</given-names></name></person-group><article-title>Two sesquiterpene isocyanides and a sesquiterpene thiocyanate from the marine sponge <italic>Acanthella</italic> cf. <italic>cavernosa</italic> and the nudibranch <italic>Phyllidia ocellata</italic></article-title><source>Tetrahedron Lett.</source><year>1992</year><volume>33</volume><fpage>6823</fpage><lpage>6826</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)61785-9</pub-id></element-citation></ref><ref id="B376-marinedrugs-18-00657"><label>376.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Pierens</surname><given-names>G.K.</given-names></name><name><surname>Skinner-Adams</surname><given-names>T.</given-names></name><name><surname>Andrews</surname><given-names>K.T.</given-names></name><name><surname>Bernhardt</surname><given-names>P.V.</given-names></name><name><surname>Krenske</surname><given-names>E.H.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Antimalarial isocyano and isothiocyanato sesquiterpenes with tri-and bicyclic skeletons from the nudibranch <italic>Phyllidia ocellata</italic></article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>1422</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00354</pub-id><pub-id pub-id-type="pmid">26056748</pub-id></element-citation></ref><ref id="B377-marinedrugs-18-00657"><label>377.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jomori</surname><given-names>T.</given-names></name><name><surname>Shibutani</surname><given-names>T.</given-names></name><name><surname>Ahmadi</surname><given-names>P.</given-names></name><name><surname>Suzuka</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>J.</given-names></name></person-group><article-title>A New Isocyanosesquiterpene from the nudibranch <italic>Phyllidiella pustulosa</italic></article-title><source>Nat. Prod. Commun.</source><year>2015</year><volume>10</volume><fpage>1913</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1177/1934578X1501001126</pub-id><pub-id pub-id-type="pmid">26749824</pub-id></element-citation></ref><ref id="B378-marinedrugs-18-00657"><label>378.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Kakou</surname><given-names>Y.</given-names></name><name><surname>Quinoa</surname><given-names>E.</given-names></name></person-group><article-title>Mycothiazole, a polyketide heterocycle from a marine sponge</article-title><source>J. Am. Chem. Soc.</source><year>1988</year><volume>110</volume><fpage>4365</fpage><lpage>4368</lpage><pub-id pub-id-type="doi">10.1021/ja00221a042</pub-id></element-citation></ref><ref id="B379-marinedrugs-18-00657"><label>379.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenschein</surname><given-names>R.N.</given-names></name><name><surname>Johnson</surname><given-names>T.A.</given-names></name><name><surname>Tenney</surname><given-names>K.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>A reassignment of (&#x02212;)-mycothiazole and the isolation of a related diol</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>145</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1021/np0503597</pub-id><?supplied-pmid 16441088?><pub-id pub-id-type="pmid">16441088</pub-id></element-citation></ref><ref id="B380-marinedrugs-18-00657"><label>380.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Silva</surname><given-names>E.D.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Furanoditerpenoids from the dorid nudibranch <italic>Casella atromarginata</italic></article-title><source>Heterocycles</source><year>1982</year><volume>17</volume><fpage>167</fpage><lpage>170</lpage></element-citation></ref><ref id="B381-marinedrugs-18-00657"><label>381.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cavaliere</surname><given-names>P.</given-names></name><name><surname>Ungur</surname><given-names>N.</given-names></name><name><surname>D'Souza</surname><given-names>L.</given-names></name><name><surname>Parameswaram</surname><given-names>P.S.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>New scalaranes from the nudibranch <italic>Glossodoris atromarginata</italic> and its sponge prey</article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>1367</fpage><lpage>1370</lpage><pub-id pub-id-type="doi">10.1021/np9900932</pub-id><?supplied-pmid 10543894?><pub-id pub-id-type="pmid">10543894</pub-id></element-citation></ref><ref id="B382-marinedrugs-18-00657"><label>382.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>H.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>Reinscheid</surname><given-names>U.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Three new spongian diterpenes from the Fijian marine sponge <italic>Spongia</italic> sp.</article-title><source>Nat. Prod. Commun.</source><year>2009</year><volume>4</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1177/1934578X0900400303</pub-id><?supplied-pmid 19413106?><pub-id pub-id-type="pmid">19413106</pub-id></element-citation></ref><ref id="B383-marinedrugs-18-00657"><label>383.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Docimo</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Scalarane metabolites of the nudibranch <italic>Glossodoris rufomarginata</italic> and its dietary sponge from the South China Sea</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>2104</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.1021/np040087s</pub-id><pub-id pub-id-type="pmid">15620263</pub-id></element-citation></ref><ref id="B384-marinedrugs-18-00657"><label>384.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur-Galvis</surname><given-names>L.</given-names></name><name><surname>Zuluaga</surname><given-names>C.</given-names></name><name><surname>Arn&#x000f3;</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>M.A.</given-names></name><name><surname>Zaragoz&#x000e1;</surname><given-names>R.J.</given-names></name></person-group><article-title>Cytotoxic effect (on tumor cells) and in vitro antiviral activity against herpes simplex virus of synthetic spongiane diterpenes</article-title><source>J. Nat. Prod.</source><year>2002</year><volume>65</volume><fpage>189</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1021/np010206t</pub-id><pub-id pub-id-type="pmid">11858754</pub-id></element-citation></ref><ref id="B385-marinedrugs-18-00657"><label>385.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamel</surname><given-names>H.N.</given-names></name><name><surname>Kim</surname><given-names>Y.B.</given-names></name><name><surname>Rimoldi</surname><given-names>J.M.</given-names></name><name><surname>Fronczek</surname><given-names>F.R.</given-names></name><name><surname>Ferreira</surname><given-names>D.</given-names></name><name><surname>Slattery</surname><given-names>M.</given-names></name></person-group><article-title>Scalarane sesterterpenoids: Semisynthesis and biological activity</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>1492</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1021/np900326a</pub-id><pub-id pub-id-type="pmid">19658408</pub-id></element-citation></ref><ref id="B386-marinedrugs-18-00657"><label>386.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.Y.</given-names></name><name><surname>Sung</surname><given-names>P.J.</given-names></name><name><surname>Chang</surname><given-names>Y.L.</given-names></name><name><surname>Pan</surname><given-names>S.L.</given-names></name><name><surname>Teng</surname><given-names>C.M.</given-names></name></person-group><article-title>Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells</article-title><source>Biomed Res. Int.</source><year>2015</year><volume>2015</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1155/2015/738241</pub-id></element-citation></ref><ref id="B387-marinedrugs-18-00657"><label>387.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>A diterpene related to cladiellin from a Pacific soft coral</article-title><source>Tetrahedron Lett.</source><year>1980</year><volume>21</volume><fpage>4055</fpage><lpage>4056</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(80)88064-6</pub-id></element-citation></ref><ref id="B388-marinedrugs-18-00657"><label>388.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sodano</surname><given-names>S.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name></person-group><article-title>Janolusimide, a lipophilic tripeptide toxin from the nudibranch mollusc <italic>Janolus cristatus</italic></article-title><source>Tetrahedron Lett.</source><year>1986</year><volume>27</volume><fpage>2505</fpage><lpage>2508</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)84569-4</pub-id></element-citation></ref><ref id="B389-marinedrugs-18-00657"><label>389.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Marine natural products: New results from Mediterranean invertebrates</article-title><source>Pure Appl. Chem.</source><year>1986</year><volume>58</volume><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1351/pac198658030375</pub-id></element-citation></ref><ref id="B390-marinedrugs-18-00657"><label>390.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name><name><surname>Gordon</surname><given-names>D.P.</given-names></name><name><surname>Page</surname><given-names>M.J.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name></person-group><article-title>Isolation and stereospecific synthesis of janolusimide B from a New Zealand collection of the bryozoan <italic>Bugula flabellata</italic></article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>530</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1021/np500752y</pub-id><?supplied-pmid 25494238?><pub-id pub-id-type="pmid">25494238</pub-id></element-citation></ref><ref id="B391-marinedrugs-18-00657"><label>391.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Stereochemistry of ichthyotoxic diacylglycerols from opisthobranch molluscs</article-title><source>Tetrahedron Lett.</source><year>1990</year><volume>31</volume><fpage>6093</fpage><lpage>6094</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)98037-7</pub-id></element-citation></ref><ref id="B392-marinedrugs-18-00657"><label>392.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Two ichthyotoxic diacylglycerols from the opisthobranch mollusc <italic>Umbraculum mediterraneum</italic></article-title><source>Tetrahedron Lett.</source><year>1988</year><volume>29</volume><fpage>3613</fpage><lpage>3616</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(88)85308-5</pub-id></element-citation></ref><ref id="B393-marinedrugs-18-00657"><label>393.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Scopa</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Umbraculumin-B, an unusual 3- hydroxybutyric acid ester from the opisthobranch mollusc <italic>Umbraculum mediterraneum</italic></article-title><source>Tetrahedron Lett.</source><year>1989</year><volume>30</volume><fpage>1147</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)80383-X</pub-id></element-citation></ref><ref id="B394-marinedrugs-18-00657"><label>394.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleeper</surname><given-names>H.L.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Navenones A&#x02013;C: Trail-breaking alarm pheromones from the marine opisthobranch <italic>Navanax inermis</italic></article-title><source>J. Am. Chem. Soc.</source><year>1977</year><volume>99</volume><fpage>2367</fpage><lpage>2368</lpage><pub-id pub-id-type="doi">10.1021/ja00449a072</pub-id><pub-id pub-id-type="pmid">193884</pub-id></element-citation></ref><ref id="B395-marinedrugs-18-00657"><label>395.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imperato</surname><given-names>F.</given-names></name><name><surname>Minale</surname><given-names>L.</given-names></name><name><surname>Riccio</surname><given-names>R.</given-names></name></person-group><article-title>Constituents of the digestive gland of molluscs of the genus <italic>Aplysia</italic>. II. Halogenated monoterpenes from <italic>Aplysia limacina</italic></article-title><source>Experientia</source><year>1977</year><volume>33</volume><fpage>1273</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1007/BF01920128</pub-id></element-citation></ref><ref id="B396-marinedrugs-18-00657"><label>396.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>4-acetylaplykurodin B and aplykurodinone B, two ichthyotoxic degraded sterols from the Mediterranean mollusk <italic>Aplysia fasciata</italic></article-title><source>J. Nat. Prod.</source><year>1992</year><volume>5</volume><fpage>989</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1021/np50085a027</pub-id></element-citation></ref><ref id="B397-marinedrugs-18-00657"><label>397.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>M.J.</given-names></name><name><surname>Zub&#x000ed;a</surname><given-names>E.</given-names></name><name><surname>Salv&#x000e1;</surname><given-names>J.</given-names></name></person-group><article-title>3-epi-aplykurodinone B, a new degraded sterol from <italic>Aplysia fasciata</italic></article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>488</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1021/np9607464</pub-id><pub-id pub-id-type="pmid">9170292</pub-id></element-citation></ref><ref id="B398-marinedrugs-18-00657"><label>398.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name></person-group><article-title>Isolation and structures of aplykurodins A and B, two new isoprenoids from the marine mollusk <italic>Aplysia kurodai</italic></article-title><source>Tetrahedron Lett.</source><year>1986</year><volume>27</volume><fpage>1153</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)84203-3</pub-id></element-citation></ref><ref id="B399-marinedrugs-18-00657"><label>399.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Ebisawa</surname><given-names>Y.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name></person-group><article-title>Aplyparvunin, a bioactive acetogenin from the sea hare <italic>Aplysia parvula</italic></article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>6073</fpage><lpage>6074</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)01205-V</pub-id></element-citation></ref><ref id="B400-marinedrugs-18-00657"><label>400.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPhail</surname><given-names>K.L.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name></person-group><article-title>(3Z)-Bromofucin from a South African sea hare</article-title><source>Nat. Prod. Res.</source><year>2005</year><volume>19</volume><fpage>449</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1080/14786410412331271960</pub-id><?supplied-pmid 15938190?><pub-id pub-id-type="pmid">15938190</pub-id></element-citation></ref><ref id="B401-marinedrugs-18-00657"><label>401.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midland</surname><given-names>S.L.</given-names></name><name><surname>Wing</surname><given-names>R.M.</given-names></name><name><surname>Sims</surname><given-names>J.J.</given-names></name></person-group><article-title>New crenulides from the sea hare <italic>Aplysia vaccaria</italic></article-title><source>J. Org. Chem.</source><year>1983</year><volume>48</volume><fpage>1906</fpage><lpage>1909</lpage><pub-id pub-id-type="doi">10.1021/jo00159a026</pub-id></element-citation></ref><ref id="B402-marinedrugs-18-00657"><label>402.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H.H.</given-names></name><name><surname>McEnroe</surname><given-names>F.J.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Acetoxycrenulide, a new bicyclic cyclopropane-containing diterpenoid from the brown seaweed <italic>Dictyota crenulata</italic></article-title><source>J. Org. Chem.</source><year>1983</year><volume>48</volume><fpage>1903</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1021/jo00159a025</pub-id></element-citation></ref><ref id="B403-marinedrugs-18-00657"><label>403.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Zub&#x000ed;a</surname><given-names>E.</given-names></name><name><surname>Mart&#x000ee;nez</surname><given-names>E.</given-names></name><name><surname>Ortea</surname><given-names>J.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Structure and stereochemistry of aplyolides A&#x02212; E, lactonized dihydroxy fatty acids from the skin of the marine mollusk <italic>Aplysia depilans</italic></article-title><source>J. Org. Chem.</source><year>1997</year><volume>62</volume><fpage>5471</fpage><lpage>5475</lpage><pub-id pub-id-type="doi">10.1021/jo961805l</pub-id></element-citation></ref><ref id="B404-marinedrugs-18-00657"><label>404.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Fritsch</surname><given-names>N.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Stypotriol and stypoldione; ichthyotoxins of mixed biogenesis from the marine alga <italic>Stypopodium zonale</italic></article-title><source>Tetrahedron Lett.</source><year>1979</year><volume>2</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)85907-4</pub-id></element-citation></ref><ref id="B405-marinedrugs-18-00657"><label>405.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuniyoshi</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name></person-group><article-title>A biologically active diphenyl ether from the green alga <italic>Cladophora fascicularis</italic></article-title><source>Experientia</source><year>1985</year><volume>41</volume><fpage>523</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1007/BF01966182</pub-id></element-citation></ref><ref id="B406-marinedrugs-18-00657"><label>406.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doty</surname><given-names>M.S.</given-names></name><name><surname>Aguilar-Santos</surname><given-names>G.</given-names></name></person-group><article-title>Transfer of toxic algal substances in marine food chains</article-title><source>Pac. Sci.</source><year>1970</year><volume>24</volume><fpage>351</fpage><lpage>355</lpage></element-citation></ref><ref id="B407-marinedrugs-18-00657"><label>407.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Defensive relationships between <italic>Caulerpa prolifera</italic> and its shelled sacoglossan predators</article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>1994</year><volume>175</volume><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/0022-0981(94)90026-4</pub-id></element-citation></ref><ref id="B408-marinedrugs-18-00657"><label>408.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Ros</surname><given-names>J.D.</given-names></name></person-group><article-title>Oxytoxins, bioactive molecules produced by the marine opisthobranch mollusc <italic>Oxynoe olivacea</italic> from a diet-derived precursor</article-title><source>Experientia</source><year>1990</year><volume>46</volume><fpage>767</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1007/BF01939963</pub-id><pub-id pub-id-type="pmid">2373206</pub-id></element-citation></ref><ref id="B409-marinedrugs-18-00657"><label>409.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Naik</surname><given-names>C.D.</given-names></name><name><surname>Wahidulla</surname><given-names>S.</given-names></name><name><surname>D&#x02019;Sousa</surname><given-names>L.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Volvatellin, cauerpenyne-related product from the sacoglossan <italic>Volvatella</italic> sp.</article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>931</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1021/np990011+</pub-id><?supplied-pmid 10395525?><pub-id pub-id-type="pmid">10395525</pub-id></element-citation></ref><ref id="B410-marinedrugs-18-00657"><label>410.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>K.R.</given-names></name></person-group><article-title>Evolution of the sacoglossa (Mollusca, Opisthobranchia) and the ecological associations with their food plants</article-title><source>Evol. Ecol.</source><year>1997</year><volume>11</volume><fpage>301</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1023/A:1018468420368</pub-id></element-citation></ref><ref id="B411-marinedrugs-18-00657"><label>411.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>L&#x000f3;pez Gresa</surname><given-names>M.P.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>L.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>New caulerpenyne-derived metabolites of an <italic>Elysia</italic> sacoglossan from the south Indian coast</article-title><source>Molecules</source><year>2006</year><volume>11</volume><fpage>808</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.3390/11100808</pub-id><?supplied-pmid 17971757?><pub-id pub-id-type="pmid">17971757</pub-id></element-citation></ref><ref id="B412-marinedrugs-18-00657"><label>412.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Muniain</surname><given-names>C.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Iannicelli</surname><given-names>O.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>First chemical study of the sacoglossan <italic>Elysia patagonica</italic>: Isolation of a &#x003b3;-pyrone propionate hydroperoxide</article-title><source>Biochem. System. Ecol.</source><year>2013</year><volume>49</volume><fpage>172</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2013.03.019</pub-id></element-citation></ref><ref id="B413-marinedrugs-18-00657"><label>413.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosliner</surname><given-names>T.M.</given-names></name></person-group><article-title>The genus <italic>Thuridilla</italic> (Opisthobranchia: Elysiidae) from thetropical indo-pacific, with a revision of the phylogeny of the elysiidae</article-title><source>Calif. Acad. Sci.</source><year>1995</year><volume>59</volume><fpage>1</fpage><lpage>54</lpage></element-citation></ref><ref id="B414-marinedrugs-18-00657"><label>414.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawe</surname><given-names>R.D.</given-names></name><name><surname>Wright</surname><given-names>J.L.C.</given-names></name></person-group><article-title>The major polypropionate metabolites from the sacoglossan mollusc <italic>Elysia chlorotica</italic></article-title><source>Tetrahedron Lett.</source><year>1986</year><volume>27</volume><fpage>2559</fpage><lpage>2562</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)84584-0</pub-id></element-citation></ref><ref id="B415-marinedrugs-18-00657"><label>415.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>C.D.</given-names></name><name><surname>Faulkner</surname><given-names>J.</given-names></name><name><surname>Solheim</surname><given-names>B.A.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Tridachione, a propionate-derived metabolite of the opisthobranch mollusc <italic>Tridachiella diomedea</italic></article-title><source>J. Am. Chem. Soc.</source><year>1978</year><volume>100</volume><fpage>1002</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1021/ja00471a074</pub-id></element-citation></ref><ref id="B416-marinedrugs-18-00657"><label>416.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>C.</given-names></name><name><surname>Faulkner</surname><given-names>J.</given-names></name></person-group><article-title>The metabolites of the marine molluscs <italic>Tridachiella diomedea</italic> and <italic>Tridachia crispata</italic></article-title><source>Tetrahedron</source><year>1981</year><volume>37</volume><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(81)85059-4</pub-id></element-citation></ref><ref id="B417-marinedrugs-18-00657"><label>417.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ksebati</surname><given-names>M.B.</given-names></name><name><surname>Schmitz</surname><given-names>F.J.</given-names></name></person-group><article-title>Tridachiapyrones: Propionate-derived metabolites from the sacoglossan mollusc <italic>Tridachia crispata</italic></article-title><source>J. Org. Chem.</source><year>1985</year><volume>50</volume><fpage>5637</fpage><lpage>5642</lpage><pub-id pub-id-type="doi">10.1021/jo00350a042</pub-id></element-citation></ref><ref id="B418-marinedrugs-18-00657"><label>418.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Croz</surname><given-names>L.</given-names></name><name><surname>Mat&#x000e9;</surname><given-names>J.L.</given-names></name><name><surname>San-Mart&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name></person-group><article-title>Elysiapyrones from <italic>Elysia diomedea</italic>. Do such metabolites evidence an enzymatically assisted electrocyclization cascade for the biosynthesis of their bicyclo[4.2.0]octane core?</article-title><source>Org. Lett.</source><year>2005</year><volume>7</volume><fpage>415</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1021/ol0477428</pub-id><?supplied-pmid 15673253?><pub-id pub-id-type="pmid">15673253</pub-id></element-citation></ref><ref id="B419-marinedrugs-18-00657"><label>419.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Marrero</surname><given-names>A.R.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Croz</surname><given-names>L.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name></person-group><article-title>Validating and endoperoxide as a key intermediate in the biosynthesis of elysiapyrones</article-title><source>Org. Lett.</source><year>2008</year><volume>10</volume><fpage>3057</fpage><lpage>3060</lpage><pub-id pub-id-type="doi">10.1021/ol8010425</pub-id><?supplied-pmid 18572945?><pub-id pub-id-type="pmid">18572945</pub-id></element-citation></ref><ref id="B420-marinedrugs-18-00657"><label>420.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Petrocellis</surname><given-names>L.</given-names></name><name><surname>Orlando</surname><given-names>P.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Ventriglia</surname><given-names>M.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name></person-group><article-title>Novel diterpenoid diacylglycerols from marine molluscs: Potent morphogens and protein kinase C activators</article-title><source>Experientia</source><year>1996</year><volume>52</volume><fpage>874</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1007/BF01938873</pub-id><?supplied-pmid 8925883?><pub-id pub-id-type="pmid">8925883</pub-id></element-citation></ref><ref id="B421-marinedrugs-18-00657"><label>421.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochlowski</surname><given-names>J.E.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Bass</surname><given-names>L.S.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Metabolites of the dorid nudibranch <italic>Chromodoris sedna</italic></article-title><source>J. Org. Chem.</source><year>1983</year><volume>48</volume><fpage>1738</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1021/jo00158a030</pub-id></element-citation></ref><ref id="B422-marinedrugs-18-00657"><label>422.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Nagata</surname><given-names>H.</given-names></name><name><surname>Hirota</surname><given-names>H.</given-names></name><name><surname>Tsuyuki</surname><given-names>T.</given-names></name></person-group><article-title>Astrogorgiadiol and astrogorgin, inhibitors of cell division in fertilized starfish eggs, from a gorgonian <italic>Astrogorgia</italic> sp.</article-title><source>Tetrahedron Lett.</source><year>1989</year><volume>30</volume><fpage>7079</fpage><lpage>7082</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)93428-8</pub-id></element-citation></ref><ref id="B423-marinedrugs-18-00657"><label>423.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochi</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Shirase</surname><given-names>K.</given-names></name><name><surname>Kotsuki</surname><given-names>H.</given-names></name></person-group><article-title>Calicophirins A and B, two new insect growth inhibitory diterpenoids from a gorgonian coral <italic>Calicogorgia</italic> sp.</article-title><source>Heterocycles (Sendai)</source><year>1991</year><volume>32</volume><fpage>19</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3987/COM-90-5624</pub-id></element-citation></ref><ref id="B424-marinedrugs-18-00657"><label>424.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmely</surname><given-names>S.</given-names></name><name><surname>Ilan</surname><given-names>M.</given-names></name><name><surname>Kashman</surname><given-names>Y.</given-names></name></person-group><article-title>2-Amino Imidazole Alkaloids from the Marine Sponge <italic>Leucetta chagosensis</italic></article-title><source>Tetrahedron</source><year>1989</year><volume>45</volume><fpage>2193</fpage><lpage>2200</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)80079-X</pub-id></element-citation></ref><ref id="B425-marinedrugs-18-00657"><label>425.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname><given-names>T.</given-names></name><name><surname>Tintillier</surname><given-names>F.</given-names></name><name><surname>Lucasson</surname><given-names>A.</given-names></name><name><surname>Moriou</surname><given-names>C.</given-names></name><name><surname>Bonno</surname><given-names>E.</given-names></name><name><surname>Petek</surname><given-names>S.</given-names></name><name><surname>Magr&#x000e9;</surname><given-names>K.</given-names></name><name><surname>Al Mourabit</surname><given-names>A.</given-names></name><name><surname>Saulnier</surname><given-names>D.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name></person-group><article-title>Quorum sensing inhibitors from <italic>Leucetta chagosensis</italic> Dendy, 1863</article-title><source>Lett. Appl. Microbiol.</source><year>2015</year><volume>61</volume><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1111/lam.12461</pub-id><pub-id pub-id-type="pmid">26138555</pub-id></element-citation></ref><ref id="B426-marinedrugs-18-00657"><label>426.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvi</surname><given-names>K.A.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Loughhead</surname><given-names>D.G.</given-names></name></person-group><article-title>Structures and total synthesis of 2-aminoimidazoles from a <italic>Notodoris</italic> nudibranch</article-title><source>J. Nat. Prod.</source><year>1991</year><volume>54</volume><fpage>1509</fpage><lpage>1515</lpage><pub-id pub-id-type="doi">10.1021/np50078a004</pub-id></element-citation></ref><ref id="B427-marinedrugs-18-00657"><label>427.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>Franzblau</surname><given-names>S.G.</given-names></name></person-group><article-title>Assessment of antimycobacterial activity of a series of mainly marine derived natural products</article-title><source>Planta Med.</source><year>2000</year><volume>66</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1055/s-2000-8534</pub-id><pub-id pub-id-type="pmid">10865450</pub-id></element-citation></ref><ref id="B428-marinedrugs-18-00657"><label>428.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>M.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>McClintock</surname><given-names>J.B.</given-names></name><name><surname>Perry</surname><given-names>T.L.</given-names></name><name><surname>Puglisi</surname><given-names>M.P.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name></person-group><article-title>Ecological roles for water-borne metabolites from Antarctic soft corals</article-title><source>Mar. Ecol. Progr. Ser.</source><year>1997</year><volume>161</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.3354/meps161133</pub-id></element-citation></ref><ref id="B429-marinedrugs-18-00657"><label>429.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kladi</surname><given-names>M.</given-names></name><name><surname>Ntountaniotis</surname><given-names>D.</given-names></name><name><surname>Zervou</surname><given-names>M.</given-names></name><name><surname>Vagias</surname><given-names>C.</given-names></name><name><surname>Ioannou</surname><given-names>E.</given-names></name><name><surname>Roussis</surname><given-names>V.</given-names></name></person-group><article-title>Glandulaurencianols A&#x02013;C, brominated diterpenes from the red alga, <italic>Laurencia glandulifera</italic> and the sea hare, <italic>Aplysia punctata</italic></article-title><source>Tetrahedron Lett.</source><year>2014</year><volume>55</volume><fpage>2835</fpage><lpage>2837</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2014.03.083</pub-id></element-citation></ref><ref id="B430-marinedrugs-18-00657"><label>430.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findlay</surname><given-names>J.A.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name></person-group><article-title>Novel terpenoids from the sea hare <italic>Aplysia punctata</italic></article-title><source>Can. J. Chem.</source><year>2002</year><volume>80</volume><fpage>1697</fpage><lpage>1707</lpage><pub-id pub-id-type="doi">10.1139/v02-189</pub-id></element-citation></ref><ref id="B431-marinedrugs-18-00657"><label>431.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caccamese</surname><given-names>S.</given-names></name><name><surname>Toscano</surname><given-names>R.M.</given-names></name><name><surname>Cerrini</surname><given-names>S.</given-names></name><name><surname>Gavuzzo</surname><given-names>E.</given-names></name></person-group><article-title>Laurencianol, a new halogenated diterpenoid from the marine alga <italic>Laurencia obtusa</italic></article-title><source>Tetrahedron Lett.</source><year>1982</year><volume>23</volume><fpage>114</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)87630-3</pub-id></element-citation></ref><ref id="B432-marinedrugs-18-00657"><label>432.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Kanda</surname><given-names>F.</given-names></name><name><surname>Kamiya</surname><given-names>H.</given-names></name></person-group><article-title>Occurrence of pyropheophorbides a and b in the viscera of the sea hare <italic>Aplysia juliana</italic></article-title><source>Nippon Suisan Gakk.</source><year>1991</year><volume>57</volume><fpage>1983</fpage><pub-id pub-id-type="doi">10.2331/suisan.57.1983</pub-id></element-citation></ref><ref id="B433-marinedrugs-18-00657"><label>433.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atta-ur-Rahman</surname><given-names>K.A.</given-names></name><name><surname>Abbas</surname><given-names>S.A.</given-names></name><name><surname>Sultana</surname><given-names>T.</given-names></name><name><surname>Shameel</surname><given-names>M.</given-names></name></person-group><article-title>A diterpenoid lactone from <italic>Aplysia juliana</italic></article-title><source>J. Nat. Prod.</source><year>1991</year><volume>54</volume><fpage>886</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1021/np50075a026</pub-id><pub-id pub-id-type="pmid">1955886</pub-id></element-citation></ref><ref id="B434-marinedrugs-18-00657"><label>434.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkendorff</surname><given-names>K.</given-names></name><name><surname>Davis</surname><given-names>A.R.</given-names></name><name><surname>Rogers</surname><given-names>C.N.</given-names></name><name><surname>Bremner</surname><given-names>J.B.</given-names></name></person-group><article-title>Free fatty acids and sterols in the benthic spawn of aquatic molluscs, and their associated antimicrobial properties</article-title><source>J. Exp. Mar. Biol. Ecol.</source><year>2005</year><volume>316</volume><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jembe.2004.10.001</pub-id></element-citation></ref><ref id="B435-marinedrugs-18-00657"><label>435.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisugi</surname><given-names>J.</given-names></name><name><surname>Ohye</surname><given-names>H.</given-names></name><name><surname>Kamiya</surname><given-names>H.</given-names></name><name><surname>Yamazaki</surname><given-names>M.</given-names></name></person-group><article-title>Biopolymers from marine invertebrates. XIII. Characterization of an antibacterial protein, dolabellanin A, from the albumen gland of the sea hare, <italic>Dolabella auricularia</italic></article-title><source>Chem. Pharm. Bull.</source><year>1992</year><volume>40</volume><fpage>1537</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1248/cpb.40.1537</pub-id></element-citation></ref><ref id="B436-marinedrugs-18-00657"><label>436.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>Biofouling and antifouling</article-title><source>Nat. Prod. Rep.</source><year>2004</year><volume>21</volume><fpage>94</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1039/b302231p</pub-id><pub-id pub-id-type="pmid">15039837</pub-id></element-citation></ref><ref id="B437-marinedrugs-18-00657"><label>437.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikawa</surname><given-names>K.</given-names></name><name><surname>Nakahara</surname><given-names>H.</given-names></name><name><surname>Shirokura</surname><given-names>Y.</given-names></name><name><surname>Nogata</surname><given-names>Y.</given-names></name><name><surname>Yoshimura</surname><given-names>E.</given-names></name><name><surname>Umezawa</surname><given-names>T.</given-names></name><name><surname>Okino</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>F.</given-names></name></person-group><article-title>Total synthesis of 10-isocyano-4-cadinene and its stereoisomers and evaluations of antifouling activities</article-title><source>J. Org. Chem.</source><year>2011</year><volume>76</volume><fpage>6558</fpage><lpage>6573</lpage><pub-id pub-id-type="doi">10.1021/jo2008109</pub-id><pub-id pub-id-type="pmid">21755975</pub-id></element-citation></ref><ref id="B438-marinedrugs-18-00657"><label>438.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>J.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name></person-group><article-title>Two new cytotoxic carbonimidic dichlorides from the nudibranch <italic>Reticulidia fungia</italic></article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>1339</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1021/np990186j</pub-id><?supplied-pmid 10514331?><pub-id pub-id-type="pmid">10514331</pub-id></element-citation></ref><ref id="B439-marinedrugs-18-00657"><label>439.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Targett</surname><given-names>N.M.</given-names></name><name><surname>Bishop</surname><given-names>S.S.</given-names></name><name><surname>McConnell</surname><given-names>O.J.</given-names></name><name><surname>Yoder</surname><given-names>J.A.</given-names></name></person-group><article-title>Antifouling agents against the benthic marine diatom, <italic>Navicula salinicola</italic> Homarine from the gorgonians <italic>Leptogorgia virgulata</italic> and <italic>L. setacea</italic> and analogs</article-title><source>J. Chem. Ecol.</source><year>1983</year><volume>9</volume><fpage>817</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1007/BF00987807</pub-id><?supplied-pmid 24407755?><pub-id pub-id-type="pmid">24407755</pub-id></element-citation></ref><ref id="B440-marinedrugs-18-00657"><label>440.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>D.</given-names></name></person-group><article-title>A Proposed Definition of Mental Illness. Critical Issues in Psychiatric Diagnosis</article-title><source>Ph.D. Thesis</source><publisher-name>New York University</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1978</year></element-citation></ref><ref id="B441-marinedrugs-18-00657"><label>441.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berking</surname><given-names>S.</given-names></name></person-group><article-title>Is homarine a morphogen in the marine hydroid <italic>Hydractinia</italic>?</article-title><source>Roux&#x02019;s Arch. Dev. Biol.</source><year>1986</year><volume>195</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1007/BF00444039</pub-id><?supplied-pmid 28305275?><pub-id pub-id-type="pmid">28305275</pub-id></element-citation></ref><ref id="B442-marinedrugs-18-00657"><label>442.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berking</surname><given-names>S.</given-names></name></person-group><article-title>Homarine (N-methylpicolinic acid) and trigonelline (N-methylnicotinic acid) appear to be involved in pattern control in a marine hydroid</article-title><source>Development</source><year>1987</year><volume>99</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">3652996</pub-id></element-citation></ref><ref id="B443-marinedrugs-18-00657"><label>443.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortlepp</surname><given-names>S.</given-names></name><name><surname>Pedpradap</surname><given-names>S.</given-names></name><name><surname>Dobretsov</surname><given-names>S.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Antifouling activity of sponge-derived polybrominated diphenyl ethers and synthetic analogues</article-title><source>Biofouling</source><year>2008</year><volume>24</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1080/08927010802008096</pub-id><pub-id pub-id-type="pmid">18373284</pub-id></element-citation></ref><ref id="B444-marinedrugs-18-00657"><label>444.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Alvarez</surname><given-names>L.</given-names></name><name><surname>Passeggio</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>New3-alkylpyridines from 3 Mediterranean cephalaspidean mollusks; structure, ecological role and taxonomic relevance</article-title><source>Tetrahedron</source><year>1993</year><volume>49</volume><fpage>1307</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)85820-8</pub-id></element-citation></ref><ref id="B445-marinedrugs-18-00657"><label>445.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blihoghe</surname><given-names>D.</given-names></name><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Villela</surname><given-names>A.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Picariello</surname><given-names>G.</given-names></name><name><surname>Faimali</surname><given-names>M.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of the antifouling properties of 3-alyklpyridine compounds</article-title><source>Biofouling</source><year>2011</year><volume>27</volume><fpage>99</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1080/08927014.2010.542587</pub-id><pub-id pub-id-type="pmid">21181570</pub-id></element-citation></ref><ref id="B446-marinedrugs-18-00657"><label>446.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Tramice</surname><given-names>A.</given-names></name><name><surname>De Caro</surname><given-names>S.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Biogenesis of 3-alkylpyridine alkaloids in the marine mollusc <italic>Haminoea orbignyana</italic></article-title><source>Angew. Chem. Int. Ed.</source><year>2003</year><volume>42</volume><fpage>2633</fpage><lpage>2636</lpage><pub-id pub-id-type="doi">10.1002/anie.200250642</pub-id></element-citation></ref><ref id="B447-marinedrugs-18-00657"><label>447.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Koehler</surname><given-names>E.</given-names></name></person-group><source>&#x02018;Trailing&#x02019; Behaviour in Risbecia tryoni. Sea Slug Forum</source><publisher-name>Australian Museum</publisher-name><publisher-loc>Sydney, Australia</publisher-loc><year>1999</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.seaslugforum.net/find/760">http://www.seaslugforum.net/find/760</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-20">(accessed on 20 November 2020)</date-in-citation></element-citation></ref><ref id="B448-marinedrugs-18-00657"><label>448.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Sleeper</surname><given-names>H.L.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Stallard</surname><given-names>M.O.</given-names></name><name><surname>Sun</surname><given-names>H.H.</given-names></name></person-group><article-title>Defensive chemistry of <italic>Navanax</italic> and related opisthobranch molluscs</article-title><source>Pure Appl. Chem.</source><year>1979</year><volume>51</volume><fpage>1865</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1351/pac197951091865</pub-id></element-citation></ref><ref id="B449-marinedrugs-18-00657"><label>449.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Passeggio</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name></person-group><article-title>Alarm pheromones from the Mediterranean opisthobranch <italic>Haminoea navicula</italic></article-title><source>Experientia</source><year>1991</year><volume>47</volume><fpage>61</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1007/BF02041253</pub-id></element-citation></ref><ref id="B450-marinedrugs-18-00657"><label>450.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Giordano</surname><given-names>A.</given-names></name><name><surname>d&#x02019;Ippolito</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Polyketide origin of 3-alkylpyridines in the marine mollusc <italic>Haminoea orbignyana</italic></article-title><source>Tetrahedron Lett.</source><year>2004</year><volume>45</volume><fpage>2627</fpage><lpage>2629</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2004.01.138</pub-id></element-citation></ref><ref id="B451-marinedrugs-18-00657"><label>451.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>L.A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Alkylphenols from the cephalaspidean mollusc <italic>Haminoea callidegenita</italic></article-title><source>Tetrahedron Lett.</source><year>1998</year><volume>39</volume><fpage>2005</fpage><lpage>2008</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(98)00117-8</pub-id></element-citation></ref><ref id="B452-marinedrugs-18-00657"><label>452.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dom&#x000e8;nech</surname><given-names>A.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Ballesteros</surname><given-names>M.</given-names></name></person-group><article-title>Opisthobranch molluscs from the subtidal trawling grounds off Blanes (Girona, northeast Spain)</article-title><source>J. Mar. Biolog. Assoc.</source><year>2006</year><volume>86</volume><fpage>383</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1017/S0025315406013233</pub-id></element-citation></ref><ref id="B453-marinedrugs-18-00657"><label>453.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eilertsen</surname><given-names>M.H.</given-names></name><name><surname>Malaquias</surname><given-names>M.A.E.</given-names></name></person-group><article-title>Speciation in the dark: Diversification and biogeography of the deep-sea gastropod genus <italic>Scaphander</italic> in the Atlantic Ocean</article-title><source>J. Biogeogr.</source><year>2015</year><volume>42</volume><fpage>843</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1111/jbi.12471</pub-id><?supplied-pmid 27524853?><pub-id pub-id-type="pmid">27524853</pub-id></element-citation></ref><ref id="B454-marinedrugs-18-00657"><label>454.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Rosica</surname><given-names>A.</given-names></name><name><surname>Romano</surname><given-names>G.</given-names></name><name><surname>Laratta</surname><given-names>B.</given-names></name><name><surname>Domenech-Coll</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Biosynthesis and cellular localization of functional polyketides in the gastropod mollusc <italic>Scaphander lignarius</italic></article-title><source>Chembiochem.</source><year>2012</year><volume>13</volume><fpage>1759</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.1002/cbic.201200287</pub-id><?supplied-pmid 22829532?><pub-id pub-id-type="pmid">22829532</pub-id></element-citation></ref><ref id="B455-marinedrugs-18-00657"><label>455.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Domenech-Coll</surname><given-names>A.</given-names></name><name><surname>d&#x02019;Ippolito</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>First biosynthetic evidence on the phenyl-containing polyketides of the marine mollusc <italic>Scaphander lignarius</italic></article-title><source>Organic Lett.</source><year>2008</year><volume>10</volume><fpage>2963</fpage><lpage>2966</lpage><pub-id pub-id-type="doi">10.1021/ol800877f</pub-id></element-citation></ref><ref id="B456-marinedrugs-18-00657"><label>456.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Sala</surname><given-names>G.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Calabrese</surname><given-names>G.</given-names></name><name><surname>Dom&#x000e8;nech</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Ippolito</surname><given-names>G.</given-names></name><name><surname>Monica</surname><given-names>C.D.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Towards the biosynthesis of the aromatic products of the Mediterranean mollusc <italic>Scaphander lignarius</italic>: Isolation and synthesis of analogues of lignarenones</article-title><source>Tetrahedron</source><year>2007</year><volume>63</volume><fpage>7256</fpage><lpage>7263</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2007.04.061</pub-id></element-citation></ref><ref id="B457-marinedrugs-18-00657"><label>457.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamio</surname><given-names>M.</given-names></name><name><surname>Kicklighter</surname><given-names>C.E.</given-names></name><name><surname>Nguyen</surname><given-names>L.</given-names></name><name><surname>Germann</surname><given-names>M.W.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Isolation and structural elucidation of novel mycosporine-like amino acids as alarm cues in the defensive ink secretion of the sea hare <italic>Aplysia californica</italic></article-title><source>Helv. Chim. Acta</source><year>2011</year><volume>94</volume><fpage>1012</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1002/hlca.201100117</pub-id></element-citation></ref><ref id="B458-marinedrugs-18-00657"><label>458.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kicklighter</surname><given-names>C.E.</given-names></name><name><surname>Kamio</surname><given-names>M.</given-names></name><name><surname>Nguyen</surname><given-names>L.</given-names></name><name><surname>Germann</surname><given-names>M.W.</given-names></name><name><surname>Derby</surname><given-names>C.D.</given-names></name></person-group><article-title>Mycosporine-like amino acids are multifunctional molecules in sea hares and their marine community</article-title><source>Proc. Nat. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>11494</fpage><lpage>11499</lpage><pub-id pub-id-type="doi">10.1073/pnas.1103906108</pub-id><pub-id pub-id-type="pmid">21709250</pub-id></element-citation></ref><ref id="B459-marinedrugs-18-00657"><label>459.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000fa;&#x000f1;ez-Pons</surname><given-names>L.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Romano</surname><given-names>G.</given-names></name><name><surname>Verde</surname><given-names>C.</given-names></name><name><surname>Giordano</surname><given-names>D.</given-names></name></person-group><article-title>UV-protective compounds in marine organisms from the Southern Ocean</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>336</elocation-id><pub-id pub-id-type="doi">10.3390/md16090336</pub-id></element-citation></ref><ref id="B460-marinedrugs-18-00657"><label>460.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czeczuga</surname><given-names>B.</given-names></name></person-group><article-title>Investigations of carotenoids in some animals of the Adriatic Sea&#x02014;VI Representatives of sponges, annelids, molluscs and echinodermates</article-title><source>Comp. Biochem. Physiol. B Comp. Biochem.</source><year>1984</year><volume>78</volume><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(84)90180-9</pub-id></element-citation></ref><ref id="B461-marinedrugs-18-00657"><label>461.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname><given-names>K.</given-names></name><name><surname>Karentz</surname><given-names>D.</given-names></name><name><surname>Hedges</surname><given-names>J.</given-names></name></person-group><article-title>Mycosporine-like amino acids (MAAs) in phytoplankton, a herbivorous pteropod (<italic>Limacina helicina</italic>), and its pteropod predator (<italic>Clione antarctica</italic>) in McMurdo Bay, Antarctica</article-title><source>Mar. Biol.</source><year>2001</year><volume>139</volume><fpage>1013</fpage><lpage>1019</lpage></element-citation></ref><ref id="B462-marinedrugs-18-00657"><label>462.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name></person-group><article-title>Natural products from marine Heterobranchs: An overview of recent results</article-title><source>Chem. J. Mold.</source><year>2019</year><volume>14</volume><fpage>9</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.19261/cjm.2019.617</pub-id></element-citation></ref><ref id="B463-marinedrugs-18-00657"><label>463.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name></person-group><article-title>Shaping the polypropionate biosynthesis in the solar-powered mollusc <italic>Elysia viridis</italic></article-title><source>ChemBioChem.</source><year>2009</year><volume>10</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1002/cbic.200800531</pub-id><pub-id pub-id-type="pmid">19115330</pub-id></element-citation></ref><ref id="B464-marinedrugs-18-00657"><label>464.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Is phototridachiahydropyrone a true natural product?</article-title><source>Rev. Bras. Pharmacogn.</source><year>2015</year><volume>25</volume><fpage>588</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2015.07.028</pub-id></element-citation></ref><ref id="B465-marinedrugs-18-00657"><label>465.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Crispino</surname><given-names>A.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Secondary metabolites from Mediterranean Elysioidea: Origin and biological role</article-title><source>Comp. Biochem. Physiol. B Comp. Biochem.</source><year>1994</year><volume>108</volume><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(94)90170-8</pub-id></element-citation></ref><ref id="B466-marinedrugs-18-00657"><label>466.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>C.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Photosynthetic marine molluscs: In vivo 14C incorporation into metabolites of the sacoglossan <italic>Placobranchus ocellatus</italic></article-title><source>Science</source><year>1979</year><volume>205</volume><fpage>922</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1126/science.205.4409.922</pub-id><pub-id pub-id-type="pmid">17813086</pub-id></element-citation></ref><ref id="B467-marinedrugs-18-00657"><label>467.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>K.J.</given-names></name><name><surname>Richens</surname><given-names>J.L.</given-names></name><name><surname>Bramble</surname><given-names>J.P.</given-names></name><name><surname>Han</surname><given-names>L.C.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>P.</given-names></name><name><surname>Moses</surname><given-names>J.E.</given-names></name></person-group><article-title>Photochemical activity of membrane-localised polyketide derived marine natural products</article-title><source>Tetrahedron</source><year>2017</year><volume>74</volume><fpage>1191</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2017.10.056</pub-id></element-citation></ref><ref id="B468-marinedrugs-18-00657"><label>468.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Wahidulla</surname><given-names>S.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>New &#x003b3;-pyrone propionates from the Indian Ocean sacoglossan <italic>Placobranchus ocellatus</italic></article-title><source>Tetrahedron Lett.</source><year>2005</year><volume>46</volume><fpage>465</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2004.11.085</pub-id></element-citation></ref><ref id="B469-marinedrugs-18-00657"><label>469.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Hong</surname><given-names>E.P.</given-names></name><name><surname>Schmitz</surname><given-names>F.J.</given-names></name></person-group><article-title>New polypropionate pyrones from the Philippine sacoglossan mollusc <italic>Placobranchus ocellatus</italic></article-title><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>8989</fpage><lpage>8993</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00751-1</pub-id></element-citation></ref><ref id="B470-marinedrugs-18-00657"><label>470.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>C.</given-names></name></person-group><article-title>The growth of <italic>Peltodoris atromaculata</italic> Bergh, 1880 (Gastropoda: Nudibranchia) in the laboratory</article-title><source>J. Molluscan Stud.</source><year>1996</year><volume>62</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1093/mollus/62.2.151</pub-id></element-citation></ref><ref id="B471-marinedrugs-18-00657"><label>471.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Minardi</surname><given-names>C.</given-names></name><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Prostaglandin F-1, 15-lactone fatty acyl esters: A prostaglandin lactone pathway branch developed during the reproduction and early larval stages of a marine mollusc</article-title><source>Comp. Biochem. Physiol. B Biochem.</source><year>1992</year><volume>101</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(92)90164-M</pub-id></element-citation></ref><ref id="B472-marinedrugs-18-00657"><label>472.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>A.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>A histological and chemical study of the cerata of the opisthobranch mollusc <italic>Tethys fimbria</italic></article-title><source>Mar. Biol.</source><year>1991</year><volume>111</volume><fpage>353</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1007/BF01319406</pub-id></element-citation></ref><ref id="B473-marinedrugs-18-00657"><label>473.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>A- and g-Pyrone-polypropionates from the Mediterranean ascoglossan mollusc <italic>Ercolania funerea</italic></article-title><source>Tetrahedron</source><year>1992</year><volume>48</volume><fpage>9561</fpage><lpage>9566</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)88324-1</pub-id></element-citation></ref><ref id="B474-marinedrugs-18-00657"><label>474.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Vardaro</surname><given-names>R.R.</given-names></name><name><surname>De Petrocellis</surname><given-names>L.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Histological and biochemical bases of defense mechanisms in four species of Polybranchoidea ascoglossan molluscs</article-title><source>Mar. Biol.</source><year>1993</year><volume>117</volume><fpage>367</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1007/BF00349312</pub-id></element-citation></ref><ref id="B475-marinedrugs-18-00657"><label>475.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Nuzzo</surname><given-names>G.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Cervera</surname><given-names>J.L.</given-names></name><name><surname>Malaquias</surname><given-names>M.A.E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Aplysiopsenes: An additional example of marine polyketides with a mixed acetate/propionate pathway</article-title><source>Tetrahedron Lett.</source><year>2009</year><volume>50</volume><fpage>527</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2008.11.058</pub-id></element-citation></ref><ref id="B476-marinedrugs-18-00657"><label>476.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ungur</surname><given-names>N.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Synthetic studies on natural diterpenoid glyceryl esters</article-title><source>Tetrahedron</source><year>2000</year><volume>14</volume><fpage>2503</fpage><lpage>2512</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00097-1</pub-id></element-citation></ref><ref id="B477-marinedrugs-18-00657"><label>477.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical studies on the South China Sea nudibranch <italic>Dermatobranchus ornatus</italic> and its suggested prey gorgonian <italic>Muricella</italic> sp.</article-title><source>Chin. J. Org. Chem.</source><year>2006</year><volume>26</volume><fpage>1667</fpage><lpage>1672</lpage></element-citation></ref><ref id="B478-marinedrugs-18-00657"><label>478.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>770</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref><ref id="B479-marinedrugs-18-00657"><label>479.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Lefranc</surname><given-names>F.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Betancourt</surname><given-names>T.</given-names></name><name><surname>Dasari</surname><given-names>R.</given-names></name><name><surname>Kornienko</surname><given-names>A.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name></person-group><article-title>Marine mollusk-derived agents with antiproliferative activity as promising anticancer agents to overcome chemotherapy resistance</article-title><source>Med. Res. Rev.</source><year>2017</year><volume>37</volume><fpage>702</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1002/med.21423</pub-id><pub-id pub-id-type="pmid">27925266</pub-id></element-citation></ref><ref id="B480-marinedrugs-18-00657"><label>480.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs over the last 25 years</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>461</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1021/np068054v</pub-id><?supplied-pmid 17309302?><pub-id pub-id-type="pmid">17309302</pub-id></element-citation></ref><ref id="B481-marinedrugs-18-00657"><label>481.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinothkumar</surname><given-names>S.</given-names></name><name><surname>Parameswaran</surname><given-names>P.S.</given-names></name></person-group><article-title>Recent advances in marine drug research</article-title><source>Biotechnol. Adv.</source><year>2013</year><volume>31</volume><fpage>1826</fpage><lpage>1845</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2013.02.006</pub-id><?supplied-pmid 23500952?><pub-id pub-id-type="pmid">23500952</pub-id></element-citation></ref><ref id="B482-marinedrugs-18-00657"><label>482.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nobili</surname><given-names>S.</given-names></name><name><surname>Lippi</surname><given-names>D.</given-names></name><name><surname>Witort</surname><given-names>E.</given-names></name><name><surname>Donnini</surname><given-names>M.</given-names></name><name><surname>Bausi</surname><given-names>L.</given-names></name><name><surname>Mini</surname><given-names>E.</given-names></name><name><surname>Capaccioli</surname><given-names>S.</given-names></name></person-group><article-title>Natural compounds for cancer treatment and prevention</article-title><source>Pharmacol. Res.</source><year>2009</year><volume>59</volume><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2009.01.017</pub-id><?supplied-pmid 19429468?><pub-id pub-id-type="pmid">19429468</pub-id></element-citation></ref><ref id="B483-marinedrugs-18-00657"><label>483.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Siegel</surname><given-names>R.L.</given-names></name><name><surname>Torre</surname><given-names>L.A.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA A Cancer J. Clin.</source><year>2018</year><volume>68</volume><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3322/caac.21492</pub-id><?supplied-pmid 30207593?><pub-id pub-id-type="pmid">30207593</pub-id></element-citation></ref><ref id="B484-marinedrugs-18-00657"><label>484.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howitz</surname><given-names>K.T.</given-names></name><name><surname>Sinclair</surname><given-names>D.A.</given-names></name></person-group><article-title>Xenohormesis: Sensing the chemical cues of other species</article-title><source>Cell</source><year>2008</year><volume>133</volume><fpage>387</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.04.019</pub-id><?supplied-pmid 18455976?><pub-id pub-id-type="pmid">18455976</pub-id></element-citation></ref><ref id="B485-marinedrugs-18-00657"><label>485.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>K.K.H.</given-names></name><name><surname>Holmes</surname><given-names>M.J.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Kara</surname><given-names>U.A.K.</given-names></name></person-group><article-title>In vivo antimalarial activity of the beta-carboline alkaloid manzamine A. Antimicrob</article-title><source>Agents Chemother.</source><year>2000</year><volume>44</volume><fpage>1645</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1128/AAC.44.6.1645-1649.2000</pub-id><?supplied-pmid 10817722?><pub-id pub-id-type="pmid">10817722</pub-id></element-citation></ref><ref id="B486-marinedrugs-18-00657"><label>486.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Petrocellis</surname><given-names>L.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Arca</surname><given-names>B.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Minei</surname><given-names>R.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>The effect of diterpenoidic diacylglycerols on tentacle regeneration in <italic>Hydra vulgaris</italic></article-title><source>Comp. Biochem. Physiol. C Comp. Pharmacol.</source><year>1991</year><volume>100C</volume><fpage>603</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1016/0742-8413(91)90047-W</pub-id></element-citation></ref><ref id="B487-marinedrugs-18-00657"><label>487.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvi</surname><given-names>K.A.</given-names></name><name><surname>Peters</surname><given-names>B.M.</given-names></name><name><surname>Lisa</surname><given-names>H.M.</given-names></name><name><surname>Phillip</surname><given-names>C.</given-names></name></person-group><article-title>2-Aminoimidazoles and their zinc complexes from Indo-Pacific <italic>Leucetta</italic> sponges and <italic>Notodoris</italic> nudibranchs</article-title><source>Tetrahedron</source><year>1993</year><volume>49</volume><fpage>329</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)80302-1</pub-id></element-citation></ref><ref id="B488-marinedrugs-18-00657"><label>488.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>A.R.</given-names></name><name><surname>Bowden</surname><given-names>B.F.</given-names></name><name><surname>Coll</surname><given-names>J.C.</given-names></name></person-group><article-title>New imidazole alkaloids from the sponge <italic>Leucetta</italic> sp. and the associated predatory nudibranch <italic>Notodoris gardineri</italic></article-title><source>Aust. J. Chem.</source><year>1993</year><volume>46</volume><fpage>1229</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1071/CH9931229</pub-id></element-citation></ref><ref id="B489-marinedrugs-18-00657"><label>489.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copp</surname><given-names>B.R.</given-names></name><name><surname>Fairchild</surname><given-names>C.R.</given-names></name><name><surname>Cornell</surname><given-names>L.</given-names></name><name><surname>Casazza</surname><given-names>A.M.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Ireland</surname><given-names>C.M.</given-names></name></person-group><article-title>Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent</article-title><source>J. Med. Chem.</source><year>1998</year><volume>41</volume><fpage>3909</fpage><lpage>3911</lpage><pub-id pub-id-type="doi">10.1021/jm980294n</pub-id><pub-id pub-id-type="pmid">9748366</pub-id></element-citation></ref><ref id="B490-marinedrugs-18-00657"><label>490.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaBarbera</surname><given-names>D.V.</given-names></name><name><surname>Modzelewska</surname><given-names>K.</given-names></name><name><surname>Glazar</surname><given-names>A.I.</given-names></name><name><surname>Gray</surname><given-names>P.D.</given-names></name><name><surname>Kaur</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Grossman</surname><given-names>D.</given-names></name><name><surname>Harper</surname><given-names>M.K.</given-names></name><name><surname>Kuwada</surname><given-names>S.K.</given-names></name><name><surname>Moghal</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The marine alkaloid Naamidine A promotes caspase-dependent apoptosis in tumor cells</article-title><source>Anticancer Drugs</source><year>2009</year><volume>20</volume><fpage>425</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1097/CAD.0b013e32832ae55f</pub-id><?supplied-pmid 19369860?><pub-id pub-id-type="pmid">19369860</pub-id></element-citation></ref><ref id="B491-marinedrugs-18-00657"><label>491.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graziani</surname><given-names>E.I.</given-names></name><name><surname>Allen</surname><given-names>T.M.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Lovenone, a cytotoxic degraded triterpenoid isolated from skin extracts of the North Sea dorid nudibranch <italic>Adalaria loveni</italic></article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>1763</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)00118-V</pub-id></element-citation></ref><ref id="B492-marinedrugs-18-00657"><label>492.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trindade-Silva</surname><given-names>A.E.</given-names></name><name><surname>Lim-Fong</surname><given-names>G.E.</given-names></name><name><surname>Sharp</surname><given-names>K.H.</given-names></name><name><surname>Haygood</surname><given-names>M.G.</given-names></name></person-group><article-title>Bryostatins: Biological context and biotechnological prospects</article-title><source>Curr. Opin. Biotechnol.</source><year>2010</year><volume>21</volume><fpage>834</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2010.09.018</pub-id><?supplied-pmid 20971628?><pub-id pub-id-type="pmid">20971628</pub-id></element-citation></ref><ref id="B493-marinedrugs-18-00657"><label>493.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S.K.</given-names></name></person-group><article-title>The Biology of the Bryostatins in the Marine Bryozoan <italic>Bugula neritina</italic></article-title><source>Ph.D. Thesis</source><publisher-name>University of California</publisher-name><publisher-loc>San Diego, CA, USA</publisher-loc><year>1999</year></element-citation></ref><ref id="B494-marinedrugs-18-00657"><label>494.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>G.E.</given-names></name></person-group><article-title>Bugula (Bryozoa) and Their Bacterial Symbionts: A Study in Symbiosis, Molecular Phylogenetics and Secondary Metabolism</article-title><source>Ph.D. Thesis</source><publisher-name>University of California</publisher-name><publisher-loc>San Diego, CA, USA</publisher-loc><year>2004</year></element-citation></ref><ref id="B495-marinedrugs-18-00657"><label>495.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudek</surname><given-names>S.</given-names></name><name><surname>Lopanik</surname><given-names>N.B.</given-names></name><name><surname>Waggoner</surname><given-names>L.E.</given-names></name><name><surname>Hildebrand</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Sherman</surname><given-names>D.H.</given-names></name><name><surname>Haygood</surname><given-names>M.G.</given-names></name></person-group><article-title>Identification of the putative bryostatin polyketide synthase gene cluster from <italic>Candidatus Endobugula sertula</italic>, the uncultivated microbial symbiont of the marine bryozoan <italic>Bugula neritina</italic></article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1021/np060361d</pub-id><?supplied-pmid 17253852?><pub-id pub-id-type="pmid">17253852</pub-id></element-citation></ref><ref id="B496-marinedrugs-18-00657"><label>496.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zonder</surname><given-names>J.A.</given-names></name><name><surname>Shields</surname><given-names>A.F.</given-names></name><name><surname>Zalupski</surname><given-names>M.</given-names></name><name><surname>Chaplen</surname><given-names>R.</given-names></name><name><surname>Heilbrun</surname><given-names>L.K.</given-names></name><name><surname>Arlauskas</surname><given-names>P.</given-names></name><name><surname>Philip</surname><given-names>P.A.</given-names></name></person-group><article-title>A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer</article-title><source>Clin. Cancer Res.</source><year>2001</year><volume>7</volume><fpage>38</fpage><lpage>42</lpage><?supplied-pmid 11205915?><pub-id pub-id-type="pmid">11205915</pub-id></element-citation></ref><ref id="B497-marinedrugs-18-00657"><label>497.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.S.</given-names></name><name><surname>Glaser</surname><given-names>K.B.</given-names></name><name><surname>Cuevas</surname><given-names>C.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name><name><surname>Kem</surname><given-names>W.</given-names></name><name><surname>Little</surname><given-names>R.D.</given-names></name><name><surname>McIntosh</surname><given-names>J.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Potts</surname><given-names>B.C.</given-names></name><name><surname>Shuster</surname><given-names>D.E.</given-names></name></person-group><article-title>The odyssey of marine pharmaceuticals: A current pipeline perspective</article-title><source>Trends Pharmacol. Sci.</source><year>2010</year><volume>31</volume><fpage>255</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2010.02.005</pub-id><?supplied-pmid 20363514?><pub-id pub-id-type="pmid">20363514</pub-id></element-citation></ref><ref id="B498-marinedrugs-18-00657"><label>498.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maki</surname><given-names>A.</given-names></name><name><surname>Diwakaran</surname><given-names>H.</given-names></name><name><surname>Redman</surname><given-names>B.</given-names></name><name><surname>Al-Asfar</surname><given-names>S.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Mohammad</surname><given-names>R.M.</given-names></name><name><surname>Al-Katib</surname><given-names>A.</given-names></name></person-group><article-title>The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma</article-title><source>Anticancer Drugs</source><year>1995</year><volume>6</volume><fpage>392</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1097/00001813-199506000-00005</pub-id><pub-id pub-id-type="pmid">7670136</pub-id></element-citation></ref><ref id="B499-marinedrugs-18-00657"><label>499.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skropeta</surname><given-names>D.</given-names></name><name><surname>Pastro</surname><given-names>N.</given-names></name><name><surname>Zivanovic</surname><given-names>A.</given-names></name></person-group><article-title>Kinase inhibitors from marine sponges</article-title><source>Mar. Drugs</source><year>2011</year><volume>9</volume><fpage>2131</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.3390/md9102131</pub-id><pub-id pub-id-type="pmid">22073013</pub-id></element-citation></ref><ref id="B500-marinedrugs-18-00657"><label>500.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kortmansky</surname><given-names>J.</given-names></name><name><surname>Schwartz</surname><given-names>G.K.</given-names></name></person-group><article-title>Bryostatin-1: A novel PKC inhibitor in clinical development</article-title><source>Cancer Investig.</source><year>2003</year><volume>21</volume><fpage>924</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1081/CNV-120025095</pub-id><pub-id pub-id-type="pmid">14735696</pub-id></element-citation></ref><ref id="B501-marinedrugs-18-00657"><label>501.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnel</surname><given-names>R.B.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>11-hydroxystaurosporine: A highly cytotoxic, powerful protein kinase C inhibitor from a tunicate</article-title><source>J. Org. Chem.</source><year>1992</year><volume>57</volume><fpage>6327</fpage><lpage>6329</lpage><pub-id pub-id-type="doi">10.1021/jo00049a049</pub-id></element-citation></ref><ref id="B502-marinedrugs-18-00657"><label>502.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>M.</given-names></name><name><surname>Poomalai</surname><given-names>S.</given-names></name><name><surname>Gunasekaran</surname><given-names>M.</given-names></name><name><surname>Mani</surname><given-names>P.</given-names></name><name><surname>Krishnamurthy</surname><given-names>A.</given-names></name></person-group><article-title>Bioactive compounds from marine yeast inhibits lung cancer</article-title><source>J. Appl. Pharm. Sci.</source><year>2015</year><volume>5</volume><fpage>7</fpage><lpage>15</lpage></element-citation></ref><ref id="B503-marinedrugs-18-00657"><label>503.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>N.R.</given-names></name><name><surname>Mohammad</surname><given-names>R.M.</given-names></name><name><surname>Reddy</surname><given-names>K.B.</given-names></name><name><surname>Al-Katib</surname><given-names>A.M.</given-names></name></person-group><article-title>Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh</article-title><source>Int. J. Mol. Med.</source><year>2000</year><volume>5</volume><fpage>165</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.3892/ijmm.5.2.165</pub-id><?supplied-pmid 10639596?><pub-id pub-id-type="pmid">10639596</pub-id></element-citation></ref><ref id="B504-marinedrugs-18-00657"><label>504.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Irace</surname><given-names>C.</given-names></name><name><surname>Di Pascale</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Structure and synthesis of a unique isonitrile lipid isolated from the marine mollusk <italic>Actinocyclus papillatus</italic></article-title><source>Org. Lett.</source><year>2011</year><volume>13</volume><fpage>1897</fpage><lpage>1899</lpage><pub-id pub-id-type="doi">10.1021/ol200377w</pub-id><?supplied-pmid 21405058?><pub-id pub-id-type="pmid">21405058</pub-id></element-citation></ref><ref id="B505-marinedrugs-18-00657"><label>505.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Ingels</surname><given-names>A.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name><name><surname>Pascale</surname><given-names>P.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Ungur</surname><given-names>N.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Marine terpenoid diacylguanidines: Structure, synthesis, and biological evaluation of naturally occurring actinofide and synthetic analogues</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1339</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00941</pub-id><pub-id pub-id-type="pmid">28406636</pub-id></element-citation></ref><ref id="B506-marinedrugs-18-00657"><label>506.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>M.</given-names></name><name><surname>Riess</surname><given-names>J.</given-names></name><name><surname>Lara</surname><given-names>P.N.</given-names><suffix>Jr.</suffix></name></person-group><article-title>New and emerging developments in extensive-stage small cell lung cancer therapeutics</article-title><source>Curr. Opin. Oncol.</source><year>2016</year><volume>28</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1097/CCO.0000000000000264</pub-id><pub-id pub-id-type="pmid">26844984</pub-id></element-citation></ref><ref id="B507-marinedrugs-18-00657"><label>507.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stupp</surname><given-names>R.</given-names></name><name><surname>Hegi</surname><given-names>M.E.</given-names></name><name><surname>Mason</surname><given-names>W.P.</given-names></name><name><surname>Van Den Bent</surname><given-names>M.J.</given-names></name><name><surname>Taphoorn</surname><given-names>M.J.</given-names></name><name><surname>Janzer</surname><given-names>R.C.</given-names></name><name><surname>Ludwin</surname><given-names>S.K.</given-names></name><name><surname>Allgeier</surname><given-names>A.</given-names></name><name><surname>Fisher</surname><given-names>B.</given-names></name><name><surname>Belanger</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial</article-title><source>Lancet Oncol.</source><year>2009</year><volume>10</volume><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(09)70025-7</pub-id><pub-id pub-id-type="pmid">19269895</pub-id></element-citation></ref><ref id="B508-marinedrugs-18-00657"><label>508.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perret</surname><given-names>G.Y.</given-names></name><name><surname>Uzzan</surname><given-names>B.</given-names></name></person-group><article-title>An anticancer strategic dilemma: To kill or to contain. The choice of the pharmaceutical industry in 2009</article-title><source>Fund. Clin. Pharmaccol.</source><year>2011</year><volume>25</volume><fpage>283</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.2010.00849.x</pub-id></element-citation></ref><ref id="B509-marinedrugs-18-00657"><label>509.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montagnac</surname><given-names>A.</given-names></name><name><surname>Martin</surname><given-names>M.T.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Pais</surname><given-names>M.</given-names></name></person-group><article-title>Drimane sesquiterpenes from the sponge <italic>Dysidea fusca</italic></article-title><source>J. Nat. Prod.</source><year>1996</year><volume>59</volume><fpage>866</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1021/np9603737</pub-id></element-citation></ref><ref id="B510-marinedrugs-18-00657"><label>510.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jaisamut</surname><given-names>S.</given-names></name></person-group><article-title>Terpenoids from the Nudibranch <italic>Phyllidia coelestis</italic> Bergh</article-title><source>Ph.D. Thesis</source><publisher-name>Prince of Songkla University</publisher-name><publisher-loc>Hat Yai, Thailand</publisher-loc><year>2014</year></element-citation></ref><ref id="B511-marinedrugs-18-00657"><label>511.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wratten</surname><given-names>S.J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Minor carbonimidic dichlorides from the marine sponge <italic>Pseudaxinyssa pitys</italic></article-title><source>Tetrahedron Lett.</source><year>1978</year><volume>19</volume><fpage>1395</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)94554-X</pub-id></element-citation></ref><ref id="B512-marinedrugs-18-00657"><label>512.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wratten</surname><given-names>S.J.</given-names></name><name><surname>John</surname><given-names>D.</given-names></name><name><surname>Van Engen</surname><given-names>D.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>A vinyl carbonimidic dichloride from the marine sponge Pseudaxinyssa pitys</article-title><source>Tetrahedron Lett.</source><year>1978</year><volume>19</volume><fpage>1391</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)94553-8</pub-id></element-citation></ref><ref id="B513-marinedrugs-18-00657"><label>513.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daoust</surname><given-names>J.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Merchant</surname><given-names>C.E.</given-names></name><name><surname>De Voogd</surname><given-names>N.J.</given-names></name><name><surname>Patrick</surname><given-names>B.O.</given-names></name><name><surname>Kieffer</surname><given-names>T.J.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Ansellone A, a sesterterpenoid isolated from the nudibranch <italic>Cadlina luteromarginata</italic> and the sponge <italic>Phorbas</italic> sp., activates the cAMP signaling pathway</article-title><source>Org. Lett.</source><year>2010</year><volume>12</volume><fpage>3208</fpage><lpage>3211</lpage><pub-id pub-id-type="doi">10.1021/ol101151f</pub-id><?supplied-pmid 20560657?><pub-id pub-id-type="pmid">20560657</pub-id></element-citation></ref><ref id="B514-marinedrugs-18-00657"><label>514.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirley</surname><given-names>H.J.</given-names></name><name><surname>Jamieson</surname><given-names>M.L.</given-names></name><name><surname>Brimble</surname><given-names>M.A.</given-names></name><name><surname>Bray</surname><given-names>C.D.</given-names></name></person-group><article-title>A new family of sesterterpenoids isolated around the Pacific Rim</article-title><source>Nat. Prod. Rep.</source><year>2018</year><volume>35</volume><fpage>210</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1039/C7NP00049A</pub-id><?supplied-pmid 29547216?><pub-id pub-id-type="pmid">29547216</pub-id></element-citation></ref><ref id="B515-marinedrugs-18-00657"><label>515.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Sayed</surname><given-names>K.A.</given-names></name><name><surname>Youssef</surname><given-names>D.T.A.</given-names></name><name><surname>Marchetti</surname><given-names>D.</given-names></name></person-group><article-title>Bioactive natural and semisynthetic latrunculins</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1021/np050372r</pub-id><?supplied-pmid 16499319?><pub-id pub-id-type="pmid">16499319</pub-id></element-citation></ref><ref id="B516-marinedrugs-18-00657"><label>516.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spector</surname><given-names>I.</given-names></name><name><surname>Shochet</surname><given-names>N.R.</given-names></name><name><surname>Blasberger</surname><given-names>D.</given-names></name><name><surname>Kashman</surname><given-names>Y.</given-names></name></person-group><article-title>Latrunculins; novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D</article-title><source>Cell Motil. Cytoskelet.</source><year>1989</year><volume>13</volume><fpage>127</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1002/cm.970130302</pub-id><?supplied-pmid 2776221?><pub-id pub-id-type="pmid">2776221</pub-id></element-citation></ref><ref id="B517-marinedrugs-18-00657"><label>517.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spector</surname><given-names>I.</given-names></name><name><surname>Shochet</surname><given-names>N.R.</given-names></name><name><surname>Kashman</surname><given-names>Y.</given-names></name><name><surname>Groweiss</surname><given-names>A.</given-names></name></person-group><article-title>Latrunculins: Novel marine toxins that disrupt microfilament organization in cultured cells</article-title><source>Science</source><year>1983</year><volume>219</volume><fpage>493</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1126/science.6681676</pub-id><?supplied-pmid 6681676?><pub-id pub-id-type="pmid">6681676</pub-id></element-citation></ref><ref id="B518-marinedrugs-18-00657"><label>518.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>K.A.</given-names></name><name><surname>Khanfar</surname><given-names>M.A.</given-names></name><name><surname>Shallal</surname><given-names>H.M.</given-names></name><name><surname>Muralidharan</surname><given-names>A.</given-names></name><name><surname>Awate</surname><given-names>B.</given-names></name><name><surname>Youssef</surname><given-names>D.T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.D.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name><name><surname>Shah</surname><given-names>G.</given-names></name></person-group><article-title>Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1021/np070587w</pub-id><?supplied-pmid 18298079?><pub-id pub-id-type="pmid">18298079</pub-id></element-citation></ref><ref id="B519-marinedrugs-18-00657"><label>519.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longley</surname><given-names>R.E.</given-names></name><name><surname>McConnell</surname><given-names>O.J.</given-names></name><name><surname>Essich</surname><given-names>E.</given-names></name><name><surname>Harmody</surname><given-names>D.</given-names></name></person-group><article-title>Evaluation of marine sponge metabolites for cytotoxicity and signal transduction activity</article-title><source>J. Nat. Prod.</source><year>1993</year><volume>56</volume><fpage>915</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1021/np50096a015</pub-id><pub-id pub-id-type="pmid">8350092</pub-id></element-citation></ref><ref id="B520-marinedrugs-18-00657"><label>520.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konishi</surname><given-names>H.</given-names></name><name><surname>Kikuchi</surname><given-names>S.</given-names></name><name><surname>Ochiai</surname><given-names>T.</given-names></name><name><surname>Ikoma</surname><given-names>H.</given-names></name><name><surname>Kubota</surname><given-names>T.</given-names></name><name><surname>Ichikawa</surname><given-names>D.</given-names></name><name><surname>Fujiwara</surname><given-names>H.</given-names></name><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Sakakura</surname><given-names>C.</given-names></name><name><surname>Sonoyama</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice</article-title><source>Anticancer Res.</source><year>2009</year><volume>29</volume><fpage>2091</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">19528469</pub-id></element-citation></ref><ref id="B521-marinedrugs-18-00657"><label>521.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prota</surname><given-names>A.E.</given-names></name><name><surname>Bargsten</surname><given-names>K.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Marsh</surname><given-names>M.</given-names></name><name><surname>Altmann</surname><given-names>K.H.</given-names></name><name><surname>Miller</surname><given-names>J.H.</given-names></name><name><surname>D&#x00131;az</surname><given-names>J.F.</given-names></name><name><surname>Steinmetz</surname><given-names>M.O.</given-names></name></person-group><article-title>Structural basis of microtubule stabilization by laulimalide and peloruside A. Angew</article-title><source>Chem. Int. Ed.</source><year>2014</year><volume>5</volume><fpage>1621</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1002/anie.201307749</pub-id></element-citation></ref><ref id="B522-marinedrugs-18-00657"><label>522.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>C.D.</given-names></name><name><surname>Klobukowski</surname><given-names>M.</given-names></name><name><surname>Tuszynski</surname><given-names>J.A.</given-names></name></person-group><article-title>The unique binding mode of laulimalide to two tubulin protofilaments</article-title><source>Chem. Biol. Drug Des.</source><year>2015</year><volume>86</volume><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1111/cbdd.12475</pub-id><pub-id pub-id-type="pmid">25376845</pub-id></element-citation></ref><ref id="B523-marinedrugs-18-00657"><label>523.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Randall-Hlubek</surname><given-names>D.A.</given-names></name><name><surname>Leal</surname><given-names>R.M.</given-names></name><name><surname>Hegde</surname><given-names>S.G.</given-names></name><name><surname>Hubbard</surname><given-names>R.D.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wender</surname><given-names>P.A.</given-names></name></person-group><article-title>Microtubule-stabilizing agents based on designed laulimalide analogues</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>8803</fpage><lpage>8808</lpage><pub-id pub-id-type="doi">10.1073/pnas.0402759101</pub-id><?supplied-pmid 15161976?><pub-id pub-id-type="pmid">15161976</pub-id></element-citation></ref><ref id="B524-marinedrugs-18-00657"><label>524.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>C.D.M.</given-names></name><name><surname>Klobukowski</surname><given-names>M.</given-names></name><name><surname>Tuszynski</surname><given-names>J.A.</given-names></name></person-group><article-title>Analysis of the binding mode of laulimalide to microtubules: Establishing a laulimalide-tubulin pharmacophore</article-title><source>J. Biomol. Struct. Dyn.</source><year>2016</year><volume>34</volume><fpage>1455</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1080/07391102.2015.1078115</pub-id><?supplied-pmid 26230757?><pub-id pub-id-type="pmid">26230757</pub-id></element-citation></ref><ref id="B525-marinedrugs-18-00657"><label>525.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Towle</surname><given-names>M.J.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Saxton</surname><given-names>P.</given-names></name><name><surname>Reardon</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Murphy</surname><given-names>E.A.</given-names></name><name><surname>Kuznetsov</surname><given-names>G.</given-names></name><name><surname>Johannes</surname><given-names>C.W.</given-names></name><name><surname>Tremblay</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent</article-title><source>Anticancer Res.</source><year>2007</year><volume>27</volume><fpage>1509</fpage><lpage>1518</lpage><?supplied-pmid 17595769?><pub-id pub-id-type="pmid">17595769</pub-id></element-citation></ref><ref id="B526-marinedrugs-18-00657"><label>526.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Tien</surname><given-names>G.</given-names></name><name><surname>Hernandez</surname><given-names>A.H.</given-names></name><name><surname>Plubrukarn</surname><given-names>A.</given-names></name><name><surname>Davidson</surname><given-names>B.S.</given-names></name></person-group><article-title>Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents</article-title><source>Cancer Res.</source><year>1999</year><volume>59</volume><fpage>653</fpage><lpage>660</lpage><?supplied-pmid 9973214?><pub-id pub-id-type="pmid">9973214</pub-id></element-citation></ref><ref id="B527-marinedrugs-18-00657"><label>527.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohena</surname><given-names>C.C.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>T.A.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name></person-group><article-title>Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases</article-title><source>Biochem. Pharmacol.</source><year>2013</year><volume>85</volume><fpage>1104</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2013.01.030</pub-id><?supplied-pmid 23399639?><pub-id pub-id-type="pmid">23399639</pub-id></element-citation></ref><ref id="B528-marinedrugs-18-00657"><label>528.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryor</surname><given-names>D.E.</given-names></name><name><surname>O&#x02019;Brate</surname><given-names>A.</given-names></name><name><surname>Bilcer</surname><given-names>G.</given-names></name><name><surname>D&#x000ed;az</surname><given-names>J.F.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kabaki</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>M.K.</given-names></name><name><surname>Andreu</surname><given-names>J.M.</given-names></name><name><surname>Ghosh</surname><given-names>A.K.</given-names></name><etal/></person-group><article-title>The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity</article-title><source>Biochemistry</source><year>2002</year><volume>41</volume><fpage>9109</fpage><lpage>9115</lpage><pub-id pub-id-type="doi">10.1021/bi020211b</pub-id><pub-id pub-id-type="pmid">12119025</pub-id></element-citation></ref><ref id="B529-marinedrugs-18-00657"><label>529.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanakkanthara</surname><given-names>A.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Miller</surname><given-names>J.H.</given-names></name></person-group><article-title>&#x003b2;II-tubulin and &#x003b2;III-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells</article-title><source>Mol. Cancer Ther.</source><year>2012</year><volume>11</volume><fpage>393</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-11-0614</pub-id><pub-id pub-id-type="pmid">22180309</pub-id></element-citation></ref><ref id="B530-marinedrugs-18-00657"><label>530.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanakkanthara</surname><given-names>A.</given-names></name><name><surname>Rawson</surname><given-names>P.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Miller</surname><given-names>J.H.</given-names></name></person-group><article-title>Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells</article-title><source>Pharm. Res.</source><year>2012</year><volume>29</volume><fpage>3022</fpage><lpage>3032</lpage><pub-id pub-id-type="doi">10.1007/s11095-012-0773-x</pub-id><pub-id pub-id-type="pmid">22584948</pub-id></element-citation></ref><ref id="B531-marinedrugs-18-00657"><label>531.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evidente</surname><given-names>A.</given-names></name><name><surname>Kornienko</surname><given-names>A.</given-names></name><name><surname>Lefranc</surname><given-names>F.</given-names></name><name><surname>Cimmino</surname><given-names>A.</given-names></name><name><surname>Dasari</surname><given-names>R.</given-names></name><name><surname>Evidente</surname><given-names>M.</given-names></name><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name></person-group><article-title>Sesterterpenoids with anticancer activity</article-title><source>Curr. Med. Chem.</source><year>2015</year><volume>22</volume><fpage>3502</fpage><lpage>3522</lpage><pub-id pub-id-type="doi">10.2174/0929867322666150821101047</pub-id><pub-id pub-id-type="pmid">26295461</pub-id></element-citation></ref><ref id="B532-marinedrugs-18-00657"><label>532.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>L.C.</given-names></name><name><surname>Pierens</surname><given-names>G.K.</given-names></name><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Cheney</surname><given-names>K.L.</given-names></name><name><surname>Dewapriya</surname><given-names>P.</given-names></name><name><surname>Capon</surname><given-names>R.J.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name></person-group><article-title>Cytotoxic spiroepoxide lactone and its putative biosynthetic precursor from <italic>Goniobranchus splendidus</italic></article-title><source>ACS Omega</source><year>2017</year><volume>2</volume><fpage>2672</fpage><lpage>2677</lpage><pub-id pub-id-type="doi">10.1021/acsomega.7b00641</pub-id><pub-id pub-id-type="pmid">30023672</pub-id></element-citation></ref><ref id="B533-marinedrugs-18-00657"><label>533.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rueda</surname><given-names>A.</given-names></name><name><surname>Losada</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>R.</given-names></name><name><surname>Cabanas</surname><given-names>C.</given-names></name><name><surname>Garcia-Fernandez</surname><given-names>L.F.</given-names></name><name><surname>Reyes</surname><given-names>F.</given-names></name><name><surname>Cuevas</surname><given-names>C.</given-names></name></person-group><article-title>Gracilins G-I, cytotoxic bisnorditerpenes from <italic>Spongionella pulchella</italic>, and the anti-adhesive properties of gracilin B</article-title><source>Lett. Drug. Des. Discov.</source><year>2006</year><volume>3</volume><fpage>753</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.2174/157018006778631875</pub-id></element-citation></ref><ref id="B534-marinedrugs-18-00657"><label>534.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>J.A.</given-names></name><name><surname>Alfonso</surname><given-names>A.</given-names></name><name><surname>Leiros</surname><given-names>M.</given-names></name><name><surname>Alonso</surname><given-names>E.</given-names></name><name><surname>Rateb</surname><given-names>M.E.</given-names></name><name><surname>Jaspars</surname><given-names>M.</given-names></name><name><surname>Houssen</surname><given-names>W.E.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Tabudravu</surname><given-names>J.</given-names></name><name><surname>Botana</surname><given-names>L.M.</given-names></name></person-group><article-title>Identification of <italic>Spongionella</italic> compounds as cyclosporine A mimics</article-title><source>Pharmacol. Res.</source><year>2016</year><volume>107</volume><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2016.03.029</pub-id><?supplied-pmid 27041481?><pub-id pub-id-type="pmid">27041481</pub-id></element-citation></ref><ref id="B535-marinedrugs-18-00657"><label>535.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohmoto</surname><given-names>S.</given-names></name><name><surname>McConnell</surname><given-names>O.J.</given-names></name><name><surname>Wrigth</surname><given-names>A.</given-names></name><name><surname>Cross</surname><given-names>S.</given-names></name></person-group><article-title>Isospongiadiol, a cytotoxic and antiviral diterpene from a Caribbean deep water marine sponge, <italic>Spongia</italic> sp.</article-title><source>Chem. Lett.</source><year>1987</year><volume>16</volume><fpage>1687</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.1246/cl.1987.1687</pub-id></element-citation></ref><ref id="B536-marinedrugs-18-00657"><label>536.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Ricciardi</surname><given-names>D.</given-names></name><name><surname>Fakhr</surname><given-names>I.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Chemical studies of Egyptian opisthobranchs: Spongian diterpenoids from <italic>Glossodoris atromarginata</italic></article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1021/np960690d</pub-id></element-citation></ref><ref id="B537-marinedrugs-18-00657"><label>537.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cambie</surname><given-names>R.C.</given-names></name><name><surname>Craw</surname><given-names>P.A.</given-names></name><name><surname>Stone</surname><given-names>M.J.</given-names></name><name><surname>Bergquist</surname><given-names>P.R.</given-names></name></person-group><article-title>Chemistry of sponges, IV. Spongian diterpenes from <italic>Hyatella intestinalis</italic></article-title><source>J. Nat. Prod.</source><year>1988</year><volume>51</volume><fpage>293</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1021/np50056a016</pub-id></element-citation></ref><ref id="B538-marinedrugs-18-00657"><label>538.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>M.</given-names></name></person-group><article-title>Isolation and Structural Elucidation of Cytotoxic Agents from Marine Invertebrates and Plants Sourced from the Great Barrier Reef, Australia</article-title><source>Ph.D. Thesis</source><publisher-name>James Cook University</publisher-name><publisher-loc>Townsville, Australia</publisher-loc><year>2007</year></element-citation></ref><ref id="B539-marinedrugs-18-00657"><label>539.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>K.W.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Bernhardt</surname><given-names>P.V.</given-names></name></person-group><article-title>Absolute structures and conformations of the spongian diterpenes spongia-13(16), 14-dien-3-one, epispongiadiol and spongiadiol</article-title><source>Acta Crystallogr. Sect. C Cryst. Struct. Commun.</source><year>2009</year><volume>65</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1107/S0108270109008816</pub-id><?supplied-pmid 19346615?><pub-id pub-id-type="pmid">19346615</pub-id></element-citation></ref><ref id="B540-marinedrugs-18-00657"><label>540.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wonganuchitmeta</surname><given-names>S.</given-names></name><name><surname>Yuenyongsawad</surname><given-names>S.</given-names></name><name><surname>Keawpradub</surname><given-names>N.</given-names></name><name><surname>Plubrukarn</surname><given-names>A.</given-names></name></person-group><article-title>Antitubercular sesterterpenes from the Thai sponge <italic>Brachiaster</italic> sp.</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1767</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1021/np0498354</pub-id><pub-id pub-id-type="pmid">15497961</pub-id></element-citation></ref><ref id="B541-marinedrugs-18-00657"><label>541.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazlauskas</surname><given-names>R.</given-names></name><name><surname>Murphy</surname><given-names>P.T.</given-names></name><name><surname>Quinn</surname><given-names>R.J.</given-names></name><name><surname>Wells</surname><given-names>R.J.</given-names></name></person-group><article-title>Heteronemin, a new scalarin type sesterterpene from the sponge <italic>Heteronema erecta</italic></article-title><source>Tetrahedron Lett.</source><year>1976</year><volume>17</volume><fpage>2631</fpage><lpage>2634</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)91753-2</pub-id></element-citation></ref><ref id="B542-marinedrugs-18-00657"><label>542.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopf</surname><given-names>S.</given-names></name><name><surname>Viola</surname><given-names>K.</given-names></name><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Jarukamjorn</surname><given-names>K.</given-names></name><name><surname>Rarova</surname><given-names>L.</given-names></name><name><surname>Kretschy</surname><given-names>N.</given-names></name><name><surname>Teichmann</surname><given-names>M.</given-names></name><name><surname>Vonach</surname><given-names>C.</given-names></name><name><surname>Saiko</surname><given-names>P.</given-names></name><name><surname>Giessrigl</surname><given-names>B.</given-names></name><etal/></person-group><article-title>In vitro characterisation of the anti-intravasative properties of the marine product heteronemin</article-title><source>Arch. Toxicol.</source><year>2013</year><volume>87</volume><fpage>1851</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.1007/s00204-013-1045-1</pub-id><pub-id pub-id-type="pmid">23543012</pub-id></element-citation></ref><ref id="B543-marinedrugs-18-00657"><label>543.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnermann</surname><given-names>M.J.</given-names></name><name><surname>Beaudry</surname><given-names>C.M.</given-names></name><name><surname>Egorova</surname><given-names>A.V.</given-names></name><name><surname>Polishchuk</surname><given-names>R.S.</given-names></name><name><surname>Suetterlin</surname><given-names>C.</given-names></name><name><surname>Overman</surname><given-names>L.E.</given-names></name></person-group><article-title>Golgi-modifying properties of macfarlandin E and the synthesis and evaluation of its 2,7-dioxabicyclo[3.2.1]octan-3-one core</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>6158</fpage><lpage>6163</lpage><pub-id pub-id-type="doi">10.1073/pnas.1001421107</pub-id><pub-id pub-id-type="pmid">20332207</pub-id></element-citation></ref><ref id="B544-marinedrugs-18-00657"><label>544.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>S.K.</given-names></name><name><surname>Pattenden</surname><given-names>G.</given-names></name></person-group><article-title>Total synthesis of ulapualide A, a novel tris-oxazole containing macrolide from the marine nudibranch <italic>Hexabranchus sanguineus</italic></article-title><source>Tetrahedron Lett.</source><year>1998</year><volume>39</volume><fpage>6095</fpage><lpage>6098</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(98)01257-X</pub-id></element-citation></ref><ref id="B545-marinedrugs-18-00657"><label>545.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>E.</given-names></name><name><surname>Saxton</surname><given-names>J.</given-names></name><name><surname>Baker-Glenn</surname><given-names>C.</given-names></name><name><surname>Moal</surname><given-names>I.</given-names></name><name><surname>Hirst</surname><given-names>J.D.</given-names></name><name><surname>Pattenden</surname><given-names>G.</given-names></name><name><surname>Shaw</surname><given-names>P.E.</given-names></name></person-group><article-title>Effects of ulapualide A and synthetic macrolide analogues on actin dynamics and gene regulation</article-title><source>Cell Mol. Life Sci.</source><year>2007</year><volume>64</volume><fpage>487</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1007/s00018-007-6427-1</pub-id><?supplied-pmid 17279315?><pub-id pub-id-type="pmid">17279315</pub-id></element-citation></ref><ref id="B546-marinedrugs-18-00657"><label>546.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrish</surname><given-names>S.M.</given-names></name><name><surname>Yoshida</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Williams</surname><given-names>P.G.</given-names></name></person-group><article-title>Ulapualides C-E Isolated from a Hawaiian <italic>Hexabranchus sanguineus</italic> Egg Mass</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>726</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00896</pub-id><?supplied-pmid 28098996?><pub-id pub-id-type="pmid">28098996</pub-id></element-citation></ref><ref id="B547-marinedrugs-18-00657"><label>547.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name></person-group><article-title>Kabiramide C, a novel antifungal macrolide from nudibranch eggmasses</article-title><source>J. Am. Chem. Soc.</source><year>1986</year><volume>108</volume><fpage>847</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1021/ja00264a053</pub-id></element-citation></ref><ref id="B548-marinedrugs-18-00657"><label>548.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirirak</surname><given-names>T.</given-names></name><name><surname>Kittiwisut</surname><given-names>S.</given-names></name><name><surname>Janma</surname><given-names>C.</given-names></name><name><surname>Yuenyongsawad</surname><given-names>S.</given-names></name><name><surname>Suwanborirux</surname><given-names>K.</given-names></name><name><surname>Plubrukarn</surname><given-names>A.</given-names></name></person-group><article-title>Kabiramides J and K, trisoxazole macrolides from the sponge <italic>Pachastrissa nux</italic></article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1288</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.1021/np100886y</pub-id><pub-id pub-id-type="pmid">21410162</pub-id></element-citation></ref><ref id="B549-marinedrugs-18-00657"><label>549.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Bai</surname><given-names>J.</given-names></name><name><surname>Klenchin</surname><given-names>V.A.</given-names></name><name><surname>Rayment</surname><given-names>I.</given-names></name><name><surname>Marriott</surname><given-names>G.</given-names></name></person-group><article-title>Biomolecular mimicry in the actin cytoskeleton: Mechanisms underlying the cytotoxicity of kabiramide C and related macrolides</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>13851</fpage><lpage>13856</lpage><pub-id pub-id-type="doi">10.1073/pnas.2233339100</pub-id><pub-id pub-id-type="pmid">14612571</pub-id></element-citation></ref><ref id="B550-marinedrugs-18-00657"><label>550.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braet</surname><given-names>F.</given-names></name><name><surname>Spector</surname><given-names>I.</given-names></name><name><surname>Shochet</surname><given-names>N.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name><name><surname>Menu</surname><given-names>E.</given-names></name><name><surname>De Zanger</surname><given-names>R.</given-names></name><name><surname>Wisse</surname><given-names>E.</given-names></name></person-group><article-title>The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells</article-title><source>BMC Cell Biol.</source><year>2002</year><volume>3</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/1471-2121-3-7</pub-id><pub-id pub-id-type="pmid">11806752</pub-id></element-citation></ref><ref id="B551-marinedrugs-18-00657"><label>551.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>G.D.</given-names></name><name><surname>Jeon</surname><given-names>J.E.</given-names></name><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name></person-group><article-title>Antimetastatic effect of halichondramide, a trisoxazole macrolide from the marine sponge <italic>Chondrosia corticata</italic>, on human prostate cancer cells via modulation of epithelial-to-mesenchymal transition</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>2472</fpage><lpage>2485</lpage><pub-id pub-id-type="doi">10.3390/md11072472</pub-id><pub-id pub-id-type="pmid">23860239</pub-id></element-citation></ref><ref id="B552-marinedrugs-18-00657"><label>552.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>G.D.</given-names></name><name><surname>Jeon</surname><given-names>J.E.</given-names></name><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name></person-group><article-title>Anti-proliferative effect of (19Z)-halichondramide, a novel marine macrolide isolated from the sponge <italic>Chondrosia corticata</italic>, is associated with G2/M cell cycle arrest and suppression of mTOR signaling in human lung cancer cells</article-title><source>Toxicol. In Vitro</source><year>2013</year><volume>27</volume><fpage>694</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2012.11.001</pub-id><pub-id pub-id-type="pmid">23147639</pub-id></element-citation></ref><ref id="B553-marinedrugs-18-00657"><label>553.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Cavaliere</surname><given-names>P.</given-names></name><name><surname>Wahidulla</surname><given-names>S.</given-names></name><name><surname>Naik</surname><given-names>C.G.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>A new antitumor isoquinoline alkaloid from the marine nudibranch <italic>Jorunna funebris</italic></article-title><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>7305</fpage><lpage>7308</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00629-3</pub-id></element-citation></ref><ref id="B554-marinedrugs-18-00657"><label>554.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oku</surname><given-names>N.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>van Soest</surname><given-names>R.W.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge <italic>Neopetrosia</italic> sp.</article-title><source>J. Nat. Prod.</source><year>2003</year><volume>66</volume><fpage>1136</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1021/np030092g</pub-id><?supplied-pmid 12932144?><pub-id pub-id-type="pmid">12932144</pub-id></element-citation></ref><ref id="B555-marinedrugs-18-00657"><label>555.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Drugs and drug candidates from marine sources: An assessment of the current &#x0201c;State of Play&#x0201d;</article-title><source>Planta Med.</source><year>2016</year><volume>82</volume><fpage>775</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1055/s-0042-101353</pub-id><?supplied-pmid 26891002?><pub-id pub-id-type="pmid">26891002</pub-id></element-citation></ref><ref id="B556-marinedrugs-18-00657"><label>556.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petek</surname><given-names>B.J.</given-names></name><name><surname>Jones</surname><given-names>R.L.</given-names></name></person-group><article-title>PM00104 (Zalypsis&#x000ae;): A marine derived alkylating agent</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>12328</fpage><lpage>12335</lpage><pub-id pub-id-type="doi">10.3390/molecules190812328</pub-id><?supplied-pmid 25153860?><pub-id pub-id-type="pmid">25153860</pub-id></element-citation></ref><ref id="B557-marinedrugs-18-00657"><label>557.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Fontana</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Metabolites of marine opisthobranchs: Chemistry and biological activity</article-title><source>Bioactive Compounds from Natural Sources; Isolation, Characterization and Biological Properties</source><person-group person-group-type="editor"><name><surname>Tringali</surname><given-names>C.</given-names></name></person-group><publisher-name>Taylor and Francis</publisher-name><publisher-loc>London, UK</publisher-loc><year>2001</year><fpage>579</fpage><lpage>637</lpage></element-citation></ref><ref id="B558-marinedrugs-18-00657"><label>558.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malve</surname><given-names>H.</given-names></name></person-group><article-title>Exploring the ocean for new drug developments: Marine pharmacology</article-title><source>J. Pharm. Bioallied Sci.</source><year>2016</year><volume>8</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.4103/0975-7406.171700</pub-id><pub-id pub-id-type="pmid">27134458</pub-id></element-citation></ref><ref id="B559-marinedrugs-18-00657"><label>559.</label><element-citation publication-type="patent"><person-group person-group-type="author"><name><surname>Cuevas</surname><given-names>C.</given-names></name><name><surname>Perez</surname><given-names>M.</given-names></name><name><surname>Francesch</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>C.</given-names></name><name><surname>Chicharro</surname><given-names>J.L.</given-names></name><name><surname>Gallego</surname><given-names>P.</given-names></name><name><surname>Zarzuelo</surname><given-names>M.</given-names></name><name><surname>de la Calle</surname><given-names>F.</given-names></name><name><surname>Manzanares</surname><given-names>I.</given-names></name></person-group><article-title>Hemisynthetic method and intermediates thereof</article-title><source>PCT Application</source><patent>WO 2000069862 A2</patent><day>23</day><month>11</month><year>2000</year><volume>34</volume><fpage>1359</fpage><lpage>1390</lpage></element-citation></ref><ref id="B560-marinedrugs-18-00657"><label>560.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charupant</surname><given-names>K.</given-names></name><name><surname>Suwanborirux</surname><given-names>K.</given-names></name><name><surname>Amnuoypol</surname><given-names>S.</given-names></name><name><surname>Saito</surname><given-names>E.</given-names></name><name><surname>Kubo</surname><given-names>A.</given-names></name><name><surname>Saito</surname><given-names>N.</given-names></name></person-group><article-title>Jorunnamycins A&#x02013;C, new stabilized renieramycin-type bistetrahydroisoquinolines isolated from the Thai nudibranch <italic>Jorunna funebris</italic></article-title><source>Chem. Pharm. Bull.</source><year>2007</year><volume>55</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1248/cpb.55.81</pub-id></element-citation></ref><ref id="B561-marinedrugs-18-00657"><label>561.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charupant</surname><given-names>K.</given-names></name><name><surname>Daikuhara</surname><given-names>N.</given-names></name><name><surname>Saito</surname><given-names>E.</given-names></name><name><surname>Amnuoypol</surname><given-names>S.</given-names></name><name><surname>Suwanborirux</surname><given-names>K.</given-names></name><name><surname>Owa</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>N.</given-names></name></person-group><article-title>Chemistry of renieramycins. Part 8: Synthesis and cytotoxicity evaluation of renieramycin M-jorunnamycin a analogues</article-title><source>Bioorg. Med. Chem.</source><year>2009</year><volume>17</volume><fpage>4548</fpage><lpage>4558</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2009.05.009</pub-id><pub-id pub-id-type="pmid">19457672</pub-id></element-citation></ref><ref id="B562-marinedrugs-18-00657"><label>562.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>J.R.</given-names></name><name><surname>Ong</surname><given-names>C.K.</given-names></name><name><surname>Ng</surname><given-names>C.C.Y.</given-names></name><name><surname>Rajasegaran</surname><given-names>V.</given-names></name><name><surname>Heng</surname><given-names>H.L.</given-names></name><name><surname>Yu</surname><given-names>W.S.S.</given-names></name><name><surname>Tan</surname><given-names>B.K.T.</given-names></name><name><surname>Madhukumar</surname><given-names>P.</given-names></name><name><surname>Teo</surname><given-names>M.C.C.</given-names></name><name><surname>Ngeow</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1</article-title><source>Cancer Med.</source><year>2015</year><volume>4</volume><fpage>1871</fpage><lpage>1878</lpage><pub-id pub-id-type="doi">10.1002/cam4.551</pub-id><pub-id pub-id-type="pmid">26432421</pub-id></element-citation></ref><ref id="B563-marinedrugs-18-00657"><label>563.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname><given-names>E.E.</given-names></name><name><surname>Durinck</surname><given-names>S.</given-names></name><name><surname>e Melo</surname><given-names>F.D.S.</given-names></name><name><surname>Tremayne</surname><given-names>J.</given-names></name><name><surname>Kljavin</surname><given-names>N.</given-names></name><name><surname>Tan</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Pham</surname><given-names>T.</given-names></name><name><surname>Hongo</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function</article-title><source>Nature</source><year>2016</year><volume>529</volume><fpage>97</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/nature16466</pub-id><pub-id pub-id-type="pmid">26700806</pub-id></element-citation></ref><ref id="B564-marinedrugs-18-00657"><label>564.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W.F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>M.T.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Mao</surname><given-names>S.C.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>New isoquinolinequinone alkaloids from the South China Sea nudibranch <italic>Jorunna funebris</italic> and its possible sponge-prey <italic>Xestospongia</italic> sp.</article-title><source>Fitoterapia</source><year>2014</year><volume>96</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2014.04.011</pub-id><pub-id pub-id-type="pmid">24769286</pub-id></element-citation></ref><ref id="B565-marinedrugs-18-00657"><label>565.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>R.Y.</given-names></name><name><surname>Chen</surname><given-names>W.T.</given-names></name><name><surname>Kurt&#x000e1;n</surname><given-names>T.</given-names></name><name><surname>M&#x000e1;ndi</surname><given-names>A.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Bioactive isoquinolinequinone alkaloids from the South China Sea nudibranch <italic>Jorunna funebris</italic> and its sponge-prey <italic>Xestospongia</italic> sp.</article-title><source>Fut. Med. Chem.</source><year>2016</year><volume>8</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.4155/fmc.15.169</pub-id></element-citation></ref><ref id="B566-marinedrugs-18-00657"><label>566.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castiello</surname><given-names>D.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>High molecular weight polyacetylenes from the nudibranch <italic>Peltodoris atromaculata</italic> and the sponge <italic>Petrosia ficiformis</italic></article-title><source>Tetrahedron Lett.</source><year>1980</year><volume>21</volume><fpage>5047</fpage><lpage>5050</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)71129-4</pub-id></element-citation></ref><ref id="B567-marinedrugs-18-00657"><label>567.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gemballa</surname><given-names>S.</given-names></name><name><surname>Schermutzki</surname><given-names>F.</given-names></name></person-group><article-title>Cytotoxic haplosclerid sponges preferred: A field study on the diet of the dotted sea slug <italic>Peltodoris atromaculata</italic> (Doridoidea: Nudibranchia)</article-title><source>Mar. Biol.</source><year>2004</year><volume>144</volume><fpage>1213</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1007/s00227-003-1279-1</pub-id></element-citation></ref><ref id="B568-marinedrugs-18-00657"><label>568.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Nuzzo</surname><given-names>G.</given-names></name><name><surname>Takada</surname><given-names>K.</given-names></name><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Sequestered fulvinol-related polyacetylenes in <italic>Peltodoris atromaculata</italic></article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>1678</fpage><lpage>1684</lpage><pub-id pub-id-type="doi">10.1021/np500298h</pub-id><?supplied-pmid 24950030?><pub-id pub-id-type="pmid">24950030</pub-id></element-citation></ref><ref id="B569-marinedrugs-18-00657"><label>569.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castiello</surname><given-names>D.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>de Rosa, S.; de Stefano, S.; Izzo, G.; Sodano, G. In Colloq</article-title><source>Int. CNRS</source><year>1979</year><volume>291</volume><fpage>413</fpage></element-citation></ref><ref id="B570-marinedrugs-18-00657"><label>570.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueoka</surname><given-names>R.</given-names></name><name><surname>Ise</surname><given-names>Y.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name></person-group><article-title>Cytotoxic polyacetylenes related to petroformyne-1 from the marine sponge <italic>Petrosia</italic> sp.</article-title><source>Tetrahedron</source><year>2009</year><volume>65</volume><fpage>5204</fpage><lpage>5208</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2009.04.091</pub-id></element-citation></ref><ref id="B571-marinedrugs-18-00657"><label>571.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>M.G.</given-names></name><name><surname>Zubia</surname><given-names>E.</given-names></name><name><surname>Carballo</surname><given-names>J.L.</given-names></name><name><surname>Salv&#x000e1;</surname><given-names>J.</given-names></name></person-group><article-title>Fulvinol, a new long-chain diacetylenic metabolite from the sponge <italic>Reniera fulva</italic></article-title><source>J. Nat. Prod.</source><year>1996</year><volume>59</volume><fpage>1069</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1021/np960436l</pub-id></element-citation></ref><ref id="B572-marinedrugs-18-00657"><label>572.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rapson</surname><given-names>T.D.</given-names></name></person-group><article-title>Bioactive 4-Methoxypyrrolic Natural Products from Two South African Marine Invertebrates</article-title><source>Master&#x02019;s Sc. Thesis</source><publisher-name>Rhodes University</publisher-name><publisher-loc>Rhodes, South Africa</publisher-loc><year>2004</year></element-citation></ref><ref id="B573-marinedrugs-18-00657"><label>573.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlinck</surname><given-names>R.G.</given-names></name><name><surname>Hajdu</surname><given-names>E.</given-names></name><name><surname>da Rocha</surname><given-names>R.M.</given-names></name><name><surname>de Oliveira</surname><given-names>J.H.</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>I.L.</given-names></name><name><surname>Seleghim</surname><given-names>M.H.</given-names></name><name><surname>Granato</surname><given-names>A.C.</given-names></name><name><surname>de Almeida</surname><given-names>E.V.</given-names></name><name><surname>Nu&#x000f1;ez</surname><given-names>C.V.</given-names></name><name><surname>Muricy</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Challenges and rewards of research in marine natural products chemistry in Brazil</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>510</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1021/np0304316</pub-id><pub-id pub-id-type="pmid">15043447</pub-id></element-citation></ref><ref id="B574-marinedrugs-18-00657"><label>574.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalcanti</surname><given-names>B.C.</given-names></name><name><surname>J&#x000fa;nior</surname><given-names>H.V.</given-names></name><name><surname>Seleghim</surname><given-names>M.H.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.</given-names></name><name><surname>Cunha</surname><given-names>G.M.</given-names></name><name><surname>Moraes</surname><given-names>M.O.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name></person-group><article-title>Cytotoxic and genotoxic effects of tambjamine D, an alkaloid isolated from the nudibranch <italic>Tambja eliora</italic>, on Chinese hamster lung fibroblasts</article-title><source>Chem. Biol. Interact.</source><year>2008</year><volume>174</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2008.05.029</pub-id><pub-id pub-id-type="pmid">18573243</pub-id></element-citation></ref><ref id="B575-marinedrugs-18-00657"><label>575.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkerton</surname><given-names>D.M.</given-names></name><name><surname>Banwell</surname><given-names>M.G.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>de Moraes</surname><given-names>M.O.</given-names></name><name><surname>Cavalcanti</surname><given-names>B.C.</given-names></name><name><surname>Barros</surname><given-names>F.W.A.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name></person-group><article-title>Antimicrobial and cytotoxic activities of synthetically derived tambjamines C and E-J, BE-18591, and a related alkaloid from the marine bacterium <italic>Pseudoalteromonas tunicata</italic></article-title><source>Chem. Biodivers.</source><year>2010</year><volume>7</volume><fpage>1311</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201000030</pub-id><pub-id pub-id-type="pmid">20491087</pub-id></element-citation></ref><ref id="B576-marinedrugs-18-00657"><label>576.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melvin</surname><given-names>M.S.</given-names></name><name><surname>Ferguson</surname><given-names>D.C.</given-names></name><name><surname>Lindquist</surname><given-names>N.</given-names></name><name><surname>Manderville</surname><given-names>R.A.</given-names></name></person-group><article-title>DNA binding by 4-methoxypyrrolic natural products. Preference for intercalation at AT sites by tambjamine E and prodigiosin</article-title><source>J. Org. Chem.</source><year>1999</year><volume>64</volume><fpage>6861</fpage><lpage>6869</lpage><pub-id pub-id-type="doi">10.1021/jo990944a</pub-id><pub-id pub-id-type="pmid">11674696</pub-id></element-citation></ref><ref id="B577-marinedrugs-18-00657"><label>577.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldrich</surname><given-names>L.N.</given-names></name><name><surname>Stoops</surname><given-names>S.L.</given-names></name><name><surname>Crews</surname><given-names>B.C.</given-names></name><name><surname>Marnett</surname><given-names>L.J.</given-names></name><name><surname>Lindsley</surname><given-names>C.W.</given-names></name></person-group><article-title>Total synthesis and biological evaluation of tambjamine K and a library of unnatural analogs</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2010</year><volume>20</volume><fpage>5207</fpage><lpage>5211</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.06.154</pub-id><?supplied-pmid 20655217?><pub-id pub-id-type="pmid">20655217</pub-id></element-citation></ref><ref id="B578-marinedrugs-18-00657"><label>578.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazlauskas</surname><given-names>R.</given-names></name><name><surname>Marwood</surname><given-names>J.F.</given-names></name><name><surname>Murphy</surname><given-names>P.T.</given-names></name><name><surname>Wells</surname><given-names>R.J.</given-names></name></person-group><article-title>A blue pigment from a compound ascidian</article-title><source>Aust. J. Chem.</source><year>1982</year><volume>35</volume><fpage>215</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1071/CH9820215</pub-id></element-citation></ref><ref id="B579-marinedrugs-18-00657"><label>579.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melvin</surname><given-names>M.S.</given-names></name><name><surname>Wooton</surname><given-names>K.E.</given-names></name><name><surname>Rich</surname><given-names>C.C.</given-names></name><name><surname>Saluta</surname><given-names>G.R.</given-names></name><name><surname>Kucera</surname><given-names>G.L.</given-names></name><name><surname>Lindquist</surname><given-names>N.</given-names></name><name><surname>Manderville</surname><given-names>R.A.</given-names></name></person-group><article-title>Copper-nuclease efficiency correlates with cytotoxicity for the 4-methoxypyrrolic natural products</article-title><source>J. Inorg. Biochem.</source><year>2001</year><volume>87</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/S0162-0134(01)00338-5</pub-id><pub-id pub-id-type="pmid">11730894</pub-id></element-citation></ref><ref id="B580-marinedrugs-18-00657"><label>580.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name></person-group><article-title>Bioactive marine metabolites. VIII. Isolation of an antimicrobial blue pigment from the bryozoan <italic>Bugula dentata</italic></article-title><source>Experientia</source><year>1986</year><volume>42</volume><fpage>84</fpage><pub-id pub-id-type="doi">10.1007/BF01975907</pub-id></element-citation></ref><ref id="B581-marinedrugs-18-00657"><label>581.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>P.I.</given-names></name><name><surname>Moreno</surname><given-names>D.</given-names></name><name><surname>Javier</surname><given-names>A.A.</given-names></name><name><surname>Torroba</surname><given-names>T.</given-names></name><name><surname>P&#x000e9;rez-Tom&#x000e1;s</surname><given-names>R.</given-names></name><name><surname>Quesada</surname><given-names>R.</given-names></name></person-group><article-title>Tambjamine alkaloids and related synthetic analogs: Efficient transmembrane anion transporters</article-title><source>ChemComm.</source><year>2012</year><volume>48</volume><fpage>1556</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1039/C1CC11300C</pub-id></element-citation></ref><ref id="B582-marinedrugs-18-00657"><label>582.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W.Q.</given-names></name><name><surname>Song</surname><given-names>L.J.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Yan</surname><given-names>Z.W.</given-names></name><name><surname>Fu</surname><given-names>G.H.</given-names></name></person-group><article-title>Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer</article-title><source>J. Cancer Res. Clinical Oncol.</source><year>2009</year><volume>135</volume><fpage>1323</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1007/s00432-009-0573-9</pub-id><pub-id pub-id-type="pmid">19330352</pub-id></element-citation></ref><ref id="B583-marinedrugs-18-00657"><label>583.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liedauer</surname><given-names>R.</given-names></name><name><surname>Svoboda</surname><given-names>M.</given-names></name><name><surname>Wlcek</surname><given-names>K.</given-names></name><name><surname>Arrich</surname><given-names>F.</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>W.</given-names></name><name><surname>Toma</surname><given-names>C.</given-names></name><name><surname>Thalhammer</surname><given-names>T.</given-names></name></person-group><article-title>Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts</article-title><source>Oncol. Rep.</source><year>2009</year><volume>22</volume><fpage>1485</fpage><lpage>1492</lpage><pub-id pub-id-type="pmid">19885603</pub-id></element-citation></ref><ref id="B584-marinedrugs-18-00657"><label>584.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buxhofer-Ausch</surname><given-names>V.</given-names></name><name><surname>Secky</surname><given-names>L.</given-names></name><name><surname>Wlcek</surname><given-names>K.</given-names></name><name><surname>Svoboda</surname><given-names>M.</given-names></name><name><surname>Kounnis</surname><given-names>V.</given-names></name><name><surname>Briasoulis</surname><given-names>E.</given-names></name><name><surname>Tzakos</surname><given-names>A.G.</given-names></name><name><surname>Jaeger</surname><given-names>W.</given-names></name><name><surname>Thalhammer</surname><given-names>T.</given-names></name></person-group><article-title>Tumor-specific expression of organic anion-transporting polypeptides: Transporters as novel targets for cancer therapy</article-title><source>J. Drug Deliv.</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2013/863539</pub-id></element-citation></ref><ref id="B585-marinedrugs-18-00657"><label>585.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>AbuAli</surname><given-names>G.</given-names></name><name><surname>Grimm</surname><given-names>S.</given-names></name></person-group><article-title>Isolation and characterization of the anticancer gene organic cation transporter like-3 (ORCTL3)</article-title><source>Anticancer Genes</source><publisher-name>Springer</publisher-name><publisher-loc>London, UK</publisher-loc><year>2014</year><fpage>213</fpage><lpage>227</lpage></element-citation></ref><ref id="B586-marinedrugs-18-00657"><label>586.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name></person-group><article-title>Organic anion-transporting polypeptides: A novel approach for cancer therapy</article-title><source>J. Drug. Target.</source><year>2014</year><volume>22</volume><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.3109/1061186X.2013.832767</pub-id><pub-id pub-id-type="pmid">23987090</pub-id></element-citation></ref><ref id="B587-marinedrugs-18-00657"><label>587.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>B.</given-names></name><name><surname>Scheuer</surname><given-names>P.</given-names></name></person-group><article-title>The punaglandins: 10-chloroprostanoids from the octocoral <italic>Telesto riisei</italic></article-title><source>J. Nat. Prod.</source><year>1994</year><volume>57</volume><fpage>1346</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1021/np50112a003</pub-id><pub-id pub-id-type="pmid">7857405</pub-id></element-citation></ref><ref id="B588-marinedrugs-18-00657"><label>588.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pika</surname><given-names>J.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Four sesquiterpenes from the South African nudibranch <italic>Leminda millecra</italic></article-title><source>Tetrahedron</source><year>1994</year><volume>50</volume><fpage>3065</fpage><lpage>3070</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)81106-6</pub-id></element-citation></ref><ref id="B589-marinedrugs-18-00657"><label>589.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPhail</surname><given-names>K.L.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name><name><surname>Starmer</surname><given-names>J.</given-names></name></person-group><article-title>Sequestered chemistry of the arminacean nudibranch <italic>Leminda millecra</italic> in Algoa Bay, South Africa</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>1183</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1021/np010085x</pub-id><?supplied-pmid 11575953?><pub-id pub-id-type="pmid">11575953</pub-id></element-citation></ref><ref id="B590-marinedrugs-18-00657"><label>590.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whibley</surname><given-names>C.E.</given-names></name><name><surname>McPhail</surname><given-names>K.L.</given-names></name><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Maritz</surname><given-names>M.F.</given-names></name><name><surname>Leaner</surname><given-names>V.D.</given-names></name></person-group><article-title>: Birrer, M.J.; Davies-Coleman, M.T.; Hendricks, D.T. Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones</article-title><source>Mol. Cancer Ther.</source><year>2007</year><volume>6</volume><fpage>2535</fpage><lpage>2543</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-06-0760</pub-id><?supplied-pmid 17876050?><pub-id pub-id-type="pmid">17876050</pub-id></element-citation></ref><ref id="B591-marinedrugs-18-00657"><label>591.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasheverov</surname><given-names>I.E.</given-names></name><name><surname>Shelukhina</surname><given-names>I.V.</given-names></name><name><surname>Kudryavtsev</surname><given-names>D.S.</given-names></name><name><surname>Makarieva</surname><given-names>T.N.</given-names></name><name><surname>Spirova</surname><given-names>E.N.</given-names></name><name><surname>Guzii</surname><given-names>A.G.</given-names></name><name><surname>Stonik</surname><given-names>V.A.</given-names></name><name><surname>Tsetlin</surname><given-names>V.I.</given-names></name></person-group><article-title>6-Bromohypaphorine from marine nudibranch mollusk <italic>Hermissenda crassicornis</italic> is an agonist of human &#x003b1;7 nicotinic acetylcholine receptor</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>1255</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.3390/md13031255</pub-id><pub-id pub-id-type="pmid">25775422</pub-id></element-citation></ref><ref id="B592-marinedrugs-18-00657"><label>592.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Irace</surname><given-names>C.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Castelluccio</surname><given-names>F.</given-names></name><name><surname>Di Pascale</surname><given-names>A.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Santamaria</surname><given-names>R.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Structure and cytotoxicity of phidianidines A and B: First finding of 1, 2, 4-oxadiazole system in a marine natural product</article-title><source>Organic Lett.</source><year>2011</year><volume>13</volume><fpage>2516</fpage><lpage>2519</lpage><pub-id pub-id-type="doi">10.1021/ol200234r</pub-id></element-citation></ref><ref id="B593-marinedrugs-18-00657"><label>593.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brogan</surname><given-names>J.T.</given-names></name><name><surname>Stoops</surname><given-names>S.L.</given-names></name><name><surname>Lindsley</surname><given-names>C.W.</given-names></name></person-group><article-title>Total synthesis and biological evaluation of phidianidines A and B uncovers unique pharmacological profiles at CNS targets</article-title><source>ACS Chem. Neurosci.</source><year>2012</year><volume>3</volume><fpage>658</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1021/cn300064r</pub-id><pub-id pub-id-type="pmid">23019492</pub-id></element-citation></ref><ref id="B594-marinedrugs-18-00657"><label>594.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.Y.</given-names></name><name><surname>Snider</surname><given-names>B.B.</given-names></name></person-group><article-title>Synthesis of phidianidines A and B</article-title><source>J. Org. Chem.</source><year>2012</year><volume>77</volume><fpage>4832</fpage><lpage>4836</lpage><pub-id pub-id-type="doi">10.1021/jo300449n</pub-id><pub-id pub-id-type="pmid">22524523</pub-id></element-citation></ref><ref id="B595-marinedrugs-18-00657"><label>595.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Pagano</surname><given-names>D.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis of phidianidine B, a highly cytotoxic 1, 2, 4-oxadiazole marine metabolite</article-title><source>Arkivoc</source><year>2012</year><volume>9</volume><fpage>220</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.3998/ark.5550190.0013.919</pub-id></element-citation></ref><ref id="B596-marinedrugs-18-00657"><label>596.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchanan</surname><given-names>J.C.</given-names></name><name><surname>Petersen</surname><given-names>B.P.</given-names></name><name><surname>Chamberland</surname><given-names>S.</given-names></name></person-group><article-title>Concise total synthesis of phidianidine A and B</article-title><source>Tetrahedron Lett.</source><year>2013</year><volume>54</volume><fpage>6002</fpage><lpage>6004</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2013.08.063</pub-id></element-citation></ref><ref id="B597-marinedrugs-18-00657"><label>597.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maftei</surname><given-names>C.V.</given-names></name><name><surname>Fodor</surname><given-names>E.</given-names></name><name><surname>Jones</surname><given-names>P.G.</given-names></name><name><surname>Franz</surname><given-names>M.H.</given-names></name><name><surname>Kelter</surname><given-names>G.</given-names></name><name><surname>Fiebig</surname><given-names>H.</given-names></name><name><surname>Neda</surname><given-names>I.</given-names></name></person-group><article-title>Synthesis and characterization of novel bioactive 1, 2, 4-oxadiazole natural product analogs bearing the N-phenylmaleimide and N-phenylsuccinimide moieties</article-title><source>Beilstein J. Org. Chem.</source><year>2013</year><volume>9</volume><fpage>2202</fpage><lpage>2215</lpage><pub-id pub-id-type="doi">10.3762/bjoc.9.259</pub-id><pub-id pub-id-type="pmid">24222789</pub-id></element-citation></ref><ref id="B598-marinedrugs-18-00657"><label>598.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C.S.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Gong</surname><given-names>J.X.</given-names></name><name><surname>Wang</surname><given-names>Z.Z.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>H.Y.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Synthesis and biological evaluation of novel marine-derived indole-based 1, 2, 4-oxadiazoles derivatives as multifunctional neuroprotective agents</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2015</year><volume>25</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2014.11.068</pub-id><?supplied-pmid 25499879?><pub-id pub-id-type="pmid">25499879</pub-id></element-citation></ref><ref id="B599-marinedrugs-18-00657"><label>599.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>C.S.</given-names></name><name><surname>Gao</surname><given-names>L.X.</given-names></name><name><surname>Gong</surname><given-names>J.X.</given-names></name><name><surname>Wang</surname><given-names>Z.H.</given-names></name><name><surname>Li</surname><given-names>J.Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.W.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><fpage>778</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.12.097</pub-id><?supplied-pmid 26774579?><pub-id pub-id-type="pmid">26774579</pub-id></element-citation></ref><ref id="B600-marinedrugs-18-00657"><label>600.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Ibrar</surname><given-names>A.</given-names></name><name><surname>Abbas</surname><given-names>N.</given-names></name></person-group><article-title>Oxadiazoles as privileged motifs for promising anticancer leads: Recent advances and future prospects</article-title><source>Archiv. Pharm. Chem. Life Sci.</source><year>2014</year><volume>347</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/ardp.201300231</pub-id><?supplied-pmid 24265208?><pub-id pub-id-type="pmid">24265208</pub-id></element-citation></ref><ref id="B601-marinedrugs-18-00657"><label>601.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>D.</given-names></name><name><surname>Boudreau</surname><given-names>M.A.</given-names></name><name><surname>Leemans</surname><given-names>E.</given-names></name><name><surname>Spink</surname><given-names>E.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Testero</surname><given-names>S.A.</given-names></name><name><surname>O&#x02019;Daniel</surname><given-names>P.I.</given-names></name><name><surname>Lastochkin</surname><given-names>E.</given-names></name><name><surname>Chang</surname><given-names>M.</given-names></name><name><surname>Mobashery</surname><given-names>S.</given-names></name></person-group><article-title>Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2015</year><volume>25</volume><fpage>4854</fpage><lpage>4857</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.06.044</pub-id><?supplied-pmid 26144346?><pub-id pub-id-type="pmid">26144346</pub-id></element-citation></ref><ref id="B602-marinedrugs-18-00657"><label>602.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukin</surname><given-names>A.</given-names></name><name><surname>Karapetian</surname><given-names>R.</given-names></name><name><surname>Ivanenkov</surname><given-names>Y.</given-names></name><name><surname>Krasavin</surname><given-names>M.</given-names></name></person-group><article-title>Privileged 1,2,4-oxadiazoles in anticancer drug design: Novel 5-aryloxymethyl-1,2,4-oxadiazole leads for prostate cancer therapy</article-title><source>Lett. Drug Des. Discov.</source><year>2016</year><volume>13</volume><fpage>198</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.2174/1570180812999150812164251</pub-id></element-citation></ref><ref id="B603-marinedrugs-18-00657"><label>603.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitasse-Santos</surname><given-names>P.</given-names></name><name><surname>Sueth-Santiago</surname><given-names>V.</given-names></name><name><surname>Lima</surname><given-names>M.E.F.</given-names></name></person-group><article-title>1,2,4- and 1,3,4-oxadiazoles as scaffolds in the development of antiparasitic agents</article-title><source>J. Brazil Chem. Soc.</source><year>2018</year><volume>29</volume><fpage>435</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.21577/0103-5053.20170208</pub-id></element-citation></ref><ref id="B604-marinedrugs-18-00657"><label>604.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>G.</given-names></name></person-group><article-title>1,2,4-Oxadiazole as a privileged scaffold for anti-inflammatory and analgesic activities: A review</article-title><source>Mini-Rev. Med. Chem.</source><year>2018</year><volume>18</volume><fpage>1536</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.2174/1389557518666180524112050</pub-id><pub-id pub-id-type="pmid">29792145</pub-id></element-citation></ref><ref id="B605-marinedrugs-18-00657"><label>605.</label><element-citation publication-type="patent"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Pagano</surname><given-names>D.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>1, 2, 4-Oxadiazol Derivatives, Process for Their Preparation and Use Thereof as Intermediates in the Preparation of Indolic Alkaloids</article-title><source>U.S. Patent</source><patent>20150051405A1</patent><day>19</day><month>2</month><year>2015</year></element-citation></ref><ref id="B606-marinedrugs-18-00657"><label>606.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>A.R.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Kuanoniamines A, B, C, and D: Pentacyclic alkaloids from a tunicate and its prosobranch mollusk predator <italic>Chelynotus semperi</italic></article-title><source>J. Org. Chem.</source><year>1990</year><volume>55</volume><fpage>4426</fpage><lpage>4431</lpage><pub-id pub-id-type="doi">10.1021/jo00301a040</pub-id></element-citation></ref><ref id="B607-marinedrugs-18-00657"><label>607.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singleton</surname><given-names>P.A.</given-names></name><name><surname>Moss</surname><given-names>J.</given-names></name><name><surname>Karp</surname><given-names>D.D.</given-names></name><name><surname>Atkins</surname><given-names>J.T.</given-names></name><name><surname>Janku</surname><given-names>F.</given-names></name></person-group><article-title>The mu opioid receptor: A new target for cancer therapy?</article-title><source>Cancer</source><year>2015</year><volume>121</volume><fpage>2681</fpage><lpage>2688</lpage><pub-id pub-id-type="doi">10.1002/cncr.29460</pub-id><pub-id pub-id-type="pmid">26043235</pub-id></element-citation></ref><ref id="B608-marinedrugs-18-00657"><label>608.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitale</surname><given-names>R.M.</given-names></name><name><surname>Gatti</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Barbieri</surname><given-names>F.</given-names></name><name><surname>Felicit&#x000e0;</surname><given-names>V.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Florio</surname><given-names>T.</given-names></name><name><surname>Amodeo</surname><given-names>P.</given-names></name></person-group><article-title>Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of phidianidine A as a new CXCR4 ligand exhibiting antagonist activity</article-title><source>ACS Chem. Biol.</source><year>2013</year><volume>8</volume><fpage>2762</fpage><lpage>2770</lpage><pub-id pub-id-type="doi">10.1021/cb400521b</pub-id><pub-id pub-id-type="pmid">24102412</pub-id></element-citation></ref><ref id="B609-marinedrugs-18-00657"><label>609.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieri</surname><given-names>F.</given-names></name><name><surname>Thellung</surname><given-names>S.</given-names></name><name><surname>Wurth</surname><given-names>R.</given-names></name><name><surname>Gatto</surname><given-names>F.</given-names></name><name><surname>Corsaro</surname><given-names>A.</given-names></name><name><surname>Villa</surname><given-names>V.</given-names></name><name><surname>Nizzari</surname><given-names>M.</given-names></name><name><surname>Albertelli</surname><given-names>M.</given-names></name><name><surname>Ferone</surname><given-names>D.</given-names></name><name><surname>Florio</surname><given-names>T.</given-names></name></person-group><article-title>Emerging targets in pituitary adenomas: Role of the CXCL12/CXCR4-R7 system</article-title><source>Int. J. Endocrinol.</source><year>2014</year><volume>2014</volume><fpage>753524</fpage><pub-id pub-id-type="doi">10.1155/2014/753524</pub-id><?supplied-pmid 25484899?><pub-id pub-id-type="pmid">25484899</pub-id></element-citation></ref><ref id="B610-marinedrugs-18-00657"><label>610.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Palomar</surname><given-names>A.J.</given-names></name><name><surname>Hong</surname><given-names>E.P.</given-names></name><name><surname>Schmitz</surname><given-names>F.J.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name></person-group><article-title>Cytotoxic lissoclimide-type diterpenes from the molluscs <italic>Pleurobranchus albiguttatus</italic> and <italic>Pleurobranchus forskalii</italic></article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1415</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1021/np0499620</pub-id><?supplied-pmid 15332867?><pub-id pub-id-type="pmid">15332867</pub-id></element-citation></ref><ref id="B611-marinedrugs-18-00657"><label>611.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wesson</surname><given-names>K.J.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>Keenamide A, a bioactive cyclic peptide from the marine mollusk <italic>Pleurobranchus forskalii</italic></article-title><source>J. Nat. Prod.</source><year>1996</year><volume>59</volume><fpage>629</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1021/np960153t</pub-id><?supplied-pmid 8786369?><pub-id pub-id-type="pmid">8786369</pub-id></element-citation></ref><ref id="B612-marinedrugs-18-00657"><label>612.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>K.C.</given-names></name><name><surname>Wakimoto</surname><given-names>T.</given-names></name><name><surname>Takada</surname><given-names>K.</given-names></name><name><surname>Ohtsuki</surname><given-names>T.</given-names></name><name><surname>Uchiyama</surname><given-names>N.</given-names></name><name><surname>Goda</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>I.</given-names></name></person-group><article-title>Cycloforskamide, a cytotoxic macrocyclic peptide from the sea slug <italic>Pleurobranchus forskalii</italic></article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>1388</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1021/np400404r</pub-id><pub-id pub-id-type="pmid">23848233</pub-id></element-citation></ref><ref id="B613-marinedrugs-18-00657"><label>613.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname><given-names>R.H.</given-names></name></person-group><article-title>The NCI60 human tumour cell line anticancer drug screen</article-title><source>Nat. Rev. Cancer</source><year>2006</year><volume>6</volume><fpage>813</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1038/nrc1951</pub-id><pub-id pub-id-type="pmid">16990858</pub-id></element-citation></ref><ref id="B614-marinedrugs-18-00657"><label>614.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darro</surname><given-names>F.</given-names></name><name><surname>Decaestecker</surname><given-names>C.</given-names></name><name><surname>Gaussin</surname><given-names>J.F.</given-names></name><name><surname>Mortier</surname><given-names>S.</given-names></name><name><surname>Van Ginckel</surname><given-names>R.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name></person-group><article-title>Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?</article-title><source>Int. J. Oncol.</source><year>2005</year><volume>27</volume><fpage>607</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">16077908</pub-id></element-citation></ref><ref id="B615-marinedrugs-18-00657"><label>615.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakimoto</surname><given-names>T.</given-names></name><name><surname>Tan</surname><given-names>K.C.</given-names></name><name><surname>Abe</surname><given-names>I.</given-names></name></person-group><article-title>Ergot Alkaloid from the Sea Slug <italic>Pleurobranchus forskalii</italic></article-title><source>Toxicon</source><year>2013</year><volume>72</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2013.05.021</pub-id><pub-id pub-id-type="pmid">23770424</pub-id></element-citation></ref><ref id="B616-marinedrugs-18-00657"><label>616.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulac</surname><given-names>D.</given-names></name><name><surname>Humpf</surname><given-names>H.-U.</given-names></name></person-group><article-title>Cytotoxicity and accumulation of ergot alkaloids in human primary cells</article-title><source>Toxicology</source><year>2011</year><volume>282</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2011.01.019</pub-id><pub-id pub-id-type="pmid">21295106</pub-id></element-citation></ref><ref id="B617-marinedrugs-18-00657"><label>617.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>M.R.</given-names></name><name><surname>Paull</surname><given-names>K.D.</given-names></name></person-group><article-title>Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen</article-title><source>Drug. Dev. Res.</source><year>1995</year><volume>34</volume><fpage>91</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1002/ddr.430340203</pub-id></element-citation></ref><ref id="B618-marinedrugs-18-00657"><label>618.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>F.</given-names></name><name><surname>Gao</surname><given-names>H.Q.</given-names></name><name><surname>Donia</surname><given-names>M.</given-names></name><name><surname>Merrick</surname><given-names>W.C.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Pelletier</surname><given-names>J.</given-names></name></person-group><article-title>Chlorolissoclimides: New inhibitors of eukaryotic protein synthesis</article-title><source>RNA</source><year>2006</year><volume>12</volume><fpage>717</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1261/rna.2346806</pub-id><pub-id pub-id-type="pmid">16540697</pub-id></element-citation></ref><ref id="B619-marinedrugs-18-00657"><label>619.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malochet-Grivois</surname><given-names>C.</given-names></name><name><surname>Roussakis</surname><given-names>C.</given-names></name><name><surname>Robillard</surname><given-names>N.</given-names></name><name><surname>Biard</surname><given-names>J.F.</given-names></name><name><surname>Riou</surname><given-names>D.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Verbist</surname><given-names>J.F.</given-names></name></person-group><article-title>Effects in vitro of two marine substances, chlorolissoclimide and dichlorolissoclimide, on a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6)</article-title><source>Anticancer Drug Des.</source><year>1992</year><volume>7</volume><fpage>493</fpage><lpage>505</lpage><?supplied-pmid 1337432?><pub-id pub-id-type="pmid">1337432</pub-id></element-citation></ref><ref id="B620-marinedrugs-18-00657"><label>620.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.J.</given-names></name><name><surname>Kokubo</surname><given-names>S.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Ueda</surname><given-names>K.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Haterumaimides AE, five new dichlorolissoclimide-type diterpenoids from an ascidian, <italic>Lissoclinum</italic> sp.</article-title><source>Heterocycles</source><year>2001</year><volume>54</volume><fpage>1039</fpage><lpage>1047</lpage></element-citation></ref><ref id="B621-marinedrugs-18-00657"><label>621.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.J.</given-names></name><name><surname>Kokubo</surname><given-names>S.</given-names></name><name><surname>Ueda</surname><given-names>K.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Haterumaimides F&#x02212; I, four new cytotoxic diterpene alkaloids from an ascidian <italic>Lissoclinum</italic> species</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>1169</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.1021/np010066n</pub-id><?supplied-pmid 11575950?><pub-id pub-id-type="pmid">11575950</pub-id></element-citation></ref><ref id="B622-marinedrugs-18-00657"><label>622.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.J.</given-names></name><name><surname>Kokubo</surname><given-names>S.</given-names></name><name><surname>Ueda</surname><given-names>K.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Haterumaimides J and K, potent cytotoxic diterpene alkaloids from the ascidian <italic>Lissoclinum</italic> species</article-title><source>Chem. Lett.</source><year>2002</year><volume>31</volume><fpage>1028</fpage><lpage>1029</lpage><pub-id pub-id-type="doi">10.1246/cl.2002.1028</pub-id></element-citation></ref><ref id="B623-marinedrugs-18-00657"><label>623.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>J.</given-names></name><name><surname>Ueda</surname><given-names>K.</given-names></name><name><surname>Siwu</surname><given-names>E.R.</given-names></name><name><surname>Kita</surname><given-names>M.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Cytotoxic labdane alkaloids from an ascidian <italic>Lissoclinum</italic> sp.: Isolation, structure elucidation, and structure-activity relationship</article-title><source>Bioorg. Med. Chem.</source><year>2006</year><volume>14</volume><fpage>6954</fpage><lpage>6961</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2006.06.043</pub-id><?supplied-pmid 16854586?><pub-id pub-id-type="pmid">16854586</pub-id></element-citation></ref><ref id="B624-marinedrugs-18-00657"><label>624.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>M.A.</given-names></name><name><surname>Romero</surname><given-names>D.</given-names></name><name><surname>Zapata</surname><given-names>B.</given-names></name><name><surname>Betancur-Galvis</surname><given-names>L.</given-names></name></person-group><article-title>First synthesis of lissoclimide-type alkaloids</article-title><source>Lett. Org. Chem.</source><year>2009</year><volume>6</volume><fpage>289</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.2174/157017809788489828</pub-id></element-citation></ref><ref id="B625-marinedrugs-18-00657"><label>625.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thoms</surname><given-names>C.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Sequestration and possible role of dietary alkaloids in the sponge-feeding mollusk <italic>Tylodina perversa</italic></article-title><source>Molluscs</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2006</year><fpage>261</fpage><lpage>275</lpage></element-citation></ref><ref id="B626-marinedrugs-18-00657"><label>626.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>J.</given-names></name><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Inayoshi</surname><given-names>T.</given-names></name><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Goetz</surname><given-names>G.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Kulokekahilide-1, a cytotoxic depsipeptide from the cephalaspidean mollusk <italic>Philinopsis speciosa</italic></article-title><source>J. Org. Chem.</source><year>2002</year><volume>67</volume><fpage>1760</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.1021/jo010176z</pub-id><pub-id pub-id-type="pmid">11895390</pub-id></element-citation></ref><ref id="B627-marinedrugs-18-00657"><label>627.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Kimura</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Kulokekahilide-2, a cytotoxic depsipeptide from a cephalaspidean mollusk <italic>Philinopsis speciosa</italic></article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1332</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1021/np049949f</pub-id><pub-id pub-id-type="pmid">15332851</pub-id></element-citation></ref><ref id="B628-marinedrugs-18-00657"><label>628.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umehara</surname><given-names>M.</given-names></name><name><surname>Negishi</surname><given-names>T.</given-names></name><name><surname>Tashiro</surname><given-names>T.</given-names></name><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Kimura</surname><given-names>J.</given-names></name></person-group><article-title>Structure-related cytotoxic activity from kulokekahilide-2, a cyclodepsipeptide of Hawaiian marine mollusk</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2012</year><volume>22</volume><fpage>7422</fpage><lpage>7425</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2012.10.058</pub-id><pub-id pub-id-type="pmid">23127885</pub-id></element-citation></ref><ref id="B629-marinedrugs-18-00657"><label>629.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Umehara</surname><given-names>M.</given-names></name><name><surname>Katsumata</surname><given-names>R.</given-names></name><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Kimura</surname><given-names>J.</given-names></name></person-group><article-title>The total synthesis and structure-activity relationships of a highly cytotoxic depsipeptide kulokekahilide-2 and its analogs</article-title><source>Tetrahedron</source><year>2012</year><volume>68</volume><fpage>659</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2011.10.094</pub-id></element-citation></ref><ref id="B630-marinedrugs-18-00657"><label>630.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasskog</surname><given-names>T.</given-names></name><name><surname>Andersen</surname><given-names>J.H.</given-names></name><name><surname>Hansen</surname><given-names>E.</given-names></name><name><surname>Svenson</surname><given-names>J.</given-names></name></person-group><article-title>Characterization and cytotoxicity studies of the rare 21: 4 n-7 acid and other polyunsaturated fatty acids from the marine opisthobranch <italic>Scaphander lignarius</italic>, isolated using bioassay guided fractionation</article-title><source>Mar. Drugs</source><year>2012</year><volume>10</volume><fpage>2676</fpage><lpage>2690</lpage><pub-id pub-id-type="doi">10.3390/md10122676</pub-id><?supplied-pmid 23342390?><pub-id pub-id-type="pmid">23342390</pub-id></element-citation></ref><ref id="B631-marinedrugs-18-00657"><label>631.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessels</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name></person-group><article-title>New Natural Product Isolation and Comparison of the Secondary Metabolite Content of Three Distinct Samples of the Sea Hare <italic>Aplysia dactylomela</italic> from Tenerife</article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>920</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1021/np9905721</pub-id><?supplied-pmid 10924166?><pub-id pub-id-type="pmid">10924166</pub-id></element-citation></ref><ref id="B632-marinedrugs-18-00657"><label>632.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>J.J.</given-names></name><name><surname>Lin</surname><given-names>G.H.</given-names></name><name><surname>Wing</surname><given-names>R.M.</given-names></name></person-group><article-title>Marine natural products X elatol, a halogenated sesquiterpene alcohol from the red alga <italic>Laurencia elata</italic></article-title><source>Tetrahedron Lett.</source><year>1974</year><volume>15</volume><fpage>3487</fpage><lpage>3490</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)91944-6</pub-id></element-citation></ref><ref id="B633-marinedrugs-18-00657"><label>633.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>K.L.</given-names></name><name><surname>Silva</surname><given-names>I.T.</given-names></name><name><surname>Zimmermann</surname><given-names>L.A.</given-names></name><name><surname>Lhullier</surname><given-names>C.</given-names></name><name><surname>Ma&#x000f1;alich Arana</surname><given-names>M.V.</given-names></name><name><surname>Palermo</surname><given-names>J.A.</given-names></name><name><surname>Falkenberg</surname><given-names>M.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>C.M.</given-names></name><name><surname>Schenkel</surname><given-names>E.P.</given-names></name><name><surname>Dur&#x000e1;n</surname><given-names>F.J.</given-names></name></person-group><article-title>Cytotoxic activity of semi-synthetic derivatives of elatol and isoobtusol</article-title><source>Mar. Drugs</source><year>2012</year><volume>10</volume><fpage>2254</fpage><lpage>2264</lpage><pub-id pub-id-type="doi">10.3390/md10102254</pub-id><?supplied-pmid 23170082?><pub-id pub-id-type="pmid">23170082</pub-id></element-citation></ref><ref id="B634-marinedrugs-18-00657"><label>634.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>A.G.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name><name><surname>Diaz</surname><given-names>A.</given-names></name><name><surname>Fourneron</surname><given-names>J.D.</given-names></name><name><surname>Martin</surname><given-names>J.D.</given-names></name><name><surname>Perez</surname><given-names>C.</given-names></name></person-group><article-title>Evidence for the biogenesis of halogenated chamigrenes from the red alga <italic>Laurencia obtusa</italic></article-title><source>Tetrahedron Lett</source><year>1976</year><volume>17</volume><fpage>3051</fpage><lpage>3054</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(76)80067-6</pub-id></element-citation></ref><ref id="B635-marinedrugs-18-00657"><label>635.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>T.</given-names></name><name><surname>Brito</surname><given-names>I.</given-names></name><name><surname>Moujir</surname><given-names>L.</given-names></name><name><surname>Paiz</surname><given-names>N.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name></person-group><article-title>Cytotoxic Sesquiterpenes from <italic>Aplysia dactylomela</italic></article-title><source>J. Nat. Prod.</source><year>2005</year><volume>68</volume><fpage>1677</fpage><lpage>1679</lpage><pub-id pub-id-type="doi">10.1021/np050240y</pub-id><pub-id pub-id-type="pmid">16309323</pub-id></element-citation></ref><ref id="B636-marinedrugs-18-00657"><label>636.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>A.</given-names></name><name><surname>Souza</surname><given-names>C.B.</given-names></name><name><surname>Lhullier</surname><given-names>C.</given-names></name><name><surname>Falkenberg</surname><given-names>M.</given-names></name><name><surname>Schenkel</surname><given-names>E.P.</given-names></name><name><surname>Ribeiro-do-Valle</surname><given-names>R.M.</given-names></name><name><surname>Siqueira</surname><given-names>J.M.</given-names></name></person-group><article-title>Anti-tumour effects of elatol, a marine derivative compound obtained from red algae <italic>Laurencia microcladia</italic></article-title><source>J. Pharm. Pharmacol.</source><year>2012</year><volume>64</volume><fpage>1146</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1111/j.2042-7158.2012.01493.x</pub-id><pub-id pub-id-type="pmid">22775218</pub-id></element-citation></ref><ref id="B637-marinedrugs-18-00657"><label>637.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Goietsenoven</surname><given-names>G.</given-names></name><name><surname>Hutton</surname><given-names>J.</given-names></name><name><surname>Becker</surname><given-names>J.P.</given-names></name><name><surname>Lallemand</surname><given-names>B.</given-names></name><name><surname>Robert</surname><given-names>F.</given-names></name><name><surname>Lefranc</surname><given-names>F.</given-names></name><name><surname>Pirker</surname><given-names>C.</given-names></name><name><surname>Vandenbussche</surname><given-names>G.</given-names></name><name><surname>Van Antwerpen</surname><given-names>P.</given-names></name><name><surname>Evidente</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas</article-title><source>FASEB J.</source><year>2010</year><volume>24</volume><fpage>4575</fpage><lpage>4584</lpage><pub-id pub-id-type="doi">10.1096/fj.10-162263</pub-id><pub-id pub-id-type="pmid">20643906</pub-id></element-citation></ref><ref id="B638-marinedrugs-18-00657"><label>638.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Le Mercier</surname><given-names>M.</given-names></name><name><surname>De Neve</surname><given-names>N.</given-names></name><name><surname>Sauvage</surname><given-names>S.</given-names></name><name><surname>Gras</surname><given-names>T.</given-names></name><name><surname>Roland</surname><given-names>I.</given-names></name><name><surname>Lefranc</surname><given-names>F.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name></person-group><article-title>Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model</article-title><source>J. Invest. Dermatol.</source><year>2007</year><volume>127</volume><fpage>2399</fpage><lpage>2410</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5700869</pub-id><pub-id pub-id-type="pmid">17495956</pub-id></element-citation></ref><ref id="B639-marinedrugs-18-00657"><label>639.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>F.J.</given-names></name><name><surname>Michaud</surname><given-names>D.P.</given-names></name><name><surname>Schmidt</surname><given-names>P.G.</given-names></name></person-group><article-title>Marine natural products: Parguerol, deoxyparguerol, and isoparguerol. New brominated diterpenes with modified pimarane skeletons from the sea hare <italic>Aplysia dactylomela</italic></article-title><source>J. Am. Chem. Soc.</source><year>1982</year><volume>104</volume><fpage>6415</fpage><lpage>6423</lpage><pub-id pub-id-type="doi">10.1021/ja00387a045</pub-id></element-citation></ref><ref id="B640-marinedrugs-18-00657"><label>640.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awad</surname><given-names>N.E.</given-names></name></person-group><article-title>Bioactive brominated diterpenes from the marine red alga <italic>Jania rubens</italic> (L.) Lamx</article-title><source>Phytother. Res.</source><year>2004</year><volume>18</volume><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1002/ptr.1273</pub-id><?supplied-pmid 15162360?><pub-id pub-id-type="pmid">15162360</pub-id></element-citation></ref><ref id="B641-marinedrugs-18-00657"><label>641.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>B.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>A.D.</given-names></name><name><surname>Avil&#x000e9;s</surname><given-names>E.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name></person-group><article-title>Aplysqualenols A and B: Squalene-derived polyethers with antitumoral and antiviral activity from the caribbean sea slug <italic>Aplysia dactylomela</italic></article-title><source>Eur. J. Org. Chem.</source><year>2009</year><volume>31</volume><fpage>5327</fpage><lpage>5336</lpage><pub-id pub-id-type="doi">10.1002/ejoc.200900775</pub-id><?supplied-pmid 23459021?><pub-id pub-id-type="pmid">23459021</pub-id></element-citation></ref><ref id="B642-marinedrugs-18-00657"><label>642.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>B.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>A.D.</given-names></name><name><surname>La Clair</surname><given-names>J.J.</given-names></name></person-group><article-title>Aplysqualenol A binds to the light chain of dynein type 1 (DYNLL1)</article-title><source>Angew. Chem.</source><year>2011</year><volume>123</volume><fpage>8284</fpage><lpage>8288</lpage><pub-id pub-id-type="doi">10.1002/ange.201102546</pub-id></element-citation></ref><ref id="B643-marinedrugs-18-00657"><label>643.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Balachandran</surname><given-names>R.</given-names></name><name><surname>H&#x000f6;&#x000f6;k</surname><given-names>P.</given-names></name><name><surname>Vallee</surname><given-names>R.B.</given-names></name><name><surname>Curran</surname><given-names>D.P.</given-names></name><name><surname>Day</surname><given-names>B.W.</given-names></name></person-group><article-title>Synthesis and biological evaluation of purealin and analogues as cytoplasmic dynein heavy chain inhibitors</article-title><source>J. Med. Chem.</source><year>2006</year><volume>49</volume><fpage>2063</fpage><lpage>2076</lpage><pub-id pub-id-type="doi">10.1021/jm051030l</pub-id><pub-id pub-id-type="pmid">16539395</pub-id></element-citation></ref><ref id="B644-marinedrugs-18-00657"><label>644.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>C.</given-names></name></person-group><article-title>Cytoskeleton structure and dynamic behaviour: Quick excursus from basic molecular mechanisms to some implications in cancer chemotherapy</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><year>2009</year><volume>13</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">19364082</pub-id></element-citation></ref><ref id="B645-marinedrugs-18-00657"><label>645.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>D.M.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Jurado</surname><given-names>S.</given-names></name><name><surname>King</surname><given-names>A.</given-names></name><name><surname>Bamford</surname><given-names>R.</given-names></name><name><surname>Wall</surname><given-names>M.</given-names></name><name><surname>Walia</surname><given-names>M.K.</given-names></name><name><surname>Kelly</surname><given-names>G.L.</given-names></name><name><surname>Walkley</surname><given-names>C.R.</given-names></name><name><surname>Tarlinton</surname><given-names>D.M.</given-names></name><etal/></person-group><article-title>The transcription factor ASCIZ and its target DYNLL1 are essential for the development and expansion of MYC-driven B cell lymphoma</article-title><source>Cell Rep.</source><year>2016</year><volume>14</volume><fpage>1488</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.01.012</pub-id><pub-id pub-id-type="pmid">26832406</pub-id></element-citation></ref><ref id="B646-marinedrugs-18-00657"><label>646.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>E.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Bifulco</surname><given-names>G.</given-names></name><name><surname>Cimino</surname><given-names>P.</given-names></name><name><surname>Di Micco</surname><given-names>S.</given-names></name><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Guo</surname><given-names>Y.-W.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Aplysiols A and B, squalene-derived polyethers from the mantle of the sea hare <italic>Aplysia dactylomela</italic></article-title><source>Tetrahedron</source><year>2007</year><volume>63</volume><fpage>9970</fpage><lpage>9978</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2007.07.055</pub-id></element-citation></ref><ref id="B647-marinedrugs-18-00657"><label>647.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Hartshorn</surname><given-names>M.P.</given-names></name><name><surname>McLennan</surname><given-names>T.J.</given-names></name><name><surname>Munro</surname><given-names>M.H.G.</given-names></name><name><surname>Robinson</surname><given-names>W.T.</given-names></name><name><surname>Yorke</surname><given-names>S.C.</given-names></name></person-group><article-title>Thyrsiferol: A squalene-derived metabolite of <italic>Laurencia thyrsifera</italic></article-title><source>Tetrahedron Lett.</source><year>1978</year><volume>19</volume><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)88986-3</pub-id></element-citation></ref><ref id="B648-marinedrugs-18-00657"><label>648.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahdi</surname><given-names>F.</given-names></name><name><surname>Falkenberg</surname><given-names>M.</given-names></name><name><surname>Ioannou</surname><given-names>E.</given-names></name><name><surname>Roussis</surname><given-names>V.</given-names></name><name><surname>Zhou</surname><given-names>Y.D.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name></person-group><article-title>Thyrsiferol inhibits mitochondrial respiration and HIF-1 activation</article-title><source>Phytochem. Lett.</source><year>2011</year><volume>4</volume><fpage>75</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2010.09.003</pub-id><pub-id pub-id-type="pmid">21785662</pub-id></element-citation></ref><ref id="B649-marinedrugs-18-00657"><label>649.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>J.</given-names></name><name><surname>Souto</surname><given-names>M.L.</given-names></name><name><surname>Norte</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of the cytotoxic activity of polyethers isolated from <italic>Laurencia</italic></article-title><source>Bioorg. Med. Chem.</source><year>1998</year><volume>6</volume><fpage>2237</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.1016/S0968-0896(98)80004-7</pub-id><pub-id pub-id-type="pmid">9925286</pub-id></element-citation></ref><ref id="B650-marinedrugs-18-00657"><label>650.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez</surname><given-names>C.</given-names></name><name><surname>Qui&#x000f1;o&#x000e1;</surname><given-names>E.</given-names></name><name><surname>Castedo</surname><given-names>L.</given-names></name><name><surname>Riguera</surname><given-names>R.</given-names></name></person-group><article-title>Epidioxy sterols from the tunicates <italic>Dendrodoa grossularia</italic> and <italic>Ascidiella aspersa</italic> and the gastropoda <italic>Aplysia depilans</italic> and <italic>Aplysia punctata</italic></article-title><source>J. Nat. Prod.</source><year>1986</year><volume>49</volume><fpage>905</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1021/np50047a023</pub-id></element-citation></ref><ref id="B651-marinedrugs-18-00657"><label>651.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mun</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Hahn</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>I.</given-names></name><name><surname>Won</surname><given-names>D.H.</given-names></name><name><surname>Kim</surname><given-names>E.H.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Cytotoxic 5&#x003b1;, 8&#x003b1;-epidioxy sterols from the marine sponge <italic>Monanchora</italic> sp.</article-title><source>Arch. Pharm. Res.</source><year>2015</year><volume>38</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/s12272-014-0480-8</pub-id><?supplied-pmid 25231340?><pub-id pub-id-type="pmid">25231340</pub-id></element-citation></ref><ref id="B652-marinedrugs-18-00657"><label>652.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Ishigaki</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Ekimoto</surname><given-names>H.</given-names></name><name><surname>Arakawa</surname><given-names>M.</given-names></name></person-group><article-title>Aplyronine A, a potent antitumor substance, and the congeners aplyronines B and C isolated from the sea hare <italic>Aplysia kurodai</italic></article-title><source>J. Am. Chem. Soc.</source><year>1993</year><volume>115</volume><fpage>11020</fpage><lpage>11021</lpage><pub-id pub-id-type="doi">10.1021/ja00076a082</pub-id></element-citation></ref><ref id="B653-marinedrugs-18-00657"><label>653.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Imamura</surname><given-names>Y.</given-names></name><name><surname>Yoshikawa</surname><given-names>K.</given-names></name><name><surname>Ishigaki</surname><given-names>T.</given-names></name><name><surname>Sakakura</surname><given-names>A.</given-names></name><name><surname>Mutou</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aplyronines D-H from the sea hare <italic>Aplysia kurodai</italic>: Isolation, structures, and cytotoxicity</article-title><source>Tetrahedron</source><year>2012</year><volume>68</volume><fpage>982</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2011.11.095</pub-id></element-citation></ref><ref id="B654-marinedrugs-18-00657"><label>654.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>T.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Aplaminal: A novel cytotoxic aminal isolated from the sea hare <italic>Aplysia kurodai</italic></article-title><source>Organic Lett.</source><year>2008</year><volume>10</volume><fpage>489</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1021/ol7029307</pub-id></element-citation></ref><ref id="B655-marinedrugs-18-00657"><label>655.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Takagi</surname><given-names>M.</given-names></name><name><surname>Akao</surname><given-names>A.</given-names></name><name><surname>Kanematsu</surname><given-names>K.</given-names></name><name><surname>Kamei</surname><given-names>N.</given-names></name><name><surname>Okugawa</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Cytotoxicity and actin-depolymerizing activity of aplyronine A, a potent antitumor macrolide of marine origin, and its analogs</article-title><source>Tetrahedron</source><year>2002</year><volume>58</volume><fpage>1075</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)01206-6</pub-id></element-citation></ref><ref id="B656-marinedrugs-18-00657"><label>656.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Ishigaki</surname><given-names>T.</given-names></name><name><surname>Nisiwaki</surname><given-names>M.</given-names></name><name><surname>Tsukada</surname><given-names>I.</given-names></name><name><surname>Arakawa</surname><given-names>M.</given-names></name><name><surname>Ekimoto</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aplyronine A, a potent antitumor macrolide of marine origin, and the congeners aplyronines B and C: Isolation, structures, and bioactivities</article-title><source>Tetrahedron</source><year>2007</year><volume>63</volume><fpage>3138</fpage><lpage>3167</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2007.02.011</pub-id></element-citation></ref><ref id="B657-marinedrugs-18-00657"><label>657.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name></person-group><article-title>Aplyronine A, a potent antitumour macrolide of marine origin, and the congeners aplyronines B-H: Chemistry and biology</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>27</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1039/B800263K</pub-id><pub-id pub-id-type="pmid">19374121</pub-id></element-citation></ref><ref id="B658-marinedrugs-18-00657"><label>658.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Marine natural products that interfere with multiple cytoskeletal protein interactions</article-title><source>Nat. Prod. Rep.</source><year>2015</year><volume>32</volume><fpage>534</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1039/C4NP00129J</pub-id><pub-id pub-id-type="pmid">25512265</pub-id></element-citation></ref><ref id="B659-marinedrugs-18-00657"><label>659.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>O.</given-names></name><name><surname>Morita</surname><given-names>M.</given-names></name><name><surname>Kitamura</surname><given-names>K.</given-names></name><name><surname>Teruya</surname><given-names>T.</given-names></name><name><surname>Yoneda</surname><given-names>K.</given-names></name><name><surname>Kita</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name></person-group><article-title>Apoptosis-inducing activity of the actin-depolymerizing agent aplyronine A and its side-chain derivatives</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2013</year><volume>23</volume><fpage>1467</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2012.12.052</pub-id><pub-id pub-id-type="pmid">23357626</pub-id></element-citation></ref><ref id="B660-marinedrugs-18-00657"><label>660.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname><given-names>K.</given-names></name><name><surname>Muraoka</surname><given-names>S.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Kuroda</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Takata</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Structure basis for antitumor effect of aplyronine A</article-title><source>J. Mol. Biol.</source><year>2006</year><volume>356</volume><fpage>945</fpage><lpage>954</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2005.12.031</pub-id><?supplied-pmid 16406066?><pub-id pub-id-type="pmid">16406066</pub-id></element-citation></ref><ref id="B661-marinedrugs-18-00657"><label>661.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>M.</given-names></name><name><surname>Hirayama</surname><given-names>Y.</given-names></name><name><surname>Sugiyama</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Development of highly cytotoxic and actin-depolymerizing biotin derivatives of aplyronine A</article-title><source>Angew. Chem. Int. Ed.</source><year>2011</year><volume>50</volume><fpage>9871</fpage><lpage>9874</lpage><pub-id pub-id-type="doi">10.1002/anie.201103802</pub-id><?supplied-pmid 21954061?><pub-id pub-id-type="pmid">21954061</pub-id></element-citation></ref><ref id="B662-marinedrugs-18-00657"><label>662.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>M.</given-names></name><name><surname>Hirayama</surname><given-names>Y.</given-names></name><name><surname>Yoneda</surname><given-names>K.</given-names></name><name><surname>Yamagishi</surname><given-names>K.</given-names></name><name><surname>Chinen</surname><given-names>T.</given-names></name><name><surname>Usui</surname><given-names>T.</given-names></name><name><surname>Sumiya</surname><given-names>E.</given-names></name><name><surname>Uesugi</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Inhibition of microtubule assembly by a complex of actin and antitumor macrolide aplyronine A</article-title><source>J. Am. Chem. Soc.</source><year>2013</year><volume>135</volume><fpage>18089</fpage><lpage>18095</lpage><pub-id pub-id-type="doi">10.1021/ja406580w</pub-id><?supplied-pmid 24228690?><pub-id pub-id-type="pmid">24228690</pub-id></element-citation></ref><ref id="B663-marinedrugs-18-00657"><label>663.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>W.P.</given-names></name><name><surname>Noshi</surname><given-names>M.N.</given-names></name><name><surname>El-Awa</surname><given-names>A.</given-names></name><name><surname>Fuchs</surname><given-names>P.L.</given-names></name></person-group><article-title>Synthesis of the C1-C20 and C15-C27 segments of aplyronine A</article-title><source>Org. Lett.</source><year>2011</year><volume>13</volume><fpage>6342</fpage><lpage>6345</lpage><pub-id pub-id-type="doi">10.1021/ol2024746</pub-id><?supplied-pmid 22107608?><pub-id pub-id-type="pmid">22107608</pub-id></element-citation></ref><ref id="B664-marinedrugs-18-00657"><label>664.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>I.</given-names></name><name><surname>Fink</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>L.Y.</given-names></name><name><surname>Atkinson</surname><given-names>S.J.</given-names></name><name><surname>Blakey</surname><given-names>S.B.</given-names></name></person-group><article-title>Total synthesis of aplyronine C</article-title><source>Org. Lett.</source><year>2013</year><volume>15</volume><fpage>3118</fpage><lpage>3121</lpage><pub-id pub-id-type="doi">10.1021/ol401327r</pub-id><pub-id pub-id-type="pmid">23730909</pub-id></element-citation></ref><ref id="B665-marinedrugs-18-00657"><label>665.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An&#x0017e;i&#x0010d;ek</surname><given-names>N.</given-names></name><name><surname>Williams</surname><given-names>S.</given-names></name><name><surname>Housden</surname><given-names>M.P.</given-names></name><name><surname>Paterson</surname><given-names>I.</given-names></name></person-group><article-title>Toward aplyronine payloads for antibody-drug conjugates: Total synthesis of aplyronines A and D</article-title><source>Org. Biomol. Chem.</source><year>2018</year><volume>16</volume><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1039/C7OB03204H</pub-id><pub-id pub-id-type="pmid">29393939</pub-id></element-citation></ref><ref id="B666-marinedrugs-18-00657"><label>666.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Current status of marine-derived compounds as warheads in anti-tumor drug candidates</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>99</elocation-id><pub-id pub-id-type="doi">10.3390/md15040099</pub-id></element-citation></ref><ref id="B667-marinedrugs-18-00657"><label>667.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Imamura</surname><given-names>Y.</given-names></name><name><surname>Yoshikawa</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Three new cytotoxic alkaloids, aplaminone, neoaplaminone and neoaplaminone sulfate from the marine mollusc <italic>Aplysia kurodai</italic></article-title><source>Tetrahedron Lett.</source><year>1990</year><volume>31</volume><fpage>4911</fpage><lpage>4914</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)97766-9</pub-id></element-citation></ref><ref id="B668-marinedrugs-18-00657"><label>668.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusumi</surname><given-names>T.</given-names></name><name><surname>Uchida</surname><given-names>H.</given-names></name><name><surname>Inouye</surname><given-names>Y.</given-names></name><name><surname>Ishitsuka</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Kakisawa</surname><given-names>H.</given-names></name></person-group><article-title>Novel cytotoxic monoterpenes having a halogenated tetrahydropyran from <italic>Aplysia kurodai</italic></article-title><source>J. Org. Chem.</source><year>1987</year><volume>52</volume><fpage>4597</fpage><lpage>4600</lpage><pub-id pub-id-type="doi">10.1021/jo00229a029</pub-id></element-citation></ref><ref id="B669-marinedrugs-18-00657"><label>669.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Marubayashi</surname><given-names>N.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name></person-group><article-title>Two new polyhalogenated monoterpenes from the sea hare <italic>Aplysia kurodai</italic></article-title><source>Liebigs Ann. Chem.</source><year>1988</year><volume>12</volume><fpage>1191</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1002/jlac.198819881215</pub-id></element-citation></ref><ref id="B670-marinedrugs-18-00657"><label>670.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>A.</given-names></name><name><surname>Ina</surname><given-names>K.</given-names></name><name><surname>Nozaki</surname><given-names>H.</given-names></name><name><surname>Nakayama</surname><given-names>M.</given-names></name></person-group><article-title>Structural elucidation of kurodainol, a novel halogenated monoterpene from sea hare (<italic>Aplysia kurodai</italic>)</article-title><source>Agr. Biol. Chem.</source><year>1982</year><volume>46</volume><fpage>859</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1080/00021369.1982.10865164</pub-id></element-citation></ref><ref id="B671-marinedrugs-18-00657"><label>671.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamura</surname><given-names>S.</given-names></name><name><surname>Hirata</surname><given-names>Y.</given-names></name></person-group><article-title>A naturally-occurring bromo-compound, aplysin-20 from <italic>Aplysia kurodai</italic></article-title><source>Bull. Chem. Soc. Jpn.</source><year>1971</year><volume>44</volume><fpage>2560</fpage><lpage>2562</lpage><pub-id pub-id-type="doi">10.1246/bcsj.44.2560</pub-id></element-citation></ref><ref id="B672-marinedrugs-18-00657"><label>672.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamura</surname><given-names>S.</given-names></name><name><surname>Terada</surname><given-names>Y.</given-names></name></person-group><article-title>Isoaplysin-20, a natural bromine-containing diterpene, from <italic>Aplysia kurodai</italic></article-title><source>Tetrahedron Lett.</source><year>1977</year><volume>25</volume><fpage>2171</fpage><lpage>2172</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)83710-2</pub-id></element-citation></ref><ref id="B673-marinedrugs-18-00657"><label>673.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Okumura</surname><given-names>M.</given-names></name><name><surname>Ieda</surname><given-names>S.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aplysiadiol, a new brominated diterpene from the marine mollusc <italic>Aplysia kurodai</italic></article-title><source>J. Nat. Prod.</source><year>1990</year><volume>53</volume><fpage>1619</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1021/np50072a042</pub-id></element-citation></ref><ref id="B674-marinedrugs-18-00657"><label>674.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yoshikawa</surname><given-names>K.</given-names></name><name><surname>Nakayama</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>A new bromo diterpene, epi-aplysin-20, and ent-isoconcinndiol from the marine mollusc <italic>Aplysia kurodai</italic></article-title><source>Bull. Chem. Soc. Jpn.</source><year>1992</year><volume>65</volume><fpage>2300</fpage><lpage>2302</lpage><pub-id pub-id-type="doi">10.1246/bcsj.65.2300</pub-id></element-citation></ref><ref id="B675-marinedrugs-18-00657"><label>675.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Nakayama</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aplydilactone, a novel fatty acid metabolite from the marine mollusc <italic>Aplysia kurodai</italic></article-title><source>Tetrahedron Lett.</source><year>1990</year><volume>31</volume><fpage>4907</fpage><lpage>4910</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)97765-7</pub-id></element-citation></ref><ref id="B676-marinedrugs-18-00657"><label>676.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aplysepine, a novel 1,4-benzodiazepine alkaloid from the sea hare <italic>Aplysia kurodai</italic></article-title><source>Tetrahedron Lett.</source><year>1993</year><volume>34</volume><fpage>5307</fpage><lpage>5308</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)73981-5</pub-id></element-citation></ref><ref id="B677-marinedrugs-18-00657"><label>677.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>R.</given-names></name><name><surname>Kisugi</surname><given-names>J.</given-names></name><name><surname>Yamazaki</surname><given-names>M.</given-names></name></person-group><article-title>Antifungal activity of aplysianin E, a cytotoxic protein of sea hare (<italic>Aplysia kurodai</italic>) eggs</article-title><source>Dev. Comp. Immunol.</source><year>1995</year><volume>19</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">7615134</pub-id></element-citation></ref><ref id="B678-marinedrugs-18-00657"><label>678.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>R.</given-names></name><name><surname>Kisugi</surname><given-names>J.</given-names></name><name><surname>Yamazaki</surname><given-names>M.</given-names></name></person-group><article-title>A novel antimicrobial peptide from the sea hare <italic>Dolabella auricularia</italic></article-title><source>Dev. Comp. Immunol.</source><year>2003</year><volume>27</volume><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/S0145-305X(02)00105-2</pub-id><pub-id pub-id-type="pmid">12590964</pub-id></element-citation></ref><ref id="B679-marinedrugs-18-00657"><label>679.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaviarasan</surname><given-names>T.</given-names></name><name><surname>Siva</surname><given-names>S.R.</given-names></name><name><surname>Yogamoorthi</surname><given-names>A.</given-names></name></person-group><article-title>Antimicrobial secondary metabolites from marine gastropod egg capsules and egg masses</article-title><source>Asian Pac. J. Trop Biomed.</source><year>2012</year><volume>2</volume><fpage>916</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60253-6</pub-id><pub-id pub-id-type="pmid">23569871</pub-id></element-citation></ref><ref id="B680-marinedrugs-18-00657"><label>680.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamura</surname><given-names>S.</given-names></name><name><surname>Hirata</surname><given-names>Y.</given-names></name></person-group><article-title>Structures of aplysin and aplysinol, naturally occurring bromo-compounds</article-title><source>Tetrahedron</source><year>1963</year><volume>19</volume><fpage>1485</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)99222-1</pub-id></element-citation></ref><ref id="B681-marinedrugs-18-00657"><label>681.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>G.S.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Choi</surname><given-names>B.W.</given-names></name><name><surname>Lee</surname><given-names>N.H.</given-names></name><name><surname>Hwang</surname><given-names>H.J.</given-names></name><name><surname>Ryu</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>B.H.</given-names></name></person-group><article-title>Cytotoxic activities of brominated sesquiterpenes from the red alga <italic>Laurencia okamurae</italic></article-title><source>Nat. Prod. Sci.</source><year>2002</year><volume>8</volume><fpage>103</fpage><lpage>107</lpage></element-citation></ref><ref id="B682-marinedrugs-18-00657"><label>682.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name></person-group><article-title>Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>5072</fpage><lpage>5088</lpage><pub-id pub-id-type="doi">10.3390/md12095072</pub-id><?supplied-pmid 25257790?><pub-id pub-id-type="pmid">25257790</pub-id></element-citation></ref><ref id="B683-marinedrugs-18-00657"><label>683.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>A.J.</given-names></name><name><surname>Gong</surname><given-names>L.L.</given-names></name><name><surname>Yao</surname><given-names>W.C.</given-names></name><name><surname>Ge</surname><given-names>N.</given-names></name><name><surname>Lu</surname><given-names>L.X.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name></person-group><article-title>Aplysin induces apoptosis in glioma cells through HSP90/AKT pathway</article-title><source>Exp. Biol. Med.</source><year>2015</year><volume>240</volume><fpage>639</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1177/1535370214555664</pub-id></element-citation></ref><ref id="B684-marinedrugs-18-00657"><label>684.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegazy</surname><given-names>M.E.F.</given-names></name><name><surname>Moustfa</surname><given-names>A.Y.</given-names></name><name><surname>Mohamed</surname><given-names>A.E.H.H.</given-names></name><name><surname>Alhammady</surname><given-names>M.A.</given-names></name><name><surname>Elbehairi</surname><given-names>S.E.I.</given-names></name><name><surname>Ohta</surname><given-names>S.</given-names></name><name><surname>Par&#x000e9;</surname><given-names>P.W.</given-names></name></person-group><article-title>New cytotoxic halogenated sesquiterpenes from the Egyptian sea hare, Aplysia oculifera</article-title><source>Tetrahedron Lett.</source><year>2014</year><volume>55</volume><fpage>1711</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2014.01.096</pub-id></element-citation></ref><ref id="B685-marinedrugs-18-00657"><label>685.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>M.J.</given-names></name><name><surname>Zub&#x000ed;a</surname><given-names>E.</given-names></name><name><surname>Salv&#x000e1;</surname><given-names>J.</given-names></name></person-group><article-title>New polyhalogenated monoterpenes from the sea hare <italic>Aplysia punctata</italic></article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>482</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1021/np960744j</pub-id><pub-id pub-id-type="pmid">9213585</pub-id></element-citation></ref><ref id="B686-marinedrugs-18-00657"><label>686.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennings</surname><given-names>S.C.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Dunbar</surname><given-names>D.C.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Lumbang</surname><given-names>W.</given-names></name><name><surname>Novack</surname><given-names>B.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name></person-group><article-title>Unpalatable compounds in the marine gastropod <italic>Dolabella auricularia</italic>: Distribution and effect of diet</article-title><source>J. Chem. Ecol.</source><year>1999</year><volume>25</volume><fpage>735</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1023/A:1020832414766</pub-id></element-citation></ref><ref id="B687-marinedrugs-18-00657"><label>687.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Shibata</surname><given-names>T.</given-names></name><name><surname>Takada</surname><given-names>N.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aurilol, a cytotoxic bromotriterpene isolated from the sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>515</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1021/np970514k</pub-id></element-citation></ref><ref id="B688-marinedrugs-18-00657"><label>688.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>H.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Aurisides A and B, cytotoxic macrolide glycosides from the Japanese sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Org. Chem.</source><year>1996</year><volume>61</volume><fpage>8956</fpage><lpage>8960</lpage><pub-id pub-id-type="doi">10.1021/jo961302f</pub-id><pub-id pub-id-type="pmid">11667877</pub-id></element-citation></ref><ref id="B689-marinedrugs-18-00657"><label>689.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>I.</given-names></name><name><surname>Florence</surname><given-names>G.J.</given-names></name><name><surname>Heimann</surname><given-names>A.C.</given-names></name><name><surname>Mackay</surname><given-names>A.C.</given-names></name></person-group><article-title>Stereocontrolled total synthesis of (&#x02212;)-aurisides A and B</article-title><source>Angew. Chem. Int. Ed.</source><year>2005</year><volume>44</volume><fpage>1130</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1002/anie.200462267</pub-id></element-citation></ref><ref id="B690-marinedrugs-18-00657"><label>690.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tello-Aburto</surname><given-names>R.</given-names></name><name><surname>Olivo</surname><given-names>H.F.</given-names></name></person-group><article-title>A formal synthesis of the auriside aglycon</article-title><source>Organic Lett.</source><year>2008</year><volume>10</volume><fpage>2191</fpage><lpage>2194</lpage><pub-id pub-id-type="doi">10.1021/ol8005908</pub-id><?supplied-pmid 18461949?><pub-id pub-id-type="pmid">18461949</pub-id></element-citation></ref><ref id="B691-marinedrugs-18-00657"><label>691.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Nemoto</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Doliculols A and B, the non-halogenated C15 acetogenins with cyclic ether from the sea hare <italic>Dolabella auricularia</italic></article-title><source>Tetrahedron Lett</source><year>1993</year><volume>34</volume><fpage>3461</fpage><lpage>3462</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)79183-0</pub-id></element-citation></ref><ref id="B692-marinedrugs-18-00657"><label>692.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Nagoya</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Dolabelides A and B, cytotoxic 22-membered macrolides isolated from the sea hare <italic>Dolabella auricularia</italic></article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>7491</fpage><lpage>7494</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)01605-8</pub-id></element-citation></ref><ref id="B693-marinedrugs-18-00657"><label>693.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Nagoya</surname><given-names>T.</given-names></name><name><surname>Shibata</surname><given-names>T.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Dolabelides C and D, cytotoxic macrolides isolated from the sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1021/np960612q</pub-id></element-citation></ref><ref id="B694-marinedrugs-18-00657"><label>694.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name></person-group><article-title>Cytotoxic substances from two species of Japanese sea hares: Chemistry and bioactivity</article-title><source>Proc. Japan Acad. Ser. B Phys. Biol. Sci.</source><year>2010</year><volume>86</volume><fpage>176</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.2183/pjab.86.176</pub-id></element-citation></ref><ref id="B695-marinedrugs-18-00657"><label>695.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>H.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name><name><surname>Kiryu</surname><given-names>M.</given-names></name><name><surname>Ishiwata</surname><given-names>H.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Dolabellin, a cytotoxic bisthiazole metabolite from the sea hare <italic>Dolabella auricularia</italic>: Structural determination and synthesis</article-title><source>J. Org. Chem.</source><year>1995</year><volume>60</volume><fpage>4774</fpage><lpage>4781</lpage><pub-id pub-id-type="doi">10.1021/jo00120a021</pub-id></element-citation></ref><ref id="B696-marinedrugs-18-00657"><label>696.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Auripyrones A and B, cytotoxic polypropionates from the sea hare <italic>Dolabella auricularia</italic>: Isolation and structures</article-title><source>Tetrahedron Lett.</source><year>1996</year><volume>37</volume><fpage>5151</fpage><lpage>5154</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(96)01041-6</pub-id></element-citation></ref><ref id="B697-marinedrugs-18-00657"><label>697.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lister</surname><given-names>T.</given-names></name><name><surname>Perkins</surname><given-names>M.V.</given-names></name></person-group><article-title>Total synthesis of auripyrone A. Angew</article-title><source>Chem. Int. Ed.</source><year>2006</year><volume>45</volume><fpage>2560</fpage><lpage>2564</lpage><pub-id pub-id-type="doi">10.1002/anie.200504573</pub-id></element-citation></ref><ref id="B698-marinedrugs-18-00657"><label>698.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>M.E.</given-names></name><name><surname>Chaumontet</surname><given-names>M.</given-names></name><name><surname>Salehi-Rad</surname><given-names>R.</given-names></name></person-group><article-title>Total synthesis of auripyrone B using a non-aldol aldolcuprate opening process</article-title><source>Org. Lett.</source><year>2010</year><volume>12</volume><fpage>2872</fpage><lpage>2875</lpage><pub-id pub-id-type="doi">10.1021/ol100985n</pub-id><pub-id pub-id-type="pmid">20499854</pub-id></element-citation></ref><ref id="B699-marinedrugs-18-00657"><label>699.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>M.E.</given-names></name><name><surname>Salehi-Rad</surname><given-names>R.</given-names></name></person-group><article-title>Total synthesis of auripyrone A using a tandem non-aldol aldol/Paterson aldol process as a key step</article-title><source>Angew. Chem. Int. Ed.</source><year>2009</year><volume>48</volume><fpage>8766</fpage><lpage>8769</lpage><pub-id pub-id-type="doi">10.1002/anie.200904607</pub-id></element-citation></ref><ref id="B700-marinedrugs-18-00657"><label>700.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>I.</given-names></name><name><surname>Takemura</surname><given-names>T.</given-names></name><name><surname>Fukasawa</surname><given-names>E.</given-names></name><name><surname>Ebihara</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>N.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Total synthesis of auripyrones A and B and determination of the absolute configuration of auripyrone B</article-title><source>Angew. Chem. Int. Ed.</source><year>2010</year><volume>49</volume><fpage>2401</fpage><lpage>2405</lpage><pub-id pub-id-type="doi">10.1002/anie.200906662</pub-id><?supplied-pmid 20186896?><pub-id pub-id-type="pmid">20186896</pub-id></element-citation></ref><ref id="B701-marinedrugs-18-00657"><label>701.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>P.K.</given-names></name><name><surname>O&#x02019;Malley</surname><given-names>S.J.</given-names></name><name><surname>Schmidt</surname><given-names>D.R.</given-names></name><name><surname>Leighton</surname><given-names>J.L.</given-names></name></person-group><article-title>Total synthesis of dolabelide D</article-title><source>J. Am. Chem. Soc.</source><year>2006</year><volume>128</volume><fpage>2796</fpage><lpage>2797</lpage><pub-id pub-id-type="doi">10.1021/ja058692k</pub-id><?supplied-pmid 16506747?><pub-id pub-id-type="pmid">16506747</pub-id></element-citation></ref><ref id="B702-marinedrugs-18-00657"><label>702.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>P.R.</given-names></name><name><surname>Chegondi</surname><given-names>R.</given-names></name><name><surname>Nguyen</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>C.D.</given-names></name><name><surname>Waetzig</surname><given-names>J.D.</given-names></name><name><surname>Whitehead</surname><given-names>A.</given-names></name></person-group><article-title>Total synthesis of dolabelide C: A phosphate-mediated approach</article-title><source>J. Org. Chem.</source><year>2011</year><volume>76</volume><fpage>4358</fpage><lpage>4370</lpage><pub-id pub-id-type="doi">10.1021/jo2003506</pub-id><?supplied-pmid 21528846?><pub-id pub-id-type="pmid">21528846</pub-id></element-citation></ref><ref id="B703-marinedrugs-18-00657"><label>703.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Mutou</surname><given-names>T.</given-names></name><name><surname>Shibata</surname><given-names>T.</given-names></name><name><surname>Itoh</surname><given-names>T.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Isolation and stereostructure of aurilide, a novel cyclodepsipeptide from the Japanese sea hare <italic>Dolabella auricularia</italic></article-title><source>Tetrahedron Lett.</source><year>1996</year><volume>37</volume><fpage>6771</fpage><lpage>6774</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(96)01464-5</pub-id></element-citation></ref><ref id="B704-marinedrugs-18-00657"><label>704.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>B.</given-names></name><name><surname>Gross</surname><given-names>H.</given-names></name><name><surname>Goeger</surname><given-names>D.E.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium <italic>Lyngbya majuscula</italic></article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>572</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1021/np0503911</pub-id><pub-id pub-id-type="pmid">16643028</pub-id></element-citation></ref><ref id="B705-marinedrugs-18-00657"><label>705.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Mutou</surname><given-names>T.</given-names></name><name><surname>Shibata</surname><given-names>T.</given-names></name><name><surname>Itoh</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Takada</surname><given-names>N.</given-names></name><name><surname>Hayamizu</surname><given-names>K.</given-names></name><name><surname>Takagi</surname><given-names>M.</given-names></name><name><surname>Irifune</surname><given-names>T.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Aurilide, a cytotoxic depsipeptide from the sea hare <italic>Dolabella auricularia</italic>: Isolation, structure determination, synthesis, and biological activity</article-title><source>Tetrahedron</source><year>2004</year><volume>60</volume><fpage>8509</fpage><lpage>8527</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2004.06.125</pub-id></element-citation></ref><ref id="B706-marinedrugs-18-00657"><label>706.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollingshead</surname><given-names>M.G.</given-names></name><name><surname>Alley</surname><given-names>M.C.</given-names></name><name><surname>Camalier</surname><given-names>R.F.</given-names></name><name><surname>Abbott</surname><given-names>B.J.</given-names></name><name><surname>Mayo</surname><given-names>J.G.</given-names></name><name><surname>Malspeis</surname><given-names>L.</given-names></name><name><surname>Grever</surname><given-names>M.R.</given-names></name></person-group><article-title>In vivo cultivation of tumor cells in hollow fibers</article-title><source>Life Sci.</source><year>1995</year><volume>57</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(95)00254-4</pub-id><pub-id pub-id-type="pmid">7603295</pub-id></element-citation></ref><ref id="B707-marinedrugs-18-00657"><label>707.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>S.I.</given-names></name><name><surname>Murata</surname><given-names>A.</given-names></name><name><surname>Orihara</surname><given-names>T.</given-names></name><name><surname>Shirakawa</surname><given-names>T.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Uesugi</surname><given-names>M.</given-names></name></person-group><article-title>Marine natural product aurilide activates the OPA1-mediated apoptosis by binding to prohibitin</article-title><source>Chem. Biol.</source><year>2011</year><volume>18</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2010.10.017</pub-id><pub-id pub-id-type="pmid">21276946</pub-id></element-citation></ref><ref id="B708-marinedrugs-18-00657"><label>708.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiwata</surname><given-names>H.</given-names></name><name><surname>Nemoto</surname><given-names>T.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Isolation and stereostructure of doliculide, a cytotoxic cyclodepsipeptide from the Japanese sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Org. Chem.</source><year>1994</year><volume>59</volume><fpage>4710</fpage><lpage>4711</lpage><pub-id pub-id-type="doi">10.1021/jo00096a002</pub-id></element-citation></ref><ref id="B709-marinedrugs-18-00657"><label>709.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R.</given-names></name><name><surname>Covell</surname><given-names>D.G.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Ghosh</surname><given-names>A.K.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>(&#x02212;)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>32165</fpage><lpage>32171</lpage><pub-id pub-id-type="doi">10.1074/jbc.M205076200</pub-id><pub-id pub-id-type="pmid">12077149</pub-id></element-citation></ref><ref id="B710-marinedrugs-18-00657"><label>710.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiwata</surname><given-names>H.</given-names></name><name><surname>Sone</surname><given-names>H.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Enantioselective total synthesis of doliculide, a potent cytotoxic cyclodepsipeptide of marine origin and structure-cytotoxicity relationships of synthetic doliculide congeners</article-title><source>Tetrahedron</source><year>1994</year><volume>50</volume><fpage>12853</fpage><lpage>12882</lpage><pub-id pub-id-type="doi">10.1002/chin.199515248</pub-id></element-citation></ref><ref id="B711-marinedrugs-18-00657"><label>711.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A.K.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name></person-group><article-title>Total synthesis of antitumor depsipeptide (-)-doliculide</article-title><source>Org. Lett.</source><year>2001</year><volume>3</volume><fpage>635</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1021/ol0100069</pub-id><?supplied-pmid 11178844?><pub-id pub-id-type="pmid">11178844</pub-id></element-citation></ref><ref id="B712-marinedrugs-18-00657"><label>712.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matcha</surname><given-names>K.</given-names></name><name><surname>Madduri</surname><given-names>A.V.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Ziegler</surname><given-names>S.</given-names></name><name><surname>Waldmann</surname><given-names>H.</given-names></name><name><surname>Hirsch</surname><given-names>A.K.</given-names></name><name><surname>Minnaard</surname><given-names>A.J.</given-names></name></person-group><article-title>Total synthesis of (&#x02212;)-Doliculide, structure-activity relationship studies and its binding to F-actin</article-title><source>Chem. Bio. Chem.</source><year>2012</year><volume>13</volume><fpage>2537</fpage><lpage>2548</lpage><pub-id pub-id-type="doi">10.1002/cbic.201200512</pub-id><?supplied-pmid 23129522?><pub-id pub-id-type="pmid">23129522</pub-id></element-citation></ref><ref id="B713-marinedrugs-18-00657"><label>713.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foerster</surname><given-names>F.</given-names></name><name><surname>Braig</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Altmann</surname><given-names>K.H.</given-names></name><name><surname>Vollmar</surname><given-names>A.M.</given-names></name></person-group><article-title>Pharmacological characterization of actin-binding (&#x02212;)-Doliculide</article-title><source>Bioorg. Med. Chem.</source><year>2014</year><volume>22</volume><fpage>5117</fpage><lpage>5122</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2014.03.003</pub-id><?supplied-pmid 24679674?><pub-id pub-id-type="pmid">24679674</pub-id></element-citation></ref><ref id="B714-marinedrugs-18-00657"><label>714.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrigan</surname><given-names>G.G.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Corbett</surname><given-names>T.H.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name></person-group><article-title>Symplostatin 1: A Dolastatin 10 analogue from the marine cyanobacterium <italic>Symploca hydnoides</italic></article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>1075</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1021/np980321c</pub-id><pub-id pub-id-type="pmid">9748368</pub-id></element-citation></ref><ref id="B715-marinedrugs-18-00657"><label>715.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luesch</surname><given-names>H.</given-names></name><name><surname>Harrigan</surname><given-names>G.G.</given-names></name><name><surname>Goetz</surname><given-names>G.</given-names></name><name><surname>Horgen</surname><given-names>F.D.</given-names></name></person-group><article-title>The cyanobacterial origin of potent anticancer agents originally isolated from sea hares</article-title><source>Curr. Med. Chem.</source><year>2002</year><volume>9</volume><fpage>1791</fpage><lpage>1806</lpage><pub-id pub-id-type="doi">10.2174/0929867023369051</pub-id><pub-id pub-id-type="pmid">12369878</pub-id></element-citation></ref><ref id="B716-marinedrugs-18-00657"><label>716.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engene</surname><given-names>N.</given-names></name><name><surname>Tronholm</surname><given-names>A.</given-names></name><name><surname>Salvador-Reyes</surname><given-names>L.A.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title><italic>Caldora penicillata</italic> gen. nov., comb. nov. (Cyanobacteria), a pantropical marine species with biomedical relevance</article-title><source>J. Phycol.</source><year>2015</year><volume>51</volume><fpage>670</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1111/jpy.12309</pub-id><pub-id pub-id-type="pmid">26327714</pub-id></element-citation></ref><ref id="B717-marinedrugs-18-00657"><label>717.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maderna</surname><given-names>A.</given-names></name><name><surname>Leverett</surname><given-names>C.A.</given-names></name></person-group><article-title>Recent advances in the development of new auristatins: Structural modifications and application in antibody drug conjugates</article-title><source>Mol. Pharm.</source><year>2015</year><volume>12</volume><fpage>1798</fpage><lpage>1812</lpage><pub-id pub-id-type="doi">10.1021/mp500762u</pub-id><pub-id pub-id-type="pmid">25697404</pub-id></element-citation></ref><ref id="B718-marinedrugs-18-00657"><label>718.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Brown</surname><given-names>P.</given-names></name><name><surname>Gust</surname><given-names>D.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name></person-group><article-title>Structure of the cyclic peptide dolastatin 3 from <italic>Dolabella auricularia</italic></article-title><source>J. Am. Chem. Soc.</source><year>1982</year><volume>104</volume><fpage>905</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1021/ja00367a067</pub-id></element-citation></ref><ref id="B719-marinedrugs-18-00657"><label>719.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Fujii</surname><given-names>Y.</given-names></name><name><surname>Kizu</surname><given-names>H.</given-names></name><name><surname>Boyd</surname><given-names>M.R.</given-names></name><name><surname>Boettner</surname><given-names>F.E.</given-names></name><name><surname>Doubek</surname><given-names>D.L.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Chapuis</surname><given-names>J.-C.</given-names></name><etal/></person-group><article-title>Isolation of dolastatins 10-15 from the marine mollusc <italic>Dolabella auricularia</italic></article-title><source>Tetrahedron</source><year>1993</year><volume>49</volume><fpage>9151</fpage><lpage>9170</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(93)80003-C</pub-id></element-citation></ref><ref id="B720-marinedrugs-18-00657"><label>720.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Kigoshi</surname><given-names>H.</given-names></name></person-group><article-title>Bioactive compounds from the sea hares of two genera: <italic>Aplysia</italic> and <italic>Dolabella</italic></article-title><source>Bull. Chem. Soc. Jpn.</source><year>1997</year><volume>70</volume><fpage>1479</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1246/bcsj.70.1479</pub-id></element-citation></ref><ref id="B721-marinedrugs-18-00657"><label>721.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>H.</given-names></name><name><surname>Nemoto</surname><given-names>T.</given-names></name><name><surname>Ishiwata</surname><given-names>H.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Isolation, structure, and synthesis of dolastatin D, a cytotoxic cyclic depsipeptide from the sea hare <italic>Dolabella auricularia</italic></article-title><source>Tetrahedron Lett.</source><year>1993</year><volume>34</volume><fpage>8449</fpage><lpage>8452</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)61356-4</pub-id></element-citation></ref><ref id="B722-marinedrugs-18-00657"><label>722.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>H.</given-names></name><name><surname>Nemoto</surname><given-names>T.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Isolation, structure, and synthesis of dolastatin C, a cytotoxic cyclic depsipeptide from the sea hare <italic>Dolabella auricularia</italic></article-title><source>Tetrahedron Lett.</source><year>1993</year><volume>34</volume><fpage>8445</fpage><lpage>8448</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)61355-2</pub-id></element-citation></ref><ref id="B723-marinedrugs-18-00657"><label>723.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>H.</given-names></name><name><surname>Shibata</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Dolastatin H and isodolastatin H, potent cytotoxic peptides from the sea hare <italic>Dolabella auricularia</italic>: Isolation, stereostructures, and synthesis</article-title><source>J. Am. Chem. Soc.</source><year>1996</year><volume>118</volume><fpage>1874</fpage><lpage>1880</lpage><pub-id pub-id-type="doi">10.1021/ja9519086</pub-id></element-citation></ref><ref id="B724-marinedrugs-18-00657"><label>724.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutou</surname><given-names>T.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name><name><surname>Ojika</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Isolation and stereostructures of dolastatin G and nordolastatin G, cytotoxic 35-membered cyclodepsipeptides from the Japanese sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Org. Chem.</source><year>1996</year><volume>61</volume><fpage>6340</fpage><lpage>6345</lpage><pub-id pub-id-type="doi">10.1021/jo9608228</pub-id><pub-id pub-id-type="pmid">11667475</pub-id></element-citation></ref><ref id="B725-marinedrugs-18-00657"><label>725.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luesch</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name></person-group><article-title>Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium <italic>Lyngbya majuscula</italic></article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>1702</fpage><lpage>1706</lpage><pub-id pub-id-type="doi">10.1021/np990310z</pub-id><pub-id pub-id-type="pmid">10654420</pub-id></element-citation></ref><ref id="B726-marinedrugs-18-00657"><label>726.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>The &#x0201c;utility&#x0201d; of highly toxic marine-sourced compounds</article-title><source>Mar. Drugs</source><year>2019</year><volume>17</volume><elocation-id>324</elocation-id><pub-id pub-id-type="doi">10.3390/md17060324</pub-id></element-citation></ref><ref id="B727-marinedrugs-18-00657"><label>727.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Holzapfel</surname><given-names>C.W.</given-names></name><name><surname>Van Zyl</surname><given-names>W.J.</given-names></name><name><surname>Tuinman</surname><given-names>A.A.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Baczynskyj</surname><given-names>L.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name></person-group><article-title>Antineoplastic agents. 150. The structure and synthesis of dolastatin 3</article-title><source>J. Am. Chem. Soc.</source><year>1987</year><volume>109</volume><fpage>7581</fpage><lpage>7582</lpage><pub-id pub-id-type="doi">10.1021/ja00258a081</pub-id></element-citation></ref><ref id="B728-marinedrugs-18-00657"><label>728.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>S.S.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Rubins</surname><given-names>K.</given-names></name><name><surname>Bushman</surname><given-names>F.D.</given-names></name></person-group><article-title>Dolastatin 3 and two novel cyclic peptides from a Palauan collection of <italic>Lyngbya majuscula</italic></article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1021/np990353f</pub-id><pub-id pub-id-type="pmid">10691729</pub-id></element-citation></ref><ref id="B729-marinedrugs-18-00657"><label>729.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Tuinman</surname><given-names>A.A.</given-names></name><name><surname>Boettner</surname><given-names>F.E.</given-names></name><name><surname>Kizu</surname><given-names>H.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Baczynskyj</surname><given-names>L.</given-names></name><name><surname>Tomer</surname><given-names>K.B.</given-names></name><name><surname>Bontems</surname><given-names>R.J.</given-names></name></person-group><article-title>The isolation and structure of a remarkable marine animal antineoplastic constituent: Dolastatin 10</article-title><source>J. Am. Chem. Soc.</source><year>1987</year><volume>109</volume><fpage>6883</fpage><lpage>6885</lpage><pub-id pub-id-type="doi">10.1021/ja00256a070</pub-id></element-citation></ref><ref id="B730-marinedrugs-18-00657"><label>730.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Singh</surname><given-names>S.B.</given-names></name><name><surname>Hogan</surname><given-names>F.</given-names></name><name><surname>Lloyd-Williams</surname><given-names>P.</given-names></name><name><surname>Herald</surname><given-names>D.L.</given-names></name><name><surname>Burkett</surname><given-names>D.D.</given-names></name><name><surname>Clewlow</surname><given-names>P.J.</given-names></name></person-group><article-title>The absolute configuration and synthesis of natural (-)-dolastatin 10</article-title><source>J. Am. Chem. Soc.</source><year>1989</year><volume>111</volume><fpage>5463</fpage><lpage>5466</lpage><pub-id pub-id-type="doi">10.1021/ja00196a061</pub-id></element-citation></ref><ref id="B731-marinedrugs-18-00657"><label>731.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Joshi</surname><given-names>P.</given-names></name><name><surname>Rawat</surname><given-names>D.S.</given-names></name></person-group><article-title>Clinical status of anti-cancer agents derived from marine sources</article-title><source>Anticancer Agents Med. Chem.</source><year>2008</year><volume>8</volume><fpage>603</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.2174/187152008785133074</pub-id><?supplied-pmid 18690825?><pub-id pub-id-type="pmid">18690825</pub-id></element-citation></ref><ref id="B732-marinedrugs-18-00657"><label>732.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poncet</surname><given-names>J.</given-names></name></person-group><article-title>The dolastatins, a family of promising antineoplastic agents</article-title><source>Cur. Pharm. Des.</source><year>1999</year><volume>5</volume><fpage>139</fpage><lpage>162</lpage></element-citation></ref><ref id="B733-marinedrugs-18-00657"><label>733.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain</article-title><source>Biochem. Pharmacol.</source><year>1990</year><volume>39</volume><fpage>1941</fpage><lpage>1949</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(90)90613-P</pub-id><pub-id pub-id-type="pmid">2353935</pub-id></element-citation></ref><ref id="B734-marinedrugs-18-00657"><label>734.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>S.</given-names></name><name><surname>Multani</surname><given-names>A.S.</given-names></name><name><surname>Ozen</surname><given-names>M.</given-names></name><name><surname>Richardson</surname><given-names>M.A.</given-names></name><name><surname>Newman</surname><given-names>R.A.</given-names></name></person-group><article-title>Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line</article-title><source>Oncol. Rep.</source><year>1998</year><volume>5</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.3892/or.5.2.373</pub-id><pub-id pub-id-type="pmid">9468560</pub-id></element-citation></ref><ref id="B735-marinedrugs-18-00657"><label>735.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Leal</surname><given-names>R.M.</given-names></name><name><surname>Tinley</surname><given-names>T.L.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name><name><surname>Corbett</surname><given-names>T.H.</given-names></name></person-group><article-title>The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog</article-title><source>Int. J. Cancer</source><year>2003</year><volume>104</volume><fpage>512</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/ijc.10982</pub-id><pub-id pub-id-type="pmid">12584751</pub-id></element-citation></ref><ref id="B736-marinedrugs-18-00657"><label>736.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalemkerian</surname><given-names>G.P.</given-names></name><name><surname>Ou</surname><given-names>X.</given-names></name><name><surname>Adil</surname><given-names>M.R.</given-names></name><name><surname>Rosati</surname><given-names>R.</given-names></name><name><surname>Khoulani</surname><given-names>M.M.</given-names></name><name><surname>Madan</surname><given-names>S.K.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name></person-group><article-title>Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: Induction of apoptosis and bcl-2 modification</article-title><source>Cancer Chemother. Pharmacol.</source><year>1999</year><volume>43</volume><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1007/s002800050931</pub-id><pub-id pub-id-type="pmid">10321512</pub-id></element-citation></ref><ref id="B737-marinedrugs-18-00657"><label>737.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>R.M.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Almatchy</surname><given-names>V.P.</given-names></name><name><surname>Wall</surname><given-names>N.</given-names></name><name><surname>Varterasian</surname><given-names>M.</given-names></name><name><surname>Al-Katib</surname><given-names>A.</given-names></name></person-group><article-title>Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma</article-title><source>Anticancer Drugs</source><year>1998</year><volume>9</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1097/00001813-199802000-00006</pub-id><pub-id pub-id-type="pmid">9510501</pub-id></element-citation></ref><ref id="B738-marinedrugs-18-00657"><label>738.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aherne</surname><given-names>G.W.</given-names></name><name><surname>Hardcastle</surname><given-names>A.</given-names></name><name><surname>Valenti</surname><given-names>M.</given-names></name><name><surname>Bryant</surname><given-names>A.</given-names></name><name><surname>Rogers</surname><given-names>P.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Srirangam</surname><given-names>J.K.</given-names></name><name><surname>Kelland</surname><given-names>L.R.</given-names></name></person-group><article-title>Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay</article-title><source>Cancer Chemother. Pharmacol.</source><year>1996</year><volume>38</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1007/s002800050475</pub-id><pub-id pub-id-type="pmid">8646796</pub-id></element-citation></ref><ref id="B739-marinedrugs-18-00657"><label>739.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>J.</given-names></name><name><surname>Natsume</surname><given-names>T.</given-names></name><name><surname>Fujio</surname><given-names>N.</given-names></name><name><surname>Miyasaka</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name></person-group><article-title>Induction of apoptosis in human cancer cells by TZT-1027, an antimicrotubule agent</article-title><source>Apoptosis</source><year>2000</year><volume>5</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1023/A:1009687609330</pub-id><pub-id pub-id-type="pmid">11227216</pub-id></element-citation></ref><ref id="B740-marinedrugs-18-00657"><label>740.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdier-Pinard</surname><given-names>P.</given-names></name><name><surname>Kepler</surname><given-names>J.A.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity</article-title><source>Mol. Pharmacol.</source><year>2000</year><volume>57</volume><fpage>180</fpage><lpage>187</lpage><?supplied-pmid 10617693?><pub-id pub-id-type="pmid">10617693</pub-id></element-citation></ref><ref id="B741-marinedrugs-18-00657"><label>741.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doronina</surname><given-names>S.O.</given-names></name><name><surname>Toki</surname><given-names>B.E.</given-names></name><name><surname>Torgov</surname><given-names>M.Y.</given-names></name><name><surname>Mendelsohn</surname><given-names>B.A.</given-names></name><name><surname>Cerveny</surname><given-names>C.G.</given-names></name><name><surname>Chace</surname><given-names>D.F.</given-names></name><name><surname>DeBlanc</surname><given-names>R.L.</given-names></name><name><surname>Gearing</surname><given-names>R.P.</given-names></name><name><surname>Bovee</surname><given-names>T.D.</given-names></name><name><surname>Siegall</surname><given-names>C.B.</given-names></name><etal/></person-group><article-title>Development of potent monoclonal antibody auristatin conjugates for cancer therapy</article-title><source>Nature Biotech.</source><year>2003</year><volume>21</volume><fpage>778</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1038/nbt832</pub-id><?supplied-pmid 12778055?><pub-id pub-id-type="pmid">12778055</pub-id></element-citation></ref><ref id="B742-marinedrugs-18-00657"><label>742.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinmetz</surname><given-names>M.O.</given-names></name><name><surname>Prota</surname><given-names>A.E.</given-names></name></person-group><article-title>Microtubule-targeting agents: Strategies to hijack the cytoskeleton</article-title><source>Trends Cell Biol.</source><year>2018</year><volume>28</volume><fpage>776</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2018.05.001</pub-id><?supplied-pmid 29871823?><pub-id pub-id-type="pmid">29871823</pub-id></element-citation></ref><ref id="B743-marinedrugs-18-00657"><label>743.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>M.P.</given-names></name><name><surname>Maaheimo</surname><given-names>H.</given-names></name><name><surname>Ekholm</surname><given-names>F.S.</given-names></name></person-group><article-title>New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/s41598-017-15674-1</pub-id><?supplied-pmid 29162861?><pub-id pub-id-type="pmid">28127051</pub-id></element-citation></ref><ref id="B744-marinedrugs-18-00657"><label>744.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Flahive</surname><given-names>E.</given-names></name><name><surname>Srirangam</surname><given-names>J.</given-names></name></person-group><article-title>The Dolastatins</article-title><source>Anticancer Agents from Natural Products</source><edition>2nd ed.</edition><person-group person-group-type="editor"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Kingston</surname><given-names>D.G.I.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><publisher-name>Taylor and Francis</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2011</year><fpage>263</fpage><lpage>290</lpage></element-citation></ref><ref id="B745-marinedrugs-18-00657"><label>745.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvador-Reyes</surname><given-names>L.A.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Biological targets and mechanisms of action of natural products from marine cyanobacteria</article-title><source>Nat. Prod. Rep.</source><year>2015</year><volume>32</volume><fpage>478</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1039/C4NP00104D</pub-id><?supplied-pmid 25571978?><pub-id pub-id-type="pmid">25571978</pub-id></element-citation></ref><ref id="B746-marinedrugs-18-00657"><label>746.</label><element-citation publication-type="patent"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Barkoczy</surname><given-names>J.</given-names></name><name><surname>Kantoci</surname><given-names>D.</given-names></name></person-group><article-title>Human Cancer Inhibitory Pentapeptide Amides</article-title><source>US Patent</source><patent>5410024</patent><day>25</day><month>4</month><year>1995</year></element-citation></ref><ref id="B747-marinedrugs-18-00657"><label>747.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>J.</given-names></name><name><surname>Minami</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name></person-group><article-title>Antitumor activity of TZT-1027 (Soblidotin)</article-title><source>Anticancer Res.</source><year>2006</year><volume>26</volume><fpage>1973</fpage><lpage>1981</lpage><pub-id pub-id-type="pmid">16827132</pub-id></element-citation></ref><ref id="B748-marinedrugs-18-00657"><label>748.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natsume</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>J.</given-names></name><name><surname>Ogawa</surname><given-names>K.</given-names></name><name><surname>Yasumura</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name></person-group><article-title>Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy</article-title><source>Cancer Sci.</source><year>2007</year><volume>98</volume><fpage>598</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1111/j.1349-7006.2007.00418.x</pub-id><pub-id pub-id-type="pmid">17284247</pub-id></element-citation></ref><ref id="B749-marinedrugs-18-00657"><label>749.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>A.</given-names></name><name><surname>Vieira</surname><given-names>H.</given-names></name><name><surname>Gaspar</surname><given-names>H.</given-names></name><name><surname>Santos</surname><given-names>S.</given-names></name></person-group><article-title>Marketed marine natural products in the pharmaceutical and cosmeceutical industries: Tips for success</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>1066</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.3390/md12021066</pub-id><pub-id pub-id-type="pmid">24549205</pub-id></element-citation></ref><ref id="B750-marinedrugs-18-00657"><label>750.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Kizu</surname><given-names>H.</given-names></name><name><surname>Dufresne</surname><given-names>C.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Bontems</surname><given-names>R.J.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Boettner</surname><given-names>F.E.</given-names></name><name><surname>Nieman</surname><given-names>R.A.</given-names></name></person-group><article-title>Isolation and structure of the cell growth inhibitory depsipeptides dolastatins 11 and 12</article-title><source>Heterocycles</source><year>1989</year><volume>28</volume><fpage>553</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.3987/COM-88-S33</pub-id></element-citation></ref><ref id="B751-marinedrugs-18-00657"><label>751.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Dufresne</surname><given-names>C.</given-names></name><name><surname>Cerny</surname><given-names>R.L.</given-names></name><name><surname>Herald</surname><given-names>D.L.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Kizu</surname><given-names>H.</given-names></name></person-group><article-title>Isolation and structure of the cytostatic depsipeptide dolastatin 13 from the sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Am. Chem. Soc.</source><year>1989</year><volume>111</volume><fpage>5015</fpage><lpage>5017</lpage><pub-id pub-id-type="doi">10.1021/ja00195a084</pub-id></element-citation></ref><ref id="B752-marinedrugs-18-00657"><label>752.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Dufresne</surname><given-names>C.</given-names></name><name><surname>Bates</surname><given-names>R.B.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Cerny</surname><given-names>R.L.</given-names></name><name><surname>Kizu</surname><given-names>H.</given-names></name></person-group><article-title>Antineoplastic agents. 190. Isolation and structure of the cyclodepsipeptide dolastatin 14</article-title><source>J. Org. Chem.</source><year>1990</year><volume>55</volume><fpage>2989</fpage><lpage>2990</lpage><pub-id pub-id-type="doi">10.1021/jo00297a001</pub-id></element-citation></ref><ref id="B753-marinedrugs-18-00657"><label>753.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrigan</surname><given-names>G.G.</given-names></name><name><surname>Yoshida</surname><given-names>W.Y.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name><name><surname>Park</surname><given-names>P.U.</given-names></name><name><surname>Biggs</surname><given-names>J.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Corbett</surname><given-names>T.H.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name></person-group><article-title>Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from <italic>Lyngbya majuscula</italic>/<italic>Schizothrix calcicola</italic> cyanobacterial assemblages</article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>1221</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1021/np9801211</pub-id><?supplied-pmid 9784156?><pub-id pub-id-type="pmid">9784156</pub-id></element-citation></ref><ref id="B754-marinedrugs-18-00657"><label>754.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>M.A.</given-names></name><name><surname>Bates</surname><given-names>R.B.</given-names></name><name><surname>Crane</surname><given-names>Z.D.</given-names></name><name><surname>Dicus</surname><given-names>C.W.</given-names></name><name><surname>Gramme</surname><given-names>M.R.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name><name><surname>Marcischak</surname><given-names>J.</given-names></name><name><surname>Martinez</surname><given-names>D.S.</given-names></name><name><surname>McClure</surname><given-names>K.J.</given-names></name><name><surname>Nakkiew</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Dolastatin 11 conformations, analogues and pharmacophore</article-title><source>Bioorg. Med. Chem.</source><year>2005</year><volume>13</volume><fpage>4138</fpage><lpage>4152</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2005.04.040</pub-id><?supplied-pmid 15878670?><pub-id pub-id-type="pmid">15878670</pub-id></element-citation></ref><ref id="B755-marinedrugs-18-00657"><label>755.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornburg</surname><given-names>C.C.</given-names></name><name><surname>Thimmaiah</surname><given-names>M.</given-names></name><name><surname>Shaala</surname><given-names>L.A.</given-names></name><name><surname>Hau</surname><given-names>A.M.</given-names></name><name><surname>Malmo</surname><given-names>J.M.</given-names></name><name><surname>Ishmael</surname><given-names>J.E.</given-names></name><name><surname>Youssef</surname><given-names>D.T.</given-names></name><name><surname>McPhail</surname><given-names>K.L.</given-names></name></person-group><article-title>Cyclic depsipeptides, grassypeptolides D and E and ibu-epidemethoxylyngbyastatin 3, from a Red Sea <italic>Leptolyngbya</italic> cyanobacterium</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1677</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.1021/np200270d</pub-id><?supplied-pmid 21806012?><pub-id pub-id-type="pmid">21806012</pub-id></element-citation></ref><ref id="B756-marinedrugs-18-00657"><label>756.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Kamano</surname><given-names>Y.</given-names></name><name><surname>Dufresne</surname><given-names>C.</given-names></name><name><surname>Cerny</surname><given-names>R.L.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name></person-group><article-title>Isolation and structure of the cytostatic linear depsipeptide dolastatin 15</article-title><source>J. Org. Chem.</source><year>1989</year><volume>54</volume><fpage>6005</fpage><lpage>6006</lpage><pub-id pub-id-type="doi">10.1021/jo00287a003</pub-id></element-citation></ref><ref id="B757-marinedrugs-18-00657"><label>757.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Herald</surname><given-names>D.L.</given-names></name><name><surname>Singh</surname><given-names>S.B.</given-names></name><name><surname>Thornton</surname><given-names>T.J.</given-names></name><name><surname>Mullaney</surname><given-names>J.T.</given-names></name></person-group><article-title>Antineoplastic agents. 220. Synthesis of natural (-)-dolastatin 15</article-title><source>J. Am. Chem. Soc.</source><year>1991</year><volume>113</volume><fpage>6692</fpage><lpage>6693</lpage><pub-id pub-id-type="doi">10.1021/ja00017a061</pub-id></element-citation></ref><ref id="B758-marinedrugs-18-00657"><label>758.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaji</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Kiso</surname><given-names>Y.</given-names></name><name><surname>Kuriyama</surname><given-names>N.</given-names></name></person-group><article-title>Convergent synthesis of dolastatin 15 by solid phase coupling of an N-methylamino acid</article-title><source>J. Org. Chem.</source><year>1999</year><volume>64</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1021/jo981055a</pub-id></element-citation></ref><ref id="B759-marinedrugs-18-00657"><label>759.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokosaka</surname><given-names>A.</given-names></name><name><surname>Izawa</surname><given-names>A.</given-names></name><name><surname>Sakai</surname><given-names>C.</given-names></name><name><surname>Sakurada</surname><given-names>E.</given-names></name><name><surname>Morita</surname><given-names>Y.</given-names></name><name><surname>Nishio</surname><given-names>Y.</given-names></name></person-group><article-title>Synthesis and evaluation of novel dolastatin 10 derivatives for versatile conjugations</article-title><source>Bioorg. Med. Chem.</source><year>2018</year><volume>26</volume><fpage>1643</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2018.02.011</pub-id><pub-id pub-id-type="pmid">29454703</pub-id></element-citation></ref><ref id="B760-marinedrugs-18-00657"><label>760.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Advanced preclinical and clinical trials of natural products and related compounds from marine sources</article-title><source>Curr. Med. Chem.</source><year>2004</year><volume>11</volume><fpage>1693</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.2174/0929867043364982</pub-id><pub-id pub-id-type="pmid">15279577</pub-id></element-citation></ref><ref id="B761-marinedrugs-18-00657"><label>761.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J.H.</given-names></name><name><surname>Field</surname><given-names>J.J.</given-names></name><name><surname>Kanakkanthara</surname><given-names>A.</given-names></name><name><surname>Owen</surname><given-names>J.G.</given-names></name><name><surname>Singh</surname><given-names>A.J.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name></person-group><article-title>Marine invertebrate natural products that target microtubules</article-title><source>J. Nat. Prod.</source><year>2018</year><volume>81</volume><fpage>691</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00964</pub-id><pub-id pub-id-type="pmid">29431439</pub-id></element-citation></ref><ref id="B762-marinedrugs-18-00657"><label>762.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R.</given-names></name><name><surname>Friedman</surname><given-names>S.J.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>Dolastatin 15, a potent antimitotic depsipeptide derived from <italic>Dolabella auricularia</italic>: Interaction with tubulin and effects on cellular microtubules</article-title><source>Biochem. Pharmacol.</source><year>1992</year><volume>43</volume><fpage>2637</fpage><lpage>2645</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(92)90153-A</pub-id><pub-id pub-id-type="pmid">1632820</pub-id></element-citation></ref><ref id="B763-marinedrugs-18-00657"><label>763.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>M.A.</given-names></name><name><surname>Rosati</surname><given-names>R.</given-names></name><name><surname>Pettit</surname><given-names>G.</given-names></name><name><surname>Kalemkerian</surname><given-names>G.P.</given-names></name></person-group><article-title>Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines</article-title><source>Anticancer Res.</source><year>1998</year><volume>18</volume><fpage>1021</fpage><lpage>1026</lpage><?supplied-pmid 9615758?><pub-id pub-id-type="pmid">9615758</pub-id></element-citation></ref><ref id="B764-marinedrugs-18-00657"><label>764.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Sagawa</surname><given-names>M.</given-names></name><name><surname>Nakazato</surname><given-names>T.</given-names></name><name><surname>Ikeda</surname><given-names>Y.</given-names></name><name><surname>Kizaki</surname><given-names>M.</given-names></name></person-group><article-title>A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells</article-title><source>Int. J. Oncol.</source><year>2007</year><volume>30</volume><fpage>1453</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.3892/ijo.30.6.1453</pub-id><?supplied-pmid 17487366?><pub-id pub-id-type="pmid">17487366</pub-id></element-citation></ref><ref id="B765-marinedrugs-18-00657"><label>765.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckwith</surname><given-names>M.</given-names></name><name><surname>Urba</surname><given-names>W.J.</given-names></name><name><surname>Longo</surname><given-names>D.L.</given-names></name></person-group><article-title>Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15</article-title><source>JNCI J. Nat. Cancer Ins.</source><year>1993</year><volume>85</volume><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1093/jnci/85.6.483</pub-id></element-citation></ref><ref id="B766-marinedrugs-18-00657"><label>766.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R.</given-names></name><name><surname>Edler</surname><given-names>M.C.</given-names></name><name><surname>Bonate</surname><given-names>P.L.</given-names></name><name><surname>Copeland</surname><given-names>T.D.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Luduena</surname><given-names>R.F.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: Correlation with cytotoxicity</article-title><source>Mol. Pharmacol.</source><year>2009</year><volume>75</volume><fpage>218</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1124/mol.108.051110</pub-id><pub-id pub-id-type="pmid">18927208</pub-id></element-citation></ref><ref id="B767-marinedrugs-18-00657"><label>767.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Okouneva</surname><given-names>T.</given-names></name><name><surname>Manna</surname><given-names>T.</given-names></name><name><surname>Miller</surname><given-names>H.P.</given-names></name><name><surname>Schmid</surname><given-names>S.</given-names></name><name><surname>Arthaud</surname><given-names>L.</given-names></name><name><surname>Luduena</surname><given-names>R.</given-names></name><name><surname>Jordan</surname><given-names>M.A.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name></person-group><article-title>Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate</article-title><source>Cancer Res.</source><year>2007</year><volume>67</volume><fpage>3767</fpage><lpage>3776</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-3065</pub-id><pub-id pub-id-type="pmid">17440090</pub-id></element-citation></ref><ref id="B768-marinedrugs-18-00657"><label>768.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>V.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Gidwani</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Kolb</surname><given-names>E.A.</given-names></name></person-group><article-title>Preclinical analysis of tasidotin HCl in Ewing&#x02019;s sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma</article-title><source>Clin. Cancer Res.</source><year>2007</year><volume>13</volume><fpage>5446</fpage><lpage>5454</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-2661</pub-id><pub-id pub-id-type="pmid">17875774</pub-id></element-citation></ref><ref id="B769-marinedrugs-18-00657"><label>769.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvador</surname><given-names>L.A.</given-names></name><name><surname>Biggs</surname><given-names>J.S.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Veraguamides A&#x02212; G, cyclic hexadepsipeptides from a dolastatin 16-producing cyanobacterium <italic>Symploca</italic> cf. <italic>hydnoides</italic> from Guam<italic/></article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>917</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1021/np200076t</pub-id><pub-id pub-id-type="pmid">21446699</pub-id></element-citation></ref><ref id="B770-marinedrugs-18-00657"><label>770.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Xu</surname><given-names>J.P.</given-names></name><name><surname>Hogan</surname><given-names>F.</given-names></name><name><surname>Williams</surname><given-names>M.D.</given-names></name><name><surname>Doubek</surname><given-names>D.L.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Cerny</surname><given-names>R.L.</given-names></name><name><surname>Boyd</surname><given-names>M.R.</given-names></name></person-group><article-title>Isolation and structure of the human cancer cell growth inhibitory cyclodepsipeptide dolastatin 16</article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>752</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1021/np9700230</pub-id><pub-id pub-id-type="pmid">9287413</pub-id></element-citation></ref><ref id="B771-marinedrugs-18-00657"><label>771.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogle</surname><given-names>L.M.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Isolation of four new cyclic depsipeptides, antanapeptins A&#x02212; D, and dolastatin 16 from a Madagascan collection of <italic>Lyngbya majuscula</italic></article-title><source>J. Nat. Prod.</source><year>2002</year><volume>65</volume><fpage>21</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1021/np010348n</pub-id><pub-id pub-id-type="pmid">11809058</pub-id></element-citation></ref><ref id="B772-marinedrugs-18-00657"><label>772.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monks</surname><given-names>A.</given-names></name><name><surname>Scudiero</surname><given-names>D.</given-names></name><name><surname>Skehan</surname><given-names>P.</given-names></name><name><surname>Shoemaker</surname><given-names>R.</given-names></name><name><surname>Paull</surname><given-names>K.</given-names></name><name><surname>Vistica</surname><given-names>D.</given-names></name><name><surname>Hose</surname><given-names>C.</given-names></name><name><surname>Langley</surname><given-names>J.</given-names></name><name><surname>Cronise</surname><given-names>P.</given-names></name><name><surname>Vaigro-Wolff</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</article-title><source>JNCI J. Natl. Cancer I.</source><year>1991</year><volume>83</volume><fpage>757</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1093/jnci/83.11.757</pub-id><?supplied-pmid 2041050?><pub-id pub-id-type="pmid">2041050</pub-id></element-citation></ref><ref id="B773-marinedrugs-18-00657"><label>773.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Xu</surname><given-names>J.P.</given-names></name><name><surname>Hogan</surname><given-names>F.</given-names></name><name><surname>Cerny</surname><given-names>R.L.</given-names></name></person-group><article-title>Isolation and structure of dolastatin 17</article-title><source>Heterocycles</source><year>1998</year><volume>47</volume><fpage>491</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.3987/COM-97-S(N)8</pub-id></element-citation></ref><ref id="B774-marinedrugs-18-00657"><label>774.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>J.</given-names></name><name><surname>Yazaki</surname><given-names>R.</given-names></name><name><surname>Ueno</surname><given-names>M.</given-names></name></person-group><article-title>Toward the total synthesis of onchidin, a cytotoxic cyclic depsipeptide from a mollusc</article-title><source>Chem. Asian J.</source><year>2007</year><volume>2</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1002/asia.200600232</pub-id><?supplied-pmid 17441146?><pub-id pub-id-type="pmid">17441146</pub-id></element-citation></ref><ref id="B775-marinedrugs-18-00657"><label>775.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Xu</surname><given-names>J.P.</given-names></name><name><surname>Williams</surname><given-names>M.D.</given-names></name><name><surname>Hogan</surname><given-names>F.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name><name><surname>Cerny</surname><given-names>R.L.</given-names></name></person-group><article-title>Antineoplastic agents 370. Isolation and structure of dolastatin 18</article-title><source>Bioorg. Chem. Med. Lett.</source><year>1997</year><volume>7</volume><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(97)00114-5</pub-id></element-citation></ref><ref id="B776-marinedrugs-18-00657"><label>776.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Xu</surname><given-names>J.P.</given-names></name><name><surname>Doubek</surname><given-names>D.L.</given-names></name><name><surname>Chapuis</surname><given-names>J.C.</given-names></name><name><surname>Schmidt</surname><given-names>J.M.</given-names></name></person-group><article-title>Antineoplastic Agents. 510. Isolation and structure of dolastatin 19 from the Gulf of California sea hare <italic>Dolabella auricularia</italic></article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1252</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.1021/np030198b</pub-id><pub-id pub-id-type="pmid">15332837</pub-id></element-citation></ref><ref id="B777-marinedrugs-18-00657"><label>777.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>R.E.</given-names></name></person-group><article-title>Toxins, anticancer agents, and tumor promoters from marine prokaryotes</article-title><source>Pure Appl. Chem.</source><year>1982</year><volume>54</volume><fpage>1919</fpage><lpage>1934</lpage><pub-id pub-id-type="doi">10.1351/pac198254101919</pub-id></element-citation></ref><ref id="B778-marinedrugs-18-00657"><label>778.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>M.</given-names></name></person-group><article-title>Midgut gland toxins of Hawaiian sea hares. I. Isolation and preliminary toxicological observations</article-title><source>Toxicon</source><year>1973</year><volume>11</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(73)90053-6</pub-id><pub-id pub-id-type="pmid">4721926</pub-id></element-citation></ref><ref id="B779-marinedrugs-18-00657"><label>779.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>M.</given-names></name><name><surname>Rayner</surname><given-names>M.D.</given-names></name></person-group><article-title>Midgut gland toxins of Hawaiian sea hares. II. A preliminary pharmacological study</article-title><source>Toxicon</source><year>1973</year><volume>11</volume><fpage>269</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(73)90054-8</pub-id><pub-id pub-id-type="pmid">4721927</pub-id></element-citation></ref><ref id="B780-marinedrugs-18-00657"><label>780.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashida</surname><given-names>Y.</given-names></name><name><surname>Yanagita</surname><given-names>R.C.</given-names></name><name><surname>Takahashi</surname><given-names>C.</given-names></name><name><surname>Kawanami</surname><given-names>Y.</given-names></name><name><surname>Irie</surname><given-names>K.</given-names></name></person-group><article-title>Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain</article-title><source>Bioorg. Med. Chem.</source><year>2016</year><volume>24</volume><fpage>4218</fpage><lpage>4227</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2016.07.011</pub-id><pub-id pub-id-type="pmid">27436807</pub-id></element-citation></ref><ref id="B781-marinedrugs-18-00657"><label>781.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardellina</surname><given-names>J.H.</given-names></name><name><surname>Marner</surname><given-names>F.J.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name></person-group><article-title>Seaweed dermatitis: Structure of Lyngbyatoxin A</article-title><source>Science</source><year>1979</year><volume>204</volume><fpage>193</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1126/science.107586</pub-id><pub-id pub-id-type="pmid">107586</pub-id></element-citation></ref><ref id="B782-marinedrugs-18-00657"><label>782.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardellina</surname><given-names>J.H.</given-names></name><name><surname>Marner</surname><given-names>F.J.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name></person-group><article-title>Malyngamide A, a novel chlorinated metabolite of the marine cyanophyte <italic>Lyngbya majuscula</italic></article-title><source>J. Am. Chem. Soc.</source><year>1979</year><volume>101</volume><fpage>240</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1021/ja00495a051</pub-id></element-citation></ref><ref id="B783-marinedrugs-18-00657"><label>783.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capper</surname><given-names>A.</given-names></name><name><surname>Tibbetts</surname><given-names>I.R.</given-names></name><name><surname>O&#x02019;Neil</surname><given-names>J.M.</given-names></name><name><surname>Shaw</surname><given-names>G.R.</given-names></name></person-group><article-title>The fate of <italic>Lyngbya majuscula</italic> toxins in three potential consumers</article-title><source>J. Chem. Ecol.</source><year>2005</year><volume>31</volume><fpage>1595</fpage><lpage>1606</lpage><pub-id pub-id-type="doi">10.1007/s10886-005-5800-5</pub-id><?supplied-pmid 16222795?><pub-id pub-id-type="pmid">16222795</pub-id></element-citation></ref><ref id="B784-marinedrugs-18-00657"><label>784.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suntornchashwej</surname><given-names>S.</given-names></name><name><surname>Chaichit</surname><given-names>N.</given-names></name><name><surname>Isobe</surname><given-names>M.</given-names></name><name><surname>Suwanborirux</surname><given-names>K.</given-names></name></person-group><article-title>Hectochlorin and morpholine derivatives from the Thai sea hare, <italic>Bursatella leachii</italic></article-title><source>J. Nat. Prod.</source><year>2005</year><volume>68</volume><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1021/np0500124</pub-id><?supplied-pmid 15974628?><pub-id pub-id-type="pmid">15974628</pub-id></element-citation></ref><ref id="B785-marinedrugs-18-00657"><label>785.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquez</surname><given-names>B.L.</given-names></name><name><surname>Watts</surname><given-names>K.S.</given-names></name><name><surname>Yokochi</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>M.A.</given-names></name><name><surname>Verdier-Pinard</surname><given-names>P.</given-names></name><name><surname>Jimenez</surname><given-names>J.I.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly</article-title><source>J. Nat. Prod.</source><year>2002</year><volume>65</volume><fpage>866</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1021/np0106283</pub-id><?supplied-pmid 12088429?><pub-id pub-id-type="pmid">12088429</pub-id></element-citation></ref><ref id="B786-marinedrugs-18-00657"><label>786.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleton</surname><given-names>D.R.</given-names></name><name><surname>Sewell</surname><given-names>M.A.</given-names></name><name><surname>Berridge</surname><given-names>M.V.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name></person-group><article-title>A new biologically active malyngamide from a New Zealand collection of the sea hare <italic>Bursatella leachii</italic></article-title><source>J. Nat. Prod.</source><year>2002</year><volume>65</volume><fpage>630</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1021/np010511e</pub-id><pub-id pub-id-type="pmid">11975522</pub-id></element-citation></ref><ref id="B787-marinedrugs-18-00657"><label>787.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suntornchashwej</surname><given-names>S.</given-names></name><name><surname>Suwanborirux</surname><given-names>K.</given-names></name><name><surname>Koga</surname><given-names>K.</given-names></name><name><surname>Isobe</surname><given-names>M.</given-names></name></person-group><article-title>Malyngamide X: The first (7R)-lyngbic acid that connects to a new tripeptide backbone from the Thai sea hare <italic>Bursatella leachii</italic></article-title><source>Chem. Asian J.</source><year>2007</year><volume>2</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/asia.200600219</pub-id><pub-id pub-id-type="pmid">17441144</pub-id></element-citation></ref><ref id="B788-marinedrugs-18-00657"><label>788.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischel</surname><given-names>J.L.</given-names></name><name><surname>Lemee</surname><given-names>R.</given-names></name><name><surname>Formento</surname><given-names>P.</given-names></name><name><surname>Caldani</surname><given-names>C.</given-names></name><name><surname>Moll</surname><given-names>J.L.</given-names></name><name><surname>Pesando</surname><given-names>D.</given-names></name><name><surname>Meinesz</surname><given-names>A.</given-names></name><name><surname>Grelier</surname><given-names>P.</given-names></name><name><surname>Pietra</surname><given-names>P.</given-names></name><name><surname>Guerriero</surname><given-names>A.</given-names></name></person-group><article-title>Cell growth inhibitory effects of caulerpenyne, a sesquiterpenoid from the marine algae <italic>Caulerpa taxifolia</italic></article-title><source>Anticancer Res.</source><year>1995</year><volume>15</volume><fpage>2155</fpage><lpage>2160</lpage><pub-id pub-id-type="pmid">8572617</pub-id></element-citation></ref><ref id="B789-marinedrugs-18-00657"><label>789.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavas</surname><given-names>L.</given-names></name><name><surname>Baskin</surname><given-names>Y.</given-names></name><name><surname>Yurdakoc</surname><given-names>K.</given-names></name><name><surname>Olgun</surname><given-names>N.</given-names></name></person-group><article-title>Antiproliferative and newly contributed apoptotic activities from an invasive marine alga: <italic>Caulerpa racemosa var</italic></article-title><source>cylindracea. J. Exp. Mar. Biol. Ecol.</source><year>2006</year><volume>339</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.jembe.2006.07.019</pub-id></element-citation></ref><ref id="B790-marinedrugs-18-00657"><label>790.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbier</surname><given-names>P.</given-names></name><name><surname>Guise</surname><given-names>S.</given-names></name><name><surname>Huitorel</surname><given-names>P.</given-names></name><name><surname>Amade</surname><given-names>P.</given-names></name><name><surname>Pesando</surname><given-names>D.</given-names></name><name><surname>Briand</surname><given-names>C.</given-names></name><name><surname>Peyrot</surname><given-names>V.</given-names></name></person-group><article-title>Caulerpenyne from <italic>Caulerpa taxifolia</italic> has an antiproliferative activity on tumor cell line SK-N-SH and modifies the microtubule network</article-title><source>Life Sci.</source><year>2001</year><volume>70</volume><fpage>415</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(01)01396-0</pub-id><pub-id pub-id-type="pmid">11798011</pub-id></element-citation></ref><ref id="B791-marinedrugs-18-00657"><label>791.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parent-Massin</surname><given-names>D.</given-names></name><name><surname>Fournier</surname><given-names>V.</given-names></name><name><surname>Amade</surname><given-names>P.</given-names></name><name><surname>Lemee</surname><given-names>R.</given-names></name><name><surname>Durand-Clement</surname><given-names>M.</given-names></name><name><surname>Delescluse</surname><given-names>C.</given-names></name><name><surname>Pesando</surname><given-names>D.</given-names></name></person-group><article-title>Evaluation of the toxicological risk to humans of caulerpenyne using human hematopoietic progenitors, melanocytes, and keratinocytes in culture</article-title><source>J. Toxicol. Environ. Health</source><year>1996</year><volume>47</volume><fpage>47</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1080/009841096161924</pub-id><pub-id pub-id-type="pmid">8568911</pub-id></element-citation></ref><ref id="B792-marinedrugs-18-00657"><label>792.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdron</surname><given-names>J.</given-names></name><name><surname>Barbier</surname><given-names>P.</given-names></name><name><surname>Allegro</surname><given-names>D.</given-names></name><name><surname>Villard</surname><given-names>C.</given-names></name><name><surname>Lafitte</surname><given-names>D.</given-names></name><name><surname>Commeiras</surname><given-names>L.</given-names></name><name><surname>Parrain</surname><given-names>J.L.</given-names></name><name><surname>Peyrot</surname><given-names>V.</given-names></name></person-group><article-title>Caulerpenyne binding to tubulin: Structural modifications by a non conventional pharmacological agent</article-title><source>Med. Chem.</source><year>2009</year><volume>5</volume><fpage>182</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.2174/157340609787582891</pub-id><?supplied-pmid 19275717?><pub-id pub-id-type="pmid">19275717</pub-id></element-citation></ref><ref id="B793-marinedrugs-18-00657"><label>793.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesando</surname><given-names>D.</given-names></name><name><surname>Pesci-Bardon</surname><given-names>C.</given-names></name><name><surname>Huitorel</surname><given-names>P.</given-names></name><name><surname>Girard</surname><given-names>J.P.</given-names></name></person-group><article-title>Caulerpenyne blocks MBP kinase activation controlling mitosis in sea urchin eggs</article-title><source>Eur. J. Cell. Biol.</source><year>1999</year><volume>78</volume><fpage>903</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/S0171-9335(99)80092-2</pub-id><pub-id pub-id-type="pmid">10669109</pub-id></element-citation></ref><ref id="B794-marinedrugs-18-00657"><label>794.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>Chemistry and biology of kahalalides</article-title><source>Chem. Rev.</source><year>2011</year><volume>111</volume><fpage>3208</fpage><lpage>3235</lpage><pub-id pub-id-type="doi">10.1021/cr100187n</pub-id><?supplied-pmid 21480581?><pub-id pub-id-type="pmid">21480581</pub-id></element-citation></ref><ref id="B795-marinedrugs-18-00657"><label>795.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Devi</surname><given-names>P.</given-names></name><name><surname>Carbone</surname><given-names>M.</given-names></name><name><surname>Mathieu</surname><given-names>V.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name><name><surname>Casapullo</surname><given-names>A.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name></person-group><article-title>Kahalalide F analogues from the mucous secretion of Indian sacoglossan mollusc <italic>Elysia ornata</italic></article-title><source>Tetrahedron</source><year>2016</year><volume>72</volume><fpage>625</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2015.12.003</pub-id></element-citation></ref><ref id="B796-marinedrugs-18-00657"><label>796.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashour</surname><given-names>M.</given-names></name><name><surname>Edrada</surname><given-names>R.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Wray</surname><given-names>V.</given-names></name><name><surname>W&#x000e4;tjen</surname><given-names>W.</given-names></name><name><surname>Padmakumar</surname><given-names>K.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>W.E.G.</given-names></name><name><surname>Lin</surname><given-names>W.H.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Kahalalide derivatives fromthe Indian dacoglossan mollusk <italic>Elysia grandifolia</italic></article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>1547</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1021/np060172v</pub-id><pub-id pub-id-type="pmid">17125219</pub-id></element-citation></ref><ref id="B797-marinedrugs-18-00657"><label>797.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Kahalalide F: A bioactive depsipeptide from the sacoglossan mollusk <italic>Elysia rufescens</italic> and the green alga <italic>Bryopsis</italic> sp.</article-title><source>J. Am. Chem. Soc.</source><year>1993</year><volume>115</volume><fpage>5825</fpage><lpage>5826</lpage><pub-id pub-id-type="doi">10.1021/ja00066a061</pub-id></element-citation></ref><ref id="B798-marinedrugs-18-00657"><label>798.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kan</surname><given-names>Y.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Sakamoto</surname><given-names>B.</given-names></name><name><surname>Hokama</surname><given-names>Y.</given-names></name><name><surname>Nagai</surname><given-names>H.</given-names></name></person-group><article-title>A new cyclic depsipeptide from the Hawaiian green alga <italic>Bryopsis</italic> species</article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>1169</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1021/np990053y</pub-id><pub-id pub-id-type="pmid">10479330</pub-id></element-citation></ref><ref id="B799-marinedrugs-18-00657"><label>799.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su&#x000e1;rez</surname><given-names>Y.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>L.</given-names></name><name><surname>Cuadrado</surname><given-names>A.</given-names></name><name><surname>Berciano</surname><given-names>M.</given-names></name><name><surname>Lafarga</surname><given-names>M.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>A.</given-names></name></person-group><article-title>Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells</article-title><source>Mol. Cancer Ther.</source><year>2003</year><volume>2</volume><fpage>863</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">14555705</pub-id></element-citation></ref><ref id="B800-marinedrugs-18-00657"><label>800.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janmaat</surname><given-names>M.L.</given-names></name><name><surname>Rodriguez</surname><given-names>J.A.</given-names></name><name><surname>Jimeno</surname><given-names>J.</given-names></name><name><surname>Kruyt</surname><given-names>F.A.E.</given-names></name><name><surname>Giaccone</surname><given-names>G.</given-names></name></person-group><article-title>Kahalalide F induces necrosis-like cell death that involves depletion of ErbB3 and inhibition of Akt signaling</article-title><source>Mol. Pharmacol.</source><year>2005</year><volume>68</volume><fpage>502</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1124/mol.105.011361</pub-id><pub-id pub-id-type="pmid">15908515</pub-id></element-citation></ref><ref id="B801-marinedrugs-18-00657"><label>801.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>B.</given-names></name><name><surname>Paz-Ares</surname><given-names>L.</given-names></name><name><surname>Tabernero</surname><given-names>J.</given-names></name><name><surname>Ciruelos</surname><given-names>E.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>M.</given-names></name><name><surname>Salazar</surname><given-names>R.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>A.</given-names></name><name><surname>Blanco</surname><given-names>M.</given-names></name><name><surname>Nieto</surname><given-names>A.</given-names></name><name><surname>Jimeno</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors</article-title><source>Clin. Cancer Res.</source><year>2008</year><volume>14</volume><fpage>1116</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-4366</pub-id><pub-id pub-id-type="pmid">18281545</pub-id></element-citation></ref><ref id="B802-marinedrugs-18-00657"><label>802.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rademaker-Lakhai</surname><given-names>J.M.</given-names></name><name><surname>Horenblas</surname><given-names>S.</given-names></name><name><surname>Meinhardt</surname><given-names>W.</given-names></name><name><surname>Stokvis</surname><given-names>E.</given-names></name><name><surname>de Reijke</surname><given-names>T.M.</given-names></name><name><surname>Jimeno</surname><given-names>J.M.</given-names></name><name><surname>Lopez-Lazaro</surname><given-names>L.</given-names></name><name><surname>Martin</surname><given-names>J.A.L.</given-names></name><name><surname>Beijnen</surname><given-names>J.H.</given-names></name><name><surname>Schellens</surname><given-names>J.H.</given-names></name></person-group><article-title>Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer</article-title><source>Clin. Cancer Res.</source><year>2005</year><volume>11</volume><fpage>1854</fpage><lpage>1862</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1534</pub-id><?supplied-pmid 15756010?><pub-id pub-id-type="pmid">15756010</pub-id></element-citation></ref><ref id="B803-marinedrugs-18-00657"><label>803.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sewell</surname><given-names>J.M.</given-names></name><name><surname>Mayer</surname><given-names>I.</given-names></name><name><surname>Langdon</surname><given-names>S.P.</given-names></name><name><surname>Smyth</surname><given-names>J.F.</given-names></name><name><surname>Jodrell</surname><given-names>D.I.</given-names></name><name><surname>Guichard</surname><given-names>S.M.</given-names></name></person-group><article-title>The mechanism of action of Kahalalide F: Variable cell permeability in human hepatoma cell lines</article-title><source>Eur. J. Cancer</source><year>2005</year><volume>41</volume><fpage>1637</fpage><lpage>1644</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2005.04.015</pub-id><?supplied-pmid 15953713?><pub-id pub-id-type="pmid">15953713</pub-id></element-citation></ref><ref id="B804-marinedrugs-18-00657"><label>804.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel-Lillo</surname><given-names>B.</given-names></name><name><surname>Valenzuela</surname><given-names>B.</given-names></name><name><surname>Peris-Ribera</surname><given-names>J.E.</given-names></name><name><surname>Soto-Matos</surname><given-names>A.</given-names></name><name><surname>P&#x000e9;rez-Ruixo</surname><given-names>J.J.</given-names></name></person-group><article-title>Population pharmacokinetics of kahalalide F in advanced cancer patients</article-title><source>Cancer Chemother. Pharmacol.</source><year>2015</year><volume>76</volume><fpage>365</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1007/s00280-015-2800-1</pub-id><?supplied-pmid 26093949?><pub-id pub-id-type="pmid">26093949</pub-id></element-citation></ref><ref id="B805-marinedrugs-18-00657"><label>805.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-Algarra</surname><given-names>S.</given-names></name><name><surname>Espinosa</surname><given-names>E.</given-names></name><name><surname>Rubi&#x000f3;</surname><given-names>J.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>J.J.L.</given-names></name><name><surname>Manzano</surname><given-names>J.L.</given-names></name><name><surname>Carri&#x000f3;n</surname><given-names>L.A.</given-names></name><name><surname>Plazaola</surname><given-names>A.</given-names></name><name><surname>Tanovic</surname><given-names>A.</given-names></name><name><surname>Paz-Ares</surname><given-names>L.</given-names></name></person-group><article-title>Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma</article-title><source>Eur. J. Cancer</source><year>2009</year><volume>45</volume><fpage>732</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2008.12.005</pub-id><pub-id pub-id-type="pmid">19186051</pub-id></element-citation></ref><ref id="B806-marinedrugs-18-00657"><label>806.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Waters</surname><given-names>A.L.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>An efficient and cost-effective approach to Kahalalide F N-terminal modifications using a nuisance algal bloom of <italic>Bryopsis pennata</italic></article-title><source>Biochim. Biophys. Acta (BBA) Gen. Subj.</source><year>2015</year><volume>1850</volume><fpage>1849</fpage><lpage>1854</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2015.05.004</pub-id></element-citation></ref><ref id="B807-marinedrugs-18-00657"><label>807.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shilabin</surname><given-names>A.G.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities</article-title><source>Bioorg. Med. Chem.</source><year>2011</year><volume>19</volume><fpage>6628</fpage><lpage>6632</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.06.050</pub-id><pub-id pub-id-type="pmid">21839640</pub-id></element-citation></ref><ref id="B808-marinedrugs-18-00657"><label>808.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>J.</given-names></name><name><surname>Fricke</surname><given-names>W.F.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Esquenazi</surname><given-names>E.</given-names></name><name><surname>Dorrestein</surname><given-names>P.C.</given-names></name><name><surname>Hill</surname><given-names>R.T.</given-names></name></person-group><article-title>Characterization of the bacterial community of the chemically defended hawaiian sacoglossan <italic>Elysia rufescens</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2013</year><volume>79</volume><fpage>7073</fpage><lpage>7081</lpage><pub-id pub-id-type="doi">10.1128/AEM.01568-13</pub-id><pub-id pub-id-type="pmid">24014539</pub-id></element-citation></ref><ref id="B809-marinedrugs-18-00657"><label>809.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>Y.H.</given-names></name><name><surname>Miguel</surname><given-names>A.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Jos&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Ana</surname><given-names>M.C.</given-names></name><name><surname>Perez-Soler</surname><given-names>R.</given-names></name></person-group><article-title>PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase</article-title><source>Clin. Cancer Res.</source><year>2011</year><volume>17</volume><fpage>5353</fpage><lpage>5366</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-1948</pub-id><pub-id pub-id-type="pmid">21690574</pub-id></element-citation></ref><ref id="B810-marinedrugs-18-00657"><label>810.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serova</surname><given-names>M.</given-names></name><name><surname>de Gramont</surname><given-names>A.</given-names></name><name><surname>Bieche</surname><given-names>I.</given-names></name><name><surname>Riveiro</surname><given-names>M.E.</given-names></name><name><surname>Galmarini</surname><given-names>C.M.</given-names></name><name><surname>Aracil</surname><given-names>M.</given-names></name><name><surname>Jimeno</surname><given-names>J.</given-names></name><name><surname>Faivre</surname><given-names>S.</given-names></name><name><surname>Raymond</surname><given-names>E.</given-names></name></person-group><article-title>Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>944</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.3390/md11030944</pub-id><pub-id pub-id-type="pmid">23519149</pub-id></element-citation></ref><ref id="B811-marinedrugs-18-00657"><label>811.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldwasser</surname><given-names>F.</given-names></name><name><surname>Faivre</surname><given-names>S.</given-names></name><name><surname>Alexandre</surname><given-names>J.</given-names></name><name><surname>Coronado</surname><given-names>C.</given-names></name><name><surname>Fernandez-Garc&#x00131;a</surname><given-names>E.M.</given-names></name><name><surname>Kahatt</surname><given-names>C.M.</given-names></name><name><surname>Paramio</surname><given-names>P.G.</given-names></name><name><surname>Dios</surname><given-names>J.L.</given-names></name><name><surname>Miguel-Lillo</surname><given-names>B.</given-names></name><name><surname>Raymond</surname><given-names>E.</given-names></name></person-group><article-title>Phase I study of elisidepsin (IrvalecR) in combination with carboplatin or gemcitabine in patients with advancedmalignancies</article-title><source>Invest. New Drugs</source><year>2014</year><volume>32</volume><fpage>500</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1007/s10637-013-0060-7</pub-id><pub-id pub-id-type="pmid">24395456</pub-id></element-citation></ref><ref id="B812-marinedrugs-18-00657"><label>812.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratain</surname><given-names>M.J.</given-names></name><name><surname>Geary</surname><given-names>D.</given-names></name><name><surname>Undevia</surname><given-names>S.D.</given-names></name><name><surname>Coronado</surname><given-names>C.</given-names></name><name><surname>Alfaro</surname><given-names>V.</given-names></name><name><surname>Iglesias</surname><given-names>J.L.</given-names></name><name><surname>Schilsky</surname><given-names>R.L.</given-names></name><name><surname>Miguel-Lillo</surname><given-names>B.</given-names></name></person-group><article-title>First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors</article-title><source>Invest. New Drugs</source><year>2015</year><volume>33</volume><fpage>901</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1007/s10637-015-0247-1</pub-id><?supplied-pmid 25947566?><pub-id pub-id-type="pmid">25947566</pub-id></element-citation></ref><ref id="B813-marinedrugs-18-00657"><label>813.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrero</surname><given-names>A.B.</given-names></name><name><surname>Astudillo</surname><given-names>A.M.</given-names></name><name><surname>Balboa</surname><given-names>M.A.</given-names></name><name><surname>Cuevas</surname><given-names>C.</given-names></name><name><surname>Balsinde</surname><given-names>J.</given-names></name><name><surname>Moreno</surname><given-names>S.</given-names></name></person-group><article-title>Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>9779</fpage><lpage>9787</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1981</pub-id><?supplied-pmid 19047157?><pub-id pub-id-type="pmid">19047157</pub-id></element-citation></ref><ref id="B814-marinedrugs-18-00657"><label>814.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;radi</surname><given-names>T.</given-names></name><name><surname>Roszik</surname><given-names>J.</given-names></name><name><surname>Lisboa</surname><given-names>D.</given-names></name><name><surname>Vereb</surname><given-names>G.</given-names></name><name><surname>Molina-Guijarro</surname><given-names>J.M.</given-names></name><name><surname>Galmarini</surname><given-names>C.M.</given-names></name><name><surname>Sz&#x000f6;ll&#x00151;si</surname><given-names>J.</given-names></name><name><surname>Nagy</surname><given-names>P.</given-names></name></person-group><article-title>ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment</article-title><source>Eur. J. Pharmacol.</source><year>2011</year><volume>667</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2011.05.064</pub-id><?supplied-pmid 21658382?><pub-id pub-id-type="pmid">21658382</pub-id></element-citation></ref><ref id="B815-marinedrugs-18-00657"><label>815.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Guijarro</surname><given-names>J.M.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>C.</given-names></name><name><surname>Mac&#x000ed;as</surname><given-names>&#x000c1;.</given-names></name><name><surname>Garc&#x000ed;a-Fern&#x000e1;ndez</surname><given-names>L.F.</given-names></name><name><surname>Moreno</surname><given-names>C.</given-names></name><name><surname>Reyes</surname><given-names>F.</given-names></name><name><surname>Mart&#x000ed;nez-Leal</surname><given-names>J.F.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>V.</given-names></name><name><surname>Valenzuela</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Elisidepsin interacts directly with glycosylceramides in the plasma membrane of tumor cells to induce necrotic cell death</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0140782</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0140782</pub-id><pub-id pub-id-type="pmid">26474061</pub-id></element-citation></ref><ref id="B816-marinedrugs-18-00657"><label>816.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname><given-names>R.</given-names></name><name><surname>Jones</surname><given-names>R.J.</given-names></name><name><surname>Oaknin</surname><given-names>A.</given-names></name><name><surname>Crawford</surname><given-names>D.</given-names></name><name><surname>Cuadra</surname><given-names>C.</given-names></name><name><surname>Hopkins</surname><given-names>C.</given-names></name><name><surname>Gil</surname><given-names>M.</given-names></name><name><surname>Coronado</surname><given-names>C.</given-names></name><name><surname>Soto-Matos</surname><given-names>A.</given-names></name><name><surname>Cullell-Young</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors</article-title><source>Cancer Chemother. Pharmacol.</source><year>2012</year><volume>70</volume><fpage>673</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1007/s00280-012-1951-6</pub-id><?supplied-pmid 22926637?><pub-id pub-id-type="pmid">22926637</pub-id></element-citation></ref><ref id="B817-marinedrugs-18-00657"><label>817.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>R.</given-names></name><name><surname>Anthoney</surname><given-names>A.</given-names></name><name><surname>Metges</surname><given-names>J.P.</given-names></name><name><surname>Alsina</surname><given-names>M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>J.</given-names></name><name><surname>Montagut</surname><given-names>C.</given-names></name><name><surname>Gunzer</surname><given-names>K.</given-names></name><name><surname>Laus</surname><given-names>G.</given-names></name><name><surname>Dios</surname><given-names>J.L.I.</given-names></name><etal/></person-group><article-title>Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial)</article-title><source>Cancer Chemother. Pharmacol.</source><year>2016</year><volume>77</volume><fpage>819</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1007/s00280-016-2991-0</pub-id><pub-id pub-id-type="pmid">26964995</pub-id></element-citation></ref><ref id="B818-marinedrugs-18-00657"><label>818.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciavatta</surname><given-names>M.L.</given-names></name><name><surname>Villani</surname><given-names>G.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Two new labdane aldehydes from the skin of the notaspidean <italic>Pleurobranchaea meckelii</italic></article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>8673</fpage><lpage>8676</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)01789-K</pub-id></element-citation></ref><ref id="B819-marinedrugs-18-00657"><label>819.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Marrero</surname><given-names>A.R.</given-names></name><name><surname>Dorta</surname><given-names>E.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>Rovirosa</surname><given-names>J.</given-names></name><name><surname>San Mart&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Loyola</surname><given-names>L.A.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name></person-group><article-title>New polyhydroxylated steroids from the marine pulmonate <italic>Trimusculus peruvianus</italic></article-title><source>Arkivoc J. Org. Chem.</source><year>2003</year><volume>10</volume><fpage>107</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.3998/ark.5550190.0004.a12</pub-id></element-citation></ref><ref id="B820-marinedrugs-18-00657"><label>820.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>J.</given-names></name><name><surname>Riguera</surname><given-names>R.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name></person-group><article-title>The natural polypropionate-derived esters of the mollusk <italic>Onchidium</italic> sp.</article-title><source>J. Org. Chem.</source><year>1992</year><volume>57</volume><fpage>4624</fpage><lpage>4632</lpage><pub-id pub-id-type="doi">10.1021/jo00043a018</pub-id></element-citation></ref><ref id="B821-marinedrugs-18-00657"><label>821.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z.F.</given-names></name><name><surname>Li</surname><given-names>X.L.</given-names></name><name><surname>Yao</surname><given-names>L.G.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name></person-group><article-title>Marine bis-&#x003b3;-pyrone polypropionates of onchidione family and their effects on the XBP1 gene expression</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2018</year><volume>28</volume><fpage>1093</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2018.02.010</pub-id><pub-id pub-id-type="pmid">29456105</pub-id></element-citation></ref><ref id="B822-marinedrugs-18-00657"><label>822.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>C.M.</given-names></name><name><surname>Biskupiak</surname><given-names>J.E.</given-names></name><name><surname>Hite</surname><given-names>G.J.</given-names></name><name><surname>Rapposch</surname><given-names>M.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Ruble</surname><given-names>J.R.</given-names></name></person-group><article-title>Ilikonapyrone esters, likely defense allomones of the mollusk <italic>Onchidium verruculatum</italic></article-title><source>J. Org. Chem.</source><year>1984</year><volume>49</volume><fpage>559</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1021/jo00177a039</pub-id></element-citation></ref><ref id="B823-marinedrugs-18-00657"><label>823.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arimoto</surname><given-names>H.</given-names></name><name><surname>Cheng</surname><given-names>J.-F.</given-names></name><name><surname>Nishiyama</surname><given-names>S.</given-names></name><name><surname>Yamamura</surname><given-names>S.</given-names></name></person-group><article-title>Synthetic studies on fully substituted &#x003b3;-pyrone-containing natural products: The absolute configurations of ilikonapyrone and peroniatriols I and II</article-title><source>Tetrahedron Lett.</source><year>1993</year><volume>34</volume><fpage>5781</fpage><lpage>5784</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)73859-7</pub-id></element-citation></ref><ref id="B824-marinedrugs-18-00657"><label>824.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Maschek</surname><given-names>J.A.</given-names></name></person-group><article-title>Chemical Investigation of the Antarctic Marine Invertebrates <italic>Austrodoris kerguelenensis</italic> &#x00026; <italic>Dendrilla membranosa</italic> and the Antarctic Red Alga <italic>Gigartina skottsbergii</italic></article-title><source>Ph.D. Thesis</source><publisher-name>University of South Florida</publisher-name><publisher-loc>Tampa, FL, USA</publisher-loc><year>2011</year></element-citation></ref><ref id="B825-marinedrugs-18-00657"><label>825.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>J.B.</given-names></name><name><surname>Mahdi</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Coothankandaswamy</surname><given-names>V.</given-names></name><name><surname>Jekabsons</surname><given-names>M.B.</given-names></name><name><surname>Johnson</surname><given-names>T.A.</given-names></name><name><surname>Sashidhara</surname><given-names>K.V.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name><name><surname>Zhou</surname><given-names>Y.D.</given-names></name></person-group><article-title>The marine sponge metabolite mycothiazole: A novel prototype mitochondrial complex I inhibitor</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>5988</fpage><lpage>5994</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2010.06.072</pub-id><?supplied-pmid 20637638?><pub-id pub-id-type="pmid">20637638</pub-id></element-citation></ref><ref id="B826-marinedrugs-18-00657"><label>826.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>K.J.</given-names></name><name><surname>Singh</surname><given-names>A.J.</given-names></name><name><surname>Cameron</surname><given-names>A.</given-names></name><name><surname>Tan</surname><given-names>A.S.</given-names></name><name><surname>Leahy</surname><given-names>D.C.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>D.</given-names></name><name><surname>Joshi</surname><given-names>P.</given-names></name><name><surname>La Flamme</surname><given-names>A.C.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Berridge</surname><given-names>M.V.</given-names></name><etal/></person-group><article-title>Mitochondrial genome-knockout cells demonstrate a dual mechanism of action for the electron transport complex I inhibitor mycothiazole</article-title><source>Mar. Drugs</source><year>2012</year><volume>10</volume><fpage>900</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.3390/md10040900</pub-id><?supplied-pmid 22690150?><pub-id pub-id-type="pmid">22690150</pub-id></element-citation></ref><ref id="B827-marinedrugs-18-00657"><label>827.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>M.T.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Kelly-Borges</surname><given-names>M.</given-names></name></person-group><article-title>Biogenetically diverse, bioactive constituents of a sponge, order Verongida: Bromotyramines and sesquiterpene-shikimate derived metabolites</article-title><source>J. Org. Chem.</source><year>1993</year><volume>58</volume><fpage>6565</fpage><lpage>6569</lpage><pub-id pub-id-type="doi">10.1021/jo00076a012</pub-id></element-citation></ref><ref id="B828-marinedrugs-18-00657"><label>828.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazlauskas</surname><given-names>R.</given-names></name><name><surname>Murphy</surname><given-names>P.T.</given-names></name><name><surname>Wells</surname><given-names>R.J.</given-names></name><name><surname>Noack</surname><given-names>K.</given-names></name><name><surname>Oberhansli</surname><given-names>W.E.</given-names></name><name><surname>Schonholzer</surname><given-names>P.</given-names></name></person-group><article-title>A new series of diterpenes from Australian Spongia species</article-title><source>Australian J. Chem.</source><year>1979</year><volume>32</volume><fpage>867</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1071/CH9790867</pub-id></element-citation></ref><ref id="B829-marinedrugs-18-00657"><label>829.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Allen</surname><given-names>M.S.</given-names></name><name><surname>Von Dreele</surname><given-names>R.B.</given-names></name><name><surname>Vanell</surname><given-names>L.D.</given-names></name><name><surname>Kao</surname><given-names>J.P.</given-names></name><name><surname>Blake</surname><given-names>W.</given-names></name></person-group><article-title>Antineoplastic agents. 48. The isolation and structure of aplysistatin</article-title><source>J. Am. Chem. Soc.</source><year>1977</year><volume>99</volume><fpage>262</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1021/ja00443a055</pub-id><pub-id pub-id-type="pmid">830682</pub-id></element-citation></ref><ref id="B830-marinedrugs-18-00657"><label>830.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischbach</surname><given-names>M.A.</given-names></name><name><surname>Walsh</surname><given-names>C.T.</given-names></name></person-group><article-title>Antibiotics for emerging pathogens</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>1089</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1126/science.1176667</pub-id><pub-id pub-id-type="pmid">19713519</pub-id></element-citation></ref><ref id="B831-marinedrugs-18-00657"><label>831.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>I.</given-names></name><name><surname>Taniguchi</surname><given-names>M.</given-names></name></person-group><article-title>Polygodial, an antifungal potentiator</article-title><source>J. Nat. Prod.</source><year>1988</year><volume>51</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1021/np50055a002</pub-id><pub-id pub-id-type="pmid">3286823</pub-id></element-citation></ref><ref id="B832-marinedrugs-18-00657"><label>832.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkendorff</surname><given-names>K.</given-names></name><name><surname>Davis</surname><given-names>A.R.</given-names></name><name><surname>Bremner</surname><given-names>J.B.</given-names></name></person-group><article-title>Chemical defense in the egg masses of benthic invertebrates: An assessment of antibacterial activity in 39 mollusks and 4 polychaetes</article-title><source>J. Invertebr. Pathol.</source><year>2001</year><volume>78</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1006/jipa.2001.5047</pub-id><pub-id pub-id-type="pmid">11812113</pub-id></element-citation></ref><ref id="B833-marinedrugs-18-00657"><label>833.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Sayed</surname><given-names>K.A.</given-names></name><name><surname>Bartyzel</surname><given-names>P.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Perry</surname><given-names>T.L.</given-names></name><name><surname>Zjawiony</surname><given-names>J.K.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>Marine natural products as anti-tuberculosis agents</article-title><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>949</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(99)01093-5</pub-id></element-citation></ref><ref id="B834-marinedrugs-18-00657"><label>834.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>E.K.</given-names></name><name><surname>Ramsey</surname><given-names>D.M.</given-names></name><name><surname>McAlpine</surname><given-names>S.R.</given-names></name></person-group><article-title>Total synthesis of trans,trans-sanguinamide B and conformational isomers</article-title><source>Organic Lett.</source><year>2012</year><volume>14</volume><fpage>1198</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1021/ol203290n</pub-id><?supplied-pmid 22356651?><pub-id pub-id-type="pmid">22356651</pub-id></element-citation></ref><ref id="B835-marinedrugs-18-00657"><label>835.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahyudi</surname><given-names>H.</given-names></name><name><surname>Tantisantisom</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ramsey</surname><given-names>D.M.</given-names></name><name><surname>Singh</surname><given-names>E.K.</given-names></name><name><surname>McAlpine</surname><given-names>S.R.</given-names></name></person-group><article-title>Synthesis, structure-activity analysis, and Biological Evaluation of Sanguinamide B Analogues</article-title><source>J. Org. Chem.</source><year>2012</year><volume>77</volume><fpage>10596</fpage><lpage>10616</lpage><pub-id pub-id-type="doi">10.1021/jo3017499</pub-id><?supplied-pmid 23050835?><pub-id pub-id-type="pmid">23050835</pub-id></element-citation></ref><ref id="B836-marinedrugs-18-00657"><label>836.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doralyn S.</surname><given-names>D.</given-names></name><name><surname>Evan W.</surname><given-names>R.</given-names></name><name><surname>Arthur S.</surname><given-names>E.</given-names></name><name><surname>Tadeusz F.</surname><given-names>M.</given-names></name></person-group><article-title>Structure Elucidation at the Nanomole Scale. 1. Trisoxazole Macrolides and Thiazole-Containing Cyclic Peptides from the Nudibranch Hexabranchus sanguineus</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>732</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">19254038</pub-id></element-citation></ref><ref id="B837-marinedrugs-18-00657"><label>837.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>Y.W.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Ghiselin</surname><given-names>M.T.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name></person-group><article-title>Terpenoid metabolites of the nudibranch <italic>Hexabranchus sanguineus</italic> from the South China Sea</article-title><source>Tetrahedron</source><year>2007</year><volume>63</volume><fpage>4725</fpage><lpage>4729</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2007.03.082</pub-id></element-citation></ref><ref id="B838-marinedrugs-18-00657"><label>838.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Gavagnin</surname><given-names>M.</given-names></name><name><surname>Mollo</surname><given-names>E.</given-names></name><name><surname>Trivellone</surname><given-names>E.</given-names></name><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Fakhr</surname><given-names>I.</given-names></name></person-group><article-title>Structure of the pigment of the Red Sea nudibranch <italic>Hexabranchus sanguineus</italic></article-title><source>Tetrahedron Lett.</source><year>1998</year><volume>39</volume><fpage>2635</fpage><lpage>2638</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(98)00225-1</pub-id></element-citation></ref><ref id="B839-marinedrugs-18-00657"><label>839.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Renieramycins E and F from the sponge <italic>Reniera</italic> sp. Reassignment of the stereochemistry of the renieramycins</article-title><source>J. Org. Chem.</source><year>1989</year><volume>54</volume><fpage>5822</fpage><lpage>5824</lpage><pub-id pub-id-type="doi">10.1021/jo00285a034</pub-id></element-citation></ref><ref id="B840-marinedrugs-18-00657"><label>840.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>K.V.</given-names></name><name><surname>Mohanraju</surname><given-names>R.</given-names></name><name><surname>Murthy</surname><given-names>K.N.</given-names></name><name><surname>Ramesh</surname><given-names>C.</given-names></name><name><surname>Karthick</surname><given-names>P.</given-names></name></person-group><article-title>Antimicrobial properties of nudibranchs tissues extracts from South Andaman, India</article-title><source>J. Coast. Life Med.</source><year>2015</year><volume>3</volume><fpage>582</fpage><lpage>584</lpage></element-citation></ref><ref id="B841-marinedrugs-18-00657"><label>841.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahey</surname><given-names>S.J.</given-names></name><name><surname>Carroll</surname><given-names>A.R.</given-names></name></person-group><article-title>Natural products isolated from species of <italic>Halgerda</italic> Bergh, 1880 (Mollusca: Nudibranchia) and their ecological and evolutionary implications</article-title><source>J. Chem. Ecol.</source><year>2007</year><volume>33</volume><fpage>1226</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1007/s10886-007-9288-z</pub-id><pub-id pub-id-type="pmid">17457663</pub-id></element-citation></ref><ref id="B842-marinedrugs-18-00657"><label>842.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>M.</given-names></name><name><surname>Yamaguchi</surname><given-names>Y.</given-names></name><name><surname>Hirano</surname><given-names>Y.J.</given-names></name></person-group><article-title>Bioactive natural products from nudibranchs</article-title><source>Biomaterials from Aquatic and Terrestrial Organisms</source><person-group person-group-type="editor"><name><surname>Fingerman</surname><given-names>M.</given-names></name><name><surname>Nagabhushanam</surname><given-names>R.</given-names></name></person-group><publisher-name>Science Publishers</publisher-name><publisher-loc>Enfield, NH, USA</publisher-loc><year>2006</year><fpage>513</fpage><lpage>535</lpage></element-citation></ref><ref id="B843-marinedrugs-18-00657"><label>843.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramya</surname><given-names>M.S.</given-names></name><name><surname>Sivasubramanian</surname><given-names>K.</given-names></name><name><surname>Ravichandran</surname><given-names>S.</given-names></name><name><surname>Anbuchezhian</surname><given-names>R.</given-names></name></person-group><article-title>Screening of antimicrobial compound from the sea slug <italic>Armina babai</italic></article-title><source>Bangladesh J. Pharmacol.</source><year>2014</year><volume>9</volume><fpage>268</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.3329/bjp.v9i3.18483</pub-id></element-citation></ref><ref id="B844-marinedrugs-18-00657"><label>844.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Seo</surname><given-names>Y.</given-names></name></person-group><article-title>Isolation of new ceramides from the gorgonian <italic>Acabaria undulata</italic></article-title><source>J. Nat. Prod.</source><year>1995</year><volume>58</volume><fpage>948</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1021/np50120a022</pub-id></element-citation></ref><ref id="B845-marinedrugs-18-00657"><label>845.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>M.E.</given-names></name><name><surname>Pawlik</surname><given-names>J.R.</given-names></name><name><surname>Duffy</surname><given-names>J.E.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Seaweed-herbivore-predator interactions: Host-plant specialization reduces predation on small herbivores</article-title><source>Oecologia</source><year>1989</year><volume>81</volume><fpage>418</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1007/BF00377093</pub-id><?supplied-pmid 28311198?><pub-id pub-id-type="pmid">28311198</pub-id></element-citation></ref><ref id="B846-marinedrugs-18-00657"><label>846.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Chemical defense in tropical green algae, order Caulerpales</article-title><source>Mar. Ecol. Prog. Ser.</source><year>1986</year><volume>34</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.3354/meps034157</pub-id></element-citation></ref><ref id="B847-marinedrugs-18-00657"><label>847.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>Angerhofer</surname><given-names>C.K.</given-names></name><name><surname>Greenidge</surname><given-names>P.</given-names></name><name><surname>Linden</surname><given-names>A.</given-names></name><name><surname>Desqueyroux-Faundez</surname><given-names>R.</given-names></name></person-group><article-title>Antimalarial activity: The search for marine-derived natural products with selective antimalarial activity</article-title><source>J. Nat. Prod.</source><year>1996</year><volume>59</volume><fpage>710</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1021/np9602325</pub-id><?supplied-pmid 8759172?><pub-id pub-id-type="pmid">8759172</pub-id></element-citation></ref><ref id="B848-marinedrugs-18-00657"><label>848.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angerhofer</surname><given-names>C.K.</given-names></name><name><surname>Pezzuto</surname><given-names>J.M.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>Sticher</surname><given-names>O.</given-names></name></person-group><article-title>Antimalarial activity of sesquiterpenes from the marine sponge <italic>Acanthella klethra</italic></article-title><source>J. Nat. Prod.</source><year>1992</year><volume>55</volume><fpage>1787</fpage><lpage>1789</lpage><pub-id pub-id-type="doi">10.1021/np50090a014</pub-id><?supplied-pmid 1294700?><pub-id pub-id-type="pmid">1294700</pub-id></element-citation></ref><ref id="B849-marinedrugs-18-00657"><label>849.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Gurrath</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name><name><surname>Kocak</surname><given-names>G.</given-names></name><name><surname>Neumann</surname><given-names>G.</given-names></name><name><surname>Loria</surname><given-names>P.</given-names></name><name><surname>Foley</surname><given-names>M.</given-names></name><name><surname>Tilley</surname><given-names>L.</given-names></name></person-group><article-title>Inhibition of heme detoxification processes underlies the antimalarial activity of terpene isonitrile compounds from marine sponges</article-title><source>J. Med. Chem.</source><year>2001</year><volume>44</volume><fpage>873</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1021/jm0010724</pub-id><pub-id pub-id-type="pmid">11300869</pub-id></element-citation></ref><ref id="B850-marinedrugs-18-00657"><label>850.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>A.M.</given-names></name><name><surname>Dao</surname><given-names>K.</given-names></name><name><surname>Vrubliauskas</surname><given-names>D.</given-names></name><name><surname>K&#x000f6;nst</surname><given-names>Z.A.</given-names></name><name><surname>Pierens</surname><given-names>G.K.</given-names></name><name><surname>M&#x000e1;ndi</surname><given-names>A.</given-names></name><name><surname>Andrews</surname><given-names>K.T.</given-names></name><name><surname>Skinner-Adams</surname><given-names>T.S.</given-names></name><name><surname>Clarke</surname><given-names>M.E.</given-names></name><name><surname>Narbutas</surname><given-names>P.T.</given-names></name><etal/></person-group><article-title>Catalyst-controlled stereoselective synthesis secures the structure of the antimalarial isocyanoterpene pustulosaisonitrile-1</article-title><source>J. Org. Chem.</source><year>2017</year><volume>82</volume><fpage>13313</fpage><lpage>13323</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.7b02421</pub-id><pub-id pub-id-type="pmid">29124922</pub-id></element-citation></ref><ref id="B851-marinedrugs-18-00657"><label>851.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.S.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Bader</surname><given-names>J.P.</given-names></name></person-group><article-title>Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>265</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1021/np0003995</pub-id><pub-id pub-id-type="pmid">11430019</pub-id></element-citation></ref><ref id="B852-marinedrugs-18-00657"><label>852.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Snader</surname><given-names>K.M.</given-names></name></person-group><article-title>The influence of natural products upon drug discovery</article-title><source>Nat. Prod. Rep.</source><year>2000</year><volume>17</volume><fpage>175</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1039/a902202c</pub-id><pub-id pub-id-type="pmid">10821112</pub-id></element-citation></ref><ref id="B853-marinedrugs-18-00657"><label>853.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gochfeld</surname><given-names>D.J.</given-names></name><name><surname>El Sayed</surname><given-names>K.A.</given-names></name><name><surname>Yousaf</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Bartyzel</surname><given-names>P.</given-names></name><name><surname>Dunbar</surname><given-names>D.C.</given-names></name><name><surname>Wilkins</surname><given-names>S.P.</given-names></name><name><surname>Zjawiony</surname><given-names>J.K.</given-names></name><name><surname>Schinazi</surname><given-names>R.F.</given-names></name><name><surname>Schlueter-Wirtz</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Marine natural products as lead anti-HIV agents</article-title><source>Mini-Rev. Med. Chem.</source><year>2003</year><volume>3</volume><fpage>401</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.2174/1389557033487962</pub-id><pub-id pub-id-type="pmid">12769693</pub-id></element-citation></ref><ref id="B854-marinedrugs-18-00657"><label>854.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitj&#x000e0;</surname><given-names>O.</given-names></name><name><surname>Clotet</surname><given-names>B.</given-names></name></person-group><article-title>Use of antiviral drugs to reduce COVID-19 transmission</article-title><source>Lancet Glob. Health</source><year>2020</year><volume>8</volume><fpage>e639</fpage><lpage>e640</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(20)30114-5</pub-id><pub-id pub-id-type="pmid">32199468</pub-id></element-citation></ref><ref id="B855-marinedrugs-18-00657"><label>855.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Tietjen</surname><given-names>I.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Williams</surname><given-names>D.E.</given-names></name><name><surname>Daoust</surname><given-names>J.</given-names></name><name><surname>Brockman</surname><given-names>M.A.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Sesterterpenoids isolated from the sponge <italic>Phorbas</italic> sp. activate latent HIV-1 provirus expression</article-title><source>J. Org. Chem.</source><year>2016</year><volume>81</volume><fpage>11324</fpage><lpage>11334</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.6b02312</pub-id><?supplied-pmid 27768313?><pub-id pub-id-type="pmid">27768313</pub-id></element-citation></ref><ref id="B856-marinedrugs-18-00657"><label>856.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>R.S.</given-names></name><name><surname>Bober</surname><given-names>M.A.</given-names></name><name><surname>Pinto</surname><given-names>I.</given-names></name><name><surname>Williams</surname><given-names>A.B.</given-names></name><name><surname>Jacobson</surname><given-names>P.B.</given-names></name><name><surname>de Carvalho</surname><given-names>M.S.</given-names></name></person-group><article-title>Pharmacological studies of marine novel marine metabolites</article-title><source>Advances in Marine Biotechnology</source><person-group person-group-type="editor"><name><surname>Attaway</surname><given-names>D.H.</given-names></name><name><surname>Zaborsky</surname><given-names>O.R.</given-names></name></person-group><publisher-name>Plenum Press</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1993</year><volume>Volume 1</volume><fpage>77</fpage><lpage>99</lpage></element-citation></ref><ref id="B857-marinedrugs-18-00657"><label>857.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Minale</surname><given-names>L.</given-names></name></person-group><article-title>Scalaradial, a third sesterterpene with the tetracarbocyclic skeleton of scalarin, from the sponge <italic>Cacospongia mollior</italic></article-title><source>Experientia</source><year>1974</year><volume>30</volume><fpage>846</fpage><lpage>847</lpage></element-citation></ref><ref id="B858-marinedrugs-18-00657"><label>858.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Carvalho</surname><given-names>M.S.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name></person-group><article-title>Two-step inactivation of bee venom phospholipase A2 by scalaradial</article-title><source>Biochem. Pharm.</source><year>1991</year><volume>42</volume><fpage>1621</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(91)90432-5</pub-id><pub-id pub-id-type="pmid">1930288</pub-id></element-citation></ref><ref id="B859-marinedrugs-18-00657"><label>859.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>A.P.</given-names></name><name><surname>Lobo-da-Cunha</surname><given-names>A.</given-names></name><name><surname>Taveira</surname><given-names>M.</given-names></name><name><surname>Ferreira</surname><given-names>M.</given-names></name><name><surname>Valent&#x000e3;o</surname><given-names>P.</given-names></name><name><surname>Andrade</surname><given-names>P.B.</given-names></name></person-group><article-title>Digestive gland from <italic>Aplysia depilans</italic> Gmelin: Leads for inflammation treatment</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>15766</fpage><lpage>15780</lpage><pub-id pub-id-type="doi">10.3390/molecules200915766</pub-id><pub-id pub-id-type="pmid">26343629</pub-id></element-citation></ref><ref id="B860-marinedrugs-18-00657"><label>860.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Romero</surname><given-names>C.</given-names></name><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>Rodriguez</surname><given-names>A.D.</given-names></name></person-group><article-title>Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from <italic>Aplysia dactylomela</italic> with significant in vitro anti-neuroinflammatory activity</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2014</year><volume>24</volume><fpage>344</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.11.008</pub-id><pub-id pub-id-type="pmid">24279991</pub-id></element-citation></ref><ref id="B861-marinedrugs-18-00657"><label>861.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammed</surname><given-names>K.A.</given-names></name><name><surname>Hossain</surname><given-names>C.F.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Bruick</surname><given-names>R.K.</given-names></name><name><surname>Zhou</surname><given-names>Y.D.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name></person-group><article-title>Laurenditerpenol, a new diterpene from the tropical marine alga <italic>Laurencia intricata</italic> that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>2002</fpage><lpage>2007</lpage><pub-id pub-id-type="doi">10.1021/np049753f</pub-id><pub-id pub-id-type="pmid">15620241</pub-id></element-citation></ref><ref id="B862-marinedrugs-18-00657"><label>862.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>D.Y.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name></person-group><article-title>Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer&#x02019;s disease, Parkinson&#x02019;s disease and ischemic brain stroke: Their molecular targets and action mechanisms</article-title><source>Arch. Pharm. Res.</source><year>2015</year><volume>38</volume><fpage>139</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1007/s12272-014-0503-5</pub-id><pub-id pub-id-type="pmid">25348867</pub-id></element-citation></ref><ref id="B863-marinedrugs-18-00657"><label>863.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leiros</surname><given-names>M.</given-names></name><name><surname>Alonso</surname><given-names>E.</given-names></name><name><surname>Rateb</surname><given-names>M.E.</given-names></name><name><surname>Houssen</surname><given-names>W.E.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Jaspars</surname><given-names>M.</given-names></name><name><surname>Alfonso</surname><given-names>A.</given-names></name><name><surname>Botana</surname><given-names>L.M.</given-names></name></person-group><article-title>Gracilins: Spongionella-derived promising compounds for Alzheimer disease</article-title><source>Neuropharmacol.</source><year>2015</year><volume>93</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.02.015</pub-id></element-citation></ref><ref id="B864-marinedrugs-18-00657"><label>864.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorach-Pares</surname><given-names>L.</given-names></name><name><surname>Rodriguez-Urgelles</surname><given-names>E.</given-names></name><name><surname>Nonell-Canals</surname><given-names>A.</given-names></name><name><surname>Alberch</surname><given-names>J.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Sanchez-Martinez</surname><given-names>M.</given-names></name><name><surname>Giralt</surname><given-names>A.</given-names></name></person-group><article-title>Meridianins and Lignarenone B as Potential GSK3&#x003b2; Inhibitors and Inductors of Structural Neuronal Plasticity</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>639</elocation-id><pub-id pub-id-type="doi">10.3390/biom10040639</pub-id></element-citation></ref><ref id="B865-marinedrugs-18-00657"><label>865.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>L.</given-names></name><name><surname>Flajolet</surname><given-names>M.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group><article-title>Pharmacological inhibitors of glycogen synthase kinase 3</article-title><source>Trends Pharmacol. Sci.</source><year>2004</year><volume>25</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2004.07.006</pub-id><?supplied-pmid 15559249?><pub-id pub-id-type="pmid">15559249</pub-id></element-citation></ref><ref id="B866-marinedrugs-18-00657"><label>866.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>M.K.</given-names></name><name><surname>Alkon</surname><given-names>D.L.</given-names></name></person-group><article-title>Bryostatin-1: Pharmacology and Therapeutic Potential as a CNS Drug</article-title><source>CNS Drug Rev.</source><year>2006</year><volume>12</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1527-3458.2006.00001.x</pub-id><?supplied-pmid 16834754?><pub-id pub-id-type="pmid">16834754</pub-id></element-citation></ref><ref id="B867-marinedrugs-18-00657"><label>867.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>Spinella</surname><given-names>A.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Potential alarm pheromones from the Mediterranean opisthobranch <italic>Scaphander lignarius</italic></article-title><source>Tetrahedron Lett.</source><year>1989</year><volume>30</volume><fpage>5003</fpage><lpage>5004</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)80566-9</pub-id></element-citation></ref><ref id="B868-marinedrugs-18-00657"><label>868.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>W.J.</given-names></name><name><surname>Mpitsos</surname><given-names>G.J.</given-names></name></person-group><article-title>Behavioral choice and habituation in the marine mollusk <italic>Pleurobranchaea californica</italic> MacFarland (Gastropoda, Opisthobranchia)</article-title><source>Z. Vgl. Physiol.</source><year>1971</year><volume>75</volume><fpage>207</fpage><lpage>232</lpage></element-citation></ref><ref id="B869-marinedrugs-18-00657"><label>869.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNabb</surname><given-names>P.</given-names></name><name><surname>Selwood</surname><given-names>A.I.</given-names></name><name><surname>Munday</surname><given-names>R.</given-names></name><name><surname>Wood</surname><given-names>S.A.</given-names></name><name><surname>Taylor</surname><given-names>D.I.</given-names></name><name><surname>MacKenzie</surname><given-names>L.A.</given-names></name><name><surname>van Ginkel</surname><given-names>R.</given-names></name><name><surname>Rhodes</surname><given-names>L.L.</given-names></name><name><surname>Cornelisen</surname><given-names>C.</given-names></name><name><surname>Heasman</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Detection of tetrodotoxin from the grey side-gilled sea slug <italic>Pleurobranchaea maculata</italic>, and associated dog neurotoxicosis on beaches adjacent to the Hauraki Gulf, Auckland, New Zealand</article-title><source>Toxicon</source><year>2010</year><volume>56</volume><fpage>466</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2010.04.017</pub-id><pub-id pub-id-type="pmid">20466016</pub-id></element-citation></ref><ref id="B870-marinedrugs-18-00657"><label>870.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvitti</surname><given-names>L.R.</given-names></name><name><surname>Wood</surname><given-names>S.A.</given-names></name><name><surname>Winsor</surname><given-names>L.</given-names></name><name><surname>Cary</surname><given-names>S.C.</given-names></name></person-group><article-title>Intracellular immunohistochemical detection of tetrodotoxin in <italic>Pleurobranchaea maculata</italic> (Gastropoda) and <italic>Stylochoplana</italic> sp. (Turbellaria)</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>756</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.3390/md13020756</pub-id><pub-id pub-id-type="pmid">25636158</pub-id></element-citation></ref><ref id="B871-marinedrugs-18-00657"><label>871.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chau</surname><given-names>R.</given-names></name><name><surname>Kalaitzis</surname><given-names>J.A.</given-names></name><name><surname>Neilan</surname><given-names>B.A.</given-names></name></person-group><article-title>On the origins and biosynthesis of tetrodotoxin</article-title><source>Aquat. Toxicol.</source><year>2011</year><volume>104</volume><fpage>61</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.aquatox.2011.04.001</pub-id><pub-id pub-id-type="pmid">21543051</pub-id></element-citation></ref><ref id="B872-marinedrugs-18-00657"><label>872.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvitti</surname><given-names>L.R.</given-names></name><name><surname>Wood</surname><given-names>S.A.</given-names></name><name><surname>Fairweather</surname><given-names>R.</given-names></name><name><surname>Cary</surname><given-names>S.C.</given-names></name></person-group><article-title>In situ accumulation of tetrodotoxin in non-toxic <italic>Pleurobranchaea maculata</italic> (Opisthobranchia)</article-title><source>Aquat. Sci.</source><year>2016</year><volume>79</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s00027-016-0500-5</pub-id></element-citation></ref><ref id="B873-marinedrugs-18-00657"><label>873.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hringer</surname><given-names>N.</given-names></name><name><surname>Fisch</surname><given-names>K.M.</given-names></name><name><surname>Schillo</surname><given-names>D.</given-names></name><name><surname>Bara</surname><given-names>R.</given-names></name><name><surname>Hertzer</surname><given-names>C.</given-names></name><name><surname>Grein</surname><given-names>F.</given-names></name><name><surname>Eisenbarth</surname><given-names>J.-H.</given-names></name><name><surname>Kaligis</surname><given-names>F.</given-names></name><name><surname>Schneider</surname><given-names>T.</given-names></name><name><surname>W&#x000e4;gele</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Antimicrobial potential of bacteria associated with marine sea slugs from North Sulawesi, Indonesia</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1092</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01092</pub-id><pub-id pub-id-type="pmid">28659904</pub-id></element-citation></ref><ref id="B874-marinedrugs-18-00657"><label>874.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisch</surname><given-names>K.M.</given-names></name><name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name></person-group><article-title>Toolbox for antibiotics discovery from microorganisms</article-title><source>Arch. Pharm.</source><year>2016</year><volume>349</volume><fpage>683</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1002/ardp.201600064</pub-id></element-citation></ref><ref id="B875-marinedrugs-18-00657"><label>875.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Developing natural product drugs: Supply problems and how they have been overcome</article-title><source>Pharmacol. Ther.</source><year>2016</year><volume>162</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.12.002</pub-id><?supplied-pmid 26706239?><pub-id pub-id-type="pmid">26706239</pub-id></element-citation></ref><ref id="B876-marinedrugs-18-00657"><label>876.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosta</surname><given-names>L.</given-names></name><name><surname>Pla-Roca</surname><given-names>M.</given-names></name><name><surname>Arbiol</surname><given-names>J.</given-names></name><name><surname>L&#x000f3;pez-Iglesias</surname><given-names>C.</given-names></name><name><surname>Samitier</surname><given-names>J.</given-names></name><name><surname>Cruz</surname><given-names>L.J.</given-names></name><name><surname>Kogan</surname><given-names>M.J.</given-names></name><name><surname>Albericio</surname><given-names>F.</given-names></name></person-group><article-title>Conjugation of Kahalalide F with gold nanoparticles to enhance in vitro antitumoral activity</article-title><source>Bioconjugate Chem.</source><year>2009</year><volume>20</volume><fpage>138</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1021/bc800362j</pub-id><?supplied-pmid 19072538?><pub-id pub-id-type="pmid">19072538</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="marinedrugs-18-00657-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structures of selected compounds used against predation in some Doridacea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g001"/></fig><fig id="marinedrugs-18-00657-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Structures of selected compounds used against predation in some Doridacea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g002"/></fig><fig id="marinedrugs-18-00657-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Structures of selected compounds used against predation in some Doridacea, Dendronotida, Euarminida, Aeolidida, Pleurobranchoidea, Tylodinoidea, and some Cephalaspidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g003"/></fig><fig id="marinedrugs-18-00657-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Structures of selected compounds used against predation in some Cephalaspidea, Anaspidea, Pteropoda, and Sacoglossa. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g004"/></fig><fig id="marinedrugs-18-00657-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Structures of selected compounds used against predation in Pulmonata. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g005"/></fig><fig id="marinedrugs-18-00657-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Structures of selected compounds displaying toxicity in Doridacea, Dendronotida, Euarminida, Tylodinoidea, and Cephalaspidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g006"/></fig><fig id="marinedrugs-18-00657-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Structures of selected compounds displaying toxicity in Anaspidea, Sacoglossa, and Pulmonata. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g007"/></fig><fig id="marinedrugs-18-00657-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Structures of selected antimicrobial compounds in heterobranch molluscs. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g008"/></fig><fig id="marinedrugs-18-00657-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Structures of selected antifouling compounds, pheromones, tissue regeneration compounds, sunscreens, and other ecological activities in heterobranch molluscs. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g009"/></fig><fig id="marinedrugs-18-00657-f010" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some heterobranch molluscs. These molecules may also display other activities, as reported in the text. * = compounds in clinical trials.</p></caption><graphic xlink:href="marinedrugs-18-00657-g010"/></fig><fig id="marinedrugs-18-00657-f011" orientation="portrait" position="float"><label>Figure 11</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Doridacea nudibranchs. These molecules may also display other activities, as reported in the text. * = compounds in clinical trials.</p></caption><graphic xlink:href="marinedrugs-18-00657-g011"/></fig><fig id="marinedrugs-18-00657-f012" orientation="portrait" position="float"><label>Figure 12</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Doridacea nudibranchs. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g012"/></fig><fig id="marinedrugs-18-00657-f013" orientation="portrait" position="float"><label>Figure 13</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Doridacea nudibranchs. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g013"/></fig><fig id="marinedrugs-18-00657-f014" orientation="portrait" position="float"><label>Figure 14</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Dendronotida, Euarminida, and Aeolidida nudibranchs, and Pleurobranchoidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g014"/></fig><fig id="marinedrugs-18-00657-f015" orientation="portrait" position="float"><label>Figure 15</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Pleurobranchoidea, Tylodinoidea, and Cephalaspidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g015"/></fig><fig id="marinedrugs-18-00657-f016" orientation="portrait" position="float"><label>Figure 16</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Anaspidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g016"/></fig><fig id="marinedrugs-18-00657-f017" orientation="portrait" position="float"><label>Figure 17</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Anaspidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g017"/></fig><fig id="marinedrugs-18-00657-f018" orientation="portrait" position="float"><label>Figure 18</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Anaspidea. These molecules may also display other activities, as reported in the text. * = compounds in clinical trials.</p></caption><graphic xlink:href="marinedrugs-18-00657-g018"/></fig><fig id="marinedrugs-18-00657-f019" orientation="portrait" position="float"><label>Figure 19</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Anaspidea. These molecules may also display other activities, as reported in the text. * = compounds in clinical trials.</p></caption><graphic xlink:href="marinedrugs-18-00657-g019"/></fig><fig id="marinedrugs-18-00657-f020" orientation="portrait" position="float"><label>Figure 20</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Anaspidea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g020"/></fig><fig id="marinedrugs-18-00657-f021" orientation="portrait" position="float"><label>Figure 21</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Anaspidea. These molecules may also display other activities, as reported in the text. * = compounds in clinical trials.</p></caption><graphic xlink:href="marinedrugs-18-00657-g021"/></fig><fig id="marinedrugs-18-00657-f022" orientation="portrait" position="float"><label>Figure 22</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Sacoglossa and Pulmonata. These molecules may also display other activities, as reported in the text. * = compounds in clinical trials.</p></caption><graphic xlink:href="marinedrugs-18-00657-g022"/></fig><fig id="marinedrugs-18-00657-f023" orientation="portrait" position="float"><label>Figure 23</label><caption><p>Structures of selected cytotoxic and antitumoral compounds in some Pulmonata, as well as selected antibiotic compounds in Doridacea, Euarminida, Tylodinoidea, Anaspidea, and Sacoglossa, and an antiparasitic compound from a Doridacea. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g023"/></fig><fig id="marinedrugs-18-00657-f024" orientation="portrait" position="float"><label>Figure 24</label><caption><p>Structures of selected antiparasitic compounds and antivirals from Doridacea and Sacoglossa, anti-inflammatory compounds from Anaspidea, and compounds with other pharmacological activities in heterobranch molluscs. These molecules may also display other activities, as reported in the text.</p></caption><graphic xlink:href="marinedrugs-18-00657-g024"/></fig><fig id="marinedrugs-18-00657-f025" orientation="portrait" position="float"><label>Figure 25</label><caption><p>Number of species with bioactive compounds in the different heterobranch groups.</p></caption><graphic xlink:href="marinedrugs-18-00657-g025"/></fig><table-wrap id="marinedrugs-18-00657-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t001_Table 1</object-id><label>Table 1</label><caption><p>Species number and natural products numbers (NPs) for the different heterobranch groups [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>,<xref rid="B49-marinedrugs-18-00657" ref-type="bibr">49</xref>,<xref rid="B50-marinedrugs-18-00657" ref-type="bibr">50</xref>]. * Accepted species number obtained from WoRMs (www.marinespecies.org), accessed on 11 November 2020). ** Natural products&#x02019; number, main types of molecules, and diet according to Avila et al. [<xref rid="B2-marinedrugs-18-00657" ref-type="bibr">2</xref>]. *** Only marine pulmonata are considered here. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phylum Mollusca Class Gastropoda Subclass Heterobranchia</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species #* 80548 33193</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">NPs #**</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Types of Molecules **</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Diet **</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nudibranchia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2462</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~250</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoids, alkaloids, macrolides, peptides, acidic secretions, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Porifera, bryozoa, tunicata, cnidaria, other heterobranchs, crustacea, turbellaria </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pleurobranchoidea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoids, alkaloids, peptides, acidic secretions, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tunicates, other animals</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tylodinoidea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloids, diacylglycerols, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Porifera</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cephalaspidea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">875</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyketides, polypropionates, polyacetates, ethers, acidic secretions, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Algae, other heterobranchs, porifera, other animals</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anaspidea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyketides, terpenoids, peptides, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Algae, sea grasses, cyanobacteria</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pteropoda</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">409</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polypropionates, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phytoplankton, other pteropods</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sacoglossa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">362</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~120</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoids, polypropionates, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Algae</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pulmonata</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 ***</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~75</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polypropionates, terpenoids, peptides, etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Algae</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t002_Table 2</object-id><label>Table 2</label><caption><p>Natural products used against predation in the different heterobranch groups. In brackets: number of species with antipredatory compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Predator(s) Tested</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (68)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bathydoris hodgsoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hodgsonal (<bold>1</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sea star <italic>Odontaster validus,</italic> anemone <italic>Epiactis</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-marinedrugs-18-00657" ref-type="bibr">54</xref>,<xref rid="B55-marinedrugs-18-00657" ref-type="bibr">55</xref>,<xref rid="B56-marinedrugs-18-00657" ref-type="bibr">56</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doris (Austrodoris) kerguelenensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diterpene diacylglycerides (<bold>2</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sea star <italic>Odontaster validus,</italic> anemone <italic>Epiactis</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-marinedrugs-18-00657" ref-type="bibr">58</xref>,<xref rid="B59-marinedrugs-18-00657" ref-type="bibr">59</xref>,<xref rid="B60-marinedrugs-18-00657" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aldisa sanguinea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-Oxo-chol-4-ene-24-oic acid (<bold>3</bold>), unsaturated analogue (<bold>4</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Goldfish (<italic>Carassius auratus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-marinedrugs-18-00657" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aldisa andersoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Chloro-phorbazole D (<bold>5</bold>), N1-methyl-phorbazole A (<bold>6</bold>), phorbazoles A (<bold>7</bold>), B (<bold>8</bold>), and D (<bold>9</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-marinedrugs-18-00657" ref-type="bibr">54</xref>,<xref rid="B56-marinedrugs-18-00657" ref-type="bibr">56</xref>,<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-18-00657" ref-type="bibr">76</xref>,<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sclerodoris tanya</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tanyolides A (<bold>10</bold>) and B (<bold>11</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fishes (<italic>Gibbonsia elegans</italic> and <italic>Paraclinus integrippinis</italic>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-marinedrugs-18-00657" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Paradoris (Discodoris) indecora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variabilin (<bold>12</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine and freshwater fishes </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-marinedrugs-18-00657" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrodoris limbata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polygodial (<bold>13</bold>), olepupuane (<bold>14</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine and freshwater fishes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-marinedrugs-18-00657" ref-type="bibr">80</xref>,<xref rid="B81-marinedrugs-18-00657" ref-type="bibr">81</xref>,<xref rid="B83-marinedrugs-18-00657" ref-type="bibr">83</xref>,<xref rid="B84-marinedrugs-18-00657" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrodoris arborescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7-Deacetoxyolepupuane (<bold>15</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-marinedrugs-18-00657" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrodoris carbunculosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dendrocarbins A&#x02013;N (<bold>16</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-marinedrugs-18-00657" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrodoris denisoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinnamolide (<bold>17</bold>), olepupuane (<bold>14</bold>), polygodial (<bold>13</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-marinedrugs-18-00657" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriopsilla pelseneeri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pelseneeriols 1 (<bold>18</bold>) and 2, polygodial (<bold>13</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-marinedrugs-18-00657" ref-type="bibr">95</xref>,<xref rid="B99-marinedrugs-18-00657" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriopsilla albopunctata, D. areolata, D. janaina, D. pharpa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>ent</italic>-pallescensin A (<bold>19</bold>), 15-acetoxy-<italic>ent</italic>-pallescensin (<bold>20</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-marinedrugs-18-00657" ref-type="bibr">96</xref>,<xref rid="B97-marinedrugs-18-00657" ref-type="bibr">97</xref>,<xref rid="B99-marinedrugs-18-00657" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriopsilla pharpa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polygodial (<bold>13</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fishes (<italic>Chasmodes bosquianus, Fundulus heteroclitus</italic>), crabs (<italic>Callinectes similus, Panopeus herbstii</italic>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-marinedrugs-18-00657" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia varicosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-<italic>Iso</italic>cyanopupukeanane (<bold>21</bold>), 2-<italic>iso</italic>cyanopupukeanane (<bold>22</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>,<xref rid="B107-marinedrugs-18-00657" ref-type="bibr">107</xref>,<xref rid="B108-marinedrugs-18-00657" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia coelestis, Phyllidiella pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xidaoisocyanate A (<bold>24</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axisonitrile-3 (<bold>25</bold>), amphilectene (<bold>26</bold>), kalihinol A (<bold>27</bold>), kalihinol E (<bold>28</bold>), <italic>ent</italic>-stylotelline (<bold>29</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Goldfish <italic>(C. auratus)</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B120-marinedrugs-18-00657" ref-type="bibr">120</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cadlina luteomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isocyanides (<bold>30</bold>), albicanyl acetate (<bold>31</bold>), cadlinaldehyde (<bold>32</bold>), luteone (<bold>33</bold>), 1a,2a-diacetoxyalbicanyl acetate (<bold>34</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fishes (<italic>Carassius auratura, Clinocottus analis</italic>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B126-marinedrugs-18-00657" ref-type="bibr">126</xref>,<xref rid="B127-marinedrugs-18-00657" ref-type="bibr">127</xref>,<xref rid="B128-marinedrugs-18-00657" ref-type="bibr">128</xref>,<xref rid="B129-marinedrugs-18-00657" ref-type="bibr">129</xref>,<xref rid="B130-marinedrugs-18-00657" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris africana, C. (Glossodoris) quadricolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kurospongin (<bold>36</bold>), latrunculin B (<bold>37</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish (<italic>Tilapia mosambica</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-marinedrugs-18-00657" ref-type="bibr">167</xref>,<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>,<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris hamiltoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Latrunculins A (<bold>38</bold>) and B (<bold>37</bold>), hamiltonins A&#x02013;E (<bold>41</bold>,<bold>42</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glossodoris vespa, G. averni, G. pallida</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-Deacetoxy-12-oxoscalaradial (<bold>43</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp (<italic>Palaemon serenus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B177-marinedrugs-18-00657" ref-type="bibr">177</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glossodoris pallida</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scalaradial (<bold>44</bold>), deacetylscalaradial (<bold>45</bold>), deoxoscalarin (<bold>46</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crabs (<italic>Leptodius</italic> sp.), fish (<italic>Abudefduf sexfasciatus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B176-marinedrugs-18-00657" ref-type="bibr">176</xref>,<xref rid="B177-marinedrugs-18-00657" ref-type="bibr">177</xref>,<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ceratosoma trilobatum, C. gracillimum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pallescensin B (<bold>47</bold>), (&#x02013;)-furodysinin (<bold>48</bold>), (&#x02013;)-dehydroherbadysidolide (<bold>49</bold>), (&#x02013;)-herbadysidolide (<bold>50</bold>), nakafuran-9 (<bold>51</bold>), dendrolasin (<bold>55</bold>), furodysin (<bold>58</bold>), agassizin (<bold>59</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Goldfish (<italic>C. auratus</italic>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B193-marinedrugs-18-00657" ref-type="bibr">193</xref>,<xref rid="B194-marinedrugs-18-00657" ref-type="bibr">194</xref>,<xref rid="B195-marinedrugs-18-00657" ref-type="bibr">195</xref>,<xref rid="B196-marinedrugs-18-00657" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimare (Hypselodoris) picta webbi, F. (Hypselodoris) villafranca, F. (Hypselodoris) cantabrica, F. (Hypselodoris) tricolor, F. (Hypselodoris) fontandraui</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Longifolin (<bold>52</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp (<italic>P. elegans</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B124-marinedrugs-18-00657" ref-type="bibr">124</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimare (Hypselodoris) fontandraui</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tavacpallescensin (<bold>53</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp (<italic>P. elegans</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B205-marinedrugs-18-00657" ref-type="bibr">205</xref>,<xref rid="B211-marinedrugs-18-00657" ref-type="bibr">211</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris capensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nakafuran-8 and -9 (<bold>54</bold>,<bold>51</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B213-marinedrugs-18-00657" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris obscura</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dendrolasin (<bold>55</bold>), (&#x02013;)-euryfuran (<bold>56</bold>), (+)-pallescensin A (<bold>57</bold>), (&#x02013;)-furodysinin (<bold>48</bold>), (&#x02013;)-furodysin (<bold>58</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris whitei</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02013;)-Euryfuran (<bold>56</bold>), (&#x02013;)-furodysin (<bold>58</bold>), (&#x02013;)-furosydinin (<bold>48</bold>), dendrolasin (<bold>55</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris infucata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nakafuran-8 and -9 (<bold>54</bold>,<bold>51</bold>), (&#x02013;)-furodysinin (<bold>48</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp (<italic>Penaeus vannamei</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>,<xref rid="B186-marinedrugs-18-00657" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris benneti</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Euryfuran (<bold>56</bold>), agassizin (<bold>59</bold>), dehydroherbadysidolide (<bold>49</bold>), pallescensone (<bold>60</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris (Risbecia) tryoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dehydroherbadysidolide (<bold>49</bold>), furodysinin (<bold>48</bold>), nakafuran-9 (<bold>51</bold>), dendrolasin (<bold>55</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris kanga</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furodysinin (<bold>48</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris lajensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furodysinin lactone (<bold>61</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B207-marinedrugs-18-00657" ref-type="bibr">207</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mexichromis festiva</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Euryfuran (<bold>56</bold>), dendrolasin (<bold>55</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mexichromis marieri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Euryfuran (<bold>56</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hexabranchus sanguineus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kabiramide C (<bold>62</bold>), dihydrohalichondramide (<bold>63</bold>), sanguinamides A (<bold>64</bold>) and B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish (<italic>Thalassoma lunare),</italic> crab (<italic>Dardanus megistos)</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B217-marinedrugs-18-00657" ref-type="bibr">217</xref>,<xref rid="B218-marinedrugs-18-00657" ref-type="bibr">218</xref>,<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>,<xref rid="B220-marinedrugs-18-00657" ref-type="bibr">220</xref>,<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>,<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tambja abdere, T. eliora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tambjamines A&#x02013;F (<bold>65</bold>&#x02013;<bold>70</bold>), tambjamine aldehyde (<bold>71</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B160-marinedrugs-18-00657" ref-type="bibr">160</xref>,<xref rid="B224-marinedrugs-18-00657" ref-type="bibr">224</xref>,<xref rid="B225-marinedrugs-18-00657" ref-type="bibr">225</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Roboastra tigris, Nembrotha</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tambjamines A&#x02013;F (<bold>65</bold>&#x02013;<bold>70</bold>), tambjamine aldehyde (<bold>71</bold>), tetrapyrrol (<bold>72</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B137-marinedrugs-18-00657" ref-type="bibr">137</xref>,<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>,<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>,<xref rid="B227-marinedrugs-18-00657" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tritonia hamnerorum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Julieannafuran (<bold>73</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B229-marinedrugs-18-00657" ref-type="bibr">229</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tritoniella belli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1-O-hexadecyl glycerol (<bold>74</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seastar (<italic>O. validus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B230-marinedrugs-18-00657" ref-type="bibr">230</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tritoniopsis elegans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tritoniopsins A&#x02013;D (<bold>75</bold>&#x02013;<bold>78</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B234-marinedrugs-18-00657" ref-type="bibr">234</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Marionia blainvillea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tethys fimbria, Melibe viridis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PGE<sub>2</sub>-1,15-lactone (<bold>80</bold>), PGE<sub>3</sub>-1,15-lactone (<bold>81</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Charcotia granulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Granuloside (<bold>82</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seastar (<italic>O. validus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B241-marinedrugs-18-00657" ref-type="bibr">241</xref>,<xref rid="B242-marinedrugs-18-00657" ref-type="bibr">242</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cratena pilata, Cuthona gymnota, Hermissenda crassicornis, Phestilla lugubris, Cuthona coerulea, Flabellina exoptata, F. ischitana, F. pedata, F. affinis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllodesmium magnum, Phyllodesmium guamensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11&#x003b2;-Acetoxypukalide (<bold>83</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pufferfish (<italic>Canthigaster solandri</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B236-marinedrugs-18-00657" ref-type="bibr">236</xref>,<xref rid="B249-marinedrugs-18-00657" ref-type="bibr">249</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllodesmium longicirrum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trocheliophorol (<bold>84</bold>), 4-oxochatancin (<bold>85</bold>), (2S)-<italic>iso</italic>sarcophytoxide (<bold>86</bold>), cembranoid bisepoxide 12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pufferfish (<italic>Canthigaster solandri</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B245-marinedrugs-18-00657" ref-type="bibr">245</xref>,<xref rid="B250-marinedrugs-18-00657" ref-type="bibr">250</xref>,<xref rid="B251-marinedrugs-18-00657" ref-type="bibr">251</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Tylodinoidea (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tylodina fungina, T. perversa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,5-Dibromotyrosine (<bold>87</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B256-marinedrugs-18-00657" ref-type="bibr">256</xref>,<xref rid="B257-marinedrugs-18-00657" ref-type="bibr">257</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tylodina corticalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bromotyrosine-derived alkaloids </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B258-marinedrugs-18-00657" ref-type="bibr">258</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (9)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bulla striata, Philinopsis depicta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aglajnes 1&#x02013;3 (<bold>88</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish <italic>(C. auratus)</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B269-marinedrugs-18-00657" ref-type="bibr">269</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bulla gouldiana, Navanax inermis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pulo&#x02019;upone (<bold>90</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aglaja tricolorata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reef fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea cymbalum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kumepaloxane (<bold>91</bold>), tetrahydropyran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Porcupine fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B280-marinedrugs-18-00657" ref-type="bibr">280</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea cyanomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetrahydropyran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp <italic>(P. elegans)</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sagaminopteron nigropunctatum, S. psychedelicum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,5 Dibromo-2-(2&#x02032;,4&#x02032;-dibromo-phenoxy)phenol (<bold>92</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (5)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia californica, A. dactylomela, A. parvula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysioviolin (<bold>93</bold>), phycoerythrobilin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blue crabs, lobsters</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B289-marinedrugs-18-00657" ref-type="bibr">289</xref>,<xref rid="B290-marinedrugs-18-00657" ref-type="bibr">290</xref>,<xref rid="B292-marinedrugs-18-00657" ref-type="bibr">292</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia parvula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apakaochtodene A (<bold>94</bold>) and B, costatone (<bold>95</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-marinedrugs-18-00657" ref-type="bibr">88</xref>,<xref rid="B299-marinedrugs-18-00657" ref-type="bibr">299</xref>,<xref rid="B300-marinedrugs-18-00657" ref-type="bibr">300</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stylocheilus longicauda</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysiatoxin (<bold>96</bold>), debromoaplysiatoxin (<bold>97</bold>), stylocheilamide (<bold>98</bold>), makalika ester (<bold>99</bold>), makalikone ester (<bold>100</bold>), lyngbyatoxin A acetate (<bold>101</bold>), malyngamide A (<bold>104</bold>), malyngamide B, malyngamide O (<bold>102</bold>), and malyngamide P (<bold>103</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish, amphipods, crabs, cephalaspidean</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B302-marinedrugs-18-00657" ref-type="bibr">302</xref>,<xref rid="B303-marinedrugs-18-00657" ref-type="bibr">303</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bursatella leachii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bursatellin (<bold>105</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Fish (<italic>Oreochromis mossambicus</italic> and <italic>Caffragobius gilchristi</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B311-marinedrugs-18-00657" ref-type="bibr">311</xref>,<xref rid="B312-marinedrugs-18-00657" ref-type="bibr">312</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pteropoda (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Clione limacina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pteroenone (<bold>106</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B314-marinedrugs-18-00657" ref-type="bibr">314</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (9)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ascobulla ulla</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascobullin A (<bold>107</bold>) and B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia crispata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crispatenine, onchidal (<bold>108</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia translucens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Udoteal </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish (<italic>Pomacentrus coeruleus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B320-marinedrugs-18-00657" ref-type="bibr">320</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Thuridilla hopei</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thuridillins (<bold>110</bold>), <italic>nor</italic>-thuridillonal (<bold>111</bold>), epoxylactone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shrimp (<italic>P. elegans</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>,<xref rid="B321-marinedrugs-18-00657" ref-type="bibr">321</xref>,<xref rid="B322-marinedrugs-18-00657" ref-type="bibr">322</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Costasiella ocellifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avrainvilleol (<bold>112</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cyerce cristallina, C. nigricans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyercenes (<bold>113</bold>), chlorodesmin (<bold>114</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mosquito fish (<italic>Gambusia affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>,<xref rid="B328-marinedrugs-18-00657" ref-type="bibr">328</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mourgona germaineae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclocymopol (<bold>115</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B330-marinedrugs-18-00657" ref-type="bibr">330</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Placida dendritica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polypropionate &#x003b3;-pyrones (<bold>116</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feeding deterrent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B332-marinedrugs-18-00657" ref-type="bibr">332</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pulmonata (11)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Onchidella binneyi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Onchidal (<bold>108</bold>), ancistrodial (<bold>109</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish and crabs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B319-marinedrugs-18-00657" ref-type="bibr">319</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Peronia peronii, Onchidium ssp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Onchidin (<bold>121</bold>), onchidione (<bold>122</bold>), onchidiol, 4-<italic>epi</italic>-onchidiol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sea stars</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B358-marinedrugs-18-00657" ref-type="bibr">358</xref>,<xref rid="B359-marinedrugs-18-00657" ref-type="bibr">359</xref>,<xref rid="B361-marinedrugs-18-00657" ref-type="bibr">361</xref>,<xref rid="B362-marinedrugs-18-00657" ref-type="bibr">362</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trimusculus costatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Labdanes 6&#x003b2;,7a-diacetoxylab-8,13-dien-15-ol (<bold>117</bold>), 2&#x003b1;,6&#x003b2;,7a-triacetoxylabda-8,13-dien-15-ol (<bold>118</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish (<italic>Pomadasys commersonnii)</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trimusculus reticulatus, T. costatus, T. peruvianus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x003b2;-<italic>iso</italic>valeroxylabda-8,13-dien-7&#x003b1;, 15-diol, 2&#x003b1;,7&#x003b1;-diacetoxy-6/3-<italic>iso</italic>valeroxylabda-8,13-dien- 15-ol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sea stars</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B334-marinedrugs-18-00657" ref-type="bibr">334</xref>,<xref rid="B335-marinedrugs-18-00657" ref-type="bibr">335</xref>,<xref rid="B336-marinedrugs-18-00657" ref-type="bibr">336</xref>,<xref rid="B337-marinedrugs-18-00657" ref-type="bibr">337</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria capensis, S. concinna, S. cristatus, S. serrata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siphonarienolone (<bold>119</bold>), siphonarin A (<bold>120</bold>), diemenensins A and B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B347-marinedrugs-18-00657" ref-type="bibr">347</xref>,<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>] </td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t003_Table 3</object-id><label>Table 3</label><caption><p>Number of toxic compounds in the different heterobranch groups. In brackets: number of species with toxic compounds, number of the compounds in figures, and reference numbers. # NumberSpecies (<bold>#</bold>)<bold>.</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (22)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Archidoris pseudoargus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diterpenoic acid glycerides (<bold>123</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B363-marinedrugs-18-00657" ref-type="bibr">363</xref>,<xref rid="B366-marinedrugs-18-00657" ref-type="bibr">366</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doris verrucosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verrucosins A (<bold>124</bold>) and B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity, potent activators of PKC, and promotion of tentacle regeneration in the freshwater hydrozoan <italic>Hydra vulgaris</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B371-marinedrugs-18-00657" ref-type="bibr">371</xref>,<xref rid="B420-marinedrugs-18-00657" ref-type="bibr">420</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia varicosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-<italic>Iso</italic>cyanopupukeanane (<bold>22</bold>), 9-<italic>iso</italic>cyanopupukeanane (<bold>21</bold>), 2-<italic>iso</italic>cyanoallopupukeanane (<bold>125</bold>), 9-Thiocyanatopupekeanane (<bold>126</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to brine shrimp, killifish (<italic>Oryzias latipes</italic>), and crustaceans</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>,<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia pulitzeri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axisonitrile-1 (<bold>127</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to fish (<italic>Chromis chromis</italic> and <italic>Carassius carassius</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B184-marinedrugs-18-00657" ref-type="bibr">184</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella rosans (P. bourguini)</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-<italic>Iso</italic>cyanopupukeanane (<bold>21</bold>), <italic>epi</italic>-9-<italic>iso</italic>cyanopupukeanane</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to killifish <italic>Oryzias latipes</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B373-marinedrugs-18-00657" ref-type="bibr">373</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cadlina luteomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isocyanides (<bold>30</bold>), isothiocyanates (<bold>128</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to goldfish (<italic>Carassius auratus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B126-marinedrugs-18-00657" ref-type="bibr">126</xref>,<xref rid="B127-marinedrugs-18-00657" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris africana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kurospongin (<bold>36</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-marinedrugs-18-00657" ref-type="bibr">167</xref>,<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris africana, C. quadricolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Latrunculins A (<bold>38</bold>) and B (<bold>37</bold>), kurospongin (<bold>36</bold>), 2-thiazolidinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-marinedrugs-18-00657" ref-type="bibr">167</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>,<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimida (Chromodoris) luteorosea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Norrisolide (<bold>130</bold>), polyrhaphin C (<bold>131</bold>), chelonaplysin C (<bold>132</bold>), luteorosin (<bold>133</bold>), macfarlandin A (<bold>134</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriprismatica (Glossodoris) sedna</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-Deacetyl-23-acetoxy-20-methyl-12-<italic>epi</italic>-scalaradial (<bold>135</bold>), 12-deacetyl-23-acetoxy-20-methyl-12-<italic>epi</italic>-deoxoscalarin, 12-deacetyl-20-methyl-12-<italic>epi</italic>-deoxoscalarin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to <italic>Gambusia affinis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B183-marinedrugs-18-00657" ref-type="bibr">183</xref>,<xref rid="B421-marinedrugs-18-00657" ref-type="bibr">421</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriprismatica (Glossodoris) atromarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-Deacetoxy-12-oxodeoxoscalarin (<bold>136</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to mosquito fish (<italic>G. affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B380-marinedrugs-18-00657" ref-type="bibr">380</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimida (Glossodoris) dalli, Glossodoris rufomarginata, Glossodoris pallida, Glossodoris vespa, Ardeadoris (Glossodoris) averni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homoscalarane, scalarane, 12-deacetyl-23-acetoxy-20-methyl-12-<italic>epi</italic>scalaradial (<bold>135</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to mosquito fish (<italic>G. affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B183-marinedrugs-18-00657" ref-type="bibr">183</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ceratosoma trilobatum, C. gracillimum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pallescensin B (<bold>47</bold>), (-)-furodysinin (<bold>48</bold>), (-)-dehydroherbadysidolide (<bold>49</bold>), (-)-herbadysidolide (<bold>50</bold>), nakafuran-9 (<bold>51</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B193-marinedrugs-18-00657" ref-type="bibr">193</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tethys fimbria, Melibe viridis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostaglandin-1,15-lactones (<bold>80</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to mosquito fish (<italic>G. affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>,<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dermatobranchus ornatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ophirin (<bold>137</bold>), calicophirin B, 13-deacetoxyl calicophirin B, 13-deacetoxyl-3-deacetyl calicophirin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitory activity against the growth of silkworm <italic>Bombyx mori</italic>, and inhibition of cell division in fertilized starfish eggs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B387-marinedrugs-18-00657" ref-type="bibr">387</xref>,<xref rid="B422-marinedrugs-18-00657" ref-type="bibr">422</xref>,<xref rid="B423-marinedrugs-18-00657" ref-type="bibr">423</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Janolus cristatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Janolusimide (<bold>138</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B388-marinedrugs-18-00657" ref-type="bibr">388</xref>,<xref rid="B390-marinedrugs-18-00657" ref-type="bibr">390</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Tylodinoidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Umbraculum mediterraneum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Umbraculumins A&#x02013;C (<bold>139</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to mosquito fish (<italic>G. affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B263-marinedrugs-18-00657" ref-type="bibr">263</xref>,<xref rid="B391-marinedrugs-18-00657" ref-type="bibr">391</xref>,<xref rid="B392-marinedrugs-18-00657" ref-type="bibr">392</xref>,<xref rid="B393-marinedrugs-18-00657" ref-type="bibr">393</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (7)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bulla gouldiana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niuhinone B, <italic>iso</italic>pulo&#x02019;upone (<bold>140</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity and shrimp toxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bulla occidentalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niuhinone B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity and shrimp toxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B274-marinedrugs-18-00657" ref-type="bibr">274</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Navanax inermis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niuhinone-B, <italic>iso</italic>pulo&#x02019;upone (<bold>140</bold>), 5,6-dehydroagajne-3 (<bold>141</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity and shrimp toxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B278-marinedrugs-18-00657" ref-type="bibr">278</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Philinopsis depicta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niuhinone B, aglajne 3 (<bold>88</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to <italic>G. affinis</italic> and <italic>Artemia salina</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B270-marinedrugs-18-00657" ref-type="bibr">270</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Philinopsis speciosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niuhinone A, B, pulo&#x02019;upone (<bold>90</bold>), kulolide-1 (<bold>271</bold>), pupukeamide, tolytoxin-23-acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity and shrimp toxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B272-marinedrugs-18-00657" ref-type="bibr">272</xref>,<xref rid="B273-marinedrugs-18-00657" ref-type="bibr">273</xref>,<xref rid="B275-marinedrugs-18-00657" ref-type="bibr">275</xref>,<xref rid="B276-marinedrugs-18-00657" ref-type="bibr">276</xref>,<xref rid="B277-marinedrugs-18-00657" ref-type="bibr">277</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea cyanomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brominated tetrahydropyran (<bold>142</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to mosquito fish (<italic>G. affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea cymbalum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brominated tetrahydropyran (<bold>142</bold>), kumepaloxane (<bold>91</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxic to mosquito fish (<italic>G. affinis</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B280-marinedrugs-18-00657" ref-type="bibr">280</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (7)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia fasciata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-Acetylaplykurodin-B (<bold>143</bold>), aplykurodinone B (<bold>144</bold>), 3-<italic>epi</italic>-aplykurodinone B (<bold>145</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B396-marinedrugs-18-00657" ref-type="bibr">396</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia juliana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyropheophorbides a and b, halogenated diterpenoid lactone, julianin-S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lethal to crabs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplykurodin B (<bold>146</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B398-marinedrugs-18-00657" ref-type="bibr">398</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia parvula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplyparvunin (<bold>147</bold>), (3<italic>Z</italic>)-bromofucin (<bold>148</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B399-marinedrugs-18-00657" ref-type="bibr">399</xref>,<xref rid="B400-marinedrugs-18-00657" ref-type="bibr">400</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia vaccaria</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crenulides (<bold>149</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B401-marinedrugs-18-00657" ref-type="bibr">401</xref>,<xref rid="B402-marinedrugs-18-00657" ref-type="bibr">402</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia depilans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplyolides A&#x02212;E (<bold>150</bold>&#x02013;<bold>151</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B403-marinedrugs-18-00657" ref-type="bibr">403</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stylocheilus longicauda</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Makalika ester (<bold>99</bold>), makalikone ester (<bold>100</bold>), malyngamide I (<bold>152</bold>), malyngamide O (<bold>102</bold>), malyngamide P (<bold>103</bold>), lyngbyatoxin A acetate (<bold>101</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B302-marinedrugs-18-00657" ref-type="bibr">302</xref>,<xref rid="B303-marinedrugs-18-00657" ref-type="bibr">303</xref>,<xref rid="B304-marinedrugs-18-00657" ref-type="bibr">304</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (15)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Oxynoe panamensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpicin (<bold>153</bold>), caulerpin (<bold>154</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to rats and mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B406-marinedrugs-18-00657" ref-type="bibr">406</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Oxynoe olivacea, Ascobulla fragilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpenyne (<bold>155</bold>), oxytoxin 1 (<bold>156</bold>) and 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B407-marinedrugs-18-00657" ref-type="bibr">407</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobiger serradifalci</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxytoxin 1 (<bold>156</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B407-marinedrugs-18-00657" ref-type="bibr">407</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ascobulla ulla</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascobullin A (<bold>107</bold>) and B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ascobulla ulla, Oxynoe antillarum, Lobiger souberveii, Volvatella</italic> sp., <italic>Elysia subornata, E. patina, E. nisbeti</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpenyne (<bold>155</bold>), oxytoxin-1 (<bold>156</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B409-marinedrugs-18-00657" ref-type="bibr">409</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia expansa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpenyne (<bold>155</bold>), dihydrocaulerpenyne, expansinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ichthyotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Costasiella ocellifera (C. lilianae)</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avrainvilleol (<bold>112</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to sympatric reef fishes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Placida dendritica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Iso</italic>-placidene-A (<bold>116</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strong ichthyotoxicity against <italic>Gambusia affinis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B332-marinedrugs-18-00657" ref-type="bibr">332</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cyerce cristallina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyercene A (<bold>157</bold>) and B, cyercenes 1&#x02013;5 (<bold>158</bold>,<bold>159</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strong ichthyotoxicity against <italic>G. affinis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pulmonata (2)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria maura</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vallartanones B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In laboratory assays against krill and fish (<italic>Thallasoma lunare</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B350-marinedrugs-18-00657" ref-type="bibr">350</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trimusculus costatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x003b2;,7a-Diacetoxylab-8,13-dien-15-ol (<bold>117</bold>), 2&#x003b1;,6&#x003b2;,7a-triacetoxylabda-8,13-dien-15-ol (<bold>118</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic to brine shrimp (<italic>Artemia salina)</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B333-marinedrugs-18-00657" ref-type="bibr">333</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t004_Table 4</object-id><label>Table 4</label><caption><p>Antimicrobial compounds in the different heterobranch groups. In brackets: number of species with antimicrobial compounds, number of the compounds in figures, and reference numbers. # Numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (11)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Notodoris citrina, Notodoris gardineri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Iso</italic>-naamidine-A (<bold>160</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the AI-2 channel of the marine pathogen <italic>Vibrio harveyi</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>,<xref rid="B426-marinedrugs-18-00657" ref-type="bibr">426</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Phyllidiella pustulosa, Phyllidia coelestis, Phyllidia varicosa, Phyllidia</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xidaoisocyanate A (<bold>24</bold>), axisonitrile-3 (<bold>25</bold>), 4-<italic>iso</italic>cyano-9-amorphene, 9-thiocyanato-pupukeanane (<bold>126</bold>), 3-<italic>iso</italic>cyanotheonellin (<bold>161</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-marinedrugs-18-00657" ref-type="bibr">103</xref>,<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>,<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B115-marinedrugs-18-00657" ref-type="bibr">115</xref>,<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>,<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B427-marinedrugs-18-00657" ref-type="bibr">427</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Marionia blainvillea, Phestilla lugubris, Cuthona caerulea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aglaja tricolorata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia punctata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glandulaurencianols A&#x02013;C (<bold>162</bold>,<bold>163</bold>), punctatol (<bold>164</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B429-marinedrugs-18-00657" ref-type="bibr">429</xref>,<xref rid="B430-marinedrugs-18-00657" ref-type="bibr">430</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia juliana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyropheophorbides a and b, halogenated diterpenoid lactone, julianin-S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>,<xref rid="B432-marinedrugs-18-00657" ref-type="bibr">432</xref>,<xref rid="B433-marinedrugs-18-00657" ref-type="bibr">433</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dolabella auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dolabellanin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B435-marinedrugs-18-00657" ref-type="bibr">435</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pulmonata (4)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Siphonaria</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siphonarienolone (<bold>119</bold>), diemenensins A (<bold>165</bold>) and B, siphonarin A (<bold>120</bold>), Vallartanones A and B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B348-marinedrugs-18-00657" ref-type="bibr">348</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria diemenensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diemenensin A (<bold>165</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria pectinata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pectinatone (<bold>166</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t005_Table 5</object-id><label>Table 5</label><caption><p>Antifouling compounds in the different heterobranch groups. In brackets: number of species with antifouling compounds, number of the compounds in figures, and reference numbers. # Numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (15)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia varicosa, Phyllidia rosans (P. bourguini)</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Isocyanopupukeanane (<bold>21</bold>), 3-isocyanotheonellin (<bold>161</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling against barnacle larvae </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-marinedrugs-18-00657" ref-type="bibr">93</xref>,<xref rid="B106-marinedrugs-18-00657" ref-type="bibr">106</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia sp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-Isocyanotheonellin (<bold>161</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity against barnacle larvae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-marinedrugs-18-00657" ref-type="bibr">114</xref>,<xref rid="B115-marinedrugs-18-00657" ref-type="bibr">115</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesquiterpene isonitrile </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling against barnacle larvae </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-marinedrugs-18-00657" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia ocelata, P. varicosa, P. coelestis, P. picta, Phyllidiella pustulosa, Phillidiopsis krempfi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-epi-Axisonitrile-3, 10-isocyano-4-cadinene, 2-isocyanotrachyopsane, 1,7-epidioxy-5-cadinene, 4-isocyano-9-amorphene and 10&#x003b1;-isocyano-4-amorphene, 9-thiocyanatopupukeanane sesquiterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity against barnacle larvae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>,<xref rid="B112-marinedrugs-18-00657" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Reticulidia fung&#x000ed;a</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reticulidin A (<bold>215</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B438-marinedrugs-18-00657" ref-type="bibr">438</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Marionia blainvillea, Phestilla lugubris, Cratena pilata, Cuthona caerulea, Cuthona gymnota, Hermissenda crassicornis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity, prevents microbial colonization of the slug mucus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B428-marinedrugs-18-00657" ref-type="bibr">428</xref>,<xref rid="B439-marinedrugs-18-00657" ref-type="bibr">439</xref>,<xref rid="B441-marinedrugs-18-00657" ref-type="bibr">441</xref>,<xref rid="B442-marinedrugs-18-00657" ref-type="bibr">442</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (9)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aglaja tricolorata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Homarine (<bold>79</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-18-00657" ref-type="bibr">235</xref>,<xref rid="B441-marinedrugs-18-00657" ref-type="bibr">441</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sagaminopteron nigropunctatum, S. psychedelicum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,5 Dibromo-2-(2&#x02032;,4&#x02032;-dibromo-phenoxy)phenol (<bold>92</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity against marine bacteria, diatoms, barnacle larvae, and mussel juveniles </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B282-marinedrugs-18-00657" ref-type="bibr">282</xref>,<xref rid="B443-marinedrugs-18-00657" ref-type="bibr">443</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea cyanomarginata, H. cymbalum </italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brominated tetrahydropyran (<bold>142</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea orteai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminol A,B,C (<bold>167</bold>&#x02013;<bold>168</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B444-marinedrugs-18-00657" ref-type="bibr">444</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea orbignyana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminol 1-2 (<bold>169</bold>), haminol A and B (<bold>167</bold>&#x02013;<bold>168</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity against larvae of the barnacle Amphibalanus amphitrite </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B444-marinedrugs-18-00657" ref-type="bibr">444</xref>,<xref rid="B445-marinedrugs-18-00657" ref-type="bibr">445</xref>,<xref rid="B446-marinedrugs-18-00657" ref-type="bibr">446</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea fusari</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminol 1&#x02013;6 (<bold>169</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B445-marinedrugs-18-00657" ref-type="bibr">445</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t006_Table 6</object-id><label>Table 6</label><caption><p>Alarm signal compounds in the different heterobranch groups. In brackets: number of species with alarm signal compounds, number of the compounds in figures, and reference numbers. # Numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (7)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tambja abdere, T. eliora, Roboastra tigris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tambjamines (<bold>65</bold>&#x02013;<bold>70</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones and cues</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tambja ceutae, Tambja stegosauriformis, Nembrotha spp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tambjamines (<bold>65</bold>&#x02013;<bold>70</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones and cues</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B226-marinedrugs-18-00657" ref-type="bibr">226</xref>,<xref rid="B227-marinedrugs-18-00657" ref-type="bibr">227</xref>,<xref rid="B228-marinedrugs-18-00657" ref-type="bibr">228</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (10)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Navanax inermis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Navenones A&#x02013;C (<bold>170</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B394-marinedrugs-18-00657" ref-type="bibr">394</xref>,<xref rid="B448-marinedrugs-18-00657" ref-type="bibr">448</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea exigua, H. fusari, H. orbignyana, H. orteai, H. navicula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminols (<bold>167</bold>&#x02013;<bold>169</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones employed during cross copulation, escape reaction in conspecifics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-marinedrugs-18-00657" ref-type="bibr">19</xref>,<xref rid="B449-marinedrugs-18-00657" ref-type="bibr">449</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea navicula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminols A and B (<bold>167</bold>,<bold>168</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B449-marinedrugs-18-00657" ref-type="bibr">449</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea orteai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminols A&#x02013;C (<bold>167</bold>,<bold>168</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B444-marinedrugs-18-00657" ref-type="bibr">444</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea fusari, H. hydatis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminols 1-6 (<bold>169</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B445-marinedrugs-18-00657" ref-type="bibr">445</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea japonica </italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Navenone-C (<bold>170</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B445-marinedrugs-18-00657" ref-type="bibr">445</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haminoea callidegenita</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haminols 7-11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B271-marinedrugs-18-00657" ref-type="bibr">271</xref>,<xref rid="B451-marinedrugs-18-00657" ref-type="bibr">451</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scaphander lignarius</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lignarenones (<bold>171</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm pheromones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B453-marinedrugs-18-00657" ref-type="bibr">453</xref>,<xref rid="B454-marinedrugs-18-00657" ref-type="bibr">454</xref>,<xref rid="B455-marinedrugs-18-00657" ref-type="bibr">455</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia californica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysiapalythines A&#x02013;C (mycosporine-like amino acids, MAAs), asterina, palythine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alarm cues, causing avoidance behaviors in neighboring conspecifics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B457-marinedrugs-18-00657" ref-type="bibr">457</xref>,<xref rid="B458-marinedrugs-18-00657" ref-type="bibr">458</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t007" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t007_Table 7</object-id><label>Table 7</label><caption><p>Photoprotective compounds in the different heterobranch groups. In brackets: number of species with photoprotective compounds, number of the compounds in figures, and reference numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia californica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysiapalythines A, B, C (mycosporine-like amino acids, MAAs), asterine, palythine </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sunscreens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B457-marinedrugs-18-00657" ref-type="bibr">457</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pteropoda (2)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Limacina helicina, Clione limacina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mycosporine-like amino acids (MAAs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UV photoprotection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B461-marinedrugs-18-00657" ref-type="bibr">461</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (8)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cyerce cristallina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyercene A (<bold>157</bold>) and B, cyercenes 1&#x02013;5 (<bold>158</bold>,<bold>159</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protection against sunlight-induced damage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia patagonica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phototridachiapyrone J (<bold>172</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sunscreens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B412-marinedrugs-18-00657" ref-type="bibr">412</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia crispata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tridachiahydropyrone (<bold>173</bold>), phototridachiahydropyrone (<bold>174</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sunscreens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B317-marinedrugs-18-00657" ref-type="bibr">317</xref>,<xref rid="B464-marinedrugs-18-00657" ref-type="bibr">464</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia (Tridachiella) diomedea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tridachiapyrones A&#x02013;F (<bold>175</bold>,<bold>176</bold>), elysiapyrones (<bold>177</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sunscreens, photoprotection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B417-marinedrugs-18-00657" ref-type="bibr">417</xref>,<xref rid="B418-marinedrugs-18-00657" ref-type="bibr">418</xref>,<xref rid="B419-marinedrugs-18-00657" ref-type="bibr">419</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia viridis, E. chlorotica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elysione (<bold>178</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sunscreens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B463-marinedrugs-18-00657" ref-type="bibr">463</xref>,<xref rid="B465-marinedrugs-18-00657" ref-type="bibr">465</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Placobranchus ocellatus, Placobranchus</italic> sp. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9,10-Deoxy-tridachione (<bold>179</bold>), photodeoxytridachione (<bold>180</bold>), tridachiahydropyrone B and C (<bold>181</bold>), <italic>iso</italic>-9,10-deoxy-tridachione, ocellapyrones (<bold>182</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sunscreens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B466-marinedrugs-18-00657" ref-type="bibr">466</xref>,<xref rid="B468-marinedrugs-18-00657" ref-type="bibr">468</xref>,<xref rid="B469-marinedrugs-18-00657" ref-type="bibr">469</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t008" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t008_Table 8</object-id><label>Table 8</label><caption><p>Tissue-regenerator compounds in the different heterobranch groups. In brackets: number of species with tissue-regenerator compounds, number of the compounds in figures, and reference numbers. # Numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tethys fimbria</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PGE2-1,15-lactone (<bold>80</bold>), PGE3-1,15-lactone (<bold>81</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Predator distraction by the release of their cerata, cerata regeneration </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (6)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ercolania viridis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyercenes (<bold>113</bold>, <bold>157</bold>&#x02013;<bold>159</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerata autotomy, cerata regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B332-marinedrugs-18-00657" ref-type="bibr">332</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cyerce cristallina, C. nigricans </italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyercenes (<bold>113</bold>, <bold>157</bold>&#x02013;<bold>159</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerata autotomy, cerata regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B326-marinedrugs-18-00657" ref-type="bibr">326</xref>,<xref rid="B327-marinedrugs-18-00657" ref-type="bibr">327</xref>,<xref rid="B328-marinedrugs-18-00657" ref-type="bibr">328</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysiopsis formosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysiopsenes A&#x02013;D (<bold>183</bold>,<bold>184</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerata autotomy and cerata regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B475-marinedrugs-18-00657" ref-type="bibr">475</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mourgona germaineae, Costasiella ocellifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prenylated bromohydroquino-nes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerata autotomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B325-marinedrugs-18-00657" ref-type="bibr">325</xref>,<xref rid="B330-marinedrugs-18-00657" ref-type="bibr">330</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t009" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t009_Table 9</object-id><label>Table 9</label><caption><p>Other ecological activities in the different heterobranch groups. In brackets: number of species with active compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doris kerguelenensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Austrodoral (<bold>185</bold>), austrodoric acid (<bold>186</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stress metabolites</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-marinedrugs-18-00657" ref-type="bibr">64</xref>,<xref rid="B65-marinedrugs-18-00657" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tethys fimbria</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PGs&#x02013;lactones (<bold>80</bold>,<bold>81</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Role in reproduction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B237-marinedrugs-18-00657" ref-type="bibr">237</xref>,<xref rid="B238-marinedrugs-18-00657" ref-type="bibr">238</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dermatobranchus ornatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eunicellin, ophirin (<bold>187</bold>), calicophirin B (<bold>188</bold>), 13-deacetoxycalicophirin B, 13-deacetoxy-3-deacetylcalicophirin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell division in fertilized starfish eggs </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>,<xref rid="B243-marinedrugs-18-00657" ref-type="bibr">243</xref>,<xref rid="B387-marinedrugs-18-00657" ref-type="bibr">387</xref>,<xref rid="B477-marinedrugs-18-00657" ref-type="bibr">477</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t010" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t010_Table 10</object-id><label>Table 10</label><caption><p>Cytotoxic and antitumoral compounds in the different heterobranch groups. In brackets: number of species with these compounds, number of the compounds in figures, and reference numbers. # Numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (59)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doris kerguelenensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palmadorins A (<bold>195</bold>), B (<bold>196</bold>), D (<bold>197</bold>), M (<bold>198</bold>), N (<bold>199</bold>), and O (<bold>200</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of human erythroleukemia cells (HEL), inhibition of Jak2, STAT5, and Erk1/2 activation in HEL cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-marinedrugs-18-00657" ref-type="bibr">66</xref>,<xref rid="B67-marinedrugs-18-00657" ref-type="bibr">67</xref>,<xref rid="B824-marinedrugs-18-00657" ref-type="bibr">824</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doris verrucosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verrucosins A (<bold>124</bold>) and B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of protein kinase C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B371-marinedrugs-18-00657" ref-type="bibr">371</xref>,<xref rid="B420-marinedrugs-18-00657" ref-type="bibr">420</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Notodoris citrina, N. gardineri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naamidine A (<bold>201</bold>), iso-naamidine-A (<bold>160</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the epidermal growth factor (EGF), inhibition of human tumor xenografts in mice, and promotion of caspase-dependent apoptosis in tumor cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B489-marinedrugs-18-00657" ref-type="bibr">489</xref>,<xref rid="B490-marinedrugs-18-00657" ref-type="bibr">490</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Adalaria loveni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lovenone (<bold>202</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to two HTCLs </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B491-marinedrugs-18-00657" ref-type="bibr">491</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Polycera atra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bryostatins (<bold>203</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to P388 lymphocytic leukemia and Alzheimer&#x02019;s disease cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B486-marinedrugs-18-00657" ref-type="bibr">486</xref>,<xref rid="B487-marinedrugs-18-00657" ref-type="bibr">487</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Actinocyclus papillatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02013;)-Actisonitrile (<bold>204</bold>), actinofide (<bold>205</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to tumor and non-tumor cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B361-marinedrugs-18-00657" ref-type="bibr">361</xref>,<xref rid="B479-marinedrugs-18-00657" ref-type="bibr">479</xref>,<xref rid="B504-marinedrugs-18-00657" ref-type="bibr">504</xref>,<xref rid="B503-marinedrugs-18-00657" ref-type="bibr">503</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aldisa andersoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Chloro-phorbazole D (<bold>5</bold>), N1-methyl-phorbazole A (<bold>6</bold>), phorbazoles A (<bold>7</bold>), B (<bold>8</bold>), and C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytostatic effects in vitro against several HTCLs (human SKMEL-28 melanoma and U373 glioblastoma cells)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-marinedrugs-18-00657" ref-type="bibr">55</xref>,<xref rid="B75-marinedrugs-18-00657" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-18-00657" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrodoris carbunculosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dendocarbins A&#x02013;N (16, 206), isodrimeninol (<bold>207</bold>), 11-epivaldiviolide (<bold>208</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine leukemia P388 cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-marinedrugs-18-00657" ref-type="bibr">86</xref>,<xref rid="B509-marinedrugs-18-00657" ref-type="bibr">509</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella coelestis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1-Formamido-10(1&#x02192;2)-abeopupukeanane (<bold>209</bold>), 2-formamidopupukeanane (<bold>210</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to HeLa, MCF-7, KB, HT-29 cancer cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-marinedrugs-18-00657" ref-type="bibr">111</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axinisothiocyanate K (<bold>211</bold>), isothiocyanate axisonitrile-3 (<bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to NBT-T2 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>,<xref rid="B377-marinedrugs-18-00657" ref-type="bibr">377</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella coelestis, P. pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bisabolane-type sesquiterpenoid (<bold>212</bold>), theonellin isothiocyanate (<bold>213</bold>), 7-isocyano-7,8-dihydro-&#x003b1;-bisabolene (<bold>214</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to several HCCLs </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Reticulidia fungia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reticulidins A (<bold>215</bold>) and B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic in vitro to KB cells and mouse L1210 leukemia cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B438-marinedrugs-18-00657" ref-type="bibr">438</xref>,<xref rid="B511-marinedrugs-18-00657" ref-type="bibr">511</xref>,<xref rid="B512-marinedrugs-18-00657" ref-type="bibr">512</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cadlina luteomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ansellone A (<bold>216</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of the cyclic adenosine monophosphate (cAMP) signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris elisabetina, C. hamiltoni, C. lochi, C. africana, C. annae, C. kuiteri, C. magnifica, C. quadricolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Latrunculins A (<bold>38</bold>) and B (<bold>37</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disruption of normal cell organization and function</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>,<xref rid="B168-marinedrugs-18-00657" ref-type="bibr">168</xref>,<xref rid="B169-marinedrugs-18-00657" ref-type="bibr">169</xref>,<xref rid="B170-marinedrugs-18-00657" ref-type="bibr">170</xref>,<xref rid="B171-marinedrugs-18-00657" ref-type="bibr">171</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris lochi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mycothiazole (<bold>129</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the hypoxia-inducible factor-1 (HIF-1), and suppression of the mitochondrial respiration at complex I </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B378-marinedrugs-18-00657" ref-type="bibr">378</xref>,<xref rid="B379-marinedrugs-18-00657" ref-type="bibr">379</xref>,<xref rid="B825-marinedrugs-18-00657" ref-type="bibr">825</xref>,<xref rid="B826-marinedrugs-18-00657" ref-type="bibr">826</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris lochi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laulimalide (<bold>39</bold>), isolaulimalide (<bold>40</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to the KB cell line </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B142-marinedrugs-18-00657" ref-type="bibr">142</xref>,<xref rid="B523-marinedrugs-18-00657" ref-type="bibr">523</xref>,<xref rid="B524-marinedrugs-18-00657" ref-type="bibr">524</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris inornata </italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inorolides A&#x02013;C (<bold>217</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine L1210 leukemia and human epidermoid carcinoma KB cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B156-marinedrugs-18-00657" ref-type="bibr">156</xref>,<xref rid="B531-marinedrugs-18-00657" ref-type="bibr">531</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris petechialis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Puupehenone (<bold>218</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human peripheral blood mononuclear (PBM) cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B827-marinedrugs-18-00657" ref-type="bibr">827</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Goniobranchus splendidus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epoxygoniolide-1 (<bold>219</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B532-marinedrugs-18-00657" ref-type="bibr">532</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Goniobranchus (Chromodoris) sinensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplyroseol-2 (<bold>220</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to HeLa S3 cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Goniobranchus reticulatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spongian-16-one (<bold>221</bold>), aplytandiene-3 (<bold>222</bold>), aplysulfurin (<bold>223</bold>), aplyroseol-2 (<bold>220</bold>), gracilins A (<bold>224</bold>), B (<bold>225</bold>), C (<bold>226</bold>), G (<bold>227</bold>), and M (<bold>228</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to P388 mouse leukemia, HTCLs cell lines, and BACE1 and ERK inhibition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B161-marinedrugs-18-00657" ref-type="bibr">161</xref>,<xref rid="B190-marinedrugs-18-00657" ref-type="bibr">190</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Goniobranchus (Chromodoris) obsoleta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dorisenones A&#x02013;D (<bold>229</bold>), 11&#x003b2;-hydroxyspongi-12-en-16-one (<bold>230</bold>), spongian-16-one (<bold>221</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine lymphoma L1210 and KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B154-marinedrugs-18-00657" ref-type="bibr">154</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriprismatica (Glossodoris) atromarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spongiadiol (<bold>35</bold>), spongiadiol diacetate (<bold>231</bold>), epispongiadiol (<bold>232</bold>), 12-deacetoxy-12-oxodeoxoscalarin (<bold>136</bold>), heteronemin (<bold>233</bold>), mooloolabene D (<bold>234</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to MCF-7 breast cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B180-marinedrugs-18-00657" ref-type="bibr">180</xref>,<xref rid="B182-marinedrugs-18-00657" ref-type="bibr">182</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B828-marinedrugs-18-00657" ref-type="bibr">828</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimida (Glossodoris) dalli, Doriprismatica (Glossodoris) sedna, Glossodoris rufomarginata, G. pallida, G. vespa, Ardeadoris (Glossodoris) averni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-deacetyl-23-acetoxy-20-methyl-12-epi-scalaradial (<bold>135</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of mammalian phospholipase A2 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypselodoris infucata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02013;)-Furodysinin (<bold>48</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to HeLa cell </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-marinedrugs-18-00657" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimida (Chromodoris) macfarlandi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macfarlandin E (<bold>235</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Golgi-modifying properties </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B139-marinedrugs-18-00657" ref-type="bibr">139</xref>,<xref rid="B140-marinedrugs-18-00657" ref-type="bibr">140</xref>,<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>,<xref rid="B543-marinedrugs-18-00657" ref-type="bibr">543</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hexabranchus sanguineus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ulapualides A (<bold>190</bold>), B (<bold>236</bold>) and C (<bold>237</bold>), kabiramides A (<bold>238</bold>), B (<bold>239</bold>), C (<bold>62</bold>), D (<bold>240</bold>), E (<bold>241</bold>) and G (<bold>243</bold>), dihydrohalichondramide (<bold>63</bold>), 33-methylhalichondramide (<bold>242</bold>), halichondramide (<bold>244</bold>), Hurghadin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine L1210 leukemia cells, cytotoxic to several HTCLs, and cytotoxic to human MCF-7 breast cancer cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B545-marinedrugs-18-00657" ref-type="bibr">545</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Jorunna funebris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jorumycin (<bold>189</bold>), jorunnamycins A&#x02013;C (<bold>245</bold>), renieramycin M (<bold>246</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to cancer cell lines P388, A549, HT29, and MEL28, and cytotoxic to human colon (HCT-116) and breast (MDA-MB-435) cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B560-marinedrugs-18-00657" ref-type="bibr">560</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Jorunna funebris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fennebricins A and B, N-formyl-1,2-dihydrorenierol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strong NF-&#x003ba;B inhibition, and cytotoxic to A549 and HL-60 tumor cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B564-marinedrugs-18-00657" ref-type="bibr">564</xref>,<xref rid="B565-marinedrugs-18-00657" ref-type="bibr">565</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Peltodoris atromaculata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Petroformynes (<bold>247</bold>), hydroxyl-dehydroisofulvinol (<bold>248</bold>), fulvinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine P388 leukemia cells, A549 NSCLC, HT-29 colon cancer and SKMEL-28 melanoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B567-marinedrugs-18-00657" ref-type="bibr">567</xref>,<xref rid="B568-marinedrugs-18-00657" ref-type="bibr">568</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Halgerda aurantiomaculata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zooanemonin (<bold>367</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B829-marinedrugs-18-00657" ref-type="bibr">829</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tambja capensis, T. ceutae, T. eliora, T. morosa, T. stegosauriformis, T. verconis, Roboastra tigris, Nembrotha spp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tambjamines (<bold>65</bold>&#x02013;<bold>70</bold>), tambjamine K (<bold>249</bold>), tetrapyrrole (<bold>72</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to several tumor cell lines (Caco-2 colon cancer cells, HeLa cervix cancer cells)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tritonia sp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Punaglandins (<bold>250</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B587-marinedrugs-18-00657" ref-type="bibr">587</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doto pinnatifida</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dotofide (<bold>251</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to Hs683 oligodendroglioma, U373 glioblastoma, A549 NSCLC human carcinoma, MCF-7 breast carcinoma, SKMEL-28, and mouse B16F10 cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B243-marinedrugs-18-00657" ref-type="bibr">243</xref>,<xref rid="B505-marinedrugs-18-00657" ref-type="bibr">505</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tritoniopsis elegans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tritoniopsins A&#x02013;D (<bold>75</bold>&#x02013;<bold>78</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to rat cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B234-marinedrugs-18-00657" ref-type="bibr">234</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dermatobranchus ornatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ophirin (<bold>187</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-marinedrugs-18-00657" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Leminda millecra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prenylated hydroquinone (<bold>252</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to WHCO1, WHCO6 esophageal cancer cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B588-marinedrugs-18-00657" ref-type="bibr">588</xref>,<xref rid="B589-marinedrugs-18-00657" ref-type="bibr">589</xref>,<xref rid="B590-marinedrugs-18-00657" ref-type="bibr">590</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hermissenda crassicornis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-6-bromohypaphorine (<bold>253</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human a7 nicotinic acetylcholine receptor (nAChR subtype)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B591-marinedrugs-18-00657" ref-type="bibr">591</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllodesmium briareum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brianthein W (<bold>254</bold>), excavatolide C (<bold>255</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to cancer cell line P-388 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllodesmium magnum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11-episinulariolide acetate (<bold>256</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to cancer cell line P-388 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B248-marinedrugs-18-00657" ref-type="bibr">248</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllodesmium longicirrum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trocheliophorol (<bold>84</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B245-marinedrugs-18-00657" ref-type="bibr">245</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phidiana militaris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phidianidines A (<bold>257</bold>) and B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to C6 and HeLa tumor cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B592-marinedrugs-18-00657" ref-type="bibr">592</xref>,<xref rid="B593-marinedrugs-18-00657" ref-type="bibr">593</xref>,<xref rid="B595-marinedrugs-18-00657" ref-type="bibr">595</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pleurobranchoidea (2)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pleurobranchus albiguttatus, P. forskalii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorolissoclimide (<bold>258</bold>), dichlorolissoclimide (<bold>259</bold>), haterumaimides A (<bold>260</bold>), C (<bold>267</bold>), J (<bold>265</bold>), K (<bold>266</bold>), G (<bold>268</bold>), I (<bold>269</bold>), 3&#x000df;-hydroxylissoclimide (<bold>261</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to melanoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B610-marinedrugs-18-00657" ref-type="bibr">610</xref>,<xref rid="B619-marinedrugs-18-00657" ref-type="bibr">619</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. forskalii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Keenamide A (<bold>262</bold>), cycloforskamide (<bold>263</bold>), ergosinine (<bold>264</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to P-388, A-549, MEL-20, and HT-29 tumor cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B611-marinedrugs-18-00657" ref-type="bibr">611</xref>,<xref rid="B612-marinedrugs-18-00657" ref-type="bibr">612</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Tylodinoidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tylodina perversa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iso-fistularin 3 (<bold>270</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HeLa cervix carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B257-marinedrugs-18-00657" ref-type="bibr">257</xref>,<xref rid="B625-marinedrugs-18-00657" ref-type="bibr">625</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (2)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Philinopsis speciosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kulolides 1 (<bold>271</bold>), 2 (<bold>272</bold>) and 3 (<bold>273</bold>), kulokainalide 1 (<bold>274</bold>), lulokekahilides 1 (<bold>275</bold>) and 2 (<bold>276</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to L-1210, P388 leukemia, human SK-OV-3 ovarian, tMDA-MB-435 breast cancer, human A549 NSCLC, K562 chronic myelogenous leukemia, HeLa cervix carcinoma, and MCF-7 breast cancer cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B277-marinedrugs-18-00657" ref-type="bibr">277</xref>,<xref rid="B626-marinedrugs-18-00657" ref-type="bibr">626</xref>,<xref rid="B627-marinedrugs-18-00657" ref-type="bibr">627</xref>,<xref rid="B628-marinedrugs-18-00657" ref-type="bibr">628</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scaphander lignarius</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ARA, EPA, HTA (fatty acids)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to a set of cancer and normal cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B630-marinedrugs-18-00657" ref-type="bibr">630</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (11)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia angasi, A. dactylomela, A. depilans, A. fasciata, A. juliana, A. kurodai, A. oculifera, A. punctata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysistatin (<bold>277</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to mouse P388 leukemia, human KB cancer, and HeLa cervix carcinoma cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B613-marinedrugs-18-00657" ref-type="bibr">613</xref>,<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>,<xref rid="B820-marinedrugs-18-00657" ref-type="bibr">820</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia dactylomela</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elatol (<bold>278</bold>), obtusol (<bold>279</bold>), iso-obtusol (<bold>280</bold>), linear halogenated monoterpene (<bold>281</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to ten cancer cell lines, B16F10 melanoma, HM02 gastric carcinoma, HEP-G2 liver carcinoma, and MCF-7 breast carcinoma cancer cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> [<xref rid="B631-marinedrugs-18-00657" ref-type="bibr">631</xref>,<xref rid="B633-marinedrugs-18-00657" ref-type="bibr">633</xref>,<xref rid="B632-marinedrugs-18-00657" ref-type="bibr">632</xref>,<xref rid="B633-marinedrugs-18-00657" ref-type="bibr">633</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. dactylomela</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parguerol (<bold>282</bold>), parguerol-16-acetate (<bold>283</bold>), iso-parguerol (<bold>284</bold>), iso-parguerol-16-acetate (<bold>285</bold>), deoxyparguerol (<bold>286</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to P388 leukemia and Ehrlich ascite carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B611-marinedrugs-18-00657" ref-type="bibr">611</xref>,<xref rid="B636-marinedrugs-18-00657" ref-type="bibr">636</xref>,<xref rid="B640-marinedrugs-18-00657" ref-type="bibr">640</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. dactylomela</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysqualenol A (<bold>287</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to 60 cancer cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B641-marinedrugs-18-00657" ref-type="bibr">641</xref>,<xref rid="B642-marinedrugs-18-00657" ref-type="bibr">642</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. dactylomela</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thyrsiferol (<bold>288</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to P388 leukemia and T47D human breast tumor cells, and suppression of hypoxic induction of HIF-1 target genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B647-marinedrugs-18-00657" ref-type="bibr">647</xref>,<xref rid="B648-marinedrugs-18-00657" ref-type="bibr">648</xref>,<xref rid="B649-marinedrugs-18-00657" ref-type="bibr">649</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia depilans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endoperoxide sterol (<bold>289</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HCT-116 colorectal cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B650-marinedrugs-18-00657" ref-type="bibr">650</xref>,<xref rid="B651-marinedrugs-18-00657" ref-type="bibr">651</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia fasciata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-epi-aplykurodinone B (<bold>145</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to mouse P388 leukemia, human A549 NSCLC, HT-29 colon cancer, and SKMEl-28 melanoma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B397-marinedrugs-18-00657" ref-type="bibr">397</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia juliana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyropheophorbides a and b, julianin S </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>,<xref rid="B432-marinedrugs-18-00657" ref-type="bibr">432</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplyronines A (<bold>191</bold>), B (<bold>290</bold>), C (<bold>291</bold>), D (<bold>292</bold>) and H (<bold>293</bold>), aplaminal (<bold>294</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HeLa S3 cervix carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B653-marinedrugs-18-00657" ref-type="bibr">653</xref>,<xref rid="B654-marinedrugs-18-00657" ref-type="bibr">654</xref>,<xref rid="B657-marinedrugs-18-00657" ref-type="bibr">657</xref>,<xref rid="B658-marinedrugs-18-00657" ref-type="bibr">658</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplaminone (<bold>295</bold>), neoaplaminone (<bold>296</bold>), neoaplaminone sulfate (<bold>297</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HeLa S3 cervix carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B667-marinedrugs-18-00657" ref-type="bibr">667</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysiaterpenoid A (<bold>298</bold>), aplysiapyranoids A&#x02013;D (<bold>299</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to Vero, MDCK, and B16 cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B668-marinedrugs-18-00657" ref-type="bibr">668</xref>,<xref rid="B669-marinedrugs-18-00657" ref-type="bibr">669</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kurodainol (<bold>300</bold>), aplysiaterpenoids A&#x02013;D (<bold>298</bold>), aplysin-20 (<bold>301</bold>), iso-aplysin-20, aplysiadiol (<bold>302</bold>), epi-aplysin-20, ent-isoconcinndiol (<bold>303</bold>), aplysianin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of growth inhibitory effects in various cancer cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B668-marinedrugs-18-00657" ref-type="bibr">668</xref>,<xref rid="B669-marinedrugs-18-00657" ref-type="bibr">669</xref>,<xref rid="B670-marinedrugs-18-00657" ref-type="bibr">670</xref>,<xref rid="B671-marinedrugs-18-00657" ref-type="bibr">671</xref>,<xref rid="B672-marinedrugs-18-00657" ref-type="bibr">672</xref>,<xref rid="B673-marinedrugs-18-00657" ref-type="bibr">673</xref>,<xref rid="B674-marinedrugs-18-00657" ref-type="bibr">674</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(-)-Aplysin (<bold>304</bold>), aplysinol (<bold>305</bold>), aplykurodins A (<bold>306</bold>) and B (<bold>146</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to various cancer cell lines, human A549 NSCLC, and human glioma cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B680-marinedrugs-18-00657" ref-type="bibr">680</xref>,<xref rid="B682-marinedrugs-18-00657" ref-type="bibr">682</xref>,<xref rid="B683-marinedrugs-18-00657" ref-type="bibr">683</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia oculifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oculiferane (<bold>308</bold>), epi-obtusane (<bold>309</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to PC-3 prostate, A549 NSCLC, MCF-7 breast, HepG2 liver, and HCT116 colon cancer cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B684-marinedrugs-18-00657" ref-type="bibr">684</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia punctata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Halogenated monoterpenes (<bold>310</bold>&#x02013;<bold>312</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to four tumor cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B685-marinedrugs-18-00657" ref-type="bibr">685</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dolabella auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dolabellanin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B435-marinedrugs-18-00657" ref-type="bibr">435</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>D. auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Auripyrones A (<bold>319</bold>) and B, dolabelides A (<bold>320</bold>), B (<bold>321</bold>), C (<bold>322</bold>) and D (<bold>323</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HeLa S3 cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B687-marinedrugs-18-00657" ref-type="bibr">687</xref>,<xref rid="B696-marinedrugs-18-00657" ref-type="bibr">696</xref>,<xref rid="B701-marinedrugs-18-00657" ref-type="bibr">701</xref>,<xref rid="B702-marinedrugs-18-00657" ref-type="bibr">702</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>D. auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Doliculide (<bold>325</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HeLa S3, MCF-7, and MDA-MB-231 breast cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B708-marinedrugs-18-00657" ref-type="bibr">708</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>D. auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dolastatins 3 (<bold>192</bold>), 10 (<bold>326</bold>), 11 (<bold>327</bold>), 12 (<bold>328</bold>), 13 (<bold>329</bold>), 14 (<bold>330</bold>), 15 (<bold>331</bold>), 16 (<bold>346</bold>), 17 (<bold>347</bold>), 18 (<bold>348</bold>), 19 (<bold>332</bold>), C (<bold>333</bold>), D (<bold>334</bold>), G (<bold>337</bold>) and H (<bold>335</bold>), iso-dolastatin H (<bold>336</bold>), debromoaplysiatoxin (<bold>97</bold>), anhydrodebromo-aplysiatoxin, aurilide (<bold>324</bold>), nor-dolastatin G (<bold>338</bold>), auristatins E (<bold>339</bold>), PHE (<bold>340</bold>), PYE (<bold>341</bold>), 2-AQ (<bold>342</bold>), 6-AQ (<bold>343</bold>) and PE (<bold>344</bold>), tasidotin (<bold>345</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to renal, ovarian, prostate, hepatobiliary, pancreatic cancer cell lines, P388 murine leukemia, colon 26 cancer, Lewis lung carcinoma, B16 melanoma, M5076 sarcoma, human MX-1 breast cancer, LX-1, MCF-7, colon KM20L2 cancer, and SBC-3 SCLC cell lines </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-marinedrugs-18-00657" ref-type="bibr">46</xref>,<xref rid="B688-marinedrugs-18-00657" ref-type="bibr">688</xref>,<xref rid="B694-marinedrugs-18-00657" ref-type="bibr">694</xref>,<xref rid="B703-marinedrugs-18-00657" ref-type="bibr">703</xref>,<xref rid="B705-marinedrugs-18-00657" ref-type="bibr">705</xref>,<xref rid="B717-marinedrugs-18-00657" ref-type="bibr">717</xref>,<xref rid="B718-marinedrugs-18-00657" ref-type="bibr">718</xref>,<xref rid="B719-marinedrugs-18-00657" ref-type="bibr">719</xref>,<xref rid="B721-marinedrugs-18-00657" ref-type="bibr">721</xref>,<xref rid="B722-marinedrugs-18-00657" ref-type="bibr">722</xref>,<xref rid="B724-marinedrugs-18-00657" ref-type="bibr">724</xref>,<xref rid="B744-marinedrugs-18-00657" ref-type="bibr">744</xref>,<xref rid="B750-marinedrugs-18-00657" ref-type="bibr">750</xref>,<xref rid="B751-marinedrugs-18-00657" ref-type="bibr">751</xref>,<xref rid="B766-marinedrugs-18-00657" ref-type="bibr">766</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stylocheilus longicauda</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysiatoxin (<bold>96</bold>), debromoaplysiatoxin (<bold>97</bold>), makalika (<bold>99</bold>), makalikone (<bold>100</bold>), lyngbyatoxin A (<bold>349</bold>), lyngbyatoxin A acetate (<bold>101</bold>), malyngamide B, O (<bold>102</bold>) and P (<bold>103</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to P388, A549, HT29, and HTB38 cancer cell lines, and toxic to mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B302-marinedrugs-18-00657" ref-type="bibr">302</xref>,<xref rid="B304-marinedrugs-18-00657" ref-type="bibr">304</xref>,<xref rid="B305-marinedrugs-18-00657" ref-type="bibr">305</xref>,<xref rid="B307-marinedrugs-18-00657" ref-type="bibr">307</xref>,<xref rid="B777-marinedrugs-18-00657" ref-type="bibr">777</xref>,<xref rid="B778-marinedrugs-18-00657" ref-type="bibr">778</xref>,<xref rid="B779-marinedrugs-18-00657" ref-type="bibr">779</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bursatella leachii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lyngbyatoxin A (<bold>349</bold>), debromoaplysiatoxin (<bold>97</bold>), hectochlorin (<bold>351</bold>), deacetylhectochlorin (<bold>352</bold>), malyndamides S (<bold>350</bold>) and X (<bold>353</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine P388 leukemia, human A549, NSCLC, NCI-H187 (SCLC), HT-29 colon cancer, HL60 leukemia, KB, and BC breast cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B783-marinedrugs-18-00657" ref-type="bibr">783</xref>,<xref rid="B784-marinedrugs-18-00657" ref-type="bibr">784</xref>,<xref rid="B785-marinedrugs-18-00657" ref-type="bibr">785</xref>,<xref rid="B786-marinedrugs-18-00657" ref-type="bibr">786</xref>,<xref rid="B787-marinedrugs-18-00657" ref-type="bibr">787</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia subornata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpenyne (<bold>155</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to neuroblastoma SK-N-SH cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B316-marinedrugs-18-00657" ref-type="bibr">316</xref>,<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>,<xref rid="B788-marinedrugs-18-00657" ref-type="bibr">788</xref>,<xref rid="B789-marinedrugs-18-00657" ref-type="bibr">789</xref>,<xref rid="B790-marinedrugs-18-00657" ref-type="bibr">790</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia rufescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalide F (<bold>194</bold>), iso-kahalalide F (<bold>354</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to A549 and Hs683 cell lines, and breast cancer cell lines SKBR3 and BT474 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>,<xref rid="B800-marinedrugs-18-00657" ref-type="bibr">800</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia ornata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalides F (<bold>194</bold>), Z<sub>1</sub> (<bold>356</bold>), Z<sub>2</sub> (<bold>355</bold>), elisidepsin (<bold>356</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to A549 and Hs683, breast, colon, head, neck, lung, ovary, pancreas, prostate, and melanoma cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>,<xref rid="B810-marinedrugs-18-00657" ref-type="bibr">810</xref>,<xref rid="B811-marinedrugs-18-00657" ref-type="bibr">811</xref>,<xref rid="B812-marinedrugs-18-00657" ref-type="bibr">812</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pulmonata (9)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trimusculus peruvianus </italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroxylated sterol (<bold>358</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to human HCT-116 and HT29 colon cancer cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B819-marinedrugs-18-00657" ref-type="bibr">819</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trimusculus costatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Secosterol (<bold>359</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to WHCO1 esophageal cancer cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B337-marinedrugs-18-00657" ref-type="bibr">337</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria capensis, S. concinna, S. cristatus, S. serrata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siphonarienfuranon, capensinone, denticulatins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B339-marinedrugs-18-00657" ref-type="bibr">339</xref>,<xref rid="B346-marinedrugs-18-00657" ref-type="bibr">346</xref>,<xref rid="B352-marinedrugs-18-00657" ref-type="bibr">352</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria spp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siphonarienolone (<bold>119</bold>), diemenensins A (<bold>165</bold>) and B, siphonarin A (<bold>120</bold>), vallartanones A and B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-18-00657" ref-type="bibr">27</xref>,<xref rid="B134-marinedrugs-18-00657" ref-type="bibr">134</xref>,<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B344-marinedrugs-18-00657" ref-type="bibr">344</xref>,<xref rid="B348-marinedrugs-18-00657" ref-type="bibr">348</xref>,<xref rid="B351-marinedrugs-18-00657" ref-type="bibr">351</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Onchidium sp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">onchidin (<bold>121</bold>), onchidin B (<bold>360</bold>), onchidione (<bold>122</bold>), onchidiol (<bold>361</bold>), ilikonapyrones (362,363), onchidionol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic to murine P388 and KB oral cancer cells, and regulation of some genes related to tumor growth </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-marinedrugs-18-00657" ref-type="bibr">131</xref>,<xref rid="B358-marinedrugs-18-00657" ref-type="bibr">358</xref>,<xref rid="B359-marinedrugs-18-00657" ref-type="bibr">359</xref>,<xref rid="B821-marinedrugs-18-00657" ref-type="bibr">821</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t011" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t011_Table 11</object-id><label>Table 11</label><caption><p>Number of antibiotic compounds in the different heterobranch groups. In brackets: number of species with antibiotic compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (21)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axisonitrile-3 (<bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimycobacterial activity against Mycobacterium tuberculosis </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B427-marinedrugs-18-00657" ref-type="bibr">427</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. pustulosa, P. coelestis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xidaoisocyanate A (<bold>24</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B117-marinedrugs-18-00657" ref-type="bibr">117</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia picta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pictaisonitrile 1 (<bold>23</bold>) and 2 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-marinedrugs-18-00657" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia varicosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Thiocyanatopupukeanane (<bold>126</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B247-marinedrugs-18-00657" ref-type="bibr">247</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella rosans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Isocyanopupukeanane (<bold>21</bold>), epi-9-isocyanopupukeanane</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>Bacillus subtilis</italic> and <italic>Candida albicans</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-marinedrugs-18-00657" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Doriorismatica (Glossodoris) atromarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scalaranes, heteronemin (<bold>233</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimycobacterial activity against <italic>M. tuberculosis</italic> H<sub>37</sub>Rv</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B833-marinedrugs-18-00657" ref-type="bibr">833</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glossodoris hikuerensis, G. vespa, G. cincta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heteronemin (<bold>233</bold>), scalaradial (<bold>44</bold>), 12-deacetoxy-12-oxoscalaradial (<bold>43</bold>), 12-deacetoxy-12-oxo-deoxoscalarin (<bold>136</bold>), 12-epi-scalaradial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-18-00657" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Felimida (Chromodoris) macfarlandi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macfarlandines D and E (<bold>235</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>B. subtilis</italic> in the disk assay system at 10 gg per disk, and activity against <italic>Vibrio anguillarum</italic> and Beneckea harveyi at 100 gg per disk</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B139-marinedrugs-18-00657" ref-type="bibr">139</xref>,<xref rid="B140-marinedrugs-18-00657" ref-type="bibr">140</xref>,<xref rid="B149-marinedrugs-18-00657" ref-type="bibr">149</xref>,<xref rid="B543-marinedrugs-18-00657" ref-type="bibr">543</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris willani</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deoximanoalide (<bold>364</bold>), deoxysecomanoalide (<bold>365</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial activity against <italic>Escherichia coli</italic> and <italic>B. subtilis</italic>, and inhibitor of snake venom phospholipase A2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-marinedrugs-18-00657" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris spp.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nakafuran-8 (<bold>54</bold>), nakafuran-9 (<bold>51</bold>), puupehenone (<bold>218</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>E. coli</italic>, <italic>Staphylococcus aureus</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>B. subtilis</italic>, and antifungal activity against <italic>C. albicans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B157-marinedrugs-18-00657" ref-type="bibr">157</xref>,<xref rid="B158-marinedrugs-18-00657" ref-type="bibr">158</xref>,<xref rid="B165-marinedrugs-18-00657" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hexabranchus sanguineus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kabiramides A&#x02013;E (<bold>238</bold>, <bold>239</bold>, <bold>62</bold>, <bold>240</bold>, <bold>241</bold>), sanguinamides A (<bold>64</bold>), B (<bold>366</bold>), halichondriamides (<bold>244</bold>), ulapualides A (<bold>190</bold>) and B (<bold>236</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>P. aeruginosa</italic>, and antifungal activity against <italic>C. albicans</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B208-marinedrugs-18-00657" ref-type="bibr">208</xref>,<xref rid="B219-marinedrugs-18-00657" ref-type="bibr">219</xref>,<xref rid="B221-marinedrugs-18-00657" ref-type="bibr">221</xref>,<xref rid="B222-marinedrugs-18-00657" ref-type="bibr">222</xref>,<xref rid="B545-marinedrugs-18-00657" ref-type="bibr">545</xref>,<xref rid="B834-marinedrugs-18-00657" ref-type="bibr">834</xref>,<xref rid="B835-marinedrugs-18-00657" ref-type="bibr">835</xref>,<xref rid="B836-marinedrugs-18-00657" ref-type="bibr">836</xref>,<xref rid="B837-marinedrugs-18-00657" ref-type="bibr">837</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Jorunna funebris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jorumycin (<bold>189</bold>), jorunnamycins A&#x02013;C (<bold>245</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial activityagainst <italic>B. subtilis</italic> and <italic>S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B553-marinedrugs-18-00657" ref-type="bibr">553</xref>,<xref rid="B560-marinedrugs-18-00657" ref-type="bibr">560</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Halgerda aurantiomaculata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zooanemonin (<bold>367</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B841-marinedrugs-18-00657" ref-type="bibr">841</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Roboastra tigris, Tambja abdere, T. eliora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tambjamines (<bold>65</bold>&#x02013;<bold>70</bold>, <bold>249</bold>), tetrapyrrole (<bold>72</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>B. subtilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-marinedrugs-18-00657" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Leminda millecra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Millecrones A (<bold>368</bold>) and B (<bold>369</bold>), millecrols A (<bold>370</bold>) and B (<bold>371</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic activity against <italic>C. albicans</italic>, <italic>S. aureus</italic> and <italic>B. subtilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B588-marinedrugs-18-00657" ref-type="bibr">588</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dermatobranchus otome</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DO1 (<bold>372</bold>), DO2 (<bold>373</bold>), DO3 (<bold>374</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>B. subtilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B842-marinedrugs-18-00657" ref-type="bibr">842</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Armina babai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extracts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>Pseudomonas</italic> sp. and <italic>Proteus mirabilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B843-marinedrugs-18-00657" ref-type="bibr">843</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Tylodinoidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tylodina corticalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hexadellin (<bold>375</bold>), aplysamine 2 (<bold>376</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>E. coli</italic> and <italic>S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B262-marinedrugs-18-00657" ref-type="bibr">262</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (5)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia punctata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glandulaurencianols A&#x02013;C (<bold>162</bold>,<bold>163</bold>), punctatol (<bold>164</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>B. subtilis</italic> and <italic>E. coli</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B429-marinedrugs-18-00657" ref-type="bibr">429</xref>,<xref rid="B430-marinedrugs-18-00657" ref-type="bibr">430</xref>,<xref rid="B431-marinedrugs-18-00657" ref-type="bibr">431</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia juliana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Julianin-S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B288-marinedrugs-18-00657" ref-type="bibr">288</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia kurodai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aplysianin E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifungal activity against <italic>C. albicans</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B672-marinedrugs-18-00657" ref-type="bibr">672</xref>,<xref rid="B673-marinedrugs-18-00657" ref-type="bibr">673</xref>,<xref rid="B674-marinedrugs-18-00657" ref-type="bibr">674</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dolabella auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dolabellanin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity against <italic>E. coli</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B435-marinedrugs-18-00657" ref-type="bibr">435</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bursatella leachii plei, B. leachii savignyana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bursatellin (<bold>105</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B311-marinedrugs-18-00657" ref-type="bibr">311</xref>,<xref rid="B312-marinedrugs-18-00657" ref-type="bibr">312</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (4)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia rufescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalalides A (<bold>377</bold>) and F (<bold>194</bold>), iso-kahalalide F (<bold>354</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimycobacterial activity against <italic>Mycobacterium tuberculosis</italic> and <italic>M. intracellulare</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia ornata, E. grandifolia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalalide F (<bold>194</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimycobacterial activity against <italic>M. tuberculosis</italic> and <italic>M. intracellulare</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B411-marinedrugs-18-00657" ref-type="bibr">411</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cyerce nigricans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorodesmin (<bold>114</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial and antifungal activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B845-marinedrugs-18-00657" ref-type="bibr">845</xref>,<xref rid="B846-marinedrugs-18-00657" ref-type="bibr">846</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Pulmonata (7)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Siphonaria australis, S. diemenensis, S. capensis, S. concinna, S. cristatus, S. serrata, S. pectinata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siphonarienolone (<bold>119</bold>), siphonarin A (<bold>120</bold>), pectinatone (<bold>166</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial activity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B340-marinedrugs-18-00657" ref-type="bibr">340</xref>,<xref rid="B341-marinedrugs-18-00657" ref-type="bibr">341</xref>,<xref rid="B342-marinedrugs-18-00657" ref-type="bibr">342</xref>,<xref rid="B343-marinedrugs-18-00657" ref-type="bibr">343</xref>,<xref rid="B346-marinedrugs-18-00657" ref-type="bibr">346</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t012" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t012_Table 12</object-id><label>Table 12</label><caption><p>Antiparasitic compounds in the different heterobranch groups. In brackets: number of species with antiparasitic compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (4)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidiella pustulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axisonitrile-3 (<bold>25</bold>), pustulosaisonitrile-1 (<bold>378</bold>), 10-thiocyano-4-cadinene (<bold>383</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against <italic>Plasmodium falciparum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-marinedrugs-18-00657" ref-type="bibr">118</xref>,<xref rid="B123-marinedrugs-18-00657" ref-type="bibr">123</xref>,<xref rid="B848-marinedrugs-18-00657" ref-type="bibr">848</xref>,<xref rid="B849-marinedrugs-18-00657" ref-type="bibr">849</xref>,<xref rid="B850-marinedrugs-18-00657" ref-type="bibr">850</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phyllidia ocellata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-<italic>Iso</italic>cyanoclovene (<bold>379</bold>), 2-<italic>iso</italic>cyanoclovane (<bold>380</bold>), 4,5-<italic>epi</italic>-10-<italic>iso</italic>cyanoisodauc-6-ene (<bold>381</bold>), 1-<italic>iso</italic>thiocyanatoepicaryolane (<bold>382</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against <italic>Plasmodium falciparum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B376-marinedrugs-18-00657" ref-type="bibr">376</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Notodoris gardineri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Iso</italic>-naamidine-A (<bold>160</bold>), dorimidazole A (<bold>386</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anthelminthic activity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B424-marinedrugs-18-00657" ref-type="bibr">424</xref>,<xref rid="B426-marinedrugs-18-00657" ref-type="bibr">426</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris lochi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mycothiazole (<bold>129</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anthelminthic and toxic activity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B378-marinedrugs-18-00657" ref-type="bibr">378</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Elysia rufescens</italic>, <italic>E. ornata</italic>, <italic>E. grandifolia</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalalides (<bold>194</bold>,<bold>354</bold>&#x02013;<bold>356</bold>,<bold>377</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antileishmanial activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B796-marinedrugs-18-00657" ref-type="bibr">796</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t013" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t013_Table 13</object-id><label>Table 13</label><caption><p>Antiviral compounds in the different heterobranch groups. In brackets: number of species with antiviral compounds, number of the compounds in figures, and reference numbers. # Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (7)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cadlina luteomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ansellone A (<bold>216</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of the latent proviral HIV-1 gene expression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B855-marinedrugs-18-00657" ref-type="bibr">855</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris mandapamensis, Glossodoris cincta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spongiadiol (<bold>35</bold>), <italic>epi</italic>-spongiadiol (<bold>232</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against herpes simplex virus, type 1 (HSV-1) and P388 murine leukemia cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-marinedrugs-18-00657" ref-type="bibr">166</xref>,<xref rid="B535-marinedrugs-18-00657" ref-type="bibr">535</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris hamiltoni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Latrunculins A (<bold>38</bold>) and B (<bold>37</bold>) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against HIV-1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-marinedrugs-18-00657" ref-type="bibr">153</xref>,<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris africana, C. quadricolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Latrunculin B (<bold>37</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against HIV-1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B155-marinedrugs-18-00657" ref-type="bibr">155</xref>,<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chromodoris petechialis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Puupehenone (<bold>218</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-HIV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dolabella auricularia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dolastatin 3 (<bold>192</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against HIV life cycle </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B718-marinedrugs-18-00657" ref-type="bibr">718</xref>,<xref rid="B728-marinedrugs-18-00657" ref-type="bibr">728</xref>,<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Sacoglossa (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Elysia rufescens, E. grandifolia, E. ornata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalalide F (<bold>194</bold>), <italic>iso</italic>-kahalalide F (<bold>354</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activity against herpes simplex virus II</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B331-marinedrugs-18-00657" ref-type="bibr">331</xref>,<xref rid="B794-marinedrugs-18-00657" ref-type="bibr">794</xref>,<xref rid="B795-marinedrugs-18-00657" ref-type="bibr">795</xref>,<xref rid="B797-marinedrugs-18-00657" ref-type="bibr">797</xref>,<xref rid="B853-marinedrugs-18-00657" ref-type="bibr">853</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t014" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t014_Table 14</object-id><label>Table 14</label><caption><p>Anti-inflammatory compounds in the different heterobranch groups. In brackets: number of species with anti-inflammatory compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (11)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glossodoris rufomarginata, G. pallida, G. vespa, G. averni, G. hikuerensis, G. atromarginata, G. cincta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scalaradial (<bold>44</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent inhibition of PLA<sub>2</sub>, and potent anti-inflammatory activity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B175-marinedrugs-18-00657" ref-type="bibr">175</xref>,<xref rid="B177-marinedrugs-18-00657" ref-type="bibr">177</xref>,<xref rid="B381-marinedrugs-18-00657" ref-type="bibr">381</xref>,<xref rid="B383-marinedrugs-18-00657" ref-type="bibr">383</xref>,<xref rid="B856-marinedrugs-18-00657" ref-type="bibr">856</xref>,<xref rid="B857-marinedrugs-18-00657" ref-type="bibr">857</xref>,<xref rid="B858-marinedrugs-18-00657" ref-type="bibr">858</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Goniobranchus splendidus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gracilins (<bold>224&#x02013;228</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclosporine A mimics, BACE1 and ERK inhibition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B190-marinedrugs-18-00657" ref-type="bibr">190</xref>,<xref rid="B533-marinedrugs-18-00657" ref-type="bibr">533</xref>,<xref rid="B534-marinedrugs-18-00657" ref-type="bibr">534</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tethys fimbria, Melibe viridis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostaglandin E-1,15-lactones (<bold>80</bold>, <bold>81</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction of inflammation after autotomy and tissue regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-18-00657" ref-type="bibr">77</xref>,<xref rid="B240-marinedrugs-18-00657" ref-type="bibr">240</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tritonia</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Punaglandins (<bold>250</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B587-marinedrugs-18-00657" ref-type="bibr">587</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Anaspidea (3)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia depilans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carotenoids, polyunsaturated fatty acids </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B859-marinedrugs-18-00657" ref-type="bibr">859</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplysia dactylomela</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dactyloditerpenol acetate (<bold>385</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-neuroinflammatory activity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B860-marinedrugs-18-00657" ref-type="bibr">860</xref>,<xref rid="B861-marinedrugs-18-00657" ref-type="bibr">861</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bursatella leachii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malyngamide S (<bold>350</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory activity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B786-marinedrugs-18-00657" ref-type="bibr">786</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t015" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t015_Table 15</object-id><label>Table 15</label><caption><p>Compounds used against neurodegenerative diseases in the different heterobranch groups. In brackets: number of species with these compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Nudibranchia (4)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Polycera atra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bryostatin 1 (<bold>203</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alzheimer disease (AD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B492-marinedrugs-18-00657" ref-type="bibr">492</xref>,<xref rid="B493-marinedrugs-18-00657" ref-type="bibr">493</xref>,<xref rid="B494-marinedrugs-18-00657" ref-type="bibr">494</xref>,<xref rid="B866-marinedrugs-18-00657" ref-type="bibr">866</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Goniobranchus obsoletus, G. splendidus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gracilins (<bold>224</bold>&#x02013;<bold>228</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potential against neurodegenerative diseases </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B533-marinedrugs-18-00657" ref-type="bibr">533</xref>,<xref rid="B534-marinedrugs-18-00657" ref-type="bibr">534</xref>,<xref rid="B863-marinedrugs-18-00657" ref-type="bibr">863</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cadlina luteomarginata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ansellone A (<bold>216</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cAMP activation (neurodegenerative diseases)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B513-marinedrugs-18-00657" ref-type="bibr">513</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Cephalaspidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scaphander lignarius</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lignarenone B (<bold>171</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alzheimer disease (AD) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B864-marinedrugs-18-00657" ref-type="bibr">864</xref>,<xref rid="B867-marinedrugs-18-00657" ref-type="bibr">867</xref>] </td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-18-00657-t016" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-18-00657-t016_Table 16</object-id><label>Table 16</label><caption><p>Other pharmacological activities in compounds from different heterobranch groups. In brackets: number of species with active compounds, number of the compounds in figures, and reference numbers. <bold>#</bold> Number.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds (#)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References (#)</th></tr></thead><tbody><tr><td colspan="4" align="center" valign="middle" rowspan="1">
<bold>Nudibranchia (1)</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Janolus cristatus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Janolusimide (<bold>138</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">Toxic to mice </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B390-marinedrugs-18-00657" ref-type="bibr">390</xref>,<xref rid="B388-marinedrugs-18-00657" ref-type="bibr">388</xref>]</td></tr><tr><td colspan="4" align="center" valign="middle" rowspan="1">
<bold>Pleurobranchoidea (1)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pleurobranchaea maculata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetrodotoxin (TTX) (<bold>387</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotoxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B869-marinedrugs-18-00657" ref-type="bibr">869</xref>,<xref rid="B870-marinedrugs-18-00657" ref-type="bibr">870</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>